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Executive	  Summary	  
Cancer,	  also	  known	  as	  malignant	  neoplasm,	  is	  a	  group	  of	  diseases	  characterized	  by	  the	  
uncontrolled	  growth	  of	  abnormal	  cells	  with	  the	  potential	  to	  spread	  to	  other	  parts	  of	  the	  
body.	  In	  Maine,	  cancer	  is	  the	  leading	  cause	  of	  death	  as	  well	  as	  the	  leading	  cause	  of	  
potential	  life	  lost	  before	  age	  75.	  While	  cancer	  rates	  in	  both	  Maine	  and	  the	  U.S.	  have	  
steadily	  declined	  over	  time,	  Maine’s	  cancer	  death	  rates	  have	  remained	  consistently	  
higher	  than	  U.S.	  rates.	  In	  2010,	  nearly	  8,300	  Maine	  residents	  were	  diagnosed	  with	  
cancer,	  and	  3,247	  people	  in	  Maine	  died	  from	  cancer.	  
For	  both	  youth	  and	  adults,	  there	  are	  a	  number	  of	  factors	  that	  can	  contribute	  to	  an	  
increased	  risk	  of	  developing	  cancer.	  Although	  cancer	  risk	  generally	  increases	  with	  age,	  
health	  behaviors	  and	  lifestyle	  choices	  such	  as	  tobacco	  and	  alcohol	  use,	  excess	  body	  
weight,	  poor	  diet,	  physical	  inactivity,	  and	  excessive	  exposure	  to	  ultraviolet	  light	  are	  all	  
known	  to	  increase	  an	  individual’s	  risk	  of	  being	  diagnosed	  with	  cancer.	  Environmental	  
factors,	  such	  as	  exposure	  to	  elevated	  levels	  of	  radon	  in	  indoor	  air,	  can	  also	  contribute	  to	  
the	  risk	  of	  developing	  certain	  types	  of	  cancer.	  
The	  early	  detection	  of	  cancer	  through	  routine	  screening	  can	  help	  diagnose	  cancer	  early	  
when	  treatment	  is	  more	  likely	  to	  be	  successful.	  Currently,	  population-­‐level	  screening	  
guidelines	  are	  available	  for	  breast,	  cervical,	  and	  colorectal	  cancers,	  along	  with	  lung	  
cancer	  screening	  guidelines	  for	  high-­‐risk	  individuals.	  Detecting	  cancer	  at	  an	  early	  stage	  
can	  prevent	  or	  reduce	  the	  risk	  of	  illness	  or	  death	  and	  result	  in	  greater	  quality	  of	  life.	  
State	  and	  national	  data	  were	  analyzed	  and	  compared	  to	  understand	  the	  impact	  of	  
cancer	  in	  Maine,	  including	  incidence	  and	  stage	  at	  diagnosis,	  mortality,	  cancer-­‐related	  
risk	  factors,	  screening	  rates,	  and	  survivorship.	  The	  key	  findings	  of	  this	  report	  are	  
described	  below.	  
Key	  Findings	  
Incidence	  and	  Mortality	  
All	  Cancer
• During	  2008-­‐2010,	  an	  average	  of	  8,321	  new	  cancer	  cases	  were	  diagnosed	  per
year.	  	  During	  this	  time,	  Maine’s	  age-­‐adjusted	  incidence	  cancer	  rate	  (496.8	  per
100,000)	  was	  significantly	  higher	  than	  the	  overall	  U.S.	  SEER	  rate	  (467.1	  per
100,000)	  and	  U.S.	  SEER	  white	  rate	  (475.8	  per	  100,000).
• From	  2000	  to	  2010,	  the	  age-­‐adjusted	  cancer	  incidence	  rates	  in	  Maine	  were
consistently	  higher	  than	  the	  U.S.	  SEER	  overall	  rate	  and	  U.S.	  SEER	  white	  rate;
these	  differences	  were	  statistically	  significant.	  Over	  this	  time,	  cancer	  incidence
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rates	  in	  both	  Maine	  and	  the	  U.S.	  have	  significantly	  decreased,	  but	  Maine’s	  rates	  
are	  declining	  at	  a	  faster	  pace	  than	  U.S.	  rates.	  	  
• During	  2008-­‐2010,	  the	  age-­‐adjusted	  cancer	  incidence	  rate	  among	  Maine	  males
(558.7	  per	  100,000)	  was	  23%	  higher	  than	  among	  females	  (452.6	  per	  100,000).
From	  2000	  to	  2010,	  Maine	  males	  had	  significantly	  higher	  cancer	  incidence	  rates
than	  females;	  however,	  incidence	  rates	  among	  males	  are	  declining	  at	  a	  faster
pace	  compared	  to	  females.
• Cancer	  is	  the	  leading	  cause	  of	  death	  in	  Maine.	  	  In	  2010,	  cancer	  accounted	  for
3,247	  deaths	  (34%	  of	  all	  deaths)	  in	  the	  state.
• In	  2010,	  cancer	  was	  the	  leading	  cause	  of	  years	  of	  potential	  life	  lost	  before	  age	  75
years	  in	  Maine,	  causing	  23,202	  years	  of	  potential	  life	  lost,	  with	  an	  estimated	  28%
of	  Maine’s	  total	  years	  of	  potential	  life	  lost	  due	  to	  cancer.
• In	  2010,	  Maine’s	  age-­‐adjusted	  all	  cancer	  death	  rate	  (186.6	  per	  100,000)	  was
significantly	  higher	  than	  both	  the	  U.S.	  rate	  (171.8	  per	  100,000)	  and	  the	  U.S.
white	  rate	  (171.4	  per	  100,000).
• From	  2000	  to	  2010,	  the	  all	  cancer	  death	  rates	  in	  Maine	  and	  the	  U.S.	  have
steadily	  declined,	  but	  Maine’s	  rates	  were	  consistently	  higher	  than	  rates	  for	  the
U.S.	  overall	  and	  U.S.	  whites.
• In	  2010,	  the	  age-­‐adjusted	  cancer	  death	  rate	  among	  Maine	  males	  (226.0	  per
100,000)	  was	  43%	  higher	  than	  the	  cancer	  death	  rate	  among	  females.	  (158.5	  per
100,000).	  Maine	  males	  had	  significantly	  higher	  cancer	  death	  rates	  than	  females
from	  2000	  to	  2010,	  but	  over	  this	  time,	  death	  rates	  among	  males	  were	  declining
at	  a	  similar	  (not	  significantly	  different)	  pace	  as	  the	  rate	  among	  females.
Bladder	  Cancer	  
• During	  2008-­‐2010,	  an	  average	  of	  461	  Mainers	  per	  year	  were	  diagnosed	  with
bladder	  cancer.	  During	  this	  time,	  Maine’s	  age-­‐adjusted	  incidence	  rate	  for	  bladder
cancer	  (27.3	  per	  100,000)	  was	  29%	  higher	  than	  the	  U.S.	  SEER	  overall	  rate	  (21.1
per	  100,000)	  and	  18%	  higher	  than	  the	  U.S.	  SEER	  white	  rate	  (23.2	  per	  100,000);
these	  were	  significant	  differences.
• From	  2000	  to	  2010,	  the	  age-­‐adjusted	  bladder	  cancer	  incidence	  rates	  in	  Maine
were	  consistently	  and	  significantly	  higher	  than	  the	  U.S.	  SEER	  overall	  rate	  and	  U.S.
SEER	  white	  rate.
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• During	  2008-­‐2010,	  Maine’s	  bladder	  cancer	  incidence	  rate	  among	  males	  (46.4	  per
100,000)	  was	  almost	  4	  times	  the	  bladder	  cancer	  incidence	  rate	  among	  females
(12.5	  per	  100,000).	  From	  2000	  to	  2010,	  bladder	  cancer	  incidence	  rates	  among
Maine	  females	  and	  males	  did	  not	  significantly	  change.
• In	  2010,	  106	  Mainers	  died	  from	  bladder	  cancer.	  That	  year,	  Maine’s	  age-­‐adjusted
bladder	  cancer	  death	  rate	  (6.1	  per	  100,000)	  was	  significantly	  higher	  than	  the	  U.S.
overall	  rate	  (4.4	  per	  100,000)	  and	  U.S.	  whites	  (4.6	  per	  100,000).	  Bladder	  cancer
death	  rates	  in	  Maine	  have	  been	  fairly	  constant	  between	  2000	  and	  2010.
• In	  2010,	  the	  age-­‐adjusted	  bladder	  cancer	  death	  rate	  among	  Maine	  males	  (11.6
per	  100,000)	  was	  5	  times	  the	  bladder	  cancer	  death	  rate	  among	  females	  (2.2	  per
100,000).	  	  Bladder	  cancer	  death	  rates	  have	  not	  changed	  significantly	  among
either	  Maine	  males	  or	  females	  between	  2000	  and	  2010.
Breast	  Cancer	  (female	  only)	  	  
• During	  2008-­‐2010,	  an	  average	  of	  1,105	  females	  were	  diagnosed	  with	  breast
cancer	  in	  Maine	  each	  year.	  During	  this	  time,	  Maine’s	  age-­‐adjusted	  incidence	  rate
for	  breast	  cancer	  of	  124.5	  per	  100,000	  was	  similar	  to	  (not	  significantly	  different
from)	  the	  overall	  U.S.	  SEER	  rate	  (128.0	  per	  100,000);	  however,	  Maine’s	  rate	  was
significantly	  lower	  (5.2%)	  than	  the	  U.S.	  SEER	  white	  rate	  (131.4	  per	  100,000).
• In	  Maine,	  breast	  cancer	  incidence	  rates	  significantly	  decreased	  from	  137.2	  per
100,000	  during	  2000-­‐2002	  to	  124.5	  per	  100,000	  during	  2008-­‐2010,	  with	  a	  9%
decrease	  and	  an	  annual	  average	  decline	  of	  1.2%	  over	  this	  period,	  which	  was
similar	  to	  the	  decline	  for	  the	  U.S.	  SEER	  overall	  and	  U.S.	  SEER	  white	  females.
• During	  2008-­‐2010,	  73.6%	  of	  new	  breast	  cancer	  cases	  were	  diagnosed	  at	  an	  early
stage.	  Maine	  females	  were	  diagnosed	  with	  breast	  cancer	  at	  early,	  late	  and
unknown	  stages	  at	  similar	  proportions	  as	  U.S.	  SEER	  females	  and	  U.S.	  SEER	  white
females,	  with	  most	  females	  being	  diagnosed	  for	  breast	  cancer	  at	  an	  early	  stage.
• In	  2010,	  195	  Maine	  females	  died	  from	  breast	  cancer.	  	  In	  that	  year,	  Maine’s	  age-­‐
adjusted	  death	  rate	  for	  breast	  cancer	  (20.1	  per	  100,000)	  was	  similar	  to	  (not
significantly	  different	  from)	  the	  rate	  for	  all	  U.S.	  females	  (21.9	  per	  100,000)	  and
U.S.	  white	  females	  (21.3	  per	  100,000),	  but	  the	  difference	  was	  not	  significant.
Maine’s	  age-­‐adjusted	  breast	  cancer	  death	  rates	  have	  decreased	  slightly,	  but	  not
significantly,	  from	  2000	  to	  2010.
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Cervical	  Cancer	  
• During	  2008-­‐2010,	  an	  average	  of	  47	  new	  cervical	  cancer	  cases	  were	  diagnosed	  in
Maine	  each	  year.	  During	  this	  time,	  Maine’s	  age-­‐adjusted	  cervical	  cancer
incidence	  rate	  (6.4	  per	  100,000)	  was	  similar	  to	  the	  rate	  among	  the	  U.S.	  SEER
overall	  (6.8	  per	  100,000)	  and	  U.S.	  SEER	  whites	  (6.6	  per	  100,000).	  	  This	  was	  not	  a
significant	  difference.
• From	  2000	  to	  2010,	  the	  age-­‐adjusted	  cervical	  cancer	  incidence	  rates	  in	  Maine
were	  similar	  to	  (not	  significantly	  different	  from)	  the	  U.S.	  SEER	  rate	  and	  the	  U.S.
SEER	  white	  rate.
• During	  2008-­‐2010,	  less	  than	  half	  of	  all	  new	  cervical	  cancer	  cases	  were	  diagnosed
at	  an	  early	  stage	  (45.8%).	  There	  was	  no	  significant	  difference	  in	  cervical	  cancer
diagnosis	  at	  early	  or	  late	  stage	  for	  Maine	  and	  U.S.	  females.
• Thirteen	  Maine	  females	  died	  from	  cervical	  cancer	  in	  2010.	  In	  that	  year,	  the	  age-­‐
adjusted	  cervical	  cancer	  death	  rate	  in	  Maine	  (1.4	  per	  100,000)	  was	  slightly,	  but
not	  significantly,	  lower	  than	  the	  rate	  among	  the	  U.S.	  overall	  and	  U.S.	  whites	  (2.3
and	  2.1	  per	  100,000,	  respectively).	  Although	  the	  relatively	  small	  number	  of
cervical	  cancer	  deaths	  between	  2000	  and	  2010	  makes	  it	  difficult	  to	  determine	  if
a	  trend	  exists,	  Maine’s	  cervical	  cancer	  death	  rates	  appear	  to	  have	  remained	  fairly
constant	  over	  the	  past	  decade.
Colorectal	  Cancer	  
• During	  2008-­‐2010,	  an	  average	  of	  724	  Maine	  adults	  were	  diagnosed	  with
colorectal	  cancer	  each	  year.	  The	  age-­‐adjusted	  colorectal	  cancer	  incidence	  rate	  in
Maine	  (43.1	  per	  100,000)	  was	  not	  significantly	  different	  from	  the	  U.S.	  SEER
overall	  rate	  (42.9	  per	  100,000)	  or	  the	  U.S.	  SEER	  white	  rate	  (41.8	  per	  100,000)
over	  this	  period.
• From	  2000	  to	  2010,	  Maine’s	  age-­‐adjusted	  colorectal	  cancer	  incidence	  rates	  were
significantly	  higher	  than	  the	  rates	  for	  U.S.	  SEER	  overall	  except	  in	  2007-­‐2009	  and
2008-­‐2010,	  and	  the	  rates	  for	  U.S.	  SEER	  whites	  except	  in	  2008-­‐2010.
• During	  2008-­‐2010,	  the	  age-­‐adjusted	  colorectal	  cancer	  incidence	  rate	  among
Maine	  males	  (48.8	  per	  100,000)	  was	  28%	  higher	  than	  the	  incidence	  rate	  among
females	  (38.1	  per	  100,000).	  Colorectal	  incidence	  rates	  among	  both	  Maine	  males
and	  females	  have	  significantly	  declined	  between	  2000	  and	  2010,	  but	  rates
among	  females	  are	  declining	  more	  slowly	  than	  males.
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• During	  2008-­‐2010,	  new	  colorectal	  cancer	  cases	  were	  significantly	  more	  likely	  to
be	  diagnosed	  at	  a	  late	  stage	  (49.2%)	  than	  an	  early	  stage	  (44.7%)	  in	  Maine,	  which
is	  similar	  to	  the	  pattern	  in	  the	  U.S.
• In	  2010,	  209	  Maine	  adults	  died	  from	  colorectal	  cancer.	  The	  age-­‐adjusted
colorectal	  cancer	  death	  rate	  in	  Maine	  (16.4	  per	  100,000)	  was	  similar	  to	  (not
significantly	  different	  from)	  the	  U.S.	  overall	  rate	  (15.5	  per	  100,000)	  and	  the	  U.S.
white	  rate	  (15.0	  per	  100,000).	  	  From	  2000	  to	  2010,	  colorectal	  cancer	  death	  rate
in	  Maine	  has	  declined	  significantly	  from	  23.0	  per	  100,000	  in	  2000	  to	  16.4	  per
100,000	  in	  2010.
• In	  2010,	  the	  age-­‐adjusted	  colorectal	  cancer	  death	  rate	  among	  Maine	  males	  (20.9
per	  100,000)	  was	  60%	  higher	  than	  the	  death	  rate	  among	  females	  (13.1	  per
100,000).	  Colorectal	  cancer	  death	  rates	  were	  consistently	  higher	  among	  Maine
males	  than	  females	  from	  2000	  to	  2010,	  and	  the	  death	  rates	  have	  declined	  more
slowly	  among	  males	  than	  females.
Lung	  Cancer	  
• During	  2008-­‐2010,	  an	  average	  of	  1,294	  adults	  were	  diagnosed	  with	  lung	  cancer
in	  Maine	  each	  year.	  Maine’s	  age-­‐adjusted	  lung	  cancer	  incidence	  rate	  (76.3	  per
100,000)	  was	  significantly	  higher	  than	  the	  U.S.	  SEER	  overall	  rate	  (58.9	  per
100,000;	  30%	  higher)	  and	  the	  U.S.	  SEER	  white	  rate	  (59.7	  per	  100,000;	  28%
higher)	  over	  this	  3-­‐year	  period.
• Maine’s	  age-­‐adjusted	  lung	  cancer	  incidence	  rate	  did	  not	  change	  significantly
from	  2000	  to	  2010,	  but	  the	  rates	  do	  appear	  to	  have	  consistently	  declined
between	  2003-­‐2005	  and	  2008-­‐2010.	  There	  was	  a	  significant	  decrease	  in	  lung
cancer	  incidence	  rates	  from	  2000	  to	  2010	  for	  both	  U.S.	  SEER	  overall	  and	  U.S.
SEER	  whites	  with	  about	  an	  8%	  total	  decrease	  and	  an	  annual	  average	  decline	  of
1.0%.	  
• During	  2008-­‐2010,	  the	  lung	  cancer	  incidence	  rate	  among	  Maine	  males	  (88.4	  per
100,000)	  was	  significantly	  higher	  (31%)	  than	  the	  rate	  among	  females	  (67.5	  per
100,000).	  Lung	  cancer	  incidence	  rates	  have	  declined	  among	  Maine	  males,	  but
not	  among	  Maine	  females.
• In	  Maine,	  75.2%	  (57.1	  per	  100,000)	  of	  lung	  cancers	  occurred	  at	  a	  late	  stage
during	  2008-­‐2010.	  The	  proportion	  of	  lung	  cancer	  cases	  diagnosed	  at	  an	  early,
late,	  or	  unknown	  stage	  in	  Maine	  is	  similar	  to	  those	  the	  U.S.	  overall	  and	  U.S.
whites.	  Maine	  females	  are	  more	  likely	  to	  have	  lung	  cancer	  diagnosed	  at	  an	  early
stage	  than	  males.
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• Lung	  cancer	  has	  the	  highest	  cancer	  death	  rate	  in	  Maine.	  	  In	  2010,	  a	  total	  of	  957
Mainers	  died	  from	  lung	  cancer.	  	  	  Maine’s	  age-­‐adjusted	  lung	  cancer	  death	  rate
decreased	  significantly	  from	  63.5	  per	  100,000	  in	  2002	  to	  55.1	  per	  100,000	  in
2010;	  this	  was	  a	  13.2%	  decrease	  over	  the	  9-­‐year	  period,	  and	  an	  average	  annual
decline	  of	  1.7%,	  which	  was	  similar	  to	  the	  decline	  for	  U.S	  overall	  and	  U.S.	  whites.
Since	  2002,	  there	  has	  been	  a	  significant	  decline	  in	  lung	  cancer	  death	  rates	  in
Maine,	  but	  Maine’s	  rates	  remain	  significantly	  higher	  than	  U.S.	  rates	  during	  this
period.
• In	  2010,	  the	  age-­‐adjusted	  lung	  cancer	  death	  rate	  among	  Maine	  males	  (66.1	  per
100,000)	  was	  40%	  higher	  than	  the	  rate	  among	  females	  (47.0	  per	  100,000).	  From
2000	  to	  2010,	  lung	  cancer	  death	  rates	  have	  significantly	  declined	  among	  Maine
males,	  but	  not	  Maine	  females.
Melanoma	  
• During	  2008-­‐2010,	  an	  average	  of	  355	  Mainers	  were	  diagnosed	  with	  melanoma
each	  year.	  During	  this	  time,	  Maine’s	  age-­‐adjusted	  melanoma	  incidence	  rate	  (21.9
per	  100,000)	  was	  similar	  to,	  and	  not	  significantly	  different	  from,	  the	  overall	  U.S.
SEER	  rate	  (23.2	  per	  100,000),	  but	  significantly	  lower	  than	  the	  U.S.	  SEER	  white
rate.
• In	  Maine,	  melanoma	  age-­‐adjusted	  incidence	  rates	  significantly	  increased	  from
2000-­‐2002	  (19.8	  per	  100,000)	  to	  2003-­‐2005	  (22.7	  per	  100,000),	  and	  then
stabilized	  through	  2008-­‐2010.	  In	  contrast,	  U.S.	  SEER	  white	  rates	  steadily
increased	  and	  were	  consistently	  higher	  than	  Maine’s	  rates	  from	  2000-­‐2002	  to
2008-­‐2010.
• During	  2008-­‐2010,	  the	  age-­‐adjusted	  melanoma	  incidence	  rate	  among	  Maine
males	  (26.6	  per	  100,000)	  was	  45%	  higher	  than	  the	  rate	  among	  females	  (18.4	  per
100,000.	  From	  2000	  to	  2010,	  Maine	  males	  had	  consistently	  higher	  melanoma
incidence	  rates	  than	  females.
• In	  2010,	  54	  Mainers	  died	  from	  melanoma.	  	  In	  2010,	  Maine’s	  age-­‐adjusted
melanoma	  death	  rate	  (3.1	  per	  100,000)	  was	  similar	  to	  (not	  significantly	  different
from)	  the	  overall	  U.S.	  rate	  (2.7	  per	  100,000)	  and	  the	  U.S.	  white	  rate	  (3.2	  per
100,000).	  	  Melanoma	  death	  rates	  have	  remained	  steady	  in	  Maine	  between	  2000
and	  2010.
• In	  2010,	  the	  melanoma	  death	  rate	  among	  Maine	  males	  (4.9	  per	  100,000)	  was
more	  than	  twice	  the	  death	  rate	  among	  females	  (1.8	  per	  100,000).	  Melanoma
cancer	  death	  rates	  did	  not	  change	  significantly	  among	  Maine	  males	  from	  2000	  to
2010.	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Prostate	  Cancer	  
• An	  average	  of	  1,061	  Maine	  males	  were	  diagnosed	  with	  prostate	  cancer	  each
year	  during	  2008-­‐2010.	  Maine’s	  age-­‐adjusted	  prostate	  cancer	  incidence	  rate	  has
significantly	  decreased	  from	  181.2	  per	  100,000	  during	  2000-­‐2002	  to	  129.4	  per
100,000	  during	  2008-­‐2010,	  a	  28.6%	  decline	  and	  an	  average	  annual	  decline	  of
4.0%.	  
• During	  the	  first	  part	  of	  the	  2000-­‐2010	  decade,	  the	  age-­‐adjusted	  prostate	  cancer
incidence	  rates	  in	  Maine	  were	  similar	  to	  rates	  among	  the	  U.S.	  SEER	  overall	  and
U.S.	  SEER	  white	  males.	  	  Maine’s	  prostate	  cancer	  incidence	  rates	  have	  declined
faster	  than	  the	  U.S.	  SEER	  rates	  in	  recent	  years;	  however,	  Maine’s	  rates	  during
2007-­‐2009	  and	  2008-­‐2010	  were	  significantly	  lower	  than	  the	  U.S.	  SEER	  and	  SEER
white	  rates.
• In	  Maine,	  nearly	  80%	  (77.9%)	  of	  new	  prostate	  cancer	  cases	  were	  diagnosed	  at	  an
early	  stage.	  Maine	  males	  are	  less	  likely	  to	  have	  prostate	  cancer	  diagnosed	  at	  an
early	  stage	  compared	  to	  U.S.	  SEER	  males	  and	  U.S.	  SEER	  white	  males.
• In	  2010,	  144	  Maine	  males	  died	  from	  prostate	  cancer.	  	  In	  that	  year,	  the	  age-­‐
adjusted	  prostate	  cancer	  death	  rate	  among	  Maine	  males	  was	  21.0	  per	  100,000,
which	  is	  similar	  to	  the	  rate	  for	  all	  U.S.	  males	  and	  U.S.	  white	  males.	  From	  2000	  to
2010,	  prostate	  cancer	  death	  rates	  have	  significantly	  decreased	  among	  Maine
males,	  with	  an	  average	  annual	  decrease	  of	  4.8%.
Tobacco-­‐related	  Cancer	  (excluding	  lung)	  
• During	  2008-­‐2010,	  an	  average	  of	  1,526	  Maine	  adults	  were	  diagnosed	  with
tobacco-­‐related	  cancer	  each	  year.	  During	  this	  time,	  the	  age-­‐adjusted	  tobacco-­‐
related	  cancer	  incidence	  rate	  in	  Maine	  was	  90.4	  per	  100,000,	  significantly	  higher
than	  the	  U.S.	  SEER	  overall	  rate	  of	  82.1	  per	  100,000	  and	  U.S.	  SEER	  white	  rate	  of
83.4	  per	  100,000.
• The	  age-­‐adjusted	  tobacco-­‐related	  cancer	  incidence	  rates	  in	  Maine	  remained
steady	  between	  2000	  and	  2010,	  and	  none	  of	  the	  rates	  were	  significantly
different	  across	  this	  period.	  	  In	  contrast,	  U.S.	  SEER	  overall	  tobacco-­‐incidence
rates	  have	  increased	  significantly	  over	  the	  2000-­‐2010	  decade,	  though	  the
absolute	  changes	  are	  relatively	  small.
• During	  2008-­‐2010,	  the	  age-­‐adjusted	  tobacco-­‐related	  cancer	  incidence	  rate
among	  Maine	  males	  (131.6	  per	  100,000)	  was	  twice	  the	  rate	  among	  females	  (57.4
per	  100,000);	  this	  difference	  was	  statistically	  significant.	  Tobacco-­‐related
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incidence	  rates	  have	  not	  changed	  consistently	  or	  significantly	  among	  either	  
Maine	  males	  or	  females	  from	  2000	  to	  2010.	  
• In	  2010,	  646	  Maine	  residents	  died	  from	  tobacco-­‐related	  cancer.	  	  That	  year,
Maine’s	  age-­‐adjusted	  tobacco-­‐related	  cancer	  death	  rate	  (37.3	  per	  100,000)	  was
slightly,	  but	  not	  significantly,	  higher	  than	  the	  rate	  for	  U.S	  overall	  (34.6	  per
100,000)	  and	  U.S.	  whites	  (34.4	  per	  100,000).	  Maine’s	  age-­‐adjusted	  tobacco-­‐
related	  cancer	  death	  rates	  have	  not	  significantly	  declined	  from	  2000	  to	  2010.
• In	  2010,	  the	  age-­‐adjusted	  death	  rate	  from	  tobacco-­‐related	  cancer	  among	  Maine
males	  (53.6	  per	  100,000)	  was	  twice	  the	  death	  rate	  among	  females	  (24.3	  per
100,000).	  Tobacco-­‐related	  death	  rates	  have	  not	  declined	  consistently	  or
significantly	  among	  either	  Maine	  males	  or	  females	  from	  2000	  to	  2010.
Risk	  Factors	  
Adults	  
• In	  2011,	  26.1%	  of	  Maine	  adults	  currently	  used	  any	  type	  of	  tobacco	  product
including	  smokeless	  tobacco.	  In	  2012,	  48.6%	  of	  Maine	  adults	  had	  never	  smoked,
31.1%	  were	  former	  smokers	  and	  20.3%	  were	  current	  smokers.	  	  The	  prevalence
of	  current	  smoking	  is	  similar	  in	  Maine	  and	  the	  U.S.,	  while	  the	  prevalence	  of
former	  smokers	  is	  higher	  among	  Maine	  adults	  than	  the	  U.S.	  adults.
• In	  2012,	  over	  one-­‐third	  (34.8%)	  of	  Mainers	  were	  at	  a	  healthy	  weight,	  while	  36.4%
were	  overweight	  and	  28.8%	  were	  obese.	  There	  were	  no	  significant	  differences	  in
prevalence	  rates	  between	  Maine	  and	  U.S.	  adults.
• Only	  20.6%	  of	  Maine	  adults	  adhered	  to	  weekly	  aerobic	  and	  muscle	  strengthening
activities	  according	  to	  U.S.	  CDC	  recommendations	  in	  2011;	  this	  percentage	  was
not	  significantly	  different	  for	  U.S.	  adults.
• The	  prevalence	  of	  Maine	  adults	  who	  were	  heavy	  drinkers	  was	  6.7%	  in	  2012,
which	  was	  not	  statistically	  different	  than	  the	  prevalence	  among	  U.S.	  adults.
• Maine	  adults	  consume	  one	  fruit	  and	  two	  vegetables	  each	  day,	  which	  is	  similar	  to
the	  amount	  of	  fruit	  and	  vegetables	  consumed	  by	  U.S.	  adults	  daily.
• During	  2011-­‐2012,	  5.4%	  of	  Maine	  adults	  used	  artificial	  sources	  of	  ultraviolet	  light
for	  tanning	  purposes,	  with	  the	  highest	  prevalence	  among	  females	  (7.9%)	  and
young	  adults	  (8.3%).
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• In	  2010,	  33.1%	  of	  Maine	  adults	  routinely	  used	  sunblock	  when	  outside	  on	  a	  sunny
summer	  day	  for	  more	  than	  an	  hour	  and	  the	  trend	  has	  not	  significantly	  changed
from	  2000	  to	  2010.
• Among	  Maine	  adults,	  40.9%	  routinely	  used	  at	  least	  one	  protective	  measure	  (i.e.,
wearing	  a	  hat	  to	  shade	  face,	  ears,	  or	  neck	  against	  the	  sun,	  wearing	  a	  long-­‐
sleeved	  shirt,	  or	  staying	  in	  the	  shade)	  against	  sun	  exposure	  when	  outside	  on	  a
sunny	  summer	  day	  for	  more	  than	  one	  hour	  in	  2010.	  A	  significantly	  lower
percentage	  of	  Maine	  females	  (34.3%)	  to	  routinely	  use	  at	  least	  one	  protective
measure	  against	  sun	  exposure	  compared	  to	  males	  (47.6%).
Youth	  
• In	  2013,	  18.2%	  of	  Maine	  high	  school	  students	  and	  3.8%	  of	  Maine	  middle	  school
students	  had	  used	  any	  type	  of	  tobacco	  products	  in	  the	  past	  30	  days.	  Maine	  high
school	  students	  were	  significantly	  less	  likely	  to	  use	  any	  tobacco	  product	  than
U.S. high	  school	  students.
• Nearly	  70%	  (69.7%)	  of	  Maine	  high	  school	  students	  and	  65.7%	  of	  Maine	  middle
students	  were	  at	  a	  healthy	  weight,	  while	  28.7%	  of	  high	  school	  students	  and
31.7%	  of	  middle	  school	  students	  were	  either	  overweight	  or	  obese	  in	  2013.	  The
prevalence	  of	  overweight	  and	  obese	  was	  similar	  among	  Maine	  and	  U.S.	  high
school	  students.
• In	  Maine,	  high	  school	  students	  (22.4%)	  were	  significantly	  less	  likely	  to	  engage	  in
at	  least	  60	  minutes	  of	  physical	  activity	  compared	  to	  middle	  school	  students
(28.7%).	  Maine	  high	  school	  students	  were	  less	  likely	  to	  participate	  in	  daily
physical	  activity	  than	  U.S.	  high	  school	  students	  (27.1%).
• In	  2013,	  Maine	  high	  school	  students	  (16.8%)	  were	  significantly	  less	  likely	  to
consume	  fruits	  and/or	  vegetables	  5	  or	  more	  times	  per	  day	  compared	  to	  middle
school	  students	  (19.3%).
• A	  significantly	  higher	  percentage	  of	  Maine	  high	  school	  students	  (15.0%)	  used	  an
indoor	  tanning	  device	  at	  least	  once	  in	  the	  past	  12	  months	  compared	  to	  middle
school	  students	  (6.1%)	  in	  2013.
• Maine’s	  middle	  school	  students	  (28.7%)	  were	  significantly	  more	  likely	  to
routinely	  use	  sunscreen	  compared	  to	  high	  school	  students	  (19.7%)	  in	  2013.
Maine	  high	  school	  students	  had	  a	  higher	  prevalence	  of	  routine	  sunscreen	  use




• Nearly one-third (31.4%) of Maine homes were tested for radon in indoor air in
2012. Since 2009, the prevalence of radon testing in Maine homes has remained
relatively constant.
• Among the Maine homes tested for radon in 2012, 16.3% had elevated radon
levels in indoor air.
• In 2012, among Maine homes with elevated radon levels in indoor air, the
majority (78.4%) of these homes had radon levels mitigated.
Screening 
• Breast cancer screening is higher among Maine females than U.S. females.  In
2012, among Maine females ages 40 years and older, 79.6% had a mammogram
within the past two years compared to 77.0% of U.S. females.  Among Maine
females ages 50 years and older, 82.1% had a mammogram within the past two
years compared to 74.0% of U.S. females.
• In 2012, nearly 90% (88.0%) of Maine females ages 21−65 years with an intact
cervix reported having a Pap test within the past three years.  The prevalence of
cervical cancer screening remained constant in Maine between 2002 and 2010.
• In 2012, the prevalence rate of up-to-date colorectal cancer screening among
Maine adults ages 50 years and older was 72.2%. Colorectal cancer screening
prevalence rates in Maine have stayed constant since 2008.
• More than one-third of Maine adults report having oral cancer screening.  From
2011 to 2012, the prevalence of oral cancer screening among Maine adults ages
18 years and older significantly increased from 26.9% to 34.8%.
• Nearly half of Maine males report having prostate cancer screening. In 2012,
49.6% of Maine males ages 50 years and older had a PSA test for prostate cancer
screening within the past two years.
Survivors 
• During 2011-2012, an estimated 125,944 (12.0%) of Maine adults were cancer
survivors.
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• Compared	  to	  other	  Maine	  adults,	  cancer	  survivors	  in	  Maine	  were	  more	  likely	  to
be	  female,	  older,	  have	  at	  least	  a	  college	  education,	  and	  have	  lower	  household
income.
• Maine	  cancer	  survivors	  were	  more	  likely	  to	  have	  health	  insurance	  than	  other
Maine	  adults	  and	  were	  more	  likely	  to	  have	  Medicare.
• Compared	  to	  Maine	  adults	  without	  a	  history	  of	  cancer,	  cancer	  survivors	  have	  a
significantly	  higher	  prevalence	  of	  chronic	  disease	  including	  coronary	  heart
disease	  or	  stroke,	  current	  asthma,	  diabetes,	  and	  chronic	  obstructive	  pulmonary
disease.
• Sixteen percent	  of	  cancer	  survivors	  in	  Maine	  have	  two	  or	  more	  chronic
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Introduction	  
	  
Every	  year,	  more	  than	  8,000	  Mainers	  are	  diagnosed	  with	  cancer	  and	  more	  than	  3,000	  
die	  due	  to	  cancer.	  Cancer	  is	  the	  leading	  cause	  of	  death	  in	  Maine,	  and	  Maine’s	  cancer	  
incidence	  and	  mortality	  rates	  are	  significantly	  higher	  than	  national	  rates.	  The	  Maine	  
Center	  for	  Disease	  Control	  and	  Prevention	  (Maine	  CDC)	  is	  committed	  to	  reducing	  the	  
burden	  of	  cancer	  in	  Maine	  through	  programs	  that	  promote	  healthy	  behaviors,	  improve	  
access	  to	  preventative	  services,	  and	  enhance	  use	  of	  surveillance	  data	  to	  monitor	  and	  
evaluate	  statewide	  patterns	  in	  cancer	  incidence	  (new	  cases)	  and	  deaths	  to	  support	  
targeted	  public	  health	  interventions	  and	  improve	  cancer	  prevention,	  treatment	  and	  
control	  planning.	  	  
	  
The	  Maine	  Cancer	  Surveillance	  Report	  2014	  was	  produced	  through	  a	  collaboration	  of	  the	  
Maine	  CDC	  Cancer	  Prevention	  and	  Control	  Programs	  (Breast	  and	  Cervical	  Health	  
Program,	  Comprehensive	  Cancer	  Control	  Program,	  Colorectal	  Cancer	  Control	  Program	  
and	  Maine	  Cancer	  Registry)	  and	  the	  University	  of	  Southern	  Maine	  Chronic	  Disease	  
Epidemiology	  staff.	  	  The	  Report	  provides	  a	  comprehensive	  source	  of	  current	  cancer	  data	  
for	  the	  state	  of	  Maine,	  including	  incidence	  and	  mortality	  data	  collected	  from	  2000-­‐2010	  
for	  all	  cancers	  combined,	  as	  well	  as	  for	  nine	  specific	  cancers,	  including	  the	  six	  most	  
common	  cancer	  sites	  in	  Maine:	  lung	  and	  bronchus,	  tobacco-­‐related	  cancer	  (excluding	  
lung),	  colorectal,	  female	  breast,	  prostate	  and	  bladder.	  Current	  data	  for	  two	  cancers	  
where	  preventive	  measures	  are	  available	  (cervical	  and	  melanoma)	  are	  also	  provided.	  
The	  Report	  expands	  on	  cancer	  surveillance	  beyond	  incidence	  and	  mortality	  to	  include	  
data	  on	  cancer-­‐related	  risk	  factors	  and	  behaviors,	  cancer	  screening,	  and	  cancer	  
survivorship,	  reporting	  data	  from	  state	  and	  national	  surveillance	  systems.	  	  
	  
What	  is	  cancer?	  
	  
The	  term	  “cancer”	  describes	  a	  group	  of	  diseases	  characterized	  by	  the	  unnecessary	  
growth	  and	  multiplication	  of	  abnormal	  cells.	  There	  are	  over	  100	  types	  of	  cancer,	  each	  
with	  its	  own	  risk	  factors,	  rate	  of	  progression,	  treatment,	  and	  prognosis.	  
	  
Every	  cell	  in	  the	  human	  body	  has	  its	  own	  lifecycle.	  Through	  mitosis,	  or	  cell	  division,	  old	  
or	  damaged	  cells	  are	  replaced	  with	  new	  cells	  and	  the	  normal	  cycle	  continues.	  However,	  
sometimes	  a	  cell	  becomes	  so	  damaged	  that	  it	  does	  not	  die	  when	  it	  should,	  and	  this	  
controlled	  pattern	  is	  broken.	  When	  these	  damaged	  cells	  continue	  to	  divide	  and	  multiply	  
at	  their	  own	  rate,	  masses,	  or	  tumors,	  are	  formed.	  	  Tumors	  can	  be	  benign	  or	  malignant.	  
Malignant,	  or	  cancerous,	  tumors	  can	  spread	  into	  surrounding	  tissue,	  invade	  nearby	  
organs,	  and,	  in	  advanced	  stages,	  spread	  to	  other	  parts	  of	  the	  body.	  In	  this	  process	  of	  
metastasis,	  multiple	  tumors	  form.	  Some	  cancers	  take	  years	  to	  develop	  and	  spread,	  and	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Who	  gets	  cancer?	  
Cancer	  develops	  in	  people	  of	  all	  ages,	  but	  most	  commonly	  develops	  in	  middle-­‐aged	  and	  
elderly	  individuals.	  The	  number	  of	  cancer	  cases	  has	  risen	  dramatically	  over	  the	  past	  40	  
years,	  but	  much	  of	  this	  increase	  in	  cancer	  diagnoses	  may	  be	  due	  to	  increases	  in	  
population,	  particularly	  in	  older	  age	  groups,	  or	  is	  a	  reflection	  of	  the	  advancement	  in	  
techniques	  that	  can	  detect	  cancer	  in	  its	  earlier	  stages.	  On	  average,	  one	  in	  three	  people	  
will	  be	  diagnosed	  with	  cancer	  at	  some	  point	  in	  their	  lifetime.	  Cancer	  is	  the	  leading	  cause	  
of	  death	  in	  Maine	  and	  the	  second	  most	  common	  cause	  of	  death	  in	  the	  United	  States.1	  	  
What	  causes	  cancer?	  
Just	  as	  cancer	  is	  not	  a	  single	  disease,	  most	  cancers	  do	  not	  have	  a	  single	  cause.	  	  Many	  
cancers	  can	  be	  linked	  to	  repeated	  exposure	  to	  one	  or	  more	  carcinogens,	  or	  cancer	  
causing	  agents.	  These	  agents	  can	  cause	  cells	  to	  become	  abnormal,	  initiating	  irregular	  
cell	  growth	  and	  division.	  Carcinogens	  include,	  but	  are	  not	  limited	  to,	  tobacco,	  ultraviolet	  
radiation	  from	  the	  sun,	  X-­‐rays,	  and	  chemicals	  that	  may	  contaminate	  food,	  water,	  and	  
air.	  
In	  addition	  to	  known	  environmental	  carcinogens,	  factors	  associated	  with	  modifiable	  
lifestyle	  habits	  also	  increase	  a	  person’s	  risk	  for	  developing	  cancer.	  For	  example,	  it	  is	  
estimated	  that	  30%	  of	  all	  cancers	  are	  related	  to	  tobacco	  use.	  Nutritional	  factors	  and	  
physical	  activity	  habits	  also	  contribute	  to	  an	  individual’s	  cancer	  risk.	  Overweight	  and	  
obesity	  are	  associated	  with	  increased	  risk	  for	  developing	  a	  number	  of	  cancers,	  increased	  
risk	  of	  cancer	  recurrence	  in	  survivors,	  and	  decreased	  survival	  rates	  for	  several	  cancers.	  
In	  2003,	  overweight	  and	  obesity	  were	  identified	  as	  contributing	  factors	  to	  14%	  to	  20%	  of	  
cancer-­‐related	  mortality.	  	  A	  small	  number	  of	  cancers	  have	  genetic	  risk	  factors.	  
Maine’s	  Cancer	  Surveillance	  System	  
This	  report	  was	  developed	  utilizing	  the	  Maine	  Cancer	  Surveillance	  Plan	  2013,	  which	  
provides	  a	  framework	  for	  the	  Maine	  CDC’s	  routine	  analysis,	  interpretation,	  and	  use	  of	  
cancer	  surveillance	  data.2	  	  The	  Plan	  outlines	  the	  selected	  indicators	  related	  to	  
surveillance	  efforts	  in	  cancer	  screening,	  prevention	  and	  survivorship,	  as	  well	  as	  available	  
data	  sources	  and	  intended	  analysis	  for	  each	  measure.	  Data	  on	  environmental	  risk	  
factors,	  as	  well	  as	  adult	  health	  risk	  behaviors,	  cancer	  screening	  and	  cancer	  survivorship	  
is	  collected	  through	  the	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  Data	  on	  
youth	  behavioral	  risk	  factors	  is	  collected	  through	  the	  Maine	  Integrated	  Youth	  Health	  
Survey.	  
Cancer	  incidence	  data	  are	  obtained	  from	  the	  Maine	  Cancer	  Registry	  (MCR)	  and	  the	  
National	  Cancer	  Institute’s	  Surveillance,	  Epidemiology,	  and	  End	  Results	  Program.	  Cancer	  
mortality	  data	  were	  derived	  from	  the	  National	  Vital	  Statistics	  System.	  Each	  year,	  the	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MCR	  produces	  the	  Maine	  Annual	  Cancer	  Report,	  containing	  Maine’s	  most	  recent	  cancer	  
incidence	  and	  mortality	  data.3	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This chapter examines cancer incidence (new cases) among Maine residents.  We 
examine the stage of cancer at time of diagnosis, which is a measure of how early or late 
in the growth process the cancer is commonly diagnosed in Maine.  This data provides 
us with information about whether specific cancers are being diagnosed at an early 
stage, when treatment can be most beneficial. We also compare Maine incidence and 
stage at diagnosis data with U.S. and U.S. white comparison data. 
This chapter is divided into two main sections: 
Section I:  Incidence 
Section II:  Stage at Diagnosis 
We present incidence data and statistics for all cancers combined, and for eight specific 
cancer types, presented in alphabetical order as follows:  
• Bladder cancer
• Breast cancer (female only)
• Cervical cancer
• Colorectal cancer
• Lung cancer (including bronchus)
• Melanoma
• Prostate cancer
• Tobacco-related cancer (excluding lung cancer)
Of the cancers listed, five cancers account for the largest percentage of new cancer 
cases in Maine each year (in order) — lung, tobacco-related (excluding lung), colorectal 
cancer, and breast cancer among women and prostate cancer among men.  Other 
cancers presented (e.g., bladder, cervical, and melanoma) contribute to fewer new 
cancer cases in Maine, but are included because they are of interest to statewide 
stakeholders and partners in cancer prevention and control. 
For some cancers, the number of new cases in a one-year period is too small to calculate 
reliable rate estimates. In this chapter, we combined data for all cancers into 3-year 
aggregate (e.g., 2000-2002) data to obtain stable rate estimates for interpretation.  
Maine incidence data are from the Maine CDC Cancer Registry, a statewide        
population-based surveillance system of cancer diagnoses.  Incidence data used for U.S. 
comparisons are obtained from the National Cancer Institute’s Surveillance, 
Epidemiology, and End Results (SEER) Program, which aggregates incidence data from 
multiple state and local cancer registries to provide a more generalized perspective of 
cancer incidence in the U.S. population.  In this report, we used data from SEER 9, which 
 Maine Cancer Surveillance Report 2014 Page 15
Cancer Incidence 
includes registries from Atlanta, Connecticut, Detroit, Hawaii, Iowa, New Mexico, San 
Francisco-Oakland, Seattle-Puget Sound, and Utah.  The SEER 9 registry represents 9.4% 
of U.S. population, so the number of new cases represents only a fraction of the total 
number of new cancer cases diagnosed in the entire U.S. in that specific time frame. See 
Appendix IV for more information about SEER registries. 
Section I:  Incidence 
All cancer 
This section focuses on incidence from all types of cancer combined.  In this section, 
“cancer incidence” and “cancer incidence rates” means incidence and incidence rates for 
all types of cancer combined. 
How do cancer incidence rates in Maine compare to those of the U.S.? 
Cancer rates in Maine are significantly higher than U.S. rates. 
• From 2000 to 2010, the age-adjusted cancer incidence rates in Maine were
consistently higher than the U.S. SEER overall rate and U.S. SEER whites rate;
these differences were statistically significant (Table 2.1, Figure 2.1).
Figure 2.1. All Cancer Incidence Rates by 3-Year Period, Maine and U.S., 2000-2010 
Maine Data Source: Maine CDC Cancer Registry, November 2012 NPCR data submission (1995-2010). U.S. Data Source: SEER 9 
Research Data (1973-2010). Rates are calculated using SEER*Stat Version 8.1.5. 
All cancer: SEER Site Recode: 20010-37000 (which include ICD-O-3 codes: C00-C97). 
Age adjusted rates are new cases per 100,000 population age-adjusted to the U.S. 2000 standard population. 
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• During 2008-2010, Maine’s age-adjusted incidence cancer rate (496.8 per 
100,000) was significantly higher than the overall U.S. SEER rate (467.1 per 
100,000) and U.S. SEER whites rate (475.8 per 100,000; Table 2.1, Figure 2.1). 
 
• In Maine, the age-adjusted cancer incidence rate among males (558.7 per 
100,000) was significantly higher (4%) than the rate for both U.S. SEER males 
(533.3 per 100,000) and U.S. SEER white males (536.6 per 100,000) during 2008-
2010.  The rate for Maine females (452.6 per 100,000) was significantly higher 
than the rate of U.S. SEER females (420.1 per 100,000; 8% higher) and U.S. SEER 
white females (432.9 per 100,000; 4% higher; Table 2.2). 
 
What are the trends in cancer incidence rates in Maine? 
 
Cancer incidence rates in both Maine and the U.S. are decreasing.  Maine’s cancer 
incidence rates have remained consistently higher than U.S. rates, but are declining at 
a faster pace than U.S. rates. 
 
• During 2008-2010, an average of 8,321 new cancer cases were diagnosed per 
year (Table 2.1). 
 
• Maine’s age-adjusted cancer incidence rate significantly decreased (7.0%) from 
534.3 per 100,000 during 2000-2002 to 496.8 per 100,000 during 2008-2010; 
most of this decline has occurred since 2004-2006 (Table 2.1; Figure 2.1). 
 
• The average annual decline in Maine’s cancer incidence rate (0.9%) indicates a 
faster decline in the rate of new cancer cases in the state compared to the 
average decline in the U.S. SEER overall rate (0.5%) and U.S. SEER whites rate 
(0.6%) from 2000 to 2010 (Table 2.1; Figure 2.1). 
 
Are there differences in cancer incidence rates by sex in Maine? 
 
Maine males have significantly higher cancer incidence rates than females, but rates 
among males are declining at a faster pace than among females. 
 
• In Maine, males had significantly higher cancer incidence rates than females 
from 2000 to 2010 (Table 2.2; Figure 2.2). 
 
• During 2008-2010, the age-adjusted cancer incidence rate among Maine males 
(558.7 per 100,000) was 23% higher than that among females (452.6 per 
100,000; Table 2.2; Figure 2.2). 
 
• From 2000 to 2010, males had significantly higher cancer incidence rates than 
females in Maine; however, incidence rates among males were declining at a 
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faster pace (average annual decline: 1.6%) compared to females (average annual 








Are there differences in cancer incidence rates by age group in Maine? 
 
In Maine, cancer incidence rates increase with increasing age.  
 
• In Maine, cancer incidence rates increased with age during 2000 to 2010, which 
was similar to the age pattern observed for the U.S. SEER overall and U.S. SEER 
whites (Table 2.3). 
 
• Cancer incidence rates among Mainers ages 75 and older vary from year to year 
during 2000 to 2010, but only rates in 2007-2009 and 2008-2010 were 
significantly lower than previous years.  From 2000 to 2010, cancer incidence 
rates among Mainers ages 65−74 years were steady until the latter part of the 
decade; rates in 2006-2008, 2007-2009, and 2008-2010 were significantly lower 
than the 2000-2002 rate.  Annual cancer incidence rates among Mainers ages 
35−64 years significantly increased in the middle of the decade; rates from 2004-
2006 and later years were significantly higher than the 2000-2002 rate. Among 
Mainers ages 0−34 years, the cancer incidence rates were fairly constant during 
Figure 2.2. All Cancer Incidence Rates by 3-Year Period and Sex, Maine, 2000-2010 
Data Source: Maine CDC Cancer Registry, November 2012 NPCR data submission (1995-2010). Rates are calculated using 
SEER*Stat Version 8.1.5.                                                                                                                                                 
All cancer: SEER Site Recode: 20010-37000 (which include ICD-O-3 codes: C00-C97).                                                                             
Age adjusted rates are new cases per 100,000 population age-adjusted to the U.S. 2000 standard population. 
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2000 to 2010; only the rate in 2002-2004 was significantly higher than the 2000-









• During 2008-2010, the crude cancer incidence rate among Mainers ages 75 years 
and older (2,527.2 per 100,000) was 1.3 times the rate of those ages 65–74 years 
(2,016.1 per 100,000), 4.3 times the rate of those ages 35–64 years (586.2 per 
100,000), and 62.4 times the rate of those 0–34 years (40.5 per 100,000); these 
differences were statistically significant (Table 2.3; Figure 2.3). 
 
Are there differences in cancer incidence rates by geography?  
 
Counties and public health districts with the highest cancer incidence rates tend to be 
in eastern and western Maine.   
 
• Oxford, Penobscot, and Washington counties had highest age-adjusted cancer 
incidence rates in Maine, but only Penobscot County’s rate (547.3 per 100,000) 
was significantly higher (7%) than the state rate (511.0 per 100,000) during 2006-
2010 (Table 2.4; Map 2.1). 
 
Figure 2.3. All Cancer Incidence Rates by 3-Year Period and Age Group, Maine, 2000-2010 
Data Source: Maine CDC Cancer Registry, November 2012 NPCR data submission (1995-2010). Rates are calculated using 
SEER*Stat Version 8.1.5.                                                                                                                                                 
All cancer: SEER Site Recode: 20010-37000 (which include ICD-O-3 codes: C00-C97).                                                                             
Age adjusted rates are new cases per 100,000 population age-adjusted to the U.S. 2000 standard population. 
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• During 2006-2010, the age-adjusted cancer incidence rate in Penobscot County, 
the highest county rate in Maine (547.3 per 100,000), was significantly higher 
(18%) than the rate in Lincoln County, the lowest county rate in Maine (464.9 per 
100,000; Table 2.4; Map 2.1). 
 
• Penquis District had the highest age-adjusted cancer incidence rate among 
public health districts rate in the state (539.8 per 100,000), significantly higher 
(6%) than the state rate (511.0 per 100,000) and the rates of several other Maine 
districts (Table 2.4, Map 2.2). 
 
See maps at the end of the chapter. 
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Bladder cancer  
 
Bladder cancer in this section refers to urinary bladder cancer.   
 
How do bladder cancer incidence rates in Maine compare to those of the U.S.? 
 
Maine’s bladder cancer incidence rates are consistently and significantly higher than 
the U.S. rates. Bladder cancer incidence rates are significantly higher in Maine females 
and males than U.S. counterparts. 
 
• From 2000 to 2010, the age-adjusted bladder cancer incidence rates in Maine 
were consistently and significantly higher than the U.S. SEER overall rate and U.S. 





• During 2008-2010, Maine’s age-adjusted incidence rate for bladder cancer (27.3 
per 100,000) was 29% higher than the U.S. SEER overall rate (21.1 per 100,000) 
and 18% higher than the U.S. SEER white rate (23.2 per 100,000); these are 
significant differences (Table 2.5, Figure 2.4).   
 
• During 2008-2010, the age-adjusted bladder cancer incidence rate among Maine 
males (46.4 per 100,000) was 25% higher than the rate among U.S. SEER males 
(37.2 per 100,000) and 14% higher than the rate among U.S. SEER white males 
Figure 2.4. Bladder Cancer Incidence Rates by 3-Year Period, Maine and U.S., 2000-2010 
Maine Data Source: Maine CDC Cancer Registry, November 2012 NPCR data submission (1995-2010). U.S. Data Source: SEER 9 
Research Data (1973-2010). Rates are calculated using SEER*Stat Version 8.1.5. 
Bladder cancer: SEER Site Recode ICD-O-3: 29010 (which include ICD-O-3 code: C670-C679). 
Age adjusted rates are new cases per 100,000 population age-adjusted to the U.S. 2000 standard population. 
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(40.7 per 100,000); these differences are statistically significant.  A similar, 
significant pattern was observed for Maine females. The rate for Maine females 
during this 3-year period (12.5 per 100,000) was 37% higher than the rate of U.S. 
SEER females (9.1 per 100,000) and 28% higher than the rate for U.S. SEER white 
females (9.8 per 100,000; Table 2.6). 
 
What are the trends in bladder cancer incidence rates in Maine? 
 
Bladder cancer incidence rates in Maine have stayed constant since 2000. 
 
• During 2008-2010, an average of 461 Mainers per year were diagnosed with 
bladder cancer (Table 2.5).   
 
• Between 2000 and 2010, Maine’s age-adjusted bladder cancer incidence rate 
remained steady (28.5 vs. 27.3 per 100,000), with no significant change over 
time period. Likewise, bladder cancer incidence rates for U.S SEER overall and 
U.S. SEER whites have not significantly changed over this time period (Table 2.5, 
Figure 2.4).   
 
Are there differences in bladder cancer incidence rates by sex in Maine? 
 
Maine males have significantly higher bladder cancer incidence rates than Maine 
females. Bladder cancer incidence rates have stayed constant from 2000 to 2010 for 
both males and females in Maine. 
 
• Maine males had significantly higher bladder cancer incidence rates than 
females from 2000 to 2010 (Table 2.6, Figure 2.5).   
 
• During 2008-2010, Maine’s age-adjusted bladder cancer incidence rate among 
males (46.4 per 100,000) was almost 4 times the bladder cancer incidence rate 
among females (12.5 per 100,000; Table 2.6, Figure 2.5).    
• During 2000 to 2010, bladder cancer incidence rates among Maine females and 
males have fluctuated from year to year, but there have been no significant 
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Are there differences in bladder cancer incidence rates by age group in Maine? 
 
 Bladder cancer incidence rates in Maine increase with age. 
 
• In Maine, bladder cancer incidence rates increased with age during 2000 to 
2010. Similarly, this age pattern was observed for the U.S. SEER overall and U.S. 
SEER whites (Table 2.7). 
 
• During 2008-2010, the crude bladder cancer incidence rate among Mainers ages 
75 years and older (189.7 per 100,000) was 1.5 times the rate of those ages 65–
74 years (128.4 per 100,000), 8 times the rate of those ages 35–64 years (22.7 
per 100,000), and 632 times the rate of those ages 0–34 years (0.3 per 100,000); 
these differences were statistically significant (Table 2.7, Figure 2.6).  
 
• While bladder cancer incidence rates appear to vary from year to year within 
each age group, none of these rates significantly differ over time within any of 
the age groups (Table 2.7). 
 
  
Figure 2.5. Bladder Cancer Incidence Rates by 3-Year Period and Sex, Maine and U.S., 
2000-2010 
Maine Data Source: Maine CDC Cancer Registry, November 2012 NPCR data submission (1995-2010). Rates are calculated using 
SEER*Stat Version 8.1.5. 
Bladder cancer: SEER Site Recode ICD-O-3: 29010 (which include ICD-O-3 code: C670-C679). 
Age adjusted rates are new cases per 100,000 population age-adjusted to the U.S. 2000 standard population. 
 Maine Cancer Surveillance Report 2014 Page 23
 Cancer Incidence 
 
 
Are there differences in bladder cancer incidence rates by geography?  
 
Bladder cancer incidence rates do not vary greatly by county or public health district 
of residence in Maine. 
 
• Although Androscoggin, Franklin, and York counties had the highest age-adjusted 
bladder cancer incidence rates in the state during 2006-2010, none of these 
rates were significantly higher than the overall Maine rate (Table 2.8, Map 2.3). 
 
• During 2006-2010, the age-adjusted bladder cancer rate in Waldo County (20.0 
per 100,000) was significantly lower than the state rate (28.3 per 100,000) and 
the rates of Androscoggin and York counties (31.9 and 31.4 per 100,000, 
respectively; Table 2.8, Map 2.3). 
 
• While York District had the highest age-adjusted bladder cancer incidence rate of 
the public health districts in the state during 2006-2010 at 31.4 per 100,000, its 
Figure 2.6. Crude Incidence Rates by Type of Cancer and Age Group, Maine, 2008-2010 
Data Source: Maine CDC Cancer Registry, November 2012 NPCR data submission (1995-2010). Rates are calculated using SEER*Stat Version 8.1.5. 
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rate was not significantly different from the overall Maine rate or the rate of any 
other district (Table 2.8, Map 2.4). 
 
See maps at the end of the chapter. 
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Breast cancer (female only) 
 
While breast cancer does occur among males, this section focuses on female breast 
cancer incidence.  In this section, “breast cancer incidence” and “breast cancer incidence 
rates” means incidence and incidence rates for female breast cancer. 
 
How do breast cancer incidence rates in Maine compare to those of the U.S.? 
 
Breast cancer incidence rates in Maine are similar to U.S. rates, and significantly lower 
than U.S. white rates.  
 
• From 2000 to 2010, the age-adjusted breast cancer incidence rates in Maine 
were similar to (and not significantly different from) the U.S. SEER overall rate. 
For most of the decade, Maine’s breast cancer incidence rates were similar to 
the rates of U.S. SEER whites, except during 2007-2009 and 2008-2010 when 
Maine’s rates were significantly lower than U.S. SEER white rates (Table 2.9, 








• During 2008-2010, Maine’s age-adjusted incidence rate for breast cancer of 
124.5 per 100,000 was similar to (not significantly different from) the overall U.S. 
SEER rate (128.0 per 100,000), and was significantly lower (5.2%) than the U.S. 
SEER white rate (131.4 per 100,000; Table 2.9, Figure 2.7). 
 
Figure 2.7. Female Breast Cancer Incidence Rates by 3-Year Period, Maine and U.S., 
2000-2010 
Maine Data Source: Maine CDC Cancer Registry, November 2012 NPCR data submission (1995-2010). U.S. Data Source: SEER 9 
Research Data (1973-2010). Rates are calculated using SEER*Stat Version 8.1.5. 
Breast Cancer: SEER Site Recode ICD-O-3: 26000 (which include ICD-O-3/WHO 2008 code: C500-C509). 
Age adjusted rates are new cases per 100,000 population age-adjusted to the U.S. 2000 standard population. 
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What are the trends in breast cancer incidence rates in Maine? 
 
Breast cancer incidence rates are decreasing in Maine.  
 
• During 2008-2010, an average of 1,105 females were diagnosed with breast 
cancer in Maine each year (Table 2.9). 
 
• In Maine, age-adjusted breast cancer incidence rates significantly decreased 
from 137.2 per 100,000 during 2000-2002 to 124.5 per 100,000 during 2008-
2010, with a 9% decrease and an annual average decline of 1.2% over this period 
(Table 2.9, Figure 2.7).   
 
• Similarly, age-adjusted breast cancer incidence rates declined significantly over 
this time period for the U.S. SEER overall and U.S. SEER whites.  Maine’s average 
annual decline (1.2%) was similar to the decline for U.S. SEER overall (0.8%) and 
U.S. SEER whites (1.0%; Table 2.9, Figure 2.7). 
 
Are there differences in breast cancer incidence rates by age group in Maine? 
 
Breast cancer incidence rates are highest among Maine females ages 65 years and 
older. 
 
• During 2000 to 2010, breast cancer incidence rates were significantly higher 
among Maine females in the 65–74 and 75 years and older age groups compared 
to those in younger age groups (Table 2.10). 
 
• Although Maine females ages 65–74 years appeared to have a higher crude 
breast cancer incidence rate (434.1 per 100,000) than those ages 75 years and 
older (415.7 per 100,000) during 2008-2010, there was no significant difference 
in the rates between these groups. However, during this time, the breast cancer 
incidence rates among Maine females ages 65–74 years and 75 years and older 
(434.1 and 415.7 per 100,000, respectively) were more than twice the rate of 
those ages 35–64 years (199.6 per 100,000), and more than 70 times the rate of 
those ages 0–34 years (5.7 per 100,000); these differences were statistically 
significant (Table 2.10, Figure 2.6).   
 
• Unlike Maine’s age pattern, among U.S. SEER overall and white populations in 
2008-2010, breast cancer incidence rates among females ages 65–74 years were 
significantly higher than females ages 75 years and older (Table 2.10).  
• In Maine, breast cancer incidence rates within age groups younger than 75 years 
fluctuate a lot from year to year and tended to have large confidence intervals, 
making it difficult to statistically detect a trend if one existed. From 2000 to 
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2010, annual breast cancer incidence rates among Maine females in the 75 years 
and older age group suggest there is a declining trend, but there was no 
significant difference in the rates across this time period (Table 2.10).  
 
Are there differences in breast cancer incidence rates by geography?  
 
Breast cancer incidence rates do not vary greatly by county and public health district 
in Maine.  
 
• While Kennebec, Hancock, Piscataquis and Waldo counties had the highest age-
adjusted breast cancer incidence rates during 2006-2010, these rates were not 
significantly higher than Maine’s overall rate (Table 2.11, Map 2.5). 
 
• The breast cancer incidence rate in Kennebec County, the highest county rate in 
the state (age-adjusted rate: 137.1 per 100,000) was significantly higher (30%) 
than the rate in Aroostook County, the lowest county rate in the state (age-
adjusted rate: 105.7 per 100,000; Table 2.11, Map 2.5). 
 
• During 2006-2010, only the rate in Aroostook (as a county and a public health 
district) at 105.7 per 100,000 was significantly lower (16%) than the state rate 
(126.4 per 100,000; Table 2.11, Map 2.5 and Map 2.6). 
 
See maps at the end of the chapter. 
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Cervical cancer 
 
How do cervical cancer incidence rates in Maine compare to those of the U.S.? 
 
Cervical cancer incidence rates in Maine are similar to rates for the U.S. overall and 
U.S. whites. 
 
• From 2000 to 2010, the age-adjusted cervical cancer incidence rates in Maine 
were similar to (not significantly different from) the U.S. SEER rate and the U.S. 
SEER whites rate (Table 2.12, Figure 2.8). 
 
• During 2008-2010, Maine’s age-adjusted cervical cancer incidence rate (6.4 per 
100,000) was similar to the rate among the U.S. SEER overall (6.8 per 100,000) 
and U.S. SEER whites (6.6 per 100,000).  This was not a significant difference 







What are the trends in cervical cancer incidence rates in Maine? 
 
In Maine, cervical cancer incidence rates remained constant over the past decade. 
 
• During 2008-2010, an average of 47 new cervical cancer cases were diagnosed in 
Maine each year (Table 2.12). 
 
Figure 2.8. Cervical Cancer Incidence Rates by 3-Year Period, Maine and U.S., 2000-2010 
Maine Data Source: Maine CDC Cancer Registry, November 2012 NPCR data submission (1995-2010). U.S. Data Source: SEER 9 
Research Data (1973-2010). Rates are calculated using SEER*Stat Version 8.1.5. 
Cervical cancer: SEER Site Recode ICD-O-3: 27010  (which include ICD-O-3 code: C530-C539). 
Age adjusted rates are new cases per 100,000 population age-adjusted to the U.S. 2000 standard population. 
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• While Maine’s cervical cancer incidence rate appears to decrease from 2000-
2002 to 2008-2010, the rates did not change significantly during this period 
(Table 2.12, Figure 2.8).   
 
• Unlike Maine, cervical cancer incidence rates among the U.S. SEER population 
were significantly lower in the latter part of the decade (2004-2006 through 
2008-2010) compared to 2000-2002 and 2001-2003 rates. U.S. SEER whites also 
had a significant decrease in cervical cancer incidence rates during 2006-2008, 
2007-2009, and 2008-2010 compared to the 2000-2002 rate (Table 2.12, Figure 
2.8).   
 
Are there differences in cervical cancer incidence rates by age group in Maine? 
 
Cervical cancer incidence rates among Maine females increase with age from 0–34 
years to 35–64 years, and then stay constant across older age groups. 
 
• Among Maine females, during 2000 to 2010, cervical cancer incidence rates 
significantly increased with age from the 0–34 years to age groups of 35 years 
and older. Cervical cancer incidence rates were similar among the 35–64, 65–74, 
and 75 years and older age groups (Table 2.13). 
 
• Unlike Maine’s age pattern, for the overall U.S. SEER and SEER white population, 
cervical cancer incidence rates significantly increased from the 0–34 years age 
group to the 35–64 and 65–74 age groups, but then significantly decreased in 
the 75 years and older age group (Table 2.13). 
 
• During 2008-2010, the crude cervical cancer incidence rate among Maine 
females in the 35–64, 65–74, and 75 years and older (9.4, 11.6, and 9.5 per 
100,000, respectively) age groups were 3.6, 4.5, and 3.7 times higher 
respectively, than the rate of those ages 0–34 years (2.6 per 100,000; Table 2.13, 
Figure 2.6).   
 
Are there differences in cervical cancer incidence rates by geography?  
 
The number of cervical cancer incidence rates by Maine county and public health 
district in 2006-2010 were too small to assess geographic differences.   
 
The relatively small number of cervical cancer incidences at the county and public health 
district level in Maine during 2006-2010 make it difficult to assess geographic 
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Colorectal cancer 
 
How do colorectal cancer incidence rates in Maine compare to those of the U.S.? 
 
In Maine, colorectal cancer incidence rates were consistently higher than those of the 
U.S. over most of the past decade; however, since 2008, Maine’s rates were similar to 
U.S. rates. 
 
• From 2000 to 2010, Maine’s age-adjusted colorectal cancer rates were 
significantly higher than the rates for U.S. SEER overall except in 2007-2009 and 
2008-2010, and rates for U.S. SEER whites except in 2008-2010 (Table 2.15, 
Figure 2.9).   
 
• During 2008-2010, the age-adjusted colorectal cancer incidence rate in Maine 
(43.1 per 100,000) was not significantly different from the U.S. SEER overall rate 
(42.9 per 100,000) or the U.S. SEER white rate (41.8 per 100,000; Table 2.15, 
Figure 2.9).   
 
• During 2008-2010, the age-adjusted colorectal cancer incidence rates for both 
Maine males and females were not significantly different from rates for U.S. 








Figure 2.9. Colorectal Cancer Incidence Rates by 3-Year Period, Maine and U.S., 2000-2010 
Maine Data Source: Maine CDC Cancer Registry, November 2012 NPCR data submission (1995-2010). U.S. Data Source: SEER 9 
Research Data (1973-2010). Rates are calculated using SEER*Stat Version 8.1.5. 
Colorectal Cancer: SEER Site Recode ICD-O-3: 21041-21049, 21051, 21052 (which include ICD-O-3 codes: C180-
C189, C260, C199, C209).  
Age adjusted rates are new cases per 100,000 population age-adjusted to the U.S. 2000 standard population. 
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What are the trends in colorectal cancer incidence rates in Maine? 
 
From 2000 to 2010, colorectal cancer incidence rates in Maine significantly decreased, 
and at a faster pace than the decline among U.S. populations.  
 
• During 2008-2010, an average of 724 Maine adults were diagnosed with 
colorectal cancer each year (Table 2.15). 
 
• In Maine, the age-adjusted colorectal cancer incidence rate decreased 
significantly from 59.5 per 100,000 during 2000-2002 to 43.1 per 100,000 during 
2008-2010, representing a 27.6% decline (average annual decline: 3.9%) over 
this period. This rate of decline was higher in Maine than for the U.S. SEER 
overall and for U.S. SEER whites, with average annual decline of 2.7% and 2.9%, 
respectively (Table 2.15, Figure 2.9).   
 
Are there differences in colorectal cancer incidence rates by sex in Maine? 
 
Maine males have consistently and significantly higher colorectal cancer incidence 
rates than Maine females. Colorectal cancer incidence rates among females declined 
more slowly than rates among males in Maine.  
 
• Maine males had consistently and significantly higher colorectal cancer incidence 
rates than females.  A similar pattern was observed in U.S. SEER overall and U.S. 
SEER whites populations, in which males had significantly higher colorectal 
cancer rates than females (Table 2.16, Figure 2.10).   
 
Figure 2.10. Colorectal Cancer Incidence Rates by 3-Year Period and Sex, Maine, 2000-2010 
Data Source: Maine CDC Cancer Registry, November 2012 NPCR data submission (1995-2010). Rates are calculated using SEER*Stat 
Version 8.1.5. 
Colorectal Cancer: SEER Site Recode ICD-O-3: 21041-21049, 21051, 21052 (which include ICD-O-3 codes: C180-C189, C260, C199, C209).  
Age adjusted rates are new cases per 100,000 population age-adjusted to the U.S. 2000 standard population.  Maine Cancer Surveillance Report 2014 Page 32
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• The age-adjusted colorectal cancer incidence rate among Maine males (48.8 per 
100,000) was 28% higher than the incidence rate among females (38.1 per 
100,000) during 2008-2010 (Table 2.16, Figure 2.10).   
 
• Among Maine males, the age-adjusted colorectal cancer incidence rates declined 
significantly (29.4%) from 2000-2002 to 2008-2010 (69.1 to 48.8 per 100,000).  
For Maine females, age-adjusted colorectal cancer incidence rates also declined 
significantly (27.4%) from 2000-2002 to 2008-2010 (52.5 to 38.1 per 100,000). 
Between 2000 and 2010, the average annual decline was slower for females at 
3.9% compared to the average annual decline for males at 4.2% (Table 2.16, 
Figure 2.10).   
 
Are there differences in colorectal cancer incidence rates by age group in Maine? 
 
In Maine, colorectal cancer incidence rates increase significantly with increasing age, 
with the highest incidence rate in the oldest age group. 
 
• During 2000 to 2010, colorectal cancer incidence rates in Maine increased with 
age in Maine, which was similar to the age pattern observed for U.S. SEER overall 
and U.S. SEER whites (Table 2.17). 
 
• During 2008-2010, the crude colorectal cancer incidence rate among Mainers 
ages 75 years and older (299.3 per 100,000) was almost twice the rate for those 
ages 65−74 years (156.1 per 100,000), 7 times the rate for those ages 35−64 
years (43.4 per 100,000), and 230 times the rate for those ages 0−34 years (1.3 
per 100,000; Table 2.17, Figure 2.6).   
 
• Between 2000 and 2010, colorectal cancer incidence rates among Mainers ages 
65−74 years and 75 years and older decreased significantly (65−74 years: 38.2% 
total decline, 5.8% average annual decline; 75 years and older: 32.2% total 
decline, 4.7% average annual decline).  For Mainers ages 0−34 years and 35−64 
years, colorectal cancer incidence rates did not change significantly over this 
period (Table 2.17). 
 
Are there differences in colorectal cancer incidence rates by geography?  
 
Counties and public health districts with the highest colorectal cancer incidence rates 
tend to be located in northern Maine.  
 
• Aroostook, Franklin, Penobscot, and Washington counties had the highest age-
adjusted colorectal cancer incidence rates during 2006-2010, but only the rates 
in Aroostook and Penobscot counties (57.6 and 53.2 per 100,000, respectively) 
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were significantly higher than the overall Maine rate (45.9 per 100,000) and the 
rates of several other counties (Table 2.18, Map 2.7). 
 
• From 2006-2010, the age-adjusted colorectal cancer incidence rate in Aroostook 
County, the highest county rate in Maine (57.6 per 100,000), was significantly 
higher (58%) than the rate in Knox County, the lowest county rate in the state 
(36.4 per 100,000; Table 2.18, Map 2.7). 
 
• Aroostook and Penquis districts had the highest age-adjusted colorectal cancer 
incidence rates among public health districts in the Maine, and the rates for both 
districts (57.6 and 52.5 per 100,000, respectively) were significantly higher than 
the overall Maine rate (45.9 per 100,000; Table 2.18, Map 2.8). 
 
• The age-adjusted colorectal cancer incidence rate in Aroostook District, the 
highest district rate in Maine (57.6 per 100,000) was significantly higher (42%) 
than the rate of the Midcoast District, the lowest district rate in Maine (40.6 per 
100,000; Table 2.18, Map 2.8). 
 
See maps at the end of the chapter. 
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Lung cancer 
 
How do lung cancer incidence rates in Maine compare to those of the U.S.? 
 
In Maine, lung cancer incidence rates are consistently and significantly higher than 
U.S. rates. Maine females and males tend to have significantly higher lung cancer 
incidence rates compared to their U.S. counterparts. 
 
• From 2000 to 2010, the age-adjusted lung cancer incidence rates in Maine were 
consistently and significantly higher than the rates among U.S. SEER overall and 





• During 2008-2010, the age-adjusted lung cancer incidence rate in Maine (76.3 
per 100,000) was significantly higher than the U.S. SEER overall rate (58.9 per 
100,000; 30% higher) and the U.S. SEER white rate (59.7 per 100,000; 28% 
higher; Table 2.19, Figure 2.11). 
 
• During 2008-2010, the age-adjusted lung cancer incidence rate among Maine 
males (88.4 per 100,000) was significantly higher (28%) than the rate among 
both U.S. SEER males (69.8 per 100,000) and U.S. SEER white males (69.0 per 
100,000). For Maine females during this time period, the age-adjusted rate of 
lung cancer incidence (67.5 per 100,000) was 33% higher than the rate among 
U.S. females (50.9 per 100,000) and 27% higher than the rate of U.S. white 
Figure 2.11. Lung Cancer Incidence Rates by 3-Year Period, Maine and U.S., 2000-2010 
Maine Data Source: Maine CDC Cancer Registry, November 2012 NPCR data submission (1995-2010). U.S. Data Source: SEER 9 Research 
Data (1973-2010). Rates are calculated using SEER*Stat Version 8.1.5. 
Lung cancer: SEER Site Recode ICD-O-3: 22030 (which include ICD-O-3 code: C340-C349). 
Age adjusted rates are new cases per 100,000 population age-adjusted to the U.S. 2000 standard population. 
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females (53.0 per 100,000); these were statistically significant differences (Table 
2.20). 
 
What are the trends in lung cancer incidence rates in Maine? 
 
Since 2000, lung cancer incidence rates have declined, but not significantly, among 
Mainers. 
 
• During 2008-2010, an average of 1,294 adults were diagnosed with lung cancer 
in Maine each year (Table 2.19). 
 
• Maine’s age-adjusted lung cancer incidence rate did not change significantly 
from 2000 to 2010, but the rates do appear to have consistently declined 
between 2003-2005 and 2008-2010. There was a significant decrease in lung 
cancer incidence rates from 2000 to 2010 for both U.S. SEER overall and U.S. 
SEER whites with about an 8% total decrease and an annual average decline of 
1.0% (Table 2.19, Figure 2.11). 
 
Are there differences in lung cancer incidence rates by sex in Maine? 
 
In Maine, lung cancer incidence rates are significantly higher among males than 
females. Lung cancer incidence rates have declined among Maine males, but not 
Maine females. 
 
• From 2000 to 2010, age-adjusted lung cancer incidence rates among Maine 
males were significantly higher than those among Maine females in all years 
between 2000 and 2010 (Table 2.20, Figure 2.12). 
 
• During 2008-2010, the age-adjusted lung cancer incidence rate among Maine 
males (88.4 per 100,000) was significantly higher (31%) than the rate among 
females (67.5 per 100,000; Table 2.20, Figure 2.12). 
 
• Age-adjusted lung cancer incidence rates among Maine males declined 
significantly between 2000-2002 (102.8 per 100,000) and 2008-2010 (88.4 per 
100,000). In contrast, lung cancer incidence rates among Maine females have 
not declined during this period (Table 2.20, Figure 2.12). 
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Are there differences in lung cancer incidence rates by age group in Maine? 
 
As for many cancers, the lung cancer incidence rate in Maine increases with age. 
 
• In Maine, lung cancer incidence rates increased with age during 2000 to 2010, 
which was similar to the age pattern for U.S. SEER overall and U.S. SEER whites 
(Table 2.21). 
 
• During 2008-2010, the crude incidence rate for lung cancer among Mainers ages 
75 years and older (464.8 per 100,000) was 1.2 times the rate for those ages 
65−74 years (378.0 per 100,000), 6.4 times the rate for those ages 35−64 years 
(72.2 per 100,000), and 775 times the rate for those ages 0−34 years (0.6 per 
100,000); these differences were statistically significant (Table 2.21, Figure 2.6).  
 
• Lung cancer incidence rates among Mainers ages 0−34 years and 35−64 years 
have not changed significantly between 2000 and 2010.  Lung cancer incidence 
rates among those ages 65−74 years declined consistently, though not 
significantly, between 2000 and 2010.  Among those ages 75 years and older, 
lung cancer incidence rates suggested an increase from 2000-2002 to 2005-2007, 
and then a decrease from 2006-2008 to 2008-2010; however, there was not a 
significant difference in the rates over this time period (Table 2.21). 
 
Figure 2.12. Lung Cancer Incidence Rates by 3-Year Period and Sex, Maine, 2000-2010 
Data Source: Maine CDC Cancer Registry, November 2012 NPCR data submission (1995-2010). Rates are calculated using 
SEER*Stat Version 8.1.5. 
Lung cancer: SEER Site Recode ICD-O-3: 22030 (which include ICD-O-3 code: C340-C349). 
Age adjusted rates are new cases per 100,000 population age-adjusted to the U.S. 2000 standard population. 
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Are there differences in lung cancer incidence rates by geography?  
 
Counties and public health districts with the highest lung cancer incidence rates tend 
to be in northern and eastern Maine.  
 
• Androscoggin, Aroostook, Penobscot, and Washington counties had the highest 
age-adjusted lung cancer incidence rates during 2006-2010, but only the rates in 
Androscoggin, Penobscot and Washington counties (87.1, 92.8, and 92.4 per 
100,000, respectively) were significantly higher than the overall Maine rate (77.5 
per 100,000; Table 2.22, Map 2.9). 
 
• The lung cancer incidence rate in Penobscot counties (age-adjusted rate: 92.8 
per 100,000), the highest county rate in Maine, was significantly higher (69%) 
than the rate in Lincoln County, the lowest county rate in the state (age-adjusted 
rate: 54.9 per 100,000; Table 2.22, Map 2.9). 
 
• Aroostook, Penquis and Western districts had the highest age-adjusted lung 
cancer incidence rates among the public health districts in Maine, but only 
Penquis District’s rate (90.1 per 100,000) was significantly higher than the overall 
Maine rate (77.5 per 100,000; Table 2.22, Map 2.10). 
 
• The lung cancer incidence rates in Cumberland, Midcoast, and York districts (age-
adjusted rates: 70.3, 67.6, and 70.9 per 100,000, respectively) were significantly 
lower than those in Aroostook, Penquis, and Western districts (Table 2.22, Map 
2.10). 
 
See maps at the end of the chapter. 
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Melanoma 
 
How do melanoma incidence rates in Maine compare to those of the U.S.? 
 
Melanoma incidence rates in Maine are similar to overall U.S. rates, but lower than 
rates for U.S. whites.  
 
• From 2000 to 2010, the age-adjusted melanoma incidence rates in Maine were 
similar to U.S. SEER rates, and were only significantly higher than the overall U.S. 
SEER rates during 2001-2003, 2002-2004, and 2003-2005.  However, Maine’s 
melanoma incidence rates were consistently and significantly lower than the 






• During 2008-2010, the Maine age-adjusted melanoma incidence rate (21.9 per 
100,000) was similar to, and not significantly different from, the overall U.S. SEER 
rate (23.2 per 100,000), but significantly lower than the U.S. SEER white rate 
(28.5 per 100,000; Table 2.23, Figure 2.13). 
 
• Melanoma incidence rates among Maine females and males were similar to 
those of the U.S SEER population, but significantly lower the U.S. SEER white 
population (Table 2.24, Figure 2.14). 
 
Figure 2.13. Melanoma Incidence Rates by 3-Year Period, Maine and U.S., 2000-2010 
Maine Data Source: Maine CDC Cancer Registry, November 2012 NPCR data submission (1995-2010). U.S. Data Source: SEER 9 
Research Data (1973-2010). Rates are calculated using SEER*Stat Version 8.1.5. 
Melanoma: SEER Site Recode ICD-O-3: 25010 (which include ICD-O-3 code: C440-C449). 
Age adjusted rates are new cases per 100,000 population age-adjusted to the U.S. 2000 standard population. 
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What are the trends in melanoma incidence rates in Maine? 
 
In Maine, melanoma incidence rates stayed consistent from 2000 to 2010. 
 
• During 2008-2010, an average of 355 Mainers were diagnosed with melanoma 
each year (Table 2.23). 
 
• In Maine, melanoma age-adjusted incidence rates significantly increased from 
2000-2002 (19.8 per 100,000) to 2003-2005 (22.7 per 100,000), and then 
stabilized through 2008-2010.  In contrast, U.S. SEER white rates steadily 
increased and were consistently higher than Maine’s rates from 2000-2002 to 
2008-2010 (Table 2.23, Figure 2.13). 
 
Are there differences in melanoma incidence rates by sex in Maine? 
 
In Maine, males have consistently higher melanoma incidence rates than females.  
 
• From 2000 and 2010, Maine males had consistently higher melanoma incidence 






Figure 2.14. Melanoma Incidence Rates by 3-Year Period and Sex, Maine and U.S., 
2000-2010 
Data Source: Maine CDC Cancer Registry, November 2012 NPCR data submission (1995-2010). Rates are calculated using 
SEER*Stat Version 8.1.5. 
Melanoma: SEER Site Recode ICD-O-3: 25010 (which include ICD-O-3 code: C440-C449). 
Age adjusted rates are new cases per 100,000 population age-adjusted to the U.S. 2000 standard population. 
 Maine Cancer Surveillance Report 2014 Page 40
 Cancer Incidence 
• During 2008-2010, the age-adjusted melanoma incidence rate among Maine 
males (26.6 per 100,000) was 45% higher than the rate among females (18.4 per 
100,000). A similar, significant pattern was observed between males and females 
for U.S. SEER overall and U.S. SEER whites (Table 2.24, Figure 2.14). 
 
• Among Maine males, the age-adjusted melanoma incidence rates varied slightly 
from year to year, but did not significantly change between 2000 and 2010. For 
Maine females, melanoma incidence rates also did not show substantial change 
over this period; the only significant difference was between the time periods of 
2000-2002 at 16.5 per 100,000 and 2005-2007 at 20.3 per 100,000 (Table 2.24, 
Figure 2.14). 
 
Are there differences in melanoma incidence rates by age group in Maine? 
 
In Maine, melanoma incidence rates are highest in those ages 65 years and older. 
 
• Melanoma incidence rates were significantly higher among Mainers in the 65–74 
years and 75 years and older age groups compared to younger age groups during 
2008-2010; the rates between the older age groups were not significantly 
different. Similar to Maine’s observed age pattern, melanoma incidence rates 
increased with age in the U.S. SEER overall and white populations during this 
time (Table 2.25). 
 
• During 2008-2010, the melanoma incidence rate among Mainers ages 75 years 
and older (84.4 per 100,000) appeared to be higher than the rate for those ages 
65–74 years (66.5 per 100,000), but these rates were not statistically different.  
Melanoma incidence rates among Mainers ages 75 years and older was 2.7 times 
the rate for those ages 35–64 years (31.1 per 100,000), and 25.6 times the rate 
for those ages 0–34 years (3.3 per 100,000).  These differences were statistically 
significant (Table 2.25, Figure 2.6).   
 
• From 2000 to 2010, there was no significant difference over time in melanoma 
incidence rates among Mainers ages 0–34 years. Annual melanoma incidence 
rates appear to increase over time among Mainers in the 35–64, 65–74 and the 
75 years and older age groups, but these differences were not statistically 
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Are there differences in melanoma incidence rates by geography?  
 
Counties and public health districts with the highest melanoma incidence rates tend to 
be in southern Maine.   
 
• Although Cumberland, Knox, Sagadahoc and York counties had the highest age-
adjusted melanoma incidence rates in Maine during 2006-2010, only the rates in 
Cumberland, Knox, and York counties (28.0, 36.1, and 26.7 per 100,000, 
respectively) were significantly higher the overall Maine rate (22.1 per 100,000; 
Table 2.26, Map 2.11). 
 
• The melanoma incidence rate in Knox County, the highest county rate in Maine 
(36.1 per 100,000) was 3 times the rate in Franklin County, the lowest county 
rate in the state (11.5 per 100,000); this difference was statistically significant 
(Table 2.26, Map 2.11). 
 
• Cumberland, Midcoast, and York districts had the highest age-adjusted 
melanoma incidence rates in the state during 2006-2010, and these rates (28.0, 
26.6, 26.7 per 100,000, respectively) were significantly higher than the overall 
Maine rate (22.1 per 100,000; Table 2.26, Map 2.12). 
 
• During 2006-2010, Cumberland District’s age-adjusted melanoma incidence rate, 
the highest district rate in the state at 28.0 per 100,000, was twice the rate in 
Aroostook District, the lowest district rate in the state (12.5 per 100,000; Table 
2.26, Map 2.12). 
 
See maps at the end of the chapter. 
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Prostate cancer 
 
How do prostate cancer incidence rates in Maine compare to those of the U.S.? 
 
Prostate cancer incidence rates in Maine are similar to U.S. rates in the early 2000s, 
but are significantly lower than U.S. rates in the latter part of the decade. 
 
• During the first part of the 2000-2010 decade, the age-adjusted prostate cancer 
incidence rates in Maine were similar to rates among the U.S. SEER overall and 
U.S. SEER white males.  Maine’s prostate cancer incidence rates have declined 
faster than the U.S. SEER rates in recent years such that Maine’s rates during 
2007-2009 and 2008-2010 were significantly lower than the U.S. SEER and SEER 






• During 2008-2010, the age-adjusted prostate cancer incidence rate in Maine 
(129.4 per 100,000) was significantly lower than the overall U.S. SEER rate (151.9 
per 100,000) and the rate for U.S. SEER white males (146.2 per 100,000; Table 
2.27, Figure 2.15). 
 
Figure 2.15. Prostate Cancer Incidence Rates by 3-Year Period, Maine and U.S., 2000-2010 
Maine Data Source: Maine CDC Cancer Registry, November 2012 NPCR data submission (1995-2010). U.S. Data Source: SEER 9 
Research Data (1973-2010). Rates are calculated using SEER*Stat Version 8.1.5. 
Prostate cancer: SEER Site Recode ICD-O-3: 28010 (which include ICD-O-3 code: C619). 
Age adjusted rates are new cases per 100,000 population age-adjusted to the U.S. 2000 standard population. 
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What are the trends in prostate cancer incidence rates in Maine? 
 
Prostate cancer incidence rates in Maine are decreasing more rapidly than U.S rates. 
 
• An average of 1,061 Maine males were diagnosed with prostate cancer each 
year during 2008-2010 (Table 2.27). 
 
• In Maine, the age-adjusted prostate cancer incidence rate has significantly 
decreased from 181.2 per 100,000 during 2000-2002 to 129.4 per 100,000 
during 2008-2010, a 28.6% overall decline and an average annual decline of 4.0% 
(Table 2.27, Figure 2.15).   
 
• From 2000 to 2010, prostate cancer incidence rates among Maine males were 
declining at a faster pace (average annual decline: 4.0%) compared to males in 
the U.S. SEER overall (average annual decline: 2.3%) and U.S. SEER whites 
(average annual decline: 2.6%; Table 2.27, Figure 2.15).   
 
Are there differences in prostate cancer incidence rates by age group in Maine? 
 
In Maine, prostate cancer incidence rates are highest among males ages 65-74 years.  
 
• During 2000 to 2010, prostate cancer incidence rates were significantly higher 
among Maine males in the 65–74 age group compared to those in the 0–34 and 
35–64 age groups. Prostate cancer incidence rates among males ages 65–74 
years were significantly higher than rates among males ages 75 years and older 
during most of this decade, except in 2000-2002 and 2001-2003. This age pattern 
was similar for the U.S. SEER overall and U.S. SEER white population (Table 2.28). 
 
• During 2008-2010, the crude prostate cancer incidence rate among Maine males 
ages 65–74 years (753.1 per 100,000) was 1.3 times the rate for those ages 75 
years and older and 4.8 times the rate for those ages 35–64 years (156.5 per 
100,000); these differences were statistically significant. During this time period, 
very few prostate cancer cases were diagnosed in the 0–34 age group in Maine 
(Table 2.28, Figure 2.6).   
 
• From 2000 to 2010, there was a significant decrease in prostate cancer incidence 
rates among Maine males ages 65–74 years and 75 years and older. Among 
Maine males ages 35–64 years, prostate cancer incidence rates significantly 
increased between 2000-2002 and 2006-2008, but have since decreased 
significantly. Over this time, very few prostate cancer cases were diagnosed 
among Maine males ages 0–34 years (Table 2.28). 
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Are there differences in prostate cancer incidence rates by geography?  
 
Counties and public health districts with the highest prostate cancer incidence rates 
tend to be in southern and eastern Maine.   
 
• Although Androscoggin, Knox, Washington, and York counties had the highest 
age-adjusted prostate cancer incidence rates in Maine during 2006-2010, these 
rates were not significantly higher than the overall Maine rate (Table 2.29, Map 
2.13). 
 
• The prostate cancer incidence rate in York County, the highest county rate in 
Maine (age-adjusted rate: 156.8 per 100,000) during 2006-2010, was 
significantly higher than rates in Aroostook and Piscataquis counties in Maine, 
the lowest county rates in Maine (age-adjusted rates: 108.0 and 100.4 per 
100,000, respectively; Table 2.29, Map 2.13). 
 
• Although Downeast and York districts had the highest age-adjusted prostate 
cancer incidence rates in the state, these rates were not significantly higher than 
the overall Maine rate (Table 2.29, Map 2.14) 
 
• Aroostook District has the lowest prostate cancer incidence rate in the state 
(age-adjusted rate: 108.0 per 100,000), significantly lower than the Maine overall 
rate (age-adjusted rate: 144.8 per 100,000) and all other Maine districts (Table 
2.29, Map 2.14). 
 
See maps at the end of the chapter. 
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Tobacco-related cancer (excluding lung cancer) 
 
This section examines tobacco-related cancers other than lung cancer. Tobacco-related 
cancers are those that the U.S. Surgeon General has determined have a direct causal link 
to tobacco use.  Tobacco-related (excluding lung) cancers include laryngeal, oral cavity 
and pharynx, esophageal, stomach, pancreatic, kidney and renal pelvis, urinary bladder, 
and cervical cancers, and acute myeloid leukemia. 
 
How do tobacco-related cancer incidence rates in Maine compare to those of the U.S.? 
 
In Maine, males have significantly higher tobacco-related cancer incidence rates than 
U.S. males, while tobacco-related cancer incidence rates among Maine and U.S. 
females are similar. Tobacco-related cancer incidence rates in Maine are significantly 
higher than U.S. rates. 
 
• From 2000 to 2010, the age-adjusted tobacco-related cancer incidence rates in 
Maine were consistently and significantly higher than the rates for U.S. SEER 






• During 2008-2010, the age-adjusted tobacco-related cancer incidence rate in 
Maine was 90.4 per 100,000, significantly higher than the U.S. SEER overall rate 
Figure 2.16. Tobacco-Related Cancer Incidence Rates by 3-Year Period, Maine and 
U.S., 2000-2010 
Maine Data Source: Maine CDC Cancer Registry, November 2012 NPCR data submission (1995-2010). U.S. Data Source: SEER 9 
Research Data (1973-2010). Rates are calculated using SEER*Stat Version 8.1.5. 
Tobacco-related cancers (excluding lung) include the following: laryngeal, oral cavity and pharynx, esophageal, stomach, pancreatic, kidney 
and renal pelvis, urinary bladder, cervical cancers, and acute myeloid leukemia.  Please see Appendix II for SEER and ICD-O-3 codes.                                                                                                                                                                                                              
Age adjusted rates are new cases per 100,000 population age-adjusted to the U.S. 2000 standard population. 
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of 82.1 per 100,000 and U.S. SEER white rate of 83.4 per 100,000 (Table 2.30, 
Figure 2.16). 
 
• During 2008-2010, the age-adjusted tobacco-related cancer incidence rate 
among Maine males (131.6 per 100,000) was 13% higher than U.S. SEER males 
overall (116.9 per 100,000) and 10% higher than U.S. white males (119.9 per 
100,000); these differences were statistically significant.  The rate for Maine 
females in this period (57.4 per 100,000) was similar to (and not significantly 
different from) that of U.S. SEER females (55.0 per 100,000) and U.S. SEER white 
females (54.3 per 100,000; Table 2.30). 
 
What are the trends in tobacco-related cancer incidence rates in Maine? 
 
In Maine, tobacco-related cancer incidence rates have stayed constant over the past 
decade. 
 
• During 2008-2010, an average of 1,526 Maine adults were diagnosed with 
tobacco-related cancer each year (Table 2.30). 
 
• The age-adjusted tobacco-related cancer incidence rates in Maine remained 
steady between 2000 and 2010, and none of the rates were significantly 
different across this period (Table 2.30, Figure 2.16). 
 
• In contrast to Maine, U.S. SEER overall tobacco-incidence rates have increased 
significantly over the 2000-2010 decade, though the absolute changes are 
relatively small (Table 2.30, Figure 2.16).  
 
• Among U.S. SEER whites, tobacco-related cancer incidence rates were 
significantly higher in the latter years of the decade (2004 to 2010) compared to 
rates in earlier years (2000-2002 and 2001 -2003; Table 2.30, Figure 2.16). 
 
Are there differences in tobacco-related cancer incidence rates by sex in Maine? 
 
In Maine, tobacco-related cancer incidence rates are significantly higher among males 
than females.  
 
• In Maine, between 2000 and 2010, the age-adjusted tobacco-related cancer 
incidence rates among males were significantly higher than females (Table 2.31, 
Figure 2.17). 
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• During 2008-2010, the age-adjusted tobacco-related cancer incidence rate 
among Maine males (131.6 per 100,000) was twice the rate among females (57.4 
per 100,000); this difference was statistically significant. A similar, significant 
pattern was observed between males and females for U.S. SEER overall and U.S. 
SEER whites (Table 2.31, Figure 2.17). 
 
• Tobacco-related cancer incidence rates have not changed consistently or 
significantly among either Maine males or females from 2000 to 2010 (Table 
2.31, Figure 2.17). 
 
Are there differences in tobacco-related cancer incidence rates by age group in 
Maine? 
 
In Maine, the tobacco-related cancer incidence rate increases with age and is 
significantly higher in the oldest age group (75 years and older). 
 
• During 2000 to 2010, tobacco-related cancer incidence rates in Maine increased 
with age. This age pattern was similar for the U.S. SEER overall and U.S. SEER 
whites (Table 2.32). 
 
• During 2008-2010, the crude tobacco-related cancer incidence rate among 
Maine adults ages 75 years and older (510.4 per 100,000) was 1.4 times the rate 
Figure 2.17. Tobacco-Related Cancer Incidence Rates by 3-Year Period and Sex, Maine 
and U.S., 2000-2010 
Data Source: Maine CDC Cancer Registry, November 2012 NPCR data submission (1995-2010). Rates are calculated using 
SEER*Stat Version 8.1.5. 
Tobacco-related cancers (excluding lung) include the following: laryngeal, oral cavity and pharynx, esophageal, stomach, pancreatic, 
kidney and renal pelvis, urinary bladder, cervical cancers, and acute myeloid leukemia.  Please see Appendix II for SEER and ICD-O-
3 codes.                                                                                                                                                                                                              
Age adjusted rates are new cases per 100,000 population age-adjusted to the U.S. 2000 standard population. 
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for those ages 65–74 years (372.0 per 100,000), 5 times the rate for those ages 
35–64 years (102.0 per 100,000), and 113 times the rate for those ages 0–34 (4.5 
per 100,000); these differences were statistically significant (Table 2.32, Figure 
2.6). 
 
• In Maine, tobacco-related cancer incidence rates were stable over time within 
each age group from 2000 to 2010, and there were no significant changes in over 
time in any age group during this period (Table 2.32). 
 
Are there differences in tobacco-related cancer incidence rates by geography?  
 
Tobacco-related cancer incidence rates do not vary substantially by county or district 
in Maine.  
 
• Androscoggin, Oxford, Penobscot and York counties had the highest age-
adjusted tobacco-related cancer incidence rates in Maine (100.8, 99.2, 94.7, 95.7 
per 100,000, respectively) during 2006-2010, but none of these rates were 
significantly higher than the overall state rate (91.9 per 100,000) or any other 
Maine county (Table 2.33, Map 2.15). 
 
• Western and York districts had the highest age-adjusted tobacco-related cancer 
incidence rates among public health districts in the state during 2006-2010, but 
neither was significantly different from the overall Maine rate or any other 
Maine district (Table 2.33, Map 2.16). 
 
See maps at the end of the chapter. 
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Section II:  Stage at Diagnosis 
 
When a person is newly diagnosed with cancer, it is critical to determine the stage (or 
progression) of the cancer. Knowing the stage at diagnosis helps to estimate the 
patient’s prognosis for survival, plan optimal treatment, and decide whether the patient 
is eligible for a clinical trial.  
 
Staging is based on knowing how a cancer progresses.1 Different cancers behave in 
different ways. For most cancers, determining the stage at diagnosis is based on three 
main criteria: 
1) Site of the primary tumor and type of cancer cell 
2) Tumor size and extension  
3) Metastasis (spread) of cancer cells to lymph nodes (nearby or more distant) or to 
other organs in the body and brain 
 
Using these criteria, health professionals can determine whether the cancer is at an 
early stage (in situ or localized) or late stage (regional or distant); see Appendix IV for 
details. In some circumstances, there might not be enough information to define the 
extent of tumor growth, so the stage at cancer diagnosis is considered unknown.  
Detecting the cancer at an early stage increases the likelihood that treatment will be 
effective for essentially all cancers, thus possibly improving the patient’s prognosis and 
chances for survival.  
 
In this section, data on stage at diagnosis are provided by the Maine CDC Cancer 
Registry for one 3-year period (2008-2010).  For cancer types presented, stage at 
diagnosis is categorized as early-stage cancer, late-stage cancer, and unknown.  For 
simplicity and ease of interpretation, only percentage of cancer diagnosed at each stage 
are presented in the figures; however, their associated age-adjusted rates are in the 
data tables (see Appendix I). 
 
 
Breast cancer (females only) 
 
At what stages are new breast cancer cases commonly diagnosed among Maine 
females? 
 
Among Maine females, almost three-fourths of new breast cancer cases are diagnosed 
at an early stage. 
 
• During 2008-2010, 73.6% of new breast cancer cases were diagnosed at an early 
stage (age-adjusted rate: 117.2 per 100,000), 24.8% at a late stage (40.6 per 
100,000), and 1.6% had an unknown stage at diagnosis (2.3 per 100,000; Table 
2.34, Figure 2.18). 
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How does stage at breast cancer diagnosis among Maine females compare to the U.S. 
females? 
 
Stage at diagnosis for breast cancer follows a similar pattern in Maine as in the U.S.  
 
• The percentage and age-adjusted rate of early-stage breast cancer diagnosis 
among Maine females (73.6%, 117.2 per 100,000) was similar to those among 
females in the U.S. SEER overall (71.9%; 117.8 per 100,000) and U.S. SEER white 
females (72.6%; 121.6 per 100,000) during 2008-2010 (Table 2.34, Figure 2.18). 
 
• Maine females were diagnosed with breast cancer at early, late and unknown 
stages at similar proportion as U.S. SEER females and U.S. SEER white females, 
with most females being diagnosed with breast cancer at an early stage (Table 
2.34, Figure 2.18). 
 
 
Figure 2.18. Incident Female Breast Cancer at Stage of Diagnosis, Maine, U.S. SEER 9 
and U.S. SEER 9 Whites, 2008-2010 
 
Maine Data Source: Maine CDC Cancer Registry, November 2012 NPCR data submission (1995-2010). 
U.S. Data Source: SEER 9 Research Data (1973-2010). Percentages are calculated using SEER*Stat 
Version 8.1.5.  
Breast Cancer: SEER Site Recode ICD-O-3: 26000 (which include ICD-O-3/WHO 2008 code: C500-
C509). 
Stage at diagnosis is determined when the cancer was first diagnosed and has been summarized as early 
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Cervical cancer 
 
At what stages are new cervical cancer cases commonly diagnosed among Maine 
females? 
 
Less than half of all new cervical cancer cases among Maine females are diagnosed at 
an early stage. 
 
• During 2008-2010, 45.8% of new cervical cancer cases were diagnosed at an 
early stage (age-adjusted rate: 3.4 per 100,000), 50.7% at a late stage (2.8 per 
100,000), and 3.5% were diagnosed at an unknown stage (0.2 per 100,000; Table 































Figure 2.19. Incident Cervical Cancer at Stage of Diagnosis, Maine, U.S. SEER 9 
and U.S. SEER 9 Whites, 2008-2010 
 
Maine Data Source: Maine CDC Cancer Registry, November 2012 NPCR data submission (1995-2010). 
U.S. Data Source: SEER 9 Research Data (1973-2010). Percentages are calculated using SEER*Stat 
Version 8.1.5.  
Cervical Cancer: SEER Site Recode ICD-O-3: 27010 (which include ICD-O-3/WHO 2008 code: C530-C539). 
Stage at diagnosis is determined when the cancer was first diagnosed and has been summarized as early 
stage (in situ and localized), late stage (regional and distant), or unknown.  
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How does stage at cervical cancer diagnosis among Maine females compare to the 
U.S. females? 
 
There is no significant difference in cervical cancer diagnosis at early or late stage for 
Maine and U.S. females.  
 
• During 2008-2010, among Maine females, the proportion and rate of early-stage 
cervical cancer diagnosis (45.8%; 3.4 per 100,000) was similar to (and not 
significantly different from) those among U.S. SEER females (48.8%; 3.4 per 
100,000) and U.S. SEER white females (50.6%; 3.5 per 100,000; Table 2.35, Figure 
2.19). 
 
• In Maine, the proportion of females diagnosed with cervical cancer at early, late 
and unknown stages followed a similar pattern to that of U.S. SEER females and 
U.S. SEER white females, with equal proportions of females being diagnosed for 





At what stages are new colorectal cancer cases commonly diagnosed in Maine? 
 
In Maine, nearly 50% of new colorectal cancer cases are diagnosed at a late stage.  
 
• During 2008-2010, 44.7% of colorectal cancer cases were diagnosed at an early 
stage (age-adjusted rate: 20.2 per 100,000), 49.2% at a late stage (22.5 per 
100,000), and for 6.1% (2.7 per 100,000) the stage at diagnosis was unknown 
(Table 2.36, Figure 2.20). 
 
• During 2008-2010, new colorectal cancer cases were significantly more likely to 
be diagnosed at a late stage (49.2%) than an early stage (44.7%) in Maine (Table 
2.36, Figure 2.20). 
 
How does stage at colorectal cancer diagnosis in Maine compare to the U.S.? 
 
New colorectal cancer cases tend to be diagnosed at a late stage both in Maine and 
the U.S. Maine has a higher proportion of new colorectal cancer cases with an 
unknown stage at diagnosis than the U.S. 
 
• During 2008-2010, the percentage and age-adjusted rate of early-stage 
colorectal cancer diagnosis among Mainers (44.7%; 20.2 per 100,000) was similar 
to (and not significantly different from) those among the U.S. SEER overall 
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(43.0%; 19.1 per 100,000) and U.S. SEER whites (42.9%; 18.5 per 100,000; Table 
2.36, Figure 2.20). 
 
• In Maine, a significantly higher proportion of new colorectal cancer cases had an 
unknown stage at diagnosis (6.1%) compared to U.S. SEER overall (4.7%) and U.S. 
SEER whites (4.5%) during 2008-2010 (Table 2.36, Figure 2.20). 
 
• During 2008-2010, the proportion of Maine males and females diagnosed with 
colorectal cancer at early, late and unknown stages followed a similar pattern to 
that of the U.S. SEER overall and U.S. SEER whites, with new cases more 

























Are there sex differences in stage at diagnosis among new colorectal cancer cases in 
Maine? 
 
Late-stage colorectal cancer diagnosis is common among both Maine males and 
females. Maine females tend to be more likely to have colorectal cancer with an 
unknown stage at diagnosis than U.S. females. 
 
• During 2008-2010, Maine males had significantly higher colorectal cancer rates 
at all stages at diagnosis compared to females, but the proportion of colorectal 
Figure 2.20. Incident Colorectal Cancer at Stage of Diagnosis by Sex, Maine, U.S. SEER 9 
and U.S. SEER 9 Whites, 2008-2010 
 
Maine Data Source: Maine CDC Cancer Registry, November 2012 NPCR data submission (1995-2010). U.S. Data Source: SEER 9 Research Data (1973-
2010). Percentages are calculated using SEER*Stat Version 8.1.5.  
Colorectal Cancer: SEER Site Recode ICD-O-3: 21041-21049, 21051, 21052 (which include ICD-O-3 codes: C180-C189, C260, C199, C209).  
Stage at diagnosis is determined when the cancer was first diagnosed and has been summarized as early stage (in situ and localized), late stage (regional 
and distant), or unknown.  
 
Maine U.S. SEER 9 U.S. SEER 9 Whites 
 
45 43 43 42 46 43 42 44 44 
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cancer diagnosed at each stage was not statistically different between males and 
females (Table 2.37, Figure 2.20). 
 
• In Maine, both females and males were significantly more likely to have 
colorectal cancer diagnosed at a late stage (49.9% and 48.6%, respectively) 
compared to early stage (43.1% and 46.1%, respectively) during 2008-2010. 
There was no significant difference between females and males in the 
proportion of colorectal cancer cases diagnosed with an unknown stage (7.0% 
and 5.3%, respectively; Table 2.37, Figure 2.20). 
 
• There was no significant difference in early- or late-stage colorectal cancer 
diagnosis among Maine males and females compared those in the U.S. SEER 
overall and U.S. SEER whites (Table 2.37, Figure 2.20).  
 
• The proportion of new colorectal cancer cases diagnosed among Maine females 
at an unknown stage (7.0%) was significantly higher than those among U.S. SEER 




At what stages are new lung cancer cases commonly diagnosed in Maine? 
 
Almost 75% of new lung cancers are diagnosed at a late stage in Maine.   
 
• During 2008-2010, among Mainers, 19.3% (age-adjusted rate: 14.6 per 100,000) 
of lung cancer diagnosis occurred at early-stage, 75.2% (57.1 per 100,000) 
occurred at a late stage, and in 5.5% (4.2 per 100,000) the stage at diagnosis was 
unknown (Table 2.38, Figure 2.21). 
 
• New lung cancer cases in Maine were significantly more likely to be diagnosed at 
a late stage (75.2%) than an early stage (19.3%) during 2008-2010 (Table 2.38, 
Figure 2.21). 
 
How does stage at lung cancer diagnosis in Maine compare to the U.S.? 
 
The proportion of lung cancer cases diagnosed at an early, late, or unknown stage in 
Maine is similar to those in the U.S. overall and U.S. whites.  
 
• During 2008-2010, the percentage and age-adjusted rate of late-stage lung 
cancer diagnosis among Mainers (75.2%; 57.1 per 100,000) was similar to (and 
not significantly different from) those among the U.S. SEER overall (75.7%; 44.4 
per 100,000) and U.S. SEER whites (74.9%; 44.6 per 100,000; Table 2.38, Figure 
2.21). 
 Maine Cancer Surveillance Report 2014 Page 55












• The proportion of new lung cancer cases among Mainers that had an unknown 
stage at diagnosis (5.5%) was similar to the proportion among U.S. SEER overall 
(5.8%) and U.S. SEER whites (5.9%) during 2008-2010 (Table 2.38, Figure 2.21). 
 
• In Maine, the proportion of males and females diagnosed with lung cancer at 
early, late and unknown stages was similar to that of the U.S. SEER overall and 
U.S. SEER whites, with most new lung cancer cases being diagnosed at late stage 
during 2008-2010 (Table 2.38, Figure 2.21). 
 
Are there sex differences in stage at diagnosis among new lung cancer cases in Maine? 
 
Maine males and females tend to have lung cancer diagnosed at a late stage.  Maine 
females are more likely to have lung cancer diagnosed at an early stage than males. 
 
• During 2008-2010, both Maine females and males were significantly more likely 
to have lung cancer to be diagnosed at a late stage (73.5% and 76.7%, 
respectively) compared to early stage (21.6% and 17.2%, respectively). The 
proportion of lung cancer cases diagnosed with an unknown stage was not 
significantly different between females and males (4.9% and 6.0%, respectively; 
Table 2.39, Figure 2.21). 
Figure 2.21. Incident Lung Cancer at Stage of Diagnosis by Sex, Maine, U.S. SEER 9 and 
U.S. SEER 9 Whites, 2008-2010 
 
Maine Data Source: Maine CDC Cancer Registry, November 2012 NPCR data submission (1995-2010). U.S. Data Source: SEER 9 Research Data (1973-
2010). Percentages are calculated using SEER*Stat Version 8.1.5.  
Lung cancer: SEER Site Recode ICD-O-3: 22030 (which include ICD-O-3 code: C340-C349). 
Stage at diagnosis is determined when the cancer was first diagnosed and has been summarized as early stage (in situ and localized), late stage (regional 
and distant), or unknown.  
 
Maine U.S. SEER 9 U.S. SEER 9 Whites 
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• Maine females were significantly more likely to have lung cancer diagnosed at an 
early stage (21.6%) than males (17.2%), but there was no significant difference 
between females and males in diagnosis at late stage or having an unknown 
stage at diagnosis.  Among U.S. SEER and U.S. SEER whites, females were 
significantly more likely to have lung cancer diagnosed at an early stage and 
significantly less likely to have lung cancer diagnosed as a late stage compared to 
males (Table 2.39, Figure 2.21).  
 
• There was no significant difference in lung cancer diagnosis at any stage among 
Maine males and females compared those in the U.S. SEER overall and U.S. SEER 




At what stages are new prostate cancer cases commonly diagnosed among Maine 
males? 
 
In Maine, nearly 80% of new prostate cancer cases are diagnosed at an early stage. 
 
• During 2008-2010, 77.9% of new prostate cancer cases were diagnosed at an 
early stage (age-adjusted rate: 99.9 per 100,000), 17.7% at a late stage (22.7 per 
100,000), and 4.5% were diagnosed at an unknown stage (6.8 per 100,000; Table 
2.40, Figure 2.22). 
 





Figure 2.22. Incident Prostate Cancer at Stage of Diagnosis, Maine, U.S. SEER 9       
and U.S. SEER 9 White, 2008-2010 
 
Maine Data Source: Maine CDC Cancer Registry, November 2012 NPCR data submission (1995-2010). 
U.S. Data Source: SEER 9 Research Data (1973-2010). Percentages are calculated using SEER*Stat 
Version 8.1.5.  
Prostate cancer: SEER Site Recode ICD-O-3: 28010 (which include ICD-O-3 code: C619). 
Stage at diagnosis is determined when the cancer was first diagnosed and has been summarized as early 
stage (in situ and localized), late stage (regional and distant), or unknown.   Maine Cancer Surveillance Report 2014 Page 57
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How does stage at prostate cancer diagnosis in Maine compare to the U.S.? 
 
Maine males are less likely to have prostate cancer diagnosed at an early stage 
compared to U.S. males. Males in Maine are also more likely to have prostate cancer 
diagnosed at an unknown stage than U.S. males.  
 
• During 2008-2010, Maine males were significantly less likely to have prostate 
cancer diagnosed at an early stage (77.9%, 99.9 per 100,000) compared to U.S. 
SEER males (80.7%; 122.8 per 100,000) and U.S. SEER white males (80.8%; 118.4 
per 100,000; Table 2.40, Figure 2.22). 
 
• In Maine, the proportion of males diagnosed with prostate cancer at a late stage 
was similar to that of U.S. SEER males and U.S. SEER white males (Table 2.40, 
Figure 2.22). 
 
• Maine males were significantly more likely to be diagnosed with prostate cancer 
at an unknown stage (4.5%; 6.8 per 100,000) than U.S. SEER males (2.7%; 4.6 per 
100,000) and U.S. SEER white males (2.2%; 3.7 per 100,000).  U.S. SEER males are 
also more likely to have prostate cancer diagnosed at an unknown stage than 
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In	  this	  chapter,	  we	  examine	  cancer	  deaths	  and	  death	  rates	  in	  Maine,	  and	  compare	  
Maine	  data	  to	  overall	  U.S.	  and	  U.S.	  white	  populations	  to	  identify	  state-­‐specific	  
differences.	  We	  present	  death	  data	  and	  statistics	  for	  all	  cancers	  combined,	  and	  for	  eight	  
specific	  cancer	  types,	  presented	  in	  alphabetical	  order	  as	  follows:	  	  
	  
• Bladder	  cancer	  
• Breast	  cancer	  (female	  only)	  
• Cervical	  cancer	  
• Colorectal	  cancer	  
• Lung	  cancer	  (including	  bronchus)	  	  
• Melanoma	  
• Prostate	  cancer	  
• Tobacco-­‐related	  cancer	  (excluding	  lung	  cancer)	  
	  
Of	  these,	  five	  cancers	  account	  for	  most	  cancer	  deaths	  in	  Maine	  —	  lung,	  tobacco-­‐related	  
(excluding	  lung),	  colorectal	  cancer,	  and	  breast	  cancer	  among	  women	  and	  prostate	  
cancer	  among	  men.	  	  Although	  the	  remaining	  three	  cancers	  —	  bladder,	  cervical,	  and	  
melanoma	  —	  are	  less	  common,	  they	  were	  included	  because	  they	  are	  of	  interest	  to	  





Data Source: Maine Mortality Data; Data, Research and Vital Statistics, Maine CDC.                           
Note: The disease is listed f irst, followed by the total number of  deaths, then the percent of  total deaths.  ICD -­‐10 codes: Cancer C00-­‐C97; Heart Disease 
I00-­‐I09, I11, I13, I20-­‐I51; Stroke I60-­‐I69; Chronic Lower Respiratory Disease J40-­‐J47; Unintentional InjuriesV01-­‐X59,Y85-­‐Y86; Alzheimer’s Disease G30.
Figure 3.1. Leading Causes of Death, Maine, 2010
Cancer, 3,247, 34%
Heart Disease, 
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All	  cancer	  
This	  section	  focuses	  on	  deaths	  from	  all	  types	  of	  cancer	  combined.	  	  In	  this	  section,	  “cancer	  
deaths”	  and	  “cancer	  death	  rates”	  means	  deaths	  and	  death	  rates	  for	  all	  types	  of	  cancer	  
combined.	  
How	  common	  are	  deaths	  from	  cancer	  in	  Maine	  and	  the	  U.S.?	  
Cancer	  is	  the	  leading	  cause	  of	  death	  in	  Maine	  and	  the	  second	  leading	  cause	  of	  death	  
among	  all	  Americans.	  
• In	  2010,	  cancer	  was	  the	  leading	  cause	  of	  death	  in	  Maine,	  causing	  3,247	  deaths
(34%	  of	  all	  deaths;	  Figure	  3.1).
• In	  2010,	  cancer	  was	  the	  second	  leading	  cause	  of	  death	  in	  the	  U.S	  (after	  heart
disease),	  with	  more	  than	  574,000	  cancer	  deaths	  (23%	  of	  all	  deaths)	  in	  the	  U.S.	  in
that	  year.1
• On	  average,	  9	  Mainers	  die	  from	  cancer	  each	  day	  (Table	  3.1).
• In	  2010,	  cancer	  was	  the	  leading	  cause	  of	  years	  of	  potential	  life	  lost	  before	  age	  75
years	  in	  Maine,	  causing	  23,202	  years	  of	  potential	  life	  lost,	  with	  an	  estimated	  28%
of	  Maine’s	  total	  years	  of	  potential	  life	  lost	  due	  to	  cancer	  (Figure	  3.2).2
	  Figure 3.2. Leading Causes of Years of Potential Life Lost Before Age 75, Maine, 2010 
Data Source: WISQARS System; National Center for Health Statistics Vital Statistics System. Accessed December 20, 2013. 
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How	  do	  cancer	  death	  rates	  in	  Maine	  compare	  to	  those	  of	  the	  U.S.? 
The	  cancer	  death	  rate	  in	  Maine	  is	  significantly	  higher	  than	  the	  overall	  U.S.	  rate	  and	  is	  
the	  highest	  rate	  among	  New	  England	  states.	  
• From	  2000	  to	  2010,	  the	  age-­‐adjusted	  cancer	  death	  rates	  in	  Maine	  were
consistently	  higher	  than	  both	  the	  U.S.	  rate	  and	  the	  U.S.	  white	  rate	  (Table	  3.1,
Figure	  3.3).
• In	  2010,	  the	  age-­‐adjusted	  cancer	  death	  rate	  in	  Maine	  (186.6	  per	  100,000)	  was
significantly	  higher	  (9%)	  than	  both	  the	  U.S.	  rate	  (171.8	  per	  100,000)	  and	  the	  U.S.
white	  rate	  (171.4	  per	  100,000,	  Table	  3.1,	  Figure	  3.3).
• In	  2010,	  Maine	  had	  the	  11th	  highest	  cancer	  death	  rate	  among	  the	  50	  states	  and
the	  District	  of	  Columbia.3
• Among	  the	  six	  New	  England	  states,	  Maine	  had	  the	  highest	  cancer	  death	  rate	  in
2010.3	  





















Maine U.S. U.S. Whites
Data Source: Underlying mortality data provided by National Center for Health Statistics. Rates are calculated using SEER*Stat Version 8.1.5. 
All cancer: SEER Cause of Death Recode: 20010-37000 (which include ICD-10 codes: C00-C97) as the underlying cause of death.      
Age adjusted rates are deaths per 100,000 population age-adjusted to the U.S. 2000 standard population. 
Rates might be slightly underestimated due to missing underlying cause of death information for Maine residents who died out of state in 2010. 
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What	  are	  the	  trends	  in	  cancer	  death	  rates	  in	  Maine	  and	  the	  U.S.?	  
While	  cancer	  death	  rates	  in	  both	  Maine	  and	  the	  U.S.	  have	  steadily	  declined	  over	  time,	  
Maine’s	  cancer	  death	  rates	  have	  remained	  consistently	  higher	  than	  U.S.	  rates.	  
• Since	  2000,	  cancer	  death	  rates	  have	  steadily	  and	  significantly	  declined	  in	  both
Maine	  and	  the	  U.S.	  (Table	  3.1,	  Figure	  3.3).
• Maine’s	  age-­‐adjusted	  cancer	  death	  rate	  declined	  12.3%	  from	  212.8	  per	  100,000
in	  2000	  to	  186.6	  per	  100,000	  in	  2010	  (Table	  3.1,	  Figure	  3.3).
• From	  2000	  to	  2010,	  the	  average	  annual	  decline	  in	  Maine’s	  cancer	  death	  rate	  was
1.4%,	  which	  is	  similar	  to	  the	  average	  decline	  in	  the	  U.S.	  of	  1.3%	  (Table	  3.1,	  Figure
3.3).	  
Are	  there	  differences	  in	  cancer	  death	  rates	  by	  sex	  in	  Maine?	  	  
In	  Maine,	  males	  have	  significantly	  higher	  cancer	  death	  rates	  than	  females.	  
• There	  is	  a	  sex	  disparity	  in	  cancer	  death	  rates	  in	  Maine,	  with	  males	  having
significantly	  higher	  death	  rates	  than	  females	  from	  2000	  to	  2010	  (Table	  3.2,
Figure	  3.4).






















Data Source: Underlying mortality data provided by National Center for Health Statistics. Rates are calculated using SEER*Stat Version 8.1.5. 
All cancer: SEER Cause of Death Recode: 20010-37000 (which include ICD-10 codes: C00-C97) as the underlying cause of death.        
Age adjusted rates are deaths per 100,000 population age-adjusted to the U.S. 2000 standard population. 
Rates might be slightly underestimated due to missing underlying cause of death information for Maine residents who died out of state in 2010. 
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• In	  2010,	  the	  age-­‐adjusted	  cancer	  death	  rate	  among	  Maine	  males	  (226.0	  per
100,000)	  was	  43%	  higher	  than	  females	  (age-­‐adjusted	  rate:	  158.5	  per	  100,000;
Table	  3.2,	  Figure	  3.4).
• Maine	  males	  had	  significantly	  higher	  cancer	  death	  rates	  than	  females	  from	  2000
to	  2010,	  but	  over	  this	  time,	  death	  rates	  among	  males	  were	  declining	  at	  a	  similar
(not	  significantly	  different)	  pace	  as	  rates	  among	  females	  (Table	  3.2,	  Figure	  3.4).
• In	  2010,	  cancer	  death	  rates	  among	  Maine	  males	  and	  females	  were	  also
significantly	  higher	  than	  those	  of	  males	  and	  females	  for	  U.S.	  overall	  and	  U.S.
whites	  (Table	  3.2).
Are	  there	  differences	  in	  cancer	  death	  rates	  by	  age	  group	  in	  Maine?	  	  
In	  Maine,	  cancer	  death	  rates	  are	  significantly	  higher	  in	  older	  age	  groups	  than	  younger	  
age	  groups.	  
• From	  2000	  to	  2010,	  cancer	  death	  rates	  increased	  with	  age,	  and	  were	  low	  among
Mainers	  under	  35	  years	  of	  age.	  	  This	  age	  pattern	  is	  similar	  for	  the	  U.S.	  overall	  and
U.S.	  whites	  (Table	  3.3).
• Cancer	  death	  rates	  among	  Mainers	  ages	  0−34	  years	  and	  75	  and	  older	  have	  not
changed	  significantly	  from	  2000	  to	  2010.	  	  Annual	  cancer	  death	  rates	  among
Mainers	  ages	  65−74	  years	  suggests	  there	  may	  be	  a	  declining	  trend;	  rates	  in	  2007,
2008,	  2009,	  and	  2010	  were	  significantly	  lower	  than	  rates	  in	  2000	  and	  2002.	  The
2010	  cancer	  death	  rate	  among	  Mainers	  ages	  35−64	  years	  appears	  higher	  than
previous	  years,	  and	  is	  significantly	  higher	  than	  the	  2001	  rate,	  but	  additional	  years
of	  data	  are	  needed	  to	  determine	  whether	  or	  not	  this	  is	  an	  increasing	  trend
(Table	  3.3,	  Figure	  3.5).
• In	  2010,	  the	  cancer	  death	  rate	  among	  Mainers	  ages	  75	  years	  and	  older	  (1,469.3
per	  100,000)	  was	  twice	  the	  rate	  of	  those	  ages	  65−74	  years	  (723.5	  per	  100,000)
and	  9	  times	  the	  rate	  of	  those	  ages	  35−64	  years	  (165.2	  per	  100,000);	  these
differences	  were	  statistically	  significant.	  The	  annual	  number	  of	  cancer	  deaths
among	  Mainers	  ages	  0−34	  years	  in	  2010	  was	  too	  low	  to	  provide	  statistically
reliable	  rates	  in	  this	  age	  group	  (Table	  3.3,	  Figure	  3.5).
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Are	  there	  differences	  in	  cancer	  death	  rates	  by	  geography?	  	  
Counties	  and	  public	  health	  districts	  with	  the	  highest	  cancer	  death	  rates	  tend	  to	  be	  in	  
northern,	  northeastern,	  and	  western	  Maine.	  	  	  
• Kennebec	  and	  Washington	  counties	  had	  significantly	  higher	  age-­‐adjusted	  cancer
death	  rates	  than	  Maine	  overall	  (187.7	  per	  100,000)	  during	  2006-­‐2010	  (Table	  3.4,
Map	  3.1).
• The	  cancer	  death	  rate	  in	  Washington	  County,	  the	  highest	  county	  rate	  in	  Maine
(age-­‐adjusted	  rate:	  209.3	  per	  100,000),	  was	  25%	  higher	  than	  the	  rate	  in	  Lincoln
County,	  the	  lowest	  county	  rate	  in	  Maine	  (age-­‐adjusted	  rate:	  168.1	  per	  100,000);
this	  difference	  was	  statistically	  significant	  (Table	  3.4,	  Map	  3.1).
• Central	  District	  had	  the	  highest	  age-­‐adjusted	  cancer	  death	  rate	  (203.3	  per
100,000)	  among	  public	  health	  districts	  in	  the	  state,	  which	  was	  significantly	  higher
(9%)	  than	  the	  state	  rate	  (187.7	  per	  100,000;	  Table	  3.4,	  Map	  3.2).
• The	  cancer	  death	  rate	  in	  Central	  District	  (203.3	  per	  100,000),	  the	  highest	  district
rate	  in	  the	  state,	  was	  15%	  higher	  than	  the	  rate	  in	  Midcoast	  District,	  the	  lowest
district	  rate	  in	  the	  state	  (age-­‐adjusted	  rate:	  176.5	  per	  100,000);	  this	  difference
was	  statistically	  significant	  (Table	  3.4,	  Map	  3.2).
See	  maps	  at	  the	  end	  of	  the	  chapter.	  
Figure 3.5. All Cancer Death Rates by Year and Age Group, Maine, 2000-2010 
Data Source: Underlying mortality data provided by National Center for Health Statistics. Rates are calculated using SEER*Stat Version 8.1.5. 
All cancer: SEER Cause of Death Recode: 20010-37000 (which include ICD-10 codes: C00-C97) as the underlying cause of death.      
Age adjusted rates are deaths per 100,000 population age-adjusted to the U.S. 2000 standard population. 
Rates might be slightly underestimated due to missing underlying cause of death information for Maine residents who died out of state in 2010. 
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Bladder	  cancer	  
Bladder	  cancer	  in	  this	  section	  refers	  to	  urinary	  bladder	  cancer.	  	  
How	  do	  bladder	  cancer	  death	  rates	  in	  Maine	  compare	  to	  those	  of	  the	  U.S.?	  
Maine	  has	  consistently	  higher	  bladder	  cancer	  death	  rates	  compared	  to	  the	  U.S.	  
Bladder	  cancer	  death	  rates	  are	  significantly	  higher	  in	  Maine	  males	  compared	  to	  U.S.	  
males,	  but	  rates	  among	  Maine	  females	  are	  similar	  to	  those	  of	  U.S.	  females.	  
• From	  2000	  to	  2010,	  Maine’s	  age-­‐adjusted	  bladder	  cancer	  death	  rates	  were
consistently	  higher	  than	  the	  U.S.	  rate	  (significantly	  higher	  in	  all	  years	  except
2005),	  and	  higher	  than	  the	  U.S.	  white	  rate	  in	  most,	  but	  not	  all,	  years	  (Table	  3.5,
Figure	  3.6).
• In	  2010,	  Maine’s	  age-­‐adjusted	  death	  rate	  for	  bladder	  cancer	  (6.1	  per	  100,000)
was	  39%	  higher	  than	  the	  U.S.	  rate	  (4.4	  per	  100,000)	  and	  33%	  higher	  than	  the
U.S.	  white	  rate	  (4.6	  per	  100,000);	  these	  differences	  were	  statistically	  significant
(Table	  3.5,	  Figure	  3.6).
• In	  2010,	  the	  age-­‐adjusted	  bladder	  cancer	  death	  rate	  among	  Maine	  males	  (11.6
per	  100,000)	  was	  51%	  higher	  than	  the	  rate	  among	  U.S.	  males	  (7.7	  per	  100,000)
and	  43%	  higher	  than	  the	  rate	  among	  U.S.	  white	  males	  (8.1	  per	  100,000);	  these
Figure 3.6. Bladder Cancer Death Rates by Year, Maine and U.S., 2000-2010 
Data Source: Underlying mortality data provided by National Center for Health Statistics. Rates are calculated using SEER*Stat Version 8.1.5. 
Bladder cancer: SEER Cause of Death Recode: 29010 (which include ICD-10 code: C67) as the underlying cause of death.        
Age adjusted rates are deaths per 100,000 population age-adjusted to the U.S. 2000 standard population. 
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differences	  were	  statistically	  significant.	  	  The	  rate	  for	  Maine	  females	  in	  this	  year	  
(2.2	  per	  100,000)	  was	  similar	  to	  that	  of	  U.S.	  females	  (2.2	  per	  100,000)	  and	  U.S.	  
white	  females	  (2.2	  per	  100,000;	  Table	  3.6).	  
What	  are	  the	  trends	  in	  bladder	  cancer	  death	  rates	  in	  Maine?	  
Since	  2000,	  bladder	  cancer	  death	  rates	  in	  Maine	  have	  remained	  fairly	  constant.	  
• In	  2010,	  106	  Mainers	  died	  due	  to	  bladder	  cancer	  (Table	  3.5,	  Figure	  3.6).
• The	  age-­‐adjusted	  bladder	  cancer	  death	  rate	  in	  Maine	  remained	  fairly	  constant
from	  2000	  to	  2010	  (5.7	  vs.	  6.1	  per	  100,000)	  and	  there	  has	  been	  no	  significant
change	  over	  time.	  	  Similarly,	  bladder	  cancer	  death	  rates	  for	  U.S	  overall	  and	  U.S.
whites	  were	  steady	  over	  this	  time	  (Table	  3.5,	  Figure	  3.6).
Are	  there	  differences	  in	  bladder	  cancer	  death	  rates	  by	  sex	  in	  Maine?	  
Maine	  males	  have	  significantly	  higher	  bladder	  cancer	  death	  rates	  than	  Maine	  females.	  
• From	  2000	  to	  2010,	  Maine	  males	  had	  significantly	  higher	  bladder	  cancer	  death
rates	  than	  females	  (Table	  3.6,	  Figure	  3.7).
• In	  2010,	  the	  age-­‐adjusted	  bladder	  cancer	  death	  rate	  among	  Maine	  males	  (11.6
per	  100,000)	  was	  5	  times	  the	  bladder	  cancer	  death	  rate	  among	  females	  (2.2	  per
100,000;	  Table	  3.6,	  Figure	  3.7).
• Although	  bladder	  cancer	  death	  rates	  among	  Maine	  males	  appear	  to	  have
increased	  in	  the	  past	  few	  years,	  this	  change	  was	  not	  statistically	  significant.
Bladder	  cancer	  death	  rates	  did	  not	  change	  significantly	  among	  either	  Maine
males	  or	  females	  between	  2000	  and	  2010	  (Table	  3.6,	  Figure	  3.7).
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Data Source: Underlying mortality data provided by National Center for Health Statistics. Rates are calculated using SEER*Stat Version 8.1.5. 
Bladder cancer: SEER Cause of Death Recode: 29010 (which include ICD-10 code: C67) as the underlying cause of death.        
Age adjusted rates are deaths per 100,000 population age-adjusted to the U.S. 2000 standard population. 
Rates might be slightly underestimated due to missing underlying cause of death information for Maine residents who died out of state in 2010. 
Are	  there	  differences	  in	  bladder	  cancer	  death	  rates	  by	  age	  group	  in	  Maine?	  	  
As	  for	  many	  cancers,	  bladder	  cancer	  death	  rates	  in	  Maine	  increase	  with	  age.	  
• In	  Maine,	  bladder	  cancer	  death	  rates	  increased	  with	  age	  during	  2000	  to	  2010.
This	  age	  pattern	  is	  similar	  for	  the	  U.S.	  overall	  and	  U.S.	  whites	  (Table	  3.7).
• In	  2010,	  the	  bladder	  cancer	  death	  rate	  among	  Mainers	  ages	  75	  years	  and	  older
(61.8	  per	  100,000)	  was	  3	  times	  the	  rate	  of	  those	  ages	  65–74	  years	  (19.4	  per
100,000)	  and	  15	  times	  the	  rate	  of	  those	  ages	  35–64	  years	  (4.0	  per	  100,000);
these	  differences	  were	  statistically	  significant.	  The	  annual	  number	  of	  bladder
cancer	  deaths	  among	  Mainers	  ages	  0–34	  years	  was	  too	  low	  to	  provide
statistically	  reliable	  rates	  (Table	  3.7,	  Figure	  3.8).
• Although	  bladder	  cancer	  death	  rates	  appear	  to	  vary	  from	  year	  to	  year	  within
each	  age	  group,	  none	  of	  these	  differences	  were	  statistically	  significant	  in	  any	  of
the	  age	  groups	  (Table	  3.7).
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Are	  there	  differences	  in	  bladder	  cancer	  death	  rates	  by	  geography?	  	  
Bladder	  cancer	  death	  rates	  do	  not	  vary	  significantly	  by	  county	  or	  public	  health	  district	  
of	  residence	  in	  Maine.	  
• While	  Androscoggin,	  Lincoln,	  and	  Washington	  counties	  had	  the	  highest	  age-­‐
adjusted	  bladder	  cancer	  death	  rates	  in	  the	  state	  during	  2006-­‐2010,	  these	  rates
were	  not	  significantly	  higher	  than	  the	  overall	  Maine	  rate	  or	  the	  rate	  of	  any	  other
Maine	  county	  (Table	  3.8,	  Map	  3.3).
• Although	  Western	  District	  had	  the	  highest	  bladder	  cancer	  death	  rate	  of	  all	  the
public	  health	  districts	  in	  the	  state	  during	  2006-­‐2010	  (age-­‐adjusted	  rate:	  7.1	  per
100,000),	  this	  was	  not	  significantly	  higher	  than	  the	  state	  rate	  or	  the	  rate	  of	  any
other	  Maine	  district	  	  (Table	  3.8,	  Map	  3.4).
See	  maps	  at	  the	  end	  of	  the	  chapter.
Data Source: Underlying mortality data provided by National Center for Health Statistics. Rates are calculated using SEER*Stat Version 8.1.5. 
Rates are deaths per 100,000 population. 
Rates might be slightly underestimated due to missing underlying cause of death information for Maine residents who died out of state in 2010. 
†Rates are flagged as unreliable when the rate is calculated with a numerator less than 20. 
**Data are suppressed by SEER*Stat to protect privacy due to small numbers. 
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Breast	  cancer	  (females	  only)	  
	  
While	  breast	  cancer	  does	  occur	  among	  males,	  this	  section	  focuses	  on	  female	  breast	  
cancer	  deaths.	  	  In	  this	  section,	  “breast	  cancer	  deaths”	  and	  “breast	  cancer	  death	  rates”	  
means	  deaths	  and	  death	  rates	  among	  females.	  
	  
How	  do	  breast	  cancer	  death	  rates	  in	  Maine	  compare	  to	  those	  of	  the	  U.S.?	  
	  
Breast	  cancer	  death	  rates	  in	  Maine	  are	  not	  significantly	  different	  than	  U.S.	  rates.	  	  
	  
• Although	  breast	  cancer	  death	  rates	  in	  Maine	  appear	  to	  be	  lower	  than	  U.S.	  rates	  
during	  the	  2000	  to	  2010	  period,	  only	  in	  2001	  was	  Maine’s	  breast	  cancer	  death	  
rate	  significantly	  lower	  than	  the	  U.S.	  rates;	  Maine’s	  rate	  was	  not	  significantly	  
different	  from	  the	  U.S.	  rates	  in	  any	  other	  year	  (Table	  3.9,	  Figure	  3.9).	  
	  
• In	  2010,	  the	  Maine	  age-­‐adjusted	  death	  rate	  for	  breast	  cancer	  (20.1	  per	  100,000)	  
was	  similar	  to	  (not	  significantly	  different	  from)	  the	  overall	  U.S.	  rate	  (21.9	  per	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Data Source: Underlying mortality data provided by National Center for Health Statistics. Rates are calculated using SEER*Stat Version 8.1.5. 
Female breast cancer: SEER Cause of Death Recode: 26000 (which include ICD-10 code: C50) as the underlying cause of death.                                                                                       
Age adjusted rates are deaths per 100,000 population age-adjusted to the U.S. 2000 standard population. 
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What	  are	  the	  trends	  in	  breast	  cancer	  death	  rates	  in	  Maine?	  
	  
Breast	  cancer	  death	  rates	  are	  decreasing	  slightly,	  but	  not	  significantly,	  in	  Maine.	  	  
	  
• In	  2010,	  195	  females	  died	  from	  breast	  cancer	  in	  Maine	  (Table	  3.9).	  
	  
• The	  age-­‐adjusted	  breast	  cancer	  death	  rates	  have	  decreased	  slightly	  in	  Maine	  
from	  24.2	  per	  100,000	  in	  2000	  to	  20.1	  per	  100,000	  in	  2010,	  but	  there	  has	  been	  
no	  consistent	  or	  significant	  decline	  over	  time.	  	  While	  the	  breast	  cancer	  death	  
rate	  was	  highest	  in	  2003,	  significantly	  higher	  than	  several	  recent	  years,	  rates	  
have	  remained	  stable	  since	  2004	  (Table	  3.9,	  Figure	  3.9).	  	  	  
	  
• There	  was	  a	  consistent	  and	  significant	  decline	  in	  age-­‐adjusted	  breast	  cancer	  
death	  rates	  for	  both	  U.S.	  overall	  and	  U.S.	  white	  females	  at	  about	  18%	  over	  the	  
11-­‐year	  period,	  and	  an	  annual	  average	  decline	  of	  2.0%	  (Table	  3.9,	  Figure	  3.9).	  	  	  
	  
Are	  there	  differences	  in	  breast	  cancer	  death	  rates	  by	  age	  group	  in	  Maine?	  
	  
In	  Maine,	  breast	  cancer	  death	  rates	  increase	  with	  age.	  	  	  
	  
• In	  Maine,	  breast	  cancer	  death	  rates	  increased	  with	  age	  during	  2000	  to	  2010.	  This	  
age	  pattern	  is	  similar	  for	  the	  U.S.	  overall	  and	  U.S.	  whites	  (Table	  3.10)	  	  
	  
• In	  2010,	  Maine	  females	  ages	  75	  years	  and	  older	  had	  breast	  cancer	  death	  rates	  
(145.7	  per	  100,000)	  twice	  the	  rate	  of	  those	  ages	  65–74	  years	  (74.2	  per	  100,000)	  
and	  5	  times	  the	  rate	  of	  those	  ages	  35–64	  years	  (21.3	  per	  100,000);	  these	  
differences	  were	  statistically	  significant.	  The	  annual	  number	  of	  breast	  cancer	  
deaths	  among	  Maine	  females	  ages	  0–34	  years	  was	  too	  low	  to	  provide	  
statistically	  reliable	  rates	  (Table	  3.10,	  Figure	  3.8).	  
	  
• Breast	  cancer	  rates	  within	  age	  groups	  in	  Maine	  fluctuate	  from	  year	  to	  year	  and	  
have	  large	  confidence	  intervals,	  making	  it	  difficult	  to	  statistically	  detect	  a	  trend,	  
if	  one	  existed.	  	  From	  2000	  to	  2010,	  breast	  cancer	  death	  rates	  in	  Maine	  did	  not	  
consistently	  or	  significantly	  change	  within	  any	  of	  the	  age	  groups	  (Table	  3.10).	  	  
	  
Are	  there	  differences	  in	  breast	  cancer	  death	  rates	  by	  geography?	  	  
	  
Breast	  cancer	  death	  rates	  do	  not	  vary	  significantly	  by	  county	  or	  public	  health	  district	  
of	  residence	  in	  Maine.	  	  
	  
• While	  Kennebec,	  Knox	  and	  Oxford	  counties	  had	  the	  highest	  age-­‐adjusted	  breast	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than	  the	  overall	  Maine	  rate	  or	  the	  rate	  of	  any	  other	  Maine	  county	  (Table	  3.11,	  
Map	  3.5).	  
	  
• Although	  Aroostook,	  Central,	  and	  Downeast	  districts	  had	  the	  highest	  age-­‐
adjusted	  breast	  cancer	  death	  rates	  among	  public	  health	  districts	  in	  the	  state	  
during	  2006-­‐2010,	  these	  rates	  were	  not	  significant	  differently	  than	  the	  overall	  
Maine	  rate	  or	  the	  rate	  of	  any	  other	  Maine	  district	  (Table	  3.11,	  Map	  3.6).	  
	  
See	  maps	  at	  the	  end	  of	  the	  chapter.
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Cervical	  cancer	  
How	  do	  cervical	  cancer	  death	  rates	  in	  Maine	  compare	  to	  those	  of	  the	  U.S.?	  
Cervical	  cancer	  death	  rates	  in	  Maine	  are	  slightly,	  but	  not	  significantly,	  lower	  than	  U.S.	  
rates.	  
• Annual	  cervical	  cancer	  death	  rates	  in	  Maine	  are	  based	  upon	  fewer	  than	  20
deaths,	  which	  means	  that	  they	  may	  be	  statistically	  unreliable	  (for	  instance,	  they
may	  vary	  from	  year	  to	  year	  due	  purely	  to	  statistical	  variability)	  and	  should	  be
interpreted	  with	  caution.
• From	  2000	  to	  2010,	  the	  age-­‐adjusted	  cervical	  cancer	  death	  rates	  in	  Maine	  were
similar	  to	  the	  U.S.	  rate	  and	  the	  U.S.	  white	  rate	  (Table	  3.12,	  Figure	  3.10).
• In	  2010,	  the	  age-­‐adjusted	  cervical	  cancer	  death	  rate	  in	  Maine	  (1.4	  per	  100,000)
was	  slightly,	  but	  not	  significantly,	  lower	  than	  the	  rate	  among	  the	  U.S.	  overall	  and
U.S.	  whites	  (2.3	  and	  2.1	  per	  100,000,	  respectively;	  Table	  3.12,	  Figure	  3.10).

























Maine U.S. U.S. Whites
Data Source: Underlying mortality data provided by National Center for Health Statistics. Rates are calculated using SEER*Stat Version 8.1.5. 
Cervical cancer: SEER Cause of Death Recode: 27010 (which include ICD-10 code: C53) as the underlying cause of death.        
Age adjusted rates are deaths per 100,000 population age-adjusted to the U.S. 2000 standard population. 
Rates might be slightly underestimated due to missing underlying cause of death information for Maine residents 
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What	  are	  the	  trends	  in	  cervical	  cancer	  death	  rates	  in	  Maine?	  
	  
Cervical	  cancer	  death	  rates	  in	  Maine	  have	  remained	  steady	  over	  the	  past	  decade.	  
	  
• In	  2010,	  13	  Maine	  females	  died	  due	  to	  cervical	  cancer	  (Table	  3.12).	  
	  
• The	  relatively	  small	  number	  (<20)	  of	  cervical	  cancer	  deaths	  each	  year	  in	  Maine	  
result	  in	  relatively	  large	  confidence	  intervals	  and	  make	  it	  difficult	  to	  statistically	  
detect	  a	  trend	  if	  one	  existed.	  	  Although	  the	  age-­‐adjusted	  cervical	  cancer	  death	  
rates	  in	  Maine	  fluctuated	  from	  year	  to	  year	  between	  2000	  and	  2010,	  and	  rates	  
appear	  to	  have	  consistently	  declined	  between	  2007	  and	  2010;	  none	  of	  these	  
changes	  were	  statistically	  significant	  (Table	  3.12,	  Figure	  3.10).	  
	  
• Over	  this	  same	  period,	  2000	  to	  2010,	  age-­‐adjusted	  cervical	  cancer	  death	  rates	  
declined	  significantly	  in	  the	  U.S.	  overall	  and	  U.S.	  whites	  (Table	  3.12,	  Figure	  3.10).	  	  
	  
Are	  there	  differences	  in	  cervical	  cancer	  death	  rates	  by	  age	  group	  in	  Maine?	  
	  
The	  annual	  numbers	  of	  cervical	  cancer	  deaths	  within	  age	  groups	  in	  Maine	  are	  too	  
small	  to	  assess	  differences	  by	  age	  group.	  	  In	  the	  U.S.,	  cervical	  cancer	  death	  rates	  
increase	  significantly	  with	  increasing	  age.	  	  
	  
• The	  number	  of	  cervical	  cancer	  deaths	  among	  Maine	  females	  is	  too	  low	  to	  
provide	  reliable	  rates	  by	  age	  group	  (Table	  3.13).	  
	  
• Cervical	  cancer	  death	  rates	  did	  increase	  significantly	  with	  increasing	  age	  among	  
U.S.	  females	  overall	  and	  among	  U.S.	  white	  females	  (Table	  3.13).	  	  
	  
• In	  2010,	  for	  the	  U.S.	  overall,	  cervical	  cancer	  death	  rates	  increased	  from	  3.9	  per	  
100,000	  in	  the	  35–64	  year	  age	  group	  to	  5.2	  in	  the	  65–74	  year	  age	  group	  and	  6.1	  
in	  the	  75	  years	  and	  older	  age	  group.	  	  Among	  U.S.	  whites,	  cervical	  cancer	  death	  
rates	  increased	  from	  3.7	  per	  100,000	  in	  the	  35–64	  year	  age	  group	  to	  4.6	  in	  the	  
65–74	  year	  age	  group	  and	  5.3	  in	  the	  75	  years	  and	  older	  age	  group	  (Table	  3.13).	  
	  
Are	  there	  differences	  in	  cervical	  cancer	  death	  rates	  by	  geography?	  	  
	  
The	  number	  of	  cervical	  cancer	  death	  rates	  by	  Maine	  county	  and	  public	  health	  district	  
in	  2006	  to	  2010	  were	  too	  small	  to	  assess	  geographic	  differences.	  	  	  
	  
• The	  relatively	  small	  number	  of	  cervical	  cancer	  deaths	  at	  the	  county	  and	  public	  
health	  district	  level	  in	  Maine	  during	  2006-­‐2010	  result	  in	  most	  county	  and	  district	  
rates	  being	  suppressed	  to	  protect	  privacy	  or	  flagged	  as	  statistically	  unreliable,	  
making	  it	  difficult	  to	  assess	  geographic	  differences	  (Table	  3.14).	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Colorectal	  cancer	  	  
How	  do	  colorectal	  cancer	  death	  rates	  in	  Maine	  compare	  to	  those	  of	  the	  U.S.?	  
Colorectal	  cancer	  death	  rates	  in	  Maine	  are	  similar	  to	  those	  of	  the	  U.S.	  
• From	  2000	  to	  2010,	  the	  age-­‐adjusted	  colorectal	  cancer	  death	  rates	  in	  Maine
were	  similar	  to	  (and	  not	  significantly	  different	  from)	  the	  overall	  U.S.	  rates.
Maine	  colorectal	  cancer	  rates	  were	  significantly	  higher	  than	  the	  rates	  for	  U.S.
whites	  in	  2000,	  2002,	  and	  2007	  only;	  Maine	  and	  U.S.	  white	  rates	  were	  not
significantly	  different	  in	  any	  of	  the	  other	  years	  from	  2000	  to	  2010	  (Table	  3.15,
Figure	  3.11).
• In	  2010,	  the	  age-­‐adjusted	  colorectal	  cancer	  death	  rate	  in	  Maine	  (16.4	  per
100,000)	  was	  similar	  to	  (and	  not	  significantly	  different	  from)	  the	  U.S.	  rate	  (15.5
per	  100,000)	  and	  U.S.	  white	  rate	  (15.0	  per	  100,000;	  Table	  3.15,	  Figure	  3.11).
• In	  2010,	  the	  age-­‐adjusted	  colorectal	  cancer	  death	  rates	  for	  both	  Maine	  males
and	  females	  were	  not	  significantly	  different	  from	  rates	  for	  U.S.	  and	  U.S.	  white
rates	  for	  both	  sexes	  (Table	  3.15).

























Maine U.S. U.S. Whites
Data Source: Underlying mortality data provided by National Center for Health Statistics. Rates are calculated using SEER*Stat Version 8.1.5. 
Colorectal cancer: SEER Cause of Death Recode: 21041-21049, 21051, 21052 (which include ICD-10 codes: C180-C189, C260, C199, C209) 
as the underlying cause of death.        
Age adjusted rates are deaths per 100,000 population age-adjusted to the U.S. 2000 standard population. 
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What	  are	  the	  trends	  in	  colorectal	  cancer	  death	  rates	  in	  Maine?	  
	  
Colorectal	  cancer	  death	  rates	  in	  Maine	  declined	  significantly	  between	  2000	  and	  2010.	  
	  
• In	  2010,	  290	  Mainers	  died	  from	  colorectal	  cancer	  (Table	  3.15).	  
	  
• Maine’s	  age-­‐adjusted	  colorectal	  cancer	  death	  rate	  declined	  significantly	  from	  
23.0	  per	  100,000	  in	  2000	  to	  16.4	  per	  100,000	  in	  2010.	  This	  represents	  a	  28.7%	  
decline	  over	  the	  11-­‐year	  period,	  and	  an	  average	  annual	  decline	  of	  2.9%.	  This	  rate	  
of	  decline	  was	  similar	  for	  U.S.	  overall	  and	  U.S.	  whites	  (Table	  3.15,	  Figure	  3.11).	  	  	  
	  
• Although	  Maine’s	  age-­‐adjusted	  colorectal	  cancer	  death	  rate	  appears	  to	  increase	  
between	  2009	  and	  2010;	  this	  change	  was	  not	  statistically	  significant	  (Table	  3.15,	  
Figure	  3.11).	  
	  
Are	  there	  differences	  in	  colorectal	  cancer	  death	  rates	  by	  sex	  in	  Maine?	  
	  
Maine	  males	  have	  consistently	  higher	  colorectal	  cancer	  death	  rates	  than	  Maine	  
females.	  Colorectal	  cancer	  death	  rates	  among	  Maine	  males	  declined	  more	  slowly	  than	  
rates	  among	  Maine	  females.	  	  
	  
• From	  2000	  to	  2010,	  Maine	  males	  had	  consistently	  higher	  colorectal	  cancer	  death	  
rates	  than	  Maine	  females,	  though	  this	  difference	  was	  not	  statistically	  significant	  
in	  all	  years.	  	  This	  was	  similar	  to	  the	  pattern	  in	  the	  U.S.	  overall,	  where	  males	  had	  
significantly	  higher	  colorectal	  cancer	  rates	  than	  females	  (Table	  3.16,	  Figure	  3.12).	  
	  


























Data Source: Underlying mortality data provided by National Center for Health Statistics. Rates are calculated using SEER*Stat Version 8.1.5. 
Colorectal cancer: SEER Cause of Death Recode: 21041-21049, 21051, 21052 (which include ICD-10 codes: C180-C189, C260, C199, C209) 
as the underlying cause of death.         
Age adjusted rates are deaths per 100,000 population age-adjusted to the U.S. 2000 standard population. 
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• In	  2010,	  the	  age-­‐adjusted	  colorectal	  death	  rate	  among	  Maine	  males	  (20.9	  per	  
100,000)	  was	  60%	  higher	  than	  the	  death	  rate	  among	  females	  (age-­‐adjusted	  rate:	  
13.1	  per	  100,000;	  Table	  3.16,	  Figure	  3.12).	  
	  
• Colorectal	  cancer	  death	  rates	  among	  Maine	  males	  declined	  significantly	  between	  
2002	  and	  2004	  (27.8	  to	  18.0	  per	  100,000),	  but	  have	  not	  changed	  significantly	  
since.	  Age-­‐adjusted	  colorectal	  cancer	  death	  rates	  among	  females	  declined	  
significantly	  (26.8%)	  from	  17.9	  per	  100,000	  in	  2004	  to	  13.1	  per	  100,000	  in	  2010.	  
Between	  2000	  and	  2010,	  the	  average	  annual	  decline	  for	  females	  was	  4.1%,	  while	  
the	  average	  annual	  decline	  for	  males	  was	  only	  0.3%	  (Table	  3.16,	  Figure	  3.12).	  
	  
Are	  there	  differences	  in	  colorectal	  cancer	  death	  rates	  by	  age	  group	  in	  Maine?	  
	  
Colorectal	  cancer	  death	  rates	  in	  Maine	  are	  higher	  in	  older	  age	  groups	  than	  younger	  
age	  groups.	  
	  
• In	  Maine,	  colorectal	  cancer	  death	  rates	  increased	  with	  age	  during	  2000	  to	  2010.	  
This	  age	  pattern	  was	  similar	  for	  the	  U.S.	  overall	  and	  U.S.	  whites	  (Table	  3.17).	  
	  
• In	  2010,	  the	  colorectal	  cancer	  death	  rate	  among	  Mainers	  ages	  75	  years	  and	  older	  
(143.9	  per	  100,000)	  was	  3	  times	  the	  rate	  for	  those	  ages	  65−74	  years	  (52.9	  per	  
100,000)	  and	  10	  times	  the	  rate	  for	  those	  ages	  35−64	  years	  (15.0	  per	  100,000);	  
these	  differences	  were	  statistically	  significant.	  	  The	  number	  of	  colorectal	  cancer	  
deaths	  among	  Mainers	  ages	  0−34	  years	  was	  too	  low	  to	  provide	  statistically	  
reliable	  rates	  (Table	  3.17,	  Figure	  3.8).	  
	  
• Colorectal	  cancer	  death	  rates	  among	  Mainers	  ages	  75	  years	  and	  older	  declined	  
significantly	  between	  2000	  and	  2010	  (30.3%	  decline	  and	  2.4%	  average	  annual	  
decline).	  	  Annual	  colorectal	  cancer	  death	  rates	  among	  Mainers	  ages	  65−74	  years	  
suggests	  there	  may	  be	  a	  declining	  trend,	  but	  only	  the	  2008	  and	  2010	  rates	  were	  
significantly	  lower	  than	  the	  2002	  rate.	  	  Colorectal	  cancer	  death	  rates	  among	  
Mainers	  ages	  35−64	  years	  have	  not	  changed	  significantly	  (Table	  3.17).	  	  
	  
Are	  there	  differences	  in	  colorectal	  cancer	  death	  rates	  by	  geography?	  	  
	  
Counties	  and	  public	  health	  districts	  with	  the	  highest	  colorectal	  cancer	  death	  rates	  tend	  
to	  be	  in	  northern	  Maine.	  	  
	  
• Aroostook,	  Franklin,	  Piscataquis,	  and	  Somerset	  counties	  had	  the	  highest	  age-­‐
adjusted	  colorectal	  cancer	  death	  rates	  during	  2006-­‐2010,	  but	  only	  Franklin	  
County’s	  rate	  (27.5	  per	  100,000)	  was	  significantly	  higher	  than	  the	  overall	  Maine	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• The	  colorectal	  cancer	  death	  rate	  in	  Franklin	  County,	  the	  highest	  county	  rate	  in	  
Maine	  (age-­‐adjusted	  rate:	  27.5	  per	  100,000),	  was	  more	  than	  twice	  as	  high	  as	  the	  
rate	  in	  Hancock	  County,	  the	  lowest	  county	  rate	  in	  the	  state	  (age-­‐adjusted	  rate:	  
11.8	  per	  100,000);	  this	  difference	  was	  statistically	  significant	  (Table	  3.18,	  Map	  
3.7).	  
	  
• Aroostook	  and	  Central	  districts	  had	  the	  highest	  age-­‐adjusted	  colorectal	  cancer	  
death	  rates	  among	  public	  health	  districts	  in	  the	  state,	  but	  these	  were	  not	  
significantly	  higher	  than	  the	  overall	  state	  rate	  (Table	  3.18,	  Map	  3.8).	  
	  
• The	  colorectal	  cancer	  death	  rates	  in	  Aroostook	  and	  Central	  districts,	  the	  two	  
highest	  district	  rates	  in	  Maine	  (age-­‐adjusted	  rate:	  20.8	  and	  19.2	  per	  100,000,	  
respectively)	  were	  significantly	  higher	  than	  the	  rates	  of	  Downeast	  and	  Midcoast	  
districts,	  the	  two	  lowest	  district	  rates	  in	  Maine	  (age-­‐adjusted	  rate:	  12.4	  and	  13.8	  
per	  100,000,	  respectively;	  Table	  3.18,	  Map	  3.8).	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Lung	  cancer	  	  
	  
How	  do	  lung	  cancer	  death	  rates	  in	  Maine	  compare	  to	  those	  of	  the	  U.S.?	  
	  
Lung	  cancer	  death	  rates	  in	  Maine	  are	  consistently	  higher	  than	  U.S.	  rates.	  Maine	  
females	  have	  significantly	  higher	  lung	  cancer	  death	  rates	  compared	  to	  U.S.	  females.	  
	  
• From	  2000	  to	  2010,	  the	  age-­‐adjusted	  lung	  cancer	  death	  rates	  in	  Maine	  were	  
consistently	  higher	  than	  the	  U.S.	  rate	  and	  the	  U.S.	  white	  rate.	  	  Maine’s	  rates	  
were	  significantly	  higher	  than	  the	  U.S.	  rates	  in	  all	  years	  except	  2001	  (Table	  3.19,	  
Figure	  3.13).	  
	  
• In	  2010,	  the	  age-­‐adjusted	  lung	  cancer	  death	  rate	  in	  Maine	  (55.1	  per	  100,000)	  
was	  15%	  higher	  than	  the	  U.S.	  rate	  (47.4	  per	  100,000)	  and	  the	  U.S.	  white	  rate	  
(48.1	  per	  100,000);	  these	  differences	  were	  statistically	  significant	  (Table	  3.19,	  
Figure	  3.13).	  
	  
• In	  2010,	  the	  age-­‐adjusted	  lung	  cancer	  death	  rate	  among	  Maine	  males	  (66.1	  per	  
100,000)	  was	  similar	  to	  (and	  not	  significantly	  different	  from)	  the	  rate	  among	  U.S.	  
males	  (60.1	  per	  100,000)	  and	  U.S.	  white	  males	  (59.9	  per	  100,000).	  	  The	  rate	  for	  
Maine	  females	  in	  this	  year	  (47.0	  per	  100,000)	  was	  24%	  higher	  than	  the	  rate	  
among	  U.S.	  females	  (37.9	  per	  100,000)	  and	  20%	  higher	  than	  the	  rate	  of	  U.S.	  
white	  females	  (39.2	  per	  100,000);	  these	  differences	  were	  statistically	  significant	  
(Table	  3.20).	  

























Maine U.S. U.S. Whites
Data Source: Underlying mortality data provided by National Center for Health Statistics. Rates are calculated using SEER*Stat Version 8.1.5. 
Lung cancer: SEER Cause of Death Recode: 22030 (which include ICD-10 code: C34) as the underlying cause of death.         
Age adjusted rates are deaths per 100,000 population age-adjusted to the U.S. 2000 standard population. 
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Data Source: Underlying mortality data provided by National Center for Health Statistics. Rates are calculated using SEER*Stat Version 8.1.5. 
Lung cancer: SEER Cause of Death Recode: 22030 (which include ICD-10 code: C34) as the underlying cause of death.         
Age adjusted rates are deaths per 100,000 population age-adjusted to the U.S. 2000 standard population. 
Rates might be slightly underestimated due to missing underlying cause of death information for Maine residents who died out of state in 2010. 
What	  are	  the	  trends	  in	  lung	  cancer	  death	  rates	  in	  Maine?	  
	  
Lung	  cancer	  death	  rates	  have	  declined	  significantly	  in	  Maine	  since	  2002.	  
	  
• In	  2010,	  957	  adults	  died	  due	  to	  lung	  cancer	  in	  Maine	  (Table	  3.19).	  
	  
• Maine’s	  age-­‐adjusted	  lung	  cancer	  death	  rate	  decreased	  significantly	  from	  63.5	  
per	  100,000	  in	  2002	  to	  55.1	  per	  100,000	  in	  2010;	  this	  was	  a	  13.2%	  decrease	  over	  
the	  9-­‐year	  period,	  and	  an	  average	  annual	  decline	  of	  1.7%.	  Maine’s	  average	  
annual	  decline	  was	  similar	  to	  that	  for	  U.S.	  overall	  (1.8%)	  and	  U.S.	  whites	  (1.7%;	  
Table	  3.19,	  Figure	  3.13).	  
	  
• Although	  Maine’s	  age-­‐adjusted	  lung	  cancer	  death	  rate	  appears	  to	  have	  increased	  
slightly	  between	  2009	  and	  2010,	  this	  change	  was	  not	  statistically	  significant.	  	  
	  
Are	  there	  differences	  in	  lung	  cancer	  death	  rates	  by	  sex	  in	  Maine?	  
	  
Lung	  cancer	  death	  rates	  are	  significantly	  higher	  among	  Maine	  males	  than	  Maine	  
females.	  Lung	  cancer	  death	  rates	  have	  declined	  among	  Maine	  males,	  but	  not	  Maine	  
females.	  
	  
• Age-­‐adjusted	  lung	  cancer	  death	  rates	  among	  Maine	  males	  were	  significantly	  
higher	  than	  those	  among	  Maine	  females	  in	  all	  years	  between	  2000	  and	  2010	  































Maine	  Cancer	  Surveillance	  Report	  2014	  
• In	  2010,	  the	  age-­‐adjusted	  lung	  cancer	  death	  rate	  among	  Maine	  males	  (66.1	  per	  
100,000)	  was	  40%	  higher	  than	  the	  rate	  among	  females	  (47.0	  per	  100,000);	  this	  
difference	  was	  statistically	  significant	  (Table	  3.20,	  Figure	  3.14).	  
	  
• Age-­‐adjusted	  lung	  cancer	  death	  rates	  among	  Maine	  males	  declined	  significantly	  
between	  2002	  and	  2009	  (81.8	  to	  66.0	  per	  100,000).	  During	  this	  same	  time	  
period,	  lung	  cancer	  death	  rates	  did	  not	  change	  significantly	  among	  Maine	  
females	  (Table	  3.20,	  Figure	  3.14).	  
	  
Are	  there	  differences	  in	  lung	  cancer	  death	  rates	  by	  age	  group	  in	  Maine?	  
	  
Maine’s	  lung	  cancer	  death	  rate	  increases	  with	  age.	  
	  
• In	  Maine,	  lung	  cancer	  death	  rates	  increased	  with	  age	  during	  2000	  to	  2010.	  This	  
age	  pattern	  is	  similar	  for	  the	  U.S.	  overall	  and	  U.S.	  whites	  (Table	  3.21).	  
	  
• In	  2010,	  the	  lung	  cancer	  death	  rate	  among	  Mainers	  ages	  75	  years	  and	  older	  
(400.3	  per	  100,000)	  was	  almost	  twice	  the	  rate	  for	  those	  ages	  65−74	  years	  (240.9	  
per	  100,000)	  and	  8	  times	  the	  rate	  for	  those	  ages	  35−64	  years	  (49.6	  per	  100,000);	  
these	  differences	  were	  statistically	  significant.	  	  The	  annual	  number	  of	  lung	  
cancer	  deaths	  among	  Mainers	  ages	  0−34	  years	  was	  too	  low	  to	  provide	  
statistically	  reliable	  rates	  (Table	  3.21,	  Figure	  3.8).	  	  
	  
• Lung	  cancer	  death	  rates	  among	  Mainers	  ages	  35−64	  and	  75	  years	  and	  older	  have	  
not	  changed	  significantly	  between	  2000	  and	  2010.	  	  Annual	  lung	  cancer	  death	  
rates	  among	  Mainers	  ages	  65−74	  years	  suggests	  there	  may	  be	  a	  declining	  trend,	  
with	  generally	  lower	  rates	  during	  the	  last	  half	  of	  the	  decade	  and	  generally	  higher	  
rates	  during	  the	  first	  half	  of	  the	  decade,	  but	  only	  the	  2007	  and	  2010	  rates	  were	  
significantly	  lower	  than	  the	  2000	  and	  2002	  rates	  (Table	  3.21).	  	  
	  
Are	  there	  differences	  in	  lung	  cancer	  death	  rates	  by	  geography?	  	  
	  
Counties	  with	  the	  highest	  lung	  cancer	  death	  rates	  tend	  to	  be	  in	  the	  mid-­‐section	  of	  
Maine,	  and	  the	  public	  health	  districts	  with	  the	  highest	  lung	  cancer	  death	  rates	  tend	  to	  
be	  in	  northern	  and	  western	  Maine.	  	  
	  
• Penobscot,	  Somerset,	  and	  Washington	  counties	  had	  the	  highest	  age-­‐adjusted	  
lung	  cancer	  death	  rates	  during	  2006-­‐2010,	  but	  only	  Penobscot	  County’s	  rate	  
(age-­‐adjusted	  rate:	  63.2	  per	  100,000)	  was	  significantly	  higher	  (15%)	  than	  the	  
overall	  Maine	  rate	  (56.1	  per	  100,000;	  Table	  3.22,	  Map	  3.9).	  
	  
• Lung	  cancer	  death	  rates	  in	  Androscoggin,	  Kennebec,	  and	  Penobscot	  counties	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rate	  in	  Lincoln	  County,	  the	  lowest	  county	  rate	  in	  the	  state	  (age-­‐adjusted	  rate:	  
45.3	  per	  100,000;	  Table	  3.22,	  Map	  3.9).	  
	  
• Aroostook,	  Central,	  Penquis	  and	  Western	  districts	  had	  the	  highest	  age-­‐adjusted	  
lung	  cancer	  death	  rates	  among	  the	  public	  health	  districts	  in	  Maine,	  but	  these	  
rates	  were	  not	  significantly	  higher	  than	  the	  overall	  Maine	  rate	  (Table	  3.22,	  Map	  
3.10).	  
	  
• The	  lung	  cancer	  death	  rates	  in	  Central,	  Penquis,	  and	  Western	  districts	  (age-­‐
adjusted	  rates:	  60.4,	  62.0,	  and	  60.4	  per	  100,000,	  respectively)	  were	  significantly	  
higher	  than	  those	  in	  Cumberland	  and	  York	  districts	  (51.6	  and	  51.2	  per	  100,000,	  
respectively;	  Table	  3.22,	  Map	  3.10).	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Melanoma	  
	  
How	  do	  melanoma	  death	  rates	  in	  Maine	  compare	  to	  those	  of	  the	  U.S.?	  
	  
In	  Maine,	  melanoma	  death	  rates	  are	  similar	  to	  overall	  U.S.	  rates	  and	  the	  rate	  for	  U.S.	  
whites.	  	  
	  
• From	  2000	  to	  2010,	  the	  age-­‐adjusted	  melanoma	  death	  rates	  in	  Maine	  were	  
similar	  to	  (not	  significantly	  different	  from)	  the	  overall	  U.S.	  rates	  and	  the	  rates	  for	  
U.S.	  whites	  (Table	  3.23,	  Figure	  3.15).	  
	  
• In	  2010,	  the	  Maine	  age-­‐adjusted	  melanoma	  death	  rate	  of	  3.1	  per	  100,000	  was	  
similar	  to	  (not	  significantly	  different	  from)	  the	  overall	  U.S.	  rate	  (2.7	  per	  100,000)	  
and	  the	  U.S.	  white	  rate	  (3.2	  per	  100,000;	  Table	  3.23,	  Figure	  3.15).	  
	  
• There	  was	  no	  difference	  in	  melanoma	  death	  rates	  by	  sex	  among	  Maine	  females	  
and	  males	  compared	  to	  males	  and	  females	  for	  U.S	  overall	  and	  U.S.	  whites	  (Table	  
3.24,	  Figure	  3.16).	  
	  
	  

























Maine U.S. U.S. Whites
Data Source: Underlying mortality data provided by National Center for Health Statistics. Rates are calculated using SEER*Stat Version 8.1.5. 
Melanoma: SEER Cause of Death Recode: 25010 (which include ICD-10 code: C43) as the underlying cause of death.                                                                                           
Age adjusted rates are deaths per 100,000 population age-adjusted to the U.S. 2000 standard population. 





















What	  are	  the	  trends	  in	  melanoma	  death	  rates	  in	  Maine?	  
	  
Melanoma	  death	  rates	  in	  Maine	  have	  remained	  steady	  between	  2000	  and	  2010.	  
	  
• In	  2010,	  54	  Mainers	  died	  from	  melanoma	  (Table	  3.23).	  
	  
• Melanoma	  death	  rates	  have	  remained	  steady,	  with	  no	  statistically	  significant	  
changes,	  in	  Maine	  between	  2000	  and	  2010,	  which	  was	  similar	  to	  the	  pattern	  
seen	  for	  U.S.	  rates	  (Table	  3.23,	  Figure	  3.15).	  
	  
Are	  there	  differences	  in	  melanoma	  death	  rates	  by	  sex	  in	  Maine?	  
	  
Maine	  males	  have	  consistently	  higher	  melanoma	  death	  rates	  than	  females.	  	  
	  
• In	  Maine,	  males	  had	  consistently	  higher	  melanoma	  death	  rates	  than	  females	  
between	  2000	  and	  2010,	  although	  the	  difference	  was	  statistically	  significant	  only	  
in	  2002,	  2009,	  and	  2010	  (Table	  3.24,	  Figure	  3.16).	  
	  
• In	  2010,	  the	  age-­‐adjusted	  melanoma	  death	  rate	  among	  Maine	  males	  (4.9	  per	  
100,000)	  was	  more	  than	  twice	  the	  rate	  among	  females	  (1.8	  per	  100,000).	  
Melanoma	  death	  rates	  among	  Maine	  females	  might	  be	  statistically	  unreliable	  
because	  of	  the	  relatively	  low	  annual	  number	  of	  melanoma	  deaths	  (Table	  3.24,	  
Figure	  3.16).	  
Figure 3.16. Average Melanoma Death Rates by Sex, Maine, 2006-2010 
	  
† 
Data Source: Underlying mortality data provided by National Center for Health Statistics. Rates are calculated using SEER*Stat Version 8.1.5. 
Melanoma: SEER Cause of Death Recode: 25010 (which include ICD-10 code: C43) as the underlying cause of death. 
Age adjusted rates are deaths per 100,000 population. 
Rates might be slightly underestimated due to missing underlying cause of death information for Maine residents who died out of state in 2010. 
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• Age-­‐adjusted	  melanoma	  death	  rates	  among	  Maine	  males	  fluctuated	  from	  year	  to	  
year,	  but	  did	  not	  change	  significantly	  between	  2000	  and	  2010.	  Melanoma	  death	  
rates	  among	  Maine	  females	  also	  did	  not	  change	  significantly	  over	  this	  time	  
period,	  but	  might	  be	  statistically	  unreliable	  because	  of	  the	  relatively	  low	  annual	  
number	  of	  melanoma	  deaths	  (Table	  3.24,	  Figure	  3.16).	  
	  
Are	  there	  differences	  in	  melanoma	  death	  rates	  by	  age	  group	  in	  Maine?	  
	  
Melanoma	  death	  rates	  are	  higher	  in	  older	  age	  groups	  than	  younger	  age	  groups.	  
	  
• In	  2010,	  melanoma	  death	  rates	  appeared	  to	  increase	  with	  increasing	  age,	  
although	  the	  differences	  are	  not	  statistically	  significant.	  The	  U.S.	  melanoma	  
death	  rates	  also	  increase	  with	  increasing	  age.	  	  Melanoma	  death	  rates	  among	  
Mainers	  ages	  0–34	  years,	  65–74	  years,	  and	  75	  years	  and	  older	  may	  be	  unreliable	  
due	  to	  the	  relatively	  small	  number	  of	  annual	  melanoma	  deaths	  in	  these	  age	  
groups	  (Table	  3.25,	  Figure	  3.8).	  	  	  
	  
• Melanoma	  death	  rates	  did	  not	  change	  significantly	  from	  2000	  to	  2010	  within	  any	  
of	  the	  age	  groups	  in	  Maine,	  but	  the	  relatively	  low	  numbers	  of	  annual	  melanoma	  
deaths	  in	  each	  age	  group	  make	  it	  difficult	  to	  assess	  age-­‐specific	  trends	  over	  time	  
(Table	  3.25).	  	  
	  
Are	  there	  differences	  in	  melanoma	  death	  rates	  by	  geography?	  	  
	  
Melanoma	  death	  rates	  do	  not	  vary	  significantly	  by	  public	  health	  district	  in	  Maine.	  	  
	  
• The	  relatively	  small	  number	  of	  melanoma	  deaths	  at	  the	  county	  level	  in	  Maine	  
during	  2006-­‐2010	  result	  in	  most	  county	  rates	  being	  suppressed	  to	  protect	  
privacy,	  or	  flagged	  as	  statistically	  unreliable,	  making	  it	  difficult	  to	  assess	  
geographic	  differences	  (Table	  3.26).	  
	  
• Although	  York	  and	  Downeast	  districts	  had	  the	  highest	  age-­‐adjusted	  melanoma	  
death	  rates	  in	  the	  state,	  these	  rates	  were	  not	  significantly	  higher	  than	  the	  overall	  
Maine	  rate	  or	  the	  rate	  of	  any	  other	  Maine	  district	  (Table	  3.26,	  Map	  3.11).	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Prostate	  cancer	  
	  
How	  do	  prostate	  cancer	  death	  rates	  in	  Maine	  compare	  to	  those	  of	  the	  U.S.?	  
	  
Prostate	  cancer	  death	  rates	  in	  Maine	  are	  similar	  to	  U.S.	  rates.	  
	  
• From	  2000	  to	  2010,	  the	  age-­‐adjusted	  prostate	  cancer	  death	  rates	  in	  Maine	  were	  
similar	  to	  rates	  among	  the	  U.S.	  overall	  and	  U.S.	  white	  males;	  only	  in	  2001	  was	  
Maine’s	  rate	  significantly	  higher	  than	  the	  U.S.	  white	  rate	  (Table	  3.27,	  Figure	  
3.17).	  	  
	  
• In	  2010,	  the	  age-­‐adjusted	  prostate	  cancer	  death	  rate	  in	  Maine	  (21.0	  per	  100,000)	  
was	  similar	  to	  (not	  significantly	  different	  from)	  the	  overall	  U.S.	  rate	  of	  21.8	  per	  
100,000	  and	  the	  rate	  for	  U.S.	  white	  males	  of	  20.1	  per	  100,000	  (Table	  3.27,	  Figure	  
3.17).	  
	  
What	  are	  the	  trends	  in	  prostate	  cancer	  death	  rates	  in	  Maine?	  
	  
Among	  Maine	  males,	  prostate	  cancer	  death	  rates	  are	  steadily	  decreasing.	  
	  
• In	  2010,	  144	  males	  in	  Maine	  died	  from	  prostate	  cancer	  (Table	  3.27).	  
	  

























Maine U.S. U.S. Whites
Data Source: Underlying mortality data provided by National Center for Health Statistics. Rates are calculated using SEER*Stat Version 8.1.5. 
Prostate cancer: SEER Cause of Death Recode: 28010 (which include ICD-10 code: C61) as the underlying cause of death.                                                                                    
Age adjusted rates are deaths per 100,000 population age-adjusted to the U.S. 2000 standard population. 
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• Maine’s	  age-­‐adjusted	  prostate	  cancer	  death	  rate	  has	  significantly	  decreased	  
from	  33.7	  per	  100,000	  in	  2001	  to	  21.0	  per	  100,000	  in	  2010,	  a	  37.7%	  decline	  over	  
the	  10-­‐year	  period,	  and	  an	  average	  annual	  decline	  of	  4.8%	  (Table	  3.27,	  Figure	  
3.17).	  
	  
• Similarly,	  prostate	  cancer	  death	  rates	  declined	  significantly	  over	  this	  time	  period	  
for	  the	  U.S.	  overall	  and	  U.S.	  whites.	  	  Maine’s	  average	  annual	  decline	  (4.8%)	  was	  
slightly	  greater	  than	  the	  decline	  for	  U.S.	  overall	  (3.3%)	  and	  U.S.	  whites	  (3.2%;	  
Table	  3.27,	  Figure	  3.17).	  
	  
Are	  there	  differences	  in	  prostate	  cancer	  death	  rates	  by	  age	  group	  in	  Maine?	  
	  
Prostate	  cancer	  death	  rates	  in	  Maine	  increase	  with	  age.	  	  	  
	  
• In	  Maine,	  prostate	  cancer	  death	  rates	  increased	  with	  age	  during	  2000	  and	  2010.	  
This	  age	  pattern	  is	  similar	  for	  the	  U.S.	  overall	  and	  U.S.	  whites	  (Table	  3.28).	  
	  
• In	  2010,	  the	  prostate	  cancer	  death	  rate	  among	  Mainers	  ages	  75	  years	  and	  older	  
(266.9	  per	  100,000)	  was	  5	  times	  the	  rate	  for	  those	  ages	  65–74	  years	  (53.7	  per	  
100,000)	  and	  almost	  70	  times	  the	  rate	  for	  those	  ages	  35–64	  years	  (3.9	  per	  
100,000);	  these	  differences	  were	  statistically	  significant.	  The	  prostate	  cancer	  
death	  rate	  among	  males	  ages	  0–34	  years	  and	  35–64	  years	  might	  be	  unreliable	  
because	  of	  the	  relatively	  low	  number	  of	  prostate	  cancer	  deaths	  in	  these	  age	  
groups	  (Table	  3.28,	  Figure	  3.8).	  	  	  	  
	  
• From	  2000	  to	  2010,	  prostate	  cancer	  death	  rates	  did	  not	  change	  significantly	  in	  
any	  age	  group	  of	  Maine	  males;	  however,	  the	  annual	  rates	  vary	  considerably	  and	  
have	  large	  confidence	  intervals,	  which	  make	  it	  difficult	  to	  assess	  trends	  over	  time	  
(Table	  3.28).	  	  	  
	  
Are	  there	  differences	  in	  prostate	  cancer	  death	  rates	  by	  geography?	  	  
	  
Counties	  and	  public	  health	  districts	  with	  the	  highest	  prostate	  cancer	  death	  rates	  tend	  
to	  be	  in	  central	  and	  eastern	  Maine.	  	  	  
	  
• Although	  Franklin,	  Hancock,	  Kennebec,	  and	  Sagadahoc	  counties	  had	  the	  highest	  
age-­‐adjusted	  prostate	  cancer	  death	  rates	  in	  Maine	  during	  2006-­‐2010,	  these	  rates	  
were	  not	  significantly	  higher	  than	  the	  overall	  Maine	  rate	  (Table	  3.29,	  Map	  3.12).	  
	  
• The	  prostate	  cancer	  death	  rate	  in	  Hancock	  County,	  the	  highest	  county	  rate	  in	  
Maine	  (age-­‐adjusted	  rate:	  30.6	  per	  100,000)	  during	  2006-­‐2010,	  was	  twice	  as	  high	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rate:	  14.0	  per	  100,000);	  this	  difference	  was	  statistically	  significant	  (Table	  3.29,	  
Map	  3.12).	  
	  
• Although	  Central	  and	  Downeast	  districts	  had	  the	  highest	  age-­‐adjusted	  prostate	  
cancer	  death	  rates	  in	  the	  state,	  these	  rates	  were	  not	  significantly	  higher	  than	  the	  
overall	  Maine	  rate	  (Table	  3.29,	  Map	  3.13)	  
	  
• Prostate	  cancer	  death	  rates	  in	  Central,	  Cumberland,	  Downeast,	  and	  Midcoast	  
districts	  (25.4,	  24.6,	  28.1,	  and	  25.2	  per	  100,000,	  respectively)	  were	  significantly	  
higher	  than	  in	  Aroostook	  District,	  the	  lowest	  district	  rate	  in	  Maine	  (age-­‐adjusted	  
rate:	  14.0	  per	  100,000;	  Table	  3.29,	  Map	  3.13).	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Tobacco-­‐related	  cancer	  (excluding	  lung	  cancer)	  
	  
This	  section	  examines	  tobacco-­‐related	  cancers	  other	  than	  lung	  cancer.	  Tobacco-­‐related	  
cancers	  are	  those	  that	  the	  U.S.	  Surgeon	  General	  has	  determined	  have	  a	  direct	  causal	  link	  
to	  tobacco	  use.	  	  Tobacco-­‐related	  (excluding	  lung)	  cancers	  include	  laryngeal,	  oral	  cavity	  
and	  pharynx,	  esophageal,	  stomach,	  pancreatic,	  kidney	  and	  renal	  pelvis,	  urinary	  bladder,	  
and	  cervical	  cancers,	  and	  acute	  myeloid	  leukemia.	  
	  
How	  do	  tobacco-­‐related	  cancer	  death	  rates	  in	  Maine	  compare	  to	  those	  of	  the	  U.S.?	  
	  
Maine	  males	  have	  significantly	  higher	  tobacco-­‐related	  cancer	  death	  rates	  than	  U.S.	  
males,	  while	  tobacco-­‐related	  cancer	  death	  rates	  among	  U.S.	  females	  and	  Maine	  
females	  are	  similar.	  Overall,	  tobacco-­‐related	  cancer	  death	  rates	  in	  Maine	  are	  slightly	  
higher	  than	  U.S.	  rates.	  
	  
• From	  2000	  to	  2010,	  the	  age-­‐adjusted	  tobacco-­‐related	  cancer	  death	  rates	  in	  
Maine	  were	  consistently	  higher	  than	  the	  rates	  for	  U.S.	  and	  U.S.	  whites,	  although	  






• In	  2010,	  the	  age-­‐adjusted	  tobacco-­‐related	  cancer	  death	  rate	  in	  Maine	  was	  37.3	  
per	  100,000,	  which	  was	  slightly,	  but	  not	  significantly,	  higher	  than	  the	  U.S.	  rate	  of	  
Figure 3.18. Tobacco-related Cancer Death Rates by Year, Maine and U.S., 2000-2010 
Data Source: Underlying mortality data provided by National Center for Health Statistics. Rates are calculated using SEER*Stat Version 8.1.5. 
Tobacco-related cancers (excluding lung) include the following: laryngeal, oral cavity and pharynx, esophageal, stomach, pancreatic, kidney 
and renal pelvis, urinary bladder, cervical cancers, and acute myeloid leukemia as the underlying cause of death. Please see Appendix II for 
SEER and ICD-10 codes.                                                                                                                                                                                                               
Age adjusted rates are deaths per 100,000 population age-adjusted to the U.S. 2000 standard population. 
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34.6	  per	  100,000	  and	  U.S.	  white	  rate	  of	  34.4	  per	  100,000	  (Table	  3.30,	  Figure	  
3.18).	  
	  
• In	  2010,	  the	  age-­‐adjusted	  tobacco-­‐related	  cancer	  death	  rate	  among	  Maine	  males	  
(53.6	  per	  100,000)	  was	  12%	  higher	  than	  those	  of	  both	  U.S.	  males	  (47.7	  per	  
100,000)	  and	  U.S.	  white	  males	  (47.8	  per	  100,000);	  these	  differences	  were	  
statistically	  significant.	  	  The	  rate	  for	  Maine	  females	  in	  this	  year	  (24.3	  per	  
100,000)	  was	  similar	  to	  that	  of	  U.S.	  females	  (24.6	  per	  100,000)	  and	  U.S.	  white	  
females	  (24.1	  per	  100,000;	  Table	  3.31).	  
	  
What	  are	  the	  trends	  in	  tobacco-­‐related	  cancer	  death	  rates	  in	  Maine?	  
	  
Tobacco-­‐related	  cancer	  death	  rates	  in	  Maine	  have	  remained	  steady	  over	  time.	  
	  
• In	  2010,	  646	  Mainers	  died	  due	  to	  tobacco-­‐related	  cancer	  (Table	  3.30).	  
	  
• While	  Maine’s	  age-­‐adjusted	  tobacco-­‐related	  cancer	  death	  rates	  fluctuated	  some	  
from	  year	  to	  year	  between	  2000	  and	  2010,	  only	  the	  2008	  rate	  (34.7	  per	  100,000)	  
was	  significantly	  lower	  (16.2%)	  than	  the	  2000	  rate	  (41.4	  per	  100,000;	  Table	  3.30,	  
Figure	  3.18).	  
	  
• Although	  tobacco-­‐related	  cancer	  death	  rates	  have	  not	  changed	  significantly	  in	  
Maine,	  age-­‐adjusted	  U.S.	  rates	  have	  declined	  significantly	  from	  36.3	  per	  100,000	  
in	  2000	  to	  34.6	  per	  100,000	  in	  2010;	  a	  4.7%	  overall	  decrease	  with	  an	  average	  
annual	  decline	  of	  0.4%.	  Tobacco-­‐related	  cancer	  death	  rates	  among	  U.S.	  whites	  
were	  significantly	  lower	  in	  the	  latter	  part	  of	  the	  decade	  (2006	  to	  2010)	  compared	  
to	  2000	  and	  2001	  rates	  (Table	  3.30,	  Figure	  3.18).	  
	  
Are	  there	  differences	  in	  tobacco-­‐related	  cancer	  death	  rates	  by	  sex	  in	  Maine?	  
	  
Tobacco-­‐related	  cancer	  death	  rates	  are	  significantly	  higher	  among	  Maine	  males	  than	  
females.	  	  
	  
• Maine	  males	  had	  significantly	  higher	  age-­‐adjusted	  tobacco-­‐related	  cancer	  death	  
rates	  than	  females	  between	  2000	  and	  2010	  (Table	  3.31,	  Figure	  3.19).	  	  
	  
• In	  2010,	  the	  age-­‐adjusted	  tobacco-­‐related	  cancer	  death	  rate	  among	  Maine	  males	  
(53.6	  per	  100,000)	  was	  twice	  the	  death	  rate	  among	  females	  (24.3	  per	  100,000);	  
this	  difference	  was	  statistically	  significant	  (Table	  3.31,	  Figure	  3.19).	  
	  
• Tobacco-­‐related	  deaths	  rates	  have	  not	  declined	  consistently	  or	  significantly	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Are	  there	  differences	  in	  tobacco-­‐related	  cancer	  death	  rates	  by	  age	  group	  in	  Maine?	  
	  
Tobacco-­‐related	  cancer	  death	  rate	  in	  Maine	  is	  significantly	  higher	  in	  older	  age	  groups.	  
	  
• In	  Maine,	  tobacco-­‐related	  cancer	  death	  rates	  increased	  with	  age	  during	  2000	  to	  
2010.	  This	  age	  pattern	  is	  similar	  for	  the	  U.S.	  overall	  and	  U.S.	  whites	  (Table	  3.32).	  
	  
• In	  2010,	  the	  tobacco-­‐related	  cancer	  death	  rate	  among	  Mainers	  ages	  75	  years	  and	  
older	  (282.7	  per	  100,000)	  was	  almost	  twice	  the	  rate	  for	  those	  ages	  65–74	  years	  
(145.6	  per	  100,000)	  and	  74	  times	  the	  rate	  for	  those	  ages	  35–64	  years	  (34.1	  per	  
100,000);	  these	  differences	  were	  statistically	  significant.	  	  The	  annual	  number	  of	  
tobacco-­‐related	  cancer	  deaths	  among	  Mainers	  ages	  0–34	  years	  was	  too	  low	  to	  
provide	  statistically	  reliable	  rates	  (Table	  3.32,	  Figure	  3.8).	  	  	  
	  
• Tobacco-­‐related	  cancer	  death	  rates	  remained	  steady	  in	  Maine	  within	  each	  age	  































Data Source: Underlying mortality data provided by National Center for Health Statistics. Rates are calculated using SEER*Stat Version 8.1.5. 
Tobacco-related cancers (excluding lung) include the following: laryngeal, oral cavity and pharynx, esophageal, stomach, pancreatic, kidney 
and renal pelvis, urinary bladder, cervical cancers, and acute myeloid leukemia as the underlying cause of death. Please see Appendix II for 
SEER and ICD-10 codes.                                                                                                                                                                                                               
Age adjusted rates are deaths per 100,000 population age-adjusted to the U.S. 2000 standard population. 
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Are	  there	  differences	  in	  tobacco-­‐related	  cancer	  death	  rates	  by	  geography?	  	  
	  
Counties	  with	  the	  highest	  tobacco-­‐related	  cancer	  death	  rates	  are	  located	  in	  western	  
and	  eastern	  Maine.	  Public	  health	  districts	  with	  the	  highest	  tobacco-­‐related	  cancer	  
death	  rates	  are	  located	  in	  western	  Maine.	  	  
	  
• Androscoggin,	  Oxford,	  Kennebec,	  and	  Washington	  counties	  had	  the	  highest	  age-­‐
adjusted	  tobacco-­‐related	  cancer	  death	  rates	  in	  Maine	  during	  2006-­‐2010,	  but	  
only	  the	  rate	  in	  Oxford	  County	  (44.1	  per	  100,000)	  was	  significantly	  higher	  (22%)	  
than	  the	  overall	  Maine	  rate	  (36.0	  per	  100,000;	  Table	  3.33,	  Map	  3.14).	  
	  
• The	  tobacco-­‐related	  cancer	  death	  rate	  in	  Oxford	  County,	  the	  highest	  county	  rate	  
in	  the	  state	  (44.1	  per	  100,000)	  during	  2006-­‐2010,	  was	  significantly	  higher	  (49%)	  
than	  the	  rate	  in	  Hancock	  County,	  the	  lowest	  county	  rate	  in	  the	  state	  (29.6	  per	  
100,000;	  Table	  3.33,	  Map	  3.14).	  
	  
• Central	  and	  Western	  districts	  had	  the	  highest	  age-­‐adjusted	  tobacco-­‐related	  
cancer	  death	  rates	  among	  public	  health	  districts	  in	  the	  state	  during	  2006-­‐2010,	  
but	  only	  the	  rate	  in	  Western	  District	  (age-­‐adjusted	  rate:	  41.5	  per	  100,000)	  was	  
significantly	  higher	  (15%)	  than	  the	  overall	  state	  rate	  (36.0	  per	  100,000;	  Table	  
3.33,	  Map	  3.15).	  
	  
• The	  tobacco-­‐related	  cancer	  death	  rate	  in	  Western	  District,	  the	  highest	  district	  
rate	  in	  the	  state	  (41.5	  per	  100,000),	  was	  significantly	  higher	  than	  in	  Cumberland,	  
Midcoast,	  and	  Penquis	  districts	  (34.2,	  32.9,	  and	  33.9	  per	  100,000,	  respectively;	  
Table	  3.33,	  Map	  3.15).	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Cancer	  Risk	  Factors	  
	  
Many	  factors	  including	  certain	  behaviors,	  diet,	  and	  environmental	  exposures	  can	  
contribute	  to	  an	  increased	  risk	  of	  developing	  cancer.	  	  In	  this	  chapter,	  we	  examine	  the	  
prevalence	  of	  factors	  associated	  with	  cancer	  risk	  among	  Maine	  adults	  and	  youth	  as	  well	  
as	  radon	  exposure	  as	  an	  environmental	  risk	  factor.	  	  
	  
This	  chapter	  is	  divided	  into	  three	  main	  sections:	  
	  
Section	  I:	  	  Adult	  Risk	  Factors	  
Section	  II:	  Youth	  Risk	  Factors	  
Section	  III:	  Environmental	  Risk	  Factors	  
	  
Sections	  I	  and	  II	  are	  further	  divided	  into	  subsections	  to	  address	  general	  risk	  factors	  
associated	  with	  different	  types	  of	  cancer	  (i.e.,	  any	  tobacco	  use,	  weight	  status,	  physical	  
activity,	  heavy	  drinking	  [adults	  only],	  and	  fruit	  and	  vegetable	  consumption)	  and	  
melanoma-­‐specific	  risk	  factors	  (i.e.,	  use	  of	  artificial	  sources	  of	  ultraviolet	  light	  or	  an	  
indoor	  tanning	  device,	  routine	  use	  of	  sunblock	  or	  sunscreen,	  and	  routine	  use	  of	  at	  least	  
one	  protective	  measure	  against	  prolonged	  sun	  exposure).	  	  Section	  III	  focuses	  primarily	  
on	  radon	  exposure	  and	  testing	  in	  Maine	  homes.	  
	  	  
Section	  I:	  Adult	  Risk	  Factors	  
	  
Cancer	  risk	  in	  adults	  generally	  increases	  with	  age;	  however,	  there	  are	  a	  number	  of	  
lifestyle	  and	  health	  behaviors	  that	  are	  known	  to	  increase	  an	  individual’s	  risk	  for	  being	  
diagnosed	  with	  cancer.	  Tobacco	  use	  -­‐	  namely,	  cigarette	  smoking	  -­‐	  is	  the	  leading	  cause	  of	  
preventable	  death	  in	  the	  U.S.	  as	  well	  as	  a	  leading	  cause	  of	  cancer.1	  It	  is	  estimated	  that,	  
in	  2014,	  approximately	  30%	  of	  all	  cancer	  deaths	  will	  be	  caused	  by	  tobacco	  use.2	  Heavy	  
or	  regular	  alcohol	  use	  has	  also	  been	  linked	  to	  a	  variety	  of	  cancers	  and	  the	  risks	  increase	  
with	  the	  amount	  of	  alcohol	  consumed.	  Additionally,	  the	  cancer	  risks	  of	  using	  both	  
tobacco	  and	  alcohol	  are	  greater	  than	  would	  be	  expected	  from	  the	  individual	  risks	  
associated	  with	  alcohol	  and	  tobacco	  use.3	  There	  is	  increasing	  evidence	  that	  diet	  and	  
physical	  activity	  may	  affect	  cancer	  risk	  in	  adults.	  It	  is	  estimated	  that	  nearly	  one-­‐third	  of	  
cancer	  cases	  in	  the	  U.S.	  can	  be	  attributed	  to	  excess	  body	  weight,	  physical	  inactivity,	  
and/or	  poor	  nutrition	  and	  could	  be	  prevented	  through	  healthier	  lifestyle	  choices.2	  Adults	  
may	  also	  reduce	  cancer	  risk	  through	  protective	  behaviors.	  Melanoma	  (or	  skin	  cancer),	  
the	  most	  common	  cancer	  in	  the	  U.S.,	  may	  be	  prevented	  by	  avoiding	  indoor	  tanning	  and	  
excessive	  sun	  exposure.	  
	  
In	  this	  section,	  data	  related	  to	  cancer	  risk	  among	  Maine	  and	  U.S.	  adults	  are	  from	  the	  
Behavioral	  Risk	  Factor	  Surveillance	  System	  (BRFSS).	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A.	  General	  Risk	  Factors	  
Any	  Tobacco	  Use	  
‘Any	  tobacco	  use’	  is	  defined	  as	  current	  use	  of	  any	  tobacco	  product	  including	  cigarettes,	  
cigars,	  flavored	  cigars	  (small	  and	  large	  size),	  chewing	  tobacco,	  and	  snuff.	  
How	  does	  the	  prevalence	  of	  tobacco	  use	  among	  Maine	  adults	  compare	  to	  U.S.	  adults?	  
One	  in	  five	  Maine	  adults	  are	  current	  cigarette	  smokers,	  and	  one	  in	  four	  currently	  use	  
any	  tobacco	  product.	  	  Nearly	  50%	  of	  adults	  in	  Maine	  are	  former	  or	  current	  cigarette	  
smokers.	  The	  percentage	  of	  former	  smokers	  among	  Maine	  adults	  is	  higher	  than	  
among	  U.S.	  adults,	  but	  the	  percentage	  of	  current	  smokers	  is	  similar	  in	  Maine	  and	  U.S.	  
adults.	  
• In	  2011,	  26.1%	  of	  Maine	  adults	  currently	  used	  any	  type	  of	  tobacco	  product
including	  smokeless	  tobacco	  (Table	  4.1,	  Figure	  4.1).
• In	  2012,	  48.6%	  of	  Maine	  adults	  never	  smoked	  cigarettes,	  31.1%	  were	  former
cigarette	  smokers	  and	  20.3%	  were	  current	  cigarette	  smokers	  (Table	  4.1).
Figure 4.1. Prevalence of Cancer Risk Factors among Adults, Maine and U.S., 2011-2012	  
Data source: Maine Behavioral Risk Factor Surveillance System. 
All percentages are weighted to be more representative of the general adult population of Maine and to adjust for non-response. 
Any tobacco use = Current use of any tobacco product including cigarettes, cigars, flavored cigars (small and large size), chewing tobacco, and snuff. 
Recommended physical activity = Percentage of Maine adults ages 18 years and older who reported meeting current CDC recommendations for aerobic 
exercise and muscle strengthening  (participating in ≥150 minutes of aerobic exercise and muscle strengthening on two or more days per week). 
Heavy drinking = Percentage of Maine adults ages 18 years and older who reported having more than two drinks per day for males and more than one drink 
per day for females. 
U.S. median of 50 states and the District of Columbia. 
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• In	  2012,	  the	  proportion	  of	  former	  smokers	  among	  Maine	  adults	  was	  higher	  than
among	  U.S.	  adults	  (31.1%	  vs.	  25.6%,	  respectively)	  and	  the	  proportion	  of	  adults
who	  never	  smoked	  was	  lower	  among	  Maine	  adults	  than	  U.S.	  adults	  (48.5%	  vs.
54.4%,	  respectively.	  	  The	  proportion	  of	  current	  smokers	  between	  Maine	  and	  U.S.
adults	  was	  similar	  at	  20.3%	  and	  19.6%,	  respectively	  (Table	  4.1,	  Figure	  4.1).
Weight	  Status	  
‘Weight	  status’	  for	  adults	  has	  three	  categories:	  having	  a	  body	  mass	  index	  (BMI)	  ≥18.5	  
and	  <25.0	  kg/m2	  (healthy	  weight),	  a	  BMI	  ≥25.0	  and	  <30.0	  kg/m2	  (overweight),	  or	  a	  BMI	  
≥30.0	  kg/m2	  (obese)	  based	  on	  self-­‐reported	  weight	  and	  height	  measurements.	  	  	  
How	  does	  the	  prevalence	  of	  healthy	  weight,	  overweight	  or	  obesity	  among	  Maine	  
adults	  compare	  to	  U.S.	  adults?	  
About	  one-­‐third	  of	  Maine	  adults	  are	  at	  a	  healthy	  weight.	  	  There	  is	  no	  significant	  
difference	  in	  the	  prevalence	  of	  healthy	  weight,	  overweight	  or	  obesity	  between	  Maine	  
and	  U.S.	  adults.	  	  
• In	  2012,	  34.8%	  of	  Maine	  adults	  were	  at	  a	  healthy	  weight,	  36.4%	  were
overweight,	  and	  28.8%	  were	  obese	  (Table	  4.1,	  Figure	  4.1).
• The	  prevalence	  of	  healthy	  weight,	  overweight	  or	  obesity	  among	  Maine	  adults
was	  similar	  to	  (not	  significantly	  different	  from)	  from	  U.S	  adults	  (Table	  4.1,	  Figure
4.1).	  
Recommended	  Physical	  Activity	  
The	  U.S.	  CDC	  recommends	  that	  adults	  engage	  in	  at	  least	  150	  minutes	  of	  moderate-­‐
intensity	  aerobic	  activity	  every	  week	  and	  muscle	  strengthening	  activities	  at	  least	  two	  
days	  a	  week.4	  
‘Recommended	  physical	  activity’	  is	  defined	  as	  meeting	  current	  CDC	  recommendations	  for	  
aerobic	  exercise	  and	  muscle	  strengthening.	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What	  is	  the	  prevalence	  of	  recommended	  physical	  activity	  among	  Maine	  adults	  
compared	  to	  U.S.	  adults?	  
	  
Only	  one	  in	  five	  Maine	  adults	  engage	  in	  weekly	  physical	  activity	  according	  to	  U.S.	  CDC	  
recommendations.	  There	  is	  no	  significant	  difference	  in	  the	  percentage	  of	  Maine	  and	  
U.S	  adults	  who	  engage	  in	  recommended	  physical	  activity.	  
	  
• In	  2011,	  20.6%	  of	  Maine	  adults	  adhered	  to	  weekly	  aerobic	  and	  muscle	  
strengthening	  activities	  according	  to	  U.S.	  CDC	  recommendations	  (Table	  4.1,	  
Figure	  4.1).	  
	  
• Although	  the	  proportion	  of	  Maine	  adults	  who	  met	  U.S	  CDC	  recommendations	  for	  
physical	  activity	  was	  only	  20.6%	  in	  2011,	  it	  was	  not	  significantly	  different	  from	  
the	  proportion	  of	  U.S.	  adults	  who	  met	  recommended	  physical	  activity	  guidelines	  




‘Heavy	  drinking’	  is	  defined	  as	  having	  more	  than	  two	  drinks	  per	  day	  for	  males	  and	  more	  
than	  one	  drink	  per	  day	  for	  females.	  
	  
How	  does	  the	  prevalence	  of	  heavy	  drinking	  compare	  between	  Maine	  and	  U.S.	  adults?	  
	  
Less	  than	  10%	  of	  Maine	  adults	  are	  heavy	  drinkers.	  	  The	  prevalence	  of	  heavy	  drinking	  is	  
similar	  among	  Maine	  and	  U.S.	  adults.	  	  	  
• In	  2012,	  the	  percentage	  of	  Maine	  adults	  who	  were	  heavy	  drinkers	  was	  6.7%	  
(Table	  4.1,	  Figure	  4.1).	  
	  
• The	  proportion	  of	  heavy	  drinkers	  among	  Maine	  adults	  was	  not	  statistically	  
different	  from	  U.S.	  adults	  (6.7%	  vs.	  6.1%,	  respectively;	  Table	  4.1,	  Figure	  4.1).	  
	  
Fruit	  and	  Vegetable	  Consumption	  
	  
The	  U.S.	  CDC	  recommends	  adults	  calculate	  how	  many	  fruits	  and	  vegetables	  they	  should	  
be	  eating	  each	  day	  based	  on	  age,	  sex,	  and	  level	  of	  physical	  activity,	  and	  provides	  an	  
online	  calculator.5	  National	  data	  on	  the	  median	  of	  daily	  fruit	  and	  vegetable	  consumption	  
was	  taken	  from	  the	  U.S.	  CDC’s	  State	  Indicator	  Report	  on	  Fruits	  and	  Vegetables,	  2013.6	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What	  is	  the	  prevalence	  of	  fruit	  and	  vegetable	  consumption	  among	  Maine	  adults	  
compared	  to	  U.S.	  adults?	  
	  
Maine	  adults	  tend	  consume	  about	  one	  fruit	  and	  two	  vegetables	  per	  day,	  which	  is	  
similar	  to	  the	  amount	  of	  fruit	  and	  vegetables	  consumed	  by	  U.S.	  adults	  daily.	  
	  
• According	  the	  U.S.	  CDC,	  the	  median	  fruit	  consumption	  among	  Maine	  adults	  was	  
1.2	  times	  daily,	  which	  was	  similar	  to	  the	  median	  of	  1.1	  times	  among	  U.S.	  adults	  
(Table	  4.1).	  
	  
• The	  median	  vegetable	  consumption	  among	  Maine	  adults	  was	  1.7	  times	  daily,	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B.	  Melanoma-­‐specific	  Risk	  Factors	  
	  
Artificial	  Sources	  of	  Ultraviolet	  Light	  Use	  
	  
‘Artificial	  sources	  of	  ultraviolet	  light	  use’	  is	  defined	  as	  ever	  use	  of	  artificial	  sources	  of	  
ultraviolet	  light	  such	  as	  sunlamps	  or	  tanning	  booths.	  
	  
What	  is	  the	  prevalence	  of	  artificial	  ultraviolet	  light	  source	  use	  among	  Maine	  adults?	  
	  
Roughly	  6%	  of	  Maine	  adults	  use	  artificial	  sources	  of	  ultraviolet	  light.	  
	  
• In	  2012,	  5.7%	  of	  Maine	  adults	  ever	  used	  artificial	  sources	  of	  ultraviolet	  light	  for	  
tanning	  purposes	  (Table	  4.2,	  Figure	  4.2).	  
	  
What	  are	  the	  trends	  in	  artificial	  ultraviolet	  light	  source	  use	  among	  adults	  in	  Maine?	  
	  
The	  prevalence	  of	  artificial	  ultraviolet	  light	  source	  use	  did	  not	  change	  from	  2011	  to	  
2012.	  
	  
• The	  proportion	  of	  Maine	  adults	  that	  ever	  used	  artificial	  ultraviolet	  light	  sources	  
for	  tanning	  slightly	  increased	  from	  5.0%	  in	  2011	  to	  5.7%	  in	  2012,	  but	  this	  change	  
was	  not	  statistically	  significant	  (Table	  4.2,	  Figure	  4.2).	  
Figure 4.2. Ultraviolet Light Exposure-Related Cancer Risk Factors among Adults by Year, 
Maine, 2002-2012	  
Data source: Maine Behavioral Risk Factor Surveillance System (BRFSS). 
All percentages are weighted to be more representative of the general adult population of Maine and to adjust for non-response. 
Definition: Ever use of artificial sources of ultraviolet light = Percentage of Maine adults ages 18 years and older who reported using artificial sources 
of ultraviolet light such as sunlamps or tanning booths; Routine sunblock use  = Percentage of Maine adults ages 18 years and older who reported 
using sunblock ‘Always’ or ‘Nearly Always’ when outside on a sunny summer day for more than an hour; Routine use of at least one protective 
measures against sun exposure = Percentage of Maine adults ages 18 years and older who reported using at least one of the protective measures 
(i.e., wearing a hat to shade face, ears, or neck against sun, wearing long-sleeved shirt, or staying in the shade) against sun exposure ‘Always’ or 
‘Nearly Always’ when outside on a sunny summer day for more than an hour. 
Change in BRFSS survey methodology represented by break in graph line.  Due to changes in survey methodology, data collected in 2011 and in 
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Are	  there	  differences	  in	  artificial	  ultraviolet	  light	  source	  use	  among	  Maine	  adults	  by	  
demographic	  factors?	  
The	  prevalence	  of	  artificial	  ultraviolet	  light	  source	  use	  is	  highest	  among	  females,	  
young	  adults,	  and	  those	  with	  any	  lifetime	  diagnosis	  of	  depression	  or	  anxiety.	  	  	  
• During	  2011-­‐2012,	  Maine	  females	  were	  significantly	  more	  likely	  to	  use	  artificial
sources	  of	  ultraviolet	  light	  (7.9%)	  compared	  to	  males	  (2.7%;	  Table	  4.3,	  Figure
4.3).	  
	  
• Mainers	  ages	  18−44	  years	  were	  significantly	  more	  likely	  to	  use	  artificial	  sources
of	  ultraviolet	  light	  for	  tanning	  (8.3%)	  than	  those	  ages	  45−64	  years	  (4.6%).	  The
number	  of	  Mainers	  ages	  65	  years	  and	  older	  was	  too	  small	  to	  reliably	  estimate
use	  of	  artificial	  ultraviolet	  light	  sources	  (Table	  4.3,	  Figure	  4.4).
• The	  percentage	  of	  Maine	  adults	  who	  ever	  used	  artificial	  sources	  of	  ultraviolet
light	  was	  significantly	  higher	  among	  those	  with	  some	  college	  education	  (7.2%)
compared	  to	  those	  with	  a	  Bachelor’s	  degree	  or	  higher	  (3.6%;	  Table	  4.3,	  Figure
4.5).	  
Figure 4.3. Ultraviolet Light Exposure-Related Cancer Risk Factors among Adults by Sex, 
Maine, 2010-2012*	  
Data source: Maine Behavioral Risk Factor Surveillance System (BRFSS). 
All percentages are weighted to be more representative of the general adult population of Maine and to adjust for non-response. 
Definition: Artificial sources of ultraviolet light use = Percentage of Maine adults ages 18 years and older who reported ever using artificial sources of 
ultraviolet light such as sunlamps or tanning booths; Routine sunblock use or routine use of at least one protective measure against sun exposure = Use 
of sunblock or protective measures (i.e., wearing a hat, wearing a long-sleeved shirt, or staying in the shade) against sun exposure ‘Always’ or ‘Nearly 
Always’ when outside on a sunny summer day for more than an hour. 
*Regular use of sunblock or at least one protective measure against sun exposure is from 2010 BRFSS data; data for 2010 is the most current data 
available for these indicators. Data on artificial sources of ultraviolet light use is from 2011 and 2012 BRFSS. 
†Use with caution. Estimates based on n<50 might be unstable. 
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• During	  2011-­‐2012,	  the	  number	  of	  Maine	  adults	  with	  an	  annual	  household	  
income	  less	  than	  $50,000	  was	  too	  low	  to	  reliably	  estimate	  the	  proportion	  of	  who	  
ever	  used	  of	  artificial	  sources	  of	  ultraviolet	  light	  by	  income.	  	  However,	  among	  
Maine	  adults	  in	  the	  highest	  household	  income	  group	  ($50,000	  or	  more),	  7.1%	  
used	  artificial	  ultraviolet	  light	  sources	  for	  tanning	  (Table	  4.3,	  Figure	  4.6).	  
	  
• During	  2011-­‐2012,	  6.1%	  of	  Maine	  adults	  with	  private	  insurance	  had	  ever	  used	  
artificial	  ultraviolet	  light	  sources	  for	  tanning.	  	  The	  number	  of	  Mainers	  with	  
Medicare,	  Medicaid	  (MaineCare)	  or	  other	  insurance	  was	  too	  low	  to	  assess	  
differences	  in	  use	  of	  artificial	  sources	  of	  ultraviolet	  light	  by	  type	  of	  health	  
















• The	  number	  of	  Mainers	  with	  current	  depression	  was	  too	  small	  to	  reliably	  
estimate	  the	  percentage	  who	  ever	  used	  artificial	  ultraviolet	  light	  sources	  for	  
tanning.	  Among	  adults	  without	  current	  depression,	  the	  percentage	  of	  adults	  ever	  
used	  artificial	  ultraviolet	  light	  sources	  was	  5.4%	  (Table	  4.3,	  Figure	  4.8).	  
	  
• A	  significantly	  higher	  percentage	  of	  Mainers	  with	  any	  lifetime	  diagnosis	  of	  
depression	  or	  anxiety	  (7.6%)	  used	  artificial	  sources	  of	  ultraviolet	  light	  compared	  
to	  those	  without	  any	  lifetime	  diagnosis	  (4.4%;	  Table	  4.3,	  Figure	  4.9).	  
Figure 4.4. Ultraviolet Light Exposure-Related Cancer Risk Factors among Adults by 
Age, Maine, 2010-2012*	  
Data source: Maine Behavioral Risk Factor Surveillance System. 
All percentages are weighted to be more representative of the general adult population of Maine and to adjust for non-response. 
Definition: Artificial sources of ultraviolet light use = Percentage of Maine adults ages 18 years and older who reported ever using artificial sources 
of ultraviolet light such as sunlamps or tanning booths; Routine sunblock use or routine use of at least one protective measure against sun 
exposure = Use of sunblock or protective measures (i.e., wearing a hat, wearing a long-sleeved shirt, or staying in the shade) against sun exposure 
‘Always’ or ‘Nearly Always’ when outside on a sunny summer day for more than an hour. 
*Routine sunblock use or routine use of at least one protective measure against sun exposure is from 2010 BRFSS data; data for 2010 is the most 
current data available for these indicators. Data on artificial sources of ultraviolet light use is from 2011 and 2012 BRFSS. 
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• Among	  Maine	  adults,	  5.5%	  of	  whites	  and	  5.4%	  of	  non-­‐Hispanics	  ever	  used
artificial	  sources	  of	  ultraviolet	  light.	  	  The	  number	  of	  non-­‐white	  or	  Hispanic	  Maine
adults	  was	  too	  small	  to	  determine	  if	  there	  were	  differences	  in	  the	  prevalence	  of
artificial	  ultraviolet	  light	  source	  use	  by	  race	  or	  ethnicity	  (Table	  4.4).
Are	  there	  differences	  in	  artificial	  ultraviolet	  light	  source	  use	  among	  Maine	  adults	  by	  
geography?	  
The	  number	  of	  Maine	  adults	  who	  reported	  use	  of	  artificial	  sources	  of	  ultraviolet	  light	  
source	  was	  too	  small	  to	  assess	  geographic	  differences.	  
• During	  2011-­‐2012,	  the	  relatively	  small	  number	  of	  adults	  who	  used	  artificial
sources	  of	  ultraviolet	  light	  at	  the	  county	  and	  public	  health	  district	  level	  in	  Maine
result	  in	  most	  county	  and	  district	  prevalence	  rates	  being	  suppressed	  or	  flagged
as	  statistically	  unreliable,	  making	  it	  difficult	  to	  assess	  geographic	  differences
(Table	  4.5).
Routine	  Sunblock	  Use	  
‘Routine	  sunblock	  use’	  is	  defined	  as	  using	  a	  sunblock	  ‘Always’	  or	  ‘Nearly	  Always’	  when	  
outside	  on	  a	  sunny	  summer	  day	  for	  more	  than	  an	  hour.	  
Data	  on	  routine	  sunblock	  use	  from	  the	  2010	  BRFSS	  is	  the	  most	  recent	  data	  available.	  
What	  is	  the	  prevalence	  of	  routine	  sunblock	  use	  among	  adults	  in	  Maine?	  
One-­‐third	  of	  Maine	  adults	  routinely	  use	  sunblock.	  
• In	  2010,	  33.1%	  of	  Maine	  adults	  routinely	  used	  sunblock	  when	  outside	  on	  a	  sunny
summer	  day	  for	  more	  than	  an	  hour	  (Table	  4.2,	  Figure	  4.2).
What	  are	  the	  trends	  in	  routine	  sunblock	  use	  among	  Maine	  adults?	  
From	  2000	  to	  2010,	  routine	  sunblock	  use	  among	  adults	  in	  Maine	  has	  stayed	  
consistent.	  
• Although	  routine	  sunblock	  use	  has	  varied	  among	  Mainers	  from	  2002	  to	  2010	  and
use	  is	  higher	  in	  some	  years	  than	  others,	  there	  is	  no	  significant	  trend	  (Table	  4.2,
Figure	  4.2).
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Are	  there	  differences	  in	  routine	  sunblock	  use	  among	  Maine	  adults	  by	  demographic	  
factors?	  
Routine	  sunblock	  use	  is	  lowest	  among	  males,	  those	  with	  less	  education,	  those	  with	  
lower	  household	  incomes,	  those	  with	  certain	  types	  of	  health	  insurance	  coverage	  
(Medicare	  and	  Medicaid	  [MaineCare]),	  and	  those	  with	  current	  depression.	  
• A	  significantly	  lower	  percentage	  of	  Maine	  males	  routinely	  use	  sunblock	  (20.4%)
compared	  to	  Maine	  females	  (45.6%;	  Table	  4.6,	  Figure	  4.3).
• There	  was	  no	  significant	  difference	  in	  the	  prevalence	  of	  routine	  sunblock	  use
between	  Maine	  adults	  ages	  18−44	  years	  (32.0%),	  ages	  45−64	  years	  (34.9%),	  and
ages	  65	  and	  older	  (32.0%;	  Table	  4.6,	  Figure	  4.4).
• Maine	  adults	  with	  a	  high	  school	  education	  were	  significantly	  less	  likely	  to
routinely	  use	  sunblock	  (25.2%)	  compared	  to	  those	  with	  some	  college	  education
(33.2%),	  and	  those	  with	  a	  Bachelor’s	  degree	  or	  higher	  (42.7%).	  The	  number	  of
adults	  with	  less	  than	  a	  high	  school	  education	  was	  too	  small	  to	  provide	  a	  reliable
estimate	  of	  routine	  sunblock	  use	  in	  this	  group	  (Table	  4.6,	  Figure	  4.5).
• The	  percentages	  of	  Maine	  adults	  with	  an	  annual	  household	  income	  less	  than
$15,000	  who	  routinely	  used	  sunblock	  (24.5%),	  $15,000-­‐24,999	  (27.2%),	  and
$25,000-­‐34,999	  (26.3%)	  were	  significantly	  lower	  than	  those	  with	  an	  income	  of
$50,000	  or	  more	  (38.3%;	  Table	  4.6,	  Figure	  4.6).
Figure 4.5. Use of Artifical Sources of Ultraviolet Light and Protective Measures 
against Sun Exposure among Adults by Level of Education, Maine, 2010-2012*	  
†	  
** 
Data source: Maine Behavioral Risk Factor Surveillance System. 
All percentages are weighted to be more representative of the general adult population of Maine and to adjust for non-response. 
Definition: Artificial sources of ultraviolet light use = Percentage of Maine adults ages 18 years and older who reported ever using artificial sources of 
ultraviolet light such as sunlamps or tanning booths; Routine sunblock use or routine use of at least one protective measure against sun exposure = Use 
of sunblock or protective measures (i.e., wearing a hat, wearing a long-sleeved shirt, or staying in the shade) against sun exposure ‘Always’ or ‘Nearly 
Always’ when outside on a sunny summer day for more than an hour. 
*Routine use of sunblock or at least one protective measure against sun exposure is from 2010 BRFSS data; data for 2010 is the most current data 
available for these indicators. Data on artificial sources of ultraviolet light use is from 2011 and 2012 BRFSS. 
**Data statistically unreliable; total respondents < 50 or 95% CI half-width is >10. 
†Use with caution. Estimates based on n<50 might be unstable. 
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• Maine	  adults	  with	  Medicare	  (29.2%),	  Medicaid	  or	  MaineCare	  (26.5%)	  were
significantly	  less	  likely	  to	  routinely	  use	  sunblock	  compared	  to	  those	  with	  private
health	  insurance	  (38.1%).	  There	  was	  no	  significant	  difference	  between	  those
with	  private	  insurance	  and	  other	  types	  of	  insurance	  (33.7%).	  	  The	  number	  of
uninsured	  individuals	  was	  too	  small	  to	  provide	  a	  reliable	  estimate	  of	  routine
sunblock	  use	  in	  this	  group	  (Table	  4.6,	  Figure	  4.7).
Figure 4.6. Use of Artifical Sources of Ultraviolet Light and Protective Measures 
against Sun Exposure among Adults by Annual Household Income, Maine, 2010-2012*	  
†	   †	   †	   †	  
Data source: Maine Behavioral Risk Factor Surveillance System. 
All percentages are weighted to be more representative of the general adult population of Maine and to adjust for non-response. 
Definition: Artificial sources of ultraviolet light use = Percentage of Maine adults ages 18 years and older who reported ever using artificial sources of 
ultraviolet light such as sunlamps or tanning booths; Routine sunblock use or routine use of at least one protective measure against sun exposure = Use 
of sunblock or protective measures (i.e., wearing a hat, wearing a long-sleeved shirt, or staying in the shade) against sun exposure ‘Always’ or ‘Nearly 
Always’ when outside on a sunny summer day for more than an hour. 
*Routine use of sunblock or at least one protective measure against sun exposure is from 2010 BRFSS data; data for 2010 is the most current data 
available for these indicators. Data on artificial sources of ultraviolet light use is from 2011 and 2012 BRFSS.
†Use with caution. Estimates based on n<50 might be unstable.
Figure 4.7. Use of Artifical Sources of Ultraviolet Light and Protective Measures against 




Data source: Maine Behavioral Risk Factor Surveillance System. 
All percentages are weighted to be more representative of the general adult population of Maine and to adjust for non-response. 
Definition: Artificial sources of ultraviolet light use = Percentage of Maine adults ages 18 years and older who reported ever using artificial sources of 
ultraviolet light such as sunlamps or tanning booths; Routine sunblock use or routine use of at least one protective measure against sun exposure = Use 
of sunblock or protective measures (i.e., wearing a hat, wearing a long-sleeved shirt, or staying in the shade) against sun exposure ‘Always’ or ‘Nearly 
Always’ when outside on a sunny summer day for more than an hour. 
*Routine use of sunblock or at least one protective measure against sun exposure is from 2010 BRFSS data; data for 2010 is the most current data 
available for these indicators. Data on artificial sources of ultraviolet light use is from 2011 and 2012 BRFSS.
†Use with caution. Estimates based on n<50 might be unstable.
‡Sample size was too small to represent the uninsured population of Maine adults.
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• The	  prevalence	  of	  routine	  sunblock	  use	  was	  significantly	  lower	  among	  Maine
adults	  with	  current	  depression	  (19.5%)	  than	  adults	  without	  current	  depression
(34.3%;	  Table	  4.6,	  Figure	  4.8).
• There	  was	  no	  significant	  difference	  in	  the	  prevalence	  of	  routine	  sunblock	  use
among	  Maine	  adults	  with	  any	  lifetime	  diagnosis	  of	  depression	  or	  anxiety	  (30.2%)
compared	  to	  those	  without	  any	  lifetime	  diagnosis	  (34.3%;	  Table	  4.6,	  Figure	  4.9).
• Among	  Maine	  adults,	  33.5%	  of	  whites	  and	  33.2%	  of	  non-­‐Hispanics	  routinely	  used
sunblock.	  The	  number	  of	  non-­‐white	  or	  Hispanic	  Maine	  adults	  was	  too	  small	  to
determine	  if	  there	  were	  differences	  in	  the	  prevalence	  of	  routine	  sunblock	  use	  by
race	  or	  ethnicity	  (Table	  4.7).
Are	  there	  differences	  in	  the	  prevalence	  of	  routine	  sunblock	  use	  among	  Maine	  adults	  
by	  geography?	  
Counties	  and	  public	  health	  districts	  with	  the	  lowest	  prevalence	  of	  routine	  sunblock	  
use	  are	  located	  in	  northern	  and	  eastern	  Maine.	  	  
• In	  2010,	  Aroostook,	  Hancock,	  and	  Waldo	  counties	  had	  the	  lowest	  prevalence	  of
routine	  sunblock	  use	  in	  Maine,	  but	  only	  Aroostook	  County’s	  prevalence	  (22.2%)
was	  significantly	  lower	  than	  Maine	  overall	  (33.1%;	  Table	  4.8,	  Map	  4.1).
Figure 4.8. Use of Artifical Sources of Ultraviolet Light and Protective Measures 
against Sun Exposure among Adults by Current Depression, Maine, 2010-2012*	  
†	  
Data source: Maine Behavioral Risk Factor Surveillance System. 
All percentages are weighted to be more representative of the general adult population of Maine and to adjust for non-response. 
Definition: Artificial sources of ultraviolet light use = Percentage of Maine adults ages 18 years and older who reported ever using artificial sources of 
ultraviolet light such as sunlamps or tanning booths; Routine sunblock use or routine use of at least one protective measure against sun exposure = Use of 
sunblock or protective measures (i.e., wearing a hat, wearing a long-sleeved shirt, or staying in the shade) against sun exposure ‘Always’ or ‘Nearly 
Always’ when outside on a sunny summer day for more than an hour. 
Current depression = Self-reported symptoms of current depression based on PHQ-2 depression scale. 
*Routine use of sunblock or at least one protective measure against sun exposure is from 2010 BRFSS data; data for 2010 is the most current data 
available for these indicators. Data on artificial sources of ultraviolet light use is from 2011 and 2012 BRFSS. 
†Use with caution. Estimates based on n<50 might be unstable. 
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• Aroostook	  County	  had	  the	  lowest	  prevalence	  of	  routine	  sunblock	  use	  in	  the	  state	  
(22.2%),	  significantly	  lower	  than	  Lincoln	  County,	  the	  highest	  prevalence	  in	  the	  
Maine	  (43.1%;	  Table	  4.8,	  Map	  4.1).	  
	  
• Although	  Aroostook	  and	  Downeast	  districts	  had	  the	  lowest	  prevalence	  of	  routine	  
sunblock	  use	  in	  the	  state	  in	  2010	  at	  22.2%	  and	  26.7%	  respectively,	  only	  the	  
prevalence	  in	  Aroostook	  District	  was	  significantly	  lower	  than	  the	  Maine	  overall	  
(33.1%;	  Table	  4.8,	  Map	  4.2).	  
	  
• Aroostook	  District	  had	  a	  significantly	  lower	  prevalence	  of	  routine	  sunblock	  use	  
(22.2%)	  than	  Cumberland	  District	  (43.0%),	  which	  had	  the	  highest	  prevalence	  in	  
the	  state	  (Table	  4.8,	  Map	  4.2).	  
	  
See	  maps	  at	  the	  end	  of	  the	  chapter.	  
	  
Routine	  Use	  of	  At	  Least	  One	  Protective	  Measure	  Against	  Sun	  Exposure	  
	  
‘Routine	  use	  of	  at	  least	  one	  protective	  measure	  against	  sun	  exposure’	  is	  defined	  as	  
wearing	  a	  hat	  to	  shade	  face,	  ears,	  or	  neck,	  wearing	  a	  long-­‐sleeved	  shirt,	  or	  staying	  in	  the	  
shade	  against	  sun	  exposure	  ‘Always’	  or	  	  ‘Nearly	  Always’	  when	  outside	  on	  a	  sunny	  
summer	  day	  for	  more	  than	  an	  hour.	  
	  
Data	  on	  routine	  use	  of	  sun	  protective	  measures	  from	  the	  2010	  BRFSS	  are	  the	  most	  recent	  
data	  available.	  
	  
What	  is	  the	  prevalence	  of	  routine	  use	  of	  at	  least	  one	  sun	  protective	  measure	  among	  
Maine	  adults?	  
	  
In	  Maine,	  four	  in	  ten	  adults	  routinely	  use	  at	  least	  one	  sun	  protective	  measure.	  
	  
• In	  2010,	  40.9%	  of	  Maine	  adults	  routinely	  used	  at	  least	  one	  protective	  measure	  
against	  sun	  exposure	  when	  outside	  on	  a	  sunny	  summer	  day	  for	  more	  than	  one	  
hour	  (Table	  4.2,	  Figure	  4.2).	  
	  
What	  are	  the	  trends	  in	  routine	  use	  of	  at	  least	  one	  sun	  protective	  measure	  among	  
Maine	  adults?	  
	  
From	  2002	  to	  2010,	  the	  percentage	  of	  Maine	  adults	  who	  routinely	  use	  at	  least	  one	  sun	  
protective	  measure	  declined.	  
	  
• The	  prevalence	  of	  routine	  use	  of	  at	  least	  one	  sun	  protective	  measure	  among	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Are	  there	  differences	  in	  the	  prevalence	  of	  routine	  use	  of	  at	  least	  one	  sun	  protective	  
measure	  among	  Maine	  adults	  by	  demographic	  factors?	  
	  
The	  prevalence	  of	  Maine	  adults	  who	  routinely	  use	  of	  at	  least	  one	  sun	  protective	  
measure	  is	  lowest	  among	  females,	  young	  adults,	  those	  with	  higher	  household	  income,	  
and	  those	  with	  private	  insurance	  or	  Medicaid	  (MaineCare).	  	  	  
	  
• From	  2010,	  Maine	  females	  were	  significantly	  less	  likely	  to	  routinely	  use	  at	  least	  
one	  protective	  measure	  against	  sun	  exposure	  (34.3%)	  compared	  to	  males	  
(47.6%;	  Table	  4.9,	  Figure	  4.3).	  
	  
• Maine	  adults	  ages	  18−44	  years	  were	  significantly	  less	  likely	  to	  routinely	  use	  at	  
least	  one	  protective	  measure	  against	  sun	  exposure	  (28.5%)	  than	  those	  ages	  
45−64	  years	  (43.4%)	  and	  those	  ages	  65	  years	  and	  older	  (64.7%;	  Table	  4.8,	  Figure	  
4.4).	  
	  
• The	  percentage	  of	  Maine	  adults	  who	  routinely	  use	  at	  least	  one	  protective	  
measure	  against	  sun	  exposure	  was	  similar	  (and	  not	  significantly	  different)	  
between	  those	  with	  a	  less	  than	  a	  high	  school	  education	  (44.3%),	  those	  with	  a	  
high	  school	  diploma	  (41.5%),	  those	  with	  some	  college	  education	  (39.3%),	  and	  
those	  with	  a	  Bachelor’s	  degree	  or	  higher	  (41.6%;	  Table	  4.9,	  Figure	  4.5).	  
	  
• Mainers	  with	  an	  annual	  household	  income	  of	  $50,000	  or	  more	  were	  significantly	  
less	  likely	  to	  routinely	  use	  at	  least	  one	  protective	  measure	  against	  sun	  exposure	  
(36.8%)	  compared	  to	  those	  with	  an	  income	  of	  less	  than	  $15,000	  (53.4%)	  and	  
$15,000-­‐24,999	  (46.1%;	  Table	  4.9,	  Figure	  4.6).	  
	  
• A	  significantly	  lower	  percentage	  of	  Maine	  adults	  with	  private	  insurance	  and	  
Medicaid	  (MaineCare)	  routinely	  use	  at	  least	  one	  protective	  measure	  against	  sun	  
exposure	  (36.1%	  and	  29.2%,	  respectively)	  compared	  to	  those	  with	  Medicare	  
(59.6%)	  and	  other	  insurance	  types	  (50.4%;	  Table	  4.9,	  Figure	  4.7).	  
	  
• In	  Maine,	  45.2%	  of	  adults	  with	  current	  depression	  routinely	  use	  at	  least	  one	  
protective	  measure	  against	  sun	  exposure	  compared	  to	  40.5%	  of	  those	  without	  
current	  depression;	  this	  was	  not	  a	  significant	  difference	  (Table	  4.9,	  Figure	  4.8).	  
	  
• There	  was	  no	  significant	  difference	  in	  the	  proportion	  of	  Mainers	  with	  any	  
lifetime	  diagnosis	  of	  depression	  or	  anxiety	  (41.3%)	  who	  routinely	  use	  at	  least	  one	  
protective	  measure	  against	  sun	  exposure	  compared	  to	  those	  without	  any	  
lifetime	  diagnosis	  (40.8%;	  Table	  4.9,	  Figure	  4.9).	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• Among	  Maine	  adults,	  41.0%	  of	  whites	  and	  40.8%	  of	  non-­‐Hispanics	  reported	  
routine	  use	  at	  least	  one	  protective	  measure	  against	  sun	  exposure.	  	  The	  number	  
of	  non-­‐white	  or	  Hispanic	  Maine	  adults	  was	  too	  small	  to	  determine	  if	  there	  were	  
differences	  in	  the	  prevalence	  of	  routine	  use	  at	  least	  one	  protective	  measure	  
against	  sun	  exposure	  by	  race	  or	  ethnicity	  (Table	  4.10).	  	  
	  
Are	  there	  differences	  in	  routine	  use	  at	  least	  one	  protective	  measure	  against	  sun	  
exposure	  among	  Maine	  adults	  by	  geography?	  
	  
Routine	  use	  of	  at	  least	  one	  protective	  measure	  against	  sun	  exposure	  does	  not	  vary	  
significantly	  by	  county	  or	  public	  health	  district	  in	  Maine.	  
	  
• Although	  Hancock,	  Penobscot,	  and	  York	  counties	  had	  the	  lowest	  prevalence	  of	  
routine	  use	  of	  at	  least	  one	  protective	  measure	  against	  sun	  exposure	  in	  2010,	  
none	  were	  significantly	  lower	  than	  the	  prevalence	  of	  Maine	  overall	  or	  of	  any	  
other	  Maine	  county	  (Table	  4.11,	  Map	  4.3).	  
	  
• The	  prevalence	  of	  routine	  use	  of	  at	  least	  one	  protective	  measure	  against	  sun	  
exposure	  in	  Downeast	  and	  York	  districts,	  the	  lowest	  in	  the	  state,	  was	  not	  
significantly	  different	  from	  the	  prevalence	  in	  Maine	  oveall	  or	  of	  any	  other	  Maine	  
district	  (Table	  4.11,	  Map	  4.4).	  
	  
See	  maps	  at	  the	  end	  of	  the	  chapter.	  
Data source: Maine Behavioral Risk Factor Surveillance System. 
All percentages are weighted to be more representative of the general adult population of Maine and to adjust for non-response. 
Definition: Artificial sources of ultraviolet light use = Percentage of Maine adults ages 18 years and older who reported ever using artificial sources of 
ultraviolet light such as sunlamps or tanning booths; Routine sunblock use or routine use of at least one protective measure against sun exposure = Use 
of sunblock or protective measures (i.e., wearing a hat, wearing a long-sleeved shirt, or staying in the shade) against sun exposure ‘Always’ or ‘Nearly 
Always’ when outside on a sunny summer day for more than an hour. 
Lifetime depression or anxiety = Current depression or any lifetime diagnosis of depression or anxiety. 
*Routine use of sunblock or at least one protective measure against sun exposure is from 2010 BRFSS data; data for 2010 is the most current data 
available for these indicators. Data on artificial sources of ultraviolet light use is from 2011 and 2012 BRFSS. 
 
 	  
Figure 4.9. Use of Ultraviolet Light and Protective Measures against Sun Exposure among 
Adults by Lifetime Depression or Anxiety, Maine, 2010-2012*	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Section	  II:	  	  Youth	  Risk	  Factors	  
	  
Risk	  behaviors	  that	  develop	  in	  youth	  can	  later	  affect	  adult	  health,	  including	  cancer	  risk.	  
Adolescence	  is	  an	  optimal	  time	  to	  intervene	  on	  behavioral	  risk	  factors	  to	  prevent	  cancer	  
or	  reduce	  cancer	  risk.	  	  During	  this	  time,	  it	  is	  important	  to	  identify	  and	  reduce	  harmful	  
exposures	  linked	  to	  cancer	  and	  promote	  protective	  behaviors.7	  
	  
Data	  on	  factors	  linked	  to	  cancer	  risk	  among	  Maine	  youth	  were	  collected	  from	  middle	  
school	  students	  (grades	  seven	  and	  8)	  and	  high	  school	  students	  (grades	  9-­‐12)	  by	  the	  
Maine	  Integrated	  Youth	  Health	  Survey	  (MIYHS).	  National	  data	  from	  high	  school	  students	  
came	  from	  the	  Youth	  Risk	  Behavior	  Survey	  (YRBS).8	  For	  more	  information	  about	  these	  
data	  sources,	  please	  see	  ‘Data	  Sources’	  in	  Appendix	  III.	  
	  
A.	  General	  Risk	  Factors	  
	  
Any	  Current	  Tobacco	  Use	  
	  
‘Any	  current	  tobacco	  use’	  is	  defined	  as	  use	  of	  any	  tobacco	  product	  including	  cigarettes,	  
cigars,	  cigarillos,	  little	  cigars,	  and	  smokeless	  tobacco	  in	  the	  past	  30	  days	  before	  the	  
survey.	  
	  
How	  does	  the	  prevalence	  of	  current	  tobacco	  use	  among	  Maine	  youth	  compare	  to	  U.S.	  
youth?	  
	  
In	  Maine,	  high	  school	  students	  have	  a	  higher	  prevalence	  of	  current	  tobacco	  use	  
compared	  to	  middle	  school	  students.	  	  The	  prevalence	  of	  current	  tobacco	  use	  was	  
lower	  among	  Maine	  high	  school	  students	  than	  U.S.	  high	  school	  students.	  
	  
• In	  2013,	  a	  significantly	  higher	  percentage	  of	  Maine	  high	  school	  students	  (18.2%)	  
used	  any	  type	  of	  tobacco	  product	  in	  the	  past	  30	  days	  compared	  to	  middle	  school	  
students	  (3.8%;	  Table	  4.12,	  Figure	  4.10).	  
	  
• In	  2013,	  18.2%	  of	  Maine	  high	  school	  students	  currently	  used	  any	  tobacco	  
product,	  significantly	  lower	  than	  the	  22.4%	  of	  U.S.	  high	  school	  students.	  National	  
data	  on	  any	  tobacco	  use	  among	  middle	  school	  students	  was	  not	  available	  (Table	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‘Weight	  status’	  for	  youth	  has	  three	  categories:	  having	  a	  body	  mass	  index	  (BMI)	  of	  <5th	  
percentile	  but	  <85th	  percentile	  (healthy	  weight),	  a	  BMI	  of	  ≥85th	  percentile	  but	  <95th	  
percentile	  (overweight),	  or	  a	  BMI	  ≥95th	  percentile	  (obese)	  for	  youth	  of	  the	  same	  age	  and	  
sex	  according	  to	  standard	  growth	  charts.	  	  Weight	  status	  was	  calculated	  from	  self-­‐
reported	  weight	  and	  height	  measurements	  from	  the	  MIYHS	  for	  Maine	  youth	  and	  YRBS	  






Figure 4.10. Prevalence of Cancer Risk Factors among Middle School and High School Students, 
Maine and U.S., 2013*	  	  	  	  	  	  	  	  	  	  	  	  	  
Maine data source: 2013 Maine Integrated Youth Health Survey. U.S. data source: 2013 Youth Risk Behavior Survey. 
All percentages are weighted to be more representative of the student population of Maine and to adjust for non-response. 
*Data for U.S. high school students taken from the 2013 Youth Risk Behavior Survey. 
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How	  does	  the	  prevalence	  of	  healthy	  weight,	  overweight	  or	  obesity	  among	  Maine	  
youth	  compare	  to	  U.S.	  youth?	  
	  
Nearly	  70%	  of	  Maine	  middle	  and	  high	  school	  students	  are	  at	  a	  healthy	  weight.	  Maine	  
high	  school	  students	  are	  more	  likely	  to	  be	  at	  a	  healthy	  weight	  than	  Maine	  middle	  
school	  students.	  The	  prevalence	  of	  overweight	  or	  obesity	  among	  Maine	  high	  school	  
students	  is	  similar	  to	  U.S.	  high	  school	  students.	  
	  
• In	  2013,	  69.7%	  of	  Maine	  high	  school	  students	  and	  65.7%	  of	  Maine	  middle	  
students	  were	  at	  a	  healthy	  weight,	  while	  28.7%	  of	  high	  school	  students	  and	  
31.7%	  of	  middle	  school	  students	  were	  either	  overweight	  or	  obese	  (Table	  4.12,	  
Figure	  4.10).	  
	  
• Maine	  high	  school	  students	  were	  significantly	  more	  likely	  to	  be	  at	  a	  healthy	  
weight	  (69.7%)	  compared	  to	  Maine	  middle	  school	  students	  (65.7%),	  but	  there	  
were	  not	  significant	  differences	  in	  the	  prevalence	  of	  overweight	  or	  obesity	  
(Table	  4.12,	  Figure	  4.10).	  
	  
• In	  2013,	  Maine	  high	  school	  students	  had	  similar	  prevalence	  rates	  of	  overweight	  
and	  obesity	  (16.0%	  and	  12.7%,	  respectively)	  as	  U.S.	  high	  school	  students	  (16.6%	  
and	  13.7%,	  respectively).	  Data	  on	  overweight	  or	  obesity	  among	  U.S.	  middle	  
school	  students	  or	  healthy	  weight	  among	  U.S.	  high	  school	  students	  were	  not	  
available	  (Table	  4.12,	  Figure	  4.10).	  
	  
Daily	  Physical	  Activity	  
	  
The	  U.S.	  CDC	  recommends	  that	  youth	  engage	  in	  physical	  activity	  at	  least	  60	  minutes	  per	  
day,	  including	  muscle	  strengthening	  and/or	  bone	  strengthening	  activities	  at	  least	  3	  days	  
a	  week.9	  
	  
‘Daily	  physical	  activity’	  is	  defined	  as	  engaging	  in	  at	  least	  60	  minutes	  of	  physical	  activity	  
per	  day	  on	  all	  seven	  days	  before	  the	  survey.	  	  
How	  does	  the	  prevalence	  of	  daily	  physical	  activity	  among	  Maine	  youth	  compare	  to	  
U.S.	  youth?	  
	  
In	  Maine,	  high	  school	  students	  are	  less	  likely	  to	  engage	  in	  daily	  physical	  activity	  than	  
middle	  school	  students.	  	  Maine	  high	  school	  students	  have	  a	  lower	  prevalence	  of	  daily	  
physical	  activity	  than	  U.S.	  high	  school	  students.	  
	  
• In	  Maine,	  high	  school	  students	  (22.4%)	  were	  significantly	  less	  likely	  to	  engage	  in	  
at	  least	  60	  minutes	  of	  daily	  physical	  activity	  compared	  to	  middle	  school	  students	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• Maine	  high	  school	  students	  (22.4%)	  were	  less	  likely	  to	  participate	  in	  daily	  
physical	  activity	  than	  U.S.	  high	  school	  students	  (27.1%).	  National	  data	  on	  daily	  
physical	  activity	  among	  middle	  school	  students	  was	  not	  available	  (Table	  4.12,	  
Figure	  4.10).	  
	  
	  Fruit	  and	  Vegetable	  Consumption	  
	  
Similar	  to	  adults,	  the	  U.S.	  CDC	  recommends	  calculating	  how	  many	  fruits	  and	  vegetables	  
youth	  should	  eat	  each	  day	  based	  on	  age,	  sex,	  and	  level	  of	  physical	  activity.5	  
	  
‘Fruit	  and	  vegetable	  consumption’	  is	  defined	  as	  eating	  fruits	  and/or	  vegetables	  five	  or	  
more	  times	  per	  day	  during	  the	  past	  seven	  days	  before	  the	  survey.	  
	  
What	  is	  the	  prevalence	  of	  fruit	  and	  vegetable	  consumption	  among	  youth	  in	  Maine?	  
	  
High	  school	  students	  had	  a	  lower	  prevalence	  of	  fruit	  and	  vegetable	  consumption	  than	  
middle	  school	  students	  in	  Maine.	  
	  
• In	  2013,	  a	  significantly	  lower	  percentage	  of	  Maine	  high	  school	  students	  (16.8%)	  
consumed	  fruits	  and/or	  vegetables	  five	  or	  more	  times	  per	  day	  compared	  to	  
middle	  school	  students	  (19.3%).	  	  Data	  on	  the	  consumption	  of	  fruits	  and/or	  
vegetables	  five	  or	  more	  times	  per	  day	  among	  U.S.	  youth	  was	  not	  available	  in	  
YRBS	  (Table	  4.12,	  Figure	  4.10).	  
	  
B.	  Melanoma-­‐specific	  Risk	  Factors	  
	  
Indoor	  Tanning	  Device	  Use	  
	  
‘Indoor	  tanning	  device	  use’	  is	  defined	  as	  use	  of	  an	  indoor	  tanning	  device	  such	  as	  a	  
sunlamp,	  sunbed,	  or	  tanning	  booth	  at	  least	  one	  time	  during	  the	  past	  12	  months.	  
	  
How	  does	  the	  prevalence	  of	  indoor	  tanning	  device	  use	  among	  Maine	  youth	  compare	  
to	  U.S.	  youth?	  
	  
In	  Maine,	  high	  school	  students	  are	  significantly	  more	  likely	  to	  use	  an	  indoor	  tanning	  
device	  than	  middle	  school	  students.	  	  The	  prevalence	  of	  indoor	  tanning	  device	  use	  was	  
similar	  between	  Maine	  and	  U.S.	  high	  school	  students.	  
	  
• In	  2013,	  a	  significantly	  higher	  percentage	  of	  Maine	  high	  school	  students	  (15.0%)	  
used	  an	  indoor	  tanning	  device	  at	  least	  once	  in	  the	  past	  year	  compared	  to	  middle	  
school	  students	  (6.1%;	  Table	  4.12,	  Figure	  4.11).	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• In	  2013,	  a	  similar	  percentage	  of	  high	  school	  students	  in	  Maine	  (15.0%)	  and	  U.S.
(12.8%)	  used	  an	  indoor	  tanning	  device.	  	  Data	  on	  indoor	  tanning	  device	  use	  U.S.
middle	  school	  students	  was	  not	  available	  in	  YRBS	  (Table	  4.12).
• From	  2009	  to	  2013,	  high	  school	  students	  consistently	  used	  indoor	  tanning
devices	  more	  than	  middle	  school	  students;	  these	  differences	  were	  significant
(Table	  4.13,	  Figure	  4.11).
What	  are	  the	  trends	  in	  indoor	  tanning	  device	  use	  among	  youth	  in	  Maine?	  
Among	  Maine	  middle	  and	  high	  school	  students,	  use	  of	  indoor	  tanning	  devices	  has	  
significantly	  declined	  from	  2009	  to	  2013.	  
• A	  significantly	  higher	  percentage	  of	  high	  school	  students	  in	  Maine	  used	  an
indoor	  tanning	  device	  in	  2009	  (22.5%)	  compared	  to	  2011	  (16.4%)	  and	  2013
(15.0%).	  The	  same	  (and	  significant)	  trend	  was	  observed	  among	  middle	  school
students	  with	  9.2%	  in	  2009	  compared	  to	  6.8%	  in	  2011	  and	  6.1%	  in	  2013	  (Table
4.13,	  Figure	  4.11).
• Among	  Maine	  high	  school	  students,	  use	  of	  indoor	  tanning	  devices	  significantly 
declined	  from	  22.5%	  in	  2009	  to	  15.0%	  in	  2013	  (Table	  4.13,	  Figure	  4.11).
Figure 4.11. Ultraviolet Light Exposure-Related Cancer Risk Factors among Middle and High 
School Students by Year, Maine, 2009-2013	  
Data source: Maine Integrated Youth Health Survey. 
All percentages are weighted to be more representative of the general student population of Maine and to adjust for non-response. 
Definition: Use of an indoor tanning device = Percentage of Maine middle and high school students who reported using an indoor tanning device such 
as a sunlamp, sunbed, or tanning booth at least one time in during the past 12 months; Regular use of sunscreen = Percentage of Maine middle and 
high school students who reported using a sunscreen with a SPF of 15 or higher ‘Most of the time’ or ‘Always’ when outside on a sunny day for more 
than an hour. 
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• Use	  of	  indoor	  tanning	  devices	  followed	  a	  similar	  trend	  among	  Maine	  middle	  
school	  students,	  declining	  significantly	  from	  9.2%	  in	  2009	  to	  6.1%	  in	  2013	  (Table	  
4.13,	  Figure	  4.11).	  
	  
Are	  there	  differences	  in	  indoor	  tanning	  device	  use	  among	  youth	  by	  demographic	  
factors?	  
	  
Among	  middle	  school	  students	  in	  Maine,	  there	  were	  no	  significant	  differences	  in	  use	  
of	  indoor	  tanning	  devices	  by	  sex,	  age,	  or	  grade.	  	  Among	  high	  school	  students,	  use	  of	  
indoor	  tanning	  devices	  was	  highest	  among	  females,	  those	  in	  older	  age	  groups,	  those	  in	  
the	  higher	  grade	  levels,	  and	  Hispanics.	  	  
	  
• In	  2013,	  Maine	  high	  school	  females	  were	  significantly	  more	  likely	  to	  use	  indoor	  
tanning	  devices	  (19.9%)	  compared	  to	  males	  (10.0%).	  	  There	  was	  no	  significant	  
difference	  in	  the	  use	  of	  indoor	  tanning	  devices	  by	  sex	  among	  middle	  school	  
students	  in	  Maine	  (Table	  4.14	  and	  Table	  4.15,	  Figure	  4.12).	  
	  
• Among	  Maine	  high	  school	  students,	  use	  of	  indoor	  tanning	  devices	  tended	  to	  rise	  
with	  increasing	  age.	  	  High	  school	  students	  16	  years	  old	  (14.5%),	  17	  years	  old	  
(18.6%)	  and	  18	  years	  old	  (21.8%)	  were	  significantly	  more	  likely	  to	  use	  indoor	  
tanning	  devices	  than	  those	  15	  years	  old	  (10.7%)	  or	  14	  years	  or	  younger	  (10.5%).	  
Among	  middle	  school	  students	  in	  Maine,	  there	  was	  no	  significant	  difference	  in	  
















Figure 4.12. Ultraviolet Light Exposure-Related Cancer Risk Factors among Middle and High 
School Students by Sex, Maine, 2013	  
	  Middle School Students High School Students 
Data source: Maine Integrated Youth Health Survey. 
All percentages are weighted to be more representative of the general student population of Maine and to adjust for non-response. 
Definition: Indoor tanning device use = Percentage of Maine middle and high school students who reported using an indoor tanning device such as a sunlamp, 
sunbed, or tanning booth at least one time in during the past 12 months; Routine sunscreen use = Percentage of Maine middle and high school students who 
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• Likewise,	  a	  significantly	  higher	  percentage	  of	  Maine	  high	  school	  students	  in	  11th	  
grade	  and	  12th	  grade	  (15.5%	  and	  21.1%,	  respectively)	  used	  an	  indoor	  tanning	  
device	  in	  the	  past	  12	  months	  compared	  to	  those	  in	  9th	  grade	  and	  10th	  grade	  
(9.7%	  and	  12.8%,	  respectively).	  There	  was	  no	  statistically	  significant	  difference	  in	  
the	  use	  of	  indoor	  tanning	  devices	  by	  grade	  level	  among	  Maine	  middle	  school	  
students	  (Table	  4.14	  and	  Table	  4.15,	  Figure	  4.13).	  	  
	  
• In	  Maine,	  5.6%	  of	  non-­‐Hispanic	  white	  middle	  school	  students	  and	  14.5%	  of	  non-­‐
Hispanic	  white	  high	  school	  students	  used	  an	  indoor	  tanning	  device	  during	  the	  
past	  12	  months.	  The	  numbers	  of	  Hispanic	  middle	  school	  students	  and	  non-­‐white	  
students	  were	  too	  low	  to	  determine	  if	  there	  were	  differences	  in	  the	  prevalence	  





























Middle School Students 
Figure 4.13. Ultraviolet Light Exposure-Related Cancer Risk Factors among Middle and 
High School Students by Grade, Maine, 2013	  
High School Students 
Data source: Maine Integrated Youth Health Survey. 
All percentages are weighted to be more representative of the general student population of Maine and to adjust for non-response. 
Definition: Indoor tanning device use = Percentage of Maine middle and high school students who reported using an indoor tanning device such as a 
sunlamp, sunbed, or tanning booth at least one time in during the past 12 months; Routine sunscreen use = Percentage of Maine middle and high school 
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• Hispanic	  middle	  school	  students	  were	  more	  likely	  to	  have	  used	  an	  indoor	  tanning	  
device	  (16.7%)	  compared	  to	  non-­‐Hispanic	  white	  middle	  school	  students	  (5.6%;	  
Table	  4.14).	  
	  
• A	  significantly	  higher	  percentage	  of	  Hispanic	  high	  school	  students	  used	  an	  indoor	  
tanning	  device	  during	  the	  past	  12	  months	  (23.1%)	  compared	  to	  non-­‐Hispanic	  
white	  high	  school	  students	  (14.5%;	  Table	  4.15).	  	  
	  
• Among	  Maine	  high	  school	  students,	  homosexual	  (gay	  or	  lesbian)	  students	  were	  
more	  likely	  to	  use	  an	  indoor	  tanning	  device	  during	  the	  past	  12	  months	  compared	  
to	  heterosexual	  (straight)	  students	  (14.9%),	  bisexual	  students	  (13.7%),	  and	  
students	  unsure	  of	  their	  sexuality	  (14.%;	  Table	  4.15).	  	  
	  
Routine	  Sunscreen	  Use	  
	  
	  ‘Routine	  sunscreen	  use’	  is	  defined	  as	  using	  a	  sunscreen	  with	  a	  SPF	  of	  15	  or	  higher	  ‘Most	  
of	  the	  time’	  or	  ‘Always’	  when	  outside	  on	  a	  sunny	  day	  for	  more	  than	  an	  hour.	  
	  
How	  does	  the	  prevalence	  of	  routine	  sunscreen	  use	  among	  Maine	  youth	  compare	  to	  
U.S.	  youth?	  
	  
Middle	  school	  students	  have	  a	  higher	  prevalence	  of	  routine	  sunscreen	  use	  than	  high	  
school	  students	  in	  Maine.	  A	  greater	  percentage	  of	  Maine	  high	  school	  students	  
routinely	  use	  sunscreen	  than	  U.S.	  high	  school	  students.	  
	  
• In	  2013,	  a	  significantly	  higher	  percentage	  of	  middle	  school	  students	  (28.7%)	  
routinely	  used	  sunscreen	  compared	  to	  high	  school	  students	  (19.7%)	  in	  Maine	  
(Table	  4.12,	  Figure	  4.11).	  
	  
• In	  2013,	  Maine	  high	  school	  students	  (19.7%)	  had	  a	  higher	  prevalence	  of	  routine	  
sunscreen	  use	  compared	  to	  U.S.	  high	  school	  students	  (10.1%).	  National	  data	  on	  
routine	  sunscreen	  use	  among	  U.S.	  middle	  school	  students	  was	  not	  available	  in	  
YRBS	  (Table	  4.12).	  
	  
• From	  2009	  to	  2013,	  routine	  sunscreen	  use	  was	  consistently	  and	  significantly	  
higher	  among	  middle	  school	  students	  compared	  to	  high	  school	  students	  (Table	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What	  are	  the	  trends	  in	  routine	  sunscreen	  use	  among	  youth	  in	  Maine?	  
	  
The	  prevalence	  of	  middle	  and	  high	  school	  students	  who	  routinely	  use	  sunscreen	  has	  
stayed	  consistent	  since	  2009.	  	  
• In	  Maine,	  the	  proportion	  of	  middle	  and	  high	  school	  students	  who	  routinely	  use	  
sunscreen	  did	  not	  change	  significantly	  between	  2009	  (33.0%	  and	  21.4%,	  
respectively)	  and	  2013	  (28.7%	  and	  19.7%,	  respectively;	  Table	  4.13,	  Figure	  4.11).	  
	  
Are	  there	  differences	  in	  routine	  sunscreen	  use	  among	  youth	  by	  demographic	  factors?	  
	  
In	  Maine,	  the	  percentage	  of	  middle	  and	  high	  school	  students	  who	  routinely	  use	  
sunscreen	  is	  lowest	  among	  males,	  those	  in	  the	  oldest	  age	  groups,	  and	  those	  in	  the	  
higher	  grade	  levels.	  Among	  Maine	  high	  school	  and	  middle	  school	  students,	  non-­‐
Hispanic	  white	  students	  were	  more	  likely	  to	  routinely	  use	  sunscreen	  than	  Hispanics	  
and	  most	  other	  race	  groups.	  
	  
• In	  2013,	  middle	  school	  and	  high	  schools	  males	  in	  Maine	  were	  significantly	  less	  
likely	  to	  routinely	  use	  sunscreen	  (23.9%	  and	  14.5%,	  respectively)	  compared	  to	  
females	  (33.4%	  and	  24.9%,	  respectively;	  Table	  4.16	  and	  Table	  4.17,	  Figure	  4.12).	  
	  
• Among	  middle	  school	  students	  in	  Maine,	  a	  significantly	  lower	  percentage	  of	  
those	  ages	  14	  and	  older	  (21.1%)	  routinely	  used	  sunscreen	  compared	  to	  those	  13	  
years	  old	  (29.6%)	  and	  ages	  12	  or	  younger	  (35.0%).	  	  A	  similar	  pattern	  was	  
observed	  among	  high	  school	  students	  showing	  a	  decline	  in	  routine	  sunscreen	  
use	  with	  increasing	  age,	  but	  only	  those	  age	  17	  years	  (18.0%)	  had	  a	  significantly	  
lower	  rate	  than	  those	  ages	  14	  years	  or	  younger	  (23.5%;	  Table	  4.16	  and	  Table	  
4.17).	  
	  
• For	  Maine	  middle	  school	  students,	  those	  in	  the	  8th	  grade	  were	  significantly	  less	  
likely	  to	  routinely	  used	  sunscreen	  (24.6%)	  compared	  to	  those	  in	  the	  7th	  grade	  
(33.5%).	  Although	  routine	  sunscreen	  use	  appeared	  to	  decrease	  by	  grade	  among	  
high	  school	  students,	  there	  was	  no	  statistically	  significant	  difference	  (Table	  4.16	  
and	  Table	  4.17,	  Figure	  4.13).	  	  
• In	  Maine,	  29.5%	  of	  non-­‐Hispanic	  white	  students	  in	  middle	  school	  and	  20.0%	  of	  
white	  non-­‐Hispanic	  students	  in	  high	  school	  routinely	  used	  sunscreen.	  The	  
number	  of	  Hispanic	  middle	  school	  students	  and	  non-­‐white	  students	  was	  too	  
small	  to	  determine	  if	  there	  were	  differences	  in	  the	  prevalence	  of	  routine	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• Non-­‐Hispanic	  white	  middle	  school	  students	  were	  more	  likely	  to	  routinely	  use	  
sunscreen	  (29.5%)	  than	  Hispanic	  ,	  black,	  and	  American	  Indian	  or	  Alaska	  Native	  
students	  (20.0%,	  	  14.1%,	  and	  19.8,%,	  respectively	  (Table	  4.17).	  	  	  
	  
• Likewise,	  non-­‐Hispanic	  white	  high	  school	  students	  were	  more	  likely	  to	  routinely	  
use	  sunscreen	  (20.0%)	  than	  Hispanic	  and	  black	  students	  (14.6%	  and	  7.9%,	  
respectively;	  Table	  4.17).	  	  	  
	  
• Among	  Maine	  high	  school	  students,	  there	  was	  no	  significant	  difference	  in	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Section	  III:	  	  Environmental	  Risk	  Factors	  
	  
Radon	  is	  the	  second	  leading	  cause	  of	  lung	  cancer	  in	  the	  U.S.	  after	  tobacco	  use.10	  Radon	  
is	  a	  colorless,	  odorless,	  and	  tasteless	  radioactive	  gas	  that	  naturally	  occurs	  in	  rocks	  and	  
soils.	  Although	  radon	  can	  be	  found	  throughout	  the	  U.S.,	  the	  rocks	  and	  soils	  in	  Maine	  
generate	  more	  radon	  than	  most	  other	  states.	  	  Radon	  can	  be	  released	  from	  soil	  or	  
groundwater	  into	  the	  indoor	  air	  of	  a	  house,	  and	  then	  get	  trapped	  inside.	  Exposure	  to	  
elevated	  levels	  of	  radon	  in	  indoor	  air	  increases	  the	  risk	  of	  lung	  cancer.	  Testing	  for	  radon	  
is	  the	  only	  way	  to	  determine	  if	  a	  house	  has	  elevated	  levels	  of	  radon	  in	  indoor	  air.	  
	  
In	  this	  section,	  data	  on	  radon	  testing	  were	  taken	  from	  the	  Maine	  BRFSS.	  Prevalence	  
estimates	  were	  calculated	  based	  on	  the	  number	  of	  households	  (not	  individuals)	  surveyed	  
in	  Maine.	  
	  
Radon	  Testing	  in	  Indoor	  Air	  in	  Maine	  Homes	  
	  
What	  is	  the	  prevalence	  of	  household	  radon	  testing	  of	  indoor	  air	  in	  Maine?	  
	  
Nearly	  one-­‐third	  of	  Maine	  homes	  have	  been	  tested	  for	  radon	  in	  indoor	  air.	  
	  
• In	  2012,	  31.4%	  of	  Maine	  homes	  had	  been	  	  tested	  for	  radon	  in	  indoor	  air	  (Table	  
4.18).	  
	  
What	  are	  the	  trends	  in	  household	  radon	  testing	  of	  indoor	  air	  in	  Maine?	  
	  
Household	  testing	  of	  radon	  in	  indoor	  air	  has	  stayed	  consistent	  since	  2009.	  	  
	  
• The	  percentage	  of	  Maine	  homes	  testing	  for	  radon	  in	  indoor	  air	  has	  remained	  
relatively	  constant	  at	  30.1%	  in	  2009,	  29.0%	  in	  2010,	  30.8%	  in	  2011,	  and	  31.4%	  in	  
2012	  (Table	  4.18,	  Figure	  4.14).	  
	  
Are	  there	  differences	  in	  household	  radon	  testing	  of	  indoor	  air	  by	  household	  income?	  
	  
The	  prevalence	  of	  Maine	  homes	  tested	  for	  radon	  was	  highest	  among	  those	  with	  a	  
household	  income	  of	  $50,000	  or	  more.	  
	  
• Maine	  homes	  with	  an	  annual	  household	  income	  of	  $50,000	  or	  more	  were	  
significantly	  more	  likely	  to	  have	  had	  indoor	  air	  tested	  for	  radon	  (42.3%)	  
compared	  to	  homes	  with	  an	  income	  of	  less	  than	  $15,000	  (24.8%),	  $15,000-­‐
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Are	  there	  differences	  in	  household	  radon	  testing	  of	  indoor	  air	  by	  geography?	  
	  
Counties	  and	  public	  health	  districts	  with	  the	  highest	  prevalence	  of	  Maine	  homes	  
tested	  for	  radon	  in	  indoor	  air	  are	  located	  in	  southern	  and	  midcoast	  region	  in	  Maine.	  	  
	  
• In	  2012,	  Cumberland,	  Lincoln,	  Sagadahoc,	  and	  York	  counties	  had	  the	  highest	  
prevalence	  of	  Maine	  homes	  with	  indoor	  air	  tested	  for	  radon	  in	  Maine,	  but	  only	  
Cumberland	  County’s	  prevalence	  (44.7%)	  was	  significantly	  higher	  than	  Maine	  
overall	  (31.4%;	  Table	  4.20,	  Map	  4.5).	  	  	  
	  
• Although	  Cumberland,	  Midcoast,	  and	  York	  districts	  had	  the	  highest	  prevalence	  of	  
homes	  tested	  for	  radon	  in	  indoor	  air	  in	  the	  state,	  only	  Cumberland	  District’s	  
prevalence	  (44.7%)	  was	  significantly	  higher	  than	  the	  state	  overall	  (31.4%)	  and	  
every	  other	  district	  in	  the	  state	  except	  York	  District	  (36.3%;	  Table	  4.20,	  Map	  4.6).	  
	  
See	  maps	  at	  the	  end	  of	  the	  chapter.	  
	  
Elevated	  Levels	  of	  Radon	  in	  Maine	  Homes	  
	  
Among	  Maine	  homes	  tested	  for	  radon	  in	  indoor	  air,	  what	  is	  the	  prevalence	  of	  elevated	  
radon	  levels	  in	  those	  homes?	  
	  
Less	  than	  20%	  of	  Maine	  homes	  tested	  had	  elevated	  radon	  levels	  in	  indoor	  air.	  
	  
• In	  2012,	  among	  the	  31.4%	  of	  Maine	  homes	  tested	  for	  radon,	  16.3%	  had	  elevated	  
radon	  levels	  in	  indoor	  air	  (Table	  4.18).	  
Figure 4.14. Homes with Radon Testing of Indoor Air by Year, Maine, 2009-2012	  
Data source: Maine Behavioral Risk Factor Surveillance System (BRFSS). 
All percentages are weighted to be more representative of the general adult population of Maine and to adjust for non-response. 
Definition: Percentage of Maine households that reported indoor air was tested for radon, households with elevated radon levels, and 
households with elevated radon levels mitigated. 
Change in BRFSS survey methodology represented by break in graph line.  Due to changes in survey methodology, data collected in 2011 and 
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Among	  Maine	  homes	  tested	  for	  radon	  in	  indoor	  air,	  what	  are	  the	  trends	  in	  elevated	  
radon	  levels	  in	  those	  homes?	  
The	  prevalence	  of	  elevated	  radon	  levels	  in	  tested	  Maine	  homes	  has	  not	  significantly	  
changed.	  	  
• The	  proportion	  of	  tested	  Maine	  homes	  that	  had	  elevated	  radon	  levels	  in	  indoor
air	  has	  stayed	  fairly	  consistent	  at	  16.9%	  in	  2009,	  14.8%	  in	  2010,	  15.8%	  in	  2011,
and	  16.3%	  in	  2012	  (Table	  4.18,	  Figure	  4.14).
Are	  there	  differences	  in	  Maine	  homes	  with	  elevated	  radon	  levels	  by	  income	  group?	  
The	  number	  of	  homes	  with	  elevated	  radon	  levels	  was	  too	  small	  to	  assess	  differences	  
by	  income	  group.	  	  
• In	  2012,	  the	  number	  of	  tested	  Maine	  homes	  was	  too	  low	  to	  reliably	  estimate 
elevated	  radon	  levels	  by	  income (Table	  4.19).
Are	  there	  differences	  in	  Maine	  homes	  with	  elevated	  radon	  levels	  by	  geography?	  
The	  number	  of	  homes	  with	  elevated	  radon	  levels	  by	  Maine	  county	  and	  public	  health	  
district	  in	  2012	  were	  too	  small	  to	  assess	  geographic	  differences.	  	  	  
• In	  2012,	  the	  relatively	  low	  number	  of	  homes	  with	  elevated	  radon	  levels	  at	  the
county	  and	  public	  health	  district	  level	  in	  Maine	  result	  in	  most	  county	  and	  district
prevalence	  rates	  being	  suppressed	  or	  flagged	  as	  statistically	  unreliable,	  making	  it
difficult	  to	  assess	  geographic	  differences.
Mitigation	  of	  Elevated	  Radon	  Levels	  in	  Maine	  Homes	  
Among	  tested	  Maine	  homes	  with	  elevated	  radon	  levels	  in	  indoor	  air,	  percentage	  of	  
these	  tested	  levels	  reduced	  or	  fixed	  (mitigated)?	  
Almost	  80%	  of	  Maine	  homes	  with	  elevated	  radon	  levels	  in	  indoor	  air	  had	  these	  levels	  
mitigated.	  	  	  
• In	  2012,	  among	  the	  tested	  Maine	  homes	  that	  had	  elevated	  levels	  of	  radon	  in
indoor	  air,	  78.4%	  of	  homes	  had	  these	  levels	  mitigated	  (Table	  4.18).
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Among	  tested	  Maine	  homes	  with	  elevated	  radon	  levels	  in	  indoor	  air,	  what	  are	  the	  
trends	  in	  having	  elevated	  radon	  levels	  mitigated?	  
	  
In	  Maine,	  the	  percentage	  of	  tested	  Maine	  homes	  in	  which	  elevated	  radon	  levels	  were	  
mitigated	  remained	  fairly	  constant.	  
	  
• Although	  the	  percentage	  of	  Maine	  homes	  with	  elevated	  radon	  levels	  in	  indoor	  
air	  that	  were	  fixed	  appears	  to	  rise	  from	  70.2%	  in	  2011	  to	  78.4%	  in	  2012,	  this	  
difference	  was	  not	  significant.	  	  The	  prevalence	  of	  homes	  with	  radon	  levels	  
mitigated	  also	  appeared	  to	  increase	  from	  2009	  (75.3%)	  to	  2010	  (82.1%),	  but	  this	  
difference	  was	  not	  signficant	  (Table	  4.19).	  
	  
Are	  there	  differences	  in	  the	  percentage	  of	  Maine	  homes	  with	  elevated	  radon	  levels	  
mitigated	  by	  income	  group?	  
	  
The	  number	  of	  Maine	  homes	  with	  elevated	  radon	  levels	  that	  were	  mitigated	  was	  too	  
small	  to	  examine	  differences	  by	  income	  group.	  	  
	  
• In	  2012,	  the	  number	  of	  Maine	  homes	  with	  elevated	  levels	  mitigated	  was	  too	  low	  
to	  assess	  differences	  by	  income	  group	  (Table	  4.20).	  
	  
Are	  there	  differences	  in	  the	  percentage	  of	  	  Maine	  homes	  with	  elevated	  radon	  levels	  
mitigated	  by	  geography?	  
	  
The	  number	  of	  homes	  with	  elevated	  radon	  levels	  that	  were	  mitigated	  were	  too	  small	  
to	  assess	  differences	  by	  geography.	  	  	  
	  
• The	  low	  number	  of	  homes	  with	  elevated	  radon	  levels	  that	  were	  mitigated	  at	  the	  
county	  and	  public	  health	  level	  in	  Maine	  in	  2012	  result	  in	  most	  county	  and	  district	  
prevalence	  rates	  being	  suppressed	  or	  flagged	  as	  statistically	  unreliable,	  making	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Cancer	  Screening	  
	  
What	  is	  cancer	  screening?	  
	  
Cancer	  screening	  is	  used	  to	  detect	  cancer	  (or	  conditions	  that	  cause	  cancer)	  in	  a	  person	  
before	  symptoms	  appear.	  For	  some	  cancers	  like	  cervical	  and	  colorectal,	  screening	  tests	  
can	  find	  abnormal	  cells	  that	  can	  be	  removed	  to	  prevent	  the	  development	  of	  cancer.	  	  For	  
other	  cancers	  like	  breast,	  screening	  tests	  can	  help	  find	  cancer	  at	  an	  early	  stage	  when	  
treatment	  is	  more	  likely	  to	  improve	  health	  outcomes.	  	  
Why	  is	  cancer	  screening	  an	  important	  public	  health	  topic?	  
	  
Cancer	  screening	  is	  important	  because	  it	  can	  lead	  to	  the	  prevention	  or	  early	  detection	  of	  
certain	  types	  of	  cancer.	  Detecting	  cancer	  at	  an	  early	  stage	  reduces	  the	  risk	  of	  death	  and	  
illness,	  as	  well	  as	  dollars	  spent	  on	  treatment,	  lost	  productivity,	  and	  improves	  quality	  of	  
life.	  
	  
Population-­‐based	  screening	  for	  breast,	  cervical	  and	  colorectal	  cancers	  can	  reduce	  
cancer-­‐related	  deaths.1-­‐4	  In	  December	  2013,	  the	  U.S.	  Preventive	  Services	  Task	  Force	  
issued	  new	  screening	  recommendations	  for	  lung	  cancer,	  but	  limited	  recommendations	  
to	  heavy	  smokers	  or	  former	  smokers.5	  For	  other	  cancers,	  such	  as	  oral	  and	  prostate,	  the	  
benefits	  of	  screening	  in	  reducing	  incidence	  and	  mortality	  have	  not	  been	  proven.	  	  
	  
What	  should	  Maine	  adults	  know	  about	  cancer	  screening?	  
	  
There	  are	  a	  variety	  of	  tests	  used	  to	  screen	  for	  different	  types	  of	  cancer.	  	  It	  is	  important	  
to	  know	  when	  and	  how	  often	  to	  be	  screened	  for	  different	  cancers	  as	  well	  as	  the	  benefits	  
and	  potential	  risks	  of	  screening.	  	  National	  recommendations	  for	  cancer	  screening	  have	  
been	  developed	  by	  organizations	  including	  the	  American	  Cancer	  Society,	  American	  
College	  of	  Obstetrics	  and	  Gynecology,	  and	  the	  U.S.	  Preventive	  Services	  Task	  Force.	  
These	  recommendations	  provide	  standard	  guidelines	  for	  cancer	  screening	  based	  on	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Breast	  cancer	  screening	  
	  
Breast	  cancer	  is	  the	  most	  common	  cancer	  among	  women	  in	  Maine.	  	  With	  the	  exception	  
of	  skin	  cancer,	  it	  is	  also	  the	  most	  common	  cancer	  among	  American	  women.	  Having	  
routine	  screening	  for	  breast	  cancer	  is	  important	  to	  lower	  the	  risk	  of	  dying	  from	  the	  
disease.	  	  In	  this	  section,	  breast	  cancer	  screening	  will	  be	  examined	  among	  females	  in	  age	  
groups	  of	  40	  years	  and	  older	  and	  50	  years	  and	  older	  based	  on	  national	  
recommendations	  from	  different	  organizations.	  
	  
	  
National	  recommendations	  	  
	  
Guidelines	  for	  screening	  vary	  by	  national	  organization	  as	  shown	  below:	  
	  
The	  American	  Cancer	  Society	  
recommends1	  	  
The	  U.S.	  Preventive	  Service	  Task	  Force	  
recommends2	  
Mammogram	  every	  year	  starting	  at	  
age	  40.	  
	  
Mammogram	  every	  two	  years	  from	  ages	  
50−74	  or	  screening	  earlier	  than	  age	  50	  based	  
on	  informed	  decisions	  about	  individual	  
benefits	  and	  risks.	  	  Women	  who	  are	  at	  higher	  
risk,	  such	  as	  family	  history	  or	  genetic	  
predisposition	  for	  breast	  cancer,	  should	  
discuss	  with	  their	  healthcare	  provider	  to	  




In	  this	  section,	  breast	  cancer	  screening	  is	  defined	  as	  having	  received	  a	  mammogram	  
within	  the	  past	  two	  years,	  and	  is	  reported	  among	  women	  40	  years	  and	  older	  and	  also	  50	  
years	  and	  older.	  	  
	  
How	  does	  the	  prevalence	  of	  breast	  cancer	  screening	  in	  Maine	  compare	  to	  the	  U.S.?	  
	  
Maine	  females	  have	  a	  higher	  prevalence	  of	  breast	  cancer	  screening	  compared	  to	  U.S.	  
females.	  
	  
• From	  2002	  to	  2010,	  the	  prevalence	  of	  breast	  cancer	  screening	  (receiving	  a	  
mammogram	  within	  the	  past	  two	  years)	  was	  consistently	  higher	  among	  Maine	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What	  are	  the	  trends	  in	  breast	  cancer	  screening	  in	  Maine?	  
	  
The	  prevalence	  of	  breast	  cancer	  screening	  in	  Maine	  has	  remained	  consistent	  over	  the	  
past	  decade.	  
	  
• In	  2012,	  79.6%	  of	  Maine	  females	  ages	  40	  years	  and	  older	  had	  a	  mammogram	  
within	  the	  past	  two	  years	  compared	  to	  77.0%	  of	  U.S.	  females.	  Among	  Maine	  
females	  ages	  50	  years	  and	  older,	  82.1%	  had	  a	  mammogram	  within	  the	  past	  two	  
years	  compared	  to	  74.0%	  of	  U.S.	  females	  (Table	  5.1,	  Figure	  5.1).	  
	  
• The	  proportion	  of	  Maine	  and	  U.S.	  females	  who	  had	  breast	  cancer	  screening	  has	  


















Are	  there	  differences	  in	  the	  prevalence	  of	  breast	  cancer	  screening	  by	  demographic	  
factors?	  	  
	  
In	  Maine,	  the	  prevalence	  of	  breast	  cancer	  screening	  is	  lowest	  in	  the	  youngest	  (40−49	  
years)	  and	  oldest	  (75	  years	  and	  older)	  age	  groups.	  Lower	  education,	  lower	  household	  
income,	  and	  having	  current	  depression	  are	  associated	  with	  a	  lower	  prevalence	  of	  
breast	  cancer	  screening	  among	  Maine	  females.	  	  
	  
• In	  2012,	  among	  Maine	  females	  ages	  40	  years	  and	  older,	  a	  significantly	  lower	  
percentage	  of	  those	  ages	  40−49	  years	  (71.9%)	  had	  breast	  cancer	  screening	  
compared	  to	  those	  ages	  50−64	  years	  (83.3%)	  and	  65−74	  years	  (84.4%).	  	  Among	  
females	  ages	  50	  years	  and	  older,	  a	  significantly	  lower	  percentage	  of	  those	  ages	  
75	  years	  and	  older	  (76.5%)	  had	  breast	  cancer	  screening	  compared	  to	  those	  ages	  
50−64	  years	  (83.3%)	  and	  65−74	  years	  (84.4%;	  Table	  5.2,	  Table	  5.5).	  
Data source: Maine Behavioral Risk Factor Surveillance System (BRFSS). 
All percentages are weighted to be more representative of the general adult population of Maine and to adjust for non-response. 
Definition: Percentage of Maine and U.S. females who reported they had a mammogram within the past two years. 
Change in BRFSS survey methodology represented by break in graph line.  Due to changes in survey methodology, data collected in 
2011 and in subsequent years cannot be compared with data prior to 2011. 
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• For	  Maine	  females	  ages	  40	  years	  and	  older,	  those	  with	  less	  than	  a	  high	  school	  
education	  were	  significantly	  less	  likely	  to	  have	  mammogram	  within	  the	  past	  two	  
years	  (71.9%)	  compared	  to	  those	  with	  a	  Bachelor’s	  degree	  or	  higher	  (81.0%).	  	  For	  
females	  ages	  50	  and	  over,	  there	  was	  a	  similar,	  significant	  pattern	  among	  those	  
with	  less	  than	  a	  high	  school	  education	  (73.5%)	  compared	  to	  those	  with	  a	  





















• For	  Maine	  females	  ages	  40	  years	  and	  older,	  those	  with	  an	  annual	  household	  
income	  of	  less	  than	  $15,000	  (72.3%)	  had	  a	  significantly	  lower	  prevalence	  of	  
breast	  cancer	  screening	  compared	  to	  those	  with	  an	  income	  of	  $35,000-­‐49,000	  
(82.8%)	  and	  $50,000	  or	  more	  (83.9%).	  For	  females	  ages	  50	  years	  and	  older,	  a	  
similar,	  significant	  pattern	  was	  observed	  among	  those	  with	  an	  annual	  household	  
income	  of	  less	  $15,000	  (74.0%)	  compared	  to	  those	  with	  an	  income	  of	  $35,000-­‐
49,000	  (86.3%)	  and	  $50,000	  or	  more	  (87.3%;	  Table	  5.2,	  Table	  5.5,	  Figure	  5.3.a).	  
	  
• There	  was	  no	  significant	  difference	  in	  the	  prevalence	  of	  breast	  cancer	  screening	  
by	  type	  of	  health	  insurance	  coverage	  among	  Maine	  females	  ages	  40	  years	  and	  
older.	  	  This	  non-­‐significant	  pattern	  was	  similar	  among	  females	  ages	  50	  years	  and	  
older.	  For	  both	  age	  groups,	  the	  number	  of	  uninsured	  adults	  was	  too	  small	  to	  
provide	  a	  reliable	  estimate	  of	  breast	  cancer	  screening	  in	  this	  group	  (Table	  5.2,	  
Table	  5.5,	  Figure	  5.4.a).	  
Figure 5.2.a. Breast, Cervical, and Colorectal Cancer Screening among Maine Adults 
by Level of Education, 2012	  
Data source: Maine Behavioral Risk Factor Surveillance System. 
All percentages are weighted to be more representative of the general adult population of Maine and to adjust for non-response. 
Definition: Up-to-Date Colorectal Cancer Screening = Percentage of Maine adults ages 50 years and over who reported that they had a 
sigmoidoscopy within the past five years and a home blood stool test (e.g., FOBT, FIT) within the past three years, a home blood stool 









































Figure 5.3.a. Breast, Cervical, and Colorectal Cancer Screening among Maine Adults 
by Level of Annual Household Income, 2012	  
Data source: Maine Behavioral Risk Factor Surveillance System. 
All percentages are weighted to be more representative of the general adult population of Maine and to adjust for non-response. 
Definition: Up-to-Date Colorectal Cancer Screening = Percentage of Maine adults ages 50 years and over who reported that they had a 
sigmoidoscopy within the past five years and a home blood stool test (e.g., FOBT, FIT) within the past three years, a home blood stool 
test within the past year, or a colonoscopy within the past 10 years. 	  
Figure 5.4.a. Breast, Cervical, and Colorectal Cancer Screening among Maine Adults 
by Type of Health Insurance Coverage, 2012*	  
Data source: Maine Behavioral Risk Factor Surveillance System. 
All percentages are weighted to be more representative of the general adult population of Maine and to adjust for non-response. 
Definition: Up-to-Date Colorectal Cancer Screening = Percentage of Maine adults ages 50 years and over who reported that they had a 
sigmoidoscopy within the past five years and a home blood stool test (e.g., FOBT, FIT) within the past three years, a home blood stool 
test within the past year, or a colonoscopy within the past 10 years. 
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• For	  Maine	  females	  ages	  40	  years	  and	  older,	  those	  with	  current	  depression	  were	  
significantly	  less	  likely	  to	  have	  a	  mammogram	  within	  the	  past	  two	  years	  (66.3%)	  
compared	  to	  those	  without	  current	  depression	  (80.6%).	  For	  females	  ages	  50	  
years	  and	  older,	  there	  was	  a	  similar,	  significant	  pattern	  at	  69.7%	  and	  83.3%,	  





















• For	  Maine	  females	  ages	  40	  years	  and	  older,	  the	  prevalence	  of	  breast	  cancer	  
screening	  among	  those	  with	  any	  lifetime	  diagnosis	  of	  depression	  or	  anxiety	  
(75.6%)	  was	  slightly,	  but	  not	  significantly,	  lower	  compared	  to	  those	  without	  any	  
lifetime	  diagnosis	  (81.5%).	  	  A	  similar,	  non-­‐significant	  pattern	  was	  observed	  
among	  females	  ages	  50	  years	  and	  older	  at	  79.0%	  and	  83.9%,	  respectively	  (Table	  
5.2,	  Table	  5.5,	  Figure	  5.6.a).	  	  	  
	  
• Among	  Maine	  females	  ages	  40	  years	  and	  older,	  79.8%	  of	  whites	  and	  79.6%	  of	  
non-­‐Hispanics	  had	  breast	  cancer	  screening.	  	  For	  females	  ages	  50	  years	  and	  older,	  
the	  prevalence	  was	  slightly	  higher,	  but	  not	  significantly,	  at	  82.2%	  for	  both	  whites	  
and	  non-­‐Hispanics.	  For	  both	  age	  groups,	  the	  number	  of	  non-­‐white	  or	  Hispanic	  
females	  was	  too	  small	  to	  determine	  differences	  in	  the	  prevalence	  of	  breast	  
cancer	  screening	  by	  race	  or	  ethnicity	  (Table	  5.3,	  Table	  5.6).	  	  	  
	  
Figure 5.5.a. Breast, Cervical, and Colorectal Cancer Screening among Maine Adults 
by Current Depression, 2012	  
Data source: Maine Behavioral Risk Factor Surveillance System. 
All percentages are weighted to be more representative of the general adult population of Maine and to adjust for non-response. 
Definition: Up-to-Date Colorectal Cancer Screening = Percentage of Maine adults ages 50 years and over who reported that they had a 
sigmoidoscopy within the past five years and a home blood stool test (e.g., FOBT, FIT) within the past three years, a home blood stool test 
within the past year, or a colonoscopy within the past 10 years. 

























Are	  there	  differences	  in	  the	  prevalence	  of	  breast	  cancer	  screening	  by	  geography?	  	  
	  
Counties	  and	  public	  health	  districts	  with	  the	  lowest	  prevalence	  of	  breast	  cancer	  
screening	  are	  located	  in	  eastern	  Maine.	  	  
	  
• During	  2012,	  Waldo	  and	  Washington	  counties	  had	  the	  lowest	  prevalence	  rates	  of	  
breast	  cancer	  screening	  in	  the	  state	  for	  females	  in	  both	  age	  groups	  (ages	  40	  
years	  and	  older	  and	  50	  years	  and	  older).	  For	  both	  age	  groups,	  Washington	  
County’s	  prevalence	  (67.6%	  and	  70.0%,	  respectively)	  was	  significantly	  lower	  than	  
Maine	  overall	  (79.6%	  and	  82.1%,	  respectively;	  Table	  5.4,	  Table	  5.7,	  Map	  5.1,	  
Map	  5.3).	  
	  
• Penobscot	  County	  had	  the	  highest	  prevalence	  rates	  of	  breast	  cancer	  screening	  in	  
the	  state	  for	  females	  ages	  40	  years	  and	  older	  and	  ages	  50	  years	  and	  older.	  	  
Penobscot	  County’s	  prevalence	  (83.0%)	  was	  not	  significantly	  higher	  than	  the	  
state	  overall,	  but	  was	  significantly	  higher	  than	  Washington	  County’s	  prevalence	  
(67.6%;	  Table	  5.4,	  Table	  5.7,	  Map	  5.1,	  Map	  5.3).	  
	  
• During	  2012,	  Downeast	  and	  Midcoast	  districts	  had	  the	  lowest	  prevalence	  of	  
breast	  cancer	  screening	  in	  the	  state	  for	  females	  ages	  40	  years	  and	  older	  and	  50	  
years	  and	  older.	  	  However,	  for	  females	  ages	  40	  years	  and	  older,	  only	  Midcoast	  
District’s	  rate	  (73.9%)	  was	  significantly	  lower	  than	  the	  overall	  Maine	  rate	  
(82.1%).	  For	  females	  ages	  50	  years	  and	  older,	  no	  district	  rates	  were	  significantly	  
Figure 5.6.a. Breast, Cervical, and Colorectal Cancer Screening among Maine Adults 
by Lifetime Depression or Anxiety, 2012	  
Data source: Maine Behavioral Risk Factor Surveillance System. 
All percentages are weighted to be more representative of the general adult population of Maine and to adjust for non-response. 
Definition: Up-to-Date Colorectal Cancer Screening = Percentage of Maine adults ages 50 years and over who reported that they had a 
sigmoidoscopy within the past five years and a home blood stool test (e.g., FOBT, FIT) within the past three years, a home blood stool 
test within the past year, or a colonoscopy within the past 10 years. 
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lower	  than	  the	  state	  overall	  or	  any	  other	  Maine	  district	  (Table	  5.4,	  Table	  5.7,	  
Map	  5.2,	  Map	  5.4).	  
	  
• Penquis	  District	  had	  the	  highest	  prevalence	  of	  breast	  cancer	  screening	  for	  
females	  ages	  40	  years	  and	  older,	  while	  Penquis	  and	  Aroostook	  districts	  had	  the	  
highest	  prevalence	  for	  females	  ages	  50	  years	  and	  older.	  For	  both	  age	  groups,	  no	  
district	  had	  a	  significantly	  higher	  breast	  cancer	  screening	  prevalence	  than	  the	  
state	  or	  any	  other	  Maine	  district	  (Table	  5.4,	  Table	  5.7,	  Map	  5.2,	  Map	  5.4).	  	  
	  
See	  maps	  at	  the	  end	  of	  the	  chapter.
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Cervical	  cancer	  screening	  
Cervical	  cancer	  used	  to	  be	  the	  leading	  cause	  of	  cancer	  death	  for	  American	  women.	  In	  
the	  past	  40	  years,	  there	  has	  been	  a	  significant	  decline	  in	  the	  cervical	  cancer	  incidence	  
and	  mortality	  because	  more	  women	  have	  Pap	  tests	  to	  screen	  for	  cervical	  cancer.2	  
Cervical	  cancer	  is	  highly	  preventable	  when	  pre-­‐cancerous	  lesions	  are	  found	  early	  
through	  screening.	  
National	  recommendations	  
The	  U.S.	  Preventive	  Services	  Task	  Force	  recommends3	  
• Do	  not	  screen	  with	  Pap	  test	  for	  women	  younger	  than	  age	  21
• Screen	  with	  Pap	  test	  every	  three	  years	  for	  women	  ages	  21−65
• Screen	  with	  Pap	  test	  and	  human	  papillomavirus	  (HPV)	  test	  (co-­‐testing)	  every	  five
years	  for	  women	  ages	  30−65
In	  this	  section,	  cervical	  cancer	  screening	  is	  defined	  as	  having	  received	  a	  Pap	  test	  within	  
the	  past	  three	  years,	  and	  is	  reported	  among	  women	  ages	  21-­‐65	  years	  with	  an	  intact	  
cervix.	  
What	  is	  the	  prevalence	  of	  cervical	  cancer	  screening	  in	  Maine?	  
Nearly	  90%	  of	  Maine	  females	  ages	  21−65	  years	  with	  an	  intact	  cervix	  had	  a	  Pap	  test	  
within	  the	  past	  three	  years.	  	  
• In	  2012,	  88.0%	  of	  Maine	  females	  ages	  21−65	  years	  with	  an	  intact	  cervix	  had	  a
Pap	  test	  within	  the	  past	  three	  years	  (Table	  5.8).
What	  are	  the	  trends	  in	  cervical	  cancer	  screening	  prevalence	  in	  Maine?	  
From	  2002	  to	  2010,	  the	  prevalence	  of	  cervical	  cancer	  screening	  in	  Maine	  
remained constant.	  
• The	  percentage	  of	  females	  who	  had	  cervical	  cancer	  screening remained 























Are	  there	  differences	  in	  the	  prevalence	  of	  cervical	  cancer	  screening	  by	  demographic	  
factors?	  
	  
The	  prevalence	  of	  cervical	  cancer	  screening	  is	  lowest	  among	  Maine	  females	  with	  less	  
education	  and	  lower	  household	  income.	  
	  
• In	  2012,	  the	  prevalence	  of	  Pap	  testing	  was	  slightly,	  but	  not	  significantly,	  lower	  
among	  Maine	  females	  ages	  55-­‐65	  (84.6%)	  compared	  to	  those	  ages	  21−39	  years	  
(88.6%)	  and	  40−54	  years	  (89.4%;	  Table	  5.9).	  
	  
• Maine	  females	  with	  less	  than	  a	  high	  school	  diploma	  had	  a	  significantly	  lower	  
prevalence	  of	  Pap	  testing	  (81.4%)	  compared	  to	  those	  with	  a	  Bachelor’s	  degree	  or	  
higher	  (93.0%;	  Table	  5.9,	  Figure	  5.2.a).	  	  
	  
• Maine	  females	  with	  an	  annual	  household	  income	  less	  than	  $15,000	  were	  
significantly	  less	  likely	  to	  report	  receiving	  a	  Pap	  test	  within	  the	  past	  three	  years	  
(80.7%)	  compared	  to	  females	  with	  an	  annual	  household	  income	  of	  $50,000	  or	  
more	  (92.5%;	  Table	  5.9,	  Figure	  5.3.a).	  
	  
• Although	  Maine	  females	  with	  Medicare	  appear	  to	  be	  less	  likely	  to	  report	  
receiving	  a	  Pap	  test	  within	  the	  past	  three	  years	  (85.9%)	  compared	  to	  those	  with	  
private	  health	  insurance	  (91.3%);	  however,	  this	  difference	  was	  not	  statistically	  
significant.	  The	  number	  of	  uninsured	  females	  was	  too	  small	  to	  provide	  a	  reliable	  
estimate	  of	  cervical	  cancer	  screening	  in	  this	  group	  (Table	  5.9,	  Figure	  5.4.a).	  
	  
Figure 5.7. Cancer Screening among Maine Adults by Year, 2002-2012	  
Data source: Maine Behavioral Risk Factor Surveillance System (BRFSS). 
All percentages are weighted to be more representative of the general adult population of Maine and to adjust for non-response. 
Change in BRFSS survey methodology represented by break in graph line. Due to changes in survey methodology, data collected 
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• The	  percentage	  of	  Maine	  females	  with	  current	  depression	  who	  had	  Pap	  testing	  
(78.0%)	  was	  lower	  (but	  not	  significantly	  different	  from)	  those	  without	  current	  
depression	  (87.4%;	  Table	  5.9,	  Figure	  5.5.a).	  
	  
• There	  was	  no	  significant	  difference	  in	  the	  prevalence	  of	  Pap	  testing	  among	  
Maine	  females	  with	  any	  lifetime	  diagnosis	  of	  depression	  or	  anxiety	  (84.6%)	  
compared	  to	  those	  without	  any	  lifetime	  diagnosis	  (87.6%;	  Table	  5.9,	  Figure	  
5.6.a).	  
	  
• Among	  Maine	  females,	  88.7%	  of	  whites	  and	  88.0%	  of	  non-­‐Hispanics	  had	  a	  Pap	  
test	  within	  the	  past	  three	  years.	  The	  number	  of	  non-­‐white	  or	  Hispanic	  females	  
was	  too	  small	  to	  determine	  differences	  in	  the	  prevalence	  of	  Pap	  testing	  by	  race	  
or	  ethnicity	  (Table	  5.10).	  
	  
Are	  there	  differences	  in	  the	  prevalence	  of	  cervical	  cancer	  screening	  by	  geography?	  
	  
Counties	  with	  the	  lowest	  prevalence	  of	  cervical	  cancer	  screening	  tend	  to	  be	  located	  in	  
eastern	  and	  western	  Maine,	  while	  public	  health	  districts	  with	  the	  prevalence	  of	  lowest	  
cervical	  cancer	  screening	  are	  located	  in	  eastern	  Maine.	  	  
	  
• While	  Franklin,	  Hancock,	  Oxford,	  and	  Washington	  counties	  had	  the	  lowest	  
prevalence	  rates	  of	  cervical	  cancer	  screening	  in	  the	  state	  in	  2012,	  none	  were	  
significantly	  lower	  than	  Maine	  overall	  (Table	  5.11,	  Map	  5.5).	  
	  
• The	  prevalence	  of	  cervical	  cancer	  screening	  in	  Androscoggin	  County,	  the	  highest	  
county	  in	  the	  state	  (94.3%)	  was	  significantly	  higher	  than	  the	  prevalence	  in	  
Hancock	  County,	  the	  lowest	  county	  in	  the	  state	  (79.0%;	  Table	  5.11,	  Map	  5.5).	  
	  
• During	  2012,	  Downeast	  District	  had	  the	  lowest	  prevalence	  of	  cervical	  cancer	  
screening	  in	  the	  state	  (80.5%),	  which	  was	  significantly	  lower	  than	  the	  prevalence	  
in	  Cumberland	  District,	  the	  highest	  district	  in	  the	  state	  (91.6%),	  but	  not	  the	  state	  
prevalence	  (Table	  5.11,	  Map	  5.6).	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Colorectal	  cancer	  screening	  
	  
Colorectal	  cancer	  is	  the	  third	  leading	  cause	  of	  cancer-­‐related	  death	  in	  Maine,	  and	  the	  
second	  leading	  cause	  of	  cancer-­‐related	  death	  nationally.	  Screening	  for	  colorectal	  cancer	  
can	  help	  prevent	  the	  disease	  by	  detecting	  precancerous	  cells	  or	  growths	  (polyps)	  in	  the	  
colon	  and	  rectum,	  so	  they	  can	  be	  removed.	  It	  also	  can	  detect	  colorectal	  cancer	  at	  an	  
early	  stage,	  when	  treatment	  is	  most	  successful	  in	  lowering	  the	  risk	  of	  dying	  from	  the	  





For	  all	  adults	  starting	  at	  age	  50,	  the	  U.S.	  Preventive	  Services	  Task	  Force	  recommends	  the	  
following	  for	  up-­‐to-­‐date	  colorectal	  cancer	  screening4:	  
	  
• Colonoscopy	  every	  10	  years,	  or	  
	  
• Sigmoidoscopy	  every	  five	  years,	  when	  done	  in	  combination	  with	  a	  home	  blood	  
stool	  test	  (e.g.,	  fecal	  occult	  blood	  test	  [FOBT],	  fecal	  immunochemical	  test	  [FIT]),	  
the	  home	  stool	  blood	  test	  should	  be	  done	  every	  three	  years,	  or	  
	  
• Home	  blood	  stool	  test	  every	  year	  
	  
Adults	  who	  have	  a	  family	  history	  of	  colorectal	  cancer,	  genetic	  tendency,	  or	  disease	  of	  
the	  colon	  or	  rectum	  (e.g.,	  inflammatory	  bowel	  disease)	  are	  at	  higher	  risk	  for	  colorectal	  
cancer.	  	  High-­‐risk	  individuals	  should	  discuss	  with	  their	  healthcare	  provider	  if	  screening	  is	  
suggested	  before	  age	  50.	  
	  
In	  this	  section,	  being	  up-­‐to-­‐date	  with	  colorectal	  cancer	  screening	  is	  defined	  as	  having	  
received	  a	  home	  blood	  stool	  test	  (e.g.,	  FOBT	  or	  FIT)	  within	  the	  past	  year,	  or	  a	  
sigmoidoscopy	  within	  the	  past	  five	  years	  and	  a	  home	  blood	  stool	  test	  within	  the	  past	  
three	  years,	  or	  a	  colonoscopy	  within	  the	  past	  10	  years,	  and	  is	  reported	  among	  adults	  
ages	  50	  years	  and	  older.	  
	  
What	  is	  the	  prevalence	  of	  colorectal	  cancer	  screening	  in	  Maine?	  
	  
Over	  70%	  of	  adults	  ages	  50	  years	  and	  older	  are	  up-­‐to-­‐date	  with	  colorectal	  cancer	  
screening	  in	  Maine.	  	  	  
	  
• In	  2012,	  the	  prevalence	  of	  up-­‐to-­‐date	  colorectal	  cancer	  screening	  among	  Maine	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• Among	  adults	  ages	  50	  years	  and	  older:	  
	  
o 69.3%	  had	  a	  colonoscopy	  within	  the	  past	  10	  years;	  
	  
o 0.7%	  had	  a	  sigmoidoscopy	  within	  the	  past	  five	  years	  and	  a	  home	  blood	  
stool	  test	  within	  the	  past	  three	  years;	  
	  
o 9.0%	  had	  a	  home	  blood	  stool	  test	  within	  the	  past	  year	  (Figure	  5.7).	  
	  
• In	  2010,	  among	  adults	  ages	  50−75	  years,	  the	  age-­‐adjusted	  prevalence	  of	  up-­‐to-­‐
date	  colorectal	  cancer	  screening	  in	  Maine	  was	  75.4%	  compared	  to	  64.5%	  in	  U.S.	  











Data source: Maine Behavioral Risk Factor Surveillance System. 
All percentages are weighted to be more representative of the general adult population of Maine and to adjust for non-response. 
Definition:  Up-to-Date with Colorectal Cancer Screening = Percentage of Maine adults ages 50 years and over who reported that they 
had a sigmoidoscopy within the past five years and a home blood stool test (e.g., FOBT, FIT) within the past three years, a home blood 
stool test within the past year, or a colonoscopy within the past 10 years. 
*The 2010 U.S. estimate is a median estimate for all 50 states and the District of Columbia. 
**Data for 2010 Maine and median U.S. estimate is age-adjusted to 2010 BRFSS population.   	  
Figure 5.8. Adults Who Were Up-to-Date with Colorectal Cancer Screening by Type of 
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What	  are	  the	  trends	  in	  colorectal	  cancer	  screening	  prevalence	  in	  Maine?	  
	  
In	  Maine,	  the	  prevalence	  of	  colorectal	  cancer	  screening	  remained	  fairly	  constant	  since	  
2008.	  
	  
• The	  percentage	  of	  Maine	  adults	  who	  were	  up-­‐to-­‐date	  with	  colorectal	  cancer	  
screening	  has	  remained	  consistent	  at	  72.1%	  in	  2008,	  73.2%	  in	  2009,	  and	  72.8%	  in	  
2010	  (Table	  5.8,	  Figure	  5.7).	  
	  
Are	  there	  differences	  in	  the	  prevalence	  in	  colorectal	  screening	  by	  demographic	  
factors?	  
	  
The	  prevalence	  of	  up-­‐to-­‐date	  colorectal	  cancer	  screening	  is	  lowest	  among	  certain	  age	  
groups	  and	  those	  with	  less	  education	  and	  lower	  household	  income.	  	  
	  
• Although	  the	  prevalence	  of	  up-­‐to-­‐date	  colorectal	  cancer	  screening	  appears	  
higher	  among	  females	  (73.3%)	  than	  males	  (70.9%),	  this	  was	  not	  a	  significant	  
difference	  (Table	  5.12).	  
	  
• A	  significantly	  lower	  percentage	  of	  Maine	  adults	  ages	  50−64	  years	  (69.3%)	  and	  
ages	  75	  and	  older	  (71.5%)	  had	  up-­‐to-­‐date	  colorectal	  cancer	  screening	  compared	  
to	  adults	  ages	  65−74	  years	  (79.8%;	  Table	  5.12).	  
	  
• Maine	  adults	  with	  less	  than	  a	  high	  school	  education	  were	  significantly	  less	  likely	  
to	  have	  up-­‐to-­‐date	  colorectal	  cancer	  screening	  (60.0%)	  compared	  to	  those	  with	  a	  
high	  school	  diploma	  (68.9%),	  some	  college	  education	  (75.5%),	  and	  those	  with	  a	  
Bachelor’s	  degree	  or	  higher	  (77.7%;	  Table	  5.12,	  Figure	  5.2.a).	  
	  
• The	  percentage	  of	  Maine	  adults	  with	  an	  annual	  household	  income	  less	  than	  
$15,000	  who	  had	  up-­‐to-­‐date	  colorectal	  cancer	  screening	  (61.4%)	  was	  
significantly	  lower	  than	  those	  with	  an	  income	  of	  $35,000-­‐49,000	  (75.4%)	  and	  
$50,000	  or	  more	  (77.9%;	  Table	  5.12,	  Figure	  5.3.a).	  
	  
• There	  was	  no	  significant	  difference	  in	  the	  prevalence	  in	  colorectal	  cancer	  
screening	  between	  Maine	  adults	  with	  private	  health	  insurance	  (74.8%),	  
Medicare	  (76.3%),	  Medicaid	  or	  MaineCare	  (66.4%),	  or	  other	  types	  of	  health	  
insurance	  (78.3%).	  	  The	  number	  of	  uninsured	  individuals	  was	  too	  small	  to	  
provide	  a	  reliable	  estimate	  of	  up-­‐to-­‐date	  colorectal	  cancer	  screening	  in	  this	  
group	  (Table	  5.12,	  Figure	  5.4.a).	  
	  
• While	  the	  prevalence	  of	  up-­‐to-­‐date	  colorectal	  cancer	  screening	  was	  lower	  among	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current	  depression	  (72.8%),	  this	  was	  not	  a	  significant	  difference	  (Table	  5.12,	  
Figure	  5.5.a).	  
	  
• There	  was	  no	  significant	  difference	  in	  the	  prevalence	  of	  up-­‐to-­‐date	  colorectal	  
cancer	  screening	  among	  Maine	  adults	  with	  any	  lifetime	  diagnosis	  of	  depression	  
or	  anxiety	  (73.9%)	  compared	  to	  those	  without	  any	  lifetime	  diagnosis	  (71.9%;	  
Table	  5.12,	  Figure	  5.6.a).	  
	  
• Among	  Maine	  adults,	  72.7%	  of	  whites	  and	  72.5%	  of	  non-­‐Hispanics	  had	  up-­‐to-­‐
date	  colorectal	  cancer	  screening.	  The	  number	  of	  non-­‐white	  or	  Hispanic	  Maine	  
adults	  was	  too	  small	  to	  determine	  if	  there	  were	  differences	  in	  the	  prevalence	  of	  
up-­‐to-­‐date	  screening	  by	  race	  or	  ethnicity	  (Table	  5.13).	  	  
	  
Are	  there	  differences	  in	  the	  prevalence	  of	  colorectal	  cancer	  screening	  by	  geography?	  
	  
Counties	  with	  the	  lowest	  prevalence	  of	  up-­‐to-­‐date	  colorectal	  cancer	  screening	  are	  
located	  in	  northwestern	  and	  eastern	  Maine.	  There	  are	  no	  significant	  differences	  in	  the	  
prevalence	  of	  up-­‐to-­‐date	  colorectal	  cancer	  screening	  among	  Maine	  public	  health	  
districts.	  	  
	  
• While	  Franklin,	  Knox,	  Somerset,	  Waldo,	  and	  Washington	  counties	  had	  the	  lowest	  
prevalence	  rates	  of	  up-­‐to-­‐date	  colorectal	  cancer	  screening	  in	  the	  state	  during	  
2012,	  only	  Waldo	  County’s	  prevalence	  (61.2%)	  was	  significantly	  lower	  than	  the	  
state	  overall	  (72.2%;	  Table	  5.14,	  Map	  5.7).	  
	  
• During	  2012,	  Kennebec,	  Lincoln,	  and	  Oxford	  counties	  had	  the	  highest	  colorectal	  
cancer	  screening	  prevalence	  rates	  in	  the	  state,	  but	  none	  were	  significantly	  higher	  
than	  Maine	  overall.	  	  Kennebec	  and	  Lincoln	  counties	  did	  have	  significantly	  higher	  
colorectal	  cancer	  screening	  prevalence	  rates	  (both	  77.7%)	  than	  Waldo	  County	  
(61.2%;	  Table	  5.14,	  Map	  5.7).	  
	  
• Although	  Downeast	  and	  Midcoast	  districts	  had	  the	  lowest	  prevalence	  of	  up-­‐to-­‐
date	  colorectal	  cancer	  screening	  in	  the	  state	  (70.1%	  and	  69.6%	  respectively),	  
neither	  were	  significantly	  different	  than	  the	  state	  prevalence	  or	  the	  prevalence	  
of	  any	  other	  Maine	  district	  (Table	  5.14,	  Map	  5.8).	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Oral	  cancer	  screening	  
	  
The	  term	  “oral	  cancer”	  refers	  to	  any	  cancers	  of	  the	  oral	  cavity	  and	  the	  pharynx.	  	  In	  the	  
U.S.,	  the	  number	  of	  people	  who	  have	  been	  diagnosed	  with	  or	  who	  have	  died	  from	  
cancer	  of	  the	  oral	  cavity	  and	  pharynx	  has	  declined	  over	  the	  last	  several	  decades.	  	  This	  
decline	  can	  be	  attributed	  to	  declines	  in	  risk	  factors,	  and	  to	  earlier	  diagnosis	  and	  
improved	  treatment.	  	  People	  who	  use	  tobacco	  products,	  including	  cigarettes	  and	  snuff,	  
and	  those	  with	  heavy	  alcohol	  use	  are	  at	  higher	  risk	  for	  oral	  cancer,	  and	  might	  benefit	  




There	  is	  no	  standard	  recommendation	  for	  routine	  oral	  cancer	  screening	  at	  this	  time.	  
However,	  screening	  guidelines	  have	  been	  offered	  by	  organizations	  to	  promote	  oral	  
cancer	  awareness,	  which	  include:	  
	  
• Discussing	  oral	  cancer	  screening	  with	  your	  dentist	  or	  healthcare	  provider	  
	  
• Having	  periodic	  oral	  exams	  during	  routine	  dental	  visits	  
	  
	  
In	  this	  section,	  oral	  cancer	  screening	  is	  defined	  as	  having	  ever	  received	  an	  oral	  cancer	  
screening,	  and	  is	  reported	  among	  all	  adults	  ages	  18	  and	  older.	  These	  data	  are	  based	  on	  
self-­‐report,	  and	  although	  the	  exam	  is	  described	  in	  the	  survey	  question,	  respondents	  may	  
or	  may	  not	  accurately	  remember	  and	  report	  whether	  they	  received	  an	  oral	  cancer	  
screening,	  as	  it	  may	  be	  done	  as	  a	  routine	  part	  of	  a	  dental	  exam.	  
	  
What	  is	  the	  prevalence	  of	  oral	  cancer	  screening	  in	  Maine?	  
	  
About	  one-­‐third	  of	  Maine	  adults	  report	  ever	  having	  oral	  cancer	  screening.	  
	  
• In	  2012,	  34.8%	  of	  Maine	  adults	  ages	  18	  years	  and	  over	  were	  ever	  screened	  for	  
oral	  cancer	  (Table	  5.15).	  
	  
What	  are	  the	  trends	  in	  oral	  cancer	  screening	  prevalence	  in	  Maine?	  
	  
Oral	  cancer	  screening	  among	  Maine	  adults	  increased	  from	  2011	  to	  2012.	  
	  
• From	  2011	  to	  2012,	  the	  prevalence	  of	  oral	  cancer	  screening	  significantly	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Are	  there	  differences	  in	  the	  prevalence	  of	  oral	  cancer	  screening	  by	  demographic	  
factors?	  
	  
In	  Maine,	  the	  prevalence	  of	  oral	  cancer	  screening	  is	  lowest	  among	  males,	  those	  with	  
less	  education	  and	  household	  income,	  and	  those	  with	  Medicaid	  or	  MaineCare.	  Oral	  
cancer	  screening	  is	  also	  lowest	  among	  Maine	  adults	  with	  current	  depression	  or	  any	  
lifetime	  diagnosis	  of	  depression	  or	  anxiety.	  	  	  
	  
• Maine	  males	  were	  significantly	  less	  likely	  to	  have	  oral	  cancer	  screening	  than	  
females	  at	  31.7%	  and	  37.8%,	  respectively	  (Table	  5.16).	  
	  
• The	  percentage	  of	  Mainers	  who	  had	  oral	  cancer	  screening	  significantly	  increased	  
with	  increasing	  education	  levels,	  from	  10.5%	  among	  those	  with	  less	  than	  a	  high	  
school	  diploma	  to	  52.1%	  among	  those	  with	  at	  least	  a	  bachelor’s	  degree	  (Table	  


















• Maine	  adults	  with	  an	  annual	  household	  income	  less	  than	  $15,000	  were	  
significantly	  less	  likely	  to	  have	  oral	  cancer	  screening	  (12.2%)	  compared	  to	  those	  
with	  an	  income	  of	  $15,000-­‐$24,999	  (23.8%),	  $25,000-­‐$34,999	  (32.7%),	  $35,000-­‐
$9,999	  (36.8%),	  and	  $50,000	  and	  more	  (50.9%;	  Table	  5.16,	  Figure	  5.3.b).	  
	  
• The	  prevalence	  of	  oral	  cancer	  screening	  was	  significantly	  lower	  among	  Maine	  
adults	  with	  Medicaid	  or	  MaineCare	  (13.1%)	  compared	  to	  those	  with	  private	  
health	  insurance	  (45.1%),	  Medicare	  (34.4%),	  and	  other	  types	  of	  health	  insurance	  
(42.4%).	  The	  prevalence	  of	  oral	  cancer	  screening	  was	  significantly	  higher	  among	  
Figure 5.2.b. Oral and Prostate Cancer Screening among Maine Adults by Level of 
Education, 2012	  
Data source: Maine Behavioral Risk Factor Surveillance System. 
All percentages are weighted to be more representative of the general adult population of Maine and to adjust for non-response. 
†Use with caution. Estimates based on n<50 might be unstable.  
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Maine	  adults	  with	  private	  insurance	  compared	  to	  those	  with	  Medicaid	  or	  
MaineCare	  or	  with	  Medicare.	  The	  number	  of	  uninsured	  adults	  was	  too	  small	  to	  






















Figure 5.3.b. Oral and Prostate Cancer Screening among Maine Adults by Level of 
Annual Household Income, 2012	  
Data source: Maine Behavioral Risk Factor Surveillance System. 
All percentages are weighted to be more representative of the general adult population of Maine and to adjust for non-response. 	  
	  
**	  
Figure 5.4.b. Oral and Prostate Cancer Screening among Maine Adults by Type of 
Health Insurance Coverage, 2012*	  
Data source: Maine Behavioral Risk Factor Surveillance System. 
All percentages are weighted to be more representative of the general adult population of Maine and to adjust for non-response. 
*Sample size was too small to provide reliable estimates for the uninsured population of Maine adults. 
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• A	  significantly	  lower	  percentage	  of	  Maine	  adults	  who	  had	  current	  depression	  
had	  oral	  cancer	  screening	  (20.0%)	  compared	  to	  adults	  without	  current	  
depression	  (36.2%;	  Table	  5.16,	  Figure	  5.5.b).	  
	  
	  
• Maine	  adults	  with	  any	  lifetime	  diagnosis	  of	  depression	  or	  anxiety	  (29.0%)	  were	  
significantly	  less	  likely	  to	  report	  oral	  cancer	  screening	  compared	  to	  those	  
















Figure 5.5.b. Oral and Prostate Cancer Screening among Maine Adults by Current 
Depression, 2012	  
	  Data source: Maine Behavioral Risk Factor Surveillance System. All percentages are weighted to be more representative of the general adult population of Maine and to adjust for non-response. Current depression = Self-reported symptoms of current depression based on PHQ-2 depression scale. 
 
 	  
Figure 5.6.b. Oral and Prostate Cancer Screening among Maine Adults by Lifetime 
Depression or Anxiety, 2012	  
Data source: Maine Behavioral Risk Factor Surveillance System. 
All percentages are weighted to be more representative of the general adult population of Maine and to adjust for non-response. 
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• Among	  Maine	  adults,	  35.1%	  whites	  and	  34.7%	  of	  non-­‐Hispanics	  had	  oral	  cancer	  
screening.	  The	  number	  of	  non-­‐white	  or	  Hispanic	  adults	  was	  too	  small	  to	  
determine	  if	  there	  were	  differences	  in	  the	  prevalence	  of	  oral	  cancer	  screening	  by	  
race	  or	  ethnicity	  (Table	  5.17).	  
	  
Are	  there	  differences	  in	  the	  prevalence	  of	  oral	  cancer	  screening	  by	  geography?	  
	  
Counties	  and	  public	  health	  districts	  with	  the	  lowest	  oral	  cancer	  screening	  prevalence	  
rates	  tend	  to	  be	  located	  in	  northern	  and	  western	  Maine.	  
	  
• During	  2012,	  Aroostook	  and	  Oxford,	  counties	  had	  the	  lowest	  prevalence	  rates	  in	  
the	  state,	  but	  only	  Aroostook	  County’s	  prevalence	  (19.9%)	  was	  significantly	  
lower	  than	  Maine	  overall	  (34.8%)	  and	  the	  prevalence	  in	  Cumberland	  (46.3%),	  
Knox	  (41.2%),	  Penobscot	  (35.9%),	  Sagadahoc	  (43.2%),	  and	  York	  (45.6%)	  counties.	  
(Table	  5.18,	  Map	  5.9).	  
	  
• Cumberland	  and	  York	  counties	  (46.3%	  and	  45.6%,	  respectively)	  had	  a	  
significantly	  higher	  percentage	  of	  adults	  who	  had	  oral	  cancer	  screening	  
compared	  to	  the	  state	  overall	  (34.8%;	  Table	  5.18,	  Map	  5.9).	  
	  
• During	  2012,	  Aroostook	  District	  (19.9%)	  had	  a	  significantly	  lower	  prevalence	  of	  
oral	  cancer	  screening	  than	  Maine	  overall	  (34.8%)	  and	  the	  prevalence	  rates	  in	  
Cumberland	  (46.3%),	  Downeast	  (39.2%),	  Midcoast	  (36.5%),	  Penquis	  (33.5%),	  and	  
York	  (45.6%)	  districts	  (Table	  5.18,	  Map	  5.10).	  
	  
• Cumberland	  and	  York	  districts	  (46.3%	  and	  45.6%,	  respectively)	  had	  the	  highest	  
prevalence	  of	  oral	  cancer	  screening	  in	  the	  state,	  and	  were	  significantly	  higher	  
than	  the	  state	  prevalence	  (34.8%;	  Table	  5.18,	  Map	  5.10).	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Prostate	  cancer	  screening	  
	  
Prostate	  cancer	  is	  the	  most	  common	  cancer	  among	  men	  in	  Maine	  and,	  with	  the	  
exception	  of	  skin	  cancer,	  nationwide.	  Cancers	  in	  the	  male	  prostate	  tend	  to	  grow	  slowly	  




• Discussing	  prostate	  cancer	  screening	  with	  your	  health	  care	  provider	  starting	  at	  
age	  50.	  	  Men	  at	  higher	  risk	  of	  prostate	  cancer	  should	  receive	  information	  about	  
screening	  before	  age	  50.	  
	  
• Learn	  more	  about	  their	  prostate	  cancer	  risk	  to	  determine	  if	  screening	  is	  
necessary.	  
	  
• Learn	  more	  about	  the	  risks	  of,	  benefits	  of,	  and	  alternatives	  to	  screening.	  
The	  U.S.	  Preventive	  Services	  Task	  Force	  recommends	  against	  PSA	  testing	  for	  prostate	  
cancer	  screening	  because	  current	  evidence	  shows	  that	  the	  benefits	  do	  not	  outweigh	  the	  
harms.	  The	  task	  force	  recognizes,	  however,	  that	  PSA	  screening	  has	  become	  common,	  
and	  that	  some	  men	  will	  continue	  to	  request	  it	  and	  some	  doctors	  will	  continue	  to	  offer	  it	  
to	  their	  patients.	  Because	  of	  this,	  the	  task	  force	  recommends	  that	  decisions	  regarding	  
PSA	  testing	  should	  be	  based	  on	  a	  discussion	  between	  the	  doctor	  and	  patient	  on	  the	  
possible	  benefits	  and	  harms	  of	  testing	  and	  an	  informed	  choice	  by	  patients.7	  
In	  this	  section,	  prostate	  cancer	  screening	  is	  defined	  as	  having	  received	  a	  PSA	  test	  within	  
the	  past	  two	  years,	  and	  is	  reported	  among	  men	  ages	  50	  years	  and	  older.	  
What	  is	  the	  prevalence	  of	  prostate	  cancer	  screening	  in	  Maine?	  
	  
Almost	  half	  of	  Maine	  males	  ages	  50	  years	  and	  older	  report	  having	  prostate	  cancer	  
screening.	  
	  
• In	  2012,	  49.6%	  of	  Maine	  males	  ages	  50	  years	  and	  older	  had	  a	  PSA	  test	  for	  
prostate	  cancer	  screening	  within	  the	  past	  two	  years	  (Table	  5.19).	  
	  
What	  are	  the	  trends	  in	  prostate	  cancer	  screening	  prevalence	  in	  Maine?	  
	  
The	  prevalence	  of	  prostate	  cancer	  screening	  increased	  from	  2004	  to	  2008,	  but	  
declined	  significantly	  from	  2008	  to	  2010.	  	  
	  
• The	  percentage	  of	  Maine	  males	  ages	  50	  years	  and	  older	  who	  had	  a	  PSA	  test	  in	  
the	  past	  two	  years	  significantly	  increased	  from	  60.6%	  in	  2004	  to	  71.9%	  in	  2008,	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• Although	  the	  prevalence	  of	  prostate	  cancer	  screening	  in	  2012	  looks	  quite	  a	  bit	  
lower	  than	  in	  2010,	  these	  prevalence	  rates	  cannot	  be	  directly	  compared;	  this	  
appearance	  of	  a	  decline	  may	  be	  due	  to	  the	  major	  change	  in	  survey	  method	  in	  
2011.	  	  Trends	  in	  prostate	  cancer	  screening	  from	  2012	  onward	  will	  be	  assessed	  
once	  more	  recent	  data	  is	  available.	  
	  
Are	  there	  differences	  in	  the	  prevalence	  of	  prostate	  cancer	  screening	  by	  demographic	  
factors?	  
	  
Among	  Maine	  males	  ages	  50	  years	  and	  older,	  those	  in	  the	  youngest	  (50−64	  years)	  and	  
oldest	  (75	  years	  and	  older)	  age	  groups,	  those	  with	  lower	  education	  or	  household	  
income,	  and	  those	  with	  private	  health	  insurance	  have	  the	  lowest	  prevalence	  of	  
prostate	  cancer	  screening.	  	  
	  
• Maine	  males	  ages	  50−64	  years	  and	  75	  years	  and	  older	  were	  significantly	  less	  
likely	  to	  have	  a	  PSA	  test	  within	  the	  past	  two	  years	  (43.4%	  and	  50.4%,	  
respectively)	  compared	  to	  males	  ages	  65−74	  years	  (64.2%;	  Table	  5.19).	  
	  
• A	  significantly	  lower	  percentage	  of	  Maine	  males	  with	  less	  than	  a	  high	  school	  
education	  and	  those	  with	  a	  high	  school	  education	  (38.2%	  and	  46.7%,	  
respectively)	  had	  PSA	  testing	  compared	  to	  those	  with	  a	  Bachelor’s	  degree	  or	  
higher	  (55.8%;	  Table	  5.19,	  Figure	  5.2.b).	  
	  
• Males	  with	  an	  income	  less	  than	  $15,000	  (35.1%)	  and	  those	  with	  an	  income	  of	  
$15,000-­‐$24,999	  (37.4%)	  were	  significantly	  less	  likely	  to	  have	  PSA	  testing	  than	  
those	  with	  an	  income	  of	  $25,000-­‐34,999	  (51.5%)	  and	  higher	  income	  levels	  (Table	  
5.19,	  Figure	  5.3.b).	  
	  
• Maine	  males	  with	  private	  health	  insurance	  were	  significantly	  less	  likely	  to	  have	  a	  
PSA	  test	  within	  the	  past	  two	  years	  (49.5%)	  compared	  to	  males	  with	  Medicare	  
(59.6%)	  or	  other	  types	  of	  health	  insurance	  (61.4%).	  	  The	  number	  of	  males	  with	  
Medicaid	  or	  MaineCare	  or	  who	  were	  uninsured	  was	  too	  small	  to	  provide	  a	  
reliable	  estimate	  of	  prostate	  cancer	  screening	  in	  these	  groups	  (Table	  5.19,	  Figure	  
5.4.b).	  
	  
• There	  was	  no	  significant	  difference	  in	  the	  prevalence	  of	  prostate	  cancer	  
screening	  among	  Maine	  males	  with	  current	  depression	  (42.9%)	  or	  any	  lifetime	  
diagnosis	  of	  depression	  or	  anxiety	  (50.6%)	  compared	  to	  those	  without	  current	  
depression	  (49.4%)	  or	  any	  lifetime	  diagnosis	  (48.4%;	  Table	  5.19,	  Figure	  5.5.b,	  
Figure	  5.6.b).	  
	  
• Among	  Maine	  males,	  49.8%	  of	  white	  and	  49.7%	  of	  non-­‐Hispanic	  had	  PSA	  testing	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determine	  if	  there	  were	  differences	  in	  the	  prevalence	  of	  PSA	  testing	  by	  race	  or	  
ethnicity	  (Table	  5.20).	  
	  
Are	  there	  differences	  in	  prostate	  cancer	  screening	  prevalence	  rates	  by	  geography?	  
	  
Public	  health	  districts	  in	  Maine	  with	  the	  lowest	  prostate	  cancer	  screening	  prevalence	  
rates	  tend	  to	  be	  located	  in	  the	  mid-­‐section	  of	  Maine.	  	  The	  county-­‐level	  numbers	  of	  
males	  50	  years	  and	  older	  in	  the	  survey	  in	  2012	  were	  too	  small	  to	  assess	  county	  
differences.	  
	  
• During	  2012,	  the	  relatively	  small	  county-­‐level	  numbers	  of	  men	  50	  years	  and	  
older	  in	  the	  survey	  resulted	  in	  most	  county	  PSA	  testing	  prevalence	  rates	  being	  
suppressed	  due	  to	  statistical	  unreliability,	  making	  it	  difficult	  to	  assess	  geographic	  
differences	  by	  county	  (Table	  5.21).	  
	  
• While	  Midcoast	  and	  Penquis	  districts	  had	  the	  lowest	  prevalence	  rates	  of	  PSA	  
testing	  in	  the	  state	  in	  2012,	  these	  rates	  were	  not	  significantly	  different	  from	  the	  
Maine	  overall	  rate	  (Table	  5.21,	  Map	  5.11).	  
	  
• The	  prevalence	  of	  PSA	  testing	  in	  Aroostook	  District,	  the	  highest	  rate	  in	  the	  state	  
(59.2%),	  was	  significantly	  higher	  than	  the	  prevalence	  in	  Midcoast	  District,	  the	  
lowest	  rate	  in	  the	  state	  (42.1%;	  Table	  5.21,	  Map	  5.11).	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Cancer	  Survivors	  
	  
Over	  the	  past	  three	  decades,	  improvements	  in	  early	  detection	  and	  treatment	  have	  
resulted	  in	  people	  living	  longer	  after	  being	  diagnosed	  with	  cancer.	  In	  2011,	  nearly	  14	  
million	  Americans	  were	  living	  after	  a	  cancer	  diagnosis.1,2	  	  It	  is	  estimated	  that	  67%	  of	  
people	  diagnosed	  with	  cancer	  will	  live	  at	  least	  five	  years	  after	  diagnosis.2	  	  	  With	  the	  aging	  
of	  the	  U.S.	  population,	  the	  number	  of	  people	  with	  cancer	  diagnoses	  is	  expected	  to	  
continually	  increase.3	  Like	  other	  U.S.	  states,	  Maine’s	  population	  is	  becoming	  increasing	  
older.	  
	  
Previous	  chapters	  addressed	  Maine’s	  cancer	  incidence	  rates	  and	  mortality	  rates	  for	  
selected	  cancer	  types,	  and	  screening	  rates	  for	  detectable	  cancers.	  	  The	  intent	  of	  the	  
Cancer	  Survivors	  chapter	  is	  to	  provide	  the	  demographic	  characteristics	  of	  Maine	  
residents	  who	  have	  been	  diagnosed	  with	  cancer	  at	  some	  point	  in	  their	  life.	  	  Data	  was	  
obtained	  from	  the	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System	  (BRFSS)	  in	  2011	  and	  
2012	  in	  response	  to	  the	  question:	  “Has	  a	  doctor,	  nurse,	  or	  other	  health	  professional	  
ever	  told	  you	  that	  you	  had	  any	  of	  the	  following:	  	  (Ever	  told)	  you	  had	  skin	  cancer?	  (Ever	  
told)	  you	  had	  other	  types	  of	  cancer?”	  	  Maine	  adults	  who	  responded	  “yes”	  to	  either	  
question	  were	  considered	  as	  having	  a	  history	  of	  cancer	  and	  were	  included	  in	  this	  
analysis.	  
	  
In	  this	  chapter,	  “cancer	  survivors”	  are	  defined	  as	  “Maine	  adults	  with	  any	  cancer	  history”,	  
and	  “other	  Maine	  adults”	  are	  defined	  as	  “Maine	  adults	  without	  any	  cancer	  history”.	  
	  
What	  is	  the	  prevalence	  of	  Maine	  adults	  with	  any	  cancer	  history?	  
	  
Nearly	  126,000	  Maine	  adults	  have	  a	  history	  of	  cancer.	  
	  
• During	  2011-­‐2012,	  an	  estimated	  125,944	  (12.0%)	  Maine	  adults	  had	  any	  cancer	  
history	  (Table	  6.1).	  	  
	  
Are	  there	  differences	  in	  the	  sex	  distribution	  by	  cancer	  history	  among	  Maine	  adults?	  	  
	  
Maine	  cancer	  survivors	  are	  more	  likely	  to	  be	  female.	  
	  
• During	  2011-­‐2012,	  a	  significantly	  greater	  proportion	  of	  Maine	  cancer	  survivors	  
were	  female	  (58.9%)	  than	  male	  (41.1%;	  Table	  6.1,	  Figure	  6.1).	  
	  
• Maine	  cancer	  survivors	  are	  more	  likely	  to	  be	  female	  (58.9%)	  compared	  to	  other	  


















Are	  there	  differences	  in	  the	  age	  distribution	  by	  cancer	  history	  among	  Maine	  adults?	  	  
	  
Maine	  cancer	  survivors	  tend	  to	  be	  older	  than	  other	  Maine	  adults.	  	  
	  
• During	  2011-­‐2012,	  more	  than	  half	  (52.2%)	  of	  Maine	  cancer	  survivors	  were	  over	  
the	  age	  of	  65	  years,	  44.1%	  were	  ages	  35−64	  years,	  and	  less	  than	  4%	  (3.8%)	  were	  








Maine Adults with Any Cancer History 
 




Data source: Maine Behavioral Risk Factor Surveillance System. 
Any cancer history includes a history of skin cancer.    
‘All Other Maine Adults’ are defined as those without a self-reported history of cancer. 
All percentages are weighted to be more representative of the general adult population of Maine and to adjust for non-response. 
Figure 6.2. Age Distribution among Maine Adults with Any Cancer History, 2011-2012 
Data source: Maine Behavioral Risk Factor Surveillance System. 
Any cancer history includes a history of skin cancer.    
Age distribution is defined in years. 
‘All Other Maine Adults’ are defined as those without a self-reported history of cancer. 




Maine	  Cancer	  Surveillance	  Report	  2014	  
• Maine	  cancer	  survivors	  were	  significantly	  older	  compared	  to	  the	  age	  distribution	  
of	  other	  Maine	  adults	  (Table	  6.1,	  Figure	  6.2).	  
	  
• Maine	  cancer	  survivors	  were	  significantly	  more	  likely	  to	  be	  in	  the	  55−64	  years	  
(22.9%),	  65−74	  years	  (23.1%),	  and	  75	  years	  and	  older	  (29.1%)	  age	  groups	  
compared	  to	  other	  Maine	  adults	  (17.6%,	  10.0%,	  and	  6.8%,	  respectively;	  Table	  
6.1,	  Figure	  6.2).	  
	  
Are	  there	  differences	  in	  the	  education	  and	  income	  distributions	  by	  cancer	  history	  
among	  Maine	  adults?	  	  
	  
Maine	  cancer	  survivors	  were	  more	  likely	  to	  have	  at	  least	  a	  college	  education	  than	  
other	  Maine	  adults.	  	  Maine	  cancer	  survivors	  tend	  to	  have	  lower	  annual	  household	  
income	  than	  other	  Maine	  adults.	  	  
	  
• During	  2011-­‐2012,	  10.8%	  of	  Maine	  cancer	  survivors	  had	  less	  than	  a	  high	  school	  
education,	  33.5%	  had	  a	  high	  school	  education,	  28.6%	  had	  some	  college	  
education,	  and	  27.0%	  had	  a	  Bachelor’s	  degree	  or	  higher	  (Table	  6.1).	  	  
	  
• Maine	  cancer	  survivors	  were	  significantly	  more	  likely	  to	  have	  a	  Bachelor’s	  degree	  
or	  higher	  education	  (27.0%)	  compared	  to	  other	  Maine	  adults	  (24.5%);	  the	  
percentages	  in	  other	  education	  groups	  were	  similar	  between	  Maine	  cancer	  
survivors	  and	  other	  Maine	  adults	  (Table	  6.1).	  
	  
• During	  2011-­‐2012,	  more	  than	  one-­‐third	  (35.3%)	  of	  Maine	  cancer	  survivors	  had	  
an	  annual	  household	  income	  of	  less	  than	  $25,000,	  more	  than	  one-­‐fourth	  (28.7%)	  
had	  an	  income	  of	  $25,000-­‐$49,999,	  and	  more	  than	  one-­‐third	  (36.0%)	  had	  an	  
income	  of	  $50,000	  or	  more	  (Table	  6.1).	  
	  
• Maine	  cancer	  survivors	  tended	  to	  have	  lower	  annual	  household	  incomes	  than	  
other	  Maine	  adults.	  Maine	  cancer	  survivors	  were	  significantly	  more	  likely	  to	  be	  
in	  the	  $15,000-­‐$29,999	  income	  group	  (21.6%)	  than	  other	  Maine	  adults	  (18.6%),	  
and	  they	  were	  significantly	  less	  likely	  to	  be	  in	  the	  $50,000	  or	  more	  income	  group	  











Are there differences in health insurance status by cancer history among Maine 
adults?  
In Maine, cancer survivors tend to have health insurance and most have private 
insurance or Medicare. Maine cancer survivors are more likely to have health 
insurance and more likely to have Medicare than other Maine adults. 
• Maine cancer survivors were significantly more likely to have health insurance







Figure 6.3. Health Insurance Coverage among Maine Adults with Any Cancer History, 
2011-2012* 
Health Insurance Status 
 Type of Health Insurance Coverage 
Data source: Maine Behavioral Risk Factor Surveillance System. 
Any cancer history includes a history of skin cancer.    
‘All Other Maine Adults’ are defined as those without a self-reported history of cancer.
All percentages are weighted to be more representative of the general adult population of Maine and to adjust for non-response. 
*Sample size was too small to represent the uninsured population of Maine adults.  Maine Cancer Surveillance Report 2014 Page 176
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• During	  2011-­‐2012,	  the	  most	  common	  type	  of	  health	  insurance	  among	  Maine
cancer	  survivors	  was	  Medicare	  (43.9%),	  followed	  by	  private	  health	  insurance
(36.5%),	  then	  Medicaid	  (MaineCare)	  (10.6%),	  and	  other	  insurance	  (9.0%;	  Table
6.1,	  Figure	  6.3).
• A	  significantly	  lower	  percentage	  of	  Maine	  cancer	  survivors	  had	  private	  health
insurance	  (36.5%)	  or	  Medicaid	  (MaineCare)	  (10.6%)	  compared	  to	  other	  Maine
adults	  (59.5%	  and	  15.6%,	  respectively).	  A	  higher	  proportion	  of	  Maine	  cancer
survivors	  had	  Medicare	  (43.9%)	  compared	  to	  other	  Maine	  adults	  (17.3%;	  Table
6.1,	  Figure	  6.3).
Are	  there	  differences	  in	  the	  prevalence	  of	  depression	  and	  anxiety	  by	  cancer	  history	  
among	  Maine	  adults?	  
Maine	  cancer	  survivors	  had	  similar	  prevalence	  rates	  of	  current	  depression	  and	  any	  
lifetime	  depression	  or	  anxiety	  as	  other	  Maine	  adults.	  	  
• During	  2011-­‐2012,	  the	  percentage	  of	  Maine	  cancer	  survivors	  with	  current
depression	  was	  11.9%.	  The	  prevalence	  of	  current	  depression	  was	  similar,	  and
not	  significantly	  different,	  among	  cancer	  survivors	  and	  other	  Maine	  adults
(11.6%;	  Table	  6.1).
• Among	  Maine	  cancer	  survivors,	  36.1%	  had	  a	  lifetime	  diagnosis	  of	  depression	  or
anxiety.	  This	  was	  similar	  to	  (not	  significantly	  different	  from)	  the	  prevalence
among	  other	  Maine	  adults	  (32.5%;	  Table	  6.1).
Are	  there	  differences	  in	  the	  prevalence	  of	  other	  chronic	  diseases	  by	  cancer	  history	  
among	  Maine	  adults?	  
Maine	  cancer	  survivors	  have	  higher	  prevalence	  of	  other	  chronic	  diseases	  compared	  to	  
other	  Maine	  adults.	  
• Maine	  cancer	  survivors	  were	  significantly	  more	  likely	  to	  have	  a	  history	  of
coronary	  heart	  disease	  (CHD)	  or	  stroke	  (18.8%)	  compared	  to	  other	  Maine	  adults
(8.1%;	  Table	  6.1,	  Figure	  6.4).
• Maine	  cancer	  survivors	  were	  significantly	  more	  likely	  to	  have	  current	  asthma
(13.6%)	  compared	  to	  other	  Maine	  adults	  (11.3%;	  Table	  6.1,	  Figure	  6.4).
• During	  2011-­‐2012,	  16.3%	  of	  Maine	  cancer	  survivors	  had	  diabetes	  compared	  to
8.7%	  of	  other	  Maine	  adults;	  this	  was	  a	  significant	  difference	  (Table	  6.1,	  Figure
6.4).	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• Maine	  cancer	  survivors	  were	  significantly	  more	  likely	  to	  have	  chronic	  obstructive
pulmonary	  disease	  (COPD)	  than	  other	  Maine	  adults	  (14.7%	  vs.	  6.8%;	  Table	  6.1,
Figure	  6.4).
• A	  significantly	  greater	  percentage	  of	  Maine	  cancer	  survivors	  reported	  having	  two 
or	  more	  chronic	  diseases	  (16.1%)	  compared	  to	  other	  Maine	  adults	   (7.0%;	  Table 
6.1,	  Figure	  6.4).
Are	  there	  differences	  in	  the	  distribution	  of	  race	  and	  ethnic	  groups	  by	  cancer	  history	  
among	  Maine	  adults?	  
Maine	  cancer	  survivors	  were	  more	  likely	  to	  be	  non-­‐Hispanic	  and	  white	  than	  other	  
Maine	  adults,	  though	  the	  difference	  in	  percentages	  were	  small.	  	  
• Among	  Maine	  cancer	  survivors,	  97.7%	  were	  white	  and	  99.5%	  were	  non-­‐
Hispanic.	  	  The	  number	  of	  non-­‐white	  and	  Hispanic	  individuals	  was	  too	  low	  to
provide	  reliable	  estimates	  (Table	  6.2).
• Although	  Maine	  cancer	  survivors	  were	  more	  likely	  to	  be	  white	  (97.7%)	  and	  non-­‐
Hispanic	  (99.5%)	  than	  other	  Maine	  adults	  (96.3%	  and	  98.8%,	  respectively),	  the
percentage	  point	  differences	  were	  small	  (less	  than	  two	  percentage	  points;	  Table
6.2).	  
Figure 6.4. Chronic Disease Status among Maine Adults with Any Cancer History, 2011-2012 
Data source: Maine Behavioral Risk Factor Surveillance System. 
Abbreviations: CHD, Coronary Heart Disease; COPD, Chronic Obstructive Pulmonary Disease 
Any cancer history includes a history of skin cancer.   
 ‘All Other Maine Adults’ are defined as those without a self-reported history of cancer.
All percentages are weighted to be more representative of the general adult population of Maine and to adjust for non-response. 
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Are	  there	  differences	  in	  the	  county	  or	  public	  health	  district	  of	  residence	  by	  cancer	  
history	  among	  Maine	  adults?	  	  
The	  distribution	  of	  county	  and	  public	  health	  districts	  of	  residence	  among	  Maine	  cancer	  
survivors	  tends	  to	  match	  the	  general	  population	  distribution,	  with	  most	  cancer	  
survivors	  living	  in	  the	  most	  populous	  counties	  and	  districts.	  	  Cancer	  survivors	  were	  
more	  likely	  to	  live	  in	  the	  Midcoast	  region	  of	  Maine	  compared	  to	  other	  Maine	  adults.	  	  
• During	  2011-­‐2012,	  more	  than	  one-­‐third	  (34.0%)	  of	  Maine	  cancer	  survivors	  lived
in	  Maine’s	  most	  populous	  counties,	  Cumberland	  and	  York,	  and	  another	  10.1%
lived	  in	  the	  third	  most	  populous	  county,	  Penobscot	  County	  (Table	  6.3,	  Map	  6.1).
• Compared	  to	  other	  Maine	  adults,	  Maine	  cancer	  survivors	  were	  significantly	  less
likely	  to	  live	  in	  Androscoggin	  (8.4%	  vs.	  6.0%,	  respectively)	  and	  Hancock	  (4.4%	  vs.
3.9%)	  counties,	  and	  were	  significantly	  more	  likely	  to	  live	  in	  Knox	  (2.9%	  vs.	  3.8%)
and	  Lincoln	  (2.8%	  vs.	  3.9%)	  counties	  (Table	  6.3,	  Map	  6.1).
• During	  2011-­‐2012,	  more	  than	  one-­‐third	  (34.0%)	  of	  Maine	  cancer	  survivors	  lived
in	  Maine’s	  most	  populous	  public	  health	  districts,	  Cumberland	  and	  York	  (Table
6.3,	  Map	  6.2).
• Compared	  to	  other	  Maine	  adults,	  Maine	  cancer	  survivors	  were	  significantly	  less
likely	  to	  live	  in	  Central	  (14.5%	  vs.	  12.2%,	  respectively)	  and	  Western	  (15.9%	  vs.
13.7%)	  districts,	  and	  were	  significantly	  more	  likely	  to	  live	  in	  Midcoast	  district
(11.5%	  vs.	  14.6%;	  Table	  6.3,	  Map	  6.2).
See	  maps	  at	  the	  end	  of	  the	  chapter.	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Table	  2.1.	  All	  cancer	  incidence	  by	  3-­‐year	  period,	  Maine,	  U.S.	  SEER	  9	  and	  U.S.	  SEER	  9	  whites,	  2000-­‐2010.	  





	  Crude	   Age-­‐adjusted	   Average	  
Annual	  
Number	  




Rate	   95%CI	   Rate	   95%	  CI	   Rate	   95%CI	   Rate	   95%CI	  
2000-­‐2002	   	  	  	  	  	  	  	  	  7,759	   603.3	   595.5	  -­‐	  611.1	   534.3	   527.4	  -­‐	  541.2	   125,481	   487.8	   486.3	  -­‐	  489.4	   104,461	   498.0	   496.3	  -­‐	  499.8	  
2001-­‐2003	   	  	  	  	  	  	  	  	  7,874	   607.6	   599.8	  -­‐	  615.4	   533.3	   526.5	  -­‐	  540.2	   126,494	   484.2	   482.7	  -­‐	  485.8	   104,914	   494.6	   492.9	  -­‐	  496.3	  
2002-­‐2004	   	  	  	  	  	  	  	  	  8,034	   615.4	   607.7	  -­‐	  623.2	   534.5	   527.7	  -­‐	  541.3	   127,400	   479.8	   478.3	  -­‐	  481.3	   105,188	   489.9	   488.2	  -­‐	  491.6	  
2003-­‐2005	   	  	  	  	  	  	  	  	  8,169	   622.1	   614.4	  -­‐	  630.0	   534.3	   527.5	  -­‐	  541.0	   128,221	   474.7	   473.2	  -­‐	  476.3	   105,580	   485.4	   483.7	  -­‐	  487.1	  
2004-­‐2006	   	  	  	  	  	  	  	  	  8,400	   637.0	   629.1	  -­‐	  644.9	   539.3	   532.6	  -­‐	  546.1	   130,538	   474.5	   473.0	  -­‐	  476.0	   107,095	   485.3	   483.6	  -­‐	  487.0	  
2005-­‐2007	   	  	  	  	  	  	  	  	  8,462	   639.5	   631.7	  -­‐	  647.4	   533.4	   526.7-­‐	  540.0	   133,558	   476.0	   474.5	  -­‐	  477.5	   109,133	   486.9	   485.2	  -­‐	  488.6	  
2006-­‐2008	   	  	  	  	  	  	  	  	  8,509	   641.2	   633.4	  -­‐	  649.1	   525.5	   519.0	  -­‐	  532.1	   136,451	   476.4	   474.9	  -­‐	  477.9	   110,905	   486.6	   484.9	  -­‐	  488.3	  
2007-­‐2009	   	  	  	  	  	  	  	  	  8,399	   631.9	   624.2	  -­‐	  639.8	   509.4	   503.0	  -­‐	  515.8	   138,990	   474.9	   473.4	  -­‐	  476.3	   112,329	   484.3	   482.7	  -­‐	  486.0	  
2008-­‐2010	   	  	  	  	  	  	  	  	  8,321	   626.0	   618.3	  -­‐	  633.8	   496.8	   490.5	  -­‐	  503.1	   139,759	   467.1	   465.7	  -­‐	  468.6	   112,351	   475.8	   474.2	  -­‐	  477.4	  
Maine	  Data	  Source:	  Maine	  CDC	  Cancer	  Registry,	  November	  2012	  NPCR	  data	  submission	  (1995-­‐2010).	  U.S.	  Data	  Source:	  SEER	  9	  Research	  Data	  1973-­‐2010).	  
*The	  SEER	  9	  registries	  are	  Atlanta,	  Connecticut,	  Detroit,	  Hawaii,	  Iowa,	  New	  Mexico,	  San	  Francisco-­‐Oakland,	  Seattle-­‐Puget	  Sound,	  and	  Utah	  and	  represent
9.4%	  of	  U.S.	  population.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Incidence:	  The	  number	  of	  people	  who	  develop	  cancer	  (new	  cancer	  cases)	  during	  a	  specified	  period	  of	  time	  in	  a	  specified	  population.	  	  
All	  cancer:	  SEER	  Site	  Recode:	  20010-­‐37000	  (which	  include	  ICD-­‐O-­‐3	  codes:	  C00-­‐C797).	  
Incidence	  case	  definitions	  exclude	  histologies	  consistent	  with	  Kaposi	  sarcoma	  and	  mesothelioma,	  where	  applicable.	  
Crude	  Rates	  are	  new	  cases	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  new	  cases	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	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Table	  2.2.	  All	  cancer	  incidence	  by	  3-­‐year	  period	  and	  sex,	  Maine,	  2000-­‐2010.	  
3-­‐Year	  Period	  




	  Crude	   Age-­‐adjusted	   Average	  
Annual	  
Number	  
Crude	   Age-­‐adjusted	   Average	  
Annual	  
Number	  
Crude	   Age-­‐adjusted	  
Rate	   95%CI	   Rate	   95%	  CI	   Rate	   95%CI	   Rate	   95%CI	   Rate	   95%CI	   Rate	   95%CI	  
2000-­‐2002	   7,759	   603.3	   595.5	  -­‐	  611.1	   534.3	   527.4	  -­‐	  541.2	   3,704	   561.4	   551.0	  -­‐	  571.9	   465.1	   456.4	  -­‐	  473.9	   4,055	   647.4	   635.9	  -­‐	  659.0	   635.9	   624.5	  -­‐	  647.5	  
2001-­‐2003	   7,874	   607.6	   599.8	  -­‐	  615.4	   533.3	   526.5	  -­‐	  540.2	   3,732	   561.9	   551.6	  -­‐	  572.4	   462.5	   453.9	  -­‐	  471.2	   4,142	   655.5	   644.0	  -­‐	  667.1	   636.6	   625.3	  -­‐	  648.0	  
2002-­‐2004	   8,034	   615.4	   607.7	  -­‐	  623.2	   534.5	   527.7	  -­‐	  541.3	   3,807	   569.7	   559.3	  -­‐	  580.2	   464.0	   455.4	  -­‐	  472.7	   4,227	   663.4	   651.9	  -­‐	  675.0	   633.2	   622.1	  -­‐	  644.5	  
2003-­‐2005	   8,169	   622.1	   614.4	  -­‐	  630.0	   534.3	   527.5	  -­‐	  541.0	   3,897	   580.3	   569.8	  -­‐	  590.9	   468.4	   459.8	  -­‐	  477.1	   4,272	   665.9	   654.5	  -­‐	  677.6	   625.9	   614.9	  -­‐	  637.0	  
2004-­‐2006	   8,400	   637.0	   629.1	  -­‐	  644.9	   539.3	   532.6	  -­‐	  546.1	   4,025	   597.1	   586.5	  -­‐	  607.8	   476.5	   467.9	  -­‐	  485.2	   4,375	   678.7	   667.1	  -­‐	  690.4	   626.4	   615.5	  -­‐	  637.4	  
2005-­‐2007	   8,462	   639.5	   631.7	  -­‐	  647.4	   533.4	   526.7	  –	  540.0	   4,058	   600.2	   589.6	  -­‐	  611.0	   474.0	   465.4	  -­‐	  482.6	   4,404	   680.5	   669.0	  -­‐	  692.2	   617.1	   606.4	  -­‐	  627.9	  
2006-­‐2008	   8,509	   641.2	   633.4	  -­‐	  649.1	   525.5	   519.0	  -­‐	  532.1	   4,070	   600.5	   589.9	  -­‐	  611.2	   467.9	   459.5	  -­‐	  476.5	   4,439	   683.7	   672.1	  -­‐	  695.4	   605.6	   595.2	  -­‐	  616.2	  
2007-­‐2009	   8,399	   631.9	   624.2	  -­‐	  639.8	   509.4	   503.0	  -­‐	  515.8	   4,046	   596.1	   585.6	  -­‐	  606.8	   458.3	   450.0	  -­‐	  466.7	   4,353	   669.3	   657.8	  -­‐	  680.8	   580.1	   570.0	  -­‐	  590.4	  
2008-­‐2010	   8,321	   626.0	   618.3	  -­‐	  633.8	   496.8	   490.5	  -­‐	  503.1	   4,038	   595.0	   584.5	  -­‐	  605.7	   452.6	   444.3	  -­‐	  461.0	   4,283	   658.3	   647.0	  -­‐	  669.8	   558.7	   548.8	  -­‐	  568.7	  
U.S.	  SEER	  9	  	  
2008-­‐2010*	  
139,759	   485.9	   484.5	  -­‐	  487.4	   467.1	   465.7	  -­‐	  468.6	   67,928	   465.3	   463.3	  -­‐	  467.3	   420.1	   418.3	  -	  422.0	   71,832	   507.2	   505.0	  -­‐	  509.3	   533.3	   531.0	  -­‐	  535.6	  
U.S.	  SEER	  9	  Whites	  
2008-­‐2010*	  
112,351	   527.5	   525.7	  -­‐	  529.2	   475.8	   474.2	  -­‐	  477.4	   54,456	   508.5	   506.0	  -	  511.0	   432.9	   430.7	  -	  435.0	   57,896	   546.6	   544.1	  -­‐	  549.2	   536.6	   534.1	  -­‐	  539.2	  
Maine	  Data	  Source:	  Maine	  CDC	  Cancer	  Registry,	  November	  2012	  NPCR	  data	  submission	  (1995-­‐2010).	  U.S.	  Data	  Source:	  SEER	  9	  Research	  Data	  (1973-­‐2010).	  
*The	  SEER	  9	  registries	  are	  Atlanta,	  Connecticut,	  Detroit,	  Hawaii,	  Iowa,	  New	  Mexico,	  San	  Francisco-­‐Oakland,	  Seattle-­‐Puget	  Sound,	  and	  Utah	  and	  represent	  9.4%	  of	  U.S.	  population.
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Incidence:	  The	  number	  of	  people	  who	  develop	  cancer	  (new	  cancer	  cases)	  during	  a	  specified	  period	  of	  time	  in	  a	  specified	  population.	  
All	  cancer:	  SEER	  Site	  Recode:	  20010-­‐37000	  (which	  include	  ICD-­‐O-­‐3	  codes:	  C00-­‐C797).	  
Incidence	  case	  definitions	  exclude	  histologies	  consistent	  with	  Kaposi	  sarcoma	  and	  mesothelioma,	  where	  applicable.	  
Crude	  Rates	  are	  new	  cases	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  new	  cases	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	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Table 2.3. All cancer incidence by 3-year period and age group, Maine, 2000-2010. 
  Ages 0─34 years Ages 35─64 years  Ages 65─74 years  Ages 75 years and older 




Number Rate 95% CI 
Average 
Annual 
Number Rate 95% CI 
Average 
Annual 
Number Rate 95% CI 
Average 
Annual 
Number Rate 95% CI 
2000-2002            195  34.7 32.0 - 37.6         2,917  540.0 528.7 - 551.4 2,197 2,283.9 2,229.1 - 2,339.7         2,450  2,753.7 2,691.1 - 2,817.4 
2001-2003            215  38.5 35.6 - 41.5         2,985  543.3 532.1 - 554.6 2,180 2,260.9 2,206.5 - 2,316.4         2,494  2,762.7 2,700.5 - 2,826.0 
2002-2004            232  41.4 38.4 - 44.6         3,113  557.9 546.6 - 569.3 2,151 2,224.0 2,170.1 - 2,278.9         2,538  2,773.5 2,711.6 - 2,836.5 
2003-2005            226  40.6 37.6 - 43.8         3,202  566.0 554.8 - 577.5 2,177 2,239.2 2,185.2 - 2,294.2         2,563  2,768.2 2,706.7 - 2,830.8 
2004-2006            224  40.5 37.5 - 43.7         3,353  585.6 574.2 - 597.1 2,208 2,249.9 2,196.1 - 2,304.8         2,614  2,788.4 2,727.1 - 2,850.9 
2005-2007            220  39.9 36.9 - 43.1         3,383  584.9 573.6 - 596.4 2,213 2,222.3 2,169.1 - 2,276.4         2,646  2,784.9 2,724.0 - 2,846.9 
2006-2008            220  40.3 37.2 - 43.4         3,453  593.4 582.0 - 604.9 2,210 2,160.2 2,108.5 - 2,212.8         2,626  2,727.2 2,667.3 - 2,788.1 
2007-2009            216  39.7 36.7 - 42.9         3,432  588.6 577.3 - 600.1 2,190 2,068.6 2,018.9 - 2,119.3         2,561  2,636.1 2,577.5 - 2,695.8 
2008-2010            218  40.5 37.5 - 43.7         3,415  586.2 574.9 - 597.7 2,213 2,016.1 1,967.9 - 2,065.2         2,474  2,527.2 2,470.0 - 2,585.4 
U.S. SEER 9          
2008-2010* 5,224 38.1 37.5 - 38.7 61,100 529.2 526.8 - 531.7 34,626 1,886.6 1,875.1 - 1,898.1 38,810 2,336.0 2,322.6 - 2,349.4 
U.S. SEER 9 Whites  
2008-2010* 4,007 41.0 40.3 - 41.8 47,342 544.3 541.4 - 547.1 28,150 1,920.8 1,907.9 - 1,933.8 32,852 2,391.5 2,376.6 - 2,406.5 
Maine Data Source: Maine CDC Cancer Registry, November 2012 NPCR data submission (1995-2010). U.S. Data Source: SEER 9 Research Data (1973-2010). 
*The SEER 9 registries are Atlanta, Connecticut, Detroit, Hawaii, Iowa, New Mexico, San Francisco-Oakland, Seattle-Puget Sound, and Utah and represent 
9.4% of U.S. population. 
95% CI: 95% confidence interval of the rate. 
Cancer Incidence: The number of people who develop cancer (new cancer cases) during a specified period of time in a specified population.   
All cancer: SEER Site Recode: 20010-37000 (which include ICD-O-3 codes: C00-C797). 
Incidence case definitions exclude histologies consistent with Kaposi sarcoma and mesothelioma, where applicable. 
Crude Rates are new cases per 100,000 population. 
Age-adjusted rates are not calculated for age-specific groups. 
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Table	  2.4.	  All	  cancer	  incidence	  by	  county	  and	  public	  health	  district,	  Maine,	  2006-­‐2010.	  
Average	  Annual	  
Number	  
Crude	   Age-­‐Adjusted	  
Rate	   95%	  CI	   Rate	   95%	  CI	  
Maine	  total	   8,413	   633.7	   627.7	  -­‐	  639.8	   511.0	   506.0	  -­‐	  516.0	  
County	  
Androscoggin	   637	   590.0	   569.7	  -­‐	  610.9	   520.1	   502.0	  -­‐	  538.7	  
Aroostook	   496	   684.4	   657.7	  -­‐	  711.9	   491.6	   471.8	  -­‐	  511.9	  
Cumberland	   1,629	   581.9	   569.3	  -­‐	  594.7	   503.6	   492.5	  -­‐	  514.9	  
Franklin	   181	   591.8	   553.9	  -­‐	  631.6	   468.1	   437.4	  -­‐	  500.5	  
Hancock	   387	   713.3	   681.9	  -­‐	  745.8	   519.7	   496.1	  -­‐	  544.3	  
Kennebec	   769	   630.9	   611.1	  -­‐	  651.2	   512.4	   496.0	  -­‐	  529.2	  
Knox	   295	   734.9	   697.9	  -­‐	  773.4	   519.1	   492.0	  -­‐	  547.4	  
Lincoln	   245	   706.3	   667.3	  -­‐	  747.0	   464.9	   438.0	  -­‐	  493.3	  
Oxford	   402	   694.4	   664.3	  -­‐	  725.4	   535.4	   511.7	  -­‐	  559.9	  
Penobscot	   962	   628.9	   611.3	  -­‐	  646.9	   547.3	   531.7	  -­‐	  563.2	  
Piscataquis	   128	   731.5	   676.0	  -­‐	  790.3	   494.0	   455.1	  -­‐	  535.9	  
Sagadahoc	   209	   586.8	   551.8	  -­‐	  623.5	   478.1	   448.9	  -­‐	  508.9	  
Somerset	   318	   608.5	   578.9	  -­‐	  639.1	   478.9	   455.2	  -­‐	  503.5	  
Waldo	   255	   658.2	   622.6	  -­‐	  695.4	   518.7	   489.7	  -­‐	  549.0	  
Washington	   252	   761.3	   719.9	  -­‐	  804.5	   533.5	   503.6	  -­‐	  565.0	  
York	   1,244	   630.0	   614.4	  -­‐	  645.8	   516.1	   503.1	  -­‐	  529.3	  
Public	  health	  district	  
Aroostook	   496	   684.4	   657.7	  -­‐	  711.9	   491.6	   471.8	  -­‐	  511.9	  
Central	   1,087	   624.2	   607.7	  -­‐	  641.0	   501.9	   488.4	  -­‐	  515.7	  
Cumberland	   1,629	   581.9	   569.3	  -­‐	  594.7	   503.6	   492.5	  -­‐	  514.9	  
Downeast	   640	   731.5	   706.4	  -­‐	  757.3	   524.5	   505.9	  -­‐	  543.6	  
Midcoast	   1,004	   673.0	   654.5	  -­‐	  691.8	   495.1	   481.1	  -­‐	  509.5	  
Penquis	   1,090	   639.5	   622.6	  -­‐	  656.7	   539.8	   525.4	  -­‐	  554.6	  
Western	   1,220	   621.0	   605.6	  -­‐	  636.8	   516.2	   503.2	  -­‐	  529.5	  
York	   1,244	   630.0	   614.4	  -­‐	  645.8	   516.1	   503.1	  -­‐	  529.3	  
Maine	  Data	  Source:	  Maine	  CDC	  Cancer	  Registry,	  November	  2012	  NPCR	  data	  submission	  (1995-­‐2010).	  U.S.	  Data	  Source:	  SEER	  9	  
Research	  Data	  (1973-­‐2010).	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Incidence:	  The	  number	  of	  people	  who	  develop	  cancer	  (new	  cancer	  cases)	  during	  a	  specified	  period	  of	  time	  in	  a	  specified	  
population.	  	  	  
All	  cancer:	  SEER	  Site	  Recode:	  20010-­‐37000	  (which	  include	  ICD-­‐O-­‐3	  codes:	  C00-­‐C797).	  
Incidence	  case	  definitions	  exclude	  histologies	  consistent	  with	  Kaposi	  sarcoma	  and	  mesothelioma,	  where	  applicable.	  
Crude	  Rates	  are	  new	  cases	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  new	  cases	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
Page 186 Maine Cancer Surveillance Report 2014
Table	  2.5.	  Bladder	  cancer	  incidence	  by	  3-­‐year	  period,	  Maine,	  U.S.	  SEER	  9	  and	  U.S.	  SEER	  9	  whites,	  2000-­‐2010.	  





	  Crude	   Age-­‐adjusted	   Average	  
Annual	  
Number	  




Rate	   95%CI	   Rate	   95%	  CI	   Rate	   95%CI	   Rate	   95%CI	  
2000-­‐2002	   417	   32.4	   30.7	  -­‐	  34.3	   28.5	   27.0	  -­‐	  30.2	   5,494	   21.6	   21.3	  -­‐	  22.0	   4,991	   23.8	   23.4	  -­‐	  24.2	  
2001-­‐2003	   434	   33.5	   31.7	  -­‐	  35.4	   29.1	   27.6	  -­‐	  30.8	   5,551	   21.5	   21.2	  -­‐	  21.9	   5,038	   23.7	   23.4	  -­‐	  24.1	  
2002-­‐2004	   444	   34.0	   32.2	  -­‐	  35.9	   29.3	   27.7	  -­‐	  30.9	   5,613	   21.5	   21.1	  -­‐	  21.8	   5,071	   23.6	   23.2	  -­‐	  24.0	  
2003-­‐2005	   449	   34.2	   32.4	  -­‐	  36.1	   29.1	   27.5	  -­‐	  30.7	   5,766	   21.7	   21.4	  -­‐	  22.0	   5,186	   23.8	   23.5	  -­‐	  24.2	  
2004-­‐2006	   455	   34.5	   32.7	  -­‐	  36.4	   28.8	   27.3	  -­‐	  30.4	   5,841	   21.6	   21.3	  -­‐	  21.9	   5,231	   23.7	   23.4	  -­‐	  24.1	  
2005-­‐2007	   468	   35.4	   33.6	  -­‐	  37.3	   29.1	   27.6	  -­‐	  30.6	   5,991	   21.7	   21.4	  -­‐	  22.1	   5,351	   23.9	   23.5	  -­‐	  24.3	  
2006-­‐2008	   471	   35.5	   33.7	  -­‐	  37.4	   28.8	   27.3	  -­‐	  30.3	   6,039	   21.5	   21.2	  -­‐	  21.9	   5,380	   23.7	   23.3	  -­‐	  24.1	  
2007-­‐2009	   463	   34.9	   33.1	  -­‐	  36.7	   27.8	   26.3	  -­‐	  29.3	   6,118	   21.3	   21.0	  -­‐	  21.6	   5,421	   23.4	   23.1	  -­‐	  23.8	  
2008-­‐2010	   461	   34.7	   32.9	  -­‐	  36.5	   27.3	   25.9	  -­‐	  28.8	   6,173	   21.1	   20.8	  -­‐	  21.4	   5,458	   23.2	   22.8	  -­‐	  23.6	  
Maine	  Data	  Source:	  Maine	  CDC	  Cancer	  Registry,	  November	  2012	  NPCR	  data	  submission	  (1995-­‐2010).	  U.S.	  Data	  Source:	  SEER	  9	  Research	  Data	  (1973-­‐2010).	  
*The	  SEER	  9	  registries	  are	  Atlanta,	  Connecticut,	  Detroit,	  Hawaii,	  Iowa,	  New	  Mexico,	  San	  Francisco-­‐Oakland,	  Seattle-­‐Puget	  Sound,	  and	  Utah	  and	  represent	  9.4%
of	  U.S.	  population.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Incidence:	  The	  number	  of	  people	  who	  develop	  cancer	  (new	  cancer	  cases)	  during	  a	  specified	  period	  of	  time	  in	  a	  specified	  population.	  
Bladder	  cancer:	  SEER	  Site	  Recode:	  29010	  (which	  includes	  ICD-­‐O-­‐3	  codes:	  C670-­‐C679).	  
Incidence	  case	  definitions	  exclude	  histologies	  consistent	  with	  Kaposi	  sarcoma	  and	  mesothelioma,	  where	  applicable.	  
Crude	  Rates	  are	  new	  cases	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  new	  cases	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	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Table	  2.6.	  Bladder	  cancer	  incidence	  by	  3-­‐year	  period	  and	  sex,	  Maine,	  2000-­‐2010.	  




	  Crude	   Age-­‐adjusted	   Average	  
Annual	  
Number	  
Crude	   Age-­‐adjusted	   Average	  
Annual	  
Number	  
Crude	   Age-­‐adjusted	  
3-­‐Year	  Period	   Rate	   95%CI	   Rate	   95%	  CI	   Rate	   95%CI	   Rate	   95%CI	   Rate	   95%CI	   Rate	   95%CI	  
2000-­‐2002	   417	   32.4	   30.7	  -­‐	  34.3	   28.5	   27.0	  -­‐	  30.2	   115	   17.4	   15.6	  -­‐	  19.3	   13.8	   12.4	  -­‐	  15.4	   303	   48.3	   45.2	  -­‐	  51.6	   48.6	   45.5	  -­‐	  52.0	  
2001-­‐2003	   434	   33.5	   31.7	  -­‐	  35.4	   29.1	   27.6	  -­‐	  30.8	   108	   16.2	   14.5	  -­‐	  18.1	   12.6	   11.2	  -­‐	  14.1	   326	   51.6	   48.5	  -­‐	  55.0	   51.3	   48.1	  -­‐	  54.7	  
2002-­‐2004	   444	   34.0	   32.2	  -­‐	  35.9	   29.3	   27.7	  -­‐	  30.9	   113	   17.0	   15.2	  -­‐	  18.9	   13.1	   11.7	  -­‐	  14.6	   330	   51.8	   48.7	  -­‐	  55.2	   50.5	   47.4	  -­‐	  53.8	  
2003-­‐2005	   449	   34.2	   32.4	  -­‐	  36.1	   29.1	   27.5	  -­‐	  30.7	   119	   17.8	   16.0	  -­‐	  19.7	   13.6	   12.2	  -­‐	  15.1	   330	   51.4	   48.2	  -­‐	  54.7	   49.7	   46.6	  -­‐	  52.9	  
2004-­‐2006	   455	   34.5	   32.7	  -­‐	  36.4	   28.8	   27.3	  -­‐	  30.4	   125	   18.6	   16.8	  -­‐	  20.6	   14.1	   12.7	  -­‐	  15.6	   329	   51.1	   48.0	  -­‐	  54.4	   48.3	   45.3	  -­‐	  51.5	  
2005-­‐2007	   468	   35.4	   33.6	  -­‐	  37.3	   29.1	   27.6	  -­‐	  30.6	   130	   19.2	   17.3	  -­‐	  21.2	   14.3	   12.9	  -­‐	  15.8	   339	   52.3	   49.2	  -­‐	  55.7	   48.9	   45.9	  -­‐	  52.0	  
2006-­‐2008	   471	   35.5	   33.7	  -­‐	  37.4	   28.8	   27.3	  -­‐	  30.3	   122	   18.0	   16.2	  -­‐	  20.0	   13.3	   12.0	  -­‐	  14.8	   349	   53.7	   50.5	  -­‐	  57.1	   49.2	   46.2	  -­‐	  52.3	  
2007-­‐2009	   463	   34.9	   33.1	  -­‐	  36.7	   27.8	   26.3	  -­‐	  29.3	   119	   17.5	   15.7	  -­‐	  19.4	   12.8	   11.5	  -­‐	  14.3	   345	   53.0	   49.8	  -­‐	  56.3	   47.4	   44.5	  -­‐	  50.4	  
2008-­‐2010	   461	   34.7	   32.9	  -­‐	  36.5	   27.3	   25.9	  -­‐	  28.8	   116	   17.1	   15.4	  -­‐	  19.0	   12.5	   11.2	  -­‐	  13.9	   344	   52.9	   49.8	  -­‐	  56.3	   46.4	   43.6	  -­‐	  49.4	  
U.S.	  SEER	  9	  	  	  	  	  	  	  	  	  
2008-­‐2010*	  	   6,173	   21.5	   21.2	  -­‐	  21.8	   21.1	   20.8	  -­‐	  21.4	   1,500	   10.3	   10.0	  -­‐	  10.6	   9.1	   8.8	  -­‐	  9.3	   4,673	   33.0	   32.5	  -­‐	  33.5	   37.2	   36.6	  -­‐	  37.8	  
U.S.	  SEER	  9	  Whites	  
2008-­‐2010*	  
5,458	   25.6	   25.2	  –	  26.0	   23.2	   22.8	  -­‐	  23.6	   1,289	   12.0	   11.7	  -­‐	  12.4	   9.8	   9.5	  -­‐	  10.1	   4,169	   39.4	   38.7	  -­‐	  40.1	   40.7	   40.0	  -­‐	  41.4	  
Maine	  Data	  Source:	  Maine	  CDC	  Cancer	  Registry,	  November	  2012	  NPCR	  data	  submission	  (1995-­‐2010).	  U.S.	  Data	  Source:	  SEER	  9	  Research	  Data	  (1973-­‐2010).	  
*The	  SEER	  9	  registries	  are	  Atlanta,	  Connecticut,	  Detroit,	  Hawaii,	  Iowa,	  New	  Mexico,	  San	  Francisco-­‐Oakland,	  Seattle-­‐Puget	  Sound,	  and	  Utah	  and	  represent	  9.4%	  of	  U.S.	  population.
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Incidence:	  The	  number	  of	  people	  who	  develop	  cancer	  (new	  cancer	  cases)	  during	  a	  specified	  period	  of	  time	  in	  a	  specified	  population.	  
Bladder	  cancer:	  SEER	  Site	  Recode:	  29010	  (which	  includes	  ICD-­‐O-­‐3	  codes:	  C670-­‐C679).	  
Incidence	  case	  definitions	  exclude	  histologies	  consistent	  with	  Kaposi	  sarcoma	  and	  mesothelioma,	  where	  applicable.	  
Crude	  Rates	  are	  new	  cases	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  new	  cases	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	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Table 2.7. Bladder cancer incidence by 3-year period and age group, Maine, 2000-2010. 
3-Year Period 
 Ages 0─34 years Ages 35─64 years  Ages 65─74 years  Ages 75 years and older 
 Crude Crude Crude Crude 
Average 
Annual 
Number Rate 95% CI 
Average 
Annual 
Number Rate 95% CI 
Average 
Annual 
Number Rate 95% CI 
Average 
Annual 
Number Rate 95% CI 
2000-2002             3  0.5 0.2 - 1.0 121 22.5 20.2 - 24.9 123 127.8 115.1 - 141.6            170  191.1 174.8 - 208.4 
2001-2003             2  0.4 0.2 - 0.9 116 21.2 19.0 - 23.5 131 135.9 122.8 - 150.0            184  204.2 187.5 - 221.9 
2002-2004             1  0.2 0.1 - 0.6 120 21.4 19.3 - 23.8 132 136.5 123.4 - 150.6            191  208.3 191.6 - 226.1 
2003-2005             1  0.2 0.0 - 0.5 124 22.0 19.8 - 24.3 130 133.7 120.8 - 147.7            194  209.2 192.5 - 226.9 
2004-2006             2  0.3 0.1 - 0.7 132 23.1 20.9 - 25.5 128 130.5 117.7 - 144.2            193  205.5 189.1 - 223.0 
2005-2007             2  0.4 0.1 - 0.8 136 23.5 21.2 - 25.9 132 132.9 120.1 - 146.6            198  208.7 192.3 - 226.2 
2006-2008             2  0.4 0.2 - 0.9 131 22.5 20.3 - 24.8 139 136.2 123.4 - 149.9            199  206.3 190.1 - 223.6 
2007-2009             1  0.2 0.1 - 0.6 131 22.4 20.2 - 24.7 145 137.3 124.7 - 150.8            186  191.5 175.9 - 208.0 
2008-2010             2  0.3 0.1 - 0.7 132 22.7 20.5 - 25.1 141 128.4 116.5 - 141.3            186  189.7 174.2 - 206.1 
U.S. SEER 9         
2008-2010* 30 0.2 0.2 - 0.3 1,673 14.5 14.1 - 14.9 1,681 91.6 89.1 - 94.1 2,789 167.9 164.3 - 171.5 
U.S. SEER 9 Whites  
2008-2010* 26 0.3 0.2 - 0.3 1,437 16.5 16.0 - 17.0 1,488 101.5 98.6 - 104.6 2,507 182.5 178.4 - 186.7 
Maine Data Source: Maine CDC Cancer Registry, November 2012 NPCR data submission (1995-2010). U.S. Data Source: SEER 9 Research Data (1973-2010). 
*The SEER 9 registries are Atlanta, Connecticut, Detroit, Hawaii, Iowa, New Mexico, San Francisco-Oakland, Seattle-Puget Sound, and Utah and represent 
9.4% of U.S. population. 
95% CI: 95% confidence interval of the rate. 
Cancer Incidence: The number of people who develop cancer (new cancer cases) during a specified period of time in a specified population.   
Bladder cancer: SEER Site Recode: 29010 (which includes ICD-O-3 codes: C670-C679). 
Incidence case definitions exclude histologies consistent with Kaposi sarcoma and mesothelioma, where applicable. 
Crude Rates are new cases per 100,000 population. 
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Crude	   Age-­‐Adjusted	  
Rate	   	  	  	  	  	  95%	  CI	   Rate	   	  	  	  95%	  CI	  
Maine	  total	   471	   35.5	  	   34.0	  -­‐	  36.9	  	   28.3	  	   27.1	  -­‐	  29.5	  	  
	   	   	   	   	   	  County	   	   	   	   	   	  
Androscoggin	   40	   36.7	  	   31.8	  -­‐	  42.2	  	   31.9	  	   27.6	  -­‐	  36.7	  	  
Aroostook	   27	   37.3	  	   31.3	  -­‐	  44.1	  	   25.8	  	   21.6	  -­‐	  30.7	  	  
Cumberland	   90	   32.3	  	   29.4	  -­‐	  35.4	  	   28.1	  	   25.5	  -­‐	  30.9	  	  
Franklin	   13	   41.8	  	   32.2	  -­‐	  53.3	  	   33.2	  	   25.5	  -­‐	  42.8	  	  
Hancock	   21	   39.0	  	   32.0	  -­‐	  47.2	  	   28.3	  	   23.0	  -­‐	  34.4	  	  
Kennebec	   39	   31.7	  	   27.4	  -­‐	  36.5	  	   25.6	  	   22.0	  -­‐	  29.5	  	  
Knox	   16	   40.4	  	   32.1	  -­‐	  50.2	  	   28.2	  	   22.3	  -­‐	  35.3	  	  
Lincoln	   17	   47.8	  	   38.1	  -­‐	  59.3	  	   30.2	  	   24.0	  -­‐	  37.9	  	  
Oxford	   23	   39.1	  	   32.2	  -­‐	  47.0	  	   29.0	  	   23.8	  -­‐	  35.0	  	  
Penobscot	   50	   32.7	  	   28.8	  -­‐	  37.0	  	   28.3	  	   24.9	  -­‐	  32.1	  	  
Piscataquis	   5	   29.6	  	   19.4	  -­‐	  43.4	  	   20.0	  	   13.0	  -­‐	  30.2	  	  
Sagadahoc	   11	   31.4	  	   23.7	  -­‐	  40.8	  	   26.3	  	   19.7	  -­‐	  34.4	  	  
Somerset	   20	   38.7	  	   31.5	  -­‐	  47.0	  	   30.9	  	   25.1	  -­‐	  37.7	  	  
Waldo	   10	   26.3	  	   19.6	  -­‐	  34.6	  	   20.0	  	   14.8	  -­‐	  26.7	  	  
Washington	   13	   39.8	  	   30.8	  -­‐	  50.7	  	   25.9	  	   20.0	  -­‐	  33.4	  	  
York	   76	   38.3	  	   34.5	  -­‐	  42.4	  	   31.4	  	   28.3	  -­‐	  34.8	  	  
Public	  health	  district	   	   	   	   	   	  
Aroostook	   27	   37.3	  	   31.3	  -­‐	  44.1	  	   25.8	  	   21.6	  -­‐	  30.7	  	  
Central	   59	   33.8	  	   30.0	  -­‐	  37.8	  	   27.2	  	   24.2	  -­‐	  30.6	  	  
Cumberland	   90	   32.3	  	   29.4	  -­‐	  35.4	  	   28.1	  	   25.5	  -­‐	  30.9	  	  
Downeast	   34	   39.3	  	   33.7	  -­‐	  45.7	  	   27.2	  	   23.3	  -­‐	  31.8	  	  
Midcoast	   54	   36.3	  	   32.1	  -­‐	  40.9	  	   26.3	  	   23.2	  -­‐	  29.7	  	  
Penquis	   55	   32.4	  	   28.7	  -­‐	  36.4	  	   27.3	  	   24.1	  -­‐	  30.8	  	  
Western	   75	   38.2	  	   34.4	  -­‐	  42.3	  	   31.2	  	   28.1	  -­‐	  34.6	  	  
York	   76	   38.3	  	   34.5	  -­‐	  42.4	  	   31.4	  	   28.3	  -­‐	  34.8	  	  
Maine	  Data	  Source:	  Maine	  CDC	  Cancer	  Registry,	  November	  2012	  NPCR	  data	  submission	  (1995-­‐2010).	  U.S.	  Data	  Source:	  SEER	  9	  
Research	  Data	  (1973-­‐2010).	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Incidence:	  The	  number	  of	  people	  who	  develop	  cancer	  (new	  cancer	  cases)	  during	  a	  specified	  period	  of	  time	  in	  a	  specified	  
population.	  	  	  
Bladder	  cancer:	  SEER	  Site	  Recode:	  29010	  (which	  includes	  ICD-­‐O-­‐3	  codes:	  C670-­‐C679).	  
Incidence	  case	  definitions	  exclude	  histologies	  consistent	  with	  Kaposi	  sarcoma	  and	  mesothelioma,	  where	  applicable.	  
Crude	  Rates	  are	  new	  cases	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  new	  cases	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	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Table	  2.9.	  Female	  breast	  cancer	  incidence	  by	  3-­‐year	  period,	  Maine,	  U.S.	  SEER	  9	  and	  U.S.	  SEER	  9	  whites,	  2000-­‐2010.	  





	  Crude	   Age-­‐adjusted	   Average	  
Annual	  
Number	  




Rate	   95%CI	   Rate	   95%	  CI	   Rate	   95%CI	   Rate	   95%CI	  
2000-­‐2002	   1,074	   162.8	   157.2	  -­‐	  168.5	   137.2	   132.4	  -­‐	  142.0	   19,306	   136.9	   135.8	  –	  138.0	   16,185	   142.9	   141.7	  -­‐	  144.2	  
2001-­‐2003	   1,071	   161.2	   155.7	  -­‐	  166.9	   134.4	   129.8	  -­‐	  139.2	   19,140	   133.6	   132.6	  -­‐	  134.7	   15,926	   139.2	   137.9	  -­‐	  140.5	  
2002-­‐2004	   1,047	   156.7	   151.3	  -­‐	  162.3	   129.0	   124.5	  -­‐	  133.6	   18,925	   130.1	   129.0	  -­‐	  131.2	   15,608	   134.9	   133.7	  -­‐	  136.2	  
2003-­‐2005	   1,069	   159.2	   153.8	  -­‐	  164.8	   129.8	   125.3	  -­‐	  134.5	   18,784	   127.1	   126.1	  -­‐	  128.2	   15,404	   131.7	   130.5	  –	  133.0	  
2004-­‐2006	   1,084	   160.8	   155.3	  -­‐	  166.4	   129.6	   125.1	  -­‐	  134.2	   19,065	   126.8	   125.8	  -­‐	  127.9	   15,528	   131.1	   129.9	  -­‐	  132.3	  
2005-­‐2007	   1,109	   164.1	   158.6	  -­‐	  169.8	   130.6	   126.2	  -­‐	  135.2	   19,392	   126.8	   125.7	  -­‐	  127.8	   15,725	   131.1	   129.9	  -­‐	  132.3	  
2006-­‐2008	   1,114	   164.3	   158.8	  -­‐	  170.0	   128.5	   124.1	  -­‐	  133.0	   19,802	   127.3	   126.2	  -­‐	  128.3	   15,920	   131.1	   129.9	  -­‐	  132.3	  
2007-­‐2009	   1,108	   163.3	   157.8	  -­‐	  168.9	   126.4	   122.1	  -­‐	  130.9	   20,376	   128.7	   127.7	  -­‐	  129.8	   16,285	   132.2	   131.0	  -­‐	  133.4	  
2008-­‐2010	   1,105	   162.8	   157.3	  -­‐	  168.4	   124.5	   120.2	  -­‐	  128.9	   20,634	   128.0	   127.0	  -­‐	  129.1	   16,408	   131.4	   130.2	  -­‐	  132.6	  
Maine	  Data	  Source:	  Maine	  CDC	  Cancer	  Registry,	  November	  2012	  NPCR	  data	  submission	  (1995-­‐2010).	  U.S.	  Data	  Source:	  SEER	  9	  Research	  Data	  (1973-­‐2010).	  	  
*The	  SEER	  9	  registries	  are	  Atlanta,	  Connecticut,	  Detroit,	  Hawaii,	  Iowa,	  New	  Mexico,	  San	  Francisco-­‐Oakland,	  Seattle-­‐Puget	  Sound,	  and	  Utah	  and	  represent	  
9.4%	  of	  U.S.	  population.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Incidence:	  The	  number	  of	  people	  who	  develop	  cancer	  (new	  cancer	  cases)	  during	  a	  specified	  period	  of	  time	  in	  a	  specified	  population.	  	  	  
Breast	  cancer:	  SEER	  Site	  Recode:	  26000	  (which	  includes	  ICD-­‐O-­‐3	  codes:	  C500-­‐C509).	  
Incidence	  case	  definitions	  exclude	  histologies	  consistent	  with	  Kaposi	  sarcoma	  and	  mesothelioma,	  where	  applicable.	  
Crude	  Rates	  are	  new	  cases	  per	  100,000	  population.	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Table 2.10. Female breast cancer incidence by 3-year period and age group, Maine, 2000-2010. 
  Ages 0─34 years Ages 35─64 years  Ages 65─74 years  Ages 75 years and older 




Number Rate 95%CI 
Average 
Annual 
Number Rate 95%CI 
Average 
Annual 
Number Rate 95%CI 
Average 
Annual 
Number Rate 95%CI 
2000-2002           14  5.2 3.7 - 7.0            562  204.9 195.2 - 214.9 234 453.0 420.1 - 487.7            263  468.1 436.0 - 502.0 
2001-2003           14  5.2 3.8 - 7.0            569  203.6 194.0 - 213.5 222 430.9 398.8 - 464.9            266  468.2 436.2 - 501.8 
2002-2004           16  5.9 4.4 - 7.8            561  197.7 188.3 - 207.3 211 409.2 377.9 - 442.3            259  453.0 421.8 - 486.0 
2003-2005           14  5.0 3.6 - 6.8            574  199.7 190.4 - 209.4 220 424.9 393.0 - 458.6            262  454.1 422.9 - 487.0 
2004-2006           14  5.1 3.7 - 6.9            583  200.3 191.0 - 209.9 235 452.5 419.8 - 487.2            252  433.6 403.2 - 465.6 
2005-2007           15  5.7 4.1 - 7.6            592  201.3 192.1 - 210.9 248 471.6 438.3 - 506.7            254  433.4 403.2 - 465.3 
2006-2008           17  6.2 4.6 - 8.2            601  203.1 193.8 - 212.7 239 443.6 411.8 - 477.3            257  434.6 404.4 - 466.3 
2007-2009           16  6.0 4.4 - 7.9            600  202.2 192.9 - 211.7 236 424.3 393.6 - 456.7            256  431.2 401.2 - 462.8 
2008-2010           15  5.7 4.1 - 7.6            592  199.6 190.4 - 209.1 250 434.1 403.6 - 466.3            248  415.7 386.4 - 446.7 
U.S. SEER 9          
2008-2010* 367 5.4 5.1 - 5.8 11,779 200.8 198.7 - 202.9 4,268 434.8 427.3 - 442.4    4,221 416.0 408.8 - 423.3 
U.S. SEER 9 Whites  
2008-2010* 248 5.2 4.8 - 5.6 9,053 208.2 205.8 - 210.7 3,495 451.2 442.7 - 460.0    3,613 432.8 424.7 - 441.0 
Maine Data Source: Maine CDC Cancer Registry, November 2012 NPCR data submission (1995-2010). U.S. Data Source: SEER 9 Research Data (1973-2010). 
*The SEER 9 registries are Atlanta, Connecticut, Detroit, Hawaii, Iowa, New Mexico, San Francisco-Oakland, Seattle-Puget Sound, and Utah and represent 
9.4% of U.S. population. 
95% CI: 95% confidence interval of the rate. 
Cancer Incidence: The number of people who develop cancer (new cancer cases) during a specified period of time in a specified population.   
Female breast cancer: SEER Site Recode: 26000 (which includes ICD-O-3 codes: C500-C509). 
Incidence case definitions exclude histologies consistent with Kaposi sarcoma and mesothelioma, where applicable. 
Crude Rates are new cases per 100,000 population. 
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Crude	   Age-­‐Adjusted	  
Rate	   95%	  CI	   Rate	   95%	  CI	  
Maine	  total	   1,108	   163.4	  	   159.1	  -­‐	  167.7	  	   126.4	  	   123.0	  -­‐	  129.8	  	  
	   	   	   	   	   	  County	   	   	   	   	   	  
Androscoggin	   74	   133.7	  	   120.4	  -­‐	  148.0	  	   111.7	  	   100.4	  -­‐	  124.0	  	  
Aroostook	   54	   147.9	  	   130.9	  -­‐	  166.6	  	   105.7	  	   92.9	  -­‐	  119.8	  	  
Cumberland	   235	   163.3	  	   154.1	  -­‐	  172.9	  	   132.3	  	   124.7	  -­‐	  140.3	  	  
Franklin	   24	   155.9	  	   129.4	  -­‐	  186.1	  	   118.8	  	   98.2	  -­‐	  142.9	  	  
Hancock	   53	   192.8	  	   170.4	  -­‐	  217.4	  	   134.3	  	   118.1	  -­‐	  152.3	  	  
Kennebec	   110	   176.1	  	   161.7	  -­‐	  191.5	  	   137.1	  	   125.7	  -­‐	  149.4	  	  
Knox	   37	   183.2	  	   157.8	  -­‐	  211.5	  	   129.3	  	   110.5	  -­‐	  150.8	  	  
Lincoln	   33	   184.1	  	   156.9	  -­‐	  214.6	  	   117.5	  	   99.3	  -­‐	  138.6	  	  
Oxford	   49	   169.0	  	   148.6	  -­‐	  191.5	  	   127.4	  	   111.6	  -­‐	  145.0	  	  
Penobscot	   118	   152.3	  	   140.2	  -­‐	  165.1	  	   126.6	  	   116.4	  -­‐	  137.5	  	  
Piscataquis	   18	   204.7	  	   164.8	  -­‐	  251.3	  	   134.4	  	   107.1	  -­‐	  167.5	  	  
Sagadahoc	   28	   150.4	  	   126.4	  -­‐	  177.7	  	   121.8	  	   101.8	  -­‐	  144.8	  	  
Somerset	   39	   148.4	  	   128.3	  -­‐	  170.7	  	   111.9	  	   96.6	  -­‐	  129.2	  	  
Waldo	   35	   176.1	  	   150.9	  -­‐	  204.3	  	   135.6	  	   115.5	  -­‐	  158.5	  	  
Washington	   27	   162.7	  	   136.6	  -­‐	  192.4	  	   115.6	  	   96.3	  -­‐	  138.1	  	  
York	   172	   170.0	  	   158.9	  -­‐	  181.8	  	   132.1	  	   123.2	  -­‐	  141.5	  	  
Public	  health	  district	   	   	   	   	   	  
Aroostook	   54	   147.9	  	   130.9	  -­‐	  166.6	  	   105.7	  	   92.9	  -­‐	  119.8	  	  
Central	   149	   167.9	  	   156.1	  -­‐	  180.4	  	   129.6	  	   120.2	  -­‐	  139.4	  	  
Cumberland	   235	   163.3	  	   154.1	  -­‐	  172.9	  	   132.3	  	   124.7	  -­‐	  140.3	  	  
Downeast	   81	   181.4	  	   164.2	  -­‐	  200.0	  	   127.4	  	   114.8	  -­‐	  141.1	  	  
Midcoast	   132	   173.7	  	   160.7	  -­‐	  187.4	  	   126.2	  	   116.4	  -­‐	  136.6	  	  
Penquis	   136	   157.7	  	   146.1	  -­‐	  170.0	  	   127.7	  	   118.1	  -­‐	  137.9	  	  
Western	   147	   147.5	  	   137.0	  -­‐	  158.5	  	   117.5	  	   109.0	  -­‐	  126.5	  	  
York	   172	   170.0	  	   158.9	  -­‐	  181.8	  	   132.1	  	   123.2	  -­‐	  141.5	  	  
Maine	  Data	  Source:	  Maine	  CDC	  Cancer	  Registry,	  November	  2012	  NPCR	  data	  submission	  (1995-­‐2010).	  U.S.	  Data	  Source:	  SEER	  9	  
Research	  Data	  (1973-­‐2010).	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Incidence:	  The	  number	  of	  people	  who	  develop	  cancer	  (new	  cancer	  cases)	  during	  a	  specified	  period	  of	  time	  in	  a	  specified	  
population.	  	  	  
Female	  breast	  cancer:	  SEER	  Site	  Recode:	  26000	  (which	  includes	  ICD-­‐O-­‐3	  codes:	  C500-­‐C509).	  
Incidence	  case	  definitions	  exclude	  histologies	  consistent	  with	  Kaposi	  sarcoma	  and	  mesothelioma,	  where	  applicable.	  
Crude	  Rates	  are	  new	  cases	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  new	  cases	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	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Table	  2.12.	  Cervical	  cancer	  incidence	  by	  3-­‐year	  period,	  Maine,	  U.S.	  SEER	  9	  and	  U.S.	  SEER	  9	  whites,	  2000-­‐2010.	  





	  Crude	   Age-­‐adjusted	   Average	  
Annual	  
Number	  




Rate	   95%CI	   Rate	   95%	  CI	   Rate	   95%CI	   Rate	   95%CI	  
2000-­‐2002	   53	   8.1	   6.9	  -­‐	  9.4	   7.4	   6.3	  -­‐	  8.7	   1,078	   7.7	   7.4	  -­‐	  8.0	   789	   7.3	   7.0	  -­‐	  7.6	  
2001-­‐2003	   57	   8.5	   7.3	  -­‐	  9.9	   7.8	   6.7	  -­‐	  9.1	   1,066	   7.6	   7.3	  -­‐	  7.8	   768	   7.1	   6.8	  -­‐	  7.4	  
2002-­‐2004	   58	   8.6	   7.4	  -­‐	  10	   8.0	   6.8	  -­‐	  9.3	   1,037	   7.3	   7.0	  -­‐	  7.6	   749	   6.9	   6.6	  -­‐	  7.2	  
2003-­‐2005	   57	   8.4	   7.2	  -­‐	  9.8	   7.9	   6.8	  -­‐	  9.2	   1,015	   7.1	   6.9	  -­‐	  7.4	   734	   6.8	   6.5	  -­‐	  7.1	  
2004-­‐2006	   54	   8.0	   6.8	  -­‐	  9.3	   7.5	   6.4	  -­‐	  8.8	   1,005	   7.0	   6.7	  -­‐	  7.2	   736	   6.8	   6.5	  -­‐	  7.1	  
2005-­‐2007	   50	   7.4	   6.3	  -­‐	  8.7	   7.1	   5.9	  -­‐	  8.3	   988	   6.8	   6.6	  -­‐	  7.1	   723	   6.7	   6.4	  -­‐	  7.0	  
2006-­‐2008	   50	   7.4	   6.2	  -­‐	  8.7	   6.8	   5.7	  -­‐	  8.0	   992	   6.8	   6.5	  -­‐	  7.0	   721	   6.6	   6.3	  -­‐	  6.9	  
2007-­‐2009	   50	   7.4	   6.2	  -­‐	  8.6	   6.7	   5.7	  -­‐	  8.0	   999	   6.7	   6.5	  -­‐	  7.0	   722	   6.6	   6.3	  -­‐	  6.9	  
2008-­‐2010	   47	   7.0	   5.9	  -­‐	  8.2	   6.4	   5.3	  -­‐	  7.5	   1,015	   6.8	   6.5	  -­‐	  7.0	   730	   6.6	   6.3	  -­‐	  6.9	  
Maine	  Data	  Source:	  Maine	  CDC	  Cancer	  Registry,	  November	  2012	  NPCR	  data	  submission	  (1995-­‐2010).	  U.S.	  Data	  Source:	  SEER	  9	  Research	  Data	  (1973-­‐2010).	  	  
*The	  SEER	  9	  registries	  are	  Atlanta,	  Connecticut,	  Detroit,	  Hawaii,	  Iowa,	  New	  Mexico,	  San	  Francisco-­‐Oakland,	  Seattle-­‐Puget	  Sound,	  and	  Utah	  and	  represent	  9.4%	  
of	  U.S.	  population.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Incidence:	  The	  number	  of	  people	  who	  develop	  cancer	  (new	  cancer	  cases)	  during	  a	  specified	  period	  of	  time	  in	  a	  specified	  population.	  	  	  
Cervical	  cancer:	  SEER	  Site	  Recode	  27010:	  	  (which	  includes	  ICD-­‐O-­‐3	  codes:	  C530-­‐C539).	  
Incidence	  case	  definitions	  exclude	  histologies	  consistent	  with	  Kaposi	  sarcoma	  and	  mesothelioma,	  where	  applicable.	  
Crude	  Rates	  are	  new	  cases	  per	  100,000	  population.	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Table 2.13. Cervical cancer incidence by 3-year period and age group, Maine, 2000-2010. 
  Ages 0─34 years Ages 35─64 years  Ages 65─74 years  Ages 75 years and older 




Number Rate 95%CI 
Average 
Annual 
Number Rate 95%CI 
Average 
Annual 
Number Rate 95%CI 
Average 
Annual 
Number Rate 95%CI 
2000-2002             6  2.3 1.4 - 3.6           35  12.8 10.4 - 15.4 6 12.2 7.4 - 19.1             6  10.1 5.9 - 16.1 
2001-2003             7  2.5 1.6 - 3.9           37  13.2 10.9 - 16.0 6 11.6 6.9 - 18.4             7  11.7 7.2 - 18.1 
2002-2004             8  3.0 2.0 - 4.5           36  12.6 10.3 - 15.2 8 14.9 9.4 - 22.3             6  10.5 6.2 - 16.6 
2003-2005             8  3.0 2.0 - 4.5           34  11.7 9.5 - 14.2 8 14.8 9.4 - 22.2             7  12.1 7.5 - 18.6 
2004-2006             8  2.8 1.8 - 4.2           33  11.3 9.2 - 13.8 8 15.4 9.9 - 22.9             5  9.2 5.2 - 14.9 
2005-2007             7  2.7 1.7 - 4.1           32  10.9 8.8 - 13.3 7 13.9 8.7 - 21.1             4  6.2 3.1 - 11.2 
2006-2008             7  2.6 1.6 - 4.0           32  10.8 8.8 - 13.2 6 11.8 7.1 - 18.4             5  7.9 4.3 - 13.2 
2007-2009             7  2.7 1.7 - 4.2           30  10.2 8.2 - 12.6 7 12.0 7.3 - 18.5             6  9.5 5.6 - 15.3 
2008-2010             7  2.6 1.6 - 4.0           28    9.4 7.5 - 11.7 7 11.6 7.1 - 17.9             6  9.5 5.5 - 15.2 
U.S. SEER 9         
2008-2010* 153 2.3 2.1 - 2.5 666 11.4 10.9 - 11.9 111 11.3 10.1 - 12.6 85 8.4 7.4 - 9.5 
U.S. SEER 9 Whites  
2008-2010* 119 2.5 2.3 - 2.8 475 10.9 10.4 - 11.5 77 9.9 8.7 - 11.3 59 7.1 6.1 - 8.2 
Maine Data Source: Maine CDC Cancer Registry, November 2012 NPCR data submission (1995-2010). U.S. Data Source: SEER 9 Research Data (1973-2010). 
95% CI: 95% confidence interval of the rate. 
*The SEER 9 registries are Atlanta, Connecticut, Detroit, Hawaii, Iowa, New Mexico, San Francisco-Oakland, Seattle-Puget Sound, and Utah and represent 
9.4% of U.S. population. 
Cancer Incidence: The number of people who develop cancer (new cancer cases) during a specified period of time in a specified population.   
Cervical cancer: SEER Site Recode: 27010 (which includes ICD-O-3 codes: C530-C539). 
Incidence case definitions exclude histologies consistent with Kaposi sarcoma and mesothelioma, where applicable. 
Crude Rates are new cases per 100,000 population. 




Page 195 Maine Cancer Surveillance Report 2014
  




Crude	   Age-­‐Adjusted	  
Rate	   	  	  	  	  	  	  	  	  	  	  95%	  CI	   Rate	   	  	  	  	  	  	  	  	  	  	  95%	  CI	  
Maine	  total	   49	   7.3	   6.4	  -­‐	  8.2	   6.6	   5.8	  -­‐	  7.6	  
	   	   	   	   	   	  County	   	   	   	   	   	  
Androscoggin	   4	   8.0	   5.0	  -­‐	  12.1	   7.6	   4.7	  -­‐	  11.5	  
Aroostook	   3	   8.2	   4.6	  -­‐	  13.5	   7.1	   3.8	  -­‐	  12.2	  
Cumberland	   10	   7.1	   5.3	  -­‐	  9.3	   6.7	   4.9	  -­‐	  8.8	  
Franklin	   2	   11.5	   5.3	  -­‐	  21.8	   9.6	   4.1	  -­‐	  19.1	  
Hancock	   2	   7.2	   3.5	  -­‐	  13.3	   5.9	   2.7	  -­‐	  11.5	  
Kennebec	   6	   9.9	   6.7	  -­‐	  14.1	   9.2	   6.2	  -­‐	  13.3	  
Knox	   DSP	   DSP	   DSP	   DSP	   DSP	  
Lincoln	   1	   6.8	   2.5	  -­‐	  14.7	   5.9	   1.8	  -­‐	  14.0	  
Oxford	   DSP	   DSP	   DSP	   DSP	   DSP	  
Penobscot	   4	   4.9	   2.9	  -­‐	  7.6	   4.6	   2.7	  -­‐	  7.3	  
Piscataquis	   DSP	   DSP	   DSP	   DSP	   DSP	  
Sagadahoc	   1	   6.5	   2.4	  -­‐	  14.2	   6.2	   2.2	  -­‐	  13.9	  
Somerset	   3	   11.4	   6.4	  -­‐	  18.7	   10.1	   5.5	  -­‐	  17.1	  
Waldo	   3	   14.2	   7.7	  -­‐	  23.8	   12.5	   6.5	  -­‐	  21.7	  
Washington	   1	   8.3	   3.3	  -­‐	  17.1	   8.2	   3.1	  -­‐	  17.6	  
York	   6	   5.9	   4.0	  -­‐	  8.5	   5.5	   3.7	  -­‐	  8.0	  
Public	  health	  district	   	   	   	   	   	  
Aroostook	   3	   8.2	   4.6	  -­‐	  13.5	   7.1	   3.8	  -­‐	  12.2	  
Central	   9	   10.3	   7.6	  -­‐	  13.8	   9.4	   6.8	  -­‐	  12.7	  
Cumberland	   10	   7.1	   5.3	  -­‐	  9.3	   6.7	   4.9	  -­‐	  8.8	  
Downeast	   3	   7.6	   4.4	  -­‐	  12.2	   6.8	   3.8	  -­‐	  11.2	  
Midcoast	   6	   8.1	   5.5	  -­‐	  11.6	   7.3	   4.8	  -­‐	  10.6	  
Penquis	   4	   4.6	   2.8	  -­‐	  7.1	   4.3	   2.6	  -­‐	  6.7	  
Western	   7	   7.2	   5.0	  -­‐	  10.0	   6.6	   4.6	  -­‐	  9.2	  
York	   6	   5.9	   4.0	  -­‐	  8.5	   5.5	   3.7	  -­‐	  8.0	  
Maine	  Data	  Source:	  Maine	  CDC	  Cancer	  Registry,	  November	  2012	  NPCR	  data	  submission	  (1995-­‐2010).	  U.S.	  Data	  Source:	  SEER	  9	  
Research	  Data	  (1973-­‐2010).	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
DSP:	  Data	  suppressed	  to	  protect	  privacy	  where	  count	  <6	  for	  5-­‐year	  period.	  
Cancer	  Incidence:	  The	  number	  of	  people	  who	  develop	  cancer	  (new	  cancer	  cases)	  during	  a	  specified	  period	  of	  time	  in	  a	  specified	  
population.	  	  	  
Cervical	  cancer:	  SEER	  Site	  Recode:	  27010	  (which	  includes	  ICD-­‐O-­‐3	  codes:	  C530-­‐C539).	  
Incidence	  case	  definitions	  exclude	  histologies	  consistent	  with	  Kaposi	  sarcoma	  and	  mesothelioma,	  where	  applicable.	  
Crude	  Rates	  are	  new	  cases	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  new	  cases	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	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Table	  2.15.	  	  Colorectal	  cancer	  incidence	  by	  3-­‐year	  period,	  Maine,	  U.S.	  SEER	  9	  and	  U.S.	  SEER	  9	  whites,	  2000-­‐2010.	  





	  Crude	   Age-­‐adjusted	   Average	  
Annual	  
Number	  




Rate	   95%CI	   Rate	   95%	  CI	   Rate	   95%CI	   Rate	   95%CI	  
2000-­‐2002	   873	   67.9	   65.3	  -­‐	  70.5	   59.5	   57.2	  -­‐	  61.8	   13,691	   53.6	   53.1	  -­‐	  54.1	   11,170	   53.0	   52.4	  -­‐	  53.6	  
2001-­‐2003	   872	   67.3	   64.7	  -­‐	  69.9	   58.5	   56.3	  -­‐	  60.8	   13,624	   52.5	   52.0	  -­‐	  53.0	   11,049	   51.8	   51.2	  -­‐	  52.3	  
2002-­‐2004	   897	   68.7	   66.2	  -­‐	  71.4	   59.2	   56.9	  -­‐	  61.4	   13,530	   51.2	   50.7	  -­‐	  51.8	   10,909	   50.5	   49.9	  -­‐	  51.0	  
2003-­‐2005	   870	   66.3	   63.7	  -­‐	  68.9	   56.5	   54.3	  -­‐	  58.7	   13,299	   49.5	   49.0	  -­‐	  50.0	   10,703	   48.9	   48.4	  -­‐	  49.4	  
2004-­‐2006	   854	   64.8	   62.3	  -­‐	  67.3	   54.4	   52.3	  -­‐	  56.6	   13,177	   48.1	   47.7	  -­‐	  48.6	   10,539	   47.5	   47.0	  -­‐	  48.0	  
2005-­‐2007	   830	   62.8	   60.3	  -­‐	  65.3	   52.0	   49.9	  -­‐	  54.1	   13,118	   46.9	   46.5	  -­‐	  47.4	   10,431	   46.3	   45.7	  -­‐	  46.8	  
2006-­‐2008	   792	   59.7	   57.3	  -­‐	  62.1	   48.5	   46.6	  -­‐	  50.5	   13,128	   46.0	   45.6	  -­‐	  46.5	   10,367	   45.3	   44.8	  -­‐	  45.8	  
2007-­‐2009	   775	   58.3	   55.9	  -­‐	  60.7	   46.7	   44.8	  -­‐	  48.7	   13,063	   44.8	   44.3	  -­‐	  45.2	   10,217	   43.8	   43.3	  -­‐	  44.3	  
2008-­‐2010	   724	   54.5	   52.2	  -­‐	  56.8	   43.1	   41.3	  -­‐	  45.0	   12,791	   42.9	   42.4	  -­‐	  43.3	   9,903	   41.8	   41.3	  -­‐	  42.2	  
Maine	  Data	  Source:	  Maine	  CDC	  Cancer	  Registry,	  November	  2012	  NPCR	  data	  submission	  (1995-­‐2010).	  U.S.	  Data	  Source:	  SEER	  9	  Research	  Data	  (1973-­‐2010).	  	  
*The	  SEER	  9	  registries	  are	  Atlanta,	  Connecticut,	  Detroit,	  Hawaii,	  Iowa,	  New	  Mexico,	  San	  Francisco-­‐Oakland,	  Seattle-­‐Puget	  Sound,	  and	  Utah	  and	  represent	  9.4%	  
of	  U.S.	  population. 
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Incidence:	  The	  number	  of	  people	  who	  develop	  cancer	  (new	  cancer	  cases)	  during	  a	  specified	  period	  of	  time	  in	  a	  specified	  population.	  	  	  
Colorectal	  cancer:	  SEER	  Site	  Recode:	  21041-­‐21049,	  21051,	  21052	  (which	  include	  ICD-­‐O-­‐3	  codes:	  C180-­‐C189,	  C260,	  C199,	  C209).	  
Incidence	  case	  definitions	  exclude	  histologies	  consistent	  with	  Kaposi	  sarcoma	  and	  mesothelioma,	  where	  applicable.	  
Crude	  Rates	  are	  new	  cases	  per	  100,000	  population.	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Table	  2.16.	  Colorectal	  cancer	  incidence	  by	  3-­‐year	  period	  and	  sex,	  Maine,	  2000-­‐2010.	  
	   	  Maine	  Overall	   Females	   	  Males	  




Number	   Rate	   95%CI	   Rate	   95%	  CI	  
Average	  
Annual	  
Number	   Rate	   95%CI	   Rate	   95%CI	  
Average	  
Annual	  
Number	   Rate	   95%CI	   Rate	   95%CI	  
2000-­‐2002	   873	   67.9	   65.3	  -­‐	  70.5	   59.5	   57.2	  -­‐	  61.8	   444	   67.3	   63.7	  -­‐	  71.0	   52.5	   49.6	  -­‐	  55.4	   429	   68.5	   64.8	  -­‐	  72.3	   69.1	   65.4	  -­‐	  73.1	  
2001-­‐2003	   872	   67.3	   64.7	  -­‐	  69.9	   58.5	   56.3	  -­‐	  60.8	   422	   63.5	   60.0	  -­‐	  67.1	   49.4	   46.7	  -­‐	  52.2	   450	   71.3	   67.5	  -­‐	  75.2	   71.3	   67.5	  -­‐	  75.3	  
2002-­‐2004	   897	   68.7	   66.2	  -­‐	  71.4	   59.2	   56.9	  -­‐	  61.4	   438	   65.5	   62.0	  -­‐	  69.2	   50.6	   47.9	  -­‐	  53.5	   459	   72.1	   68.3	  -­‐	  76.0	   70.2	   66.5	  -­‐	  74.1	  
2003-­‐2005	   870	   66.3	   63.7	  -­‐	  68.9	   56.5	   54.3	  -­‐	  58.7	   425	   63.3	   59.9	  -­‐	  66.9	   48.5	   45.8	  -­‐	  51.3	   445	   69.3	   65.7	  -­‐	  73.1	   66.2	   62.7	  -­‐	  69.9	  
2004-­‐2006	   854	   64.8	   62.3	  -­‐	  67.3	   54.4	   52.3	  -­‐	  56.6	   427	   63.3	   59.9	  -­‐	  66.9	   48.0	   45.4	  -­‐	  50.8	   427	   66.3	   62.7	  -­‐	  70.0	   61.9	   58.5	  -­‐	  65.5	  
2005-­‐2007	   830	   62.8	   60.3	  -­‐	  65.3	   52.0	   49.9	  -­‐	  54.1	   420	   62.1	   58.7	  -­‐	  65.6	   46.5	   44.0	  -­‐	  49.2	   411	   63.5	   60.0	  -­‐	  67.1	   58.6	   55.3	  -­‐	  62.0	  
2006-­‐2008	   792	   59.7	   57.3	  -­‐	  62.1	   48.5	   46.6	  -­‐	  50.5	   402	   59.3	   56.0	  -­‐	  62.8	   43.9	   41.4	  -­‐	  46.5	   390	   60.1	   56.7	  -­‐	  63.6	   54.0	   50.9	  -­‐	  57.3	  
2007-­‐2009	   775	   58.3	   55.9	  -­‐	  60.7	   46.7	   44.8	  -­‐	  48.7	   393	   58.0	   54.7	  -­‐	  61.4	   42.3	   39.9	  -­‐	  44.9	   381	   58.6	   55.3	  -­‐	  62.1	   51.7	   48.7	  -­‐	  54.9	  
2008-­‐2010	   724	   54.5	   52.2	  -­‐	  56.8	   43.1	   41.3	  -­‐	  45.0	   356	   52.4	   49.3	  -­‐	  55.7	   38.1	   35.8	  -­‐	  40.6	   368	   56.6	   53.3	  -­‐	  60.1	   48.8	   45.9	  -­‐	  51.8	  
U.S.	  SEER	  9	  	  	  	  	  	  	  	  	  
2008-­‐2010*	   12,791	   44.5	   44.0	  -­‐	  44.9	   42.9	   42.4	  -­‐	  43.3	   6,287	   43.1	   42.5	  -­‐	  43.7	   38.0	   37.4	  -­‐	  38.5	   6,504	   45.9	   45.3	  -­‐	  46.6	   48.9	   48.2	  -­‐	  49.6	  
U.S.	  SEER	  9	  Whites	  
2008-­‐2010*	   9,903	   46.5	   46.0	  –	  47.0	   41.8	   41.3	  -­‐	  42.2	   4,843	   45.2	   44.5	  –	  46.0	   36.9	   36.3	  -­‐	  37.5	   5,060	   47.8	   47.0	  -­‐	  48.5	   47.5	   46.8	  -­‐	  48.3	  
Maine	  Data	  Source:	  Maine	  CDC	  Cancer	  Registry,	  November	  2012	  NPCR	  data	  submission	  (1995-­‐2010).	  U.S.	  Data	  Source:	  SEER	  9	  Research	  Data	  (1973-­‐2010).	  	  
*The	  SEER	  9	  registries	  are	  Atlanta,	  Connecticut,	  Detroit,	  Hawaii,	  Iowa,	  New	  Mexico,	  San	  Francisco-­‐Oakland,	  Seattle-­‐Puget	  Sound,	  and	  Utah	  and	  represent	  9.4%	  of	  U.S.	  population.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Incidence:	  The	  number	  of	  people	  who	  develop	  cancer	  (new	  cancer	  cases)	  during	  a	  specified	  period	  of	  time	  in	  a	  specified	  population.	  	  	  
Colorectal	  cancer:	  SEER	  Site	  Recode:	  21041-­‐21049,	  21051,	  21052	  (which	  include	  ICD-­‐O-­‐3	  codes:	  C180-­‐C189,	  C260,	  C199,	  C209).	  
Incidence	  case	  definitions	  exclude	  histologies	  consistent	  with	  Kaposi	  sarcoma	  and	  mesothelioma,	  where	  applicable.	  
Crude	  Rates	  are	  new	  cases	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  new	  cases	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	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Table 2.17. Colorectal cancer incidence by 3-year period and age group, Maine, 2000-2010. 
  Ages 0─34 years Ages 35─64 years  Ages 65─74 years  Ages 75 years and older 




Number Rate 95%CI 
Average 
Annual 
Number Rate 95%CI 
Average 
Annual 
Number Rate 95%CI 
Average 
Annual 
Number Rate 95%CI 
2000-2002             4  0.7 0.4 - 1.2         233  43.2 40.0 - 46.5 243 252.6 234.6 - 271.6         393  441.3 416.5 - 467.3 
2001-2003             7  1.3 0.8 - 2.0         242  44.0 40.9 - 47.4 235 243.8 226.1 - 262.4         388  429.4 405.1 - 454.8 
2002-2004             8  1.5 1.0 - 2.2         269  48.3 45.0 - 51.7 232 239.5 222.0 - 258.0         388  424.0 399.9 - 449.0 
2003-2005             9  1.6 1.0 - 2.3         269  47.6 44.4 - 51.0 230 236.9 219.6 - 255.3         362  390.6 367.7 - 414.6 
2004-2006             5  1.0 0.6 - 1.6         273  47.7 44.5 - 51.1 220 223.9 207.1 - 241.6         356  379.7 357.3 - 403.2 
2005-2007             5  0.8 0.5 - 1.4         265  45.8 42.6 - 49.1 207 208.2 192.1 - 225.2         354  372.2 350.2 - 395.3 
2006-2008             6  1.1 0.7 - 1.7         262  45.1 42.0 - 48.3 186 181.5 166.7 - 197.2         338  351.0 329.7 - 373.3 
2007-2009             7  1.3 0.8 - 2.0         260  44.6 41.5 - 47.8 181 171.3 157.2 - 186.3         326  336.0 315.2 - 357.7 
2008-2010             7  1.3 0.8 - 2.0         253  43.4 40.3 - 46.6 171 156.1 142.9 - 170.2         293  299.3 279.8 - 319.8 
U.S. SEER 9           
2008-2010* 175 1.3 1.2 - 1.4 4,988 43.2 42.5 - 43.9 2,940 160.2 156.8 - 163.5 4,689 282.2 277.6 - 286.9 
U.S. SEER 9 Whites  
2008-2010* 130 1.3 1.2 - 1.5 3,566 41.0 40.2 - 41.8 2,277 155.3 151.7 - 159.1 3,930 286.1 281.0 - 291.3 
Maine Data Source: Maine CDC Cancer Registry, November 2012 NPCR data submission (1995-2010). U.S. Data Source: SEER 9 Research Data (1973-2010). 
*The SEER 9 registries are Atlanta, Connecticut, Detroit, Hawaii, Iowa, New Mexico, San Francisco-Oakland, Seattle-Puget Sound, and Utah and represent 
9.4% of U.S. population. 
95% CI: 95% confidence interval of the rate. 
Cancer Incidence: The number of people who develop cancer (new cancer cases) during a specified period of time in a specified population.   
Colorectal cancer: SEER Site Recode: 21041-21049, 21051, 21052 (which include ICD-O-3 codes: C180-C189, C260, C199, C209). 
Incidence case definitions exclude histologies consistent with Kaposi sarcoma and mesothelioma, where applicable. 
Crude Rates are new cases per 100,000 population. 
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Crude	   Age-­‐Adjusted	  
Rate	   	  	  	  	  95%	  CI	   Rate	   	  	  	  	  95%	  CI	  
Maine	  total	   761	   57.3	  	   55.5	  -­‐	  59.2	  	   45.9	  	   44.5	  -­‐	  47.4	  	  
	   	   	   	   	   	  County	   	   	   	   	   	  
Androscoggin	   55	   50.8	  	   45.0	  -­‐	  57.2	  	   44.7	  	   39.5	  -­‐	  50.4	  	  
Aroostook	   59	   82.0	  	   73.0	  -­‐	  91.9	  	   57.6	  	   51.1	  -­‐	  64.8	  	  
Cumberland	   136	   48.7	  	   45.1	  -­‐	  52.5	  	   42.1	  	   38.9	  -­‐	  45.4	  	  
Franklin	   19	   61.3	  	   49.6	  -­‐	  75.1	  	   50.1	  	   40.3	  -­‐	  61.7	  	  
Hancock	   35	   64.8	  	   55.6	  -­‐	  75.1	  	   45.2	  	   38.7	  -­‐	  52.8	  	  
Kennebec	   67	   54.8	  	   49.1	  -­‐	  61.0	  	   44.7	  	   39.9	  -­‐	  49.8	  	  
Knox	   22	   54.3	  	   44.6	  -­‐	  65.6	  	   36.4	  	   29.8	  -­‐	  44.4	  	  
Lincoln	   21	   59.9	  	   49.0	  -­‐	  72.6	  	   37.6	  	   30.5	  -­‐	  46.1	  	  
Oxford	   34	   59.1	  	   50.6	  -­‐	  68.7	  	   45.1	  	   38.6	  -­‐	  52.6	  	  
Penobscot	   93	   60.9	  	   55.5	  -­‐	  66.7	  	   53.2	  	   48.4	  -­‐	  58.3	  	  
Piscataquis	   13	   71.8	  	   55.2	  -­‐	  91.8	  	   49.1	  	   37.4	  -­‐	  64.0	  	  
Sagadahoc	   18	   51.0	  	   41.1	  -­‐	  62.6	  	   40.8	  	   32.6	  -­‐	  50.4	  	  
Somerset	   28	   53.2	  	   44.7	  -­‐	  62.8	  	   42.8	  	   35.9	  -­‐	  50.7	  	  
Waldo	   24	   62.5	  	   51.8	  -­‐	  74.6	  	   48.5	  	   40.0	  -­‐	  58.4	  	  
Washington	   26	   78.4	  	   65.5	  -­‐	  93.1	  	   52.4	  	   43.6	  -­‐	  62.6	  	  
York	   111	   56.0	  	   51.4	  -­‐	  60.9	  	   45.8	  	   42.1	  -­‐	  49.9	  	  
Public	  health	  district	   	   	   	   	   	  
Aroostook	   59	   82.0	  	   73.0	  -­‐	  91.9	  	   57.6	  	   51.1	  -­‐	  64.8	  	  
Central	   95	   54.3	  	   49.5	  -­‐	  59.4	  	   44.0	  	   40.1	  -­‐	  48.3	  	  
Cumberland	   136	   48.7	  	   45.1	  -­‐	  52.5	  	   42.1	  	   38.9	  -­‐	  45.4	  	  
Downeast	   61	   70.0	  	   62.4	  -­‐	  78.3	  	   48.0	  	   42.6	  -­‐	  53.9	  	  
Midcoast	   85	   57.0	  	   51.7	  -­‐	  62.6	  	   40.6	  	   36.7	  -­‐	  44.8	  	  
Penquis	   106	   62.1	  	   56.9	  -­‐	  67.6	  	   52.5	  	   48.1	  -­‐	  57.3	  	  
Western	   108	   54.9	  	   50.3	  -­‐	  59.7	  	   45.5	  	   41.7	  -­‐	  49.6	  	  
York	   111	   56.0	  	   51.4	  -­‐	  60.9	  	   45.8	  	   42.1	  -­‐	  49.9	  	  
Maine	  Data	  Source:	  Maine	  CDC	  Cancer	  Registry,	  November	  2012	  NPCR	  data	  submission	  (1995-­‐2010).	  U.S.	  Data	  Source:	  SEER	  9	  
Research	  Data	  (1973-­‐2010).	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Incidence:	  The	  number	  of	  people	  who	  develop	  cancer	  (new	  cancer	  cases)	  during	  a	  specified	  period	  of	  time	  in	  a	  specified	  
population.	  	  	  
Colorectal	  cancer:	  SEER	  Site	  Recode:	  21041-­‐21049,	  21051,	  21052	  (which	  include	  ICD-­‐O-­‐3	  codes:	  C180-­‐C189,	  C260,	  C199,	  C209).	  
Incidence	  case	  definitions	  exclude	  histologies	  consistent	  with	  Kaposi	  sarcoma	  and	  mesothelioma,	  where	  applicable.	  
Crude	  Rates	  are	  new	  cases	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  new	  cases	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	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Table	  2.19.	  Lung	  cancer	  incidence	  by	  3-­‐year	  period,	  Maine,	  U.S.	  SEER	  9	  and	  U.S.	  SEER	  9	  whites,	  2000-­‐2010.	  





	  Crude	   Age-­‐adjusted	   Average	  
Annual	  
Number	  




Rate	   95%CI	   Rate	   95%	  CI	   Rate	   95%CI	   Rate	   95%CI	  
2000-­‐2002	   1,185	   92.2	   89.2	  -­‐	  95.2	   81.0	   78.4	  -­‐	  83.7	   16,241	   64.1	   63.5	  -­‐	  64.7	   13,501	   64.8	   64.2	  -­‐	  65.5	  
2001-­‐2003	   1,203	   92.8	   89.8	  -­‐	  95.9	   80.9	   78.3	  -­‐	  83.6	   16,529	   64.3	   63.8	  -­‐	  64.9	   13,705	   65.1	   64.5	  -­‐	  65.8	  
2002-­‐2004	   1,226	   93.9	   90.9	  -­‐	  97.0	   80.9	   78.3	  -­‐	  83.6	   16,608	   63.7	   63.1	  -­‐	  64.3	   13,705	   64.4	   63.8	  -­‐	  65.0	  
2003-­‐2005	   1,252	   95.4	   92.4	  -­‐	  98.5	   81.2	   78.6	  -­‐	  83.9	   16,784	   63.4	   62.8	  -­‐	  63.9	   13,823	   64.2	   63.5	  -­‐	  64.8	  
2004-­‐2006	   1,269	   96.3	   93.2	  -­‐	  99.4	   80.8	   78.3	  -­‐	  83.5	   16,842	   62.5	   62.0	  -­‐	  63.1	   13,810	   63.2	   62.6	  -­‐	  63.8	  
2005-­‐2007	   1,276	   96.4	   93.4	  -­‐	  99.5	   79.7	   77.2	  -­‐	  82.3	   17,133	   62.4	   61.8	  -­‐	  62.9	   14,041	   63.3	   62.7	  -­‐	  63.9	  
2006-­‐2008	   1,280	   96.5	   93.5	  -­‐	  99.6	   78.5	   76.1	  -­‐	  81.1	   17,215	   61.5	   60.9	  -­‐	  62.0	   14,044	   62.3	   61.7	  -­‐	  62.9	  
2007-­‐2009	   1,301	   97.9	   94.8	  -­‐	  101.0	   78.2	   75.7	  -­‐	  80.7	   17,347	   60.6	   60.1	  -­‐	  61.1	   14,111	   61.5	   60.9	  -­‐	  62.1	  
2008-­‐2010	   1,294	   97.4	   94.3	  -­‐	  100.5	   76.3	   73.9	  -­‐	  78.8	   17,211	   58.9	   58.3	  -­‐	  59.4	   13,957	   59.7	   59.1	  -­‐	  60.3	  
Maine	  Data	  Source:	  Maine	  CDC	  Cancer	  Registry,	  November	  2012	  NPCR	  data	  submission	  (1995-­‐2010).	  U.S.	  Data	  Source:	  SEER	  9	  Research	  Data	  (1973-­‐2010).	  	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
*The	  SEER	  9	  registries	  are	  Atlanta,	  Connecticut,	  Detroit,	  Hawaii,	  Iowa,	  New	  Mexico,	  San	  Francisco-­‐Oakland,	  Seattle-­‐Puget	  Sound,	  and	  Utah	  and	  represent	  9.4%	  
of	  U.S.	  population.	  
Cancer	  Incidence:	  The	  number	  of	  people	  who	  develop	  cancer	  (new	  cancer	  cases)	  during	  a	  specified	  period	  of	  time	  in	  a	  specified	  population.	  	  	  
Lung	  cancer:	  SEER	  Site	  Recode:	  22030	  (which	  includes	  ICD-­‐O-­‐3	  codes:	  C340-­‐C349).	  
Incidence	  case	  definitions	  exclude	  histologies	  consistent	  with	  Kaposi	  sarcoma	  and	  mesothelioma,	  where	  applicable.	  
Crude	  Rates	  are	  new	  cases	  per	  100,000	  population.	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Table	  2.20.	  Lung	  cancer	  incidence	  by	  3-­‐year	  period	  and	  sex,	  Maine,	  2000-­‐2010.	  
	   	  Maine	  Overall	   Females	   	  Males	  
	   Average	  
Annual	  
Number	  
	  Crude	   Age-­‐adjusted	   Average	  
Annual	  
Number	  
Crude	   Age-­‐adjusted	   Average	  
Annual	  
Number	  
Crude	   Age-­‐adjusted	  
3-­‐Year	  Period	   Rate	   95%CI	   Rate	   95%	  CI	   Rate	   95%CI	   Rate	   95%CI	   Rate	   95%CI	   Rate	   95%CI	  
2000-­‐2002	   1,185	   92.2	   89.2	  -­‐	  95.2	   81.0	   78.4	  -­‐	  83.7	   528	   80.1	   76.2	  -­‐	  84.1	   65.2	   62.0	  -­‐	  68.5	   657	   104.9	   100.3	  -­‐	  109.6	   102.8	   98.3	  -­‐	  107.5	  
2001-­‐2003	   1,203	   92.8	   89.8	  -­‐	  95.9	   80.9	   78.3	  -­‐	  83.6	   545	   82.0	   78.1	  -­‐	  86.1	   66.1	   62.9	  -­‐	  69.4	   659	   104.2	   99.7	  -­‐	  108.9	   101.4	   96.9	  -­‐	  106.0	  
2002-­‐2004	   1,226	   93.9	   90.9	  -­‐	  97.0	   80.9	   78.3	  -­‐	  83.6	   552	   82.6	   78.7	  -­‐	  86.7	   66.0	   62.9	  -­‐	  69.3	   674	   105.7	   101.2	  -­‐	  110.4	   101.5	   97.1	  -­‐	  106.1	  
2003-­‐2005	   1,252	   95.4	   92.4	  -­‐	  98.5	   81.2	   78.6	  -­‐	  83.9	   568	   84.5	   80.6	  -­‐	  88.6	   66.8	   63.6	  -­‐	  70.1	   685	   106.7	   102.2	  -­‐	  111.5	   100.9	   96.6	  -­‐	  105.5	  
2004-­‐2006	   1,269	   96.3	   93.2	  -­‐	  99.4	   80.8	   78.3	  -­‐	  83.5	   580	   86.0	   82.0	  -­‐	  90.1	   67.3	   64.1	  -­‐	  70.6	   690	   107.0	   102.4	  -­‐	  111.7	   99.7	   95.4	  -­‐	  104.2	  
2005-­‐2007	   1,276	   96.4	   93.4	  -­‐	  99.5	   79.7	   77.2	  -­‐	  82.3	   588	   86.9	   82.9	  -­‐	  91.1	   66.9	   63.8	  -­‐	  70.2	   688	   106.4	   101.8	  -­‐	  111.1	   97.2	   93.0	  -­‐	  101.6	  
2006-­‐2008	   1,280	   96.5	   93.5	  -­‐	  99.6	   78.5	   76.1	  -­‐	  81.1	   597	   88.0	   84.0	  -­‐	  92.2	   67.0	   63.9	  -­‐	  70.3	   684	   105.3	   100.8	  -­‐	  110.0	   94.3	   90.2	  -­‐	  98.5	  
2007-­‐2009	   1,301	   97.9	   94.8	  -­‐	  101.0	   78.2	   75.7	  -­‐	  80.7	   613	   90.3	   86.2	  -­‐	  94.6	   67.5	   64.4	  -­‐	  70.7	   688	   105.7	   101.2	  -­‐	  110.4	   92.6	   88.5	  -­‐	  96.7	  
2008-­‐2010	   1,294	   97.4	   94.3	  -­‐	  100.5	   76.3	   73.9	  -­‐	  78.8	   621	   91.6	   87.4	  -­‐	  95.8	   67.5	   64.5	  -­‐	  70.7	   673	   103.4	   98.9	  -­‐	  108.0	   88.4	   84.5	  -­‐	  92.4	  
U.S	  SEER	  9	  	  	  	  	  	  	  	  	  
2008-­‐2010*	   17,211	   59.8	   59.3	  -­‐	  60.4	   58.9	   58.3	  -­‐	  59.4	   8,256	   56.6	   55.9	  -­‐	  57.3	   50.9	   50.3	  -­‐	  51.5	   8,956	   63.2	   62.5	  –	  64.0	   69.8	   68.9	  -­‐	  70.6	  
U.S.	  SEER	  9	  Whites	  
2008-­‐2010*	  
13,957	   65.5	   64.9	  -­‐	  66.2	   59.7	   59.1	  -­‐	  60.3	   6,805	   63.5	   62.7	  -­‐	  64.4	   53.0	   52.3	  -­‐	  53.7	   7,152	   67.5	   66.6	  -­‐	  68.4	   69.0	   68.0	  -­‐	  69.9	  
Maine	  Data	  Source:	  Maine	  CDC	  Cancer	  Registry,	  November	  2012	  NPCR	  data	  submission	  (1995-­‐2010).	  U.S.	  Data	  Source:	  SEER	  9	  Research	  Data	  (1973-­‐2010).	  	  
*The	  SEER	  9	  registries	  are	  Atlanta,	  Connecticut,	  Detroit,	  Hawaii,	  Iowa,	  New	  Mexico,	  San	  Francisco-­‐Oakland,	  Seattle-­‐Puget	  Sound,	  and	  Utah	  and	  represent	  9.4%	  of	  U.S.	  population.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Incidence:	  The	  number	  of	  people	  who	  develop	  cancer	  (new	  cancer	  cases)	  during	  a	  specified	  period	  of	  time	  in	  a	  specified	  population.	  	  	  
Lung	  cancer:	  SEER	  Site	  Recode:	  22030	  (which	  includes	  ICD-­‐O-­‐3	  codes:	  C340-­‐C349).	  
Incidence	  case	  definitions	  exclude	  histologies	  consistent	  with	  Kaposi	  sarcoma	  and	  mesothelioma,	  where	  applicable.	  
Crude	  Rates	  are	  new	  cases	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  new	  cases	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	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Table 2.21. Lung cancer incidence by 3-year period and age group, Maine, 2000-2010. 
3-Year Period 
 Ages 0─34 years Ages 35─64 years  Ages 65─74 years  Ages 75 years and older 
 Crude Crude Crude Crude 
Average 
Annual 
Number Rate 95%CI 
Average 
Annual 
Number Rate 95%CI 
Average 
Annual 
Number Rate 95%CI 
Average 
Annual 
Number Rate 95%CI 
2000-2002             2  0.4 0.1 - 0.8         386  71.4 67.4 - 75.7 405 421.3 397.9 - 445.7          392  440.6 415.8 - 466.5 
2001-2003             2  0.3 0.1 - 0.7         388  70.7 66.7 - 74.9 404 418.7 395.5 - 443.0          410  453.7 428.7 - 479.8 
2002-2004             2  0.4 0.2 - 0.9         401  71.8 67.8 - 76.0 399 412.2 389.2 - 436.2          424  463.3 438.2 - 489.5 
2003-2005             3  0.5 0.2 - 0.9         403  71.2 67.3 - 75.4 399 410.1 387.1 - 434.0          448  483.9 458.3 - 510.5 
2004-2006             3  0.5 0.2 - 1.0         406  70.8 66.9 - 74.9 393 400.2 377.7 - 423.7          468  499.2 473.4 - 526.0 
2005-2007             3  0.5 0.2 - 1.0         402  69.5 65.6 - 73.5 387 388.6 366.5 - 411.6          484  509.8 483.9 - 536.7 
2006-2008             5  0.9 0.5 - 1.4         406  69.7 65.9 - 73.7 394 384.8 363.2 - 407.4          476  494.7 469.4 - 521.0 
2007-2009             4  0.7 0.4 - 1.3         419  71.8 67.9 - 75.9 405 382.9 361.7 - 405.0          473  486.6 461.6 - 512.6 
2008-2010             3  0.6 0.3 - 1.1         421  72.2 68.3 - 76.3 415 378.0 357.3 - 399.6          455  464.8 440.5 - 490.1 
U.S. SEER 9         
2008-2010*              50 0.4 0.3 - 0.4 5,244 45.4 44.7 - 46.1 5,270 287.1 282.7 - 291.7 6,648 400.1 394.6 - 405.7 
U.S. SEER 9 Whites  
2008-2010*              35 0.4 0.3 - 0.4 3,976 45.7 44.9 - 46.5 4,330 295.5 290.4 - 300.6 5,616 408.8 402.7 - 415.1 
Maine Data Source: Maine CDC Cancer Registry, November 2012 NPCR data submission (1995-2010). U.S. Data Source: SEER 9 Research Data (1973-2010). 
*The SEER 9 registries are Atlanta, Connecticut, Detroit, Hawaii, Iowa, New Mexico, San Francisco-Oakland, Seattle-Puget Sound, and Utah and represent 
9.4% of U.S. population. 
95% CI: 95% confidence interval of the rate. 
Cancer Incidence: The number of people who develop cancer (new cancer cases) during a specified period of time in a specified population.   
Lung cancer: SEER Site Recode: 22030 (which includes ICD-O-3 codes: C340-C349). 
Incidence case definitions exclude histologies consistent with Kaposi sarcoma and mesothelioma, where applicable. 
Crude Rates are new cases per 100,000 population. 
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Table	  2.22.	  Lung	  cancer	  incidence	  by	  county	  and	  public	  health	  district,	  Maine,	  2006-­‐2010.	  
	   	   Crude	   Age-­‐Adjusted	  
	  
Average	  Annual	  
Number	   Rate	   	  	  	  95%	  CI	   Rate	   	  	  	  95%	  CI	  
Maine	  total	   1,289	   97.1	  	   94.7	  -­‐	  99.5	  	   77.5	  	   75.6	  -­‐	  79.5	  	  
	   	   	   	   	   	  County	   	   	   	   	   	  
Androscoggin	   107	   99.0	  	   90.8	  -­‐	  107.8	  	   87.1	  	   79.8	  -­‐	  94.9	  	  
Aroostook	   92	   126.8	  	   115.4	  -­‐	  138.9	  	   87.1	  	   79.2	  -­‐	  95.6	  	  
Cumberland	   224	   80.1	  	   75.5	  -­‐	  84.9	  	   70.3	  	   66.2	  -­‐	  74.6	  	  
Franklin	   26	   84.8	  	   70.9	  -­‐	  100.7	  	   67.6	  	   56.3	  -­‐	  80.6	  	  
Hancock	   57	   105.0	  	   93.1	  -­‐	  117.9	  	   76.2	  	   67.5	  -­‐	  85.9	  	  
Kennebec	   122	   99.9	  	   92.1	  -­‐	  108.2	  	   81.2	  	   74.8	  -­‐	  88.0	  	  
Knox	   41	   103.2	  	   89.6	  -­‐	  118.3	  	   70.0	  	   60.6	  -­‐	  80.7	  	  
Lincoln	   31	   89.9	  	   76.3	  -­‐	  105.1	  	   54.9	  	   46.5	  -­‐	  64.7	  	  
Oxford	   66	   113.7	  	   101.8	  -­‐	  126.7	  	   85.3	  	   76.2	  -­‐	  95.2	  	  
Penobscot	   165	   107.9	  	   100.7	  -­‐	  115.5	  	   92.8	  	   86.5	  -­‐	  99.4	  	  
Piscataquis	   20	   113.9	  	   92.7	  -­‐	  138.6	  	   75.1	  	   60.8	  -­‐	  92.4	  	  
Sagadahoc	   27	   76.8	  	   64.5	  -­‐	  90.8	  	   62.5	  	   52.3	  -­‐	  74.3	  	  
Somerset	   53	   101.4	  	   89.6	  -­‐	  114.4	  	   78.2	  	   69.0	  -­‐	  88.5	  	  
Waldo	   41	   105.8	  	   91.8	  -­‐	  121.4	  	   83.2	  	   72.0	  -­‐	  95.8	  	  
Washington	   45	   136.3	  	   119.1	  -­‐	  155.3	  	   92.4	  	   80.5	  -­‐	  105.7	  	  
York	   172	   86.9	  	   81.2	  -­‐	  92.9	  	   70.9	  	   66.2	  -­‐	  75.9	  	  
Public	  health	  district	   	   	   	   	   	  
Aroostook	   92	   126.8	  	   115.4	  -­‐	  138.9	  	   87.1	  	   79.2	  -­‐	  95.6	  	  
Central	   175	   100.4	  	   93.8	  -­‐	  107.2	  	   80.2	  	   74.9	  -­‐	  85.8	  	  
Cumberland	   224	   80.1	  	   75.5	  -­‐	  84.9	  	   70.3	  	   66.2	  -­‐	  74.6	  	  
Downeast	   102	   116.9	  	   106.9	  -­‐	  127.4	  	   82.5	  	   75.3	  -­‐	  90.1	  	  
Midcoast	   141	   94.5	  	   87.6	  -­‐	  101.7	  	   67.6	  	   62.6	  -­‐	  72.9	  	  
Penquis	   185	   108.5	  	   101.6	  -­‐	  115.7	  	   90.1	  	   84.4	  -­‐	  96.2	  	  
Western	   199	   101.1	  	   94.9	  -­‐	  107.6	  	   83.1	  	   77.9	  -­‐	  88.5	  	  
York	   172	   86.9	  	   81.2	  -­‐	  92.9	  	   70.9	  	   66.2	  -­‐	  75.9	  	  
Maine	  Data	  Source:	  Maine	  CDC	  Cancer	  Registry,	  November	  2012	  NPCR	  data	  submission	  (1995-­‐2010).	  U.S.	  Data	  Source:	  SEER	  9	  
Research	  Data	  (1973-­‐2010).	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Incidence:	  The	  number	  of	  people	  who	  develop	  cancer	  (new	  cancer	  cases)	  during	  a	  specified	  period	  of	  time	  in	  a	  specified	  
population.	  	  	  
Lung	  cancer:	  SEER	  Site	  Recode:	  22030	  (which	  includes	  ICD-­‐O-­‐3	  codes:	  C340-­‐C349).	  
Incidence	  case	  definitions	  exclude	  histologies	  consistent	  with	  Kaposi	  sarcoma	  and	  mesothelioma,	  where	  applicable.	  
Crude	  Rates	  are	  new	  cases	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  new	  cases	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	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Table	  2.23.	  Melanoma	  incidence	  by	  3-­‐year	  period,	  Maine,	  U.S.	  SEER	  9	  and	  U.S.	  SEER	  9	  whites,	  2000-­‐2010.	  





	  Crude	   Age-­‐adjusted	   Average	  
Annual	  
Number	  




Rate	   95%CI	   Rate	   95%	  CI	   Rate	   95%CI	   Rate	   95%CI	  
2000-­‐2002	   280	   21.8	   20.3	  -­‐	  23.3	   19.8	   18.5	  -­‐	  21.2	   5,087	   19.3	   19.0	  -­‐	  19.6	   4,928	   23.3	   23.0	  -­‐	  23.7	  
2001-­‐2003	   307	   23.7	   22.2	  -­‐	  25.3	   21.5	   20.2	  -­‐	  23.0	   5,205	   19.5	   19.2	  -­‐	  19.8	   5,037	   23.7	   23.3	  -­‐	  24.1	  
2002-­‐2004	   321	   24.6	   23.0	  -­‐	  26.2	   22.0	   20.6	  -­‐	  23.5	   5,360	   19.8	   19.5	  -­‐	  20.2	   5,179	   24.1	   23.8	  -­‐	  24.5	  
2003-­‐2005	   336	   25.6	   24.1	  -­‐	  27.2	   22.7	   21.3	  -­‐	  24.2	   5,721	   20.9	   20.6	  -­‐	  21.2	   5,544	   25.6	   25.2	  -­‐	  26.0	  
2004-­‐2006	   339	   25.7	   24.2	  -­‐	  27.3	   22.4	   21.0	  -­‐	  23.9	   6,051	   21.7	   21.4	  -­‐	  22.1	   5,858	   26.7	   26.3	  -­‐	  27.1	  
2005-­‐2007	   346	   26.2	   24.6	  -­‐	  27.8	   22.7	   21.3	  -­‐	  24.2	   6,253	   22.1	   21.8	  -­‐	  22.4	   6,049	   27.2	   26.8	  -­‐	  27.6	  
2006-­‐2008	   340	   25.6	   24.1	  -­‐	  27.3	   21.8	   20.5	  -­‐	  23.3	   6,423	   22.3	   22.0	  -­‐	  22.6	   6,194	   27.4	   27.1	  -­‐	  27.9	  
2007-­‐2009	   355	   26.7	   25.1	  -­‐	  28.4	   22.4	   21.0	  -­‐	  23.8	   6,610	   22.6	   22.3	  -­‐	  22.9	   6,354	   27.8	   27.4	  -­‐	  28.2	  
2008-­‐2010	   355	   26.7	   25.1	  -­‐	  28.3	   21.9	   20.6	  -­‐	  23.3	   6,914	   23.2	   22.9	  -­‐	  23.5	   6,611	   28.5	   28.1	  -­‐	  28.9	  
Maine	  Data	  Source:	  Maine	  CDC	  Cancer	  Registry,	  November	  2012	  NPCR	  data	  submission	  (1995-­‐2010).	  U.S.	  Data	  Source:	  SEER	  9	  Research	  Data	  (1973-­‐2010).	  	  
*The	  SEER	  9	  registries	  are	  Atlanta,	  Connecticut,	  Detroit,	  Hawaii,	  Iowa,	  New	  Mexico,	  San	  Francisco-­‐Oakland,	  Seattle-­‐Puget	  Sound,	  and	  Utah	  and	  represent	  9.4%	  
of	  U.S.	  population.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Incidence:	  The	  number	  of	  people	  who	  develop	  cancer	  (new	  cancer	  cases)	  during	  a	  specified	  period	  of	  time	  in	  a	  specified	  population.	  	  	  
Melanoma:	  SEER	  Site	  Recode:	  25010	  (which	  includes	  ICD-­‐O-­‐3	  codes:	  C440-­‐C449).	  
Incidence	  case	  definitions	  exclude	  histologies	  consistent	  with	  Kaposi	  sarcoma	  and	  mesothelioma,	  where	  applicable.	  
Crude	  Rates	  are	  new	  cases	  per	  100,000	  population.	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Table	  2.24.	  Melanoma	  incidence	  by	  3-­‐year	  period	  and	  sex,	  Maine,	  2000-­‐2010.	  
3-­‐Year	  Period	  




	  Crude	   Age-­‐adjusted	   Average	  
Annual	  
Number	  
Crude	   Age-­‐adjusted	   Average	  
Annual	  
Number	  
Crude	   Age-­‐adjusted	  
Rate	   95%CI	   Rate	   95%	  CI	   Rate	   95%CI	   Rate	   95%CI	   Rate	   95%CI	   Rate	   95%CI	  
2000-­‐2002	   280	   21.8	   20.3	  -­‐	  23.3	   19.8	   18.5	  -­‐	  21.2	   123	   18.7	   16.8	  -­‐	  20.7	   16.5	   14.8	  -­‐	  18.3	   157	   25.1	   22.8	  -­‐	  27.4	   24.0	   21.9	  -­‐	  26.3	  
2001-­‐2003	   307	   23.7	   22.2	  -­‐	  25.3	   21.5	   20.2	  –	  23.0	   135	   20.3	   18.3	  -­‐	  22.4	   18.1	   16.3	  -­‐	  19.9	   173	   27.3	   25.0	  -­‐	  29.8	   26.1	   23.9	  -­‐	  28.5	  
2002-­‐2004	   321	   24.6	   23.0	  -­‐	  26.2	   22.0	   20.6	  -­‐	  23.5	   139	   20.8	   18.9	  -­‐	  22.9	   18.5	   16.7	  -­‐	  20.4	   182	   28.5	   26.2	  -­‐	  31.0	   27.0	   24.8	  -­‐	  29.4	  
2003-­‐2005	   336	   25.6	   24.1	  -­‐	  27.2	   22.7	   21.3	  -­‐	  24.2	   144	   21.4	   19.5	  -­‐	  23.6	   18.9	   17.1	  -­‐	  20.8	   192	   30.0	   27.6	  -­‐	  32.5	   28.0	   25.7	  -­‐	  30.4	  
2004-­‐2006	   339	   25.7	   24.2	  -­‐	  27.3	   22.4	   21.0	  -­‐	  23.9	   151	   22.4	   20.4	  -­‐	  24.6	   19.3	   17.5	  -­‐	  21.2	   188	   29.2	   26.8	  -­‐	  31.7	   26.7	   24.5	  -­‐	  29.0	  
2005-­‐2007	   346	   26.2	   24.6	  -­‐	  27.8	   22.7	   21.3	  -­‐	  24.2	   160	   23.7	   21.6	  -­‐	  25.9	   20.3	   18.5	  -­‐	  22.3	   186	   28.8	   26.5	  -­‐	  31.3	   26.0	   23.9	  -­‐	  28.3	  
2006-­‐2008	   340	   25.6	   24.1	  -­‐	  27.3	   21.8	   20.5	  -­‐	  23.3	   156	   23.0	   21.0	  -­‐	  25.2	   19.5	   17.8	  -­‐	  21.5	   184	   28.4	   26.1	  -­‐	  30.9	   24.9	   22.8	  -­‐	  27.1	  
2007-­‐2009	   355	   26.7	   25.1	  -­‐	  28.4	   22.4	   21.0	  -­‐	  23.8	   160	   23.5	   21.5	  -­‐	  25.7	   19.8	   18.0	  -­‐	  21.7	   195	   30.0	   27.6	  -­‐	  32.6	   26.0	   23.9	  -­‐	  28.3	  
2008-­‐2010	   355	   26.7	   25.1	  -­‐	  28.3	   21.9	   20.6	  -­‐	  23.3	   153	   22.5	   20.5	  -­‐	  24.7	   18.4	   16.7	  -­‐	  20.3	   202	   31.1	   28.6	  -­‐	  33.6	   26.6	   24.5	  -­‐	  28.9	  
U.S.	  SEER	  9	  	  	  	  	  	  	  	  	  	  
2008-­‐2010*	   6,914	   24.0	   23.7	  -­‐	  24.4	   23.2	   22.9	  -­‐	  23.5	   2,958	   20.3	   19.8	  -­‐	  20.7	   18.8	   18.4	  -­‐	  19.2	   3,956	   27.9	   27.4	  -­‐	  28.4	   29.4	   28.8	  -­‐	  29.9	  
U.S.	  	  SEER	  9	  Whites	  	  
2008-­‐2010*	  
6,611	   31.0	   30.6	  -­‐	  31.5	   28.5	   28.1	  -­‐	  28.9	   2,813	   26.3	   25.7	  -­‐	  26.8	   23.6	   23.1	  -­‐	  24.2	   3,798	   35.9	   35.2	  -­‐	  36.5	   35.3	   34.6	  -­‐	  36.7	  
Maine	  Data	  Source:	  Maine	  CDC	  Cancer	  Registry,	  November	  2012	  NPCR	  data	  submission	  (1995-­‐2010).	  U.S.	  Data	  Source:	  SEER	  9	  Research	  Data	  (1973-­‐2010).	  	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Incidence:	  The	  number	  of	  people	  who	  develop	  cancer	  (new	  cancer	  cases)	  during	  a	  specified	  period	  of	  time	  in	  a	  specified	  population.	  	  	  
Melanoma:	  SEER	  Site	  Recode:	  25010	  (which	  includes	  ICD-­‐O-­‐3	  codes:	  C440-­‐C449).	  
Incidence	  case	  definitions	  exclude	  histologies	  consistent	  with	  Kaposi	  sarcoma	  and	  mesothelioma,	  where	  applicable.	  
Crude	  Rates	  are	  new	  cases	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  new	  cases	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	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Table 2.25. Melanoma incidence by 3-year period and age group, Maine, 2000-2010. 
3-Year Period 
 Ages 0─34 years Ages 35─64 years  Ages 65─74 years  Ages 75 years and older 
 Crude Crude Crude Crude 
Average 
Annual 
Number Rate 95% CI 
Average 
Annual 
Number Rate 95% CI 
Average 
Annual 
Number Rate 95% CI 
Average 
Annual 
Number Rate 95% CI 
2000-2002           22  3.9 3.0 - 4.9         143  26.5 24.1 - 29.2 55 57.5 49.1 - 67.0           60    67.4 57.9 - 78.0 
2001-2003           28  5.0 4.0 - 6.2         155  28.1 25.6 - 30.8 61 63.6 54.8 - 73.5           63    70.1 60.5 - 80.9 
2002-2004           28  5.1 4.0 - 6.3         161  28.9 26.3 - 31.5 65 66.9 57.8 - 77.0           67    72.8 63.1 - 83.7 
2003-2005           28  5.1 4.1 - 6.3         173  30.5 27.9 - 33.3 64 66.2 57.2 - 76.2           71    76.7 66.7 - 87.7 
2004-2006           23  4.1 3.2 - 5.2         177  30.8 28.3 - 33.6 65 66.2 57.3 - 76.2           75    79.6 69.6 - 90.8 
2005-2007           23  4.2 3.3 - 5.4         179  31.0 28.4 - 33.7 69 68.9 59.8 - 79.0           75    79.3 69.3 - 90.3 
2006-2008           20  3.6 2.7 - 4.6         175  30.1 27.6 - 32.8 67 65.8 57.1 - 75.5           78    81.0 71.0 - 92.1 
2007-2009           22  4.1 3.1 - 5.2         185  31.8 29.2 - 34.5 71 67.1 58.4 - 76.7           77    78.9 69.1 - 89.8 
2008-2010           18  3.3 2.5 - 4.3         181  31.1 28.6 - 33.9 73 66.5 58.0 - 75.9           83    84.4 74.3 - 95.6 
U.S. SEER 9        
2008-2010* 521 3.8 3.6 - 4.0 3,461 30.0 29.4 - 30.6 1,353 73.7 71.5 - 76.0 1,580 95.1 92.4 - 97.8 
U.S. SEER 9 Whites  
2008-2010* 488 5.0 4.7 - 5.3 3,294 37.9 37.1 - 38.6 1,299 88.6 85.9 - 91.4 1,530 111.4 108.2 - 114.6 
Maine Data Source: Maine CDC Cancer Registry, November 2012 NPCR data submission (1995-2010). U.S. Data Source: SEER 9 Research Data (1973-2010). 
*The SEER 9 registries are Atlanta, Connecticut, Detroit, Hawaii, Iowa, New Mexico, San Francisco-Oakland, Seattle-Puget Sound, and Utah and represent 
9.4% of U.S. population. 
95% CI: 95% confidence interval of the rate. 
Cancer Incidence: The number of people who develop cancer (new cancer cases) during a specified period of time in a specified population.   
Melanoma: SEER Site Recode: 25010 (which includes ICD-O-3 codes: C440-C449). 
Incidence case definitions exclude histologies consistent with Kaposi sarcoma and mesothelioma, where applicable. 
Crude Rates are new cases per 100,000 population. 
Age-adjusted rates are not calculated for age-specific groups. 
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Crude	   Age-­‐Adjusted	  
Rate	   	  	  	  	  95%	  CI	   Rate	   	  	  95%	  CI	  
Maine	  total	   350	   26.4	  	   25.1	  -­‐	  27.6	  	   22.1	  	   21.1	  -­‐	  23.2	  	  
	   	   	   	   	   	  County	   	   	   	   	   	  
Androscoggin	   22	   20.4	  	   16.8	  -­‐	  24.6	  	   18.6	  	   15.3	  -­‐	  22.5	  	  
Aroostook	   12	   16.3	  	   12.4	  -­‐	  21.0	  	   12.5	  	   9.4	  -­‐	  16.4	  	  
Cumberland	   89	   31.7	  	   28.8	  -­‐	  34.8	  	   28.0	  	   25.4	  -­‐	  30.8	  	  
Franklin	   4	   13.7	  	   8.5	  -­‐	  20.9	  	   11.5	  	   7.0	  -­‐	  18.0	  	  
Hancock	   16	   29.5	  	   23.4	  -­‐	  36.7	  	   23.2	  	   18.2	  -­‐	  29.2	  	  
Kennebec	   25	   20.5	  	   17.1	  -­‐	  24.4	  	   16.9	  	   14.0	  -­‐	  20.2	  	  
Knox	   19	   46.9	  	   37.9	  -­‐	  57.4	  	   36.1	  	   28.8	  -­‐	  44.8	  	  
Lincoln	   12	   35.1	  	   26.9	  -­‐	  45.1	  	   23.8	  	   17.9	  -­‐	  31.3	  	  
Oxford	   16	   27.7	  	   21.9	  -­‐	  34.4	  	   23.1	  	   18.2	  -­‐	  29.1	  	  
Penobscot	   31	   20.1	  	   17.1	  -­‐	  23.6	  	   19.0	  	   16.1	  -­‐	  22.3	  	  
Piscataquis	   4	   22.8	  	   13.9	  -­‐	  35.2	  	   16.4	  	   9.7	  -­‐	  26.5	  	  
Sagadahoc	   12	   32.5	  	   24.7	  -­‐	  42.0	  	   27.1	  	   20.4	  -­‐	  35.4	  	  
Somerset	   9	   16.8	  	   12.2	  -­‐	  22.6	  	   14.5	  	   10.4	  -­‐	  19.7	  	  
Waldo	   9	   23.2	  	   16.9	  -­‐	  31.1	  	   18.6	  	   13.3	  -­‐	  25.3	  	  
Washington	   6	   18.1	  	   12.2	  -­‐	  25.8	  	   12.4	  	   8.2	  -­‐	  18.2	  	  
York	   64	   32.4	  	   29.0	  -­‐	  36.2	  	   26.7	  	   23.8	  -­‐	  29.9	  	  
Public	  health	  district	   	   	   	   	   	  
Aroostook	   12	   16.3	  	   12.4	  -­‐	  21.0	  	   12.5	  	   9.4	  -­‐	  16.4	  	  
Central	   34	   19.4	  	   16.6	  -­‐	  22.6	  	   16.2	  	   13.8	  -­‐	  18.9	  	  
Cumberland	   89	   31.7	  	   28.8	  -­‐	  34.8	  	   28.0	  	   25.4	  -­‐	  30.8	  	  
Downeast	   22	   25.2	  	   20.7	  -­‐	  30.3	  	   19.1	  	   15.6	  -­‐	  23.3	  	  
Midcoast	   52	   34.6	  	   30.5	  -­‐	  39.1	  	   26.6	  	   23.4	  -­‐	  30.3	  	  
Penquis	   35	   20.4	  	   17.5	  -­‐	  23.7	  	   18.8	  	   16.0	  -­‐	  21.9	  	  
Western	   42	   21.5	  	   18.7	  -­‐	  24.6	  	   18.9	  	   16.4	  -­‐	  21.7	  	  
York	   64	   32.4	  	   29.0	  -­‐	  36.2	  	   26.7	  	   23.8	  -­‐	  29.9	  	  
Maine	  Data	  Source:	  Maine	  CDC	  Cancer	  Registry,	  November	  2012	  NPCR	  data	  submission	  (1995-­‐2010).	  U.S.	  Data	  Source:	  SEER	  9	  
Research	  Data	  (1973-­‐2010).	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Incidence:	  The	  number	  of	  people	  who	  develop	  cancer	  (new	  cancer	  cases)	  during	  a	  specified	  period	  of	  time	  in	  a	  specified	  
population.	  	  	  
Melanoma:	  SEER	  Site	  Recode:	  25010	  (which	  includes	  ICD-­‐O-­‐3	  codes:	  C440-­‐C449).	  
Incidence	  case	  definitions	  exclude	  histologies	  consistent	  with	  Kaposi	  sarcoma	  and	  mesothelioma,	  where	  applicable.	  
Crude	  Rates	  are	  new	  cases	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  new	  cases	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	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Table	  2.27.	  Prostate	  cancer	  incidence	  by	  3-­‐year	  period,	  Maine,	  U.S.	  SEER	  9	  and	  U.S.	  SEER	  9	  whites,	  2000-­‐2010.	  





	  Crude	   Age-­‐adjusted	   Average	  
Annual	  
Number	  




Rate	   95%	  CI	   Rate	   95%	  CI	   Rate	   95%	  CI	   Rate	   95%	  CI	  
2000-­‐2002	   1,169	   186.6	   180.4	  -­‐	  192.8	   181.2	   175.1	  -­‐	  187.3	   20,363	   183.5	   182.0	  -­‐	  185.0	   16,584	   180.7	   179.1	  -­‐	  182.3	  
2001-­‐2003	   1,149	   181.8	   175.8	  -­‐	  188.0	   173.5	   167.7	  -­‐	  179.5	   20,298	   179.0	   177.6	  -­‐	  180.5	   16,470	   176.3	   174.7	  -­‐	  177.9	  
2002-­‐2004	   1,151	   180.7	   174.7	  -­‐	  186.8	   168.5	   162.9	  -­‐	  174.3	   20,049	   172.7	   171.3	  -­‐	  174.1	   16,164	   169.5	   168.0	  -­‐	  171.0	  
2003-­‐2005	   1,150	   179.3	   173.4	  -­‐	  185.4	   163.7	   158.2	  -­‐	  169.4	   19,525	   164.1	   162.8	  -­‐	  165.5	   15,598	   160.2	   158.7	  -­‐	  161.7	  
2004-­‐2006	   1,205	   186.9	   180.8	  -­‐	  193.1	   166.6	   161.1	  -­‐	  172.2	   20,127	   164.8	   163.5	  -­‐	  166.1	   16,001	   160.5	   159.1	  -­‐	  162.0	  
2005-­‐2007	   1,224	   189.1	   183.0	  -­‐	  195.3	   164.8	   159.4	  -­‐	  170.3	   21,082	   167.8	   166.4	  -­‐	  169.1	   16,644	   162.9	   161.5	  -­‐	  164.4	  
2006-­‐2008	   1,253	   192.9	   186.8	  -­‐	  199.2	   163.1	   157.8	  -­‐	  168.5	   21,762	   167.6	   166.3	  -­‐	  168.9	   17,114	   162.6	   161.2	  -­‐	  164.0	  
2007-­‐2009	   1,144	   175.9	   170.1	  -­‐	  181.9	   144.0	   139.1	  -­‐	  149.0	   21,733	   161.6	   160.4	  -­‐	  162.9	   16,982	   156.3	   154.9	  -­‐	  157.7	  
2008-­‐2010	   1,061	   163.1	   157.5	  -­‐	  168.9	   129.4	   124.8	  -­‐	  134.1	   21,166	   151.9	   150.7	  -­‐	  153.1	   16,416	   146.2	   144.9	  -­‐	  147.6	  
Maine	  Data	  Source:	  Maine	  CDC	  Cancer	  Registry,	  November	  2012	  NPCR	  data	  submission	  (1995-­‐2010).	  U.S.	  Data	  Source:	  SEER	  9	  Research	  Data	  (1973-­‐2010).	  	  
*The	  SEER	  9	  registries	  are	  Atlanta,	  Connecticut,	  Detroit,	  Hawaii,	  Iowa,	  New	  Mexico,	  San	  Francisco-­‐Oakland,	  Seattle-­‐Puget	  Sound,	  and	  Utah	  and	  represent	  9.4%	  
of	  U.S.	  population.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Incidence:	  The	  number	  of	  people	  who	  develop	  cancer	  (new	  cancer	  cases)	  during	  a	  specified	  period	  of	  time	  in	  a	  specified	  population.	  	  	  
Prostate	  cancer:	  SEER	  Site	  Recode:	  28010	  (which	  includes	  ICD-­‐O-­‐3	  codes:	  C619).	  
Incidence	  case	  definitions	  exclude	  histologies	  consistent	  with	  Kaposi	  sarcoma	  and	  mesothelioma,	  where	  applicable.	  
Crude	  Rates	  are	  new	  cases	  per	  100,000	  population.	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Table 2.28. Prostate cancer incidence by 3-year period and age group, Maine, 2000-2010. 
  Ages 0─34 years Ages 35─64 years  Ages 65─74 years  Ages 75 years and older 
  Crude Crude Crude Crude 
     3-Year Period 
Average 
Annual 
Number Rate 95%CI 
Average 
Annual 
Number Rate 95%CI 
Average 
Annual 
Number Rate 95%CI 
Average 
Annual 
Number Rate 95%CI 
2000-2002             0    0.0 0.0 - 0.4         364  137.0 129.0 - 145.3 464 1,043.1 989.1 - 1,099.4         341  1,038.9 976.2 - 1,104.6 
2001-2003             0    0.0 0.0 - 0.4         369  136.7 128.8 - 145.0 455 1,014.7 961.6 - 1,070.0         325     969.1 909.2 - 1,031.8 
2002-2004             0    0.0 0.0 - 0.4         403  147.0 138.9 - 155.6 447 990.8 938.5 - 1,045.2         300     876.2 819.9 - 935.3 
2003-2005             0    0.0 0.0 - 0.4         426  153.3 145.0 - 161.9 433 951.2 900.2 - 1,004.4         291     832.3 778.0 - 889.4 
2004-2006             0    0.0 0.0 - 0.4         476  169.0 160.3 - 178.0 437 946.8 896.2 - 999.5         292     819.3 766.0 - 875.4 
2005-2007             0    0.0 0.0 - 0.4         487  171.1 162.4 - 180.1 441 938.9 889.0 - 990.9         296     813.9 761.2 - 869.3 
2006-2008             0    0.0 0.0 - 0.4         514  179.8 170.9 - 189.0 451 931.2 882.2 - 982.2         287     775.0 724.1 - 828.5 
2007-2009             0    0.0 0.0 - 0.4         480  167.4 158.9 - 176.3 411 818.7 773.7 - 865.7         253     672.2 625.2 - 721.7 
2008-2010             0    0.0 0.0 - 0.4         448  156.5 148.3 - 165.1 393 753.1 710.7 - 797.3         220     575.0 532.0 - 620.5 
U.S. SEER 9          
2008-2010* 3 0.0 0.0 - 0.1 9,375 165.1 163.1 - 167.0 7,563 885.7 874.2 - 897.3 4,225 653.4 642.0 - 664.8 
U.S. SEER 9 Whites  
2008-2010* 2 0.0 0.0 - 0.1 7,079 162.7 160.5 - 164.9 5,963 862.8 850.3 - 875.6 3,371 625.4 613.2 - 637.7 
Maine Data Source: Maine CDC Cancer Registry, November 2012 NPCR data submission (1995-2010). U.S. Data Source: SEER 9 Research Data (1973-2010). 
*The SEER 9 registries are Atlanta, Connecticut, Detroit, Hawaii, Iowa, New Mexico, San Francisco-Oakland, Seattle-Puget Sound, and Utah and represent 
9.4% of U.S. population. 
95% CI: 95% confidence interval of the rate. 
Cancer Incidence: The number of people who develop cancer (new cancer cases) during a specified period of time in a specified population.   
Prostate cancer: SEER Site Recode: 28010 (which includes ICD-O-3 codes: C619). 
Incidence case definitions exclude histologies consistent with Kaposi sarcoma and mesothelioma, where applicable. 
Crude Rates are new cases per 100,000 population. 
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Crude	   Age-­‐Adjusted	  
Rate	   95%	  CI	   Rate	   95%	  CI	  
Maine	  total	   1,148	   176.7	  	   172.1	  -­‐	  181.3	  	   144.8	  	   141.0	  -­‐	  148.7	  	  
	   	   	   	   	   	  County	   	   	   	   	   	  
Androscoggin	   87	   164.3	  	   149.2	  -­‐	  180.5	  	   154.2	  	   139.8	  -­‐	  169.8	  	  
Aroostook	   55	   154.9	  	   137.2	  -­‐	  174.3	  	   108.0	  	   95.4	  -­‐	  121.9	  	  
Cumberland	   220	   161.7	  	   152.3	  -­‐	  171.6	  	   146.9	  	   138.1	  -­‐	  156.1	  	  
Franklin	   28	   188.0	  	   158.3	  -­‐	  221.7	  	   147.1	  	   123.1	  -­‐	  174.8	  	  
Hancock	   55	   208.2	  	   184.4	  -­‐	  234.2	  	   149.0	  	   131.5	  -­‐	  168.3	  	  
Kennebec	   108	   181.3	  	   166.3	  -­‐	  197.3	  	   149.5	  	   136.9	  -­‐	  163.1	  	  
Knox	   43	   219.1	  	   190.9	  -­‐	  250.3	  	   155.1	  	   134.8	  -­‐	  177.9	  	  
Lincoln	   34	   199.9	  	   171.0	  -­‐	  232.3	  	   125.2	  	   106.8	  -­‐	  146.5	  	  
Oxford	   55	   190.7	  	   168.7	  -­‐	  214.7	  	   142.7	  	   126.0	  -­‐	  161.2	  	  
Penobscot	   123	   163.6	  	   150.9	  -­‐	  177.0	  	   147.9	  	   136.2	  -­‐	  160.3	  	  
Piscataquis	   14	   157.0	  	   121.9	  -­‐	  199.0	  	   100.4	  	   77.4	  -­‐	  129.5	  	  
Sagadahoc	   30	   173.1	  	   146.5	  -­‐	  203.1	  	   135.5	  	   114.2	  -­‐	  160.0	  	  
Somerset	   45	   173.3	  	   151.4	  -­‐	  197.6	  	   135.7	  	   118.1	  -­‐	  155.3	  	  
Waldo	   35	   182.3	  	   156.1	  -­‐	  211.6	  	   145.3	  	   123.4	  -­‐	  170.0	  	  
Washington	   37	   225.5	  	   194.1	  -­‐	  260.6	  	   156.7	  	   134.4	  -­‐	  182.0	  	  
York	   179	   185.9	  	   173.9	  -­‐	  198.5	  	   156.8	  	   146.5	  -­‐	  167.7	  	  
Public	  health	  district	   	   	   	   	   	  
Aroostook	   55	   154.9	  	   137.2	  -­‐	  174.3	  	   108.0	  	   95.4	  -­‐	  121.9	  	  
Central	   152	   178.9	  	   166.4	  -­‐	  192.1	  	   145.3	  	   135.0	  -­‐	  156.3	  	  
Cumberland	   220	   161.7	  	   152.3	  -­‐	  171.6	  	   146.9	  	   138.1	  -­‐	  156.1	  	  
Downeast	   92	   214.8	  	   195.6	  -­‐	  235.3	  	   151.7	  	   137.8	  -­‐	  166.7	  	  
Midcoast	   142	   194.2	  	   180.1	  -­‐	  209.0	  	   139.6	  	   129.3	  -­‐	  150.6	  	  
Penquis	   137	   162.9	  	   150.9	  -­‐	  175.6	  	   141.0	  	   130.4	  -­‐	  152.2	  	  
Western	   170	   175.8	  	   164.2	  -­‐	  188.1	  	   148.7	  	   138.7	  -­‐	  159.3	  	  
York	   179	   185.9	  	   173.9	  -­‐	  198.5	  	   156.8	  	   146.5	  -­‐	  167.7	  	  
Maine	  Data	  Source:	  Maine	  CDC	  Cancer	  Registry,	  November	  2012	  NPCR	  data	  submission	  (1995-­‐2010).	  U.S.	  Data	  Source:	  SEER	  9	  
Research	  Data	  (1973-­‐2010).	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Incidence:	  The	  number	  of	  people	  who	  develop	  cancer	  (new	  cancer	  cases)	  during	  a	  specified	  period	  of	  time	  in	  a	  specified	  
population.	  	  	  
Prostate	  cancer:	  SEER	  Site	  Recode:	  28010	  (which	  includes	  ICD-­‐O-­‐3	  codes:	  C619).	  
Incidence	  case	  definitions	  exclude	  histologies	  consistent	  with	  Kaposi	  sarcoma	  and	  mesothelioma,	  where	  applicable.	  
Crude	  Rates	  are	  new	  cases	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  new	  cases	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	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Table	  2.30.	  Tobacco-­‐related	  cancer	  incidence	  by	  3-­‐year	  period,	  Maine,	  U.S.	  SEER	  9	  and	  U.S.	  SEER	  9	  whites,	  2000-­‐2010.	  





	  Crude	   Age-­‐adjusted	   Average	  
Annual	  
Number	  




Rate	   95%CI	   Rate	   95%	  CI	   Rate	   95%CI	   Rate	   95%CI	  
2000-­‐2002	   1,347	   104.7	   101.5	  -­‐	  108.0	   92.5	   89.7	  -­‐	  95.4	   20,830	   81.1	   80.5	  -­‐	  81.7	   17,177	   81.7	   81.0	  -­‐	  82.4	  
2001-­‐2003	   1,382	   106.7	   103.4	  -­‐	  110.0	   93.1	   90.3	  -­‐	  96.0	   21,069	   80.8	   80.1	  -­‐	  81.4	   17,357	   81.6	   80.9	  -­‐	  82.3	  
2002-­‐2004	   1,426	   109.2	   106.0	  -­‐	  112.5	   94.3	   91.5	  -­‐	  97.2	   21,483	   81.0	   80.4	  -­‐	  81.6	   17,691	   82.2	   81.5	  -­‐	  82.9	  
2003-­‐2005	   1,461	   111.3	   108.0	  -­‐	  114.6	   95.1	   92.3	  -­‐	  97.9	   21,909	   81.3	   80.7	  -­‐	  81.9	   17,998	   82.5	   81.8	  -­‐	  83.2	  
2004-­‐2006	   1,496	   113.4	   110.2	  -­‐	  116.8	   95.6	   92.8	  -­‐	  98.5	   22,441	   81.8	   81.2	  -­‐	  82.4	   18,416	   83.2	   82.5	  -­‐	  83.9	  
2005-­‐2007	   1,504	   113.6	   110.4	  -­‐	  117.0	   94.3	   91.5	  -­‐	  97.1	   22,980	   82.1	   81.5	  -­‐	  82.8	   18,789	   83.6	   82.9	  -­‐	  84.3	  
2006-­‐2008	   1,514	   114.1	   110.8	  -­‐	  117.5	   93.0	   90.3	  -­‐	  95.8	   23,608	   82.7	   82.1	  -­‐	  83.3	   19,233	   84.2	   83.5	  -­‐	  84.9	  
2007-­‐2009	   1,510	   113.6	   110.3	  -­‐	  116.9	   91.0	   88.3	  -­‐	  93.7	   24,126	   82.7	   82.1	  -­‐	  83.3	   19,556	   84.1	   83.4	  -­‐	  84.8	  
2008-­‐2010	   1,526	   114.8	   111.5	  -­‐	  118.2	   90.4	   87.8	  -­‐	  93.2	   24,477	   82.1	   81.5	  -­‐	  82.7	   19,748	   83.4	   82.8	  -­‐	  84.1	  
Maine	  Data	  Source:	  Maine	  CDC	  Cancer	  Registry,	  November	  2012	  NPCR	  data	  submission	  (1995-­‐2010).	  U.S.	  Data	  Source:	  SEER	  9	  Research	  Data	  (1973-­‐2010).	  	  
*The	  SEER	  9	  registries	  are	  Atlanta,	  Connecticut,	  Detroit,	  Hawaii,	  Iowa,	  New	  Mexico,	  San	  Francisco-­‐Oakland,	  Seattle-­‐Puget	  Sound,	  and	  Utah	  and	  represent	  9.4%	  
of	  U.S.	  population.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Incidence:	  The	  number	  of	  people	  who	  develop	  cancer	  (new	  cancer	  cases)	  during	  a	  specified	  period	  of	  time	  in	  a	  specified	  population.	  	  	  
Tobacco-­‐related	  cancers	  (excluding	  lung)	  include	  the	  following:	  laryngeal,	  oral	  cavity	  and	  pharynx,	  esophageal,	  stomach,	  pancreatic,	  kidney	  and	  renal	  pelvis,	  
urinary	  bladder,	  cervical	  cancers,	  and	  acute	  myeloid	  leukemia.	  	  Please	  see	  Appendix	  II	  for	  SEER	  and	  ICD-­‐O-­‐3	  codes.	  	  
Incidence	  case	  definitions	  exclude	  histologies	  consistent	  with	  Kaposi	  sarcoma	  and	  mesothelioma,	  where	  applicable.	  
Crude	  Rates	  are	  new	  cases	  per	  100,000	  population.	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Table	  2.31.	  Tobacco-­‐related	  cancer	  incidence	  by	  3-­‐year	  period	  and	  sex,	  Maine,	  2000-­‐2010.	  
3-­‐Year	  Period	  




	  Crude	   Age-­‐adjusted	   Average	  
Annual	  
Number	  
Crude	   Age-­‐adjusted	   Average	  
Annual	  
Number	  
Crude	   Age-­‐adjusted	  
Rate	   95%CI	   Rate	   95%	  CI	   Rate	   95%CI	   Rate	   95%CI	   Rate	   95%CI	   Rate	   95%CI	  
2000-­‐2002	   1,347	   104.7	   101.5	  -­‐	  108.0	   92.5	   89.7	  -­‐	  95.4	   484	   73.4	   69.7	  -­‐	  77.3	   60.2	   57.1	  -­‐	  63.4	   863	   137.8	   132.5	  -­‐	  143.2	   135.0	   129.8	  -­‐	  140.4	  
2001-­‐2003	   1,382	   106.7	   103.4	  -­‐	  110.0	   93.1	   90.3	  -­‐	  96.0	   482	   72.5	   68.8	  -­‐	  76.4	   59.1	   56.1	  -­‐	  62.3	   901	   142.5	   137.2	  -­‐	  148.0	   137.6	   132.4	  -­‐	  143.0	  
2002-­‐2004	   1,426	   109.2	   106.0	  -­‐	  112.5	   94.3	   91.5	  -­‐	  97.2	   501	   75.0	   71.2	  -­‐	  78.9	   60.5	   57.4	  -­‐	  63.7	   925	   145.1	   139.8	  -­‐	  150.6	   137.6	   132.5	  -­‐	  142.9	  
2003-­‐2005	   1,461	   111.3	   108.0	  -­‐	  114.6	   95.1	   92.3	  -­‐	  97.9	   527	   78.4	   74.6	  -­‐	  82.4	   62.8	   59.7	  -­‐	  66.0	   935	   145.7	   140.4	  -­‐	  151.2	   136.6	   131.5	  -­‐	  141.8	  
2004-­‐2006	   1,496	   113.4	   110.2	  -­‐	  116.8	   95.6	   92.8	  -­‐	  98.5	   540	   80.1	   76.3	  -­‐	  84.1	   63.5	   60.4	  -­‐	  66.7	   956	   148.3	   142.9	  -­‐	  153.8	   136.4	   131.4	  -­‐	  141.6	  
2005-­‐2007	   1,504	   113.6	   110.4	  -­‐	  117.0	   94.3	   91.5	  -­‐	  97.1	   537	   79.5	   75.7	  -­‐	  83.5	   62.1	   59.1	  -­‐	  65.3	   966	   149.3	   143.9	  -­‐	  154.9	   135.5	   130.6	  -­‐	  140.7	  
2006-­‐2008	   1,514	   114.1	   110.8	  -­‐	  117.5	   93.0	   90.3	  -­‐	  95.8	   533	   78.6	   74.8	  -­‐	  82.5	   60.6	   57.6	  -­‐	  63.7	   982	   151.2	   145.8	  -­‐	  156.8	   134.2	   129.3	  -­‐	  139.2	  
2007-­‐2009	   1,510	   113.6	   110.3	  -­‐	  116.9	   91.0	   88.3	  -­‐	  93.7	   519	   76.5	   72.8	  -­‐	  80.4	   58.3	   55.4	  -­‐	  61.3	   990	   152.3	   146.8	  -­‐	  157.8	   132.3	   127.5	  -­‐	  137.3	  
2008-­‐2010	   1,526	   114.8	   111.5	  -­‐	  118.2	   90.4	   87.8	  -­‐	  93.2	   517	   76.2	   72.5	  -­‐	  80.1	   57.4	   54.5	  -­‐	  60.5	   1,009	   155.1	   149.6	  -­‐	  160.7	   131.6	   126.9	  -­‐	  136.5	  
U.S.	  SEER	  9	  	  	  	  	  	  	  	  	  	  
2008-­‐2010*	   24,477	   85.1	   84.5	  -­‐	  85.7	   82.1	   81.5	  -­‐	  82.7	   8,933	   61.2	   60.5	  -­‐	  61.9	   55.0	   54.3	  -­‐	  55.7	   15,544	   109.7	   108.8	  -­‐	  110.7	   116.9	   115.8	  -­‐	  118.0	  
U.S.	  SEER	  9	  Whites	  
2008-­‐2010*	  
19,748	   92.7	   92.0	  -­‐	  93.5	   83.4	   82.8	  -­‐	  84.1	   6,925	   64.7	   63.8	  -­‐	  65.5	   54.3	   53.6	  -­‐	  55.1	   12,823	   121.1	   119.9	  -­‐	  122.3	   119.9	   118.7	  -­‐	  121.1	  
Maine	  Data	  Source:	  Maine	  Cancer	  Registry,	  November	  2012	  NPCR	  data	  submission	  (1995-­‐2010).	  U.S.	  Data	  Source:	  SEER	  9	  Research	  Data	  (1973-­‐2010).	  	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Incidence:	  The	  number	  of	  people	  who	  develop	  cancer	  (new	  cancer	  cases)	  during	  a	  specified	  period	  of	  time	  in	  a	  specified	  population.	  	  	  
Tobacco-­‐related	  cancers	  (excluding	  lung)	  include	  the	  following:	  laryngeal,	  oral	  cavity	  and	  pharynx,	  esophageal,	  stomach,	  pancreatic,	  kidney	  and	  renal	  pelvis,	  urinary	  bladder,	  
cervical	  cancers,	  and	  acute	  myeloid	  leukemia.	  	  Please	  see	  Appendix	  II	  for	  SEER	  and	  ICD-­‐O-­‐3	  codes.	  	  
Incidence	  case	  definitions	  exclude	  histologies	  consistent	  with	  Kaposi	  sarcoma	  and	  mesothelioma,	  where	  applicable.	  
Crude	  Rates	  are	  new	  cases	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  new	  cases	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	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Table 2.32. Tobacco-related cancer (excluding lung cancer) incidence by 3-year period and age group, Maine, 2000-2010. 
  Ages 0─34 years Ages 35─64 years  Ages 65─74 years  Ages 75 years and older 




Number Rate 95%CI 
Average 
Annual 
Number Rate 95%CI 
Average 
Annual 
Number Rate 95%CI 
Average 
Annual 
Number Rate 95%CI 
2000-2002           22  3.9 3.0 - 5.0         500  92.6 88.0 - 97.4 380 394.6 372.0 - 418.2         445  500.5 474.1 - 528.1 
2001-2003           23  4.1 3.2 - 5.2         519  94.5 89.9 - 99.3 385 399.7 377.0 - 423.4         455  503.6 477.2 - 531.0 
2002-2004           27  4.9 3.9 - 6.1         546  97.8 93.1 - 102.7 379 392.2 369.7 - 415.7         473  517.2 490.6 - 544.8 
2003-2005           27  4.8 3.8 - 6.0         562  99.3 94.6 - 104.1 386 396.7 374.2 - 420.2         487  526.0 499.4 - 553.7 
2004-2006           26  4.8 3.8 - 5.9         580  101.3 96.6 - 106.2 396 403.6 381.0 - 427.2         493  526.2 499.7 - 553.7 
2005-2007           24  4.4 3.4 - 5.5         578  99.9 95.2 - 104.7 398 399.9 377.6 - 423.3         504  530.1 503.7 - 557.5 
2006-2008           23  4.1 3.2 - 5.3         582  100.0 95.4 - 104.8 406 397.2 375.2 - 420.1         503  522.7 496.7 - 549.8 
2007-2009           23  4.2 3.3 - 5.4         579  99.3 94.7 - 104.1 409 386.0 364.7 - 408.2         499  513.7 488.0 - 540.4 
2008-2010           24  4.5 3.5 - 5.7         594  102.0 97.3 - 106.8 408 372.0 351.4 - 393.4         500  510.4 484.9 - 536.9 
U.S. SEER 9          
2008-2010* 594 4.3 4.1 - 4.5 9,831 85.1 84.2 - 86.1 6,024 328.2 323.4 - 333.0 8,028 483.2 477.1 - 489.4 
U.S. SEER 9 Whites  
2008-2010* 426 4.4 4.1 - 4.6 7,623 87.6 86.5 - 88.8 4,919 325.1 317.0 - 333.3 6,780 493.5 486.8 - 500.4 
Maine Data Source: Maine CDC Cancer Registry, November 2012 NPCR data submission (1995-2010). U.S. Data Source: SEER 9 Research Data (1973-2010). 
*The SEER 9 registries are Atlanta, Connecticut, Detroit, Hawaii, Iowa, New Mexico, San Francisco-Oakland, Seattle-Puget Sound, and Utah and represent 
9.4% of U.S. population. 
95% CI: 95% confidence interval of the rate. 
Cancer Incidence: The number of people who develop cancer (new cancer cases) during a specified period of time in a specified population.   
Tobacco-related cancers (excluding lung) include the following: laryngeal, oral cavity and pharynx, esophageal, stomach, pancreatic, kidney and renal 
pelvis, urinary bladder, cervical cancers, and acute myeloid leukemia.  Please see Appendix II for SEER and ICD-O-3 codes. 
Incidence case definitions exclude histologies consistent with Kaposi sarcoma and mesothelioma, where applicable. 
Crude Rates are new cases per 100,000 population. 
Age-adjusted rates are not calculated for age-specific groups. 
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Crude	   Age-­‐Adjusted	  
Rate	   	  	  95%	  CI	   Rate	   	  	  	  	  95%	  CI	  
Maine	  total	   1,524	   114.8	   112.2	  -­‐	  117.4	   91.9	   89.8	  -­‐	  94.0	  
	   	   	   	   	   	  County	   	   	   	   	   	  
Androscoggin	   125	   115.5	   106.6	  -­‐	  124.9	   100.8	   93.0	  -­‐	  109.1	  
Aroostook	   94	   129.5	   118.1	  -­‐	  141.8	   92.4	   84.0	  -­‐	  101.4	  
Cumberland	   291	   103.9	   98.6	  -­‐	  109.3	   89.6	   85.0	  -­‐	  94.4	  
Franklin	   34	   109.6	   93.7	  -­‐	  127.5	   85.9	   73.2	  -­‐	  100.4	  
Hancock	   66	   122.3	   109.5	  -­‐	  136.2	   88.4	   78.9	  -­‐	  98.9	  
Kennebec	   137	   112.2	   104.0	  -­‐	  120.9	   91.4	   84.6	  -­‐	  98.7	  
Knox	   51	   128.1	   112.9	  -­‐	  144.8	   90.8	   79.7	  -­‐	  103.1	  
Lincoln	   46	   133.1	   116.5	  -­‐	  151.4	   86.9	   75.6	  -­‐	  99.7	  
Oxford	   76	   132.0	   119.1	  -­‐	  146.0	   99.2	   89.4	  -­‐	  109.9	  
Penobscot	   168	   109.7	   102.4	  -­‐	  117.4	   94.7	   88.3	  -­‐	  101.5	  
Piscataquis	   22	   126.5	   104.0	  -­‐	  152.3	   84.3	   68.9	  -­‐	  102.6	  
Sagadahoc	   36	   100.9	   86.7	  -­‐	  116.8	   82.1	   70.3	  -­‐	  95.4	  
Somerset	   62	   118.3	   105.4	  -­‐	  132.2	   93.1	   82.9	  -­‐	  104.4	  
Waldo	   40	   103.8	   89.9	  -­‐	  119.1	   83.1	   71.6	  -­‐	  95.9	  
Washington	   44	   132.7	   115.8	  -­‐	  151.5	   90.7	   78.8	  -­‐	  104.1	  
York	   232	   117.4	   110.7	  -­‐	  124.4	   95.7	   90.2	  -­‐	  101.4	  
Public	  health	  district	   	   	   	   	   	  
Aroostook	   94	   129.5	   118.1	  -­‐	  141.8	   92.4	   84.0	  -­‐	  101.4	  
Central	   199	   114.0	   107.0	  -­‐	  121.3	   92.1	   86.4	  -­‐	  98.1	  
Cumberland	   291	   103.9	   98.6	  -­‐	  109.3	   89.6	   85.0	  -­‐	  94.4	  
Downeast	   110	   126.2	   115.9	  -­‐	  137.2	   89.1	   81.6	  -­‐	  97.2	  
Midcoast	   174	   116.4	   108.8	  -­‐	  124.5	   85.9	   80.1	  -­‐	  92.0	  
Penquis	   190	   111.4	   104.5	  -­‐	  118.8	   93.4	   87.5	  -­‐	  99.7	  
Western	   235	   119.4	   112.7	  -­‐	  126.5	   98.0	   92.4	  -­‐	  103.9	  
York	   232	   117.4	   110.7	  -­‐	  124.4	   95.7	   90.2	  -­‐	  101.4	  
Maine	  Data	  Source:	  Maine	  CDC	  Cancer	  Registry,	  November	  2012	  NPCR	  data	  submission	  (1995-­‐2010).	  U.S.	  Data	  Source:	  SEER	  9	  
Research	  Data	  (1973-­‐2010).	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Incidence:	  The	  number	  of	  people	  who	  develop	  cancer	  (new	  cancer	  cases)	  during	  a	  specified	  period	  of	  time	  in	  a	  specified	  
population.	  	  	  
Tobacco-­‐related	  cancers	  (excluding	  lung)	  include	  the	  following:	  laryngeal,	  oral	  cavity	  and	  pharynx,	  esophageal,	  stomach,	  
pancreatic,	  kidney	  and	  renal	  pelvis,	  urinary	  bladder,	  cervical	  cancers,	  and	  acute	  myeloid	  leukemia.	  	  Please	  see	  Appendix	  II	  for	  SEER	  
and	  ICD-­‐O-­‐3	  codes.	  
Incidence	  case	  definitions	  exclude	  histologies	  consistent	  with	  Kaposi	  sarcoma	  and	  mesothelioma,	  where	  applicable.	  
Crude	  Rates	  are	  new	  cases	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  new	  cases	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
	  
 













Crude	   Age-­‐adjusted	   Proportion	  
Rate	   95%	  CI	   Rate	   95%	  CI	   %	  of	  Total	  	  	   95%	  CI	  
	  	  	  	  	  	  Maine	   	   	   	   	   	   	   	  
Early-­‐stage	   1,042	   153.5	   148.2	  -­‐	  159.0	   117.2	   113.0	  -­‐	  121.5	   73.6	   72.2	  -­‐	  74.9	  
	  Late-­‐stage	   351	   51.8	   48.7	  -­‐	  55.0	   40.6	   38.1	  -­‐	  43.3	   24.8	   23.5	  -­‐	  26.1	  
	  	  Unknown	   23	   3.4	   2.6	  -­‐	  4.3	   2.3	   1.8	  -­‐	  3.0	   1.6	   1.3	  -­‐	  2.0	  
	  	  	  	  	  	  	  	  	  	  	  	  	  Overall	   1,416	   	  	  	  	  	  208.7	   202.5	  -­‐	  215.1	   160.2	   155.2	  -­‐	  165.2	   100	   -­‐-­‐-­‐	  
U.S.	  SEER	  9*	  	   	   	   	   	   	   	   	  
Early-­‐stage	   18,960	   129.9	   128.8	  -­‐	  131.0	   117.8	   116.8	  -­‐	  118.7	   71.9	   71.5	  -­‐	  72.2	  
	  Late-­‐stage	   7,092	   48.6	   47.9	  -­‐	  49.2	   44.3	   43.6	  -­‐	  44.9	   26.9	   26.6	  -­‐	  27.2	  
	  	  Unknown	   334	   2.3	   2.2	  -­‐	  2.4	   1.9	   1.8	  -­‐	  2.1	   1.3	   1.2	  -­‐	  1.3	  
	  	  	  	  	  	  	  	  	  	  	  	  	  Overall	   26,387	   180.8	   179.5	  -­‐	  182.0	   164.0	   162.8	  -­‐	  165.1	   100.0	   -­‐-­‐-­‐	  
U.S.	  SEER	  9	  Whites*	  	   	   	   	   	   	   	   	  
Early-­‐stage	   15,156	   141.5	   140.2	  -­‐	  142.8	   121.6	   120.5	  -­‐	  122.8	   72.6	   72.2	  -­‐	  72.9	  
Late-­‐stage	   5,476	   51.1	   50.4	  -­‐	  51.9	   44.4	   43.7	  -­‐	  45.1	   26.2	   25.9	  -­‐	  26.6	  
	  	  Unknown	   252	   2.4	   2.2	  -­‐	  2.5	   1.8	   1.7	  -­‐	  1.9	   1.2	   1.1	  -­‐	  1.3	  
	  	  	  	  	  Overall	   20,884	   195.0	   193.5	  -­‐	  196.5	   167.8	   166.4	  -­‐	  169.1	   100.0	   -­‐-­‐-­‐	  
Maine	  Data	  Source:	  Maine	  CDC	  Cancer	  Registry,	  November	  2012	  NPCR	  data	  submission	  (1995-­‐2010).	  U.S.	  Data	  Source:	  SEER	  9	  
Research	  Data	  (1973-­‐2010).	  	  
*The	  SEER	  9	  registries	  are	  Atlanta,	  Connecticut,	  Detroit,	  Hawaii,	  Iowa,	  New	  Mexico,	  San	  Francisco-­‐Oakland,	  Seattle-­‐Puget	  
Sound,	  and	  Utah	  and	  represent	  9.4%	  of	  U.S.	  population.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate	  or	  proportion.	  
Cancer	  Incidence:	  The	  number	  of	  people	  who	  develop	  cancer	  (new	  cancer	  cases)	  during	  a	  specified	  period	  of	  time	  in	  a	  specified	  
population.	  	  	  
Female	  breast	  cancer:	  SEER	  Site	  Recode:	  26000	  (which	  includes	  ICD-­‐O-­‐3	  codes:	  C500-­‐C509).	  
Incidence	  case	  definitions	  exclude	  histologies	  consistent	  with	  Kaposi	  sarcoma	  and	  mesothelioma,	  where	  applicable.	  
Crude	  Rates	  are	  new	  cases	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  new	  cases	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
Definition:	  Stage	  at	  diagnosis	  =	  Summary	  of	  stage	  variable	  derived	  from	  the	  Collaborative	  Stage	  system.	  “Early-­‐stage”:	  in	  situ	  or	  
localized	  cancers,	  “Late-­‐stage”:	  regional	  or	  distant	  cancers,	  and	  “Unknown”:	  unknown	  or	  unstaged	  cancers.	  
 





Table	  2.35.	  Cervical	  cancer	  incidence	  by	  stage	  at	  diagnosis,	  Maine,	  U.S.	  SEER	  9	  and	  U.S.	  SEER	  9	  Whites,	  	  	  	  	  	  	  	  	  	  	  	  	  	  
2008-­‐2010.	  
	   Average	  
Annual	  
Number	  
Crude	   Age-­‐adjusted	   Proportion	  
	  
3-­‐Year	  Period	   Rate	   95%	  CI	   Rate	   95%	  CI	   %	  of	  Total	  	  	   95%	  CI	  
	  	  	  	  	  	  Maine	   	   	   	   	   	   	   	  
	  	  	  	  	  	  	  	  	  	  	  	  	  Early-­‐stage	   21	   3.2	   2.5	  -­‐	  4.1	   3.4	   2.6	  -­‐	  4.4	   45.8	   37.8	  -­‐	  54.0	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  Late-­‐stage	   24	   3.5	   2.8	  -­‐	  4.5	   2.8	   2.2	  -­‐	  3.5	   50.7	   42.6	  -­‐	  58.8	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Unknown	   1	   0.2	   0.1	  -­‐	  0.6	   0.2	   0.1	  -­‐	  0.4	   3.5	   1.5	  -­‐	  8.0	  
Overall	   47	   7.0	   5.9	  -­‐	  8.2	   6.4	   5.3	  -­‐	  7.5	   100.0	   -­‐-­‐-­‐	  
U.S.	  SEER	  9*	  	   	   	   	   	   	   	   	  
Early-­‐stage	   495	   3.4	   3.2	  -­‐	  3.6	   3.4	   3.2	  -­‐	  3.6	   48.8	   47.0	  -­‐	  50.5	  
	  Late-­‐stage	   478	   3.3	   3.1	  -­‐	  3.5	   3.1	   2.9	  -­‐	  3.3	   47.2	   45.4	  -­‐	  48.9	  
	  	  Unknown	   41	   0.3	   0.2	  -­‐	  0.3	   0.3	   0.2	  -­‐	  0.3	   4.1	   3.4	  -­‐	  4.8	  
Overall	   1,015	   7.0	   6.7	  -­‐	  7.2	   6.8	   6.5	  -­‐	  7.0	   100	   -­‐-­‐-­‐	  
U.S.	  SEER	  9	  Whites*	  	   	   	   	   	   	   	   	  
Early-­‐stage	   369	   3.5	   3.3	  -­‐	  3.7	   3.5	   3.3	  -­‐	  3.7	   50.6	   48.5	  -­‐	  52.7	  
Late-­‐stage	   334	   3.1	   2.9	  -­‐	  3.3	   2.9	   2.7	  -­‐	  3.1	   45.8	   43.7	  -­‐	  47.9	  
	  	  Unknown	   26	   0.2	   0.2	  -­‐	  0.3	   0.2	   0.2	  -­‐	  0.3	   3.6	   2.9	  -­‐	  4.5	  
	  	  	  	  	  Overall	   730	   6.8	   6.5	  -­‐	  7.1	   6.6	   6.3	  -­‐	  6.9	   100	   -­‐-­‐-­‐	  
Maine	  Data	  Source:	  Maine	  CDC	  Cancer	  Registry,	  November	  2012	  NPCR	  data	  submission	  (1995-­‐2010).	  U.S.	  Data	  Source:	  SEER	  9	  
Research	  Data	  (1973-­‐2010).	  	  
*The	  SEER	  9	  registries	  are	  Atlanta,	  Connecticut,	  Detroit,	  Hawaii,	  Iowa,	  New	  Mexico,	  San	  Francisco-­‐Oakland,	  Seattle-­‐Puget	  
Sound,	  and	  Utah	  and	  represent	  9.4%	  of	  U.S.	  population.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate	  or	  proportion.	  
Cancer	  Incidence:	  The	  number	  of	  people	  who	  develop	  cancer	  (new	  cancer	  cases)	  during	  a	  specified	  period	  of	  time	  in	  a	  
specified	  population.	  	  	  
Cervical	  cancer:	  SEER	  Site	  Recode:	  27010	  (which	  includes	  ICD-­‐O-­‐3	  codes:	  C530-­‐C539).	  
Incidence	  case	  definitions	  exclude	  histologies	  consistent	  with	  Kaposi	  sarcoma	  and	  mesothelioma,	  where	  applicable.	  
Crude	  Rates	  are	  new	  cases	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  new	  cases	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
Definition:	  Stage	  at	  diagnosis	  =	  Summary	  of	  stage	  variable	  derived	  from	  the	  Collaborative	  Stage	  system.	  “Early-­‐stage”:	  in	  situ	  
or	  localized	  cancers,	  “Late-­‐stage”:	  regional	  or	  distant	  cancers,	  and	  “Unknown”:	  unknown	  or	  unstaged	  cancers.	  
 





Table	  2.36.	  Colorectal	  cancer	  incidence	  by	  stage	  at	  diagnosis,	  Maine,	  U.S.	  SEER	  9	  and	  U.S.	  SEER	  9	  Whites,	  	  	  	  	  	  	  	  	  	  	  
2008-­‐2010.	  
	   Average	  
Annual	  
Number	  
Crude	   Age-­‐adjusted	   Proportion	  
	  
3-­‐Year	  Period	   Rate	   95%	  CI	   Rate	   95%	  CI	   %	  of	  Total	  	  	   95%	  CI	  
	  	  	  	  	  	  Maine	   	   	   	   	   	   	   	  
Early-­‐stage	   341	   25.7	   24.1	  -­‐	  27.3	   20.2	   18.9	  -­‐	  21.5	   44.7	   42.6	  -­‐	  46.7	  
	  Late-­‐stage	   376	   28.3	   26.7	  -­‐	  30.0	   22.5	   21.2	  -­‐	  23.9	   49.2	   47.2	  -­‐	  51.3	  
	  	  Unknown	   47	   3.5	   3.0	  -­‐	  4.1	   2.7	   2.2	  -­‐	  3.2	   6.1	   5.2	  -­‐	  7.2	  
	  	  	  	  	  	  	  	  	  	  	  	  	  Overall	   764	   57.5	   55.1	  -­‐	  59.9	   45.4	   43.5	  -­‐	  47.3	   100.0	   -­‐-­‐-­‐	  
U.S.	  SEER	  9*	  	   	   	   	   	   	   	   	  
Early-­‐stage	   5,686	   19.8	   19.5	  -­‐	  20.1	   19.1	   18.8	  -­‐	  19.4	   43.0	   42.5	  -­‐	  43.5	  
	  Late-­‐stage	   6,916	   24.0	   23.7	  -­‐	  24.4	   23.2	   22.9	  -­‐	  23.5	   52.3	   51.8	  -­‐	  52.8	  
	  	  Unknown	   622	   2.2	   2.1	  -­‐	  2.3	   2.0	   1.9	  -­‐	  2.1	   4.7	   4.5	  -­‐	  4.9	  
	  	  	  	  	  	  	  	  	  	  	  	  	  Overall	   13,223	   46.0	   45.5	  -­‐	  46.4	   44.3	   43.9	  -­‐	  44.8	   100.0	   -­‐-­‐-­‐	  
U.S.	  SEER	  9	  Whites*	  	  	   	   	   	   	   	   	  
Early-­‐stage	   4,381	   20.6	   20.2	  -­‐	  20.9	   18.5	   18.2	  -­‐	  18.8	   42.9	   42.3	  -­‐	  43.4	  
Late-­‐stage	   5,378	   25.2	   24.9	  -­‐	  25.6	   22.7	   22.4	  -­‐	  23.1	   52.6	   52.1	  -­‐	  53.2	  
	  	  Unknown	   460	   2.2	   2.0	  -­‐	  2.3	   1.8	   1.7	  -­‐	  1.9	   4.5	   4.3	  -­‐	  4.7	  
	  	  	  	  	  Overall	   10,219	   48.0	   47.4	  -­‐	  48.5	   43.1	   42.6	  -­‐	  43.6	   100.0	   -­‐-­‐-­‐	  
Maine	  Data	  Source:	  Maine	  CDC	  Cancer	  Registry,	  November	  2012	  NPCR	  data	  submission	  (1995-­‐2010).	  U.S.	  Data	  Source:	  SEER	  9	  
Research	  Data	  (1973-­‐2010).	  	  
*The	  SEER	  9	  registries	  are	  Atlanta,	  Connecticut,	  Detroit,	  Hawaii,	  Iowa,	  New	  Mexico,	  San	  Francisco-­‐Oakland,	  Seattle-­‐Puget	  
Sound,	  and	  Utah	  and	  represent	  9.4%	  of	  U.S.	  population.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate	  or	  proportion.	  
Cancer	  Incidence:	  The	  number	  of	  people	  who	  develop	  cancer	  (new	  cancer	  cases)	  during	  a	  specified	  period	  of	  time	  in	  a	  specified	  
population.	  	  	  
Colorectal	  cancer:	  SEER	  Site	  Recode:	  21041-­‐21049,	  21051,	  21052	  (which	  include	  ICD-­‐O-­‐3	  codes:	  C180-­‐C189,	  C260,	  C199,	  C209).	  
Incidence	  case	  definitions	  exclude	  histologies	  consistent	  with	  Kaposi	  sarcoma	  and	  mesothelioma,	  where	  applicable.	  
Crude	  Rates	  are	  new	  cases	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  new	  cases	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
Definition:	  Stage	  at	  diagnosis	  =	  Summary	  of	  stage	  variable	  derived	  from	  the	  Collaborative	  Stage	  system.	  “Early-­‐stage”:	  in	  situ	  or	  
localized	  cancers,	  “Late-­‐stage”:	  regional	  or	  distant	  cancers,	  and	  “Unknown”:	  unknown	  or	  unstaged	  cancers.	  
 














Crude	   Age-­‐adjusted	   Proportion	   Average	  
Annual	  
Number	  
Crude	   Age-­‐adjusted	   Proportion	  
Rate	   95%	  CI	   Rate	   95%	  CI	  
%	  of	  
Total	  	  	   95%	  CI	   Rate	   95%	  CI	   Rate	   95%	  CI	  
%	  of	  
Total	   95%	  CI	  
Maine	   	   	   	   	   	   	   	   	   	   	   	   	  
Early-­‐stage	   160	   23.6	   21.6	  -­‐	  25.8	   17.2	   15.7	  -­‐	  18.9	   43.1	   40.2	  -­‐	  46.0	   180	   27.8	   25.5	  -­‐	  30.2	   23.6	   21.6	  -­‐	  25.8	   46.1	   43.3	  -­‐	  49.0	  
	  Late-­‐stage	   185	   27.4	   25.1	  -­‐	  29.7	   20.2	   18.5	  -­‐	  22.0	   49.9	   47.0	  -­‐	  52.8	   190	   29.3	   26.9	  -­‐	  31.8	   25.2	   23.1	  -­‐	  27.4	   48.6	   45.7	  -­‐	  51.5	  
	  	  Unknown	   26	   3.8	   3.0	  -­‐	  4.8	   2.5	   2.0	  -­‐	  3.1	   7.0	   5.6	  -­‐	  8.6	   20	   3.2	   2.4	  -­‐	  4.1	   2.8	   2.1	  -­‐	  3.6	   5.3	   4.1	  -­‐	  6.7	  
	  	  	  	  	  	  	  	  	  	  	  	  Overall	   372	   54.8	   51.6	  -­‐	  58.1	   39.9	   37.5	  -­‐	  42.4	   100.0	   -­‐-­‐-­‐	   391	   60.2	   56.8	  -­‐	  63.8	   51.6	   48.6	  -­‐	  54.7	   100.0	   -­‐-­‐-­‐	  
U.S.	  SEER	  9*	  	   	   	   	   	   	   	   	   	   	   	   	   	  
Early-­‐stage	   2,730	   18.7	   18.3	  -­‐	  19.1	   16.6	   16.2	  -­‐	  17.0	   42.2	   41.5	  -­‐	  42.8	   2,955	   20.9	   20.4	  -­‐	  21.3	   22.1	   21.6	  -­‐	  22.6	   43.8	   43.1	  -­‐	  44.5	  
	  Late-­‐stage	   3,410	   23.4	   22.9	  -­‐	  23.8	   20.7	   20.3	  -­‐	  21.1	   52.6	   51.9	  -­‐	  53.3	   3,505	   24.8	   24.3	  -­‐	  25.2	   26.3	   25.8	  -­‐	  26.8	   52.0	   51.3	  -­‐	  52.7	  
	  	  Unknown	   337	   2.3	   2.2	  -­‐	  2.5	   1.8	   1.7	  -­‐	  2.0	   5.2	   4.9	  -­‐	  5.5	   284	   2.0	   1.9	  -­‐	  2.1	   2.3	   2.1	  -­‐	  2.4	   4.2	   3.9	  -­‐	  4.5	  
	  	  	  	  	  	  	  	  	  	  	  	  Overall	   6,478	   44.4	   43.8	  -­‐	  45.0	   39.1	   38.6	  -­‐	  39.7	   100.0	   -­‐-­‐-­‐	   6,745	   47.6	   47.0	  -­‐	  48.3	   50.6	   49.9	  -­‐	  51.3	   100.0	   -­‐-­‐-­‐	  
U.S.	  SEER	  9	  Whites*	  	   	   	   	   	   	   	   	   	   	   	   	   	  
Early-­‐stage	   2,084	   19.5	   19.0	  -­‐	  20.0	   16.0	   15.6	  -­‐	  16.5	   41.9	   41.1	  -­‐	  42.6	   2,297	   21.7	   21.2	  -­‐	  22.2	   21.5	   21.0	  -­‐	  22.0	   43.8	   43.1	  -­‐	  44.6	  
Late-­‐stage	   2,640	   24.7	   24.1	  -­‐	  25.2	   20.2	   19.8	  -­‐	  20.7	   53.0	   52.2	  -­‐	  53.8	   2,737	   25.8	   25.3	  -­‐	  26.4	   25.6	   25.1	  -­‐	  26.2	   52.2	   51.5	  -­‐	  53.0	  
	  	  Unknown	   255	   2.4	   2.2	  -­‐	  2.6	   1.7	   1.6	  -­‐	  1.8	   5.1	   4.8	  -­‐	  5.5	   204	   1.9	   1.8	  -­‐	  2.1	   2.0	   1.9	  -­‐	  2.2	   3.9	   3.6	  -­‐	  4.2	  
	  	  	  	  	  Overall	   4,979	   46.5	   45.8	  -­‐	  47.2	   38.0	   37.4	  -­‐	  38.6	   100.0	   -­‐-­‐-­‐	   5,239	   49.5	   48.7	  -­‐	  50.2	   49.2	   48.4	  -­‐	  49.9	   100.0	   -­‐-­‐-­‐	  
Maine	  Data	  Source:	  Maine	  CDC	  Cancer	  Registry,	  November	  2012	  NPCR	  data	  submission	  (1995-­‐2010).	  U.S.	  Data	  Source:	  SEER	  9	  Research	  Data	  (1973-­‐2010).	  	  
*The	  SEER	  9	  registries	  are	  Atlanta,	  Connecticut,	  Detroit,	  Hawaii,	  Iowa,	  New	  Mexico,	  San	  Francisco-­‐Oakland,	  Seattle-­‐Puget	  Sound,	  and	  Utah	  and	  represent	  9.4%	  of	  U.S.	  
population.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate	  or	  proportion.	  
Cancer	  Incidence:	  The	  number	  of	  people	  who	  develop	  cancer	  (new	  cancer	  cases)	  during	  a	  specified	  period	  of	  time	  in	  a	  specified	  population.	  	  	  
Colorectal	  cancer:	  SEER	  Site	  Recode:	  21041-­‐21049,	  21051,	  21052	  (which	  include	  ICD-­‐O-­‐3	  codes:	  C180-­‐C189,	  C260,	  C199,	  C209).	  
Incidence	  case	  definitions	  exclude	  histologies	  consistent	  with	  Kaposi	  sarcoma	  and	  mesothelioma,	  where	  applicable.	  
Crude	  Rates	  are	  new	  cases	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  new	  cases	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
Definition:	  Stage	  at	  diagnosis	  =	  Summary	  of	  stage	  variable	  derived	  from	  the	  Collaborative	  Stage	  system.	  “Early-­‐stage”:	  in	  situ	  or	  localized	  cancers,	  “Late-­‐stage”:	  regional	  or	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Crude	   Age-­‐adjusted	   Proportion	  
Rate	   95%	  CI	   Rate	   95%	  CI	   %	  of	  Total	  	  	   95%	  CI	  
	  	  	  	  	  	  Maine	  	   	   	   	   	   	   	   	  
Early-­‐stage	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  250	  	  	   18.8	   17.5	  -­‐	  20.2	   15.1	   14.0	  -­‐	  16.3	   19.3	   18.1	  -­‐	  20.6	  
	  Late-­‐stage	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  973	   73.2	   70.6	  -­‐	  75.9	   57.1	   55.0	  -­‐	  59.2	   75.2	   73.8	  -­‐	  76.5	  
	  	  Unknown	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  71	   5.3	   4.6	  -­‐	  6.1	   4.2	   3.6	  -­‐	  4.8	   5.5	   4.8	  -­‐	  6.2	  
	  	  	  	  	  	  	  	  	  	  	  	  	  Overall	   1,294	   97.4	   94.3	  -­‐	  100.5	   76.4	   73.9	  -­‐	  78.8	   100.0	   -­‐-­‐-­‐	  
U.S.	  SEER	  9*	  	   	   	   	   	   	   	   	  
Early-­‐stage	   3,188	   11.1	   10.9	  -­‐	  11.3	   11.1	   10.9	  -­‐	  11.3	   18.5	   18.2	  -­‐	  18.8	  
	  Late-­‐stage	   13,049	   45.4	   44.9	  -­‐	  45.8	   44.4	   44.0	  -­‐	  44.9	   75.7	   75.4	  -­‐	  76.1	  
	  	  Unknown	   991	   3.4	   3.3	  -­‐	  3.6	   3.4	   3.3	  -­‐	  3.5	   5.8	   5.6	  -­‐	  6.0	  
	  	  	  	  	  	  	  	  	  	  	  	  	  Overall	   17,228	   59.9	   59.4	  -­‐	  60.4	   58.9	   58.4	  -­‐	  59.4	   100.0	   -­‐-­‐-­‐	  
U.S.	  SEER	  9	  Whites*	  	   	   	   	   	   	   	   	  
Early-­‐stage	   2,689	   12.6	   12.3	  -­‐	  12.9	   11.7	   11.5	  -­‐	  12.0	   19.2	   18.9	  -­‐	  19.6	  
Late-­‐stage	   10,464	   49.1	   48.6	  -­‐	  49.7	   44.6	   44.1	  -­‐	  45.1	   74.9	   74.5	  -­‐	  75.3	  
	  	  Unknown	   819	   3.8	   3.7	  -­‐	  4.0	   3.4	   3.3	  -­‐	  3.6	   5.9	   5.6	  -­‐	  6.1	  
	  	  	  	  	  Overall	   13,971	   65.6	   65.0	  -­‐	  66.2	   59.8	   59.2	  -­‐	  60.4	   100.0	   -­‐-­‐-­‐	  
Maine	  Data	  Source:	  Maine	  CDC	  Cancer	  Registry,	  November	  2012	  NPCR	  data	  submission	  (1995-­‐2010).	  U.S.	  Data	  Source:	  SEER	  9	  
Research	  Data	  (1973-­‐2010).	  	  
*The	  SEER	  9	  registries	  are	  Atlanta,	  Connecticut,	  Detroit,	  Hawaii,	  Iowa,	  New	  Mexico,	  San	  Francisco-­‐Oakland,	  Seattle-­‐Puget	  Sound,	  and	  
Utah	  and	  represent	  9.4%	  of	  U.S.	  population.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate	  or	  proportion.	  
Cancer	  Incidence:	  The	  number	  of	  people	  who	  develop	  cancer	  (new	  cancer	  cases)	  during	  a	  specified	  period	  of	  time	  in	  a	  specified	  
population.	  	  	  
Lung	  cancer:	  SEER	  Site	  Recode:	  22030	  (which	  includes	  ICD-­‐O-­‐3	  codes:	  C340-­‐C349).	  
Incidence	  case	  definitions	  exclude	  histologies	  consistent	  with	  Kaposi	  sarcoma	  and	  mesothelioma,	  where	  applicable.	  
Crude	  Rates	  are	  new	  cases	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  new	  cases	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
Definition:	  Stage	  at	  diagnosis	  =	  Summary	  of	  stage	  variable	  derived	  from	  the	  Collaborative	  Stage	  system.	  “Early-­‐stage”:	  in	  situ	  or	  
localized	  cancers,	  “Late-­‐stage”:	  regional	  or	  distant	  cancers,	  and	  “Unknown”:	  unknown	  or	  unstaged	  cancers. 
 
 





Table	  2.39.	  Lung	  cancer	  incidence	  by	  stage	  at	  diagnosis	  by	  sex,	  Maine,	  U.S.	  SEER	  9	  and	  U.S.	  SEER	  9	  Whites,	  2008-­‐2010.	  







Crude	   Age-­‐adjusted	   Proportion	   Average	  
Annual	  
Number	  
Crude	   Age-­‐adjusted	   Proportion	  
Rate	   95%	  CI	   Rate	   95%	  CI	  
%	  of	  
Total	  	  	   95%	  CI	   Rate	   95%	  CI	   Rate	   95%	  CI	  
%	  of	  
Total	   95%	  CI	  
Maine	   	   	   	   	   	   	   	   	   	   	   	   	  
Early-­‐stage	   134	   19.8	   17.9	  -­‐	  21.8	   14.8	   13.4	  -­‐	  16.4	   21.6	   19.8	  -­‐	  23.5	   116	   17.8	   16.0	  -­‐	  19.8	   16.0	   14.4	  -­‐	  17.8	   17.2	   15.7	  -­‐	  19.0	  
	  Late-­‐stage	   457	   67.3	   63.8	  -­‐	  71.0	   49.7	   47.1	  -­‐	  52.5	   73.5	   71.5	  -­‐	  75.5	   516	   79.3	   75.4	  -­‐	  83.4	   66.6	   63.3	  -­‐	  70.1	   76.7	   74.8	  -­‐	  78.5	  
	  	  Unknown	   30	   4.5	   3.6	  -­‐	  5.5	   3.0	   2.4	  -­‐	  3.7	   4.9	   4.0	  -­‐	  6.0	   40	   6.3	   5.2	  -­‐	  7.5	   5.8	   4.8	  -­‐	  6.9	   6.0	   5.1	  -­‐	  7.2	  
	  	  	  	  	  	  	  	  	  	  	  	  	  Overall	   621	   91.6	   87.5	  -­‐	  95.9	   67.6	   64.5	  -­‐	  70.8	   	  	  	  	  	  100.0	   	  	  	  	  	  	  	  	  	  	  	  -­‐-­‐-­‐	   672	   103.4	   98.9	  -­‐	  108.0	   88.4	   84.5	  -­‐	  92.4	   100.0	   -­‐-­‐-­‐	  
U.S.	  SEER	  9*	  	   	   	   	   	   	   	   	   	   	   	   	   	  
Early-­‐stage	   1,697	   11.6	   11.3	  -­‐	  11.9	   10.6	   10.3	  -­‐	  10.9	   20.5	   20.0	  -­‐	  21.0	   1,490	   10.5	   10.2	  -­‐	  10.8	   12.0	   11.6	  -­‐	  12.3	   16.6	   16.2	  -­‐	  17.1	  
	  Late-­‐stage	   6,091	   41.7	   41.1	  -­‐	  42.3	   37.6	   37.0	  -­‐	  38.1	   73.7	   73.2	  -­‐	  74.3	   6,958	   49.1	   48.5	  -­‐	  49.8	   53.6	   52.9	  -­‐	  54.4	   77.6	   77.1	  -­‐	  78.1	  
	  	  Unknown	   475	   3.3	   3.1	  -­‐	  3.4	   2.8	   2.6	  -­‐	  2.9	   5.8	   5.5	  -­‐	  6.1	   515	   3.6	   3.5	  -­‐	  3.8	   4.2	   4.0	  -­‐	  4.5	   5.8	   5.5	  -­‐	  6.0	  
	  	  	  	  	  	  	  	  	  	  	  	  	  Overall	   8,263	   56.6	   55.9	  -­‐	  57.3	   50.9	   50.3	  -­‐	  51.6	   100.0	   -­‐-­‐-­‐	   8,964	   63.3	   62.5	  -­‐	  64.1	   69.8	   69.0	  -­‐	  70.7	   100.0	   -­‐-­‐-­‐	  
U.S.	  SEER	  9	  Whites*	  	   	   	   	   	   	   	   	   	   	   	   	   	  
Early-­‐stage	   1,441	   13.5	   13.1	  -­‐	  13.9	   11.4	   11.1	  -­‐	  11.8	   21.2	   20.6	  -­‐	  21.7	   1,247	   11.8	   11.4	  -­‐	  12.2	   12.3	   11.9	  -­‐	  12.7	   17.4	   16.9	  -­‐	  17.9	  
Late-­‐stage	   4,966	   46.4	   45.6	  -­‐	  47.1	   38.7	   38.1	  -­‐	  39.4	   72.9	   72.3	  -­‐	  73.5	   5,497	   51.9	   51.1	  -­‐	  52.7	   52.5	   51.7	  -­‐	  53.3	   76.8	   76.2	  -­‐	  77.3	  
	  	  Unknown	   403	   3.8	   3.6	  -­‐	  4.0	   2.9	   2.7	  -­‐	  3.1	   5.9	   5.6	  -­‐	  6.3	   415	   3.9	   3.7	  -­‐	  4.1	   4.2	   3.9	  -­‐	  4.4	   5.8	   5.5	  -­‐	  6.1	  
	  	  	  	  	  	  Overall	   6,811	   63.6	   62.7	  -­‐	  64.5	   53.0	   52.3	  -­‐	  53.8	   100.0	   -­‐-­‐-­‐	   7,159	   67.6	   66.7	  -­‐	  68.5	   69.0	   68.1	  -­‐	  70.0	   100.0	   -­‐-­‐-­‐	  
Maine	  Data	  Source:	  Maine	  CDC	  Cancer	  Registry,	  November	  2012	  NPCR	  data	  submission	  (1995-­‐2010).	  U.S.	  Data	  Source:	  SEER	  9	  Research	  Data	  (1973-­‐2010).	  	  
*The	  SEER	  9	  registries	  are	  Atlanta,	  Connecticut,	  Detroit,	  Hawaii,	  Iowa,	  New	  Mexico,	  San	  Francisco-­‐Oakland,	  Seattle-­‐Puget	  Sound,	  and	  Utah	  and	  represent	  9.4%	  of	  U.S.	  
population.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate	  or	  proportion.	  
Cancer	  Incidence:	  The	  number	  of	  people	  who	  develop	  cancer	  (new	  cancer	  cases)	  during	  a	  specified	  period	  of	  time	  in	  a	  specified	  population.	  	  	  
Lung	  cancer:	  SEER	  Site	  Recode:	  22030	  (which	  includes	  ICD-­‐O-­‐3	  codes:	  C340-­‐C349).	  
Incidence	  case	  definitions	  exclude	  histologies	  consistent	  with	  Kaposi	  sarcoma	  and	  mesothelioma,	  where	  applicable.	  
Crude	  Rates	  are	  new	  cases	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  new	  cases	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
Definition:	  Stage	  at	  diagnosis	  =	  Summary	  of	  stage	  variable	  derived	  from	  the	  Collaborative	  Stage	  system.	  “Early-­‐stage”:	  in	  situ	  or	  localized	  cancers,	  “Late-­‐stage”:	  regional	  or	  









Table	  2.40.	  Prostate	  cancer	  incidence	  by	  stage	  at	  diagnosis,	  Maine,	  U.S.	  SEER	  9	  and	  U.S.	  SEER	  9	  Whites,	  	  	  	  	  	  	  	  	  	  	  	  	  	  
2008-­‐2010.	  
	   Average	  
Annual	  
Number	  
Crude	   Age-­‐adjusted	   Proportion	  
	  
3-­‐Year	  Period	   Rate	   95%	  CI	   Rate	   95%	  CI	   %	  of	  Total	  	  	   95%	  CI	  
	  	  	  	  	  	  Maine	   	   	   	   	   	   	   	  
Early-­‐stage	   826	   127.0	   122.1	  -­‐	  132.1	   99.9	   95.9	  -­‐	  104.0	   77.9	   76.4	  -­‐	  79.3	  
	  Late-­‐stage	   187	   28.8	   26.5	  -­‐	  31.3	   22.7	   20.8	  -­‐	  24.7	   17.7	   16.4	  -­‐	  19.0	  
	  	  Unknown	   47	   7.3	   6.2	  -­‐	  8.6	   6.8	   5.7	  -­‐	  8.1	   4.5	   3.8	  -­‐	  5.3	  
	  	  	  	  	  	  	  	  	  	  	  	  	  Overall	   	  	  1,061	   163.1	   157.5	  -­‐	  168.9	   129.5	   	  	  	  	  124.9	  -­‐	  134.1	   	  	  	  	  	  	  	  	  	  	  	  100.0	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  -­‐-­‐-­‐	  
U.S.	  SEER	  9*	  	   	   	   	   	   	   	   	  
Early-­‐stage	   17,091	   120.7	   119.6	  -­‐	  121.7	   122.8	   121.7	  -­‐	  123.9	   80.7	   80.4	  -­‐	  81.0	  
	  Late-­‐stage	   3,518	   24.8	   24.4	  -­‐	  25.3	   24.5	   24.1	  -­‐	  25.0	   16.6	   16.3	  -­‐	  16.9	  
	  	  Unknown	   560	   4.0	   3.8	  -­‐	  4.1	   4.6	   4.4	  -­‐	  4.9	   2.7	   2.5	  -­‐	  2.8	  
	  	  	  	  	  	  	  	  	  	  	  	  	  Overall	   21,170	   149.5	   148.3	  -­‐	  150.6	   151.9	   150.7	  -­‐	  153.2	   100.0	   -­‐-­‐-­‐	  
U.S.	  SEER	  9	  Whites*	  	   	   	   	   	   	   	   	  
Early-­‐stage	   13,269	   125.3	   124.1	  -­‐	  126.5	   118.4	   117.3	  -­‐	  119.6	   80.8	   80.5	  -­‐	  81.2	  
Late-­‐stage	   2,786	   26.3	   25.7	  -­‐	  26.9	   24.2	   23.6	  -­‐	  24.7	   17.0	   16.6	  -­‐	  17.3	  
	  	  Unknown	   362	   3.4	   3.2	  -­‐	  3.6	   3.7	   3.4	  -­‐	  3.9	   2.2	   2.1	  -­‐	  2.3	  
	  	  	  	  	  Overall	   16,418	   155.0	   153.7	  -­‐	  156.4	   146.3	   144.9	  -­‐	  147.6	   100.0	   -­‐-­‐-­‐	  
Maine	  Data	  Source:	  Maine	  CDC	  Cancer	  Registry,	  November	  2012	  NPCR	  data	  submission	  (1995-­‐2010).	  U.S.	  Data	  Source:	  SEER	  9	  
Research	  Data	  (1973-­‐2010).	  	  
*The	  SEER	  9	  registries	  are	  Atlanta,	  Connecticut,	  Detroit,	  Hawaii,	  Iowa,	  New	  Mexico,	  San	  Francisco-­‐Oakland,	  Seattle-­‐Puget	  
Sound,	  and	  Utah	  and	  represent	  9.4%	  of	  U.S.	  population.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate	  or	  proportion.	  
Cancer	  Incidence:	  The	  number	  of	  people	  who	  develop	  cancer	  (new	  cancer	  cases)	  during	  a	  specified	  period	  of	  time	  in	  a	  specified	  
population.	  	  	  
Prostate	  cancer:	  SEER	  Site	  Recode:	  28010	  (which	  includes	  ICD-­‐O-­‐3	  codes:	  C619).	  
Incidence	  case	  definitions	  exclude	  histologies	  consistent	  with	  Kaposi	  sarcoma	  and	  mesothelioma,	  where	  applicable.	  
Crude	  Rates	  are	  new	  cases	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  new	  cases	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
Definition:	  Stage	  at	  diagnosis	  =	  Summary	  of	  stage	  variable	  derived	  from	  the	  Collaborative	  Stage	  system.	  “Early-­‐stage”:	  in	  situ	  or	  
localized	  cancers,	  “Late-­‐stage”:	  regional	  or	  distant	  cancers,	  and	  “Unknown”:	  unknown	  or	  unstaged	  cancers.	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Table	  3.1.	  All	  cancer	  deaths	  by	  year,	  Maine,	  U.S.	  and	  U.S.	  whites,	  2000-­‐2010.*	  
Year	  
	  Maine	   U.S.	   	  U.S.	  Whites	  
	   	  Crude	   Age-­‐adjusted	   	   Crude	   Age-­‐adjusted	   	   Crude	   Age-­‐adjusted	  
Number	   Rate	   95%CI	   Rate	   95%	  CI	   Number	   Rate	   95%CI	   Rate	   95%CI	   Number	   Rate	   95%CI	   Rate	   95%CI	  
2000	   3,070	   240.4	  	   232.0	  -­‐	  249.1	  	   212.8	  	   205.3	  -­‐	  220.4	  	   553,080	   196.0	  	   195.5	  -­‐	  196.5	  	   198.8	  	   198.3	  -­‐	  199.3	  	   480,004	   208.3	   207.7	  -­‐	  208.9	   196.4	  	   195.8	  -­‐	  196.9	  	  
2001	   3,045	   236.8	  	   228.5	  -­‐	  245.4	  	   208.1	  	   200.8	  -­‐	  215.6	  	   553,760	   194.3	  	   193.8	  -­‐	  194.8	  	   196.3	  	   195.8	  -­‐	  196.8	  	   479,647	   206.6	   206.0	  -­‐	  207.2	   194.0	  	   193.4	  -­‐	  194.5	  	  
2002	   3,206	   247.4	  	   238.9	  -­‐	  256.1	  	   214.8	  	   207.4	  -­‐	  222.3	  	   557,264	   193.7	  	   193.2	  -­‐	  194.3	  	   194.4	  	   193.8	  -­‐	  194.9	  	   482,477	   206.5	   205.9	  -­‐	  207.1	   192.4	  	   191.8	  -­‐	  192.9	  	  
2003	   3,120	   238.8	  	   230.5	  -­‐	  247.3	  	   205.6	  	   198.5	  -­‐	  213.0	  	   556,890	   192.0	  	   191.5	  -­‐	  192.5	  	   190.9	  	   190.4	  -­‐	  191.4	  	   481,545	   204.9	   204.3	  -­‐	  205.4	   189.1	  	   188.6	  -­‐	  189.6	  	  
2004	   3,124	   237.8	  	   229.5	  -­‐	  246.3	  	   202.1	  	   195.1	  -­‐	  209.4	  	   553,880	   189.2	  	   188.7	  -­‐	  189.7	  	   186.8	  	   186.3	  -­‐	  187.3	  	   478,128	   202.1	   201.5	  -­‐	  202.7	   185.2	  	   184.7	  -­‐	  185.7	  	  
2005	   3,218	   244.0	  	   235.7	  -­‐	  252.6	  	   204.8	  	   197.7	  -­‐	  212.0	  	   559,303	   189.3	  	   188.8	  -­‐	  189.8	  	   185.2	  	   184.7	  -­‐	  185.7	  	   482,127	   202.5	   201.9	  -­‐	  203.1	   183.9	  	   183.4	  -­‐	  184.4	  	  
2006	   3,089	   233.4	  	   225.2	  -­‐	  241.8	  	   192.8	  	   186.0	  -­‐	  199.8	  	   559,880	   187.6	  	   187.1	  -­‐	  188.1	  	   182.0	  	   181.6	  -­‐	  182.5	  	   482,569	   201.3	   200.7	  -­‐	  201.9	   181.1	  	   180.6	  -­‐	  181.6	  	  
2007	   3,112	   234.5	  	   226.3	  -­‐	  242.9	  	   189.8	  	   183.2	  -­‐	  196.7	  	   562,867	   186.9	  	   186.4	  -­‐	  187.3	  	   179.3	  	   178.8	  -­‐	  179.7	  	   483,935	   200.5	   200.0	  -­‐	  201.1	   178.3	  	   177.8	  -­‐	  178.8	  	  
2008	   3,093	   232.5	  	   224.3	  -­‐	  240.8	  	   184.6	  	   178.0	  -­‐	  191.3	  	   565,460	   185.9	  	   185.5	  -­‐	  186.4	  	   176.3	  	   175.9	  -­‐	  176.8	  	   485,886	   200.0	   199.5	  -­‐	  200.6	   175.7	  	   175.2	  -­‐	  176.2	  	  
2009	   3,133	   235.6	  	   227.5	  -­‐	  244.0	  	   185.4	  	   178.9	  -­‐	  192.1	  	   567,614	   185.0	  	   184.5	  -­‐	  185.5	  	   173.4	  	   172.9	  -­‐	  173.9	  	   486,987	   199.3	   198.8	  -­‐	  199.9	   173.0	  	   172.5	  -­‐	  173.5	  	  
	  2010*	   3,247	   244.6	  	   236.3	  -­‐	  253.2	  	   186.6	  	   180.2	  -­‐	  193.3	  	   574,738	   185.8	  	   185.3	  -­‐	  186.3	  	   171.8	  	   171.3	  -­‐	  172.2	  	   491,682	   200.1	   199.6	  -­‐	  200.7	   171.4	  	   170.9	  -­‐	  171.8	  	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
All	  cancer:	  SEER	  Cause	  of	  Death	  Recode:	  20010-­‐37000	  (which	  include	  ICD-­‐10	  codes:	  C00-­‐C97).	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  deaths	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	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Table	  3.2.	  All	  cancer	  deaths	  by	  year	  and	  sex,	  Maine,	  2000-­‐2010.*	  
Year	  
	  Maine	  Overall	   Females	   	  Males	  
	   	  Crude	   Age-­‐adjusted	   	   Crude	   Age-­‐adjusted	   	   Crude	   Age-­‐adjusted	  
Number	   Rate	   95%CI	   Rate	   95%	  CI	   Number	   Rate	   95%CI	   Rate	   95%CI	   Number	   Rate	   95%CI	   Rate	   95%CI	  
2000	  	   3,070	   240.4	  	   232.0	  -­‐	  249.1	  	   212.8	  	   205.3	  -­‐	  220.4	  	   1,523	   232.3	  	   220.8	  -­‐	  244.3	  	   183.1	  	   173.9	  -­‐	  192.7	  	   1,547	   248.9	  	   236.7	  -­‐	  261.6	  	   257.9	  	   245.0	  -­‐	  271.3	  	  
2001	  	   3,045	   236.8	  	   228.5	  -­‐	  245.4	  	   208.1	  	   200.8	  -­‐	  215.6	  	   1,436	   217.7	  	   206.6	  -­‐	  229.2	  	   170.8	  	   162.0	  -­‐	  180.0	  	   1,609	   257.0	  	   244.6	  -­‐	  269.9	  	   265.6	  	   252.5	  -­‐	  279.1	  	  
2002	  	   3,206	   247.4	  	   238.9	  -­‐	  256.1	  	   214.8	  	   207.4	  -­‐	  222.3	  	   1,521	   229.0	  	   217.6	  -­‐	  240.8	  	   178.1	  	   169.2	  -­‐	  187.4	  	   1,685	   266.7	  	   254.1	  -­‐	  279.8	  	   269.7	  	   256.8	  -­‐	  283.1	  	  
2003	  	   3,120	   238.8	  	   230.5	  -­‐	  247.3	  	   205.6	  	   198.5	  -­‐	  213.0	  	   1,548	   231.5	  	   220.1	  -­‐	  243.3	  	   179.4	  	   170.5	  -­‐	  188.7	  	   1,572	   246.5	  	   234.4	  -­‐	  259.0	  	   246.4	  	   234.2	  -­‐	  259.1	  	  
2004	  	   3,124	   237.8	  	   229.5	  -­‐	  246.3	  	   202.1	  	   195.1	  -­‐	  209.4	  	   1,506	   224.2	  	   213.0	  -­‐	  235.8	  	   171.1	  	   162.5	  -­‐	  180.1	  	   1,618	   252.1	  	   240.0	  -­‐	  264.7	  	   247.9	  	   235.8	  -­‐	  260.5	  	  
2005	  	   3,218	   244.0	  	   235.7	  -­‐	  252.6	  	   204.8	  	   197.7	  -­‐	  212.0	  	   1,526	   226.4	  	   215.2	  -­‐	  238.0	  	   171.5	  	   162.9	  -­‐	  180.4	  	   1,692	   262.5	  	   250.1	  -­‐	  275.3	  	   254.0	  	   241.8	  -­‐	  266.6	  	  
2006	  	   3,089	   233.4	  	   225.2	  -­‐	  241.8	  	   192.8	  	   186.0	  -­‐	  199.8	  	   1,461	   216.1	  	   205.1	  -­‐	  227.4	  	   161.9	  	   153.6	  -­‐	  170.5	  	   1,628	   251.4	  	   239.4	  -­‐	  264.0	  	   238.8	  	   227.1	  -­‐	  250.9	  	  
2007	  	   3,112	   234.5	  	   226.3	  -­‐	  242.9	  	   189.8	  	   183.2	  -­‐	  196.7	  	   1,496	   220.7	  	   209.7	  -­‐	  232.2	  	   162.1	  	   153.9	  -­‐	  170.7	  	   1,616	   248.9	  	   236.9	  -­‐	  261.3	  	   233.6	  	   222.1	  -­‐	  245.5	  	  
2008	  	   3,093	   232.5	  	   224.3	  -­‐	  240.8	  	   184.6	  	   178.0	  -­‐	  191.3	  	   1,448	   213.1	  	   202.3	  -­‐	  224.4	  	   154.3	  	   146.3	  -­‐	  162.7	  	   1,645	   252.7	  	   240.6	  -­‐	  265.2	  	   229.2	  	   218.0	  -­‐	  240.7	  	  
2009	  	   3,133	   235.6	  	   227.5	  -­‐	  244.0	  	   185.4	  	   178.9	  -­‐	  192.1	  	   1,472	   216.9	  	   205.9	  -­‐	  228.3	  	   155.4	  	   147.4	  -­‐	  163.8	  	   1,661	   255.2	  	   243.1	  -­‐	  267.8	  	   229.0	  	   217.9	  -­‐	  240.6	  	  
2010*	   3,247	   244.6	  	   236.3	  -­‐	  253.2	  	   186.6	  	   180.2	  -­‐	  193.3	  	   1,530	   225.7	  	   214.6	  -­‐	  237.3	  	   158.5	  	   150.5	  -­‐	  166.9	  	   1,717	   264.3	  	   252.0	  -­‐	  277.1	  	   226.0	  	   215.2	  -­‐	  237.3	  	  




	  491,682	   200.1	   199.6	  -­‐	  200.7	   171.4	   170.9	  -­‐	  171.8	   	  233,414	   188.0	   187.3	  -­‐	  188.8	   145.9	   145.3	  -­‐	  146.5	   	  258,268	   212.5	   211.6	  -­‐	  213.3	   207.1	   206.3	  -­‐	  207.9	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
All	  cancer:	  SEER	  Cause	  of	  Death	  Recode:	  20010-­‐37000	  (which	  include	  ICD-­‐10	  codes:	  C00-­‐C97).	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  deaths	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	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Table	  3.3.	  All	  cancer	  deaths	  by	  year	  and	  age	  group,	  Maine,	  2000-­‐2010.*,†	  
Year	  
	  Age	  0─34	  years	   Age	  35─64	  years	   	  Age	  65─74	  years	   	  Age	  75	  years	  and	  older	  
	  Crude	   Crude	   Crude	   Crude	  
Number	   Rate	   95%CI	   Number	   Rate	   95%CI	   Number	   Rate	   95%CI	   Number	   Rate	   95%CI	  
2000	   33	   5.9	  	   4.0	  -­‐	  8.2	  	   786	   148.1	  	   137.9	  -­‐	  158.8	  	   842	   876.5	  	   818.3	  -­‐	  937.7	  	   1,409	   1,607.6	  	   1,524.7	  -­‐	  1,693.8	  	  
2001	   32	   5.7	  	   3.9	  -­‐	  8.1	  	   780	   144.3	  	   134.4	  -­‐	  154.8	  	   790	   821.0	  	   764.7	  -­‐	  880.3	  	   1,443	   1,622.4	  	   1,539.7	  -­‐	  1,708.3	  	  
2002	   35	   6.3	  	   4.4	  -­‐	  8.7	  	   869	   158.1	  	   147.8	  -­‐	  169.0	  	   840	   871.9	  	   813.9	  -­‐	  932.9	  	   1,462	   1,618.7	  	   1,536.7	  -­‐	  1,703.8	  	  
2003	   24	   4.3	  	   2.7	  -­‐	  6.4	  	   862	   154.4	  	   144.3	  -­‐	  165.0	  	   777	   803.9	  	   748.4	  -­‐	  862.5	  	   1,457	   1,590.8	  	   1,510.1	  -­‐	  1,674.6	  	  
2004	   23	   4.1	  	   2.6	  -­‐	  6.2	  	   840	   148.4	  	   138.6	  -­‐	  158.8	  	   786	   809.0	  	   753.4	  -­‐	  867.6	  	   1,475	   1,592.1	  	   1,511.9	  -­‐	  1,675.5	  	  
2005	   25	   4.5	  	   2.9	  -­‐	  6.7	  	   901	   157.2	  	   147.1	  -­‐	  167.9	  	   778	   795.0	  	   740.1	  -­‐	  852.9	  	   1,514	   1,618.9	  	   1,538.3	  -­‐	  1,702.5	  	  
2006	   23	   4.2	  	   2.7	  -­‐	  6.3	  	   903	   155.9	  	   145.9	  -­‐	  166.4	  	   745	   749.9	  	   697.0	  -­‐	  805.7	  	   1,418	   1,491.1	  	   1,414.5	  -­‐	  1,570.7	  	  
2007	   25	   4.6	  	   3.0	  -­‐	  6.8	  	   856	   146.9	  	   137.2	  -­‐	  157.1	  	   735	   723.5	  	   672.1	  -­‐	  777.8	  	   1,496	   1,551.6	  	   1,474.0	  -­‐	  1,632.3	  	  
2008	   28	   5.2	  	   3.4	  -­‐	  7.4	  	   880	   150.7	  	   140.9	  -­‐	  161.0	  	   784	   739.7	  	   688.9	  -­‐	  793.4	  	   1,401	   1,439.0	  	   1,364.7	  -­‐	  1,516.4	  	  
2009	   29	   5.4	  	   3.6	  -­‐	  7.7	  	   853	   146.4	  	   136.7	  -­‐	  156.5	  	   780	   708.9	  	   660.0	  -­‐	  760.4	  	   1,471	   1,506.5	  	   1,430.5	  -­‐	  1,585.5	  	  
2010*	   17	   3.2†	   1.9	  -­‐	  5.1†	   960	   165.2	  	   154.9	  -­‐	  176.0	  	   820	   723.5	  	   674.9	  -­‐	  774.8	  	   1,450	   1,469.3	  	   1,394.6	  -­‐	  1,546.9	  	  
U.S.	  2010	   6,547	   4.5	  	   4.4	  -­‐	  4.6	  	   171,521	   139.7	  	   139.1	  -­‐	  140.4	  	   144,635	   661.8	  	   658.4	  -­‐	  665.2	  	   252,035	   1,353.5	  	   1,348.2	  -­‐	  1,358.7	  	  
U.S.	  Whites	  2010	   5,056	   4.5	  	   4.4	  -­‐	  4.7	  	   138,258	   139.6	  	   138.8	  -­‐	  140.3	  	   123,807	   662.7	  	   659.0	  -­‐	  666.4	  	   224,561	   1,365.6	  	   1,360.0	  -­‐	  1,371.3	  	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
All	  cancer:	  SEER	  Cause	  of	  Death	  Recode:	  20010-­‐37000	  (which	  include	  ICD-­‐10	  codes:	  C00-­‐C97).	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  not	  calculated	  for	  age-­‐specific	  groups.	  
*Counts	  and	  rates	  might	  be	  slightly	  underestimated	  due	  to	  missing	  underlying	  cause	  of	  death	  information	  for	  Maine	  residents	  who	  died	  out	  of	  state	  
in	  2010.	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Crude	   Age-­‐Adjusted	  
Rate	   95%	  CI	   Rate	   95%	  CI	  
Maine	  total	   3,135	   236.1	  	   232.4	  -­‐	  239.8	  	   187.7	  	   184.8	  -­‐	  190.7	  	  
	   	   	   	   	   	  County	   	   	   	   	   	  
Androscoggin	   241	   223.2	  	   210.8	  -­‐	  236.2	  	   193.3	  	   182.5	  -­‐	  204.7	  	  
Aroostook	   203	   279.8	  	   262.8	  -­‐	  297.6	  	   193.8	  	   181.9	  -­‐	  206.4	  	  
Cumberland	   581	   207.7	  	   200.2	  -­‐	  215.3	  	   176.9	  	   170.5	  -­‐	  183.6	  	  
Franklin	   74	   240.8	  	   216.8	  -­‐	  266.6	  	   192.6	  	   173.1	  -­‐	  213.8	  	  
Hancock	   137	   253.0	  	   234.4	  -­‐	  272.6	  	   179.7	  	   166.4	  -­‐	  194.0	  	  
Kennebec	   306	   251.3	  	   238.9	  -­‐	  264.2	  	   204.2	  	   194.0	  -­‐	  214.9	  	  
Knox	   104	   258.8	  	   237.0	  -­‐	  282.0	  	   171.9	  	   157.2	  -­‐	  187.8	  	  
Lincoln	   94	   269.6	  	   245.7	  -­‐	  295.2	  	   168.1	  	   152.9	  -­‐	  184.7	  	  
Oxford	   157	   270.6	  	   252.0	  -­‐	  290.3	  	   203.6	  	   189.5	  -­‐	  218.7	  	  
Penobscot	   342	   223.9	  	   213.4	  -­‐	  234.8	  	   193.9	  	   184.7	  -­‐	  203.4	  	  
Piscataquis	   53	   303.1	  	   267.7	  -­‐	  341.8	  	   201.1	  	   177.1	  -­‐	  227.9	  	  
Sagadahoc	   81	   225.9	  	   204.4	  -­‐	  249.0	  	   182.9	  	   165.2	  -­‐	  202.1	  	  
Somerset	   134	   256.8	  	   237.7	  -­‐	  277.0	  	   201.7	  	   186.6	  -­‐	  217.9	  	  
Waldo	   91	   234.4	  	   213.3	  -­‐	  257.0	  	   186.6	  	   169.5	  -­‐	  205.0	  	  
Washington	   101	   304.7	  	   278.7	  -­‐	  332.4	  	   209.3	  	   191.1	  -­‐	  228.9	  	  
York	   436	   220.9	  	   211.7	  -­‐	  230.4	  	   180.4	  	   172.9	  -­‐	  188.3	  	  
Public	  Health	  District	   	   	   	   	   	  
Aroostook	   203	   279.8	  	   262.8	  -­‐	  297.6	  	   193.8	  	   181.9	  -­‐	  206.4	  	  
Central	   441	   253.0	  	   242.5	  -­‐	  263.7	  	   203.3	  	   194.8	  -­‐	  212.0	  	  
Cumberland	   581	   207.7	  	   200.2	  -­‐	  215.3	  	   176.9	  	   170.5	  -­‐	  183.6	  	  
Downeast	   238	   272.6	  	   257.3	  -­‐	  288.5	  	   190.7	  	   179.9	  -­‐	  202.1	  	  
Midcoast	   369	   247.1	  	   235.9	  -­‐	  258.6	  	   176.5	  	   168.4	  -­‐	  184.9	  	  
Penquis	   396	   232.0	  	   221.9	  -­‐	  242.5	  	   194.7	  	   186.1	  -­‐	  203.5	  	  
Western	   471	   239.9	  	   230.3	  -­‐	  249.8	  	   196.3	  	   188.4	  -­‐	  204.5	  	  
York	   436	   220.9	  	   211.7	  -­‐	  230.4	  	   180.4	  	   172.9	  -­‐	  188.3	  	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  
Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
All	  cancer:	  SEER	  Cause	  of	  Death	  Recode:	  	  20010-­‐37000	  (which	  include	  ICD-­‐10	  codes:	  C00-­‐C97).	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  deaths	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
*Counts	  and	  rates	  might	  be	  slightly	  underestimated	  due	  to	  missing	  underlying	  cause	  of	  death	  information	  for	  Maine	  residents	  who	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Table	  3.5.	  Bladder	  cancer	  deaths	  by	  year,	  Maine,	  U.S.	  and	  U.S.	  whites,	  2000-­‐2010.*	  
Year	  
	  Maine	   U.S.	   	  U.S.	  Whites	  
	   	  Crude	   Age-­‐adjusted	   	   Crude	   Age-­‐adjusted	   	   Crude	   Age-­‐adjusted	  
Number	   Rate	   95%CI	   Rate	   95%	  CI	   Number	   Rate	   95%CI	   Rate	   95%CI	   Number	   Rate	   95%CI	   Rate	   95%CI	  
2000	   83	   6.5	  	   5.2	  -­‐	  8.1	  	   5.7	  	   4.5	  -­‐	  7.1	  	   12,002	   4.3	  	   4.2	  -­‐	  4.3	  	   4.3	  	   4.2	  -­‐	  4.4	  	   11,036	   4.8	  	   4.7	  -­‐	  4.9	  	   4.5	  	   4.4	  -­‐	  4.6	  	  
2001	   92	   7.2	  	   5.8	  -­‐	  8.8	  	   6.3	  	   5.1	  -­‐	  7.7	  	   12,225	   4.3	  	   4.2	  -­‐	  4.4	  	   4.3	  	   4.3	  -­‐	  4.4	  	   11,180	   4.8	  	   4.7	  -­‐	  4.9	  	   4.5	  	   4.4	  -­‐	  4.6	  	  
2002	   76	   5.9	  	   4.6	  -­‐	  7.3	  	   5.1	  	   4.0	  -­‐	  6.4	  	   12,627	   4.4	  	   4.3	  -­‐	  4.5	  	   4.4	  	   4.4	  -­‐	  4.5	  	   11,511	   4.9	  	   4.8	  -­‐	  5.0	  	   4.6	  	   4.5	  -­‐	  4.6	  	  
2003	   76	   5.8	  	   4.6	  -­‐	  7.3	  	   5.0	  	   4.0	  -­‐	  6.3	  	   12,483	   4.3	  	   4.2	  -­‐	  4.4	  	   4.3	  	   4.2	  -­‐	  4.4	  	   11,409	   4.9	  	   4.8	  -­‐	  4.9	  	   4.4	  	   4.4	  -­‐	  4.5	  	  
2004	   100	   7.6	  	   6.2	  -­‐	  9.3	  	   6.5	  	   5.3	  -­‐	  7.9	  	   13,030	   4.5	  	   4.4	  -­‐	  4.5	  	   4.4	  	   4.3	  -­‐	  4.5	  	   11,957	   5.1	  	   5.0	  -­‐	  5.1	  	   4.6	  	   4.5	  -­‐	  4.7	  	  
2005	   86	   6.5	  	   5.2	  -­‐	  8.1	  	   5.4	  	   4.3	  -­‐	  6.7	  	   13,253	   4.5	  	   4.4	  -­‐	  4.6	  	   4.4	  	   4.3	  -­‐	  4.5	  	   12,100	   5.1	  	   5.0	  -­‐	  5.2	  	   4.6	  	   4.5	  -­‐	  4.7	  	  
2006	   99	   7.5	  	   6.1	  -­‐	  9.1	  	   6.1	  	   5.0	  -­‐	  7.5	  	   13,474	   4.5	  	   4.4	  -­‐	  4.6	  	   4.4	  	   4.3	  -­‐	  4.5	  	   12,286	   5.1	  	   5.0	  -­‐	  5.2	  	   4.6	  	   4.5	  -­‐	  4.7	  	  
2007	   109	   8.2	  	   6.7	  -­‐	  9.9	  	   6.6	  	   5.4	  -­‐	  8.0	  	   13,843	   4.6	  	   4.5	  -­‐	  4.7	  	   4.4	  	   4.4	  -­‐	  4.5	  	   12,620	   5.2	  	   5.1	  -­‐	  5.3	  	   4.6	  	   4.5	  -­‐	  4.7	  	  
2008	   94	   7.1	  	   5.7	  -­‐	  8.6	  	   5.7	  	   4.6	  -­‐	  7.0	  	   14,036	   4.6	  	   4.5	  -­‐	  4.7	  	   4.4	  	   4.3	  -­‐	  4.5	  	   12,853	   5.3	  	   5.2	  -­‐	  5.4	  	   4.6	  	   4.5	  -­‐	  4.7	  	  
2009	   102	   7.7	  	   6.3	  -­‐	  9.3	  	   6.1	  	   5.0	  -­‐	  7.4	  	   14,201	   4.6	  	   4.6	  -­‐	  4.7	  	   4.4	  	   4.3	  -­‐	  4.4	  	   12,948	   5.3	  	   5.2	  -­‐	  5.4	  	   4.6	  	   4.5	  -­‐	  4.6	  	  
	  2010*	   106	   8.0	  	   6.5	  -­‐	  9.7	  	   6.1	  	   5.0	  -­‐	  7.5	  	   14,730	   4.8	  	   4.7	  -­‐	  4.8	  	   4.4	  	   4.4	  -­‐	  4.5	  	   13,403	   5.5	  	   5.4	  -­‐	  5.5	  	   4.6	  	   4.6	  -­‐	  4.7	  	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
Bladder	  cancer:	  SEER	  Cause	  of	  Death	  Recode:	  29010	  (which	  include	  ICD-­‐10	  code:	  C67).	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  deaths	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	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Table	  3.6.	  Bladder	  cancer	  deaths	  by	  year	  and	  sex,	  Maine,	  2000-­‐2010.*	  
Year	  
	  Maine	  Overall	   Females	   	  Males	  
	   	  Crude	   Age-­‐adjusted	   	   Crude	   Age-­‐adjusted	   	   Crude	   Age-­‐adjusted	  
Number	   Rate	   95%CI	   Rate	   95%	  CI	   Number	   Rate	   95%CI	   Rate	   95%CI	   Number	   Rate	   95%CI	   Rate	   95%CI	  
2000	  	   83	   6.5	  	   5.2	  -­‐	  8.1	  	   5.7	  	   4.5	  -­‐	  7.1	  	   23	   3.5	  	   2.2	  -­‐	  5.3	  	   2.6	  	   1.6	  -­‐	  3.9	  	   60	   9.7	  	   7.4	  -­‐	  12.4	  	   10.9	  	   8.3	  -­‐	  14.1	  	  
2001	  	   92	   7.2	  	   5.8	  -­‐	  8.8	  	   6.3	  	   5.1	  -­‐	  7.7	  	   31	   4.7	  	   3.2	  -­‐	  6.7	  	   3.5	  	   2.4	  -­‐	  5.1	  	   61	   9.7	  	   7.5	  -­‐	  12.5	  	   10.0	  	   7.6	  -­‐	  12.9	  	  
2002	  	   76	   5.9	  	   4.6	  -­‐	  7.3	  	   5.1	  	   4.0	  -­‐	  6.4	  	   24	   3.6	  	   2.3	  -­‐	  5.4	  	   2.7	  	   1.7	  -­‐	  4.1	  	   52	   8.2	  	   6.1	  -­‐	  10.8	  	   8.5	  	   6.3	  -­‐	  11.2	  	  
2003	  	   76	   5.8	  	   4.6	  -­‐	  7.3	  	   5.0	  	   4.0	  -­‐	  6.3	  	   30	   4.5	  	   3.0	  -­‐	  6.4	  	   3.2	  	   2.1	  -­‐	  4.6	  	   46	   7.2	  	   5.3	  -­‐	  9.6	  	   7.4	  	   5.4	  -­‐	  10.0	  	  
2004	  	   100	   7.6	  	   6.2	  -­‐	  9.3	  	   6.5	  	   5.3	  -­‐	  7.9	  	   27	   4.0	  	   2.6	  -­‐	  5.8	  	   3.0	  	   1.9	  -­‐	  4.4	  	   73	   11.4	  	   8.9	  -­‐	  14.3	  	   11.9	  	   9.3	  -­‐	  15.0	  	  
2005	  	   86	   6.5	  	   5.2	  -­‐	  8.1	  	   5.4	  	   4.3	  -­‐	  6.7	  	   22	   3.3	  	   2.0	  -­‐	  4.9	  	   2.2	  	   1.4	  -­‐	  3.4	  	   64	   9.9	  	   7.6	  -­‐	  12.7	  	   9.9	  	   7.6	  -­‐	  12.7	  	  
2006	  	   99	   7.5	  	   6.1	  -­‐	  9.1	  	   6.1	  	   5.0	  -­‐	  7.5	  	   37	   5.5	  	   3.9	  -­‐	  7.5	  	   3.9	  	   2.7	  -­‐	  5.4	  	   62	   9.6	  	   7.3	  -­‐	  12.3	  	   9.5	  	   7.2	  -­‐	  12.2	  	  
2007	  	   109	   8.2	  	   6.7	  -­‐	  9.9	  	   6.6	  	   5.4	  -­‐	  8.0	  	   35	   5.2	  	   3.6	  -­‐	  7.2	  	   3.6	  	   2.5	  -­‐	  5.1	  	   74	   11.4	  	   8.9	  -­‐	  14.3	  	   10.9	  	   8.5	  -­‐	  13.8	  	  
2008	  	   94	   7.1	  	   5.7	  -­‐	  8.6	  	   5.7	  	   4.6	  -­‐	  7.0	  	   27	   4.0	  	   2.6	  -­‐	  5.8	  	   2.8	  	   1.8	  -­‐	  4.1	  	   67	   10.3	  	   8.0	  -­‐	  13.1	  	   9.7	  	   7.5	  -­‐	  12.3	  	  
2009	  	   102	   7.7	  	   6.3	  -­‐	  9.3	  	   6.1	  	   5.0	  -­‐	  7.4	  	   28	   4.1	  	   2.7	  -­‐	  6.0	  	   2.8	  	   1.9	  -­‐	  4.2	  	   74	   11.4	  	   8.9	  -­‐	  14.3	  	   10.9	  	   8.5	  -­‐	  13.8	  	  
2010*	   106	   8.0	  	   6.5	  -­‐	  9.7	  	   6.1	  	   5.0	  -­‐	  7.5	  	   22	   3.2	  	   2.0	  -­‐	  4.9	  	   2.2	  	   1.3	  -­‐	  3.4	  	   84	   12.9	  	   10.3	  -­‐	  16.0	  	   11.6	  	   9.2	  -­‐	  14.4	  	  




13,403	   5.5	   5.4	  -­‐	  5.5	   4.6	   4.6	  -­‐	  4.7	   3,757	   3.0	   2.9	  -­‐	  3.1	   2.2	   2.1	  -­‐	  2.3	   9,646	   7.9	   7.8	  -­‐	  8.1	   8.1	   8.0	  -­‐	  8.3	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
Urinary	  bladder	  cancer:	  SEER	  Cause	  of	  Death	  Recode:	  29010	  (which	  include	  ICD-­‐10	  code:	  C67).	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  deaths	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	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Table	  3.7.	  Bladder	  cancer	  deaths	  by	  year	  and	  age	  group,	  Maine,	  2000-­‐2010.*,†	  
Year	  
	  Age	  0─34	  years	   Age	  35─64	  years	   	  Age	  65─74	  years	   	  Age	  75	  years	  and	  older	  
	  Crude	   Crude	   Crude	   Crude	  
Number	   Rate	   95%CI	   Number	   Rate	   95%CI	   Number	   Rate	   95%CI	   Number	   Rate	   95%CI	  
2000	   DSP	   DSP	   DSP	  	   11	   2.1†	   1.0	  -­‐	  3.7†	   24	   25.0	  	   16.0	  -­‐	  37.2	  	   47	   53.6	  	   39.4	  -­‐	  71.3	  	  
2001	   DSP	   DSP	   DSP	  	   15	   2.8†	   1.6	  -­‐	  4.6†	   32	   33.3	  	   22.7	  -­‐	  46.9	  	   43	   48.3	  	   35.0	  -­‐	  65.1	  	  
2002	   0	   0.0†	   0.0	  -­‐	  0.7†	   13	   2.4†	   1.3	  -­‐	  4.0†	   20	   20.8	  	   12.7	  -­‐	  32.1	  	   43	   47.6	  	   34.5	  -­‐	  64.1	  	  
2003	   0	   0.0†	   0.0	  -­‐	  0.7†	   13	   2.3†	   1.2	  -­‐	  4.0†	   16	   16.6†	   9.5	  -­‐	  26.9†	   47	   51.3†	   37.7	  -­‐	  68.2†	  
2004	   DSP	   DSP	   DSP	  	   14	   2.5†	   1.4	  -­‐	  4.2†	   23	   23.7	  	   15.0	  -­‐	  35.5	  	   62	   66.9	  	   51.3	  -­‐	  85.8	  	  
2005	   0	   0.0†	   0.0	  -­‐	  0.7†	   15	   2.6†	   1.5	  -­‐	  4.3†	   18	   18.4†	   10.9	  -­‐	  29.1†	   53	   56.7†	   42.5	  -­‐	  74.1†	  
2006	   0	   0.0†	   0.0	  -­‐	  0.7†	   20	   3.5	  	   2.1	  -­‐	  5.3	  	   14	   14.1†	   7.7	  -­‐	  23.6†	   65	   68.3†	   52.8	  -­‐	  87.1†	  
2007	   0	   0.0†	   0.0	  -­‐	  0.7†	   18	   3.1†	   1.8	  -­‐	  4.9†	   21	   20.7	  	   12.8	  -­‐	  31.6	  	   70	   72.6	  	   56.6	  -­‐	  91.7	  	  
2008	   0	   0.0†	   0.0	  -­‐	  0.7†	   12	   2.1†	   1.1	  -­‐	  3.6†	   26	   24.5	  	   16.0	  -­‐	  35.9	  	   56	   57.5	  	   43.5	  -­‐	  74.7	  	  
2009	   0	   0.0†	   0.0	  -­‐	  0.7†	   12	   2.1†	   1.1	  -­‐	  3.6†	   22	   20.0	  	   12.5	  -­‐	  30.3	  	   68	   69.6	  	   54.1	  -­‐	  88.3	  	  
2010*	   0	   0.0†	   0.0	  -­‐	  0.7†	   23	   4.0	  	   2.5	  -­‐	  5.9	  	   22	   19.4	  	   12.2	  -­‐	  29.4	  	   61	   61.8	  	   47.3	  -­‐	  79.4	  	  
U.S.	  2010	   17	   0.0†	   0.0	  -­‐	  0.0†	   2,423	   2.0	  	   1.9	  -­‐	  2.1	  	   3,019	   13.8	  	   13.3	  -­‐	  14.3	  	   9,271	   49.8	  	   48.8	  -­‐	  50.8	  	  
U.S.	  Whites	  2010	   12	   0.0†	   0.0	  -­‐	  0.0†	   2,106	   2.1	  	   2.0	  -­‐	  2.2	  	   2,733	   14.6	  	   14.1	  -­‐	  15.2	  	   8,552	   52.0	  	   50.9	  -­‐	  53.1	  	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
DSP:	  Data	  were	  suppressed	  by	  SEER*Stat	  to	  protect	  privacy	  due	  to	  small	  numbers.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
Bladder	  cancer:	  SEER	  Cause	  of	  Death	  Recode:	  29010	  (which	  include	  ICD-­‐10	  code:	  C67).	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  not	  calculated	  for	  age-­‐specific	  groups.	  
*Counts	  and	  rates	  might	  be	  slightly	  underestimated	  due	  to	  missing	  underlying	  cause	  of	  death	  information	  for	  Maine	  residents	  who	  died	  out	  of	  state	  
in	  2010.	  
†Rates	  are	  flagged	  as	  unreliable	  when	  the	  rate	  is	  calculated	  with	  a	  numerator	  less	  than	  20.	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Crude	   Age-­‐Adjusted	  
Rate	   95%	  CI	   Rate	   95%	  CI	  
Maine	  total	   102	   7.7	   7.0	  -­‐	  8.4	   6.1	   5.6	  -­‐	  6.7	  
County	  
Androscoggin	   11	   10.2	   7.7	  -­‐	  13.3	   8.7	   6.5	  -­‐	  11.4	  
Aroostook	   5	   7.2	   4.7	  -­‐	  10.5	   5.0	   3.3	  -­‐	  7.5	  
Cumberland	   20	   7.0	   5.7	  -­‐	  8.5	   5.9	   4.8	  -­‐	  7.2	  
Franklin	   DSP	   DSP	   DSP	   DSP	   DSP	  
Hancock	   4	   7.0†	   4.2	  -­‐	  10.9†	   5.1†	   3.0	  -­‐	  8.1†	  
Kennebec	   8	   6.9	   5.0	  -­‐	  9.3	   5.6	   4.0	  -­‐	  7.6	  
Knox	   3	   8.5†	   4.9	  -­‐	  13.6†	   5.6†	   3.2	  -­‐	  9.3†	  
Lincoln	   4	   12.7	   7.9	  -­‐	  19.2	   7.8	   4.8	  -­‐	  12.3	  
Oxford	   5	   9.0	   5.9	  -­‐	  13.2	   6.7	   4.4	  -­‐	  10.0	  
Penobscot	   11	   7.3	   5.5	  -­‐	  9.5	   6.3	   4.8	  -­‐	  8.3	  
Piscataquis	   2	   11.4†	   5.5	  -­‐	  21.0†	   7.7†	   3.7	  -­‐	  15.1†	  
Sagadahoc	   2	   5.6†	   2.7	  -­‐	  10.3†	   5.0†	   2.4	  -­‐	  9.4†	  
Somerset	   3	   6.5†	   3.8	  -­‐	  10.4†	   5.2†	   3.0	  -­‐	  8.5†	  
Waldo	   DSP	   DSP	   DSP	   DSP	   DSP	  
Washington	   4	   13.3	   8.3	  -­‐	  20.1	   9.2	   5.7	  -­‐	  14.3	  
York	   16	   7.9	   6.2	  -­‐	  9.9	   6.5	   5.2	  -­‐	  8.2	  
Public	  Health	  District	  
Aroostook	   5	   7.2	   4.7	  -­‐	  10.5	   5.0	   3.3	  -­‐	  7.5	  
Central	   12	   6.8	   5.2	  -­‐	  8.7	   5.4	   4.1	  -­‐	  7.1	  
Cumberland	   20	   7.0	   5.7	  -­‐	  8.5	   5.9	   4.8	  -­‐	  7.2	  
Downeast	   8	   9.4	   6.7	  -­‐	  12.7	   6.6	   4.7	  -­‐	  9.1	  
Midcoast	   11	   7.5	   5.7	  -­‐	  9.7	   5.4	   4.1	  -­‐	  7.1	  
Penquis	   13	   7.7	   6.0	  -­‐	  9.9	   6.5	   5.0	  -­‐	  8.3	  
Western	   17	   8.8	   7.0	  -­‐	  10.8	   7.1	   5.7	  -­‐	  8.8	  
York	   16	   7.9	   6.2	  -­‐	  9.9	   6.5	   5.2	  -­‐	  8.2	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  
Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
DSP:	  Data	  were	  suppressed	  by	  SEER*Stat	  to	  protect	  privacy	  due	  to	  small	  numbers.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
Bladder	  cancer:	  SEER	  Cause	  of	  Death	  Recode:	  29010	  (which	  include	  ICD-­‐10	  code:	  C67).	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  deaths	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
*Counts	  and	  rates	  might	  be	  slightly	  underestimated	  due	  to	  missing	  underlying	  cause	  of	  death	  information	  for	  Maine	  residents	  who
died	  out	  of	  state	  in	  2010.	  
†Rates	  are	  flagged	  as	  unreliable	  when	  the	  rate	  is	  calculated	  with	  a	  numerator	  less	  than	  20.	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Table	  3.9.	  Female	  breast	  cancer	  deaths	  by	  year,	  Maine,	  U.S.	  and	  U.S.	  whites,	  2000-­‐2010.*	  
Year	  
	  Maine	   U.S.	   	  U.S.	  Whites	  
	   	  Crude	   Age-­‐adjusted	   	   Crude	   Age-­‐adjusted	   	   Crude	   Age-­‐adjusted	  
Number	   Rate	   95%CI	   Rate	   95%	  CI	   Number	   Rate	   95%CI	   Rate	   95%CI	   Number	   Rate	   95%CI	   Rate	   95%CI	  
2000	   197	   30.1	  	   26.0	  -­‐	  34.6	  	   24.2	  	   20.9	  -­‐	  27.9	  	   41,872	   29.1	  	   28.9	  -­‐	  29.4	  	   26.6	  	   26.4	  -­‐	  26.9	  	   35,767	   30.6	  	   30.3	  -­‐	  30.9	  	   26.2	  	   25.9	  -­‐	  26.4	  	  
2001	   182	   27.6	  	   23.7	  -­‐	  31.9	  	   22.0	  	   18.9	  -­‐	  25.5	  	   41,394	   28.5	  	   28.3	  -­‐	  28.8	  	   26.0	  	   25.8	  -­‐	  26.3	  	   35,078	   29.8	  	   29.5	  -­‐	  30.1	  	   25.4	  	   25.2	  -­‐	  25.7	  	  
2002	   201	   30.3	  	   26.2	  -­‐	  34.7	  	   24.0	  	   20.8	  -­‐	  27.6	  	   41,514	   28.4	  	   28.1	  -­‐	  28.6	  	   25.6	  	   25.4	  -­‐	  25.9	  	   35,082	   29.7	  	   29.3	  -­‐	  30.0	  	   25.0	  	   24.8	  -­‐	  25.3	  	  
2003	   231	   34.5	  	   30.2	  -­‐	  39.3	  	   27.5	  	   24.0	  -­‐	  31.3	  	   41,619	   28.2	  	   27.9	  -­‐	  28.5	  	   25.3	  	   25.0	  -­‐	  25.5	  	   35,032	   29.4	  	   29.1	  -­‐	  29.7	  	   24.7	  	   24.4	  -­‐	  24.9	  	  
2004	   185	   27.5	  	   23.7	  -­‐	  31.8	  	   21.4	  	   18.4	  -­‐	  24.8	  	   40,954	   27.5	  	   27.2	  -­‐	  27.8	  	   24.5	  	   24.3	  -­‐	  24.7	  	   34,458	   28.8	  	   28.5	  -­‐	  29.1	  	   23.9	  	   23.7	  -­‐	  24.2	  	  
2005	   198	   29.4	  	   25.4	  -­‐	  33.8	  	   22.4	  	   19.4	  -­‐	  25.9	  	   41,116	   27.4	  	   27.1	  -­‐	  27.6	  	   24.1	  	   23.9	  -­‐	  24.4	  	   34,352	   28.5	  	   28.2	  -­‐	  28.8	  	   23.5	  	   23.2	  -­‐	  23.7	  	  
2006	   193	   28.5	  	   24.7	  -­‐	  32.9	  	   21.2	  	   18.3	  -­‐	  24.6	  	   40,820	   26.9	  	   26.6	  -­‐	  27.2	  	   23.6	  	   23.3	  -­‐	  23.8	  	   34,137	   28.2	  	   27.9	  -­‐	  28.5	  	   23.0	  	   22.8	  -­‐	  23.3	  	  
2007	   184	   27.1	  	   23.4	  -­‐	  31.4	  	   20.1	  	   17.3	  -­‐	  23.3	  	   40,598	   26.5	  	   26.2	  -­‐	  26.8	  	   23.0	  	   22.7	  -­‐	  23.2	  	   33,845	   27.7	  	   27.4	  -­‐	  28.0	  	   22.4	  	   22.2	  -­‐	  22.6	  	  
2008	   199	   29.3	  	   25.4	  -­‐	  33.7	  	   21.7	  	   18.7	  -­‐	  25.0	  	   40,589	   26.3	  	   26.0	  -­‐	  26.5	  	   22.6	  	   22.3	  -­‐	  22.8	  	   33,705	   27.5	  	   27.2	  -­‐	  27.8	  	   22.0	  	   21.7	  -­‐	  22.2	  	  
2009	   195	   28.7	  	   24.8	  -­‐	  33.1	  	   21.3	  	   18.4	  -­‐	  24.7	  	   40,676	   26.1	  	   25.8	  -­‐	  26.3	  	   22.2	  	   22.0	  -­‐	  22.5	  	   33,780	   27.4	  	   27.1	  -­‐	  27.7	  	   21.8	  	   21.5	  -­‐	  22.0	  	  
	  2010*	   195	   28.8	  	   24.9	  -­‐	  33.1	  	   20.1	  	   17.3	  -­‐	  23.2	  	   40,996	   26.1	  	   25.8	  -­‐	  26.3	  	   21.9	  	   21.7	  -­‐	  22.1	  	   33,834	   27.3	  	   27.0	  -­‐	  27.5	  	   21.3	  	   21.1	  -­‐	  21.6	  	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
Female	  breast	  cancer:	  SEER	  Cause	  of	  Death	  Recode:	  26000	  (which	  include	  ICD-­‐10	  code:	  C50).	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  deaths	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	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Table	  3.10.	  Female	  breast	  cancer	  deaths	  by	  year	  and	  age	  group,	  Maine,	  2000-­‐2010.*,†	  
Year	  
	  Age	  0─34	  years	   Age	  35─64	  years	   	  Age	  65─74	  years	   	  Age	  75	  years	  and	  older	  
	  Crude	   Crude	   Crude	   Crude	  
Number	   Rate	   95%CI	   Number	   Rate	   95%CI	   Number	   Rate	   95%CI	   Number	   Rate	   95%CI	  
2000	   DSP	   DSP	  	   DSP	  	   72	   26.7	  	   20.9	  -­‐	  33.6	  	   35	   67.4	  	   46.9	  -­‐	  93.7	  	   86	   154.8	  	   123.8	  -­‐	  191.1	  	  
2001	   0	   0.0†	   0.0	  -­‐	  1.3†	   59	   21.5	  	   16.4	  -­‐	  27.7	  	   44	   85.0	  	   61.8	  -­‐	  114.2	  	   79	   140.7	  	   111.4	  -­‐	  175.3	  	  
2002	   DSP	   DSP	  	   DSP	  	   73	   26.1	  	   20.5	  -­‐	  32.9	  	   38	   73.8	  	   52.2	  -­‐	  101.3	  	   87	   153.1	  	   122.7	  -­‐	  188.9	  	  
2003	   DSP	   DSP	  	   DSP	  	   98	   34.5	  	   28.0	  -­‐	  42.1	  	   43	   83.4	  	   60.4	  -­‐	  112.4	  	   87	   151.9	  	   121.7	  -­‐	  187.4	  	  
2004	   DSP	   DSP	  	   DSP	  	   72	   25.0	  	   19.6	  -­‐	  31.5	  	   31	   60.0	  	   40.8	  -­‐	  85.2	  	   79	   137.0	  	   108.5	  -­‐	  170.8	  	  
2005	   DSP	   DSP	  	   DSP	  	   82	   28.2	  	   22.4	  -­‐	  35.0	  	   38	   73.2	  	   51.8	  -­‐	  100.5	  	   77	   132.9	  	   104.9	  -­‐	  166.1	  	  
2006	   0	   0.0†	  	   0.0	  -­‐	  1.4†	   81	   27.5	  	   21.9	  -­‐	  34.2	  	   33	   62.9	  	   43.3	  -­‐	  88.4	  	   79	   134.5	  	   106.5	  -­‐	  167.6	  	  
2007	   DSP	   DSP	  	   DSP	  	   88	   29.7	  	   23.8	  -­‐	  36.6	  	   30	   56.2	  	   37.9	  -­‐	  80.2	  	   65	   109.5	  	   84.5	  -­‐	  139.6	  	  
2008	   DSP	   DSP	  	   DSP	  	   85	   28.6	  	   22.9	  -­‐	  35.4	  	   45	   80.7	  	   58.9	  -­‐	  108.0	  	   67	   112.5	  	   87.2	  -­‐	  142.9	  	  
2009	   DSP	   DSP	  	   DSP	  	   77	   26.0	  	   20.5	  -­‐	  32.4	  	   41	   71.0	  	   51.0	  -­‐	  96.4	  	   75	   126.2	  	   99.2	  -­‐	  158.1	  	  
2010*	   DSP	   DSP	  	   DSP	  	   63	   21.3	  	   16.3	  -­‐	  27.2	  	   44	   74.2	  	   53.9	  -­‐	  99.6	  	   87	   145.7	  	   116.7	  -­‐	  179.7	  	  
U.S.	  2010	   328	   0.5	  	   0.4	  -­‐	  0.5	  	   16,923	   27.1	  	   26.7	  -­‐	  27.5	  	   8,590	   73.5	  	   71.9	  -­‐	  75.1	  	   15,155	   133.9	  	   131.8	  -­‐	  136.1	  	  
U.S.	  Whites	  2010	   216	   0.4	  	   0.3	  -­‐	  0.5	  	   12,939	   25.9	  	   25.5	  -­‐	  26.4	  	   7,213	   72.9	  	   71.2	  -­‐	  74.6	  	   13,466	   135.6	  	   133.3	  -­‐	  137.9	  	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
DSP:	  Data	  were	  suppressed	  by	  SEER*Stat	  to	  protect	  privacy	  due	  to	  small	  numbers.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
Female	  breast	  cancer:	  SEER	  Cause	  of	  Death	  Recode:	  26000	  (which	  include	  ICD-­‐10	  code:	  C50).	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  not	  calculated	  for	  age-­‐specific	  groups.	  
*Counts	  and	  rates	  might	  be	  slightly	  underestimated	  due	  to	  missing	  underlying	  cause	  of	  death	  information	  for	  Maine	  residents	  who	  died	  out	  of	  state	  
in	  2010.	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Crude	   Age-­‐Adjusted	  
Rate	   95%	  CI	   Rate	   95%	  CI	  
Maine	  total	   193	   28.5	  	   26.7	  -­‐	  30.4	  	   20.9	  	   19.5	  -­‐	  22.3	  	  
	   	   	   	   	   	  County	   	   	   	   	   	  
Androscoggin	   15	   27.6	  	   21.7	  -­‐	  34.6	  	   22.0	  	   17.2	  -­‐	  27.7	  	  
Aroostook	   12	   33.2	  	   25.4	  -­‐	  42.6	  	   22.3	  	   16.9	  -­‐	  29.1	  	  
Cumberland	   37	   25.7	  	   22.1	  -­‐	  29.7	  	   19.4	  	   16.7	  -­‐	  22.6	  	  
Franklin	   3	   21.7†	   12.7	  -­‐	  34.8†	   15.3†	   8.8	  -­‐	  25.3†	  
Hancock	   9	   32.5	  	   23.7	  -­‐	  43.5	  	   22.1	  	   16.0	  -­‐	  30.2	  	  
Kennebec	   20	   31.3	  	   25.4	  -­‐	  38.2	  	   24.4	  	   19.7	  -­‐	  30.0	  	  
Knox	   9	   43.3	  	   31.5	  -­‐	  58.2	  	   26.8	  	   19.1	  -­‐	  37.0	  	  
Lincoln	   4	   24.8	  	   15.6	  -­‐	  37.6	  	   14.3	  	   8.9	  -­‐	  22.9	  	  
Oxford	   11	   36.3	  	   27.2	  -­‐	  47.4	  	   25.1	  	   18.7	  -­‐	  33.2	  	  
Penobscot	   19	   24.7	  	   20.0	  -­‐	  30.2	  	   19.6	  	   15.8	  -­‐	  24.0	  	  
Piscataquis	   3	   33.7†	   18.9	  -­‐	  55.6†	   19.5†	   10.9	  -­‐	  34.4†	  
Sagadahoc	   5	   27.3	  	   17.6	  -­‐	  40.2	  	   21.3	  	   13.7	  -­‐	  32.1	  	  
Somerset	   7	   25.7	  	   17.8	  -­‐	  36.0	  	   18.4	  	   12.7	  -­‐	  26.1	  	  
Waldo	   6	   30.4	  	   20.5	  -­‐	  43.4	  	   22.2	  	   14.8	  -­‐	  32.3	  	  
Washington	   6	   35.6	  	   24.0	  -­‐	  50.9	  	   22.9	  	   15.2	  -­‐	  33.9	  	  
York	   27	   26.7	  	   22.4	  -­‐	  31.6	  	   20.0	  	   16.7	  -­‐	  23.8	  	  
Public	  Health	  District	   	   	   	   	   	  
Aroostook	   12	   33.2	  	   25.4	  -­‐	  42.6	  	   22.3	  	   16.9	  -­‐	  29.1	  	  
Central	   26	   29.7	  	   24.8	  -­‐	  35.2	  	   22.6	  	   18.8	  -­‐	  26.9	  	  
Cumberland	   37	   25.7	  	   22.1	  -­‐	  29.7	  	   19.4	  	   16.7	  -­‐	  22.6	  	  
Downeast	   15	   33.7	  	   26.5	  -­‐	  42.2	  	   22.5	  	   17.6	  -­‐	  28.7	  	  
Midcoast	   24	   31.8	  	   26.4	  -­‐	  38.0	  	   21.3	  	   17.5	  -­‐	  25.7	  	  
Penquis	   22	   25.7	  	   21.1	  -­‐	  30.9	  	   19.6	  	   16.1	  -­‐	  23.8	  	  
Western	   29	   29.2	  	   24.7	  -­‐	  34.4	  	   21.8	  	   18.4	  -­‐	  25.8	  	  
York	   27	   26.7	  	   22.4	  -­‐	  31.6	  	   20.0	  	   16.7	  -­‐	  23.8	  	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  
Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
Female	  breast	  cancer:	  SEER	  Cause	  of	  Death	  Recode:	  26000	  (which	  include	  ICD-­‐10	  code:	  C50).	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  deaths	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
*Counts	  and	  rates	  might	  be	  slightly	  underestimated	  due	  to	  missing	  underlying	  cause	  of	  death	  information	  for	  Maine	  residents	  who	  
died	  out	  of	  state	  in	  2010.	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Table	  3.12.	  Cervical	  cancer	  deaths	  by	  year,	  Maine,	  U.S.	  and	  U.S.	  whites,	  2000-­‐2010.*,†	  
Year	  
	  Maine	   U.S.	   	  U.S.	  Whites	  
	   	  Crude	   Age-­‐adjusted	   	   Crude	   Age-­‐adjusted	   	   Crude	   Age-­‐adjusted	  
Number	   Rate	   95%CI	   Rate	   95%	  CI	   Number	   Rate	   95%CI	   Rate	   95%CI	   Number	   Rate	   95%CI	   Rate	   95%CI	  
2000	   14	   2.1†	   1.2	  -­‐	  3.6†	   1.8†	   1.0	  -­‐	  3.1†	   4,200	   2.9	  	   2.8	  -­‐	  3.0	  	   2.8	  	   2.7	  -­‐	  2.9	  	   3,158	   2.7	  	   2.6	  -­‐	  2.8	  	   2.5	  	   2.4	  -­‐	  2.6	  	  
2001	   12	   1.8†	   0.9	  -­‐	  3.2†	   1.6†	   0.8	  -­‐	  2.8†	   4,092	   2.8	  	   2.7	  -­‐	  2.9	  	   2.7	  	   2.6	  -­‐	  2.8	  	   3,136	   2.7	  	   2.6	  -­‐	  2.8	  	   2.4	  	   2.3	  -­‐	  2.5	  	  
2002	   17	   2.6†	   1.5	  -­‐	  4.1†	   2.1†	   1.2	  -­‐	  3.5†	   3,952	   2.7	  	   2.6	  -­‐	  2.8	  	   2.6	  	   2.5	  -­‐	  2.6	  	   2,967	   2.5	  	   2.4	  -­‐	  2.6	  	   2.3	  	   2.2	  -­‐	  2.4	  	  
2003	   15	   2.2†	   1.3	  -­‐	  3.7†	   1.8†	   1.0	  -­‐	  3.0†	   3,919	   2.7	  	   2.6	  -­‐	  2.7	  	   2.5	  	   2.4	  -­‐	  2.6	  	   2,953	   2.5	  	   2.4	  -­‐	  2.6	  	   2.2	  	   2.2	  -­‐	  2.3	  	  
2004	   17	   2.5†	   1.5	  -­‐	  4.1†	   2.0†	   1.2	  -­‐	  3.3†	   3,850	   2.6	  	   2.5	  -­‐	  2.7	  	   2.4	  	   2.3	  -­‐	  2.5	  	   2,899	   2.4	  	   2.3	  -­‐	  2.5	  	   2.2	  	   2.1	  -­‐	  2.3	  	  
2005	   16	   2.4†	   1.4	  -­‐	  3.9†	   1.9†	   1.1	  -­‐	  3.2†	   3,924	   2.6	  	   2.5	  -­‐	  2.7	  	   2.4	  	   2.3	  -­‐	  2.5	  	   2,982	   2.5	  	   2.4	  -­‐	  2.6	  	   2.2	  	   2.1	  -­‐	  2.3	  	  
2006	   14	   2.1†	   1.1	  -­‐	  3.5†	   1.7†	   0.9	  -­‐	  2.9†	   3,976	   2.6	  	   2.5	  -­‐	  2.7	  	   2.4	  	   2.3	  -­‐	  2.5	  	   3,014	   2.5	  	   2.4	  -­‐	  2.6	  	   2.2	  	   2.1	  -­‐	  2.3	  	  
2007	   19	   2.8†	   1.7	  -­‐	  4.4†	   2.2†	   1.3	  -­‐	  3.5†	   4,021	   2.6	  	   2.5	  -­‐	  2.7	  	   2.4	  	   2.3	  -­‐	  2.5	  	   3,037	   2.5	  	   2.4	  -­‐	  2.6	  	   2.2	  	   2.1	  -­‐	  2.3	  	  
2008	   17	   2.5†	   1.5	  -­‐	  4.0†	   2.0†	   1.2	  -­‐	  3.3†	   4,008	   2.6	  	   2.5	  -­‐	  2.7	  	   2.4	  	   2.3	  -­‐	  2.4	  	   3,018	   2.5	  	   2.4	  -­‐	  2.5	  	   2.2	  	   2.1	  -­‐	  2.2	  	  
2009	   15	   2.2†	   1.2	  -­‐	  3.6†	   1.6†	   0.9	  -­‐	  2.8†	   3,909	   2.5	  	   2.4	  -­‐	  2.6	  	   2.3	  	   2.2	  -­‐	  2.4	  	   2,912	   2.4	  	   2.3	  -­‐	  2.4	  	   2.1	  	   2.0	  -­‐	  2.2	  	  
	  2010*	   13	   1.9†	   1.0	  -­‐	  3.3†	   1.4†	   0.7	  -­‐	  2.5†	   3,939	   2.5	  	   2.4	  -­‐	  2.6	  	   2.3	  	   2.2	  -­‐	  2.3	  	   2,970	   2.4	  	   2.3	  -­‐	  2.5	  	   2.1	  	   2.0	  -­‐	  2.2	  	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
Cervical	  cancer:	  SEER	  Cause	  of	  Death	  Recode:	  27010	  (which	  include	  ICD-­‐10	  code:	  C53).	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  deaths	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
*Counts	  and	  rates	  might	  be	  slightly	  underestimated	  due	  to	  missing	  underlying	  cause	  of	  death	  information	  for	  Maine	  residents	  who	  died	  out	  of	  state	  in	  2010.	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Table	  3.13.	  Cervical	  cancer	  deaths	  by	  year	  and	  age	  group,	  Maine,	  2000-­‐2010.*,†	  
Year	  
	  Age	  0─34	  years	   Age	  35─64	  years	   	  Age	  65─74	  years	   	  Age	  75	  years	  and	  older	  
	  Crude	   Crude	   Crude	   Crude	  
Number	   Rate	   95%CI	   Number	   Rate	   95%CI	   Number	   Rate	   95%CI	   Number	   Rate	   95%CI	  
2000	   0	   0.0†	  	   0.0	  -­‐	  1.3†	   DSP	   DSP	  	   DSP	  	   DSP	   DSP	  	   DSP	  	   DSP	   DSP	  	   DSP	  	  
2001	   0	   0.0†	  	   0.0	  -­‐	  1.3†	   DSP	   DSP	  	   DSP	  	   DSP	   DSP	  	   DSP	  	   DSP	   DSP	  	   DSP	  	  
2002	   0	   0.0†	  	   0.0	  -­‐	  1.3†	   11	   3.9†	   2.0	  -­‐	  7.0†	   DSP	   DSP	  	   DSP	  	   DSP	   DSP	  	   DSP	  	  
2003	   0	   0.0†	  	   0.0	  -­‐	  1.3†	   DSP	   DSP	  	   DSP	  	   DSP	   DSP	  	   DSP	  	   DSP	   DSP	  	   DSP	  	  
2004	   0	   0.0†	  	   0.0	  -­‐	  1.3†	   DSP	   DSP	  	   DSP	  	   DSP	   DSP	  	   DSP	  	   DSP	   DSP	  	   DSP	  	  
2005	   0	   0.0†	  	   0.0	  -­‐	  1.4†	   DSP	   DSP	  	   DSP	  	   DSP	   DSP	  	   DSP	  	   DSP	   DSP	  	   DSP	  	  
2006	   0	   0.0†	  	   0.0	  -­‐	  1.4†	   DSP	   DSP	  	   DSP	  	   DSP	   DSP	  	   DSP	  	   DSP	   DSP	  	   DSP	  	  
2007	   0	   0.0†	  	   0.0	  -­‐	  1.4†	   11	   3.7†	   1.9	  -­‐	  6.6†	   DSP	   DSP	  	   DSP	  	   DSP	   DSP	  	   DSP	  	  
2008	   DSP	   DSP	  	   DSP	  	   DSP	   DSP	  	   DSP	  	   DSP	   DSP	  	   DSP	  	   DSP	   DSP	  	   DSP	  	  
2009	   DSP	   DSP	  	   DSP	  	   10	   3.4†	   1.6	  -­‐	  6.2†	   DSP	   DSP	  	   DSP	  	   DSP	   DSP	  	   DSP	  	  
2010*	   0	   0.0†	  	   0.0	  -­‐	  1.4†	   DSP	   DSP	  	   DSP	  	   DSP	   DSP	  	   DSP	  	   DSP	   DSP	  	   DSP	  	  
U.S.	  2010	   203	   0.3	  	   0.2	  -­‐	  0.3	  	   2,436	   3.9	  	   3.7	  -­‐	  4.1	  	   606	   5.2	  	   4.8	  -­‐	  5.6	  	   694	   6.1	  	   5.7	  -­‐	  6.6	  	  
U.S.	  Whites	  2010	   155	   0.3	  	   0.2	  -­‐	  0.3	  	   1,829	   3.7	  	   3.5	  -­‐	  3.8	  	   459	   4.6	  	   4.2	  -­‐	  5.1	  	   527	   5.3	  	   4.9	  -­‐	  5.8	  	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
DSP:	  Data	  were	  suppressed	  by	  SEER*Stat	  to	  protect	  privacy	  due	  to	  small	  numbers.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
Cervical	  cancer:	  SEER	  Cause	  of	  Death	  Recode:	  27010	  (which	  include	  ICD-­‐10	  code:	  C53).	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  not	  calculated	  for	  age-­‐specific	  groups.	  
*Counts	  and	  rates	  might	  be	  slightly	  underestimated	  due	  to	  missing	  underlying	  cause	  of	  death	  information	  for	  Maine	  residents	  who	  died	  out	  of	  state	  
in	  2010.	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Crude	   Age-­‐Adjusted	  
Rate	   95%	  CI	   Rate	   95%	  CI	  
Maine	  total	   16	   2.3	  	   1.8	  -­‐	  2.9	  	   1.8	  	   1.4	  -­‐	  2.2	  	  
	   	   	   	   	   	  County	   	   	   	   	   	  
Androscoggin	   DSP	   DSP	  	   DSP	  	   DSP	  	   DSP	  	  
Aroostook	   DSP	   DSP	  	   DSP	  	   DSP	  	   DSP	  	  
Cumberland	   3	   2.1†	   1.2	  -­‐	  3.4†	   1.7†	   0.9	  -­‐	  2.9†	  
Franklin	   DSP	   DSP	  	   DSP	  	   DSP	  	   DSP	  	  
Hancock	   DSP	   DSP	  	   DSP	  	   DSP	  	   DSP	  	  
Kennebec	   DSP	   DSP	  	   DSP	  	   DSP	  	   DSP	  	  
Knox	   DSP	   DSP	  	   DSP	  	   DSP	  	   DSP	  	  
Lincoln	   DSP	   DSP	  	   DSP	  	   DSP	  	   DSP	  	  
Oxford	   DSP	   DSP	  	   DSP	  	   DSP	  	   DSP	  	  
Penobscot	   2	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2.8†	   1.4	  -­‐	  5.1†	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2.3†	   	  	  	  	  	  	  	  	  	  1.1	  -­‐	  4.2†	  
Piscataquis	   0	   0.0†	  	   0.0	  -­‐	  8.3†	  	   	  	  	  0.0†	  	   0.0	  -­‐	  9.4†	  	  
Sagadahoc	   0	   0.0†	  	   0.0	  -­‐	  4.0†	  	   0.0†	  	   0.0	  -­‐	  4.2†	  	  
Somerset	   DSP	   DSP	  	   DSP	  	   DSP	  	   DSP	  	  
Waldo	   DSP	   DSP	  	   DSP	  	   DSP	  	   DSP	  	  
Washington	   DSP	   DSP	  	   DSP	  	   DSP	  	   DSP	  	  
York	   DSP	   DSP	  	   DSP	  	   DSP	  	   DSP	  	  
Public	  Health	  District	   	   	   	   	   	  
Aroostook	   DSP	   DSP	  	   DSP	  	   DSP	  	   DSP	  	  
Central	   3	   3.6†	   2.1	  -­‐	  5.8†	   2.8†	   1.6	  -­‐	  4.6†	  
Cumberland	   3	   2.1†	   1.2	  -­‐	  3.4†	   1.7†	   0.9	  -­‐	  2.9†	  
Downeast	   DSP	   DSP	  	   DSP	  	   DSP	  	   DSP	  	  
Midcoast	   DSP	   DSP	  	   DSP	  	   DSP	  	   DSP	  	  
Penquis	   2	   2.5†	   1.3	  -­‐	  4.6†	   2.0†	   1.0	  -­‐	  3.7†	  
Western	   3	   2.8†	   1.5	  -­‐	  4.7†	   2.4†	   1.3	  -­‐	  4.1†	  
York	   DSP	   DSP	  	   DSP	  	   DSP	  	   DSP	  	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  
Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
DSP:	  Data	  were	  suppressed	  by	  SEER*Stat	  to	  protect	  privacy	  due	  to	  small	  numbers.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
Cervical	  cancer:	  SEER	  Cause	  of	  Death	  Recode:	  27010	  (which	  include	  ICD-­‐10	  code:	  C53).	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  deaths	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
*Counts	  and	  rates	  might	  be	  slightly	  underestimated	  due	  to	  missing	  underlying	  cause	  of	  death	  information	  for	  Maine	  residents	  who	  
died	  out	  of	  state	  in	  2010.	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Table	  3.15.	  Colorectal	  cancer	  deaths	  by	  year,	  Maine,	  U.S.	  and	  U.S.	  whites,	  2000-­‐2010.*	  
Year	  
	  Maine	   U.S.	   	  U.S.	  Whites	  
	   	  Crude	   Age-­‐adjusted	   	   Crude	   Age-­‐adjusted	   	   Crude	   Age-­‐adjusted	  
Number	   Rate	   95%CI	   Rate	   95%	  CI	   Number	   Rate	   95%CI	   Rate	   95%CI	   Number	   Rate	   95%CI	   Rate	   95%CI	  
2000	   335	   26.2	  	   23.5	  -­‐	  29.2	  	   23.0	  	   20.6	  -­‐	  25.6	  	   57,434	   20.4	  	   20.2	  -­‐	  20.5	  	   20.7	  	   20.5	  -­‐	  20.8	  	   49,462	   21.5	  	   21.3	  -­‐	  21.7	  	   20.2	  	   20.0	  -­‐	  20.3	  	  
2001	   313	   24.3	  	   21.7	  -­‐	  27.2	  	   21.3	  	   19.0	  -­‐	  23.8	  	   56,808	   19.9	  	   19.8	  -­‐	  20.1	  	   20.2	  	   20.0	  -­‐	  20.3	  	   48,677	   21.0	  	   20.8	  -­‐	  21.2	  	   19.6	  	   19.4	  -­‐	  19.8	  	  
2002	   326	   25.2	  	   22.5	  -­‐	  28.0	  	   21.8	  	   19.5	  -­‐	  24.3	  	   56,603	   19.7	  	   19.5	  -­‐	  19.8	  	   19.8	  	   19.6	  -­‐	  19.9	  	   48,434	   20.7	  	   20.5	  -­‐	  20.9	  	   19.2	  	   19.1	  -­‐	  19.4	  	  
2003	   295	   22.6	  	   20.1	  -­‐	  25.3	  	   19.4	  	   17.2	  -­‐	  21.7	  	   55,783	   19.2	  	   19.1	  -­‐	  19.4	  	   19.1	  	   19.0	  -­‐	  19.3	  	   47,572	   20.2	  	   20.1	  -­‐	  20.4	  	   18.6	  	   18.4	  -­‐	  18.8	  	  
2004	   279	   21.2	  	   18.8	  -­‐	  23.9	  	   18.0	  	   16.0	  -­‐	  20.3	  	   53,580	   18.3	  	   18.1	  -­‐	  18.5	  	   18.1	  	   17.9	  -­‐	  18.2	  	   45,662	   19.3	  	   19.1	  -­‐	  19.5	  	   17.6	  	   17.5	  -­‐	  17.8	  	  
2005	   278	   21.1	  	   18.7	  -­‐	  23.7	  	   17.7	  	   15.7	  -­‐	  19.9	  	   53,005	   17.9	  	   17.8	  -­‐	  18.1	  	   17.6	  	   17.4	  -­‐	  17.7	  	   44,777	   18.8	  	   18.6	  -­‐	  19.0	  	   17.0	  	   16.8	  -­‐	  17.2	  	  
2006	   275	   20.8	  	   18.4	  -­‐	  23.4	  	   17.0	  	   15.0	  -­‐	  19.2	  	   53,196	   17.8	  	   17.7	  -­‐	  18.0	  	   17.3	  	   17.1	  -­‐	  17.4	  	   44,940	   18.7	  	   18.6	  -­‐	  18.9	  	   16.8	  	   16.6	  -­‐	  16.9	  	  
2007	   313	   23.6	  	   21.0	  -­‐	  26.3	  	   18.8	  	   16.8	  -­‐	  21.1	  	   53,219	   17.7	  	   17.5	  -­‐	  17.8	  	   16.9	  	   16.8	  -­‐	  17.1	  	   44,852	   18.6	  	   18.4	  -­‐	  18.8	  	   16.4	  	   16.3	  -­‐	  16.6	  	  
2008	   270	   20.3	  	   17.9	  -­‐	  22.9	  	   16.1	  	   14.2	  -­‐	  18.2	  	   52,857	   17.4	  	   17.2	  -­‐	  17.5	  	   16.5	  	   16.3	  -­‐	  16.6	  	   44,356	   18.3	  	   18.1	  -­‐	  18.4	  	   16.0	  	   15.8	  -­‐	  16.1	  	  
2009	   240	   18.1	  	   15.8	  -­‐	  20.5	  	   14.5	  	   12.7	  -­‐	  16.5	  	   51,848	   16.9	  	   16.8	  -­‐	  17.0	  	   15.8	  	   15.7	  -­‐	  15.9	  	   43,488	   17.8	  	   17.6	  -­‐	  18.0	  	   15.4	  	   15.2	  -­‐	  15.5	  	  
	  2010*	   290	   21.8	  	   19.4	  -­‐	  24.5	  	   16.4	  	   14.5	  -­‐	  18.4	  	   52,045	   16.8	  	   16.7	  -­‐	  17.0	  	   15.5	  	   15.4	  -­‐	  15.6	  	   43,364	   17.6	  	   17.5	  -­‐	  17.8	  	   15.0	  	   14.9	  -­‐	  15.2	  	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
Colorectal	  cancer:	  SEER	  Cause	  of	  Death	  Recode:	  21041-­‐21049,	  21051,	  21052	  (which	  include	  ICD-­‐10	  codes:	  C180-­‐C189,	  C260,	  C199,	  C209).	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  deaths	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	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Table	  3.16.	  Colorectal	  cancer	  deaths	  by	  year	  and	  sex,	  Maine,	  2000-­‐2010.*	  
Year	  
	  Maine	  Overall	   Females	   	  Males	  
	   	  Crude	   Age-­‐adjusted	   	   Crude	   Age-­‐adjusted	   	   Crude	   Age-­‐adjusted	  
Number	   Rate	   95%CI	   Rate	   95%	  CI	   Number	   Rate	   95%CI	   Rate	   95%CI	   Number	   Rate	   95%CI	   Rate	   95%CI	  
2000	  	   335	   26.2	  	   23.5	  -­‐	  29.2	  	   23.0	  	   20.6	  -­‐	  25.6	  	   190	   29.0	  	   25.0	  -­‐	  33.4	  	   21.5	  	   18.5	  -­‐	  24.9	  	   145	   23.3	  	   19.7	  -­‐	  27.5	  	   24.2	  	   20.4	  -­‐	  28.6	  	  
2001	  	   313	   24.3	  	   21.7	  -­‐	  27.2	  	   21.3	  	   19.0	  -­‐	  23.8	  	   156	   23.6	  	   20.1	  -­‐	  27.7	  	   17.7	  	   15.0	  -­‐	  20.8	  	   157	   25.1	  	   21.3	  -­‐	  29.3	  	   26.4	  	   22.4	  -­‐	  31.0	  	  
2002	  	   326	   25.2	  	   22.5	  -­‐	  28.0	  	   21.8	  	   19.5	  -­‐	  24.3	  	   155	   23.3	  	   19.8	  -­‐	  27.3	  	   17.1	  	   14.4	  -­‐	  20.0	  	   171	   27.1	  	   23.2	  -­‐	  31.4	  	   27.8	  	   23.7	  -­‐	  32.4	  	  
2003	  	   295	   22.6	  	   20.1	  -­‐	  25.3	  	   19.4	  	   17.2	  -­‐	  21.7	  	   155	   23.2	  	   19.7	  -­‐	  27.1	  	   17.3	  	   14.6	  -­‐	  20.3	  	   140	   21.9	  	   18.5	  -­‐	  25.9	  	   21.9	  	   18.4	  -­‐	  25.9	  	  
2004	  	   279	   21.2	  	   18.8	  -­‐	  23.9	  	   18.0	  	   16.0	  -­‐	  20.3	  	   163	   24.3	  	   20.7	  -­‐	  28.3	  	   17.9	  	   15.2	  -­‐	  21.0	  	   116	   18.1	  	   14.9	  -­‐	  21.7	  	   18.0	  	   14.8	  -­‐	  21.7	  	  
2005	  	   278	   21.1	  	   18.7	  -­‐	  23.7	  	   17.7	  	   15.7	  -­‐	  19.9	  	   141	   20.9	  	   17.6	  -­‐	  24.7	  	   15.2	  	   12.8	  -­‐	  18.0	  	   137	   21.3	  	   17.8	  -­‐	  25.1	  	   21.0	  	   17.6	  -­‐	  24.9	  	  
2006	  	   275	   20.8	  	   18.4	  -­‐	  23.4	  	   17.0	  	   15.0	  -­‐	  19.2	  	   134	   19.8	  	   16.6	  -­‐	  23.5	  	   14.1	  	   11.8	  -­‐	  16.8	  	   141	   21.8	  	   18.3	  -­‐	  25.7	  	   20.9	  	   17.5	  -­‐	  24.7	  	  
2007	  	   313	   23.6	  	   21.0	  -­‐	  26.3	  	   18.8	  	   16.8	  -­‐	  21.1	  	   162	   23.9	  	   20.4	  -­‐	  27.9	  	   16.8	  	   14.3	  -­‐	  19.8	  	   151	   23.3	  	   19.7	  -­‐	  27.3	  	   21.7	  	   18.3	  -­‐	  25.6	  	  
2008	  	   270	   20.3	  	   17.9	  -­‐	  22.9	  	   16.1	  	   14.2	  -­‐	  18.2	  	   125	   18.4	  	   15.3	  -­‐	  21.9	  	   12.7	  	   10.5	  -­‐	  15.2	  	   145	   22.3	  	   18.8	  -­‐	  26.2	  	   21.0	  	   17.7	  -­‐	  24.8	  	  
2009	  	   240	   18.1	  	   15.8	  -­‐	  20.5	  	   14.5	  	   12.7	  -­‐	  16.5	  	   121	   17.8	  	   14.8	  -­‐	  21.3	  	   13.0	  	   10.8	  -­‐	  15.7	  	   119	   18.3	  	   15.1	  -­‐	  21.9	  	   16.6	  	   13.7	  -­‐	  20.0	  	  
2010*	   290	   21.8	  	   19.4	  -­‐	  24.5	  	   16.4	  	   14.5	  -­‐	  18.4	  	   132	   19.5	  	   16.3	  -­‐	  23.1	  	   13.1	  	   10.9	  -­‐	  15.6	  	   158	   24.3	  	   20.7	  -­‐	  28.4	  	   20.9	  	   17.7	  -­‐	  24.6	  	  




	  	  43,364	   17.6	   17.5	  -­‐	  17.8	   15.0	   14.9	  -­‐	  15.2	   	  	  20,753	   16.7	   16.5	  -­‐	  16.9	   12.6	   12.4	  -­‐	  12.8	   	  	  22,611	   18.6	   18.4	  -­‐	  18.8	   18.1	   17.9	  -­‐	  18.4	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
Colorectal	  cancer:	  SEER	  Cause	  of	  Death	  Recode:	  21041-­‐21049,	  21051,	  21052	  (which	  include	  ICD-­‐10	  codes:	  C180-­‐C189,	  C260,	  C199,	  C209).	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  deaths	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	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Table	  3.17.	  Colorectal	  cancer	  deaths	  by	  year	  and	  age	  group,	  Maine,	  2000-­‐2010.*,†	  
Year	  
	  Age	  0─34	  years	   Age	  35─64	  years	   	  Age	  65─74	  years	   	  Age	  75	  years	  and	  older	  
	  Crude	   Crude	   Crude	   Crude	  
Number	   Rate	   95%CI	   Number	   Rate	   95%CI	   Number	   Rate	   95%CI	   Number	   Rate	   95%CI	  
2000	   DSP	   DSP	  	   DSP	  	   73	   13.8	  	   10.8	  -­‐	  17.3	  	   80	   83.3	  	   66.0	  -­‐	  103.6	  	   181	   206.5	  	   177.5	  -­‐	  238.9	  	  
2001	   DSP	   DSP	  	   DSP	  	   64	   11.8	  	   9.1	  -­‐	  15.1	  	   66	   68.6	  	   53.0	  -­‐	  87.3	  	   181	   203.5	  	   174.9	  -­‐	  235.4	  	  
2002	   0	   0.0†	   0.0	  -­‐	  0.7†	   56	   10.2	  	   7.7	  -­‐	  13.2	  	   89	   92.4	  	   74.2	  -­‐	  113.7	  	   181	   200.4	  	   172.3	  -­‐	  231.8	  	  
2003	   DSP	   DSP	  	   DSP	  	   71	   12.7	  	   9.9	  -­‐	  16.0	  	   64	   66.2	  	   51.0	  -­‐	  84.6	  	   159	   173.6	  	   147.7	  -­‐	  202.8	  	  
2004	   DSP	   DSP	  	   DSP	  	   64	   11.3	  	   8.7	  -­‐	  14.4	  	   65	   66.9	  	   51.6	  -­‐	  85.3	  	   149	   160.8	  	   136.0	  -­‐	  188.8	  	  
2005	   DSP	   DSP	  	   DSP	  	   63	   11.0	  	   8.4	  -­‐	  14.1	  	   49	   50.1	  	   37.0	  -­‐	  66.2	  	   164	   175.4	  	   149.5	  -­‐	  204.3	  	  
2006	   DSP	   DSP	  	   DSP	  	   73	   12.6	  	   9.9	  -­‐	  15.8	  	   57	   57.4	  	   43.5	  -­‐	  74.3	  	   144	   151.4	  	   127.7	  -­‐	  178.3	  	  
2007	   0	   0.0†	  	   0.0	  -­‐	  0.7†	   80	   13.7	  	   10.9	  -­‐	  17.1	  	   62	   61.0	  	   46.8	  -­‐	  78.2	  	   171	   177.4	  	   151.8	  -­‐	  206.0	  	  
2008	   DSP	   DSP	  	   DSP	  	   61	   10.4	  	   8.0	  -­‐	  13.4	  	   57	   53.8	  	   40.7	  -­‐	  69.7	  	   151	   155.1	  	   131.3	  -­‐	  181.9	  	  
2009	   DSP	   DSP	  	   DSP	  	   62	   10.6	  	   8.2	  -­‐	  13.6	  	   66	   60.0	  	   46.4	  -­‐	  76.3	  	   111	   113.7	  	   93.5	  -­‐	  136.9	  	  
2010*	   DSP	   DSP	  	   DSP	  	   87	   15.0	  	   12.0	  -­‐	  18.5	  	   60	   52.9	  	   40.4	  -­‐	  68.1	  	   142	   143.9	  	   121.2	  -­‐	  169.6	  	  
U.S.	  2010	   365	   0.2	  	   0.2	  -­‐	  0.3	  	   15,487	   12.6	  	   12.4	  -­‐	  12.8	  	   11,363	   52.0	  	   51.0	  -­‐	  53.0	  	   24,830	   133.3	  	   131.7	  -­‐	  135.0	  	  
U.S.	  Whites	  2010	   262	   0.2	  	   0.2	  -­‐	  0.3	  	   11,956	   12.1	  	   11.9	  -­‐	  12.3	  	   9,405	   50.3	  	   49.3	  -­‐	  51.4	  	   21,741	   132.2	  	   130.5	  -­‐	  134.0	  	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
DSP:	  Data	  were	  suppressed	  by	  SEER*Stat	  to	  protect	  privacy	  due	  to	  small	  numbers.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
Colorectal	  cancer:	  SEER	  Cause	  of	  Death	  Recode:	  21041-­‐21049,	  21051,	  21052	  (which	  include	  ICD-­‐10	  codes:	  C180-­‐C189,	  C260,	  C199,	  C209).	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  not	  calculated	  for	  age-­‐specific	  groups.	  
*Counts	  and	  rates	  might	  be	  slightly	  underestimated	  due	  to	  missing	  underlying	  cause	  of	  death	  information	  for	  Maine	  residents	  who	  died	  out	  of	  state
in	  2010.	  
†Rates	  are	  flagged	  as	  unreliable	  when	  the	  rate	  is	  calculated	  with	  a	  numerator	  less	  than	  20.	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Crude	   Age-­‐Adjusted	  
Rate	   95%	  CI	   Rate	   95%	  CI	  
Maine	  total	   278	   20.9	  	   19.8	  -­‐	  22.0	  	   16.5	  	   15.7	  -­‐	  17.4	  	  
	   	   	   	   	   	  County	   	   	   	   	   	  
Androscoggin	   18	   16.7	  	   13.4	  -­‐	  20.5	  	   14.4	  	   11.6	  -­‐	  17.8	  	  
Aroostook	   22	   30.4	  	   25.0	  -­‐	  36.6	  	   20.8	  	   17.1	  -­‐	  25.2	  	  
Cumberland	   53	   19.0	  	   16.8	  -­‐	  21.4	  	   16.0	  	   14.1	  -­‐	  18.1	  	  
Franklin	   10	   32.0	  	   23.7	  -­‐	  42.3	  	   27.5	  	   20.2	  -­‐	  36.7	  	  
Hancock	   9	   16.9	  	   12.4	  -­‐	  22.6	  	   11.8	  	   8.6	  -­‐	  16.0	  	  
Kennebec	   29	   23.6	  	   19.9	  -­‐	  27.8	  	   18.9	  	   15.9	  -­‐	  22.3	  	  
Knox	   8	   18.9	  	   13.4	  -­‐	  26.0	  	   12.1	  	   8.5	  -­‐	  16.9	  	  
Lincoln	   8	   23.0	  	   16.5	  -­‐	  31.4	  	   14.0	  	   9.9	  -­‐	  19.5	  	  
Oxford	   13	   22.8	  	   17.6	  -­‐	  29.0	  	   17.5	  	   13.5	  -­‐	  22.4	  	  
Penobscot	   30	   19.4	  	   16.4	  -­‐	  22.7	  	   16.7	  	   14.1	  -­‐	  19.6	  	  
Piscataquis	   6	   33.0	  	   22.1	  -­‐	  47.5	  	   22.8	  	   15.1	  -­‐	  33.7	  	  
Sagadahoc	   7	   18.5	  	   12.7	  -­‐	  26.0	  	   14.4	  	   9.8	  -­‐	  20.5	  	  
Somerset	   13	   24.9	  	   19.2	  -­‐	  31.7	  	   19.9	  	   15.4	  -­‐	  25.6	  	  
Waldo	   8	   19.6	  	   13.9	  -­‐	  26.9	  	   15.2	  	   10.7	  -­‐	  21.1	  	  
Washington	   6	   19.3	  	   13.2	  -­‐	  27.3	  	   13.4	  	   9.1	  -­‐	  19.3	  	  
York	   39	   19.7	  	   17.0	  -­‐	  22.6	  	   15.9	  	   13.7	  -­‐	  18.3	  	  
Public	  Health	  District	   	   	   	   	   	  
Aroostook	   22	   30.4	  	   25.0	  -­‐	  36.6	  	   20.8	  	   17.1	  -­‐	  25.2	  	  
Central	   42	   24.0	  	   20.9	  -­‐	  27.5	  	   19.2	  	   16.7	  -­‐	  22.0	  	  
Cumberland	   53	   19.0	  	   16.8	  -­‐	  21.4	  	   16.0	  	   14.1	  -­‐	  18.1	  	  
Downeast	   16	   17.8	  	   14.1	  -­‐	  22.3	  	   12.4	  	   9.8	  -­‐	  15.6	  	  
Midcoast	   30	   20.0	  	   16.9	  -­‐	  23.4	  	   13.8	  	   11.7	  -­‐	  16.3	  	  
Penquis	   35	   20.8	  	   17.8	  -­‐	  24.1	  	   17.4	  	   14.9	  -­‐	  20.2	  	  
Western	   41	   20.9	  	   18.1	  -­‐	  23.9	  	   17.3	  	   15.0	  -­‐	  19.9	  	  
York	   39	   19.7	  	   17.0	  -­‐	  22.6	  	   15.9	  	   13.7	  -­‐	  18.3	  	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  
Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
Colorectal	  cancer:	  SEER	  Cause	  of	  Death	  Recode:	  21041-­‐21049,	  21051,	  21052	  (which	  include	  ICD-­‐10	  codes:	  C180-­‐
C189,	  C260,	  C199,	  C209).	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  deaths	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
*Counts	  and	  rates	  might	  be	  slightly	  underestimated	  due	  to	  missing	  underlying	  cause	  of	  death	  information	  for	  Maine	  residents	  who	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Table	  3.19.	  Lung	  cancer	  deaths	  by	  year,	  Maine,	  U.S.	  and	  U.S.	  whites,	  2000-­‐2010.*	  
Year	  
	  Maine	   U.S.	   	  U.S.	  Whites	  
	   	  Crude	   Age-­‐adjusted	   	   Crude	   Age-­‐adjusted	   	   Crude	   Age-­‐adjusted	  
Number	   Rate	   95%CI	   Rate	   95%	  CI	   Number	   Rate	   95%CI	   Rate	   95%CI	   Number	   Rate	   95%CI	   Rate	   95%CI	  
2000	   896	   70.2	  	   65.6	  -­‐	  74.9	  	   62.2	  	   58.2	  -­‐	  66.5	  	   155,426	   55.1	  	   54.8	  -­‐	  55.4	  	   55.8	  	   55.6	  -­‐	  56.1	  	   136,833	   59.4	  	   59.1	  -­‐	  59.7	  	   56.0	  	   55.7	  -­‐	  56.3	  	  
2001	   860	   66.9	  	   62.5	  -­‐	  71.5	  	   58.8	  	   54.9	  -­‐	  62.9	  	   155,969	   54.7	  	   54.5	  -­‐	  55.0	  	   55.3	  	   55.0	  -­‐	  55.6	  	   137,205	   59.1	  	   58.8	  -­‐	  59.4	  	   55.5	  	   55.3	  -­‐	  55.8	  	  
2002	   948	   73.2	  	   68.6	  -­‐	  78.0	  	   63.5	  	   59.5	  -­‐	  67.6	  	   157,630	   54.8	  	   54.5	  -­‐	  55.1	  	   55.0	  	   54.7	  -­‐	  55.3	  	   138,590	   59.3	  	   59.0	  -­‐	  59.6	  	   55.3	  	   55.0	  -­‐	  55.6	  	  
2003	   951	   72.8	  	   68.2	  -­‐	  77.6	  	   62.7	  	   58.7	  -­‐	  66.8	  	   157,990	   54.5	  	   54.2	  -­‐	  54.7	  	   54.2	  	   53.9	  -­‐	  54.5	  	   138,654	   59.0	  	   58.7	  -­‐	  59.3	  	   54.5	  	   54.2	  -­‐	  54.8	  	  
2004	   951	   72.4	  	   67.9	  -­‐	  77.1	  	   61.5	  	   57.7	  -­‐	  65.6	  	   158,006	   54.0	  	   53.7	  -­‐	  54.2	  	   53.4	  	   53.1	  -­‐	  53.6	  	   138,352	   58.5	  	   58.2	  -­‐	  58.8	  	   53.7	  	   53.4	  -­‐	  54.0	  	  
2005	   946	   71.7	  	   67.2	  -­‐	  76.5	  	   60.0	  	   56.2	  -­‐	  64.0	  	   159,217	   53.9	  	   53.6	  -­‐	  54.1	  	   52.9	  	   52.6	  -­‐	  53.1	  	   139,380	   58.5	  	   58.2	  -­‐	  58.8	  	   53.3	  	   53.0	  -­‐	  53.6	  	  
2006	   971	   73.4	  	   68.8	  -­‐	  78.1	  	   60.8	  	   57.0	  -­‐	  64.8	  	   158,599	   53.2	  	   52.9	  -­‐	  53.4	  	   51.7	  	   51.5	  -­‐	  52.0	  	   138,758	   57.9	  	   57.6	  -­‐	  58.2	  	   52.3	  	   52.0	  -­‐	  52.5	  	  
2007	   913	   68.8	  	   64.4	  -­‐	  73.4	  	   55.6	  	   52.0	  -­‐	  59.4	  	   158,683	   52.7	  	   52.4	  -­‐	  52.9	  	   50.7	  	   50.5	  -­‐	  51.0	  	   138,662	   57.5	  	   57.2	  -­‐	  57.8	  	   51.3	  	   51.0	  -­‐	  51.6	  	  
2008	   931	   70.0	  	   65.6	  -­‐	  74.6	  	   55.6	  	   52.1	  -­‐	  59.4	  	   158,592	   52.2	  	   51.9	  -­‐	  52.4	  	   49.6	  	   49.3	  -­‐	  49.8	  	   138,666	   57.1	  	   56.8	  -­‐	  57.4	  	   50.3	  	   50.0	  -­‐	  50.5	  	  
2009	   912	   68.6	  	   64.2	  -­‐	  73.2	  	   53.7	  	   50.2	  -­‐	  57.4	  	   158,081	   51.5	  	   51.3	  -­‐	  51.8	  	   48.4	  	   48.2	  -­‐	  48.7	  	   138,046	   56.5	  	   56.2	  -­‐	  56.8	  	   49.2	  	   48.9	  -­‐	  49.4	  	  
	  2010*	   957	   72.1	  	   67.6	  -­‐	  76.8	  	   55.1	  	   51.6	  -­‐	  58.8	  	   158,248	   51.2	  	   50.9	  -­‐	  51.4	  	   47.4	  	   47.2	  -­‐	  47.7	  	   137,638	   56.0	  	   55.7	  -­‐	  56.3	  	   48.1	  	   47.9	  -­‐	  48.4	  	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
Lung	  cancer:	  SEER	  Cause	  of	  Death	  Recode:	  22030	  (which	  include	  ICD-­‐10	  code:	  C34).	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  deaths	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	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Table	  3.20.	  Lung	  cancer	  deaths	  by	  year	  and	  sex,	  Maine,	  2000-­‐2010.*	  
Year	  
	  Maine	  Overall	   Females	   	  Males	  
	   	  Crude	   Age-­‐adjusted	   	   Crude	   Age-­‐adjusted	   	   Crude	   Age-­‐adjusted	  
Number	   Rate	   95%CI	   Rate	   95%	  CI	   Number	   Rate	   95%CI	   Rate	   95%CI	   Number	   Rate	   95%CI	   Rate	   95%CI	  
2000	  	   896	   70.2	  	   65.6	  -­‐	  74.9	  	   62.2	  	   58.2	  -­‐	  66.5	  	   397	   60.6	  	   54.7	  -­‐	  66.8	  	   49.0	  	   44.3	  -­‐	  54.2	  	   499	   80.3	  	   73.4	  -­‐	  87.6	  	   79.9	  	   72.9	  -­‐	  87.3	  	  
2001	  	   860	   66.9	  	   62.5	  -­‐	  71.5	  	   58.8	  	   54.9	  -­‐	  62.9	  	   368	   55.8	  	   50.2	  -­‐	  61.8	  	   44.8	  	   40.3	  -­‐	  49.7	  	   492	   78.6	  	   71.8	  -­‐	  85.9	  	   79.7	  	   72.7	  -­‐	  87.2	  	  
2002	  	   948	   73.2	  	   68.6	  -­‐	  78.0	  	   63.5	  	   59.5	  -­‐	  67.6	  	   420	   63.2	  	   57.3	  -­‐	  69.6	  	   50.2	  	   45.5	  -­‐	  55.3	  	   528	   83.6	  	   76.6	  -­‐	  91.0	  	   81.8	  	   74.9	  -­‐	  89.2	  	  
2003	  	   951	   72.8	  	   68.2	  -­‐	  77.6	  	   62.7	  	   58.7	  -­‐	  66.8	  	   428	   64.0	  	   58.1	  -­‐	  70.4	  	   50.3	  	   45.7	  -­‐	  55.4	  	   523	   82.0	  	   75.1	  -­‐	  89.3	  	   80.1	  	   73.3	  -­‐	  87.4	  	  
2004	  	   951	   72.4	  	   67.9	  -­‐	  77.1	  	   61.5	  	   57.7	  -­‐	  65.6	  	   427	   63.6	  	   57.7	  -­‐	  69.9	  	   49.3	  	   44.7	  -­‐	  54.3	  	   524	   81.6	  	   74.8	  -­‐	  88.9	  	   78.6	  	   72.0	  -­‐	  85.8	  	  
2005	  	   946	   71.7	  	   67.2	  -­‐	  76.5	  	   60.0	  	   56.2	  -­‐	  64.0	  	   415	   61.6	  	   55.8	  -­‐	  67.8	  	   47.6	  	   43.1	  -­‐	  52.5	  	   531	   82.4	  	   75.5	  -­‐	  89.7	  	   77.3	  	   70.7	  -­‐	  84.3	  	  
2006	  	   971	   73.4	  	   68.8	  -­‐	  78.1	  	   60.8	  	   57.0	  -­‐	  64.8	  	   439	   64.9	  	   59.0	  -­‐	  71.3	  	   49.5	  	   44.9	  -­‐	  54.4	  	   532	   82.2	  	   75.3	  -­‐	  89.5	  	   76.7	  	   70.3	  -­‐	  83.7	  	  
2007	  	   913	   68.8	  	   64.4	  -­‐	  73.4	  	   55.6	  	   52.0	  -­‐	  59.4	  	   421	   62.1	  	   56.3	  -­‐	  68.3	  	   46.0	  	   41.6	  -­‐	  50.7	  	   492	   75.8	  	   69.2	  -­‐	  82.8	  	   69.5	  	   63.4	  -­‐	  76.0	  	  
2008	  	   931	   70.0	  	   65.6	  -­‐	  74.6	  	   55.6	  	   52.1	  -­‐	  59.4	  	   403	   59.3	  	   53.7	  -­‐	  65.4	  	   43.7	  	   39.4	  -­‐	  48.2	  	   528	   81.1	  	   74.3	  -­‐	  88.3	  	   72.0	  	   65.9	  -­‐	  78.5	  	  
2009	  	   912	   68.6	  	   64.2	  -­‐	  73.2	  	   53.7	  	   50.2	  -­‐	  57.4	  	   414	   61.0	  	   55.3	  -­‐	  67.2	  	   44.2	  	   40.0	  -­‐	  48.8	  	   498	   76.5	  	   69.9	  -­‐	  83.5	  	   66.0	  	   60.2	  -­‐	  72.2	  	  
2010*	   957	   72.1	  	   67.6	  -­‐	  76.8	  	   55.1	  	   51.6	  -­‐	  58.8	  	   444	   65.5	  	   59.6	  -­‐	  71.9	  	   47.0	  	   42.7	  -­‐	  51.7	  	   513	   79.0	  	   72.3	  -­‐	  86.1	  	   66.1	  	   60.4	  -­‐	  72.3	  	  




137,638	   56.0	   55.7	  -­‐	  56.3	   48.1	   47.9	  -­‐	  48.4	   61,997	   49.9	   49.6	  -­‐	  50.3	   39.2	   38.9	  -­‐	  39.5	   75,641	   62.2	   61.8	  -­‐	  62.7	   59.9	   59.5	  -­‐	  60.4	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
Lung	  cancer:	  SEER	  Cause	  of	  Death	  Recode:	  22030	  (which	  include	  ICD-­‐10	  code:	  C34).	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  deaths	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	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Table	  3.21.	  Lung	  cancer	  deaths	  by	  year	  and	  age	  group,	  Maine,	  2000-­‐2010.*,†	  
Year	  
	  Age	  0─34	  years	   Age	  35─64	  years	   	  Age	  65─74	  years	   	  Age	  75	  years	  and	  older	  
	  Crude	   Crude	   Crude	   Crude	  
Number	   Rate	   95%CI	   Number	   Rate	   95%CI	   Number	   Rate	   95%CI	   Number	   Rate	   95%CI	  
2000	   DSP	   DSP	  	   DSP	  	   259	   48.8	  	   43.0	  -­‐	  55.1	  	   296	   308.1	  	   274.0	  -­‐	  345.3	  	   339	   386.8	  	   346.7	  -­‐	  430.2	  	  
2001	   DSP	   DSP	  	   DSP	  	   241	   44.6	  	   39.1	  -­‐	  50.6	  	   261	   271.2	  	   239.3	  -­‐	  306.2	  	   356	   400.3	  	   359.8	  -­‐	  444.1	  	  
2002	   DSP	   DSP	  	   DSP	  	   278	   50.6	  	   44.8	  -­‐	  56.9	  	   306	   317.6	  	   283.0	  -­‐	  355.3	  	   362	   400.8	  	   360.6	  -­‐	  444.3	  	  
2003	   0	   0.0	  	   0.0	  -­‐	  0.7†	   271	   48.5	  	   42.9	  -­‐	  54.7	  	   292	   302.1	  	   268.5	  -­‐	  338.8	  	   388	   423.6	  	   382.5	  -­‐	  467.9	  	  
2004	   DSP	   DSP	  	   DSP	  	   268	   47.4	  	   41.9	  -­‐	  53.4	  	   281	   289.2	  	   256.4	  -­‐	  325.1	  	   401	   432.8	  	   391.5	  -­‐	  477.3	  	  
2005	   0	   0.0	  	   0.0	  -­‐	  0.7†	   295	   51.5	  	   45.8	  -­‐	  57.7	  	   272	   278.0	  	   245.9	  -­‐	  313.0	  	   379	   405.3	  	   365.5	  -­‐	  448.2	  	  
2006	   DSP	   DSP	  	   DSP	  	   270	   46.6	  	   41.2	  -­‐	  52.5	  	   267	   268.8	  	   237.5	  -­‐	  303.0	  	   432	   454.3	  	   412.4	  -­‐	  499.2	  	  
2007	   0	   0.0	  	   0.0	  -­‐	  0.7†	   270	   46.3	  	   41.0	  -­‐	  52.2	  	   232	   228.4	  	   199.9	  -­‐	  259.7	  	   411	   426.3	  	   386.1	  -­‐	  469.6	  	  
2008	   DSP	   DSP	  	   DSP	  	   257	   44.0	  	   38.8	  -­‐	  49.7	  	   273	   257.6	  	   227.9	  -­‐	  290.0	  	   400	   410.9	  	   371.6	  -­‐	  453.2	  	  
2009	   0	   0.0	  	   0.0	  -­‐	  0.7†	   256	   43.9	  	   38.7	  -­‐	  49.7	  	   287	   260.8	  	   231.5	  -­‐	  292.8	  	   369	   377.9	  	   340.3	  -­‐	  418.5	  	  
2010*	   DSP	   DSP	  	   DSP	  	   288	   49.6	  	   44.0	  -­‐	  55.6	  	   273	   240.9	  	   213.2	  -­‐	  271.2	  	   395	   400.3	  	   361.7	  -­‐	  441.7	  	  
U.S.	  2010	   199	   0.1	  	   0.1	  -­‐	  0.2	  	   44,567	   36.3	  	   36.0	  -­‐	  36.6	  	   48,584	   222.3	  	   220.3	  -­‐	  224.3	  	   64,898	   348.5	  	   345.8	  -­‐	  351.2	  	  
U.S.	  Whites	  2010	   154	   0.1	  	   0.1	  -­‐	  0.2	  	   36,626	   37.0	  	   36.6	  -­‐	  37.4	  	   42,484	   227.4	  	   225.2	  -­‐	  229.6	  	   58,374	   355.0	  	   352.1	  -­‐	  357.9	  	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
DSP:	  Data	  were	  suppressed	  by	  SEER*Stat	  to	  protect	  privacy	  due	  to	  small	  numbers.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
Lung	  cancer:	  SEER	  Cause	  of	  Death	  Recode:	  22030	  (which	  include	  ICD-­‐10	  code:	  C34).	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  not	  calculated	  for	  age-­‐specific	  groups.	  
*Counts	  and	  rates	  might	  be	  slightly	  underestimated	  due	  to	  missing	  underlying	  cause	  of	  death	  information	  for	  Maine	  residents	  who	  died	  out	  of	  state	  
in	  2010.	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Crude	   Age-­‐Adjusted	  
Rate	   95%	  CI	   Rate	   95%	  CI	  
Maine	  total	   937	   70.6	  	   68.6	  -­‐	  72.6	  	   56.1	  	   54.5	  -­‐	  57.8	  	  
	   	   	   	   	   	  County	   	   	   	   	   	  
Androscoggin	   75	   69.9	  	   63.0	  -­‐	  77.3	  	   60.8	  	   54.8	  -­‐	  67.3	  	  
Aroostook	   64	   88.9	  	   79.5	  -­‐	  99.2	  	   60.4	  	   54.0	  -­‐	  67.6	  	  
Cumberland	   166	   59.4	  	   55.4	  -­‐	  63.5	  	   51.6	  	   48.1	  -­‐	  55.3	  	  
Franklin	   23	   75.0	  	   61.9	  -­‐	  90.1	  	   58.9	  	   48.5	  -­‐	  71.1	  	  
Hancock	   39	   72.5	  	   62.8	  -­‐	  83.4	  	   52.2	  	   45.1	  -­‐	  60.3	  	  
Kennebec	   90	   74.0	  	   67.3	  -­‐	  81.1	  	   60.2	  	   54.7	  -­‐	  66.1	  	  
Knox	   28	   69.3	  	   58.3	  -­‐	  81.8	  	   46.4	  	   38.9	  -­‐	  55.1	  	  
Lincoln	   26	   73.7	  	   61.5	  -­‐	  87.7	  	   45.3	  	   37.6	  -­‐	  54.3	  	  
Oxford	   47	   81.6	  	   71.5	  -­‐	  92.7	  	   60.7	  	   53.1	  -­‐	  69.1	  	  
Penobscot	   112	   73.5	  	   67.5	  -­‐	  79.8	  	   63.2	  	   58.1	  -­‐	  68.7	  	  
Piscataquis	   15	   83.2	  	   65.2	  -­‐	  104.6	  	   54.1	  	   42.3	  -­‐	  68.9	  	  
Sagadahoc	   27	   75.1	  	   62.9	  -­‐	  89.0	  	   60.8	  	   50.8	  -­‐	  72.3	  	  
Somerset	   41	   78.8	  	   68.4	  -­‐	  90.4	  	   61.1	  	   52.9	  -­‐	  70.2	  	  
Waldo	   27	   70.7	  	   59.4	  -­‐	  83.6	  	   56.1	  	   47.0	  -­‐	  66.6	  	  
Washington	   32	   95.3	  	   81.0	  -­‐	  111.4	  	   63.8	  	   54.1	  -­‐	  75.0	  	  
York	   124	   62.6	  	   57.8	  -­‐	  67.7	  	   51.2	  	   47.2	  -­‐	  55.5	  	  
Public	  Health	  District	   	   	   	   	   	  
Aroostook	   64	   88.9	  	   79.5	  -­‐	  99.2	  	   60.4	  	   54.0	  -­‐	  67.6	  	  
Central	   131	   75.4	  	   69.8	  -­‐	  81.4	  	   60.4	  	   55.8	  -­‐	  65.2	  	  
Cumberland	   166	   59.4	  	   55.4	  -­‐	  63.5	  	   51.6	  	   48.1	  -­‐	  55.3	  	  
Downeast	   71	   81.2	  	   73.0	  -­‐	  90.1	  	   56.6	  	   50.8	  -­‐	  63.0	  	  
Midcoast	   108	   72.1	  	   66.1	  -­‐	  78.4	  	   51.4	  	   47.1	  -­‐	  56.1	  	  
Penquis	   127	   74.5	  	   68.8	  -­‐	  80.5	  	   62.0	  	   57.2	  -­‐	  67.0	  	  
Western	   146	   74.1	  	   68.8	  -­‐	  79.7	  	   60.4	  	   56.0	  -­‐	  65.0	  	  
York	   124	   62.6	  	   57.8	  -­‐	  67.7	  	   51.2	  	   47.2	  -­‐	  55.5	  	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  
Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
Lung	  cancer:	  SEER	  Cause	  of	  Death	  Recode:	  22030	  (which	  include	  ICD-­‐10	  code:	  C34).	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  deaths	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
*Counts	  and	  rates	  might	  be	  slightly	  underestimated	  due	  to	  missing	  underlying	  cause	  of	  death	  information	  for	  Maine	  residents	  who	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Table	  3.23.	  Melanoma	  deaths	  by	  year,	  Maine,	  U.S.	  and	  U.S.	  whites,	  2000-­‐2010.*	  
Year	  
	  Maine	   U.S.	   	  U.S.	  Whites	  
	   	  Crude	   Age-­‐adjusted	   	   Crude	   Age-­‐adjusted	   	   Crude	   Age-­‐adjusted	  
Number	   Rate	   95%CI	   Rate	   95%	  CI	   Number	   Rate	   95%CI	   Rate	   95%CI	   Number	   Rate	   95%CI	   Rate	   95%CI	  
2000	   36	   2.8	  	   2.0	  -­‐	  3.9	  	   2.5	  	   1.8	  -­‐	  3.5	  	   7,420	   2.6	  	   2.6	  -­‐	  2.7	  	   2.7	  	   2.6	  -­‐	  2.7	  	   7,245	   3.1	  	   3.1	  -­‐	  3.2	  	   3.0	  	   2.9	  -­‐	  3.1	  	  
2001	   48	   3.7	  	   2.8	  -­‐	  4.9	  	   3.3	  	   2.5	  -­‐	  4.4	  	   7,542	   2.6	  	   2.6	  -­‐	  2.7	  	   2.7	  	   2.6	  -­‐	  2.7	  	   7,403	   3.2	  	   3.1	  -­‐	  3.3	  	   3.0	  	   3.0	  -­‐	  3.1	  	  
2002	   52	   4.0	  	   3.0	  -­‐	  5.3	  	   3.5	  	   2.6	  -­‐	  4.6	  	   7,513	   2.6	  	   2.6	  -­‐	  2.7	  	   2.6	  	   2.6	  -­‐	  2.7	  	   7,352	   3.1	  	   3.1	  -­‐	  3.2	  	   3.0	  	   2.9	  -­‐	  3.0	  	  
2003	   38	   2.9	  	   2.1	  -­‐	  4.0	  	   2.6	  	   1.8	  -­‐	  3.5	  	   7,818	   2.7	  	   2.6	  -­‐	  2.8	  	   2.7	  	   2.6	  -­‐	  2.7	  	   7,648	   3.3	  	   3.2	  -­‐	  3.3	  	   3.0	  	   3.0	  -­‐	  3.1	  	  
2004	   44	   3.3	  	   2.4	  -­‐	  4.5	  	   2.9	  	   2.1	  -­‐	  3.9	  	   7,952	   2.7	  	   2.7	  -­‐	  2.8	  	   2.7	  	   2.6	  -­‐	  2.7	  	   7,801	   3.3	  	   3.2	  -­‐	  3.4	  	   3.0	  	   3.0	  -­‐	  3.1	  	  
2005	   41	   3.1	  	   2.2	  -­‐	  4.2	  	   2.6	  	   1.9	  -­‐	  3.6	  	   8,345	   2.8	  	   2.8	  -­‐	  2.9	  	   2.8	  	   2.7	  -­‐	  2.8	  	   8,146	   3.4	  	   3.3	  -­‐	  3.5	  	   3.1	  	   3.1	  -­‐	  3.2	  	  
2006	   51	   3.9	  	   2.9	  -­‐	  5.1	  	   3.3	  	   2.4	  -­‐	  4.3	  	   8,441	   2.8	  	   2.8	  -­‐	  2.9	  	   2.7	  	   2.7	  -­‐	  2.8	  	   8,250	   3.4	  	   3.4	  -­‐	  3.5	  	   3.1	  	   3.1	  -­‐	  3.2	  	  
2007	   44	   3.3	  	   2.4	  -­‐	  4.5	  	   2.8	  	   2.0	  -­‐	  3.8	  	   8,461	   2.8	  	   2.7	  -­‐	  2.9	  	   2.7	  	   2.6	  -­‐	  2.7	  	   8,258	   3.4	  	   3.3	  -­‐	  3.5	  	   3.1	  	   3.0	  -­‐	  3.1	  	  
2008	   50	   3.8	  	   2.8	  -­‐	  5.0	  	   2.9	  	   2.2	  -­‐	  3.9	  	   8,623	   2.8	  	   2.8	  -­‐	  2.9	  	   2.7	  	   2.6	  -­‐	  2.7	  	   8,450	   3.5	  	   3.4	  -­‐	  3.6	  	   3.1	  	   3.0	  -­‐	  3.1	  	  
2009	   50	   3.8	  	   2.8	  -­‐	  5.0	  	   3.1	  	   2.3	  -­‐	  4.2	  	   9,199	   3.0	  	   2.9	  -­‐	  3.1	  	   2.8	  	   2.8	  -­‐	  2.9	  	   9,000	   3.7	  	   3.6	  -­‐	  3.8	  	   3.2	  	   3.2	  -­‐	  3.3	  	  
	  2010*	   54	   4.1	  	   3.1	  -­‐	  5.3	  	   3.1	  	   2.3	  -­‐	  4.0	  	   9,154	   3.0	  	   2.9	  -­‐	  3.0	  	   2.7	  	   2.7	  -­‐	  2.8	  	   8,944	   3.6	  	   3.6	  -­‐	  3.7	  	   3.2	  	   3.1	  -­‐	  3.2	  	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
Melanoma:	  SEER	  Cause	  of	  Death	  Recode:	  25010	  (which	  include	  ICD-­‐10	  code:	  C43).	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  deaths	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
*Counts	  and	  rates	  might	  be	  slightly	  underestimated	  due	  to	  missing	  underlying	  cause	  of	  death	  information	  for	  Maine	  residents	  who	  died	  out	  of	  state	  in	  2010.	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Table	  3.24.	  Melanoma	  deaths	  by	  year	  and	  sex,	  Maine,	  2000-­‐2010.*,†	  
Year	  
	  Maine	  Overall	   Females	   	  Males	  
	   	  Crude	   Age-­‐adjusted	   	   Crude	   Age-­‐adjusted	   	   Crude	   Age-­‐adjusted	  
Number	   Rate	   95%CI	   Rate	   95%	  CI	   Number	   Rate	   95%CI	   Rate	   95%CI	   Number	   Rate	   95%CI	   Rate	   95%CI	  
2000	  	   36	   2.8	  	   2.0	  -­‐	  3.9	  	   2.5	  	   1.8	  -­‐	  3.5	  	   16	   2.4†	   1.4	  -­‐	  4.0†	   2.1†	   1.2	  -­‐	  3.5	  	   20	   3.2	  	   2.0	  -­‐	  5.0	  	   3.4	  	   2.0	  -­‐	  5.3	  	  
2001	  	   48	   3.7	  	   2.8	  -­‐	  4.9	  	   3.3	  	   2.5	  -­‐	  4.4	  	   18	   2.7†	   1.6	  -­‐	  4.3†	   2.2†	   1.3	  -­‐	  3.5	  	   30	   4.8	  	   3.2	  -­‐	  6.8	  	   4.8	  	   3.2	  -­‐	  6.9	  	  
2002	  	   52	   4.0	  	   3.0	  -­‐	  5.3	  	   3.5	  	   2.6	  -­‐	  4.6	  	   14	   2.1†	   1.2	  -­‐	  3.5†	   1.7†	   0.9	  -­‐	  3.0	  	   38	   6.0	  	   4.3	  -­‐	  8.3	  	   5.9	  	   4.2	  -­‐	  8.2	  	  
2003	  	   38	   2.9	  	   2.1	  -­‐	  4.0	  	   2.6	  	   1.8	  -­‐	  3.5	  	   14	   2.1†	   1.1	  -­‐	  3.5†	   1.7†	   0.9	  -­‐	  2.9	  	   24	   3.8	  	   2.4	  -­‐	  5.6	  	   3.6	  	   2.3	  -­‐	  5.5	  	  
2004	  	   44	   3.3	  	   2.4	  -­‐	  4.5	  	   2.9	  	   2.1	  -­‐	  3.9	  	   16	   2.4†	   1.4	  -­‐	  3.9†	   1.8†	   1.0	  -­‐	  3.1	  	   28	   4.4	  	   2.9	  -­‐	  6.3	  	   4.1	  	   2.7	  -­‐	  6.0	  	  
2005	  	   41	   3.1	  	   2.2	  -­‐	  4.2	  	   2.6	  	   1.9	  -­‐	  3.6	  	   17	   2.5†	   1.5	  -­‐	  4.0†	   1.9†	   1.1	  -­‐	  3.1	  	   24	   3.7	  	   2.4	  -­‐	  5.5	  	   3.6	  	   2.3	  -­‐	  5.4	  	  
2006	  	   51	   3.9	  	   2.9	  -­‐	  5.1	  	   3.3	  	   2.4	  -­‐	  4.3	  	   19	   2.8†	   1.7	  -­‐	  4.4†	   2.3†	   1.4	  -­‐	  3.6	  	   32	   4.9	  	   3.4	  -­‐	  7.0	  	   4.7	  	   3.2	  -­‐	  6.6	  	  
2007	  	   44	   3.3	  	   2.4	  -­‐	  4.5	  	   2.8	  	   2.0	  -­‐	  3.8	  	   15	   2.2†	   1.2	  -­‐	  3.7†	   1.8†	   1.0	  -­‐	  3.0	  	   29	   4.5	  	   3.0	  -­‐	  6.4	  	   4.1	  	   2.7	  -­‐	  6.0	  	  
2008	  	   50	   3.8	  	   2.8	  -­‐	  5.0	  	   2.9	  	   2.2	  -­‐	  3.9	  	   23	   3.4	  	   2.1	  -­‐	  5.1	  	   2.5	  	   1.5	  -­‐	  3.8	  	   27	   4.1	  	   2.7	  -­‐	  6.0	  	   3.5	  	   2.3	  -­‐	  5.1	  	  
2009	  	   50	   3.8	  	   2.8	  -­‐	  5.0	  	   3.1	  	   2.3	  -­‐	  4.2	  	   15	   2.2†	   1.2	  -­‐	  3.6†	   1.7†	   0.9	  -­‐	  2.8	  	   35	   5.4	  	   3.7	  -­‐	  7.5	  	   5.1	  	   3.5	  -­‐	  7.2	  	  
2010*	   54	   4.1	  	   3.1	  -­‐	  5.3	  	   3.1	  	   2.3	  -­‐	  4.0	  	   16	   2.4†	   1.3	  -­‐	  3.8†	   1.8†	   1.0	  -­‐	  3.0	  	   38	   5.8	  	   4.1	  -­‐	  8.0	  	   4.9	  	   3.4	  -­‐	  6.8	  	  




8,944 3.6	   3.6	  -­‐	  3.7	   3.2	   3.1	  -­‐	  3.2	   3,039 2.4	   2.4	  -­‐	  2.5	   2.0	   1.9	  –	  2.0 5,905 4.9	   4.7	  –	  5.0	   4.7	   4.6	  -­‐	  4.8	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
Melanoma:	  SEER	  Cause	  of	  Death	  Recode:	  25010	  (which	  include	  ICD-­‐10	  code:	  C43).	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  deaths	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
*Counts	  and	  rates	  might	  be	  slightly	  underestimated	  due	  to	  missing	  underlying	  cause	  of	  death	  information	  for	  Maine	  residents	  who	  died	  out	  of	  state	  in	  2010.	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Table	  3.25.	  Melanoma	  deaths	  by	  year	  and	  age	  group,	  Maine,	  2000-­‐2010.*,†	  
Year	  
	  Age	  0─34	  years	   Age	  35─64	  years	   	  Age	  65─74	  years	   	  Age	  75	  years	  and	  older	  
	  Crude	   Crude	   Crude	   Crude	  
Number	   Rate	   95%CI	   Number	   Rate	   95%CI	   Number	   Rate	   95%CI	   Number	   Rate	   95%CI	  
2000	   DSP	   DSP	  	   DSP	  	   14	   2.6†	   1.4	  -­‐	  4.4†	   DSP	   DSP	  	   DSP	  	   17	   19.4	  	   11.3	  -­‐	  31.1	  	  
2001	   DSP	   DSP	  	   DSP	  	   17	   3.1†	   1.8	  -­‐	  5.0†	   DSP	   DSP	  	   DSP	  	   20	   22.5	  	   13.7	  -­‐	  34.7	  	  
2002	   0	   0.0	  	   0.0	  -­‐	  0.7†	   22	   4.0	  	   2.5	  -­‐	  6.1	  	   11	   11.4†	   5.7	  -­‐	  20.4†	   19	   21.0†	   12.7	  -­‐	  32.9†	  
2003	   DSP	   DSP	  	   DSP	  	   19	   3.4†	   2.0	  -­‐	  5.3†	   DSP	   DSP	  	   DSP	  	   13	   14.2	  	   7.6	  -­‐	  24.3	  	  
2004	   DSP	   DSP	  	   DSP	  	   15	   2.7†	   1.5	  -­‐	  4.4†	   11	   11.3†	   5.7	  -­‐	  20.3†	   16	   17.3†	   9.9	  -­‐	  28.0†	  
2005	   DSP	   DSP	  	   DSP	  	   15	   2.6†	   1.5	  -­‐	  4.3†	   DSP	   DSP	  	   DSP	  	   16	   17.1	  	   9.8	  -­‐	  27.8	  	  
2006	   DSP	   DSP	  	   DSP	  	   16	   2.8†	   1.6	  -­‐	  4.5†	   20	   20.1	  	   12.3	  -­‐	  31.1	  	   14	   14.7	  	   8.0	  -­‐	  24.7	  	  
2007	   0	   0.0	  	   0.0	  -­‐	  0.7†	   20	   3.4	  	   2.1	  -­‐	  5.3	  	   10	   9.8†	   4.7	  -­‐	  18.1†	   14	   14.5†	   7.9	  -­‐	  24.4†	  
2008	   0	   0.0	  	   0.0	  -­‐	  0.7†	   15	   2.6†	   1.4	  -­‐	  4.2†	   16	   15.1†	   8.6	  -­‐	  24.5†	   19	   19.5†	   11.7	  -­‐	  30.5†	  
2009	   DSP	   DSP	  	   DSP	  	   20	   3.4	  	   2.1	  -­‐	  5.3	  	   DSP	   DSP	  	   DSP	  	   18	   18.4	  	   10.9	  -­‐	  29.1	  	  
2010*	   0	   0.0	  	   0.0	  -­‐	  0.7†	   22	   3.8	  	   2.4	  -­‐	  5.7	  	   12	   10.6†	   5.5	  -­‐	  18.5†	   20	   20.3†	   12.4	  -­‐	  31.3†	  
U.S.	  2010	   211	   0.1	  	   0.1	  -­‐	  0.2	  	   3,473	   2.8	  	   2.7	  -­‐	  2.9	  	   2,063	   9.4	  	   9.0	  -­‐	  9.9	  	   3,407	   18.3	  	   17.7	  -­‐	  18.9	  	  
U.S.	  Whites	  2010	   204	   0.2	  	   0.2	  -­‐	  0.2	  	   3,392	   3.4	  	   3.3	  -­‐	  3.5	  	   2,010	   10.8	  	   10.3	  -­‐	  11.2	  	   3,338	   20.3	  	   19.6	  -­‐	  21.0	  	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
DSP:	  Data	  were	  suppressed	  by	  SEER*Stat	  to	  protect	  privacy	  due	  to	  small	  numbers.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
Melanoma:	  SEER	  Cause	  of	  Death	  Recode:	  25010	  (which	  include	  ICD-­‐10	  code:	  C43).	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  not	  calculated	  for	  age-­‐specific	  groups.	  
*Counts	  and	  rates	  might	  be	  slightly	  underestimated	  due	  to	  missing	  underlying	  cause	  of	  death	  information	  for	  Maine	  residents	  who	  died	  out	  of	  state	  
in	  2010.	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Crude	   Age-­‐Adjusted	  
Rate	   95%	  CI	   Rate	   95%	  CI	  
Maine	  total	   50	   3.8	  	   3.3	  -­‐	  4.2	  	   3.0	  	   2.7	  -­‐	  3.4	  	  
	   	   	   	   	   	  County	   	   	   	   	   	  
Androscoggin	   4	   3.9	  	   2.4	  -­‐	  6.0	  	   3.4	  	   2.1	  -­‐	  5.2	  	  
Aroostook	   3	   3.6†	   1.9	  -­‐	  6.1†	   2.7†	   1.4	  -­‐	  4.9†	  
Cumberland	   8	   2.8	  	   2.0	  -­‐	  3.8	  	   2.4	  	   1.7	  -­‐	  3.4	  	  
Franklin	   DSP	   DSP	  	   DSP	  	   DSP	  	   DSP	  	  
Hancock	   3	   6.3†	   3.6	  -­‐	  10.0†	   4.4†	   2.6	  -­‐	  7.4†	  
Kennebec	   5	   4.3	  	   2.8	  -­‐	  6.2	  	   3.4	  	   2.2	  -­‐	  5.0	  	  
Knox	   DSP	   DSP	  	   DSP	  	   DSP	  	   DSP	  	  
Lincoln	   3	   7.5†	   4.0	  -­‐	  12.8†	   4.5†	   2.4	  -­‐	  8.3†	  
Oxford	   DSP	   DSP	  	   DSP	  	   DSP	  	   DSP	  	  
Penobscot	   5	   3.3	  	   2.1	  -­‐	  4.8	  	   3.0	  	   1.9	  -­‐	  4.5	  	  
Piscataquis	   DSP	   DSP	  	   DSP	  	   DSP	  	   DSP	  	  
Sagadahoc	   DSP	   DSP	  	   DSP	  	   DSP	  	   DSP	  	  
Somerset	   DSP	   DSP	  	   DSP	  	   DSP	  	   DSP	  	  
Waldo	   DSP	   DSP	  	   DSP	  	   DSP	  	   DSP	  	  
Washington	   DSP	   DSP	  	   DSP	  	   DSP	  	   DSP	  	  
York	   10	   5.0	  	   3.7	  -­‐	  6.6	  	   4.0	  	   3.0	  -­‐	  5.4	  	  
Public	  Health	  District	   	   	   	   	   	  
Aroostook	   3	   3.6†	   1.9	  -­‐	  6.1†	   2.7†	   1.4	  -­‐	  4.9†	  
Central	   7	   3.8	  	   2.6	  -­‐	  5.3	  	   3.0	  	   2.0	  -­‐	  4.2	  	  
Cumberland	   8	   2.8	  	   2.0	  -­‐	  3.8	  	   2.4	  	   1.7	  -­‐	  3.4	  	  
Downeast	   5	   5.3	  	   3.3	  -­‐	  7.9	  	   3.6	  	   2.3	  -­‐	  5.5	  	  
Midcoast	   7	   4.6	  	   3.2	  -­‐	  6.4	  	   3.2	  	   2.2	  -­‐	  4.6	  	  
Penquis	   6	   3.4	  	   2.3	  -­‐	  4.9	  	   3.0	  	   2.0	  -­‐	  4.4	  	  
Western	   6	   3.0	  	   2.0	  -­‐	  4.2	  	   2.5	  	   1.7	  -­‐	  3.6	  	  
York	   10	   5.0	  	   3.7	  -­‐	  6.6	  	   4.0	  	   3.0	  -­‐	  5.4	  	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  
Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
DSP:	  Data	  were	  suppressed	  by	  SEER*Stat	  to	  protect	  privacy	  due	  to	  small	  numbers.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
Melanoma:	  SEER	  Cause	  of	  Death	  Recode:	  25010	  (which	  include	  ICD-­‐10	  code:	  C43).	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  deaths	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
*Counts	  and	  rates	  might	  be	  slightly	  underestimated	  due	  to	  missing	  underlying	  cause	  of	  death	  information	  for	  Maine	  residents	  who	  
died	  out	  of	  state	  in	  2010.	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Table	  3.27.	  Prostate	  cancer	  deaths	  by	  year,	  Maine,	  U.S.	  and	  U.S.	  whites,	  2000-­‐2010.*	  
Year	  
	  Maine	   U.S.	   	  U.S.	  Whites	  
	   	  Crude	   Age-­‐adjusted	   	   Crude	   Age-­‐adjusted	   	   Crude	   Age-­‐adjusted	  
Number	   Rate	   95%CI	   Rate	   95%	  CI	   Number	   Rate	   95%CI	   Rate	   95%CI	   Number	   Rate	   95%CI	   Rate	   95%CI	  
2000	   147	   23.7	  	   20.0	  -­‐	  27.8	  	   28.7	  	   24.1	  -­‐	  33.7	  	   31,078	   22.4	  	   22.2	  -­‐	  22.7	  	   30.4	  	   30.1	  -­‐	  30.7	  	   25,340	   22.3	  	   22.0	  -­‐	  22.6	  	   27.8	  	   27.4	  -­‐	  28.1	  	  
2001	   184	   29.4	  	   25.3	  -­‐	  34.0	  	   33.7	  	   28.9	  -­‐	  39.0	  	   30,719	   22.0	  	   21.7	  -­‐	  22.2	  	   29.5	  	   29.2	  -­‐	  29.9	  	   25,066	   21.9	  	   21.6	  -­‐	  22.2	  	   27.0	  	   26.6	  -­‐	  27.3	  	  
2002	   148	   23.4	  	   19.8	  -­‐	  27.5	  	   26.7	  	   22.5	  -­‐	  31.4	  	   30,446	   21.6	  	   21.3	  -­‐	  21.8	  	   28.7	  	   28.4	  -­‐	  29.0	  	   24,918	   21.6	  	   21.3	  -­‐	  21.9	  	   26.4	  	   26.0	  -­‐	  26.7	  	  
2003	   160	   25.1	  	   21.3	  -­‐	  29.3	  	   28.1	  	   23.9	  -­‐	  32.9	  	   29,554	   20.8	  	   20.5	  -­‐	  21.0	  	   27.2	  	   26.9	  -­‐	  27.5	  	   24,232	   20.9	  	   20.6	  -­‐	  21.1	  	   25.0	  	   24.7	  -­‐	  25.3	  	  
2004	   158	   24.6	  	   20.9	  -­‐	  28.8	  	   27.3	  	   23.2	  -­‐	  32.0	  	   29,002	   20.2	  	   19.9	  -­‐	  20.4	  	   26.2	  	   25.9	  -­‐	  26.5	  	   23,726	   20.3	  	   20.0	  -­‐	  20.6	  	   24.0	  	   23.7	  -­‐	  24.4	  	  
2005	   156	   24.2	  	   20.5	  -­‐	  28.3	  	   26.3	  	   22.3	  -­‐	  30.8	  	   28,905	   19.9	  	   19.7	  -­‐	  20.1	  	   25.4	  	   25.1	  -­‐	  25.7	  	   23,597	   20.1	  	   19.8	  -­‐	  20.3	  	   23.3	  	   23.0	  -­‐	  23.6	  	  
2006	   148	   22.9	  	   19.3	  -­‐	  26.9	  	   24.0	  	   20.2	  -­‐	  28.2	  	   28,372	   19.3	  	   19.1	  -­‐	  19.6	  	   24.2	  	   24.0	  -­‐	  24.5	  	   23,202	   19.6	  	   19.3	  -­‐	  19.8	  	   22.3	  	   22.0	  -­‐	  22.6	  	  
2007	   138	   21.3	  	   17.9	  -­‐	  25.1	  	   22.7	  	   19.0	  -­‐	  26.8	  	   29,093	   19.6	  	   19.4	  -­‐	  19.9	  	   24.2	  	   24.0	  -­‐	  24.5	  	   23,666	   19.8	  	   19.6	  -­‐	  20.1	  	   22.2	  	   21.9	  -­‐	  22.5	  	  
2008	   150	   23.0	  	   19.5	  -­‐	  27.0	  	   23.1	  	   19.5	  -­‐	  27.1	  	   28,471	   19.0	  	   18.8	  -­‐	  19.3	  	   23.0	  	   22.7	  -­‐	  23.3	  	   23,362	   19.4	  	   19.2	  -­‐	  19.7	  	   21.3	  	   21.1	  -­‐	  21.6	  	  
2009	   158	   24.3	  	   20.6	  -­‐	  28.4	  	   24.2	  	   20.5	  -­‐	  28.3	  	   28,088	   18.6	  	   18.4	  -­‐	  18.8	  	   22.1	  	   21.9	  -­‐	  22.4	  	   22,777	   18.8	  	   18.6	  -­‐	  19.1	  	   20.3	  	   20.1	  -­‐	  20.6	  	  
	  2010*	   144	   22.2	  	   18.7	  -­‐	  26.1	  	   21.0	  	   17.6	  -­‐	  24.7	  	   28,560	   18.8	  	   18.6	  -­‐	  19.0	  	   21.8	  	   21.6	  -­‐	  22.1	  	   23,172	   19.1	  	   18.8	  -­‐	  19.3	  	   20.1	  	   19.8	  -­‐	  20.4	  	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
Prostate	  cancer:	  SEER	  Cause	  of	  Death	  Recode:	  28010	  (which	  include	  ICD-­‐10	  code:	  C61).	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  deaths	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	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Table	  3.28.	  Prostate	  cancer	  deaths	  by	  year	  and	  age	  group,	  Maine,	  2000-­‐2010.*,†	  
Year	  
	  Age	  0─34	  years	   Age	  35─64	  years	   	  Age	  65─74	  years	   	  Age	  75	  years	  and	  older	  
	  Crude	   Crude	   Crude	   Crude	  
Number	   Rate	   95%CI	   Number	   Rate	   95%CI	   Number	   Rate	   95%CI	   Number	   Rate	   95%CI	  
2000	   0	   	  	  	  0.0†	   0.0	  -­‐	  1.3†	   DSP	   DSP	  	   DSP	  	   18	   40.8†	   24.2	  -­‐	  64.5†	   120	   374.1	   310.1	  -­‐	  447.3	  
2001	   0	   0.0†	  	   0.0	  -­‐	  1.3†	   13	   4.9†	   2.6	  -­‐	  8.4†	   36	   80.9	  	   56.7	  -­‐	  112.0	  	   135	   411.8	  	   345.3	  -­‐	  487.4	  	  
2002	   0	   0.0†	  	   0.0	  -­‐	  1.3†	   DSP	   DSP	  	   DSP	  	   27	   60.2	  	   39.7	  -­‐	  87.6	  	   113	   337.2	  	   277.9	  -­‐	  405.4	  	  
2003	   0	   0.0†	  	   0.0	  -­‐	  1.3†	   11	   4.0†	   2.0	  -­‐	  7.2†	   27	   59.9	  	   39.5	  -­‐	  87.1	  	   122	   355.4	  	   295.2	  -­‐	  424.4	  	  
2004	   0	   0.0†	  	   0.0	  -­‐	  1.3†	   12	   4.3†	   2.2	  -­‐	  7.5†	   24	   52.7	  	   33.8	  -­‐	  78.5	  	   122	   348.6	  	   289.5	  -­‐	  416.2	  	  
2005	   0	   0.0†	  	   0.0	  -­‐	  1.3†	   18	   6.4†	   3.8	  -­‐	  10.1†	   27	   58.8	  	   38.7	  -­‐	  85.5	  	   111	   312.1	  	   256.7	  -­‐	  375.8	  	  
2006	   0	   0.0†	  	   0.0	  -­‐	  1.3†	   12	   4.2†	   2.2	  -­‐	  7.4†	   29	   61.8	  	   41.4	  -­‐	  88.8	  	   107	   294.4	  	   241.2	  -­‐	  355.7	  	  
2007	   0	   0.0†	  	   0.0	  -­‐	  1.3†	   DSP	   DSP	  	   DSP	  	   29	   60.2	  	   40.3	  -­‐	  86.5	  	   104	   280.6	  	   229.3	  -­‐	  340.0	  	  
2008	   0	   0.0†	  	   0.0	  -­‐	  1.3†	   11	   3.8†	   1.9	  -­‐	  6.9†	   28	   55.8	  	   37.0	  -­‐	  80.6	  	   111	   293.5	  	   241.5	  -­‐	  353.5	  	  
2009	   0	   0.0†	  	   0.0	  -­‐	  1.3†	   11	   3.8†	   1.9	  -­‐	  6.9†	   26	   49.7	  	   32.5	  -­‐	  72.8	  	   121	   316.8	  	   262.9	  -­‐	  378.6	  	  
2010*	   0	   0.0†	  	   0.0	  -­‐	  1.4†	   11	   3.9†	   1.9	  -­‐	  6.9†	   29	   53.7	  	   36.0	  -­‐	  77.1	  	   104	   266.9	  	   218.1	  -­‐	  323.4	  	  
U.S.	  2010	   DSP	   DSP	  	   DSP	  	   3,068	   5.1	  	   4.9	  -­‐	  5.3	  	   5,866	   57.7	  	   56.2	  -­‐	  59.2	  	   19,623	   268.7	  	   264.9	  -­‐	  272.4	  	  
U.S.	  Whites	  2010	   DSP	   DSP	  	   DSP	  	   2,201	   4.5	  	   4.3	  -­‐	  4.7	  	   4,501	   51.3	  	   49.8	  -­‐	  52.8	  	   16,468	   252.9	  	   249.1	  -­‐	  256.8	  	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
DSP:	  Data	  were	  suppressed	  by	  SEER*Stat	  to	  protect	  privacy	  due	  to	  small	  numbers.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
Prostate	  cancer:	  SEER	  Cause	  of	  Death	  Recode:	  28010	  (which	  include	  ICD-­‐10	  code:	  C61).	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  not	  calculated	  for	  age-­‐specific	  groups.	  
*Counts	  and	  rates	  might	  be	  slightly	  underestimated	  due	  to	  missing	  underlying	  cause	  of	  death	  information	  for	  Maine	  residents	  who	  died	  out	  of	  state	  
in	  2010.	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Crude	   Age-­‐Adjusted	  
Rate	   95%	  CI	   Rate	   95%	  CI	  
Maine	  total	   148	   22.7	  	   21.1	  -­‐	  24.4	  	   22.9	  	   21.3	  -­‐	  24.7	  	  
	   	   	   	   	   	  County	   	   	   	   	   	  
Androscoggin	   10	   18.2	  	   13.4	  -­‐	  24.1	  	   20.3	  	   14.9	  -­‐	  27.0	  	  
Aroostook	   6	   15.7	  	   10.4	  -­‐	  22.7	  	   14.0	  	   9.2	  -­‐	  20.5	  	  
Cumberland	   30	   22.2	  	   18.8	  -­‐	  26.0	  	   24.6	  	   20.8	  -­‐	  28.9	  	  
Franklin	   4	   25.3†	   15.3	  -­‐	  39.6†	   25.3†	   14.9	  -­‐	  40.2†	  
Hancock	   9	   34.6	  	   25.3	  -­‐	  46.1	  	   30.6	  	   22.3	  -­‐	  41.1	  	  
Kennebec	   16	   27.3	  	   21.7	  -­‐	  33.9	  	   27.7	  	   21.9	  -­‐	  34.4	  	  
Knox	   6	   31.3	  	   21.3	  -­‐	  44.4	  	   24.7	  	   16.7	  -­‐	  35.5	  	  
Lincoln	   6	   32.9	  	   21.9	  -­‐	  47.6	  	   24.5	  	   16.2	  -­‐	  36.0	  	  
Oxford	   6	   22.4	  	   15.3	  -­‐	  31.6	  	   20.6	  	   14.0	  -­‐	  29.3	  	  
Penobscot	   15	   20.4	  	   16.1	  -­‐	  25.6	  	   22.8	  	   17.9	  -­‐	  28.6	  	  
Piscataquis	   2	   25.4†	   12.7	  -­‐	  45.4†	   20.8†	   10.3	  -­‐	  38.7†	  
Sagadahoc	   5	   27.7	  	   17.7	  -­‐	  41.2	  	   29.5	  	   18.7	  -­‐	  44.0	  	  
Somerset	   5	   20.1	  	   13.1	  -­‐	  29.5	  	   19.6	  	   12.7	  -­‐	  29.0	  	  
Waldo	   4	   23.2	  	   14.5	  -­‐	  35.1	  	   23.7	  	   14.6	  -­‐	  36.4	  	  
Washington	   5	   29.4	  	   18.8	  -­‐	  43.8	  	   24.0	  	   15.3	  -­‐	  36.2	  	  
York	   18	   18.7	  	   15.0	  -­‐	  23.0	  	   20.1	  	   16.1	  -­‐	  24.7	  	  
Public	  Health	  District	   	   	   	   	   	  
Aroostook	   6	   15.7	  	   10.4	  -­‐	  22.7	  	   14.0	  	   9.2	  -­‐	  20.5	  	  
Central	   21	   25.1	  	   20.6	  -­‐	  30.4	  	   25.4	  	   20.8	  -­‐	  30.8	  	  
Cumberland	   30	   22.2	  	   18.8	  -­‐	  26.0	  	   24.6	  	   20.8	  -­‐	  28.9	  	  
Downeast	   14	   32.6	  	   25.4	  -­‐	  41.2	  	   28.1	  	   21.8	  -­‐	  35.7	  	  
Midcoast	   21	   28.7	  	   23.5	  -­‐	  34.8	  	   25.2	  	   20.6	  -­‐	  30.6	  	  
Penquis	   18	   21.0	  	   16.8	  -­‐	  25.8	  	   22.5	  	   18.0	  -­‐	  27.8	  	  
Western	   20	   20.5	  	   16.7	  -­‐	  25.0	  	   21.1	  	   17.1	  -­‐	  25.8	  	  
York	   18	   18.7	  	   15.0	  -­‐	  23.0	  	   20.1	  	   16.1	  -­‐	  24.7	  	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  
Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
Prostate	  cancer:	  SEER	  Cause	  of	  Death	  Recode:	  28010	  (which	  include	  ICD-­‐10	  code:	  C61).	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  deaths	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
*Counts	  and	  rates	  might	  be	  slightly	  underestimated	  due	  to	  missing	  underlying	  cause	  of	  death	  information	  for	  Maine	  residents	  who	  
died	  out	  of	  state	  in	  2010.	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Table	  3.30.	  Tobacco-­‐related	  cancer	  (excluding	  lung	  cancer)	  deaths	  by	  year,	  Maine,	  U.S.	  and	  U.S.	  whites,	  2000-­‐2010.*	  
Year	  
	  Maine	   U.S.	   	  U.S.	  Whites	  
	   	  Crude	   Age-­‐adjusted	   	   Crude	   Age-­‐adjusted	   	   Crude	   Age-­‐adjusted	  
Number	   Rate	   95%CI	   Rate	   95%	  CI	   Number	   Rate	   95%CI	   Rate	   95%CI	   Number	   Rate	   95%CI	   Rate	   95%CI	  
2000	   599	   46.9	  	   43.2	  -­‐	  50.8	  	   41.4	  	   38.2	  -­‐	  44.9	  	   100,912	   35.8	  	   35.5	  -­‐	  36.0	  	   36.3	  	   36.0	  -­‐	  36.5	  	   85,995	   37.3	  	   37.1	  -­‐	  37.6	  	   35.2	  	   35.0	  -­‐	  35.4	  	  
2001	   546	   42.5	  	   39.0	  -­‐	  46.2	  	   37.3	  	   34.2	  -­‐	  40.6	  	   102,292	   35.9	  	   35.7	  -­‐	  36.1	  	   36.2	  	   36.0	  -­‐	  36.5	  	   87,318	   37.6	  	   37.4	  -­‐	  37.9	  	   35.3	  	   35.1	  -­‐	  35.5	  	  
2002	   607	   46.8	  	   43.2	  -­‐	  50.7	  	   40.6	  	   37.4	  -­‐	  44.0	  	   103,278	   35.9	  	   35.7	  -­‐	  36.1	  	   36.0	  	   35.8	  -­‐	  36.2	  	   88,173	   37.7	  	   37.5	  -­‐	  38.0	  	   35.2	  	   34.9	  -­‐	  35.4	  	  
2003	   556	   42.6	  	   39.1	  -­‐	  46.2	  	   36.7	  	   33.7	  -­‐	  39.9	  	   104,129	   35.9	  	   35.7	  -­‐	  36.1	  	   35.6	  	   35.4	  -­‐	  35.9	  	   88,810	   37.8	  	   37.5	  -­‐	  38.0	  	   34.8	  	   34.6	  -­‐	  35.1	  	  
2004	   607	   46.2	  	   42.6	  -­‐	  50.0	  	   39.0	  	   35.9	  -­‐	  42.2	  	   105,554	   36.0	  	   35.8	  -­‐	  36.3	  	   35.5	  	   35.3	  -­‐	  35.7	  	   90,169	   38.1	  	   37.9	  -­‐	  38.4	  	   34.9	  	   34.6	  -­‐	  35.1	  	  
2005	   644	   48.8	  	   45.1	  -­‐	  52.8	  	   40.8	  	   37.7	  -­‐	  44.1	  	   107,302	   36.3	  	   36.1	  -­‐	  36.5	  	   35.5	  	   35.3	  -­‐	  35.7	  	   91,666	   38.5	  	   38.2	  -­‐	  38.7	  	   34.9	  	   34.7	  -­‐	  35.1	  	  
2006	   600	   45.3	  	   41.8	  -­‐	  49.1	  	   37.4	  	   34.4	  -­‐	  40.5	  	   108,393	   36.3	  	   36.1	  -­‐	  36.5	  	   35.2	  	   35.0	  -­‐	  35.4	  	   92,650	   38.6	  	   38.4	  -­‐	  38.9	  	   34.7	  	   34.5	  -­‐	  34.9	  	  
2007	   653	   49.2	  	   45.5	  -­‐	  53.1	  	   39.7	  	   36.7	  -­‐	  42.9	  	   109,933	   36.5	  	   36.3	  -­‐	  36.7	  	   34.9	  	   34.7	  -­‐	  35.1	  	   93,584	   38.8	  	   38.5	  -­‐	  39.0	  	   34.4	  	   34.2	  -­‐	  34.6	  	  
2008	   582	   43.7	  	   40.3	  -­‐	  47.4	  	   34.7	  	   31.9	  -­‐	  37.7	  	   111,980	   36.8	  	   36.6	  -­‐	  37.0	  	   34.8	  	   34.6	  -­‐	  35.0	  	   95,584	   39.4	  	   39.1	  -­‐	  39.6	  	   34.5	  	   34.3	  -­‐	  34.7	  	  
2009	   637	   47.9	  	   44.3	  -­‐	  51.8	  	   37.4	  	   34.5	  -­‐	  40.4	  	   112,600	   36.7	  	   36.5	  -­‐	  36.9	  	   34.3	  	   34.1	  -­‐	  34.5	  	   96,016	   39.3	  	   39.1	  -­‐	  39.5	  	   34.0	  	   33.8	  -­‐	  34.2	  	  
	  2010*	   646	   48.7	  	   45.0	  -­‐	  52.6	  	   37.3	  	   34.4	  -­‐	  40.3	  	   115,971	   37.5	  	   37.3	  -­‐	  37.7	  	   34.6	  	   34.4	  -­‐	  34.8	  	   99,035	   40.3	  	   40.1	  -­‐	  40.6	  	   34.4	  	   34.2	  -­‐	  34.6	  	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
Tobacco-­‐related	  cancer	  (excluding	  lung	  cancer):	  SEER	  Cause	  of	  Death	  Recode:	  20010,	  20020,	  20030,	  20040,	  20050,	  20060,	  20070,	  20080,	  20090,	  20100,	  21010,	  21020,	  
21100,	  22020,	  27010,	  29010,	  29020,	  35021	  (which	  include	  ICD-­‐10	  codes:	  C00-­‐C14,	  C15,	  C16,	  C25,	  C32,	  C53,	  C67,	  C92.0,	  C92.4-­‐C92.5,	  C94.0,	  C94.2).	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  deaths	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	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Table	  3.31.	  Tobacco-­‐related	  cancer	  (excluding	  lung	  cancer)	  deaths	  by	  year	  and	  sex,	  Maine,	  2000-­‐2010.*	  
Year	  
	  Maine	  Overall	   Females	   	  Males	  
	   	  Crude	   Age-­‐adjusted	   	   Crude	   Age-­‐adjusted	   	   Crude	   Age-­‐adjusted	  
Number	   Rate	   95%CI	   Rate	   95%	  CI	   Number	   Rate	   95%CI	   Rate	   95%CI	   Number	   Rate	   95%CI	   Rate	   95%CI	  
2000	  	   599	   46.9	  	   43.2	  -­‐	  50.8	  	   41.4	  	   38.2	  -­‐	  44.9	  	   239	   36.5	  	   32.0	  -­‐	  41.4	  	   28.4	  	   24.9	  -­‐	  32.3	  	   360	   57.9	  	   52.1	  -­‐	  64.2	  	   59.7	  	   53.6	  -­‐	  66.3	  	  
2001	  	   546	   42.5	  	   39.0	  -­‐	  46.2	  	   37.3	  	   34.2	  -­‐	  40.6	  	   204	   30.9	  	   26.8	  -­‐	  35.5	  	   24.1	  	   20.9	  -­‐	  27.7	  	   342	   54.6	  	   49.0	  -­‐	  60.7	  	   54.9	  	   49.2	  -­‐	  61.2	  	  
2002	  	   607	   46.8	  	   43.2	  -­‐	  50.7	  	   40.6	  	   37.4	  -­‐	  44.0	  	   236	   35.5	  	   31.1	  -­‐	  40.4	  	   27.3	  	   23.9	  -­‐	  31.1	  	   371	   58.7	  	   52.9	  -­‐	  65.0	  	   58.1	  	   52.2	  -­‐	  64.4	  	  
2003	  	   556	   42.6	  	   39.1	  -­‐	  46.2	  	   36.7	  	   33.7	  -­‐	  39.9	  	   231	   34.5	  	   30.2	  -­‐	  39.3	  	   26.6	  	   23.3	  -­‐	  30.4	  	   325	   51.0	  	   45.6	  -­‐	  56.8	  	   49.8	  	   44.4	  -­‐	  55.6	  	  
2004	  	   607	   46.2	  	   42.6	  -­‐	  50.0	  	   39.0	  	   35.9	  -­‐	  42.2	  	   233	   34.7	  	   30.4	  -­‐	  39.4	  	   26.2	  	   22.9	  -­‐	  29.9	  	   374	   58.3	  	   52.5	  -­‐	  64.5	  	   55.6	  	   50.0	  -­‐	  61.7	  	  
2005	  	   644	   48.8	  	   45.1	  -­‐	  52.8	  	   40.8	  	   37.7	  -­‐	  44.1	  	   243	   36.0	  	   31.7	  -­‐	  40.9	  	   27.1	  	   23.8	  -­‐	  30.8	  	   401	   62.2	  	   56.3	  -­‐	  68.6	  	   58.3	  	   52.6	  -­‐	  64.4	  	  
2006	  	   600	   45.3	  	   41.8	  -­‐	  49.1	  	   37.4	  	   34.4	  -­‐	  40.5	  	   236	   34.9	  	   30.6	  -­‐	  39.7	  	   25.8	  	   22.6	  -­‐	  29.4	  	   364	   56.2	  	   50.6	  -­‐	  62.3	  	   52.4	  	   47.0	  -­‐	  58.1	  	  
2007	  	   653	   49.2	  	   45.5	  -­‐	  53.1	  	   39.7	  	   36.7	  -­‐	  42.9	  	   252	   37.2	  	   32.7	  -­‐	  42.1	  	   27.0	  	   23.7	  -­‐	  30.6	  	   401	   61.8	  	   55.9	  -­‐	  68.1	  	   56.9	  	   51.3	  -­‐	  62.8	  	  
2008	  	   582	   43.7	  	   40.3	  -­‐	  47.4	  	   34.7	  	   31.9	  -­‐	  37.7	  	   222	   32.7	  	   28.5	  -­‐	  37.3	  	   23.4	  	   20.4	  -­‐	  26.9	  	   360	   55.3	  	   49.7	  -­‐	  61.3	  	   49.1	  	   44.1	  -­‐	  54.6	  	  
2009	  	   637	   47.9	  	   44.3	  -­‐	  51.8	  	   37.4	  	   34.5	  -­‐	  40.4	  	   237	   34.9	  	   30.6	  -­‐	  39.7	  	   24.4	  	   21.4	  -­‐	  27.9	  	   400	   61.5	  	   55.6	  -­‐	  67.8	  	   53.9	  	   48.6	  -­‐	  59.6	  	  
2010*	   646	   48.7	  	   45.0	  -­‐	  52.6	  	   37.3	  	   34.4	  -­‐	  40.3	  	   233	   34.4	  	   30.1	  -­‐	  39.1	  	   24.3	  	   21.2	  -­‐	  27.8	  	   413	   63.6	  	   57.6	  -­‐	  70.0	  	   53.6	  	   48.4	  -­‐	  59.2	  	  




99,035	   40.3	   40.1	  -­‐	  40.6	   34.4	   34.2	  -­‐	  34.6	   38,715	   31.2	   30.9	  -­‐	  31.5	   24.1	   23.9	  -­‐	  24.4	   60,320	   49.6	   49.2	  –	  50.0	   47.8	   47.4	  -­‐	  48.2	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
Tobacco-­‐related	  cancer	  (excluding	  lung	  cancer):	  SEER	  Cause	  of	  Death	  Recode:	  20010,	  20020,	  20030,	  20040,	  20050,	  20060,	  20070,	  20080,	  20090,	  20100,	  21010,	  21020,	  
21100,	  22020,	  27010,	  29010,	  29020,	  35021	  (which	  include	  ICD-­‐10	  codes:	  C00-­‐C14,	  C15,	  C16,	  C25,	  C32,	  C53,	  C67,	  C92.0,	  C92.4-­‐C92.5,	  C94.0,	  C94.2).	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  deaths	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	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Table	  3.32.	  Tobacco-­‐related	  cancer	  (excluding	  lung	  cancer)	  deaths	  by	  year	  and	  age	  group,	  Maine,	  2000-­‐2010.*	  
Year	  
	  Ages	  0─34	  years	   Ages	  35─64	  years	   	  Ages	  65─74	  years	   	  Ages	  75	  years	  and	  older	  
	  Crude	   Crude	   Crude	   Crude	  
Number	   Rate	   95%CI	   Number	   Rate	   95%CI	   Number	   Rate	   95%CI	   Number	   Rate	   95%CI	  
2000	   DSP	   DSP	  	   DSP	  	   143	   26.9	  	   22.7	  -­‐	  31.7	  	   187	   194.7	  	   167.8	  -­‐	  224.6	  	   264	   301.2	  	   266.0	  -­‐	  339.8	  	  
2001	   DSP	   DSP	  	   DSP	  	   148	   27.4	  	   23.2	  -­‐	  32.2	  	   159	   165.2	  	   140.6	  -­‐	  193.0	  	   234	   263.1	  	   230.5	  -­‐	  299.0	  	  
2002	   DSP	   DSP	  	   DSP	  	   170	   30.9	  	   26.5	  -­‐	  35.9	  	   158	   164.0	  	   139.4	  -­‐	  191.7	  	   276	   305.6	  	   270.6	  -­‐	  343.8	  	  
2003	   DSP	   DSP	  	   DSP	  	   163	   29.2	  	   24.9	  -­‐	  34.0	  	   143	   148.0	  	   124.7	  -­‐	  174.3	  	   243	   265.3	  	   233.0	  -­‐	  300.8	  	  
2004	   DSP	   DSP	  	   DSP	  	   184	   32.5	  	   28.0	  -­‐	  37.6	  	   152	   156.4	  	   132.6	  -­‐	  183.4	  	   269	   290.4	  	   256.7	  -­‐	  327.2	  	  
2005	   DSP	   DSP	  	   DSP	  	   203	   35.4	  	   30.7	  -­‐	  40.6	  	   161	   164.5	  	   140.1	  -­‐	  192.0	  	   277	   296.2	  	   262.3	  -­‐	  333.2	  	  
2006	   DSP	   DSP	  	   DSP	  	   194	   33.5	  	   29.0	  -­‐	  38.6	  	   145	   146.0	  	   123.2	  -­‐	  171.7	  	   256	   269.2	  	   237.2	  -­‐	  304.3	  	  
2007	   DSP	   DSP	  	   DSP	  	   187	   32.1	  	   27.7	  -­‐	  37.0	  	   159	   156.5	  	   133.1	  -­‐	  182.8	  	   305	   316.3	  	   281.8	  -­‐	  353.9	  	  
2008	   DSP	   DSP	  	   DSP	  	   180	   30.8	  	   26.5	  -­‐	  35.7	  	   145	   136.8	  	   115.5	  -­‐	  161.0	  	   252	   258.8	  	   227.9	  -­‐	  292.9	  	  
2009	   DSP	   DSP	  	   DSP	  	   177	   30.4	  	   26.1	  -­‐	  35.2	  	   173	   157.2	  	   134.7	  -­‐	  182.5	  	   282	   288.8	  	   256.1	  -­‐	  324.6	  	  
2010*	   DSP	   DSP	  	   DSP	  	   198	   34.1	  	   29.5	  -­‐	  39.2	  	   165	   145.6	  	   124.2	  -­‐	  169.6	  	   279	   282.7	  	   250.5	  -­‐	  317.9	  	  
U.S.	  2010	   1,137	   0.8	  	   0.7	  -­‐	  0.8	  	   36,408	   29.7	  	   29.4	  -­‐	  30.0	  	   28,590	   130.8	  	   129.3	  -­‐	  132.3	  	   49,836	   267.6	  	   265.3	  -­‐	  270.0	  	  
U.S.	  Whites	  2010	   858	   0.8	  	   0.7	  -­‐	  0.8	  	   29,578	   29.9	  	   29.5	  -­‐	  30.2	  	   24,358	   130.4	  	   128.7	  -­‐	  132.0	  	   44,241	   269.0	  	   266.5	  -­‐	  271.6	  	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
DSP:	  Data	  were	  suppressed	  by	  SEER*Stat	  to	  protect	  privacy	  due	  to	  small	  numbers.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
Tobacco-­‐related	  cancers	  (excluding	  lung)	  include	  the	  following:	  laryngeal,	  oral	  cavity	  and	  pharynx,	  esophageal,	  stomach,	  pancreatic,	  kidney	  and	  renal	  
pelvis,	  urinary	  bladder,	  cervical	  cancers,	  and	  acute	  myeloid	  leukemia.	  	  Please	  see	  Appendix	  II	  for	  SEER	  and	  ICD-­‐10	  codes.	  	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  not	  calculated	  for	  age-­‐specific	  groups.	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Table	  3.33.	  Tobacco-­‐related	  cancer	  (excluding	  lung	  cancer)	  deaths	  by	  county	  and	  public	  health	  district	  of	  





Crude	   Age-­‐Adjusted	  
Rate	   95%	  CI	   Rate	   95%	  CI	  
Maine	  total	   602	   45.4	  	   43.8	  -­‐	  47.0	  	   36.0	  	   34.7	  -­‐	  37.3	  	  
	   	   	   	   	   	  County	   	   	   	   	   	  
Androscoggin	   52	   48.2	  	   42.5	  -­‐	  54.4	  	   41.8	  	   36.9	  -­‐	  47.3	  	  
Aroostook	   37	   50.5	  	   43.5	  -­‐	  58.4	  	   35.5	  	   30.4	  -­‐	  41.2	  	  
Cumberland	   113	   40.4	  	   37.1	  -­‐	  43.8	  	   34.2	  	   31.4	  -­‐	  37.2	  	  
Franklin	   14	   45.0	  	   35.0	  -­‐	  57.0	  	   35.1	  	   27.2	  -­‐	  44.7	  	  
Hancock	   23	   42.0	  	   34.6	  -­‐	  50.4	  	   29.6	  	   24.4	  -­‐	  35.9	  	  
Kennebec	   59	   48.7	  	   43.3	  -­‐	  54.6	  	   39.9	  	   35.4	  -­‐	  44.8	  	  
Knox	   21	   52.4	  	   42.8	  -­‐	  63.4	  	   35.3	  	   28.8	  -­‐	  43.1	  	  
Lincoln	   17	   50.1	  	   40.1	  -­‐	  61.8	  	   30.8	  	   24.6	  -­‐	  38.4	  	  
Oxford	   34	   58.4	  	   49.9	  -­‐	  67.9	  	   44.1	  	   37.7	  -­‐	  51.5	  	  
Penobscot	   59	   38.6	  	   34.3	  -­‐	  43.2	  	   33.4	  	   29.7	  -­‐	  37.5	  	  
Piscataquis	   10	   57.0	  	   42.3	  -­‐	  75.1	  	   36.8	  	   27.2	  -­‐	  49.5	  	  
Sagadahoc	   15	   40.9	  	   32.1	  -­‐	  51.4	  	   33.7	  	   26.3	  -­‐	  42.7	  	  
Somerset	   25	   48.2	  	   40.2	  -­‐	  57.4	  	   38.2	  	   31.8	  -­‐	  45.6	  	  
Waldo	   16	   40.8	  	   32.3	  -­‐	  50.8	  	   31.8	  	   25.1	  -­‐	  40.0	  	  
Washington	   20	   59.7	  	   48.5	  -­‐	  72.7	  	   41.0	  	   33.2	  -­‐	  50.4	  	  
York	   88	   44.6	  	   40.5	  -­‐	  48.9	  	   36.2	  	   32.9	  -­‐	  39.8	  	  
Public	  Health	  District	   	   	   	   	   	  
Aroostook	   37	   50.5	  	   43.5	  -­‐	  58.4	  	   35.5	  	   30.4	  -­‐	  41.2	  	  
Central	   85	   48.6	  	   44.1	  -­‐	  53.4	  	   39.4	  	   35.7	  -­‐	  43.4	  	  
Cumberland	   113	   40.4	  	   37.1	  -­‐	  43.8	  	   34.2	  	   31.4	  -­‐	  37.2	  	  
Downeast	   43	   48.7	  	   42.4	  -­‐	  55.7	  	   33.9	  	   29.5	  -­‐	  39.0	  	  
Midcoast	   69	   46.1	  	   41.4	  -­‐	  51.2	  	   32.9	  	   29.5	  -­‐	  36.7	  	  
Penquis	   69	   40.5	  	   36.3	  -­‐	  45.0	  	   33.9	  	   30.4	  -­‐	  37.7	  	  
Western	   100	   50.7	  	   46.4	  -­‐	  55.4	  	   41.5	  	   37.9	  -­‐	  45.3	  	  
York	   88	   44.6	  	   40.5	  -­‐	  48.9	  	   36.2	  	   32.9	  -­‐	  39.8	  	  
Data	  Source:	  Underlying	  mortality	  data	  provided	  by	  National	  Center	  for	  Health	  Statistics.	  Rates	  are	  calculated	  using	  SEER*Stat	  
Version	  8.1.5.	  
95%	  CI:	  95%	  confidence	  interval	  of	  the	  rate.	  
Cancer	  Deaths:	  Deaths	  with	  malignant	  cancer	  as	  the	  underlying	  cause	  of	  death.	  
Tobacco-­‐related	  cancer	  (excluding	  lung	  cancer):	  SEER	  Cause	  of	  Death	  Recode:	  20010,	  20020,	  20030,	  20040,	  20050,	  20060,	  20070,	  
20080,	  20090,	  20100,	  21010,	  21020,	  21100,	  22020,	  27010,	  29010,	  29020,	  35021	  (which	  include	  ICD-­‐10	  codes:	  C00-­‐C14,	  C15,	  C16,	  
C25,	  C32,	  C53,	  C67,	  C92.0,	  C92.4-­‐C92.5,	  C94.0,	  C94.2).	  
Crude	  Rates	  are	  deaths	  per	  100,000	  population.	  
Age-­‐adjusted	  rates	  are	  deaths	  per	  100,000	  population	  age-­‐adjusted	  to	  the	  U.S.	  2000	  standard	  population.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
*Counts	  and	  rates	  might	  be	  slightly	  underestimated	  due	  to	  missing	  underlying	  cause	  of	  death	  information	  for	  Maine	  residents	  who	  
died	  out	  of	  state	  in	  2010.	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  Table	  4.1.	  Prevalence	  of	  cancer	  risk	  factors	  among	  Maine	  adults,	  2011-­‐2012.	  
	   	   	   Maine	   	   	   	   U.S.	  Median	  
Total	  
Respondents	   n	   N	   %	   95%	  CI	   	  
Number	  
of	  States*	   %	  
Any	  Tobacco	  Use	  (2011)	   3,748	   	   	   	   	   	   	   	  
	  	   Yes	   	   648	   256,912	   26.1	   23.7-­‐28.6	   	   NA	   NA	  
	  	   No	   	   3,100	   728,465	   73.9	   71.5-­‐76.3	   	   NA	   NA	  
Cigarette	  Smoking	  Status	  (2012)	   9,810	   	   	   	   	   	   	   	  
	  	   Never	   	   4801	   508,071	   48.6	   47.3-­‐49.8	   	   51	   54.4	  
	   Former	   	   3407	   326,178	   31.1	   30.0-­‐32.2	   	   51	   25.6	  
	   Current	   	   1602	   212,661	   20.3	   19.2-­‐21.4	   	   51	   19.6	  
Weight	  Status	  (2012)	   9,374	   	   	   	   	   	   	   	  
	  	   Healthy	  Weight	   	   3,234	   347,985	   34.8	   33.5-­‐36.0	   	   51	   34.2	  
	  	   Overweight	   	   3,519	   363,879	   36.4	   35.2-­‐37.6	   	   51	   35.8	  
	  	   Obese	   	   2,621	   287,874	   28.8	   27.6-­‐30.0	   	   51	   27.6	  
Engage	  in	  ≥150	  minutes	  of	  aerobic	  exercise	  per	  week	  (2011)	   12,356	   	   	   	   	   	   	   	  
	  	   Yes	   	   7,085	   557,716	   56.7	   55.5-­‐57.9	   	   51	   51.7	  
	  	   No	   	   6,455	   425,891	   43.3	   42.1-­‐44.5	   	   51	   48.3	  
Heavy	  Drinking	  (2012)	   9,708	   	   	   	   	   	   	   	  
	  	   Yes	   	   632	   69,706	   6.7	   6.1-­‐7.4	   	   51	   6.1	  
	   No	   	   9,076	   964,846	   93.3	   92.6-­‐93.9	   	   51	   93.9	  
	   	  
	   	   Maine	   U.S.	  Median	  
	  	  Median	  Daily	  Fruit	  and	  Vegetable	  Consumption	  (2011)**	   	   	  
	  	   Fruit	  Daily	  Consumption	   1.2	   1.1	  
	  	   Vegetable	  Daily	  Consumption	   1.7	   1.6	  
Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System	  (2011	  and	  2012).	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  Any	  tobacco	  use	  =	  Percentage	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  current	  use	  of	  any	  tobacco	  product	  including	  cigarettes,	  
cigars,	  flavored	  cigars	  (small	  and	  large	  size),	  chewing	  tobacco,	  and	  snuff;	  Cigarette	  smoking	  status	  =	  	  Percentage	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  
reported	  being	  a	  never	  smoker,	  former	  smoker,	  or	  current	  smoker;	  Weight	  status	  =	  Percentage	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  had	  a	  body	  mass	  
index	  (BMI)	  ≥18.5	  and	  <25.0	  kg/m2	  	  (healthy	  weight),	  a	  BMI	  ≥25.0	  and	  <30.0	  kg/m2	  (overweight),	  or	  a	  BMI	  <30.0	  kg/m2	  (obese)	  based	  on	  self-­‐reported	  weight	  
and	  height	  measurements;	  Heavy	  drinking	  =	  Percentage	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  having	  more	  than	  2	  drink	  per	  day	  for	  males	  or	  
more	  than	  1	  drink	  per	  day	  for	  females.	  
n:	  Number	  of	  survey	  respondents	  ages	  18	  years	  and	  older	  who	  responded	  to	  questions	  about	  tobacco	  use,	  weight	  and	  height	  measurements,	  engaging	  in	  150	  
minutes	  of	  aerobic	  exercise	  per	  week,	  heavy	  drinking,	  and	  daily	  fruit	  and	  vegetable	  consumption.	  
N:	  Estimated	  number	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  tobacco	  use,	  weight	  and	  height	  measurements,	  engaging	  in	  150	  minutes	  of	  
aerobic	  exercise	  per	  week	  ,	  heavy	  drinking,	  and	  daily	  fruit	  and	  vegetable	  consumption.	  
95%	  CI:	  	  95%	  confidence	  interval.	  
NA:	  Not	  available.	  
*Of	  50	  states	  and	  the	  District	  of	  Columbia.	  
**Data	  on	  median	  daily	  fruit	  and	  vegetable	  consumption	  obtained	  from	  the	  Centers	  for	  Disease	  Control	  and	  Prevention	  State	  Indicator	  Report	  on	  Fruits	  and	  
Vegetables,	  2013.	  	  
Due	  to	  changes	  in	  survey	  methodology,	  data	  collected	  in	  2011	  and	  in	  subsequent	  years	  cannot	  be	  compared	  with	  data	  prior	  to	  2011.	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Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System	  (BRFSS).	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  Artificial	  sources	  of	  ultraviolet	  light	  use	  =	  Percentage	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  ever	  using	  artificial	  sources	  of	  ultraviolet	  light	  such	  as	  sunlamps	  or	  tanning	  
booths;	  Routine	  sunblock	  use	  	  =	  Percentage	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  using	  sunblock	  ‘Always’	  or	  ‘Nearly	  Always’	  when	  outside	  on	  a	  sunny	  summer	  day	  for	  more	  than	  an	  
hour;	  Routine	  use	  of	  at	  least	  one	  protective	  measures	  against	  sun	  exposure	  =	  Percentage	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  using	  at	  least	  one	  of	  the	  protective	  measures	  (i.e.,	  
wearing	  a	  hat	  to	  shade	  face,	  ears,	  or	  neck	  against	  sun,	  wearing	  long-­‐sleeved	  shirt,	  or	  staying	  in	  the	  shade)	  against	  sun	  exposure	  ‘Always’	  or	  ‘Nearly	  Always’	  when	  outside	  on	  a	  sunny	  summer	  day	  for	  
more	  than	  an	  hour.	  
n:	  Number	  of	  survey	  respondents	  ages	  18	  years	  and	  older	  who	  reported	  ever	  use	  of	  artificial	  sources	  of	  ultraviolet	  light,	  routine	  sunblock	  use,	  or	  routine	  use	  of	  at	  least	  one	  protective	  measures	  
against	  sun	  exposure.	  
N:	  Estimated	  number	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  ever	  use	  of	  artificial	  sources	  of	  ultraviolet	  light,	  routine	  sunblock	  use,	  or	  routine	  use	  of	  at	  least	  one	  protective	  measures	  
against	  sun	  exposure.	  
NA:	  Not	  available.	  
95%	  CI:	  95%	  confidence	  interval.	  





	  Table	  4.2.	  Ultraviolet	  light	  exposure-­‐related	  cancer	  risk	  factors	  among	  adults	  by	  year,	  Maine,	  2002-­‐2012.	  
Year	  
Artificial	  sources	  of	  ultraviolet	  light	  use	  
	  
Routine	  sunblock	  use	  
	   Routine	  use	  of	  at	  least	  one	  protective	  measure	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
against	  sun	  exposure	  
Total	  
Respondents	   n	   N	   %	   95%	  CI	  
	   Total	  
Respondents	   	  	  n	   	  	  	  	  	  N	   %	   95%	  CI	  
	   Total	  
Respondents	   	  	  n	   	  	  	  	  	  N	   %	   95%	  CI	  
2002	   NA	   NA	   NA	   NA	   NA	   	   2,291	   833	   318,226	   34.2	   32.0	  -­‐	  36.3	   	   2,242	   1,077	   427,309	   46.8	   44.5	  -­‐	  49.2	  
2003	   NA	   NA	   NA	   NA	   NA	   	   NA	   NA	   NA	   NA	   NA	   	   NA	   NA	   NA	   NA	   NA	  
2004	   NA	   NA	   NA	   NA	   NA	   	   3,001	   1,207	   333,031	   37.8	   35.8	  -­‐	  39.8	   	   2,905	   1,333	   369,596	   43.3	   41.2	  -­‐	  45.4	  
2005	   NA	   NA	   NA	   NA	   NA	   	   NA	   NA	   NA	   NA	   NA	   	   NA	   NA	   NA	   NA	   NA	  
2006	   NA	   NA	   NA	   NA	   NA	   	   3,534	   1,273	   303,351	   32.8	   31.0	  -­‐	  34.6	   	   3,463	   1,596	   389,974	   43.0	   41.0	  -­‐	  45.0	  
2007	   NA	   NA	   NA	   NA	   NA	   	   3,593	   1,412	   346,350	   37.4	   35.4	  -­‐	  39.4	   	   NA	   NA	   NA	   NA	   NA	  
2008	   NA	   NA	   NA	   NA	   NA	   	   3,699	   1,372	   337,750	   35.2	   33.2	  -­‐	  37.1	   	   NA	   NA	   NA	   NA	   NA	  
2009	   NA	   NA	   NA	   NA	   NA	   	   NA	   NA	   NA	   NA	   NA	   	   NA	   NA	   NA	   NA	   NA	  
2010	   NA	   NA	   NA	   NA	   NA	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  3,550	   1,274	   308,768	   33.1	   31.1	  -­‐	  35.1	   	   3,493	   1,613	   375,792	   40.9	   38.7	  -­‐	  43.1	  
	   Change	  in	  BRFSS	  methods	  
2011	   3,824	   143	   49,417	   5.0	   3.9	  -­‐	  6.1	   	   NA	   NA	   NA	   NA	   NA	   	   NA	   NA	   NA	   NA	   NA	  
2012	   3,903	   151	   58,857	   5.7	   4.4	  -­‐	  7.0	   	   NA	   NA	   NA	   NA	   NA	   	   NA	   NA	   NA	   NA	   NA	  




Table	  4.3.	  Adults	  ages	  18	  years	  and	  older	  who	  ever	  used	  artificial	  sources	  of	  




Respondents	   	  	  	  	  	  	  	  	  	  	  	  n	  
Annual	  	  	  	  	  	  	  	  	  
Average	  
N	   %	   95%	  CI	  
Maine	  Total	   7,727	   294	   54,137	   5.4	   4.5	  -­‐	  6.2	  
	   	   	   	   	   	  Sex	   	   	   	   	   	  
Female	   4,691	  	   	  226	  	   41,007	   	  7.9	   6.5	  -­‐	  9.2	  
Male	   3,036	   68	   13,130	   	  2.7	   1.8	  -­‐	  3.6	  
Age	   	   	   	   	   	  
18-­‐44	   	  1,443	  	   118	  	   33,974	   8.3	   6.4	  -­‐	  10.2	  
45-­‐64	   3,413	   146	   17,708	   4.6	   3.8	  -­‐	  5.5	  
65	  and	  older	   2,815	   28	   2,016†	   	  1.0†	   0.6	  -­‐	  1.4†	  
Education	   	   	   	   	   	  
Less	  than	  high	  school	  diploma	   445	   9	   4,470†	   	  	  4.4†	   0.9	  -­‐	  7.9†	  
High	  school	  diploma	  or	  GED	   2,516	   105	   18,813	   5.4	   4.1	  -­‐	  6.7	  
Some	  college	   1,929	   105	   21,804	   7.2	   5.4	  -­‐	  9.1	  
Bachelor's	  degree	  or	  higher	   2,826	   75	   9,051	   3.6	   2.5	  -­‐	  4.6	  
Income	   	   	   	   	   	  
Less	  than	  $15,000	   933	   34	   7,247†	   	  	  5.7†	   3.2	  -­‐	  8.1†	  
$15,000-­‐24,999	   1,332	   27	   4,280†	   	  	  2.5†	   1.4	  -­‐	  3.7†	  
$25,000-­‐34,999	   871	   36	   4,909†	   	  	  4.4†	   2.5	  -­‐	  6.3†	  
$35,000-­‐49,999	   1,106	   32	   4,787†	   	  	  3.4†	   2.1	  -­‐	  4.7†	  
$50,000	  or	  more	   	  2,680	  	   	  140	  	   24,616	   	  7.1	   5.5	  -­‐	  8.7	  
Sexual	  Orientation	   	   	   	   	   	  
Heterosexual	  or	  straight	   7,350	   279	   52,269	   	  5.5	   4.6	  -­‐	  6.3	  
Homosexual	  (gay	  or	  lesbian)	   114	   10	   1,367†	   	  	  8.6†	   2.5	  -­‐	  14.6†	  
Bisexual	   65	   1	   40†	   	  	  0.4†	   0.0	  -­‐	  1.1†	  
Other	   	  DSU	  	   	  DSU	  	   DSU	   	  DSU	   DSU	  
Type	  of	  Health	  Insurance	  Coverage	   	   	   	   	   	  
Private	   3,459	   169	   29,083	   6.1	   5.0	  -­‐	  7.3	  
Medicare	   2,230	   28	   2,930†	   1.6†	   0.9	  -­‐	  2.3†	  
Medicaid	  or	  MaineCare	   702	   49	   12,058†	   8.6†	   5.5	  -­‐	  11.8†	  
Other	   501	   12	   1,126†	   1.9†	   0.8	  -­‐	  3.0†	  
Uninsured	   	  DSU	  	   	  DSU	  	   DSU	   DSU	   DSU	  
Mental	  Health	  Status	   	   	   	   	   	  
Current	  depression	   	   	   	   	   	  
Yes	   644	   28	   4,984†	   	  5.4†	   2.6	  -­‐	  8.2†	  
No	   	  7,055	  	   	  266	  	   49,153	   5.4	   4.5	  -­‐	  6.3	  
Lifetime	  depression	  or	  anxiety	   	   	   	   	   	  
Yes	   2,323	   126	   24,352	   7.6	   5.8	  -­‐	  9.5	  
No	   	  5,344	  	   	  168	  	   29,785	   4.4	   3.5	  -­‐	  5.3	  
Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  Percentage	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  ever	  using	  artificial	  sources	  of	  ultraviolet	  light	  such	  as	  
sunlamps	  or	  tanning	  booths.	  
n:	  Number	  of	  survey	  respondents	  ages	  18	  years	  and	  older	  who	  reported	  ever	  using	  artificial	  sources	  of	  ultraviolet	  light	  such	  as	  
sunlamps	  or	  tanning	  booths.	  
N:	  Estimated	  number	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  ever	  using	  artificial	  sources	  of	  ultraviolet	  light	  such	  as	  
sunlamps	  or	  tanning	  booths.	  
Annual	  Average	  N:	  	  The	  total	  N	  divided	  by	  the	  total	  number	  of	  years	  in	  a	  multi-­‐data	  analysis.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
95%	  CI:	  95%	  confidence	  interval.	  
DSU:	  Data	  statistically	  unreliable;	  total	  respondents	  <	  50	  or	  95%	  CI	  half-­‐width	  is	  >	  10.	  
†Use	  with	  caution.	  Estimates	  based	  on	  number	  of	  n<50	  might	  be	  unstable.	  
Due	  to	  changes	  in	  survey	  methodology,	  data	  collected	  in	  2011	  and	  in	  subsequent	  years	  cannot	  be	  compared	  with	  data	  prior	  to	  2011.	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Table	  4.4.	  Adults	  ages	  18	  years	  and	  older	  who	  ever	  used	  artificial	  sources	  of	  




Respondents	   n	  
Annual	  
Average	  	  
N	   %	   	  	  	  	  	  	  	  95%	  CI	  
Maine	  Total	   	  	  	  7,727	   	  	  	  	  	  294	   	  	  	  	  	  	  	  	  54,137	   5.4	   	  	  	  	  	  	  4.5	  -­‐	  6.2	  
	   	   	   	   	   	  Race	   	   	   	   	   	  
White	   7,326	   284	   52,020	   	  	  	  	  	  	  	  	  	  5.5	   4.6	  -­‐	  6.4	  
Black	  or	  African	  American	   DSU	   DSU	   DSU	   DSU	   DSU	  
American	  Indian	  or	  Alaska	  Native	   DSU	   DSU	   DSU	   DSU	   DSU	  
Asian	  or	  Pacific	  Islander	   DSU	   DSU	   DSU	   DSU	   DSU	  
Two	  or	  more	  races	   DSU	   DSU	   DSU	   DSU	   DSU	  
Other	  Race	   DSU	   DSU	   DSU	   DSU	   DSU	  
Ethnicity	   	   	   	   	   	  
Non-­‐Hispanic	   7,536	   290	   53,203	   	  	  	  	  	  	  	  	  	  	  5.4	   4.6	  -­‐	  6.3	  
Hispanic	   DSU	   DSU	   DSU	   DSU	   DSU	  
	  
	  
Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  Percentage	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  ever	  using	  artificial	  sources	  of	  ultraviolet	  light	  such	  
as	  sunlamps	  or	  tanning	  booths.	  
n:	  Number	  of	  survey	  respondents	  ages	  18	  years	  and	  older	  who	  reported	  ever	  using	  artificial	  sources	  of	  ultraviolet	  light	  such	  as	  
sunlamps	  or	  tanning	  booths.	  
N:	  Estimated	  number	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  ever	  using	  artificial	  sources	  of	  ultraviolet	  light	  such	  as	  
sunlamps	  or	  tanning	  booths.	  
Annual	  Average	  N:	  	  The	  total	  N	  divided	  by	  the	  total	  number	  of	  years	  in	  a	  multi-­‐data	  analysis.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
95%	  CI:	  95%	  confidence	  interval.	  
DSU:	  Data	  statistically	  unreliable;	  total	  respondents	  <	  50	  or	  95%	  CI	  half-­‐width	  is	  >	  10.	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Table	  4.5.	  Adults	  ages	  18	  years	  and	  older	  who	  ever	  used	  artificial	  sources	  of	  





Respondents	   	  	  	  	  	  	  	  	  	  	  	  n	  
Annual	  
Average	  	  
N	   %	   95%	  CI	  
Maine	  Total	   7,727	   294	   	  	  	  	  	  	  	  	  54,137	   5.4	   4.5	  -­‐	  6.2	  
	   	   	   	   	   	  County	   	   	   	   	   	  
Androscoggin	   482	   21	   4,012†	   	  	  5.2†	   2.4	  -­‐	  8.0†	  
Aroostook	   435	   19	   4,202†	   	  5.9†	   2.4	  -­‐	  9.3†	  
Cumberland	   1,248	   33	   4,876†	   	  2.8†	   1.7	  -­‐	  4.0†	  
Franklin	   296	   12	   1,254†	   	  4.2†	   1.4	  -­‐	  7.1†	  
Hancock	   338	   9	   2,100†	   	  4.6†	   0.2	  -­‐	  9.1†	  
Kennebec	   581	   34	   6,633†	   	  7.5†	   3.9	  -­‐	  11.1†	  
Knox	   396	   12	   718†	   	  2.4†	   1.0	  -­‐	  3.9†	  
Lincoln	   391	   12	   1,861†	   	  6.3†	   1.7	  -­‐	  11.0†	  
Oxford	   331	   16	   3,740†	   	  6.9†	   2.8	  -­‐	  11.1†	  
Penobscot	   642	   27	   5,592†	   	  5.9†	   3.4	  -­‐	  8.4†	  
Piscataquis	   192	   10	   1,056†	   	  6.3†	   1.9	  -­‐	  10.7†	  
Sagadahoc	   312	   13	   1,574†	   	  5.4†	   1.7	  -­‐	  9.0†	  
Somerset	   279	   16	   3,602†	   	  7.8†	   3.1	  -­‐	  12.5†	  
Waldo	   389	   11	   1,176†	   	  3.5†	   0.5	  -­‐	  6.5†	  
Washington	   375	   13	   1,400†	   	  4.0†	   1.6	  -­‐	  6.4†	  
York	   884	   30	   9,494†	   	  7.3†	   3.8	  -­‐	  10.8†	  
Public	  Health	  District	   	   	   	   	   	  
Aroostook	   435	   19	   4,202†	   	  5.9†	   2.4	  -­‐	  9.3†	  
Central	   860	   50	   10,235	   7.6	   4.8	  -­‐	  10.5	  
Cumberland	   1,248	   33	   4,876†	   	  2.8†	   1.7	  -­‐	  4.0†	  
Downeast	   713	   22	   3,499†	   	  4.4†	   1.6	  -­‐	  7.1†	  
Midcoast	   1,488	   48	   5,330†	   	  4.4†	   2.7	  -­‐	  6.1†	  
Penquis	   834	   37	   6,647†	   	  6.0†	   3.7	  -­‐	  8.2†	  
Western	   1,109	   49	   9,006†	   	  5.6†	   3.6	  -­‐	  7.6†	  
York	   884	   30	   9,494†	   	  7.3†	   3.8	  -­‐	  10.8†	  
	  
	  
Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  Percentage	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  ever	  using	  artificial	  sources	  of	  ultraviolet	  light	  such	  
as	  sunlamps	  or	  tanning	  booths.	  
n:	  Number	  of	  survey	  respondents	  ages	  18	  years	  and	  older	  who	  reported	  ever	  using	  artificial	  sources	  of	  ultraviolet	  light	  such	  as	  
sunlamps	  or	  tanning	  booths.	  
N:	  Estimated	  number	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  ever	  using	  artificial	  sources	  of	  ultraviolet	  light	  such	  as	  
sunlamps	  or	  tanning	  booths.	  
Annual	  Average	  N:	  	  The	  total	  N	  divided	  by	  the	  total	  number	  of	  years	  in	  a	  multi-­‐data	  analysis.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
95%	  CI:	  95%	  confidence	  interval.	  
†Use	  with	  caution.	  Estimates	  based	  on	  number	  of	  n<50	  might	  be	  unstable.	  








Table	  4.6.	  Adults	  ages	  18	  years	  and	  older	  who	  routinely	  used	  sunblock	  by	  
selected	  demographics,	  Maine,	  2010.	  
	  
Total	  
respondents	   n	   N	   %	   95%	  CI	  
Maine	  Total	   3,550	   1,274	   308,768	   33.1	   31.1	  -­‐	  35.1	  
	   	   	   	   	   	  Sex	   	   	   	   	   	  
Female	   	  	  	  	  	  	  	  	  	  	  2,121	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  966	  	   	  	  	  	  	  	  	  	  	  	  	  214,109	  	   45.6	   42.7	  -­‐	  48.4	  
Male	   	  	  	  	  	  	  	  	  	  	  1,429	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  308	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  94,659	  	   20.4	   17.8	  -­‐	  23.0	  
Age	   	   	   	   	   	  
18-­‐44	   	  	  	  	  	  	  	  	  	  	  	  	  	  793	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  282	  	   	  	  	  	  	  	  	  	  	  	  	  127,087	  	   32.0	   28.1	  -­‐	  35.8	  
45-­‐64	   	  	  	  	  	  	  	  	  	  	  1,665	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  614	  	   	  	  	  	  	  	  	  	  	  	  	  125,508	  	   34.9	   32.1	  -­‐	  37.6	  
65	  and	  older	   	  	  	  	  	  	  	  	  	  	  1,071	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  370	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  54,945	  	   32.0	   28.9	  -­‐	  35.0	  
Education	   	   	   	   	   	  
Less	  than	  high	  school	  diploma	   	  DSU	  	   	  DSU	  	   	  DSU	  	   DSU	   DSU	  
High	  school	  diploma	  or	  GED	   	  	  	  	  	  	  	  	  	  	  1,166	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  329	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  77,176	  	   25.2	   21.9	  -­‐	  28.5	  
Some	  college	   	  	  	  	  	  	  	  	  	  	  	  	  	  916	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  329	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  82,921	  	   33.2	   29.2	  -­‐	  37.1	  
Bachelor's	  degree	  or	  higher	   	  	  	  	  	  	  	  	  	  	  1,277	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  579	  	   	  	  	  	  	  	  	  	  	  	  	  138,752	  	   42.7	   39.3	  -­‐	  46.2	  
Income	   	   	   	   	   	  
Less	  than	  $15,000	   	  	  	  	  	  	  	  	  	  	  	  	  	  359	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  91	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  19,711	  	   24.5	   17.3	  -­‐	  31.6	  
$15,000-­‐24,999	   	  	  	  	  	  	  	  	  	  	  	  	  	  562	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  177	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  35,559	  	   27.2	   22.3	  -­‐	  32.0	  
$25,000-­‐34,999	   	  	  	  	  	  	  	  	  	  	  	  	  	  355	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  111	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  22,186	  	   26.3	   20.8	  -­‐	  31.8	  
$35,000-­‐49,999	   	  	  	  	  	  	  	  	  	  	  	  	  	  513	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  187	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  48,352	  	   36.1	   30.6	  -­‐	  41.7	  
$50,000	  or	  more	   	  	  	  	  	  	  	  	  	  	  1,382	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  575	  	   	  	  	  	  	  	  	  	  	  	  	  152,573	  	   38.3	   35.2	  -­‐	  41.4	  
Sexual	  Orientation	   	   	   	   	   	  
Heterosexual	  or	  straight	   	  	  	  	  	  	  	  	  	  	  3,393	  	   	  	  	  	  	  	  	  	  	  	  1,221	  	   	  	  	  	  	  	  	  	  	  	  	  297,584	  	   33.2	   31.1	  -­‐	  35.3	  
Homosexual	  (gay	  or	  lesbian)	   DSU	   DSU	   DSU	   DSU	   DSU	  
Bisexual	   DSU	   DSU	   DSU	   DSU	   DSU	  
Other	   DSU	   DSU	   DSU	   DSU	   DSU	  
Type	  of	  Health	  Insurance	  Coverage	   	   	   	   	   	  
Private	   1,775	   726	   195,249	   38.1	   35.3	  -­‐	  41.0	  
Medicare	   824	   261	   40,500	   29.2	   25.6	  -­‐	  32.8	  
Medicaid	  or	  MaineCare	   289	   90	   25,607	   26.5	   20.3	  -­‐	  32.3	  
Other	   237	   78	   19,058	   33.7	   25.7	  -­‐	  41.6	  
Uninsured	   DSU	   DSU	   DSU	   DSU	   DSU	  
Mental	  Health	  Status	   	   	   	   	   	  
Current	  depression	   	   	   	   	   	  
Yes	   	  	  	  	  	  	  	  	  	  	  	  	  	  304	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  65	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  15,829	  	   19.5	   13.4	  -­‐	  25.5	  
No	   	  	  	  	  	  	  	  	  	  	  3,232	  	   	  	  	  	  	  	  	  	  	  	  1,204	  	   	  	  	  	  	  	  	  	  	  	  	  291,718	  	   34.4	   32.2	  -­‐	  36.5	  
Lifetime	  depression	  or	  anxiety	   	   	   	   	   	  
Yes	   	  	  	  	  	  	  	  	  	  	  1,105	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  359	  	   	  	  	  	  	  	  	  	  	  	  	  	  83,193	  	   30.2	   36.7	  -­‐	  33.7	  
No	   	  	  	  	  	  	  	  	  	  	  2,423	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  907	  	   	  	  	  	  	  	  	  	  	  	  223,612	  	   34.3	   31.8	  -­‐	  36.7	  
Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  	  	  Percentage	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  using	  sunblock	  ‘Always’	  or	  ‘Nearly	  Always’	  when	  
outside	  on	  a	  sunny	  summer	  day	  for	  more	  than	  an	  hour.	  
n:	  Number	  of	  survey	  respondents	  ages	  18	  years	  and	  older	  who	  reported	  using	  sunblock	  ‘Always’	  or	  ‘Nearly	  Always’	  when	  outside	  
on	  a	  sunny	  summer	  day	  for	  more	  than	  an	  hour.	  
N:	  Estimated	  number	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  using	  sunblock	  ‘Always’	  or	  ‘Nearly	  Always’	  when	  
outside	  on	  a	  sunny	  summer	  day	  for	  more	  than	  an	  hour.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
95%	  CI:	  95%	  confidence	  interval.	  
DSU:	  Data	  statistically	  unreliable;	  total	  respondents	  <	  50	  or	  95%	  CI	  half-­‐width	  is	  >	  10.	  
Due	  to	  changes	  in	  survey	  methodology,	  data	  collected	  in	  2011	  and	  in	  subsequent	  years	  cannot	  be	  compared	  with	  data	  prior	  to	  
2011.	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Table	  4.7.	  Adults	  ages	  18	  years	  and	  older	  who	  routinely	  used	  sunblock	  by	  
race	  and	  ethnicity,	  Maine,	  2010.	  
	  
Total	  
Respondents	   n	   N	   %	   	  	  	  	  	  	  	  95%	  CI	  
Maine	  Total	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  3,550	   	  	  	  1,274	   308,768	   	  33.1	   	  	  	  	  31.1	  -­‐	  35.1	  
	   	   	   	   	   	  Race	   	   	   	   	   	  
White	   3,380	   1,223	   297,082	   33.5	   31.4	  -­‐	  35.6	  
Black	  or	  African	  American	   DSU	   DSU	   DSU	   DSU	   DSU	  
American	  Indian	  or	  Alaska	  Native	   DSU	   DSU	   DSU	   DSU	   DSU	  
Asian	  or	  Pacific	  Islander	   DSU	   DSU	   DSU	   DSU	   DSU	  
Two	  or	  More	  Races	   DSU	   DSU	   DSU	   DSU	   DSU	  
Other	  Race	   DSU	   DSU	   DSU	   DSU	   DSU	  
Ethnicity	   	   	   	   	   	  
Non-­‐Hispanic	   3,460	   1,247	   302,375	   33.2	   31.1	  -­‐	  35.2	  
Hispanic	   DSU	   DSU	   DSU	   DSU	   DSU	  
	  
	  
Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  	  	  Percentage	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  using	  sunblock	  ‘Always’	  or	  ‘Nearly	  Always’	  when	  
outside	  on	  a	  sunny	  summer	  day	  for	  more	  than	  an	  hour.	  
n:	  Number	  of	  survey	  respondents	  ages	  18	  years	  and	  older	  who	  reported	  using	  sunblock	  ‘Always’	  or	  ‘Nearly	  Always’	  when	  outside	  
on	  a	  sunny	  summer	  day	  for	  more	  than	  an	  hour.	  
N:	  Estimated	  number	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  using	  sunblock	  ‘Always’	  or	  ‘Nearly	  Always’	  when	  
outside	  on	  a	  sunny	  summer	  day	  for	  more	  than	  an	  hour.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
95%	  CI:	  95%	  confidence	  interval.	  
DSU:	  Data	  statistically	  unreliable;	  total	  respondents	  <	  50	  or	  95%	  CI	  half-­‐width	  is	  >	  10.	  







Page 262 Maine Cancer Surveillance Report 2014
  
Table	  4.8.	  Adults	  ages	  18	  years	  and	  older	  who	  routinely	  used	  sunblock	  by	  
county	  and	  public	  health	  district,	  Maine,	  2010.	  
	  
Total	  
Respondents	   n	   N	   %	   95%	  CI	  
Maine	  Total	   3,550	   1,274	   308,768	   33.1	   31.1	  -­‐	  35.1	  
	   	   	   	   	   	  County	   	   	   	   	   	  
Androscoggin	   	  219	  	   	  78	  	   	  19,809	  	   28.9	   21.5	  -­‐	  36.3	  
Aroostook	   	  223	  	   	  61	  	   	  15,891	  	   22.2	   15.0	  -­‐	  29.4	  
Cumberland	   	  590	  	   	  265	  	   	  72,440	  	   43.0	   38.2	  -­‐	  47.9	  
Franklin	   130	   38	   5,794†	   25.7†	   16.8	  -­‐	  34.6†	  
Hancock	   	  183	  	   	  57	  	   	  12,830	  	   27.8	   20.2	  -­‐	  35.4	  
Kennebec	   	  267	  	   	  96	  	   	  23,697	  	   32.8	   25.9	  -­‐	  39.7	  
Knox	   	  187	  	   	  73	  	   	  10,430	  	   36.5	   28.5	  -­‐	  44.6	  
Lincoln	   	  158	  	   	  71	  	   	  11,819	  	   43.1	   33.3	  -­‐	  52.9	  
Oxford	   DSU	   DSU	   DSU	   DSU	   DSU	  
Penobscot	   	  296	  	   	  99	  	   	  30,275	  	   33.4	   26.6	  -­‐	  40.0	  
Piscataquis	   DSU	   DSU	   DSU	   DSU	   DSU	  
Sagadahoc	   DSU	   DSU	   DSU	   DSU	   DSU	  
Somerset	   131	   35	   9,514†	   26.1†	   17.2	  -­‐	  35.0†	  
Waldo	   	  184	  	   	  54	  	   	  8,584	  	   25.6	   17.6	  -­‐	  33.6	  
Washington	   	  162	  	   	  47	  	   	  7,175†	  	   25.0†	   17.2	  -­‐	  32.7†	  
York	   	  395	  	   	  150	  	   	  44,221	  	   34.5	   28.3	  -­‐	  40.7	  
Public	  Health	  District	   	   	   	   	   	  
Aroostook	   	  223	  	   	  61	  	   	  15,891	  	   22.2	   15.0	  -­‐	  29.4	  
Central	   	  398	  	   	  131	  	   	  33,210	  	   30.5	   25.1	  -­‐	  36.0	  
Cumberland	   	  590	  	   	  265	  	   	  72,440	  	   43.0	   38.2	  -­‐	  47.9	  
Downeast	   	  345	  	   	  104	  	   	  20,005	  	   26.7	   21.2	  -­‐	  32.3	  
Midcoast	   	  653	  	   	  248	  	   	  40,180	  	   34.7	   30.1	  -­‐	  39.3	  
Penquis	   	  371	  	   	  118	  	   	  34,104	  	   32.7	   26.5	  -­‐	  38.8	  
Western	   	  490	  	   	  166	  	   	  40,585	  	   30.1	   24.7	  -­‐	  35.4	  
York	   	  395	  	   	  150	  	   	  44,221	  	   34.5	   28.3	  -­‐	  40.7	  
	  
	  
Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  	  	  Percentage	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  using	  sunblock	  ‘Always’	  or	  ‘Nearly	  Always’	  when	  
outside	  on	  a	  sunny	  summer	  day	  for	  more	  than	  an	  hour.	  
n:	  Number	  of	  survey	  respondents	  ages	  18	  years	  and	  older	  who	  reported	  using	  sunblock	  ‘Always’	  or	  ‘Nearly	  Always’	  when	  outside	  
on	  a	  sunny	  summer	  day	  for	  more	  than	  an	  hour.	  
N:	  Estimated	  number	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  using	  sunblock	  ‘Always’	  or	  ‘Nearly	  Always’	  when	  
outside	  on	  a	  sunny	  summer	  day	  for	  more	  than	  an	  hour.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
95%	  CI:	  95%	  confidence	  interval.	  
DSU:	  Data	  statistically	  unreliable;	  total	  respondents	  <	  50	  or	  95%	  CI	  half-­‐width	  is	  >	  10.	  
†Use	  with	  caution.	  Estimates	  based	  on	  number	  of	  n<50	  might	  be	  unstable.	  








Table	  4.9.	  Adults	  ages	  18	  years	  and	  older	  who	  routinely	  used	  at	  least	  one	  
protective	  measure	  against	  sun	  exposure	  by	  selected	  demographics,	  Maine,	  2010.	  
	  
Total	  
Respondents	   	  	  	  	  	  	  	  	  n	   	  	  	  	  	  	  N	   %	   95%	  CI	  
Maine	  Total	   3,493	   1,613	   375,792	   40.9	   38.7	  -­‐	  43.1	  
	   	   	   	   	   	  Sex	   	   	   	   	   	  
Female	   	  	  	  	  	  	  	  	  	  	  2,095	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  891	  	   	  	  	  	  	  	  	  	  	  	  	  159,415	  	   34.3	   31.8	  -­‐	  36.9	  
Male	   	  	  	  	  	  	  	  	  	  	  1,398	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  722	  	   	  	  	  	  	  	  	  	  	  	  	  216,377	  	   47.6	   44.1	  -­‐	  51.1	  
Age	   	   	   	   	   	  
18-­‐44	   	  	  	  	  	  	  	  	  	  	  	  	  	  784	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  212	  	   	  	  	  	  	  	  	  	  	  	  	  112,026	  	   28.5	   24.6	  -­‐	  32.4	  
45-­‐64	   	  	  	  	  	  	  	  	  	  	  1,648	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  719	  	   	  	  	  	  	  	  	  	  	  	  	  154,595	  	   43.4	   40.2	  -­‐	  46.5	  
65	  and	  older	   	  	  	  	  	  	  	  	  	  	  1,040	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  672	  	   	  	  	  	  	  	  	  	  	  	  	  107,738	  	   64.7	   61.4	  -­‐68.0	  
Education	   	   	   	   	   	  
Less	  than	  high	  school	  diploma	   182	   100	   22,226	   44.3	   33.6	  -­‐	  54.9	  
High	  school	  diploma	  or	  GED	   1,143	   528	   124,616	   41.5	   37.3	  -­‐	  45.7	  
Some	  college	   903	   576	   126,386	   39.3	   36.0	  -­‐	  42.7	  
Bachelor's	  degree	  or	  higher	   1,261	   406	   102,304	   41.6	   37.3	  -­‐	  45.8	  
Income	   	   	   	   	   	  
Less	  than	  $15,000	   353	   199	   42,146	   53.4	   44.0	  -­‐	  62.8	  
$15,000-­‐24,999	   558	   291	   59,885	   46.1	   40.3	  -­‐	  51.9	  
$25,000-­‐34,999	   347	   172	   34,697	   42.0	   35.4	  -­‐	  48.6	  
$35,000-­‐49,999	   508	   228	   55,662	   42.1	   36.5	  -­‐	  47.6	  
$50,000	  or	  more	   1,371	   552	   145,385	   36.8	   33.6	  -­‐	  39.9	  
Sexual	  Orientation	   	   	   	   	   	  
Heterosexual	  or	  straight	   	  	  	  	  	  	  	  	  	  	  3,340	  	   	  	  	  	  	  	  	  	  	  	  1,541	  	   	  	  	  	  	  	  	  	  	  	  	  361,058	  	   40.9	   38.7	  -­‐	  43.2	  
Homosexual	  (gay	  or	  lesbian)	   DSU	   DSU	   DSU	   DSU	   DSU	  
Bisexual	   DSU	   DSU	   DSU	   DSU	   DSU	  
Other	   DSU	   DSU	   DSU	   DSU	   DSU	  
Type	  of	  Health	  Insurance	  Coverage	   	   	   	   	   	  
Private	   1,752	   685	   182,383	   36.1	   33.2	  -­‐	  38.9	  
Medicare	   804	   497	   80,376	   59.6	   55.4	  -­‐	  63.8	  
Medicaid	  or	  MaineCare	   284	   114	   27,678	   29.2	   22.5	  -­‐	  35.9	  
Other	   234	   124	   28,287	   50.4	   41.9	  -­‐	  59.0	  
Uninsured	   	  DSU	  	   	  DSU	  	   	  DSU	  	   DSU	   DSU	  
Mental	  Health	  Status	   	   	   	   	   	  
Current	  depression	   	   	   	   	   	  
Yes	   	  	  	  	  	  	  	  	  	  	  	  	  	  301	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  148	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  36,476	  	   45.2	   35.5	  -­‐	  54.8	  
No	   	  	  	  	  	  	  	  	  	  	  3,181	  	   	  	  	  	  	  	  	  	  	  	  1,461	  	   	  	  	  	  	  	  	  	  	  	  	  338,598	  	   40.5	   38.3	  -­‐	  42.8	  
Lifetime	  depression	  or	  anxiety	   	   	   	   	   	  
Yes	   	  	  	  	  	  	  	  	  	  	  1,098	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  499	  	   	  	  	  	  	  	  	  	  	  	  113,284	  	   41.3	   37.1	  -­‐	  45.6	  
No	   	  	  	  	  	  	  	  	  	  	  2,376	  	   	  	  	  	  	  	  	  	  	  	  1,106	  	   	  	  	  	  	  	  	  	  	  	  261,205	  	   40.8	   38.2	  -­‐	  43.3	  	  
Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  	  Percentage	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  using	  at	  least	  one	  of	  the	  protective	  measures	  (i.e.,	  wearing	  a	  
hat	  to	  shade	  face,	  ears,	  or	  neck	  against	  the	  sun,	  wearing	  long-­‐sleeved	  shirt,	  or	  staying	  in	  the	  shade)	  against	  sun	  exposure	  ‘Always’	  or	  
‘Nearly	  Always’	  when	  outside	  on	  a	  sunny	  summer	  day	  for	  more	  than	  an	  hour.	  
n:	  Number	  of	  survey	  respondents	  ages	  18	  years	  and	  older	  who	  reported	  using	  at	  least	  one	  of	  the	  protective	  measures	  (i.e.,	  wearing	  a	  hat	  
to	  shade	  face,	  ears,	  or	  neck	  against	  sun,	  wearing	  long-­‐sleeved	  shirt,	  or	  staying	  in	  the	  shade)	  against	  sun	  exposure	  ‘Always’	  or	  ‘Nearly	  
Always’	  when	  outside	  on	  a	  sunny	  summer	  day	  for	  more	  than	  an	  hour.	  
N:	  Estimated	  number	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  using	  at	  least	  one	  of	  the	  protective	  measures	  (i.e.,	  wearing	  a	  
hat	  to	  shade	  face,	  ears,	  or	  neck	  against	  sun,	  wearing	  long-­‐sleeved	  shirt,	  or	  staying	  in	  the	  shade)	  against	  sun	  exposure	  ‘Always’	  or	  ‘Nearly	  
Always’	  when	  outside	  on	  a	  sunny	  summer	  day	  for	  more	  than	  an	  hour.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
95%	  CI:	  95%	  confidence	  interval.	  
DSU:	  Data	  statistically	  unreliable;	  total	  respondents	  <	  50	  or	  95%	  CI	  half-­‐width	  is	  >	  10.	  
Due	  to	  changes	  in	  survey	  methodology,	  data	  collected	  in	  2011	  and	  in	  subsequent	  years	  cannot	  be	  compared	  with	  data	  prior	  to	  2011.	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Table	  4.10.	  Adults	  ages	  18	  years	  and	  older	  who	  routinely	  used	  at	  least	  one	  
protective	  measure	  against	  sun	  exposure	  by	  race	  and	  ethnicity,	  Maine,	  2010.	  
Total	  
Respondents	   	  	  	  	  	  	  	  	  	  	  	  n	   	  	  	  	  	  	  	  	  	  N	   %	   	  	  	  	  	  	  	  95%	  CI	  
Maine	  Total	   3,493	   1,613	   375,792	   	  	  40.9	   	  	  	  	  38.7	  -­‐	  43.1	  
Race	  
White	   3,326	   1,534	   358,247	   41.0	   38.7	  -­‐	  43.3	  
Black	  or	  African	  American	   DSU	   DSU	   DSU	   DSU	   DSU	  
American	  Indian	  or	  Alaska	  Native	   DSU	   DSU	   DSU	   DSU	   DSU	  
Asian	  or	  Pacific	  Islander	   DSU	   DSU	   DSU	   DSU	   DSU	  
Two	  or	  More	  Races	   DSU	   DSU	   DSU	   DSU	   DSU	  
Other	  Race	   DSU	   DSU	   DSU	   DSU	   DSU	  
Ethnicity	  
Non-­‐Hispanic	   3,407	   1,570	   366,207	   40.8	   38.5	  -­‐	  43.0	  
Hispanic	   DSU	   DSU	   DSU	   DSU	   DSU	  
Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  	  Percentage	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  using	  at	  least	  one	  of	  the	  protective	  measures	  (i.e.,	  
wearing	  a	  hat	  to	  shade	  face,	  ears,	  or	  neck	  against	  sun,	  wearing	  long-­‐sleeved	  shirt,	  or	  staying	  in	  the	  shade)	  against	  sun	  exposure	  
‘Always’	  or	  ‘Nearly	  Always’	  when	  outside	  on	  a	  sunny	  summer	  day	  for	  more	  than	  an	  hour.	  
n:	  Number	  of	  survey	  respondents	  ages	  18	  years	  and	  older	  who	  reported	  using	  at	  least	  one	  of	  the	  protective	  measures	  (i.e.,	  
wearing	  a	  hat	  to	  shade	  face,	  ears,	  or	  neck	  against	  sun,	  wearing	  long-­‐sleeved	  shirt,	  or	  staying	  in	  the	  shade)	  against	  sun	  exposure	  
‘Always’	  or	  ‘Nearly	  Always’	  when	  outside	  on	  a	  sunny	  summer	  day	  for	  more	  than	  an	  hour.	  
N:	  Estimated	  number	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  using	  at	  least	  one	  of	  the	  protective	  measures	  (i.e.,	  
wearing	  a	  hat	  to	  shade	  face,	  ears,	  or	  neck	  against	  sun,	  wearing	  long-­‐sleeved	  shirt,	  or	  staying	  in	  the	  shade)	  against	  sun	  exposure	  
‘Always’	  or	  ‘Nearly	  Always’	  when	  outside	  on	  a	  sunny	  summer	  day	  for	  more	  than	  an	  hour.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
95%	  CI:	  95%	  confidence	  interval.	  
DSU:	  Data	  statistically	  unreliable;	  total	  respondents	  <	  50	  or	  95%	  CI	  half-­‐width	  is	  >	  10.	  
Due	  to	  changes	  in	  survey	  methodology,	  data	  collected	  in	  2011	  and	  in	  subsequent	  years	  cannot	  be	  compared	  with	  data	  prior	  to	  
2011.	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Table	  4.11.	  Adults	  ages	  18	  years	  and	  older	  who	  routinely	  used	  at	  least	  one	  
protective	  measure	  against	  sun	  exposure	  by	  county	  and	  public	  health	  
district,	  Maine,	  2010.	  
Total	  
Respondents	   	  	  	  	  	  	  	  	  	  n	   	  	  	  	  	  	  	  N	   %	   95%	  CI	  
Maine	  Total	   3,493	   1,613	   375,792	   40.9	   38.7	  -­‐	  43.1	  
County	  
Androscoggin	   	  	  	  	  	  	  	  	  	  	  	  	  	  212	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  99	  	   	  	  	  	  	  	  	  	  	  	  	  28,842	  	   43.1	   34.0	  -­‐	  52.3	  
Aroostook	   DSU	   DSU	   DSU	   DSU	   DSU	  
Cumberland	   	  	  	  	  	  	  	  	  	  	  	  	  	  583	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  247	  	   	  	  	  	  	  	  	  	  	  	  	  65,424	  	   39.5	   34.6	  -­‐	  44.3	  
Franklin	   DSU	   DSU	   DSU	   DSU	   DSU	  
Hancock	   	  	  	  	  	  	  	  	  	  	  	  	  	  181	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  75	  	   	  	  	  	  	  	  	  	  	  	  	  15,135	  	   33.1	   25.2	  -­‐	  41.1	  
Kennebec	   	  	  	  	  	  	  	  	  	  	  	  	  	  265	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  125	  	   	  	  	  	  	  	  	  	  	  	  	  32,603	  	   45.9	   38.5	  -­‐	  53.3	  
Knox	   	  	  	  	  	  	  	  	  	  	  	  	  	  184	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  85	  	   	  	  	  	  	  	  	  	  	  	  	  11,519	  	   40.9	   32.5	  -­‐	  49.2	  
Lincoln	   	  	  	  	  	  	  	  	  	  	  	  	  	  155	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  74	  	   	  	  	  	  	  	  	  	  	  	  	  10,736	  	   39.7	   29.9	  -­‐	  49.5	  
Oxford	   	  	  	  	  	  	  	  	  	  	  	  	  	  138	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  73	  	   	  	  	  	  	  	  	  	  	  	  	  18,881	  	   43.5	   32.6	  -­‐	  54.4	  
Penobscot	   	  	  	  	  	  	  	  	  	  	  	  	  	  291	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  133	  	   	  	  	  	  	  	  	  	  	  	  	  34,200	  	   38.2	   31.3	  -­‐	  45.1	  
Piscataquis	   DSU	   DSU	   DSU	   DSU	   DSU	  
Sagadahoc	   DSU	   DSU	   DSU	   DSU	   DSU	  
Somerset	   DSU	   DSU	   DSU	   DSU	   DSU	  
Waldo	   DSU	   DSU	   DSU	   DSU	   DSU	  
Washington	   	  	  	  	  	  	  	  	  	  	  	  	  	  161	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  79	  	   	  	  	  	  	  	  	  	  	  	  	  13,135	  	   45.8	   36.0	  -­‐	  55.6	  
York	   	  	  	  	  	  	  	  	  	  	  	  	  	  392	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  166	  	   	  	  	  	  	  	  	  	  	  	  	  47,581	  	   37.4	   31.2	  -­‐	  43.5	  
Public	  Health	  District	  
Aroostook	   DSU	   DSU	   DSU	   DSU	   DSU	  
Central	   	  	  	  	  	  	  	  	  	  	  	  	  	  393	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  181	  	   	  	  	  	  	  	  	  	  	  	  	  46,357	  	   43.5	   37.5	  -­‐	  49.5	  
Cumberland	   	  	  	  	  	  	  	  	  	  	  	  	  	  583	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  247	  	   	  	  	  	  	  	  	  	  	  	  	  65,424	  	   39.5	   34.6	  -­‐	  44.3	  
Downeast	   	  	  	  	  	  	  	  	  	  	  	  	  	  342	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  154	  	   	  	  	  	  	  	  	  	  	  	  	  28,270	  	   38.0	   31.8	  -­‐	  44.3	  
Midcoast	   	  	  	  	  	  	  	  	  	  	  	  	  	  642	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  311	  	   	  	  	  	  	  	  	  	  	  	  	  50,304	  	   44.0	   38.9	  -­‐	  49.2	  
Penquis	   	  	  	  	  	  	  	  	  	  	  	  	  	  365	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  170	  	   	  	  	  	  	  	  	  	  	  	  	  39,673	  	   38.6	   32.3	  -­‐	  44.8	  
Western	   	  	  	  	  	  	  	  	  	  	  	  	  	  477	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  235	  	   	  	  	  	  	  	  	  	  	  	  	  56,595	  	   43.0	   36.9	  -­‐	  49.1	  
York	   	  	  	  	  	  	  	  	  	  	  	  	  	  392	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  166	  	   	  	  	  	  	  	  	  	  	  	  	  47,581	  	   37.4	   31.2	  -­‐	  43.5	  
Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  	  Percentage	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  using	  at	  least	  one	  of	  the	  protective	  measures	  (i.e.,	  
wearing	  a	  hat	  to	  shade	  face,	  ears,	  or	  neck	  against	  sun,	  wearing	  long-­‐sleeved	  shirt,	  or	  staying	  in	  the	  shade)	  against	  sun	  exposure	  
‘Always’	  or	  ‘Nearly	  Always’	  when	  outside	  on	  a	  sunny	  summer	  day	  for	  more	  than	  an	  hour.	  
n:	  Number	  of	  survey	  respondents	  ages	  18	  years	  and	  older	  who	  reported	  using	  at	  least	  one	  of	  the	  protective	  measures	  (i.e.,	  
wearing	  a	  hat	  to	  shade	  face,	  ears,	  or	  neck	  against	  sun,	  wearing	  long-­‐sleeved	  shirt,	  or	  staying	  in	  the	  shade)	  against	  sun	  exposure	  
‘Always’	  or	  ‘Nearly	  Always’	  when	  outside	  on	  a	  sunny	  summer	  day	  for	  more	  than	  an	  hour.	  
N:	  Estimated	  number	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  using	  at	  least	  one	  of	  the	  protective	  measures	  (i.e.,	  
wearing	  a	  hat	  to	  shade	  face,	  ears,	  or	  neck	  against	  sun,	  wearing	  long-­‐sleeved	  shirt,	  or	  staying	  in	  the	  shade)	  against	  sun	  exposure	  
‘Always’	  or	  ‘Nearly	  Always’	  when	  outside	  on	  a	  sunny	  summer	  day	  for	  more	  than	  an	  hour.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
95%	  CI:	  95%	  confidence	  interval.	  
DSU:	  Data	  statistically	  unreliable;	  total	  respondents	  <	  50	  or	  95%	  CI	  half-­‐width	  is	  >	  10.	  
†Use	  with	  caution.	  Estimates	  based	  on	  number	  of	  n<50	  might	  be	  unstable.	  
Due	  to	  changes	  in	  survey	  methodology,	  data	  collected	  in	  2011	  and	  in	  subsequent	  years	  cannot	  be	  compared	  with	  data	  prior	  to	  
2011.	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Data	  source:	  Maine	  Integrated	  Youth	  Health	  Survey.	  
All	  percentages	  weighted	  to	  be	  more	  representative	  of	  the	  general	  student	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  	  Any	  current	  tobacco	  use	  =	  Percentage	  of	  Maine	  middle	  and	  high	  school	  students	  who	  reported	  use	  of	  any	  tobacco	  product	  including	  cigarettes,	  cigars,	  cigarillos,	  little	  cigars,	  and	  smokeless	  
tobacco	  in	  the	  past	  30	  days	  before	  the	  survey;	  Weight	  status	  =	  Percentage	  of	  Maine	  middle	  and	  high	  school	  students	  with	  a	  body	  mass	  index	  (BMI)	  ≤5th	  percentile	  but	  <85th	  percentile	  (healthy	  weight),	  a	  
BMI	  ≥85th	  percentile	  but	  <95th	  percentile	  (overweight),	  or	  a	  BMI	  ≥95th	  percentile	  (obese)	  by	  age	  and	  sex	  based	  on	  self-­‐reported	  weight	  and	  height	  measurements;	  Indoor	  tanning	  device	  use	  =	  Percentage	  of	  
Maine	  middle	  and	  high	  school	  students	  who	  reported	  using	  an	  indoor	  tanning	  device	  such	  as	  a	  sunlamp,	  sunbed,	  or	  tanning	  booth	  at	  least	  one	  time	  in	  during	  the	  past	  12	  months;	  Routine	  sunscreen	  use	  =	  
Percentage	  of	  Maine	  middle	  and	  high	  school	  students	  who	  reported	  using	  a	  sunscreen	  with	  a	  SPF	  of	  15	  or	  higher	  ‘Most	  of	  the	  time’	  or	  ‘Always’	  when	  outside	  on	  a	  sunny	  day	  for	  more	  than	  an	  hour.	  
n:	  Number	  of	  survey	  respondents	  in	  middle	  school	  or	  high	  school	  who	  responded	  to	  questions	  about	  tobacco	  use,	  weight	  and	  height	  measurements,	  physical	  activity,	  fruit	  and	  vegetable	  
consumption,	  indoor	  tanning	  device	  use,	  and	  routine	  sunscreen	  use.	  
N:	  Estimated	  number	  of	  Maine	  middle	  school	  and	  high	  school	  students	  who	  reported	  to	  questions	  about	  tobacco	  use,	  weight	  and	  height	  measurements,	  physical	  activity,	  fruit	  and	  vegetable	  
consumption,	  indoor	  tanning	  device	  use,	  and	  routine	  sunscreen	  use.	  
95%	  CI:	  95%	  confidence	  interval.	  
NA:	  Data	  not	  available.	  
*Data	  on	  U.S.	  high	  school	  students	  was	  obtained	  from	  the	  Centers	  for	  Disease	  Control	  and	  Prevention	  Youth	  Risk	  Behavior	  Survey,	  2013.
Table	  4.12.	  Prevalence	  of	  cancer	  risk	  factors	  among	  middle	  and	  high	  school	  students,	  Maine	  and	  U.S.,	  2013.*	  
Maine	   U.S.	  
Middle	  School	  Students	   High	  School	  Students	   High	  School	  Students	  
Total	  
Respondents	   n	   N	   %	   95%	  CI	  
Total	  
Respondents	   n	   N	   %	   95%	  CI	   %	   95%	  CI	  
Any	  Current	  Tobacco	  Use	   17,993	   35,534	  
	  Yes	   745	   1,008	   3.8	   3.4	  -­‐	  4.2	   6,324	   10,042	   18.2	   17.3	  -­‐	  19.1	   22.4	   19.9	  -­‐25.0	  
	  No	   17,248	   25,493	   96.2	   95.8	  -­‐	  96.6	   29,210	   45,167	   81.8	   80.9	  -­‐82.7	   NA	   NA	  
Weight	  Status	   4,331	   16,279	  
	  Healthy	  Weight	   2,996	   14,930	   65.7	   64.0	  -­‐	  67.4	   11,301	   35,496	   69.7	   68.4	  -­‐	  71.0	   NA	   NA	  
	  Overweight	   761	   3,973	   17.5	   16.5	  -­‐	  18.5	   2,268	   8,153	   16.0	   15.3	  -­‐	  16.7	   16.6	   15.4	  -­‐	  17.8	  
	  Obese	   604	   3,217	   14.2	   12.9	  -­‐	  15.4	   2,086	   6,449	   12.7	   11.8	  -­‐	  13.5	   13.7	   12.6	  -­‐	  14.9	  
Engaged	  in	  ≥60	  minutes	  of	  
physical	  activity	  daily	   17,213	   33,995	  
	  Yes	   4,940	   7,288	   28.7	   27.6	  -­‐	  29.8	   7,529	   11,867	   22.4	   21.6	  -­‐	  23.2	   27.1	   25.5	  -­‐	  28.8	  
	  No	   12,273	   18,099	   71.3	   70.2	  -­‐	  72.4	   26,466	   41,094	   77.6	   76.8	  -­‐	  78.4	   NA	   NA	  
Ate	  fruits	  and/or	  vegetables	  ≥5	  
times	  per	  day	  during	  the	  past	  7	  
days	   16,692	   32,270	  
	  Yes	   3,292	   4,736	   19.3	   18.1	  -­‐	  20.4	   5,594	   8,586	   16.8	   16.1	  -­‐	  17.6	   NA	   NA	  
	  No	   13,400	   19,846	   80.7	   79.6	  -­‐	  81.9	   27,126	   42,406	   83.2	   82.4	  -­‐	  83.9	   NA	   NA	  
Indoor	  Tanning	  Device	  Use	   4,923	   9,100	  
	  Yes	   337	   1,579	   6.1	   5.3	  -­‐	  7.0	   1,394	   8,212	   15.0	   13.6	  -­‐	  16.4	   12.8	   10.6	  -­‐	  15.4	  
	  No	   4,586	   24,185	   93.4	   93.0	  -­‐	  94.7	   7,706	   46,606	   85.0	   83.6	  -­‐	  86.4	   NA	   NA	  
Routine	  Sunscreen	  Use	   4,912	   8,957	  
Yes	   1,349	   7,381	   28.7	   26.5	  -­‐	  31.0	   1,766	   10,628	   19.7	   18.2	  -­‐	  21.2	   10.1	   9.1	  -­‐	  11.1	  
No	   3,563	   18,302	   71.3	   69.0	  –	  73.4	   7,191	   43,324	   80.3	   78.8	  -­‐	  81.8	   NA	   NA	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Data	  source:	  Maine	  Integrated	  Youth	  Health	  Survey.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  student	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  Indoor	  tanning	  device	  use	  =	  Percentage	  of	  Maine	  middle	  and	  high	  school	  students	  who	  reported	  using	  an	  indoor	  tanning	  
device	  such	  as	  a	  sunlamp,	  sunbed,	  or	  tanning	  booth	  at	  least	  one	  time	  in	  during	  the	  past	  12	  months;	  Routine	  sunscreen	  use	  =	  Percentage	  
of	  Maine	  middle	  and	  high	  school	  students	  who	  reported	  using	  a	  sunscreen	  with	  a	  SPF	  of	  15	  or	  higher	  ‘Most	  of	  the	  time’	  or	  ‘Always’	  
when	  outside	  on	  a	  sunny	  day	  for	  more	  than	  an	  hour.	  
n:	  Number	  of	  survey	  respondents	  in	  middle	  and	  high	  school	  who	  reported	  using	  an	  indoor	  tanning	  device	  such	  as	  a	  sunlamp,	  sunbed,	  or	  
tanning	  booth	  at	  least	  one	  time	  in	  during	  the	  past	  12	  months	  (use	  of	  an	  indoor	  tanning	  device)	  or	  reported	  using	  a	  sunscreen	  with	  a	  SPF	  
of	  15	  or	  higher	  ‘Most	  of	  the	  time’	  or	  ‘Always’	  when	  outside	  on	  a	  sunny	  day	  for	  more	  than	  an	  hour	  (routine	  sunscreen	  use).	  
N:	  Estimated	  number	  of	  Maine	  middle	  and	  high	  school	  students	  who	  reported	  using	  an	  indoor	  tanning	  device	  such	  as	  a	  sunlamp,	  
sunbed,	  or	  tanning	  booth	  at	  least	  one	  time	  in	  during	  the	  past	  12	  months	  (use	  of	  an	  indoor	  tanning	  device)	  or	  reported	  using	  a	  sunscreen	  
with	  a	  SPF	  of	  15	  or	  higher	  ‘Most	  of	  the	  time’	  or	  ‘Always’	  when	  outside	  on	  a	  sunny	  day	  for	  more	  than	  an	  hour	  (routine	  sunscreen	  use).	  
95%	  CI:	  95%	  confidence	  interval.	  
*In	  2009,	  routine	  sunscreen	  use	  is	  defined	  as	  the	  percentage	  of	  Maine	  middle	  and	  high	  school	  students	  who	  reported	  using	  a	  sunscreen
with	  a	  SPF	  of	  15	  or	  higher	  ‘Most	  of	  the	  time’	  or	  ‘Always’	  when	  outside	  on	  a	  sunny	  (summer)	  day	  for	  more	  than	  an	  hour.	  
Table	  4.13.	  Ultraviolet	  light	  exposure-­‐related	  cancer	  risk	  factors	  among	  middle	  and	  
high	  school	  students	  by	  year,	  Maine,	  2009-­‐2013.
Year	  
Middle	  School	  Students	   High	  School	  Students	  
Total	  
Respondents	   n	   N	   %	   95%	  CI	  
Total	  
Respondents	   	  	  n	   	  	  	  	  	  N	   %	   95%	  CI	  
Indoor	  Tanning	  Device	  Use	  
2009	   5,124	   508	   2,530	   9.2	   8.1	  -­‐	  10.2	   10,149	   2,346	   13,241	   22.5	   20.8	  -­‐	  24.2	  
2011	   4,587	   336	   1,817	   6.8	   5.9	  -­‐	  7.8	   8,918	   1,505	   9,111	   16.4	   15.3	  -­‐	  17.5	  
2013	   4,923	   337	   1,579	   6.1	   5.3	  -­‐	  7.0	   9,100	   1,394	   8,212	   15.0	   13.6	  -­‐	  16.4	  
Routine	  Sunscreen	  Use*	  
2009	   5,047	   1,614	   8,990	   33.0	   31.0	  -­‐	  34.9	   10,075	   2,104	   12,456	   21.4	   20.2	  -­‐	  22.5	  
2011	   4,593	   1,370	   8,217	   30.8	   28.4	  -­‐	  33.3	   8,867	   	  	  1,870	   11,630	   21.0	   19.5	  -­‐	  22.6	  
2013	   4,912	   1,349	   7,381	   28.7	   26.5	  -­‐	  31.0	   8,957	   	  1,766	   10,628	   19.7	   18.2	  -­‐	  21.2	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Table	  4.14.	  Middle	  school	  students	  who	  used	  an	  indoor	  tanning	  device	  at	  
least	  one	  time	  during	  the	  past	  12	  months	  by	  selected	  demographics,	  Maine,	  
2013.	  
Total	  
Respondents	   	  n	   	  	  	  	  	  	  N	   	  	  %	   95%	  CI	  
Maine	  Total	   4,923	   337	   1,579	   6.1	   5.3	  -­‐	  7.0	  
Sex	  
Female	   2,493	   171	   814	   6.5	   5.4	  -­‐	  7.6	  
Male	   2,375	   158	   730	   5.6	   4.5	  -­‐	  6.8	  
Age	  
12	  or	  younger	   1,245	   81	   397	   5.9	   4.5	  -­‐	  7.3	  
13	   2,350	   141	   682	   5.5	   4.5	  -­‐	  6.5	  
14	  and	  older	   1,304	   111	   489	   7.5	   5.9	  -­‐	  9.2	  
Grade	  
7th	   2,256	   139	   698	   5.7	   4.6	  -­‐	  6.7	  
8th	   2,558	   184	   834	   6.5	   5.1	  -­‐	  7.8	  
Race	  and	  Ethnicity	  
White*	   3,529	   198	   1,184	   5.6	   4.6	  -­‐	  6.4	  
Black	  or	  African	  American*	   153	   16	   30	   10.2	   5.5	  -­‐	  15.0	  
American	  Indian	  or	  Alaska	  Native*	   232	   18	   36	   7.5	   3.4	  -­‐	  11.7	  
Asian*	   102	   9	   30	   8.7	   1.6	  -­‐	  15.8	  
Native	  Hawaiian	  or	  Other	  Pacific	  
Islander*	   13	   4	   8	   32.1	   10.6	  -­‐	  53.7	  
Multiple	  Races*	   191	   19	   38	   9.7	   5.2	  -­‐	  14.3	  
Hispanic	   217	   37	   74	   16.7	   10.7	  -­‐	  22.7	  
Data	  source:	  Maine	  Integrated	  Youth	  Health	  Survey.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  student	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  Percentage	  of	  Maine	  middle	  school	  students	  who	  reported	  using	  an	  indoor	  tanning	  device	  such	  as	  a	  sunlamp,	  sunbed,	  or	  
tanning	  booth	  at	  least	  one	  time	  in	  during	  the	  past	  12	  months.	  
n:	  Number	  of	  survey	  respondents	  in	  middle	  school	  who	  reported	  using	  an	  indoor	  tanning	  device	  such	  as	  a	  sunlamp,	  sunbed,	  or	  	  	  	  	  	  	  	  	  	  	  
tanning	  booth	  at	  least	  one	  time	  in	  during	  the	  past	  12	  months.	  
N:	  Estimated	  number	  of	  Maine	  middle	  school	  students	  who	  reported	  using	  an	  indoor	  tanning	  device	  such	  as	  a	  sunlamp,	  sunbed,	  or	  
tanning	  booth	  at	  least	  one	  time	  in	  during	  the	  past	  12	  months.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
95%	  CI:	  95%	  confidence	  interval.	  
*Non-­‐Hispanic.
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Table	  4.15.	  High	  school	  students	  who	  used	  an	  indoor	  tanning	  device	  at	  least	  
one	  time	  during	  the	  past	  12	  months	  by	  selected	  demographics,	  Maine,	  2013.	  
Total	  
Respondents	   n	   	  	  	  	  	  	  	  	  N	   	  	  %	   95%	  CI	  
Maine	  Total	   9,100	   1,394	   8,212	   15.0	   13.6	  -­‐	  16.4	  
Sex	  
Female	   4,695	   912	   5,301	   19.9	   18.2	  -­‐	  21.5	  
Male	   4,308	   455	   2,775	   10.0	   8.6	  -­‐	  11.5	  
Age	  
14	  or	  younger	   1,416	   162	   769	   10.5	   8.5	  -­‐	  12.5	  
15	   2,336	   1,403	   1,403	   10.7	   8.7	  -­‐	  12.6	  
16	   2,285	   346	   2,032	   14.5	   12.7	  -­‐	  16.3	  
17	   2,038	   394	   2,513	   18.6	   16.6	  -­‐	  20.6	  
18	  and	  older	   971	   217	   1,427	   21.8	   18.6	  -­‐	  24.9	  
Grade	  
9th	   2,602	   268	   1,330	   9.7	   8.0	  -­‐	  11.5	  
10th	   2,262	   302	   1,720	   12.8	   10.7	  -­‐	  14.9	  
11th	   2,166	   356	   2,101	   15.5	   13.4	  -­‐	  17.6	  
12th	   1,949	   217	   2,880	   21.1	   18.5	  -­‐	  23.8	  
Race	  and	  Ethnicity	  
White*	   6,229	   1,062	   7,016	   14.5	   13.1	  -­‐	  15.9	  
Black	  or	  African	  American*	   218	   31	   	  90	   	  14.4	   10.5	  -­‐	  18.2	  
American	  Indian	  or	  Alaska	  Native*	   186	   34	   96	   	  18.6	   13.1	  -­‐	  24.1	  
Asian*	   223	   31	   98	   	  13.3	   9.9	  -­‐	  16.7	  
Native	  Hawaiian	  or	  Other	  Pacific	  
Islander*	   31	   7	   23	   25.4	   10.0	  -­‐	  40.9	  
Multiple	  Races*	   294	   40	   109	   	  13.1	   9.5	  -­‐	  16.7	  
Hispanic	   436	   101	   291	   23.1	   18.0	  -­‐	  28.1	  
Sexual	  Orientation	  
Heterosexual	  or	  straight	   8,084	   1,205	   7,305	   14.9	   13.4	  -­‐	  16.3	  
Homosexual	  (gay	  or	  lesbian)	   129	   33	   	  	  	  	  	  171	   	  22.8	   16.3	  -­‐	  29.4	  
Bisexual	   379	   60	   290	   13.7	   10.6	  -­‐	  16.8	  
Not	  Sure	   323	   58	   252	   14.3	   11.0	  -­‐	  17.7	  
Data	  source:	  Maine	  Integrated	  Youth	  Health	  Survey.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  student	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  Percentage	  of	  Maine	  high	  school	  students	  who	  reported	  using	  an	  indoor	  tanning	  device	  such	  as	  a	  sunlamp,	  sunbed,	  or	  
tanning	  booth	  at	  least	  one	  time	  in	  during	  the	  past	  12	  months.	  
n:	  Number	  of	  survey	  respondents	  in	  high	  school	  who	  reported	  using	  an	  indoor	  tanning	  device	  such	  as	  a	  sunlamp,	  sunbed,	  or
tanning	  booth	  at	  least	  one	  time	  in	  during	  the	  past	  12	  months.	  
N:	  Estimated	  number	  of	  Maine	  high	  school	  students	  who	  reported	  using	  an	  indoor	  tanning	  device	  such	  as	  a	  sunlamp,	  sunbed,	  or	  	  
tanning	  booth	  at	  least	  one	  time	  in	  during	  the	  past	  12	  months.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
95%	  CI:	  95%	  confidence	  interval.	  
*Non-­‐Hispanic.
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Table	  4.16.	  Middle	  school	  students	  who	  routinely	  used	  sunscreen	  when	  
outside	  on	  a	  sunny	  day	  for	  more	  than	  an	  hour	  by	  selected	  demographics,	  
Maine,	  2013.	  
Total	  
Respondents	   	  n	   	  	  	  	  	  	  N	   	  	  %	   95%	  CI	  
Maine	  Total	   4,912	   1,349	   7,381	   28.7	   26.5	  -­‐	  31.0	  
Sex	  
Female	   2,496	   790	   4,203	   33.4	   30.2	  -­‐	  36.8	  
Male	   2,362	   540	   3,076	   23.9	   21.6	  -­‐	  26.1	  
Age	  
12	  or	  younger	   1,231	   421	   2,327	   35.0	   30.5	  -­‐	  35.9	  
13	   2,353	   663	   3,672	   29.6	   27.0	  -­‐	  32.2	  
14	  and	  older	   1,304	   263	   1,369	   21.1	   17.7	  -­‐	  24.4	  
Grade	  
7th	   2,248	   722	   4,068	   33.5	   30.2	  -­‐	  36.8	  
8th	   2,557	   600	   3,170	   24.6	   21.8	  -­‐	  27.3	  
Race	  and	  Ethnicity	  
White*	   3,523	   1,042	   6,276	   29.5	   27.1	  -­‐	  31.9	  
Black	  or	  African	  American*	   152	   22	   41	   	  	  14.1	   8.3	  -­‐	  20.0	  
American	  Indian	  or	  Alaska	  Native*	   233	   46	   95	   	  19.8	   15.4	  -­‐	  24.2	  
Asian*	   105	   12	   26	   	  11.7	   5.4	  -­‐	  18.0	  
Native	  Hawaiian	  or	  Other	  Pacific	  
Islander*	   13	   5	   10	   	  38.9	   8.6	  -­‐	  69.2	  
Multiple	  Races*	   195	   42	   88	   	  21.9	   16.4	  -­‐	  27.3	  
Hispanic	   214	   41	   88	   	  20.1	   16.4	  -­‐	  23.8	  
Data	  source:	  Maine	  Integrated	  Youth	  Health	  Survey.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  student	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  Percentage	  of	  Maine	  middle	  school	  students	  who	  reported	  using	  a	  sunscreen	  with	  a	  SPF	  of	  15	  or	  higher	  ‘Most	  of	  the	  	  	  	  	  	  	  	  
time’	  or	  ‘Always’	  when	  outside	  on	  a	  sunny	  day	  for	  more	  than	  an	  hour.	  
n:	  Number	  of	  survey	  respondents	  in	  middle	  school	  who	  reported	  using	  a	  sunscreen	  with	  a	  SPF	  of	  15	  or	  higher	  ‘Most	  of	  the	  time’	  	  	  	  	  	  	  	  
or	  ‘Always’	  when	  outside	  on	  a	  sunny	  day	  for	  more	  than	  an	  hour.	  
N:	  Estimated	  number	  of	  Maine	  middle	  school	  students	  who	  reported	  using	  a	  sunscreen	  with	  a	  SPF	  of	  15	  or	  higher	  ‘Most	  of	  the	  	  	  	  	  	  	  	  
time’	  or	  ‘Always’	  when	  outside	  on	  a	  sunny	  day	  for	  more	  than	  an	  hour.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
95%	  CI:	  95%	  confidence	  interval.	  
*Non-­‐Hispanic.
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Table	  4.17.	  High	  school	  students	  who	  routinely	  used	  sunscreen	  when	  outside	  
on	  a	  sunny	  day	  for	  more	  than	  an	  hour	  by	  selected	  demographics,	  Maine,	  2013.	  
Total	  
Respondents	   n	   	  	  	  	  	  	  	  	  N	   	  	  %	   95%	  CI	  
Maine	  Total	   8,957	   1,766	   10,628	   19.7	   18.2	  -­‐	  21.2	  
Sex	  
Female	   4,461	   1,141	   6,569	   24.9	   22.9	  -­‐	  26.9	  
Male	   3,618	   603	   3,937	   14.5	   13.0	  -­‐	  16.1	  
Age	  
14	  or	  younger	   1,396	   325	   1,703	   23.5	   20.4	  -­‐	  26.7	  
15	   2,304	   475	   2,742	   21.1	   18.8	  -­‐	  23.4	  
16	   2,260	   423	   2,619	   18.9	   16.3	  -­‐	  21.5	  
17	   1,984	   364	   2,363	   18.0	   16.3	  -­‐	  19.7	  
18	  and	  older	   961	   170	   1,149	   17.8	   14.9	  -­‐	  20.7	  
Grade	  
9th	   2,560	   563	   3,009	   22.3	   19.8	  -­‐	  25.0	  
10th	   2,254	   419	   2,568	   19.2	   16.9	  -­‐	  21.5	  
11th	   2,112	   413	   2,577	   19.4	   17.5	  -­‐	  21.4	  
12th	   1,913	   343	   2,357	   17.7	   15.4	  -­‐	  20.0	  
Race	  and	  Ethnicity	  
White*	   7,189	   1,479	   9,518	   20.0	   18.4	  -­‐	  21.6	  
Black	  or	  African	  American*	   219	   16	   50	   7.9	   	  4.3	  -­‐	  11.4	  
American	  Indian	  or	  Alaska	  Native*	   183	   23	   68	   13.4	   	  7.7	  -­‐	  19.1	  
Asian*	   217	   38	   134	   18.9	   	  14.6	  -­‐	  22.8	  
Native	  Hawaiian	  or	  Other	  Pacific	  
Islander*	   29	   7	   21	   24.8	   	  	  8.8	  -­‐	  40.8	  
Multiple	  Races*	   285	   49	   	  84	   17.1	   	  12.2	  -­‐	  22.0	  
Hispanic	   422	   64	   179	   14.6	   11.4	  -­‐	  17.9	  
Sexual	  Orientation	  
Heterosexual	  or	  straight	   7,968	   1,571	   9,516	   19.6	   18.1	  -­‐	  21.2	  
Homosexual	  (gay	  or	  lesbian)	   122	   22	   138	   19.4	   11.9	  -­‐	  27.0	  
Bisexual	   374	   66	   	  	  	  	  	  	  	  	  	  379	   18.2	   13.1	  -­‐	  23.3	  
Not	  Sure	   312	   64	   345	   20.2	   14.7	  -­‐	  25.6	  
Data	  source:	  Maine	  Integrated	  Youth	  Health	  Survey.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  student	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  Percentage	  of	  Maine	  high	  school	  students	  who	  reported	  using	  a	  sunscreen	  with	  a	  SPF	  of	  15	  or	  higher	  ‘Most	  of	  the	  time’	  
or	  ‘Always’	  when	  outside	  on	  a	  sunny	  day	  for	  more	  than	  an	  hour.	  
n:	  Number	  of	  survey	  respondents	  in	  high	  school	  who	  reported	  using	  a	  sunscreen	  with	  a	  SPF	  of	  15	  or	  ‘Most	  of	  the	  time’	  or	  ‘Always’
when	  outside	  on	  a	  sunny	  day	  for	  more	  than	  an	  hour.	  
N:	  Estimated	  number	  of	  Maine	  high	  school	  students	  who	  using	  a	  sunscreen	  with	  a	  SPF	  of	  15	  or	  higher	  ‘Most	  of	  the	  time’	  or	  ‘Always’	  
when	  outside	  on	  a	  sunny	  day	  for	  more	  than	  an	  hour.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
95%	  CI:	  95%	  confidence	  interval.	  
*Non-­‐Hispanic.
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Table	  4.18.	  Homes	  with	  radon	  testing	  of	  indoor	  air	  by	  year,	  Maine,	  2009-­‐2012.	  
Homes	  tested	  for	  radon	   Homes	  with	  elevated	  radon	  levels	   Homes	  with	  elevated	  radon	  levels	  mitigated	  
Year	  
Total	  
Households	   n	   N	   %	   95%	  CI	  
Total	  
Households	   n	   N	   %	   95%	  CI	  
Total	  
Households	   n	   N	   %	   95%	  CI	  
2009	   3,495	   1,030	   174,754	   30.1	   28.5	  -­‐	  31.6	   986	   162	   28,187	   16.9	   14.5-­‐19.4	   148	   111	   19,288	   75.3	   68.0-­‐82.6	  
2010	   3,623	   1,033	   173,981	   29.0	   27.4	  -­‐	  30.5	   976	   138	   24,460	   14.8	   12.5-­‐17.2	   127	   101	   18,614	   82.1	   75.5-­‐88.6	  
Change	  in	  BRFSS	  methods	  
2011	   3,462	   1,028	   144,174	   30.8	   29.2	  -­‐	  32.4	   969	   143	   21,542	   15.8	   13.3-­‐18.3	   135	   97	   14,348	   70.2	   62.0-­‐78.5	  
2012	   3,604	   1,065	   152,499	   31.4	   29.7	  -­‐	  33.1	   1,014	   154	   23,727	   16.3	   13.8-­‐18.9	   145	   112	   17,515	   78.4	   71.6-­‐85.1	  
Data	  source:	  	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System	  (BRFSS).	  
	   	   	  All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  all	  households	  in	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
	   	   	  Definition:	  Percentage	  of	  Maine	  households	  that	  reported	  indoor	  air	  was	  tested	  for	  radon,	  households	  with	  elevated	  radon	  levels,	  and	  households	  with	  elevated	  radon	  levels	  mitigated.	  
n:	  Number	  of	  surveyed	  households	  	  that	  reported	  indoor	  air	  was	  tested	  for	  radon,	  households	  with	  elevated	  radon	  levels,	  and	  households	  with	  elevated	  radon	  levels	  mitigated.	  
N:	  Estimated	  number	  of	  Maine	  households	  that	  reported	  indoor	  air	  was	  tested	  for	  radon,	  households	  with	  elevated	  radon	  levels,	  and	  households	  with	  elevated	  radon	  levels	  mitigated.	  
95%	  CI:	  95%	  confidence	  interval	  
	   	   	   	   	   	   	  Due	  to	  changes	  in	  survey	  methodology,	  data	  collected	  in	  2011	  and	  in	  subsequent	  years	  cannot	  be	  compared	  with	  data	  prior	  to	  2011.	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  Table	  4.19.	  Homes	  with	  radon	  testing	  of	  indoor	  air	  by	  annual	  household	  income,	  Maine,	  2012.	  
	  	   Homes	  tested	  for	  radon	  	   Homes	  with	  elevated	  radon	  levels	  	   Homes	  with	  elevated	  radon	  levels	  mitigated	  
	  
Total	  
Households	   n	   N	   %	   95%	  CI	  
Total	  
Households	   n	   N	   %	   95%	  CI	  
Total	  
Households	   n	   N	   %	   95%	  CI	  
Maine	  Total	   3,604	   1,065	   152,499	   31.4	   29.7	  -­‐	  33.1	   1,014	   154	   23,727	   	  16.3	   13.8	  -­‐	  18.9	   145	   112	   	  	  17,515	   78.4	   71.6	  -­‐	  85.1	  
	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
Income	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
	   Less	  than	  $15,000	   404	   93	   11,388	   24.8	   19.8	  -­‐	  29.8	   80	   14	   1,441
†	   14.8†	   6.1	  -­‐	  23.5†	   DSU	   DSU	   	  	  	  	  	  	  DSU	   DSU	   DSU	  
	   $15,000-­‐24,999	   579	   114	   10,512	   19.1	   15.4	  -­‐	  22.8	   106	   11	   807
†	   8.5†	   2.8	  -­‐	  14.2†	   DSU	   DSU	   	  	  	  	  	  	  DSU	   DSU	   DSU	  
	   $25,000-­‐34,999	   368	   83	   11,443	   23.5	   18.6	  -­‐	  28.4	   77	   15	   2,448
†	   23.6†	   12.4	  -­‐	  34.7†	   DSU	   DSU	   DSU	   DSU	   DSU	  
	   $35,000-­‐49,999	   546	   135	   15,988	   23.5	   19.6	  -­‐	  27.3	   128	   11	   1,476
†	   9.6†	   3.9	  -­‐	  15.6†	   DSU	   DSU	   DSU	   DSU	   DSU	  
	   $50,000	  or	  more	   1,317	   543	   90,220	   42.3	   39.5	  -­‐	  45.2	   533	   88	   15,733	   	  17.8	   14.4	  -­‐	  21.3	   86	   70	   12,611	   82.6	   	  	  	  74.8	  -­‐	  90.4	  
Data	  source:	  	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  
	   	   	   	   	   	   	   	   	   	   	   	  All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  all	  households	  in	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
	   	   	   	   	   	   	  Definition:	  Percentage	  of	  Maine	  households	  that	  reported	  indoor	  air	  was	  tested	  for	  radon,	  households	  with	  elevated	  radon	  levels,	  and	  households	  with	  elevated	  radon	  levels	  mitigated.	  
n:	  Number	  of	  surveyed	  households	  	  that	  reported	  indoor	  air	  was	  tested	  for	  radon,	  households	  with	  elevated	  radon	  levels,	  and	  households	  with	  elevated	  radon	  levels	  mitigated.	  
N:	  Estimated	  number	  of	  Maine	  households	  that	  reported	  indoor	  air	  was	  tested	  for	  radon,	  households	  with	  elevated	  radon	  levels,	  and	  households	  with	  elevated	  radon	  levels	  mitigated.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
95%	  CI:	  95%	  confidence	  interval.	  
DSU:	  Data	  statistically	  unreliable;	  total	  households	  <	  50	  or	  95%	  CI	  half-­‐width	  is	  >	  10.	  
†Use	  with	  caution.	  Estimates	  based	  on	  number	  of	  n<50	  might	  be	  unstable.	  
Due	  to	  changes	  in	  survey	  methodology,	  data	  collected	  in	  2011	  and	  in	  subsequent	  years	  cannot	  be	  compared	  with	  data	  prior	  to	  2011.	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Table	  4.20.	  Homes	  with	  radon	  testing	  of	  household	  indoor	  air	  by	  county	  and	  
public	  health	  district,	  Maine,	  2012.	  
	  
Total	  
Households	   	  	  	  	  	  	  	  	  	  n	   	  	  	  	  	  	  	  	  N	   %	   95%	  CI	  
Maine	  Total	   3,604	   1,065	   152,499	   31.4	    	  29.7	  -­‐	  33.1	  
	   	   	   	   	   	  County	   	   	   	   	   	  
Androscoggin	   218	   50	   8,060	   23.4	   17.2	  -­‐	  29.5	  
Aroostook	   198	   42	   5,641†	   	  21.2†	   15.0	  -­‐	  27.5†	  
Cumberland	   587	   255	   44,164	   44.7	   40.4	  -­‐	  49.1	  
Franklin	   136	   31	   2,566†	   	  23.5†	   15.8	  -­‐	  31.1†	  
Hancock	   157	   43	   6,212†	   	  27.7†	   20.1	  -­‐	  35.2†	  
Kennebec	   269	   79	   12,098	   28.4	   22.6	  -­‐	  34.1	  
Knox	   180	   51	   4,946	   30.7	   22.7	  -­‐	  38.8	  
Lincoln	   178	   68	   5,544	   37.7	   30.1	  -­‐	  45.3	  
Oxford	   164	   45	   6,687†	   	  29.4†	   21.3	  -­‐	  37.5†	  
Penobscot	   302	   65	   10,558	   23.6	   18.1	  -­‐	  29.0	  
Piscataquis	   DSU	   DSU	   DSU	   DSU	   DSU	  
Sagadahoc	   146	   56	   6,243	   39.6	   30.3	  -­‐	  48.9	  
Somerset	   DSU	   DSU	   DSU	   DSU	   DSU	  
Waldo	   180	   48	   4,411	   27.8	   20.6	  -­‐	  35.0	  
Washington	   DSU	   DSU	   DSU	   DSU	   DSU	  
York	   411	   139	   23,636	   36.3	   31.2	  -­‐	  41.3	  
Public	  Health	  District	   	   	   	   	   	  
Aroostook	   198	   42	   5,641†	   	  21.2†	   15.0	  -­‐	  27.5†	  
Central	   405	   104	   16,349	   26.2	   21.5	  -­‐	  30.9	  
Cumberland	   587	   255	   44,164	   44.7	   40.4	  -­‐	  49.1	  
Downeast	   330	   72	   8,607	   23.1	   18.0	  -­‐	  28.2	  
Midcoast	   684	   223	   21,145	   33.9	   29.8	  -­‐	  37.9	  
Penquis	   400	   86	   12,219	   23.1	   18.3	  -­‐	  27.8	  
Western	   518	   126	   17,313	   25.4	   21.1	  -­‐	  29.7	  
York	   411	   139	   23,636	   36.3	   31.2	  -­‐	  41.3	  
Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  all	  households	  in	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  Percentage	  of	  Maine	  households	  that	  reported	  indoor	  air	  was	  tested	  for	  radon.	  
n:	  Number	  of	  surveyed	  households	  	  that	  reported	  indoor	  air	  was	  tested	  for	  radon.	  
N:	  Estimated	  number	  of	  Maine	  households	  that	  reported	  indoor	  air	  was	  tested	  for	  radon.	  
95%	  CI:	  95%	  confidence	  interval.	  
DSU:	  Data	  statistically	  unreliable;	  total	  households	  <	  50	  or	  95%	  CI	  half-­‐width	  is	  >	  10.	  
†Use	  with	  caution.	  Estimates	  based	  on	  n<50	  might	  be	  unstable.	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  Table	  5.1.	  Breast	  cancer	  screening	  rates	  by	  year,	  Maine	  and	  U.S.,	  2002-­‐2012.	  
	   	   	   	   	   	   	  	  	   Maine	  	   	  	   U.S.	  Median*	  
	  	   	  Ages	  ≥40	  years	  
	  
Ages	  ≥50	  years	  
	  
	  Ages	  ≥40	  years	  
	  
	  Ages	  ≥50	  years	  
Year	  
Total	  
Respondents	   n	   N	   %	   95%	  CI	  
	  
Total	  
Respondents	   n	   N	   %	   95%	  CI	  
	  
Number	  
of	  States	   %	  
	  
Number	  
of	  States	   %	  
2002	   1,008	   823	   266,421	  	   82.1	   79.6-­‐84.7	   	   684	   577	  	   187,761	  	   84.7	   81.8-­‐87.6	   	   51	   76.1	   	   51	   79.7	  
2004	   1,549	   1,254	   281,988	  	   81.8	   79.7-­‐84.0	   	   1,097	   919	  	   197,438	  	   84.7	   82.3-­‐87.1	   	   50	   74.9	   	   50	   78.1	  
2006	   1,861	   1,523	   289,158	  	   81.8	   79.9-­‐83.8	   	   1,370	   1,153	  	   208,599	  	   84.3	   82.1-­‐86.5	   	   51	   76.5	   	   51	   80.0	  
2008	   3,334	   2,778	   299,547	  	   83.3	   81.8-­‐84.8	   	   2,667	   2,252	  	   220,155	  	   85.1	   83.6-­‐86.6	   	   51	   76.0	   	   51	   79.5	  
2010	   4,159	   3,379	   293,840	  	   80.6	   79.1-­‐82.0	   	   3,374	   2,799	  	   222,269	  	   83.6	   82.1-­‐85.0	   	   51	   75.2	   	   51	   77.9	  
Change	  in	  BRFSS	  methods	  
2012	   4,625	  	   3,670	   297,219	   79.6	   78.2-­‐81.0	   	  	   3,789	   3,078	   229,676	   82.1	   80.7-­‐83.6	   	  	   51	   74.0	   	  	   51	   77.0	  
Data	  source:	  	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System	  (BRFSS).	  
	   	   	   	   	   	   	   	   	   	   	   	  All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
	   	   	   	   	   	   	  Definition:	  	  Percentage	  of	  Maine	  and	  U.S.	  females	  who	  reported	  they	  have	  had	  a	  mammogram	  within	  the	  past	  2	  years.	  
	   	   	   	   	   	   	   	  n:	  	  Number	  of	  females	  survey	  respondents	  (ages	  40	  years	  and	  older	  and	  50	  years	  and	  older)	  who	  reported	  they	  have	  had	  a	  mammogram	  within	  the	  past	  2	  years.	  
	   	   	   	  N:	  Estimated	  number	  of	  Maine	  females	  (ages	  40	  years	  and	  older	  and	  50	  years	  and	  older)	  who	  reported	  they	  have	  had	  a	  mammogram	  within	  the	  past	  2	  years.	  	  
	   	   	   	  95%	  CI:	  95%	  confidence	  interval	  
	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  *U.S.	  median	  estimates	  include	  all	  50	  states	  and	  the	  District	  of	  Columbia.	  
	   	   	   	   	   	   	   	   	   	   	   	  Due	  to	  changes	  in	  survey	  methodology,	  data	  collected	  in	  2011	  and	  in	  subsequent	  years	  cannot be	  compared	  with	  data	  prior	  to	  2011.	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Table	  5.2.	  Females	  ages	  40	  years	  and	  older	  who	  had	  a	  mammogram	  within	  
the	  past	  2	  years	  by	  selected	  demographics,	  Maine,	  2012.	  
	  
Total	  
Respondents	   n	   	  	  	  	  	  	  	  	  	  	  N	   %	   	  	  	  	  	  	  	  95%	  CI	  
Maine	  Total	   4,625 	   3,670 	   297,219 	   79.6 	   78.2	  -­‐	  81.0 	  
	   	   	   	   	   	  Age	   	   	   	   	   	  
40-­‐49	   836 	   592 	   67,543 	   71.9 	   68.4	  -­‐	  75.5 	  
50-­‐64	   1,895 	   1,572 	   129,098 	   83.3 	   81.3	  -­‐	  85.3 	  
65-­‐74	   	  	  	  	  	  	  	  1,078	   	  	  	  	  	  	  	  	  	  	  903	   	  	  	  	  	  55,396	   	  	  	  	  	  	  	  	  84.4	   	  	  	  	  81.8	  -­‐	  87.1	  
75	  and	  older	   	  	  	  	  	  	  	  	  	  	  	  816	   	  	  	  	  	  	  	  	  	  	  603	   	  	  	  	  	  45,182	   76.5 	   73.0	  -­‐	  80.1 	  
Education	   	   	   	   	   	  
Less	  than	  high	  school	  diploma	   241 	   176 	   24,078 	   71.9 	   65.2	  -­‐	  78.7 	  
High	  school	  diploma	  or	  GED	   1,458 	   1,144 	   99,329 	   79.6 	   77.1	  -­‐	  82.0 	  
Some	  college	   1,265 	   1,005 	   94,054 	   80.6 	   78.0	  -­‐	  83.1 	  
Bachelor's	  degree	  or	  higher	   1,655 	   1,341 	   79,442 	   81.0 	   78.8	  -­‐	  83.3 	  
Income	   	   	   	   	   	  
Less	  than	  $15,000	   624 	   447 	   30,103 	   72.3 	   67.7	  -­‐	  76.9 	  
$15,000-­‐24,999	   846 	   630 	   48,364 	   75.1 	   71.4	  -­‐	  78.8 	  
$25,000-­‐34,999	   460 	   361 	   28,622 	   74.8 	   69.8	  -­‐	  79.8 	  
$35,000-­‐49,999	   625 	   524 	   43,435 	   82.8 	   79.0	  -­‐	  86.6 	  
$50,000	  or	  more	   1,518 	   1,275 	   110,696 	   83.9 	   81.7	  -­‐	  86.0 	  
Sexual	  Orientation	   	   	   	   	   	  
Heterosexual	  or	  straight	   4,376 	   3,479 	   282,331 	   79.6 	   78.2	  -­‐	  81.1 	  
Homosexual	  (gay	  or	  lesbian)	   DSU	   DSU	   DSU	   DSU	   DSU	  
Bisexual	   DSU	   DSU	   DSU	   DSU	   DSU	  
Other	   DSU	   DSU	   DSU	   DSU	   DSU	  
Type	  of	  Health	  Insurance	  Coverage	   	   	   	   	   	  
Private	   2,084 	   1,737 	   153,128 	   83.4 	   81.5	  -­‐	  85.3 	  
Medicare	   1,476 	   1,184 	   81,274 	   81.5 	   79.0	  -­‐	  83.9 	  
Medicaid	  or	  MaineCare	   368 	   282 	   24,088 	   78.5 	   73.4	  -­‐	  83.5 	  
Other	   249 	   202 	   17,771 	   82.5 	   77.1	  -­‐	  87.9 	  
Uninsured	   DSU	   DSU	   DSU	   DSU	   DSU	  
Mental	  Health	  Status	   	   	   	   	   	  
Current	  depression	   	   	   	   	   	  
Yes	   314 	   217 	   20,035 	   66.3 	   59.5	  -­‐	  73.1 	  
No	   3,807 	   3,087 	   271,272 	   80.6 	   79.1	  -­‐	  82.1 	  
Lifetime	  depression	  or	  anxiety	   	   	   	   	   	  
Yes	   1,351 	   1,054 	   97,192 	   75.6 	   72.7	  -­‐	  78.5 	  
No	   2,765 	   2,246 	   194,095 	   81.5 	   79.7	  -­‐	  83.2 	  
Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  Percentage	  of	  Maine	  females	  ages	  40	  years	  and	  older	  who	  reported	  they	  had	  a	  mammogram	  within	  the	  past	  2	  years.	  
n:	  Number	  of	  female	  survey	  respondents	  who	  reported	  that	  they	  had	  a	  mammogram	  within	  the	  past	  2	  years.	  
N:	  Estimated	  number	  of	  Maine	  females	  ages	  40	  years	  and	  older	  who	  reported	  they	  had	  a	  mammogram	  within	  the	  past	  2	  years.	  	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
95%	  CI:	  95%	  confidence	  interval.	  
DSU:	  Data	  statistically	  unreliable;	  total	  respondents	  <	  50	  or	  95%	  CI	  half-­‐width	  is	  >	  10.	  
Current	  depression	  =	  Self-­‐reported	  symptoms	  of	  current	  depression	  based	  on	  PHQ-­‐2	  depression	  scale.	  
Lifetime	  depression	  or	  anxiety	  =	  Current	  depression	  or	  any	  lifetime	  diagnosis	  of	  depression	  or	  anxiety.	  
Due	  to	  changes	  in	  survey	  methodology,	  data	  collected	  in	  2011	  and	  in	  subsequent	  years	  cannot	  be	  compared	  with	  data	  prior	  to	  
2011.	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Table	  5.3.	  Females	  ages	  40	  years	  and	  older	  who	  had	  a	  mammogram	  within	  
the	  past	  2	  years	  by	  race	  and	  ethnicity,	  Maine,	  2012.	  
	  
Total	  
Respondents	   n	   	  	  	  	  	  	  	  	  	  	  N	   %	   	  	  	  	  	  	  	  	  	  95%	  CI	  
Maine	  Total	   4,625 	   3,670 	   297,219 	   79.6 	   78.2	  -­‐	  81.0 	  
	   	   	   	   	   	  Race	   	   	   	   	   	  
White	   4,425 	   3,523 	   285,489 	   79.8 	   78.4	  -­‐	  81.3 	  
Black	  or	  African	  American	   DSU	   DSU	   DSU	   DSU	   DSU	  
American	  Indian	  or	  Alaska	  Native	   DSU	   DSU	   DSU	   DSU	   DSU	  
Asian	  or	  Pacific	  Islander	   DSU	   DSU	   DSU	   DSU	   DSU	  
Two	  or	  More	  Races	   DSU	   DSU	   DSU	   DSU	   DSU	  
Other	  Race	   DSU	   DSU	   DSU	   DSU	   DSU	  
Ethnicity	   	   	   	   	   	  
Non-­‐Hispanic	   4,539 	   3,609 	   292,060 	   79.6 	   78.2	  -­‐	  81.0 	  
Hispanic	   DSU	   DSU	   DSU	   DSU	   DSU	  
Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  Percentage	  of	  Maine	  females	  ages	  40	  years	  and	  older	  who	  reported	  they	  had	  a	  mammogram	  within	  the	  past	  2	  years.	  
n:	  Number	  of	  female	  survey	  respondents	  who	  reported	  that	  they	  had	  a	  mammogram	  within	  the	  past	  2	  years.	  
N:	  Estimated	  number	  of	  Maine	  females	  ages	  40	  years	  and	  older	  who	  reported	  they	  had	  a	  mammogram	  within	  the	  past	  2	  years.	  	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
95%	  CI:	  95%	  confidence	  interval.	  
DSU:	  Data	  statistically	  unreliable;	  total	  respondents	  <	  50	  or	  95%	  CI	  half-­‐width	  is	  >	  10.	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Table	  5.4.	  Females	  ages	  40	  years	  and	  older	  who	  had	  a	  mammogram	  within	  
the	  past	  2	  years	  by	  county	  and	  public	  health	  district,	  Maine,	  2012.	  
	  
Total	  
Respondents	   n	   	  	  	  	  	  	  	  	  	  	  N	   %	   	  	  	  	  	  	  	  	  95%	  CI	  
Maine	  Total	   4,625 	   3,670 	   297,219 	   79.6 	   78.2	  -­‐	  81.0 	  
	   	   	   	   	   	  County	   	   	   	   	   	  
Androscoggin	   319 	   260 	   26,102 	   82.4 	   77.6	  -­‐	  87.3 	  
Aroostook	   269 	   225 	   20,581 	   81.2 	   75.2	  -­‐	  87.3 	  
Cumberland	   771 	   622 	   55,796 	   81.1 	   77.9	  -­‐	  84.3 	  
Franklin	   157 	   118 	   6,147 	   74.7 	   66.5	  -­‐	  82.9 	  
Hancock	   191 	   152 	   11,003 	   77.9 	   70.6	  -­‐	  85.2 	  
Kennebec	   364 	   295 	   27,175 	   80.8 	   76.0	  -­‐	  85.7 	  
Knox	   241 	   184 	   8,614 	   73.0 	   65.6	  -­‐	  80.3 	  
Lincoln	   236 	   177 	   8,466 	   73.1 	   65.9	  -­‐	  80.4 	  
Oxford	   196 	   148 	   13,700 	   72.2 	   64.7	  -­‐	  79.7 	  
Penobscot	   400 	   325 	   31,993 	   83.0 	   78.7	  -­‐	  87.3 	  
Piscataquis	   111 	   91 	   5,585 	   82.5 	   74.2	  -­‐	  90.8 	  
Sagadahoc	   187 	   147 	   8,955 	   79.4 	   72.1	  -­‐	  86.8 	  
Somerset	   155 	   123 	   11,828 	   82.5 	   76.1	  -­‐	  88.8 	  
Waldo	   207 	   154 	   8,038 	   70.0 	   61.1	  -­‐	  79.0 	  
Washington	   203 	   149 	   7,360 	   67.6 	   58.9	  -­‐	  76.3 	  
York	   537 	   437 	   40,079 	   82.2 	   78.4	  -­‐	  86.0 	  
Public	  Health	  District	   	   	   	   	   	  
Aroostook	   269 	   225 	   20,581 	   81.2 	   75.2	  -­‐	  87.3 	  
Central	  	   519 	   418 	   39,004 	   81.3 	   77.4	  -­‐	  85.2 	  
Cumberland	   771 	   622 	   55,796 	   81.1 	   77.9	  -­‐	  84.3 	  
Downeast	   394 	   301 	   18,363 	   73.4 	   67.8	  -­‐	  79.1 	  
Midcoast	   871 	   662 	   34,073 	   73.9 	   70.0	  -­‐	  77.8 	  
Penquis	   511 	   416 	   37,578 	   82.9 	   79.1	  -­‐	  86.8 	  
Western	  	   672 	   526 	   45,949 	   78.1 	   74.3	  -­‐	  81.8 	  
York	   537 	   437 	   40,079 	   82.2 	   78.4	  -­‐	  86.0 	  
Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  Percentage	  of	  Maine	  females	  ages	  40	  years	  and	  older	  who	  reported	  they	  had	  a	  mammogram	  within	  the	  past	  2	  years.	  
n:	  Number	  of	  female	  survey	  respondents	  who	  reported	  that	  they	  had	  a	  mammogram	  within	  the	  past	  2	  years.	  
N:	  Estimated	  number	  of	  Maine	  females	  ages	  40	  years	  and	  older	  who	  reported	  they	  had	  a	  mammogram	  within	  the	  past	  2	  years.	  	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
95%	  CI:	  95%	  confidence	  interval.	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Table	  5.5.	  Females	  ages	  50	  years	  and	  older	  who	  had	  a	  mammogram	  within	  
the	  past	  2	  years	  by	  selected	  demographics,	  Maine,	  2012.	  
	  
Total	  
Respondents	   n	   N	   %	   95%	  CI	  
Maine	  Total	   3,789 	   3,078 	   229,676 	   82.1 	   80.7	  -­‐	  83.6 	  
	   	   	   	   	   	  Age	   	   	   	   	   	  
50-­‐64	   1,895 	   1,572 	   129,098 	   83.3 	   81.3	  -­‐	  85.3 	  
65-­‐74	   1,078 	   903 	   55,396 	   84.4 	   81.8	  -­‐	  87.1 	  
75	  and	  older	   816 	   603 	   45,182 	   76.5 	   73.0	  -­‐	  80.1 	  
Education	   	   	   	   	   	  
Less	  than	  high	  school	  diploma	   223 	   166 	   21,600 	   73.5 	   66.6	  -­‐	  80.4 	  
High	  school	  diploma	  or	  GED	   1,217 	   980 	   77,940 	   82.8 	   80.4	  -­‐	  85.2 	  
Some	  college	   1,013 	   819 	   69,440 	   82.3 	   79.6	  -­‐	  85.0 	  
Bachelor's	  degree	  or	  higher	   1,330 	   1,109 	   60,380 	   84.5 	   82.3	  -­‐	  86.7 	  
Income	   	   	   	   	   	  
Less	  than	  $15,000	   543 	   398 	   24,865 	   74.0 	   69.2	  -­‐	  78.7 	  
$15,000-­‐24,999	   731 	   563 	   40,515 	   78.9 	   75.4	  -­‐	  82.5 	  
$25,000-­‐34,999	   394 	   319 	   23,658 	   77.8 	   72.6	  -­‐	  83.0 	  
$35,000-­‐49,999	   505 	   431 	   33,224 	   86.3 	   82.8	  -­‐	  89.9 	  
$50,000	  or	  more	   1,114 	   971 	   76,060 	   87.3 	   85.0	  -­‐	  89.7 	  
Sexual	  Orientation	   	   	   	   	   	  
Heterosexual	  or	  straight	   3,584 	   2,916 	   218,375 	   82.2 	   80.7	  -­‐	  83.7 	  
Homosexual	  (gay	  or	  lesbian)	   DSU	   DSU	   DSU	   DSU	   DSU	  
Bisexual	   DSU	   DSU	   DSU	   DSU	   DSU	  
Other	   DSU	   DSU	   DSU	   DSU	   DSU	  
Type	  of	  Health	  Insurance	  Coverage	   	   	   	   	   	  
Private	   1,528 	   1,314 	   104,715 	   86.5 	   84.5	  -­‐	  88.6 	  
Medicare	   1,445 	   1,162 	   78,764 	   81.8 	   79.3	  -­‐	  84.2 	  
Medicaid	  or	  MaineCare	   253 	   204 	   14,623 	   81.9 	   76.0	  -­‐	  87.7 	  
Other	   209 	   175 	   14,834 	   84.9 	   79.4	  -­‐	  90.5 	  
Uninsured	   DSU	   DSU	   DSU	   DSU	   DSU	  
Mental	  Health	  Status	   	   	   	   	   	  
Current	  depression	   	   	   	   	   	  
Yes	   255 	   183 	   15,005 	   69.7 	   62.4	  -­‐	  77.0 	  
No	   3,218 	   2,662 	   211,310 	   83.3 	   81.8	  -­‐	  84.8 	  
Lifetime	  depression	  or	  anxiety	   	   	   	   	   	  
Yes	   1,102 	   890 	   72,720 	   79.0 	   75.9	  -­‐	  82.0 	  
No	   2,366 	   1,951 	   153,460 	   83.9 	   82.3	  -­‐	  85.6 	  
Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  Percentage	  of	  Maine	  females	  ages	  50	  years	  and	  older	  who	  reported	  they	  had	  a	  mammogram	  within	  the	  past	  2	  years.	  
n:	  Number	  of	  female	  survey	  respondents	  who	  reported	  that	  they	  had	  a	  mammogram	  within	  the	  past	  2	  years.	  
N:	  Estimated	  number	  of	  Maine	  females	  ages	  50	  years	  and	  older	  who	  reported	  they	  had	  a	  mammogram	  within	  the	  past	  2	  years.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
95%	  CI:	  95%	  confidence	  interval.	  
DSU:	  Data	  statistically	  unreliable;	  total	  respondents	  <	  50	  or	  95%	  CI	  half-­‐width	  is	  >	  10.	  
Current	  depression	  =	  Self-­‐reported	  symptoms	  of	  current	  depression	  based	  on	  PHQ-­‐2	  depression	  scale.	  
Lifetime	  depression	  or	  anxiety	  =	  Current	  depression	  or	  any	  lifetime	  diagnosis	  of	  depression	  or	  anxiety.	  
Due	  to	  changes	  in	  survey	  methodology,	  data	  collected	  in	  2011	  and	  in	  subsequent	  years	  cannot	  be	  compared	  with	  data	  prior	  to	  
2011.	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Table	  5.6.	  Females	  ages	  50	  years	  and	  older	  who	  had	  a	  mammogram	  within	  
the	  past	  2	  years	  by	  race	  and	  ethnicity,	  Maine,	  2012.	  
	  
Total	  
Respondents	   n	   N	   %	   95%	  CI	  
Maine	  Total	   3,789 	   3,078 	   229,676 	   82.1 	   80.7	  -­‐	  83.6 	  
	   	   	   	   	   	  Race	   	   	   	   	   	  
White	   3,629 	   2,955 	   220,352 	   82.2 	   80.7	  -­‐	  83.7 	  
Black	  or	  African	  American	   DSU	   DSU	   DSU	   DSU	   DSU	  
American	  Indian	  or	  Alaska	  Native	   DSU	   DSU	   DSU	   DSU	   DSU	  
Asian	  or	  Pacific	  Islander	   DSU	   DSU	   DSU	   DSU	   DSU	  
Two	  or	  More	  Races	   DSU	   DSU	   DSU	   DSU	   DSU	  
Other	  Race	   DSU	   DSU	   DSU	   DSU	   DSU	  
Ethnicity	   	   	   	   	   	  
Non-­‐Hispanic	   3,714 	   3,025 	   225,373 	   82.2 	   80.7	  -­‐	  83.7 	  
Hispanic	   DSU	   DSU	   DSU	   DSU	   DSU	  
Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐
response.	  
Definition:	  Percentage	  of	  Maine	  females	  ages	  50	  years	  and	  older	  who	  reported	  they	  had	  a	  mammogram	  within	  the	  past	  2	  years.	  
n:	  Number	  of	  female	  survey	  respondents	  who	  reported	  that	  they	  had	  a	  mammogram	  within	  the	  past	  2	  years.	  
N:	  Estimated	  number	  of	  Maine	  females	  ages	  50	  years	  and	  older	  who	  reported	  they	  had	  a	  mammogram	  within	  the	  past	  2	  years.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
95%	  CI:	  95%	  confidence	  interval.	  
DSU:	  Data	  statistically	  unreliable;	  total	  respondents	  <	  50	  or	  95%	  CI	  half-­‐width	  is	  >	  10.	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Table	  5.7.	  Females	  ages	  50	  years	  and	  older	  who	  had	  a	  mammogram	  within	  
the	  past	  2	  years	  by	  county	  and	  public	  health	  district,	  Maine,	  2012.	  
	  
Total	  
Respondents	   n	   N	   %	   	  	  	  	  	  	  	  95%	  CI	  
Maine	  Total	   3,789 	   3,078 	   229,676 	   82.1 	   80.7	  -­‐	  83.6 	  
	   	   	   	   	   	  County	   	   	   	   	   	  
Androscoggin	   246 	   201 	   18,115 	   82.3 	   76.7	  -­‐	  87.9 	  
Aroostook	   230 	   198 	   17,053 	   85.3 	   79.7	  -­‐	  90.9 	  
Cumberland	   615 	   504 	   42,426 	   83.1 	   79.6	  -­‐	  86.6 	  
Franklin	   130 	   104 	   5,343 	   81.4 	   73.6	  -­‐	  89.2 	  
Hancock	   163 	   133 	   8,974 	   82.9 	   76.7	  -­‐	  89.2 	  
Kennebec	   281 	   236 	   19,184 	   82.9 	   77.4	  -­‐	  88.5 	  
Knox	   211 	   170 	   7,673 	   78.4 	   71.3	  -­‐	  85.4 	  
Lincoln	   206 	   161 	   7,261 	   78.9 	   72.4	  -­‐	  85.3 	  
Oxford	   151 	   122 	   10,305 	   81.1 	   73.8	  -­‐	  88.3 	  
Penobscot	   327 	   268 	   24,906 	   85.4 	   81.3	  -­‐	  89.5 	  
Piscataquis	   87 	   73 	   4,235 	   84.8 	   76.0	  -­‐	  93.6 	  
Sagadahoc	   151 	   123 	   6,785 	   84.9 	   78.2	  -­‐	  91.5 	  
Somerset	   126 	   101 	   9,111 	   82.8 	   75.7	  -­‐	  89.9 	  
Waldo	   183 	   140 	   6,913 	   71.7 	   61.9	  -­‐	  81.5 	  
Washington	   157 	   117 	   5,363 	   70.0 	   60.2	  -­‐	  79.8 	  
York	   454 	   372 	   31,409 	   82.0 	   77.8	  -­‐	  86.3 	  
Public	  Health	  District	   	   	   	   	   	  
Aroostook	   230 	   198 	   17,053 	   85.3 	   79.7	  -­‐	  90.9 	  
Central	  	   407 	   337 	   28,295 	   82.9 	   78.5	  -­‐	  87.3 	  
Cumberland	   615 	   504 	   42,426 	   83.1 	   79.6	  -­‐	  86.6 	  
Downeast	   320 	   250 	   14,337 	   77.6 	   72.0	  -­‐	  83.2 	  
Midcoast	   751 	   594 	   28,631 	   78.2 	   74.2	  -­‐	  82.1 	  
Penquis	   414 	   341 	   29,142 	   85.3 	   81.5	  -­‐	  89.1 	  
Western	  	   527 	   427 	   33,762 	   81.8 	   77.9	  -­‐	  85.7 	  
York	   454 	   372 	   31,409 	   82.0 	   77.8	  -­‐	  86.3 	  
Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  Percentage	  of	  Maine	  females	  ages	  50	  years	  and	  older	  who	  reported	  they	  had	  a	  mammogram	  within	  the	  past	  2	  years.	  
n:	  Number	  of	  female	  survey	  respondents	  who	  reported	  that	  they	  had	  a	  mammogram	  within	  the	  past	  2	  years.	  
N:	  Estimated	  number	  of	  Maine	  females	  ages	  50	  years	  and	  older	  who	  reported	  they	  had	  a	  mammogram	  within	  the	  past	  2	  years.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
95%	  CI:	  95%	  confidence	  interval.	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 Table 5.8. Screening rates for cervical and colorectal cancer by year, Maine, 2002-2012. 
  Had a Pap test within the past 3 years    Up-to-date colorectal cancer screening 
Year 
Total 
Respondents n N % 95% CI 
 
Total 
Respondents n N % 95% CI 
2002 947 885 311,694 94.0 92.4-95.6  NA NA NA NA NA 
2004 1,281 1,195 313,712 93.6 92.0-95.2  NA NA NA NA NA 
2006 1,462 1,337 316,604 92.2 90.6-93.8  NA NA NA NA NA 
2008 2,212 2,017 307,931 91.9 90.6-93.3  4,247 3,050  339,756  72.1 70.5-73.6 
2009 NA NA NA NA NA  2,594 1,880  345,629  73.2 71.2-75.2 
2010 2,581 2,335 300,552 92.1 90.9-93.2  5,366 3,929  352,336  72.8 71.4-74.2 
Change in BRFSS methods 
2012 3,019  2,658 282,477 88.0 86.5-89.5   6,199 4,531 368,937 72.2 70.9-73.6 
Data source:  Maine Behavioral Risk Factor Surveillance System (BRFSS). 
All percentages are weighted to be more representative of the general adult population of Maine and to adjust for non-response. 
Definition:  Cervical cancer = Percentage of Maine females ages 21-65 years with an intact cervix who reported they have had a Pap test within the past 3 
years; Up-to-date with colorectal cancer screening = Percentage of Maine adults ages 50 years and over who reported that they had a home blood stool 
test (e.g., FOBT or FIT) within the past year OR sigmoidoscopy within the past 5 years and a home stool test OR colonoscopy within the past 10 years. 
n:  Number of female survey respondents ages 21-65 years with an intact cervix who reported they have had a Pap test within the past 3 years (cervical 
cancer) or the number of survey respondents who reported that they were up-to-date with colorectal cancer screening (colorectal cancer). 
N:  Estimated number of Maine females ages 21-65 years with an intact cervix who reported they have had a Pap test within the past 3 years (cervical 
cancer) or the estimated number of Maine adults who reported that they were up-to-date with colorectal cancer screening (colorectal cancer). 
95% CI: 95% confidence interval 
NA: Not available 
Due to changes in survey methodology, data collected in 2011 and in subsequent years cannot be compared with data prior to 2011.  
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Table	  5.9.	  Females	  ages	  21-­‐65	  years	  who	  had	  a	  Pap	  test	  within	  the	  past	  3	  
years	  by	  selected	  demographics,	  Maine,	  2012.	  
	  
Total	  
respondents	   n	   N	   %	   	  	  	  	  	  	  95%	  CI	  
Maine	  Total	   3,019 	   2,658 	   282,477 	   88.0 	   86.5	  -­‐	  89.5 	  
	   	   	   	   	   	  Age	   	   	   	   	   	  
21-­‐39	   839 	   759 	   113,141 	   88.6 	   85.8	  -­‐	  91.4 	  
40-­‐54	   1,148 	   1,034 	   106,368 	   89.4 	   87.2	  -­‐	  91.6 	  
55	  and	  over	   1,032 	   865 	   62,968 	   84.6 	   82.0	  -­‐	  87.3 	  
Education	   	   	   	   	   	  
Less	  than	  high	  school	  diploma	   81 	   65 	   15,017 	   81.4 	   71.8	  -­‐	  91.0 	  
High	  school	  diploma	  or	  GED	   758 	   634 	   76,764 	   84.3 	   81.2	  -­‐	  87.4 	  
Some	  college	   837 	   729 	   91,684 	   87.2 	   84.3	  -­‐	  90.1 	  
Bachelor's	  degree	  or	  higher	   1,341 	   1,228 	   98,815 	   93.0 	   91.4	  -­‐	  94.6 	  
Income	   	   	   	   	   	  
Less	  than	  $15,000	   309 	   246 	   25,412 	   80.7 	   74.8	  -­‐	  86.7 	  
$15,000-­‐24,999	   442 	   364 	   41,635 	   82.6 	   78.1	  -­‐	  87.1 	  
$25,000-­‐34,999	   268 	   230 	   26,274 	   86.7 	   81.8	  -­‐	  91.5 	  
$35,000-­‐49,999	   425 	   377 	   38,711 	   89.0 	   85.4	  -­‐	  92.6 	  
$50,000	  or	  more	   1,328 	   1,232 	   125,714 	   92.5 	   90.6	  -­‐	  94.4 	  
Sexual	  Orientation	   	   	   	   	   	  
Heterosexual	  or	  straight	   2,855 	   2,527 	   268,354 	   88.6 	   87.1	  -­‐	  90.1 	  
Homosexual	  (gay	  or	  lesbian)	   DSU	   DSU	   DSU	   DSU	   DSU	  
Bisexual	   DSU	   DSU	   DSU	   DSU	   DSU	  
Other	   DSU	   DSU	   DSU	   DSU	   DSU	  
Type	  of	  Health	  Insurance	  Coverage	   	   	   	   	   	  
Private	   1,927 	   1,773 	   179,576 	   91.3 	   89.5	  -­‐	  93.0 	  
Medicare	   183 	   156 	   12,626 	   85.9 	   79.1	  -­‐	  92.7 	  
Medicaid	  or	  MaineCare	   384 	   330 	   45,295 	   87.8 	   84.0	  -­‐	  91.6 	  
Other	   150 	   131 	   14,461 	   88.7 	   82.2	  -­‐	  95.2 	  
Uninsured	   DSU	   DSU	   DSU	   DSU	   DSU	  
Mental	  Health	  Status	   	   	   	   	   	  
Current	  depression	   	   	   	   	   	  
Yes	   186 	   148 	   24,785 	   78.0 	   68.3	  -­‐	  87.8 	  
No	   2,131 	   1,886 	   255,745 	   87.4 	   85.2	  -­‐	  89.6 	  
Lifetime	  depression	  or	  anxiety	   	   	   	   	   	  
Yes	   821 	   711 	   101,617 	   84.6 	   80.7	  -­‐	  88.4 	  
No	   1,496 	   1,323 	   178,906 	   87.6 	   84.9	  -­‐	  90.2 	  
Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  
Definition:	  Percentage	  of	  Maine	  females	  ages	  21-­‐65	  years	  with	  an	  intact	  cervix	  who	  have	  had	  a	  Pap	  test	  within	  the	  past	  3	  years.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐
response.	  
n:	  Number	  of	  female	  survey	  respondents	  ages	  21-­‐65	  years	  with	  an	  intact	  cervix	  who	  reported	  that	  they	  had	  a	  Pap	  test	  within	  
the	  past	  3	  years.	  
N:	  Estimated	  number	  of	  Maine	  females	  ages	  21-­‐65	  years	  with	  an	  intact	  cervix	  who	  had	  a	  Pap	  test	  within	  the	  past	  3	  years.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
95%	  CI:	  95%	  confidence	  interval.	  
DSU:	  Data	  statistically	  unreliable;	  unweighted	  denominator	  is	  <	  50	  or	  95%	  CI	  half-­‐width	  is	  >	  10.	  
†Use	  with	  caution.	  Estimates	  based	  on	  n<50	  might	  be	  unstable.	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Table	  5.10.	  Females	  ages	  21-­‐65	  years	  who	  had	  a	  Pap	  test	  within	  the	  past	  3	  
years	  by	  race	  and	  ethnicity,	  Maine,	  2012.	  
	  
Total	  
Respondents	   n	   	  	  	  	  	  	  	  	  	  	  N	   %	   	  	  	  	  	  	  	  	  95%	  CI	  
Maine	  Total	   3,019 	   2,658 	   282,477 	   88.0 	   86.5	  -­‐	  89.5 	  
	   	   	   	   	   	  Race	   	   	   	   	   	  
White	   2,892 	   2,555 	   269,513 	   88.7 	   87.3	  -­‐	  90.1 	  
Black	  or	  African	  American	   DSU	   DSU	   DSU	   DSU	   DSU	  
American	  Indian	  or	  Alaska	  Native	   DSU	   DSU	   DSU	   DSU	   DSU	  
Asian	  or	  Pacific	  Islander	   DSU	   DSU	   DSU	   DSU	   DSU	  
Two	  or	  More	  Races	   DSU	   DSU	   DSU	   DSU	   DSU	  
Other	  Race	   DSU	   DSU	   DSU	   DSU	   DSU	  
Ethnicity	   	   	   	   	   	  
Non-­‐Hispanic	   2,980 	   2,626 	   278,536 	   88.0 	   86.5	  -­‐	  89.5 	  
Hispanic	   DSU	   DSU	   DSU	   DSU	   DSU	  
Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  Percentage	  of	  Maine	  females	  ages	  21-­‐65	  years	  with	  an	  intact	  cervix	  who	  had	  a	  Pap	  test	  within	  the	  past	  3	  years.	  
n:	  Number	  of	  female	  survey	  respondents	  ages	  21-­‐65	  years	  with	  an	  intact	  cervix	  who	  reported	  that	  they	  had	  a	  Pap	  test	  within	  
the	  past	  3	  years.	  
N:	  Estimated	  number	  of	  Maine	  females	  ages	  21-­‐65	  years	  with	  an	  intact	  cervix	  who	  had	  a	  Pap	  test	  within	  the	  past	  3	  years.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
95%	  CI:	  95%	  confidence	  interval.	  
DSU:	  Data	  statistically	  unreliable;	  total	  respondents	  <	  50	  or	  95%	  CI	  half-­‐width	  is	  >	  10.	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Table	  5.11.	  Females	  ages	  21-­‐65	  years	  who	  had	  a	  Pap	  test	  within	  the	  past	  3	  
years	  by	  county	  and	  public	  health	  district,	  Maine,	  2012.	  
	  
Total	  
Respondents	   n	   N	   %	   	  	  	  	  	  	  	  	  95%	  CI	  
Maine	  Total	   3,019 	   2,658 	   282,477 	   88.0 	   86.5	  -­‐	  89.5 	  
	   	   	   	   	   	  County	   	   	   	   	   	  
Androscoggin	   236 	   220 	   30,020 	   94.3 	   90.9	  -­‐	  97.6 	  
Aroostook	   153 	   134 	   15,839 	   89.4 	   84.0	  -­‐	  94.7 	  
Cumberland	   536 	   494 	   54,166 	   91.6 	   88.6	  -­‐	  94.6 	  
Franklin	   DSU	   DSU	   	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  	  DSU	   DSU	  
Hancock	   121 	   100 	   9,757 	   79.0 	   70.0	  -­‐	  87.9 	  
Kennebec	   266 	   236 	   27,648 	   85.7 	   79.5	  -­‐	  91.9 	  
Knox	   123 	   110 	   8,052 	   89.6 	   83.2	  -­‐	  96.0 	  
Lincoln	   129 	   113 	   7,396 	   88.9 	   82.4	  -­‐	  95.4 	  
Oxford	   121 	   101 	   12,020 	   81.4 	   73.0	  -­‐	  89.8 	  
Penobscot	   277 	   247 	   29,807 	   89.0 	   84.4	  -­‐	  93.6 	  
Piscataquis	   61 	   53 	   3,676 	   91.4 	   84.4	  -­‐	  98.3 	  
Sagadahoc	   120 	   106 	   8,840 	   90.6 	   84.6	  -­‐	  96.7 	  
Somerset	   97 	   83 	   9,516 	   86.7 	   79.2	  -­‐	  94.2 	  
Waldo	   142 	   118 	   8,542 	   85.8 	   79.2	  -­‐	  92.4 	  
Washington	   138 	   115 	   7,591 	   82.6 	   73.2	  -­‐	  92.1 	  
York	   351 	   304 	   36,766 	   86.4 	   82.0	  -­‐	  90.9 	  
Public	  Health	  District	   	   	   	   	   	  
Aroostook	   153 	   134 	   15,839 	   89.4 	   84.0	  -­‐	  94.7 	  
Central	   363 	   319 	   37,164 	   85.9 	   80.9	  -­‐	  90.9 	  
Cumberland	   536 	   494 	   54,166 	   91.6 	   88.6	  -­‐	  94.6 	  
Downeast	   259 	   215 	   17,348 	   80.5 	   74.0	  -­‐	  87.1 	  
Midcoast	   514 	   447 	   32,830 	   88.7 	   85.5	  -­‐	  91.9 	  
Penquis	   338 	   300 	   33,483 	   89.3 	   85.1	  -­‐	  93.5 	  
Western	   447 	   395 	   47,913 	   89.0 	   85.5	  -­‐	  92.5 	  
York	   351 	   304 	   36,766 	   86.4 	   82.0	  -­‐	  90.9 	  
Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  Percentage	  of	  Maine	  females	  ages	  21-­‐65	  years	  with	  an	  intact	  cervix	  who	  had	  a	  Pap	  test	  within	  the	  past	  3	  years.	  
n:	  Number	  of	  female	  survey	  respondents	  ages	  21-­‐65	  years	  with	  an	  intact	  cervix	  who	  reported	  that	  they	  had	  a	  Pap	  test	  within	  
the	  past	  3	  years.	  
N:	  Estimated	  number	  of	  Maine	  females	  ages	  21-­‐65	  years	  with	  an	  intact	  cervix	  who	  had	  a	  Pap	  test	  within	  the	  past	  3	  years.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
95%	  CI:	  95%	  confidence	  interval.	  
DSU:	  Data	  statistically	  unreliable;	  n<6	  or	  95%	  CI	  half-­‐width	  is	  >	  10.	  








Table	  5.12.	  Adults	  ages	  50	  years	  and	  older	  who	  are	  up-­‐to-­‐date	  with	  
colorectal	  cancer	  screening	  by	  selected	  demographics,	  Maine,	  2012.	  
	  
Total	  
Respondents	   n	   	  	  	  	  	  	  	  	  	  N	   %	   	  	  	  	  	  	  	  	  95%	  CI	  
Maine	  Total	   6,199 	   4,531 	   368,937 	   72.2 	   70.9	  -­‐	  73.6 	  
	   	   	   	   	   	  Sex	   	   	   	   	   	  
Female	   3,718 	   2,744 	   200,952 	   73.3 	   71.6	  -­‐	  75.1 	  
Male	   2,481 	   1,787 	   167,986 	   70.9 	   68.7	  -­‐	  73.1 	  
Age	   	   	   	   	   	  
50-­‐64	   3,199 	   2,242 	   205,551 	   69.3 	   67.4	  -­‐	  71.2 	  
65-­‐74	   1,787 	   1,424 	   97,240 	   79.8 	   77.5	  -­‐	  82.1 	  
75	  and	  older	   1,213 	   865 	   66,146 	   71.5 	   68.4	  -­‐	  74.7 	  
Education	   	   	   	   	   	  
Less	  than	  high	  school	  diploma	   358 	   208 	   31,801 	   60.0 	   54.0	  -­‐	  66.0 	  
High	  school	  diploma	  or	  GED	   1,989 	   1,389 	   120,618 	   68.9 	   66.5	  -­‐	  71.3 	  
Some	  college	   1,569 	   1,165 	   110,693 	   75.5 	   73.1	  -­‐	  78.0 	  
Bachelor's	  degree	  or	  higher	   2,274 	   1,762 	   105,229 	   77.7 	   75.7	  -­‐	  79.7 	  
Income	   	   	   	   	   	  
Less	  than	  $15,000	   763 	   484 	   32,570 	   61.4 	   56.8	  -­‐	  66.1 	  
$15,000-­‐24,999	   1,091 	   732 	   58,144 	   67.1 	   63.6	  -­‐	  70.7 	  
$25,000-­‐34,999	   677 	   483 	   40,254 	   69.9 	   65.7	  -­‐	  74.0 	  
$35,000-­‐49,999	   910 	   699 	   59,869 	   75.4 	   72.0	  -­‐	  78.9 	  
$50,000	  or	  more	   2,096 	   1,664 	   141,326 	   77.9 	   75.7	  -­‐	  80.0 	  
Sexual	  Orientation	   	   	   	   	   	  
Heterosexual	  or	  straight	   5,878 	   4,323 	   352,763 	   72.8 	   71.4	  -­‐	  74.2 	  
Homosexual	  (gay	  or	  lesbian)	   DSU	   DSU	   DSU	   DSU	   DSU	  
Bisexual	   DSU	   DSU	   DSU	   DSU	   DSU	  
Other	   DSU	   DSU	   DSU	   DSU	   DSU	  
Type	  of	  Health	  Insurance	  Coverage	   	   	   	   	   	  
Private	   2,502 	   1,893 	   167,788 	   74.8 	   72.7	  -­‐	  76.8 	  
Medicare	   2,252 	   1,715 	   123,643 	   76.3 	   74.1	  -­‐	  78.4 	  
Medicaid	  or	  MaineCare	   362 	   238 	   19,185 	   66.4 	   59.8	  -­‐	  73.0 	  
Other	   472 	   378 	   32,581 	   78.3 	   73.7	  -­‐	  82.9 	  
Uninsured	   DSU	   DSU	   DSU	   DSU	   DSU	  
Mental	  Health	  Status	   	   	   	   	   	  
Current	  depression	   	   	   	   	   	  
Yes	   421 	   287 	   28,755 	   67.8 	   62.4	  -­‐	  73.2 	  
No	   5,200 	   3,874 	   338,720 	   72.8 	   71.3	  -­‐	  74.2 	  
Lifetime	  depression	  or	  anxiety	   	   	   	   	   	  
Yes	   1,585 	   1,183 	   109,353 	   73.9 	   71.3	  -­‐	  76.5 	  
No	   4,012 	   2,964 	   257,056 	   71.9 	   70.2	  -­‐	  73.6 	  
Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  Up-­‐to-­‐date	  with	  colorectal	  cancer	  screening	  =	  Percentage	  of	  Maine	  adults	  ages	  50	  years	  and	  older	  who	  reported	  that	  
they	  had	  a	  home	  blood	  stool	  test	  (e.g.,	  FOBT	  or	  FIT)	  within	  the	  past	  year	  OR	  sigmoidoscopy	  within	  the	  past	  5	  years	  and	  home	  
blood	  stool	  test	  within	  the	  past	  3	  years	  OR	  a	  colonoscopy	  within	  the	  past	  10	  years.	  
n:	  Number	  of	  survey	  respondents	  who	  reported	  that	  they	  are	  up-­‐to-­‐date	  with	  colorectal	  cancer	  screening.	  
N:	  Estimated	  number	  of	  Maine	  adults	  ages	  50	  years	  and	  older	  who	  reported	  that	  they	  are	  up-­‐to-­‐date	  with	  colorectal	  cancer	  
screening.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
95%	  CI:	  95%	  confidence	  interval.	  
DSU:	  Data	  statistically	  unreliable;	  total	  respondents	  <	  50	  or	  95%	  CI	  half-­‐width	  is	  >	  10.	  
Current	  depression	  =	  Self-­‐reported	  symptoms	  of	  current	  depression	  based	  on	  PHQ-­‐2	  depression	  scale.	  
Lifetime	  depression	  or	  anxiety	  =	  Current	  depression	  or	  any	  lifetime	  diagnosis	  of	  depression	  or	  anxiety.	  
Due	  to	  changes	  in	  survey	  methodology,	  data	  collected	  in	  2011	  and	  in	  subsequent	  years	  cannot	  be	  compared	  with	  data	  prior	  to	  
2011.	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Table	  5.13.	  Adults	  ages	  50	  years	  and	  older	  who	  are	  up-­‐to-­‐date	  with	  colorectal	  
cancer	  screening	  by	  race	  and	  ethnicity,	  Maine,	  2012.	  
	  
Total	  
Respondents	   n	   	  	  	  	  	  	  	  	  	  N	   %	   	  	  	  	  	  	  	  	  95%	  CI	  
Maine	  Total	   6,199 	   4,531 	   368,937 	   72.2 	   70.9	  -­‐	  73.6 	  
	   	   	   	   	   	  Race	   	   	   	   	   	  
White	   5,893 	   4,334 	   354,044 	   72.7 	   71.3	  -­‐	  74.1 	  
Black	  or	  African	  American	   DSU	   DSU	   DSU	   DSU	   DSU	  
American	  Indian	  or	  Alaska	  Native	   DSU	   DSU	   DSU	   DSU	   DSU	  
Asian	  or	  Pacific	  Islander	   DSU	   DSU	   DSU	   DSU	   DSU	  
Two	  or	  More	  Races	   DSU	   DSU	   DSU	   DSU	   DSU	  
Other	  Race	   DSU	   DSU	   DSU	   DSU	   DSU	  
Ethnicity	   	   	   	   	   	  
Non-­‐Hispanic	   6,052 	   4,442 	   362,372 	   72.5 	   71.2	  -­‐	  73.9 	  
Hispanic	   DSU	   DSU	   DSU	   DSU	   DSU	  
Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  Up-­‐to-­‐date	  with	  colorectal	  cancer	  screening	  =	  Percentage	  of	  Maine	  adults	  ages	  50	  years	  and	  older	  who	  reported	  that	  
they	  had	  a	  home	  blood	  stool	  test	  (e.g.,	  FOBT	  or	  FIT)	  within	  the	  past	  year	  OR	  sigmoidoscopy	  within	  the	  past	  5	  years	  and	  home	  
blood	  stool	  test	  within	  the	  past	  3	  years	  OR	  a	  colonoscopy	  within	  the	  past	  10	  years.	  
n:	  Number	  of	  survey	  respondents	  who	  reported	  that	  they	  are	  up-­‐to-­‐date	  with	  colorectal	  cancer	  screening.	  
N:	  Estimated	  number	  of	  Maine	  adults	  ages	  50	  years	  and	  older	  who	  reported	  that	  they	  are	  up-­‐to-­‐date	  with	  colorectal	  cancer	  
screening.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
95%	  CI:	  95%	  confidence	  interval.	  
DSU:	  Data	  statistically	  unreliable;	  total	  respondents	  <	  50	  or	  95%	  CI	  half-­‐width	  is	  >	  10.	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Table	  5.14.	  Adults	  ages	  50	  years	  and	  older	  who	  are	  up-­‐to-­‐date	  with	  colorectal	  
cancer	  screening	  by	  county	  and	  public	  health	  district,	  Maine,	  2012.	  
	  
Total	  
Respondents	   n	   	  	  	  	  	  	  	  	  	  	  N	   %	   	  	  	  	  	  	  	  	  	  	  95%	  CI	  
Maine	  Total	   6,199 	   4,531 	   368,937 	   72.2 	   70.9	  -­‐	  73.6 	  
	   	   	   	   	   	  County	   	   	   	   	   	  
Androscoggin	   379 	   281 	   25,989 	   71.5 	   66.0	  -­‐	  77.0 	  
Aroostook	   351 	   245 	   23,739 	   72.2 	   67.0	  -­‐	  77.5 	  
Cumberland	   1,007 	   750 	   67,008 	   72.5 	   69.1	  -­‐	  75.9 	  
Franklin	   217 	   148 	   8,777 	   69.6 	   62.3	  -­‐	  77.0 	  
Hancock	   264 	   193 	   14,728 	   73.0 	   66.7	  -­‐	  79.3 	  
Kennebec	   468 	   368 	   34,527 	   77.7 	   73.2	  -­‐	  82.2 	  
Knox	   328 	   239 	   12,184 	   70.1 	   63.7	  -­‐	  76.6 	  
Lincoln	   320 	   241 	   12,107 	   75.0 	   69.2	  -­‐	  80.9 	  
Oxford	   269 	   203 	   19,728 	   77.7 	   72.1	  -­‐	  83.3 	  
Penobscot	   537 	   387 	   38,473 	   72.7 	   68.2	  -­‐	  77.3 	  
Piscataquis	   154 	   115 	   6,676 	   73.7 	   65.2	  -­‐	  82.2 	  
Sagadahoc	   247 	   186 	   11,462 	   73.0 	   65.8	  -­‐	  80.2 	  
Somerset	   230 	   161 	   15,121 	   70.1 	   63.4	  -­‐	  76.9 	  
Waldo	   297 	   208 	   10,961 	   61.2 	   53.2	  -­‐	  69.3 	  
Washington	   273 	   189 	   10,108 	   66.3 	   58.8	  -­‐	  73.8 	  
York	   737 	   539 	   50,598 	   71.9 	   68.0	  -­‐	  75.7 	  
Public	  Health	  District	   	   	   	   	   	  
Aroostook	   351 	   245 	   23,739 	   72.2 	   67.0	  -­‐	  77.5 	  
Central	  Maine	   698 	   529 	   49,648 	   75.2 	   71.5	  -­‐	  79.0 	  
Cumberland	   1,007 	   750 	   67,008 	   72.5 	   69.1	  -­‐	  75.9 	  
Downeast	   537 	   382 	   24,836 	   70.1 	   65.3	  -­‐	  75.0 	  
Midcoast	   1,192 	   874 	   46,713 	   69.6 	   66.0	  -­‐	  73.2 	  
Penquis	   691 	   502 	   45,149 	   72.9 	   68.8	  -­‐	  76.9 	  
Western	  Maine	   865 	   632 	   54,494 	   73.3 	   69.8	  -­‐	  76.8 	  
York	   737 	   539 	   50,598 	   71.9 	   68.0	  -­‐	  75.7 	  
Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  Up-­‐to-­‐date	  with	  colorectal	  cancer	  screening	  =	  Percentage	  of	  Maine	  adults	  ages	  50	  years	  and	  older	  who	  reported	  that	  
they	  had	  a	  home	  blood	  stool	  test	  (e.g.,	  FOBT	  or	  FIT)	  within	  the	  past	  year	  OR	  sigmoidoscopy	  within	  the	  past	  5	  years	  and	  home	  
blood	  stool	  test	  within	  the	  past	  3	  years	  OR	  a	  colonoscopy	  within	  the	  past	  10	  years.	  
n:	  Number	  of	  survey	  respondents	  who	  reported	  that	  they	  are	  up-­‐to-­‐date	  with	  colorectal	  cancer	  screening.	  
N:	  Estimated	  number	  of	  Maine	  adults	  ages	  50	  years	  and	  older	  who	  reported	  that	  they	  are	  up-­‐to-­‐date	  with	  colorectal	  cancer	  
screening.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
95%	  CI:	  95%	  confidence	  interval.	  
Due	  to	  changes	  in	  survey	  methodology,	  data	  collected	  in	  2011	  and	  in	  subsequent	  years	  cannot	  be	  compared	  with	  data	  prior	  to	  2011.	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Table	  5.15.	  Screening	  rates	  for	  oral	  and	  prostate	  cancer	  by	  year,	  Maine,	  2002-­‐2012.
Ever	  had	  oral	  cancer	  screening	   Had	  a	  PSA	  test	  within	  the	  past	  2	  years	  
Year	  
Total	  
Respondents	   n	   N	   %	   95%	  CI	  
Total	  
Respondents	   n	   N	   %	   95%	  CI	  
2002	   NA	   NA	   NA	   NA	   NA	   NA	   NA	   NA	   NA	   NA	  
2004	   NA	   NA	   NA	   NA	   NA	   672	   403	   114,210	   60.6	   56.5-­‐64.7	  
2006	   NA	   NA	   NA	   NA	   NA	   756	   470	   121,581	   62.3	   58.5-­‐66.2	  
2008	   NA	   NA	   NA	   NA	   NA	   1,539	   1,092	   146,954	   71.9	   69.4-­‐74.4	  
2010	   NA	   NA	   NA	   NA	   NA	   1,964	   1,264	   134,283	   63.0	   60.5-­‐65.5	  
Change	  in	  BRFSS	  methods	  
2011	   3,741	   1,294	   258,233	   26.9	   25.2-­‐28.7	   NA	   NA	   NA	   NA	   NA	  
2012	   3,662	   1,560	   337,597	   34.8	   32.8-­‐36.9	   2,392	   1,213	   113,575	   49.6	   47.2-­‐52.0	  
Data	  source:	  	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System	  (BRFSS).	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  Oral	  Cancer	  =	  Percentage	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  ever	  having	  oral	  cancer	  screening;	  Prostate	  Cancer	  =	  Percentage	  
of	  Maine	  males	  ages	  50	  years	  and	  older	  who	  reported	  that	  they	  had	  a	  PSA	  test	  within	  the	  past	  2	  years.	  
n:	  	  Number	  of	  survey	  respondents	  ages	  18	  years	  and	  older	  who	  reported	  ever	  having	  oral	  cancer	  screening	  (oral	  cancer)	  or	  the	  number	  of	  	  male	  survey	  
respondents	  ages	  50	  years	  and	  older	  who	  reported	  that	  they	  had	  a	  PSA	  test	  within	  the	  past	  2	  years	  (prostate	  cancer).	  
N:	  Estimated	  number	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  ever	  having	  oral	  cancer	  screening	  (oral	  cancer)	  or	  the	  estimated	  number	  of	  
Maine	  males	  ages	  50	  years	  and	  older	  who	  reported	  that	  they	  had	  a	  PSA	  test	  within	  the	  past	  2	  years	  (prostate	  cancer).	  
95%	  CI:	  95%	  confidence	  interval	  
NA:	  Not	  available	  
Due	  to	  changes	  in	  survey	  methodology,	  data	  collected	  in	  2011	  and	  in	  subsequent	  years	  cannot	  be	  compared	  with	  data	  prior	  to	  2011.	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Table	  5.16.	  Adults	  ages	  18	  years	  and	  older	  who	  have	  ever	  had	  oral	  
cancer	  screening	  by	  selected demographics,	  Maine,	  2012.	  
Total	  
Respondents	   n	   N	   %	   95%	  CI	  
Maine	  Total	   3,662  1,560  337,597  34.8  32.8	  -­‐	  36.9 
Sex	  
Female	   2,198  998  188,692  37.8  35.0	  -­‐	  40.5 
Male	   1,464  562  148,905  31.7  28.5	  -­‐	  34.9 
Age	  
18-­‐44	   DSU	   DSU	   DSU	   DSU	   DSU	  
45-­‐64	   2,208  967  251,197  35.6  33.0	  -­‐	  38.1 
65	  and	  older	   1,389  577  79,218  38.6  35.8	  -­‐	  41.5 
Education	  
Less	  than	  high	  school	  diploma	   205  27  10,443†	   10.5†	   5.1	  -­‐	  15.9†	  
High	  school	  diploma	  or	  GED	   1,179  344  88,962  26.5  23.1	  -­‐	  29.9 
Some	  college	   929  409  111,939  38.3  34.1	  -­‐	  42.5 
Bachelor's	  degree	  or	  higher	   1,346  778  125,331  52.1  48.7	  -­‐	  55.6 
Income	  
Less	  than	  $15,000	   449  84  14,723  12.2  8.7	  -­‐	  15.6 
$15,000-­‐24,999	   619  190  35,726  23.8  19.2	  -­‐	  28.4 
$25,000-­‐34,999	   367  147  31,689  32.7  25.9	  -­‐	  39.5 
$35,000-­‐49,999	   537  232  52,714  36.8  31.5	  -­‐	  42.1 
$50,000	  or	  more	   1,286  762  171,515  50.9  47.0	  -­‐	  54.8 
Sexual	  Orientation	  
Heterosexual	  or	  straight	   3,476  1,496  325,247  35.3  33.1	  -­‐	  37.4 
Homosexual	  (gay	  or	  lesbian)	   DSU	   DSU	   DSU	   DSU	   DSU	  
Bisexual	   DSU	   DSU	   DSU	   DSU	   DSU	  
Other	   DSU	   DSU	   DSU	   DSU	   DSU	  
Type	  of	  Health	  Insurance	  Coverage	  
Private	   1,613  839  207,777  45.1  41.8	  -­‐	  48.3 
Medicare	   1,080  430  61,584  34.4  30.9	  -­‐	  37.9 
Medicaid	  or	  MaineCare	   314  56  17,173  13.1  8.0	  -­‐	  18.2 
Other	   243  107  23,203  42.4  33.4	  -­‐	  51.4 
Uninsured	   DSU	   DSU	   DSU	   DSU	   DSU	  
Mental	  Health	  Status	  
Current	  depression	  
Yes	   283  81  17,022  20.0  14.5	  -­‐	  25.5 
No	   3,366  1,472  319,320  36.2  34.0	  -­‐	  38.5 
Lifetime	  depression	  or	  anxiety	  
Yes	   1,067  417  86,912  29.0  25.5	  -­‐	  32.6 
No	   2,564  1,131  247,702  37.3  34.8	  -­‐	  39.9 
Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  
	  All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  Percentage	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  ever	  having	  oral	  cancer	  screening.	  
n:	  Number	  of	  survey	  respondents	  ages	  18	  years	  and	  older	  who	  reported	  ever	  having	  oral	  cancer	  screening.	  
N:	  Estimated	  number	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  ever	  having	  oral	  cancer	  screening.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
95%	  CI:	  95%	  confidence	  interval.	  
DSU:	  Data	  statistically	  unreliable;	  total	  respondents	  <	  50	  or	  95%	  CI	  half-­‐width	  is	  >	  10.	  
†Use	  with	  caution.	  Estimates	  based	  on	  number	  of	  survey	  respondents	  <50	  might	  be	  unstable.	  
Current	  depression	  =	  Self-­‐reported	  symptoms	  of	  current	  depression	  based	  on	  PHQ-­‐2	  depression	  scale.	  
Lifetime	  depression	  or	  anxiety	  =	  Current	  depression	  or	  any	  lifetime	  diagnosis	  of	  depression	  or	  anxiety.	  
Due	  to	  changes	  in	  survey	  methodology,	  data	  collected	  in	  2011	  and	  in	  subsequent	  years	  cannot	  be	  compared	  with	  data	  prior	  to	  
2011.	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Table	  5.17.	  Adults	  ages	  18	  years	  and	  older	  who	  have	  ever	  had	  oral	  cancer	  
screening	  by	  race	  and	  ethnicity,	  Maine,	  2012.	  
Total	  
Respondents	   n	   	  	  	  	  	  	  	  	  	  	  N	   %	   	  	  	  	  	  	  	  	  95%	  CI	  
Maine	  Total	   3,662  1,560  337,597  34.8  32.8	  -­‐	  36.9 
Race	  
White	   3,464  1,497  319,302  35.1  33.0	  -­‐	  37.3 
Black	  or	  African	  American	   DSU	   DSU	   DSU	   DSU	   DSU	  
American	  Indian	  or	  Alaska	  Native	   DSU	   DSU	   DSU	   DSU	   DSU	  
Asian	  or	  Pacific	  Islander	   DSU	   DSU	   DSU	   DSU	   DSU	  
Two	  or	  More	  Races	   DSU	   DSU	   DSU	   DSU	   DSU	  
Other	  Race	   DSU	   DSU	   DSU	   DSU	   DSU	  
Ethnicity	  
Non-­‐Hispanic	   3,562  1,526  328,386  34.7  32.6	  -­‐	  36.9 
Hispanic	   DSU	   DSU	   DSU	   DSU	   DSU	  
Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  Percentage	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  ever	  having	  oral	  cancer	  screening.	  
n:	  Number	  of	  survey	  respondents	  ages	  18	  years	  and	  older	  who	  reported	  ever	  having	  oral	  cancer	  screening.	  
N:	  Estimated	  number	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  ever	  having	  oral	  cancer	  screening.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
95%	  CI:	  95%	  confidence	  interval.	  
DSU:	  Data	  statistically	  unreliable;	  total	  respondents	  <	  50	  or	  95%	  CI	  half-­‐width	  is	  >	  10.	  
Due	  to	  changes	  in	  survey	  methodology,	  data	  collected	  in	  2011	  and	  in	  subsequent	  years	  cannot	  be	  compared	  with	  data	  prior	  to	  
2011.
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Table	  5.18.	  Adults	  ages	  18	  years	  and	  older	  who	  have	  ever	  had	  oral	  cancer	  
screening	  by	  county	  and	  public	  health	  district,	  Maine,	  2012.	  
Total	  
Respondents	   n	   N	   %	   	  	  	  	  	  	  	  	  	  	  95%	  CI	  
Maine	  Total	   3,662  1,560  337,597  34.8  32.8	  -­‐	  36.9 
County	  
Androscoggin	   222  71  20,264  26.1  19.0	  -­‐	  33.2 
Aroostook	   212  53  13,694  19.9  12.9	  -­‐	  26.9 
Cumberland	   589  318  75,013  46.3  40.9	  -­‐	  51.6 
Franklin	   DSU	   DSU	   	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  	  DSU	   DSU	  
Hancock	   	  	  	  	  	  	  	  	  	  	  158	   	  	  	  	  	  	  	  	  	  	  	  	  95	   	  	  	  	  	  18,840	   	  	  	  	  	  	  	  50.4	   	  	  	  39.6	  -­‐	  61.2	  
Kennebec	   274  102  23,817  29.6  23.2	  -­‐	  36.1 
Knox	   184  97  11,709  41.2  31.8	  -­‐	  50.7 
Lincoln	   187  72  8,644  31.8  22.8	  -­‐	  40.7 
Oxford	   167  63  14,199  25.4  17.7	  -­‐	  33.2 
Penobscot	   308  130  32,146  35.9  29.1	  -­‐	  42.7 
Piscataquis	   DSU	   DSU	   	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  	  DSU	   DSU	  
Sagadahoc	   147  74  11,517  43.2  33.3	  -­‐	  53.2 
Somerset	   DSU	   DSU	   	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  	  DSU	   DSU	  
Waldo	   177  66  9,949  30.7  21.8	  -­‐	  39.6 
Washington	   172  63  8,022  25.8  17.9	  -­‐	  33.7 
York	   412  213  55,910  45.6  38.4	  -­‐	  52.7 
Public	  Health	  District	  
Aroostook	   212  53  13,694  19.9  12.9	  -­‐	  26.9 
Central	   416  141  36,441  28.0  22.5	  -­‐	  33.5 
Cumberland	   589  318  75,013  46.3  40.9	  -­‐	  51.6 
Downeast	   330  158  26,861  39.2  32.1	  -­‐	  46.3 
Midcoast	   695  309  41,819  36.5  31.8	  -­‐	  41.2 
Penquis	   407  157  36,101  33.5  27.5	  -­‐	  39.6 
Western	   529  190  45,312  27.4  22.4	  -­‐	  32.4 
York	   412  213  55,910  45.6  38.4	  -­‐	  52.7 
Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  Percentage	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  ever	  having	  oral	  cancer	  screening.	  
n:	  Number	  of	  survey	  respondents	  ages	  18	  years	  and	  older	  who	  reported	  ever	  having	  oral	  cancer	  screening.	  
N:	  Estimated	  number	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  reported	  ever	  having	  oral	  cancer	  screening.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
95%	  CI:	  95%	  confidence	  interval.	  
DSU:	  Data	  statistically	  unreliable;	  n<6	  or	  95%	  CI	  half-­‐width	  is	  >	  10.	  
Due	  to	  changes	  in	  survey	  methodology,	  data	  collected	  in	  2011	  and	  in	  subsequent	  years	  cannot	  be	  compared	  with	  data	  prior	  to	  
2011.	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Table	  5.19.	  Males	  ages	  50	  years	  and	  older	  who	  had	  a	  PSA	  test	  within	  the	  
past	  2	  years	  by	  demographics,	  Maine,	  2012.	  
Total	  
Respondents	   n	   N	   %	   95%	  CI	  
Maine	  Total	   2,392  1,213  113,575  49.6  47.2	  -­‐	  52.0 
Age	  
50-­‐64	   1,268  560  59,345  43.4  40.2	  -­‐	  46.6 
65-­‐74	   705  451  36,303  64.2  59.9	  -­‐	  68.4 
75	  and	  older	   419  202  17,927  50.4  44.7	  -­‐	  56.2 
Education	  
Less	  than	  high	  school	  diploma	   142  50  9,469  38.2  28.8	  -­‐	  47.5 
High	  school	  diploma	  or	  GED	   769  350  37,350  46.7  42.6	  -­‐	  50.7 
Some	  college	   556  296  31,794  51.5  46.7	  -­‐	  56.3 
Bachelor's	  degree	  or	  higher	   922  514  34,635  55.8  52.2	  -­‐	  59.5 
Income	  
Less	  than	  $15,000	   218  77  6,889  35.1  26.6	  -­‐	  43.6 
$15,000-­‐24,999	   365  146  13,233  37.4  31.6	  -­‐	  43.3 
$25,000-­‐34,999	   276  138  13,656  51.5  44.4	  -­‐	  58.6 
$35,000-­‐49,999	   402  210  21,022  51.5  45.7	  -­‐	  57.2 
$50,000	  or	  more	   956  555  51,575  56.5  52.8	  -­‐	  60.1 
Sexual	  Orientation	  
Heterosexual	  or	  straight	   2,262  1,162  108,439  50.3  47.8	  -­‐	  52.7 
Homosexual	  (gay	  or	  lesbian)	   DSU	   DSU	   DSU	   DSU	   DSU	  
Bisexual	   DSU	   DSU	   DSU	   DSU	   DSU	  
Other	   DSU	   DSU	   DSU	   DSU	   DSU	  
Type	  of	  Health	  Insurance	  Coverage	  
Private	   957  478  49,963  49.5  45.9	  -­‐	  53.2 
Medicare	   804  471  38,908  59.6  55.7	  -­‐	  63.6 
Medicaid	  or	  MaineCare	   DSU	   DSU	   DSU	   DSU	   DSU	  
Other	   255  152  14,824  61.4  54.3	  -­‐	  68.4 
Uninsured	   DSU	   DSU	   DSU	   DSU	   DSU	  
Mental	  Health	  Status	  
Current	  depression	  
Yes	   158  72  8,363  42.9  34.1	  -­‐	  51.6 
No	   1,939  1,005  101,093  49.4  46.8	  -­‐	  52.0 
Lifetime	  depression	  or	  anxiety	  
Yes	   477  245  27,275  50.6  45.4	  -­‐	  55.9 
No	   1,610  829  81,951  48.4  45.6	  -­‐	  51.3 
Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐
response.	  
Definition:	  Percentage	  of	  Maine	  males	  ages	  50	  years	  and	  older	  who	  reported	  that	  they	  had	  a	  PSA	  test	  within	  the	  past	  2	  years.	  
n:	  Number	  of	  male	  survey	  respondents	  ages	  50	  years	  and	  older	  who	  reported	  that	  they	  had	  a	  PSA	  test	  within	  the	  past	  2	  years.	  
N:	  Estimated	  number	  of	  Maine	  males	  ages	  50	  years	  and	  older	  who	  reported	  that	  they	  had	  a	  PSA	  test	  within	  the	  past	  2	  years.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
95%	  CI:	  95%	  confidence	  interval.	  
DSU:	  Data	  statistically	  unreliable;	  total	  respondents	  <	  50	  or	  95%	  CI	  half-­‐width	  is	  >	  10.	  
Current	  depression	  =	  Self-­‐reported	  symptoms	  of	  current	  depression	  based	  on	  PHQ-­‐2	  depression	  scale.	  
Lifetime	  depression	  or	  anxiety	  =	  Current	  depression	  or	  any	  lifetime	  diagnosis	  of	  depression	  or	  anxiety.	  
Due	  to	  changes	  in	  survey	  methodology,	  data	  collected	  in	  2011	  and	  in	  subsequent	  years	  cannot	  be	  compared	  with	  data	  prior	  to	  
2011.	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Table	  5.20.	  Males	  ages	  50	  years	  and	  older	  who	  had	  a	  PSA	  test	  within	  the	  
past	  2	  years	  by	  race	  and	  ethnicity,	  Maine,	  2012.	  
Total	  
Respondents	   n	   N	   %	   95%	  CI	  
Maine	  Total	   2,392  1,213  113,575  49.6  47.2	  -­‐	  52.0 
Race	  
White	   2,242  1,149  107,678  49.8  47.4	  -­‐	  52.3 
Black	  or	  African	  American	   DSU	   DSU	   DSU	   DSU	   DSU	  
American	  Indian	  or	  Alaska	  Native	   DSU	   DSU	   DSU	   DSU	   DSU	  
Asian	  or	  Pacific	  Islander	   DSU	   DSU	   DSU	   DSU	   DSU	  
Two	  or	  More	  Races	   DSU	   DSU	   DSU	   DSU	   DSU	  
Other	  Race	   DSU	   DSU	   DSU	   DSU	   DSU	  
Ethnicity	  
Non-­‐Hispanic	   2,315  1,179  110,647  49.7  47.3	  -­‐	  52.1 
Hispanic	   DSU	   DSU	   DSU	   DSU	   DSU	  
Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐
response.	  
Definition:	  Percentage	  of	  Maine	  males	  ages	  50	  years	  and	  older	  who	  reported	  that	  they	  had	  a	  PSA	  test	  within	  the	  past	  2	  years.	  
n:	  Number	  of	  male	  survey	  respondents	  ages	  50	  years	  and	  older	  who	  reported	  that	  they	  had	  a	  PSA	  test	  within	  the	  past	  2	  years.	  
N:	  Estimated	  number	  of	  Maine	  males	  ages	  50	  years	  and	  older	  who	  reported	  that	  they	  had	  a	  PSA	  test	  within	  the	  past	  2	  years.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
95%	  CI:	  95%	  confidence	  interval.	  
DSU:	  Data	  statistically	  unreliable;	  total	  respondents	  <	  50	  or	  95%	  CI	  half-­‐width	  is	  >	  10.	  
Due	  to	  changes	  in	  survey	  methodology,	  data	  collected	  in	  2011	  and	  in	  subsequent	  years	  cannot	  be	  compared	  with	  data	  prior	  to	  
2011.	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Table	  5.21.	  Males	  ages	  50	  years	  and	  older	  who	  had	  a	  PSA	  test	  within	  the	  
past	  2	  years	  by	  county	  and	  public	  health	  district,	  Maine,	  2012.	  
Total	  
Respondents	   n	   N	   %	   95%	  CI	  
Maine	  Total	   2,392  1,213  113,575  49.6  47.2	  -­‐	  52.0 
County	  
Androscoggin	   	  	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  DSU	   DSU	  
Aroostook	   127  71  7,905  59.2  49.8	  -­‐	  68.6 
Cumberland	   376  205  20,894  52.8  46.9	  -­‐	  58.8 
Franklin	   	  	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  DSU	   DSU	  
Hancock	   	  	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  DSU	   DSU	  
Kennebec	   186  103  11,795  54.3  46.1	  -­‐	  62.5 
Knox	   	  	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  DSU	   DSU	  
Lincoln	   	  	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  DSU	   DSU	  
Oxford	   	  	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  DSU	   DSU	  
Penobscot	   202  96  10,583  46.0  38.1	  -­‐	  53.8 
Piscataquis	   	  	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  DSU	   DSU	  
Sagadahoc	   	  	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  DSU	   DSU	  
Somerset	   	  	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  DSU	   DSU	  
Waldo	   	  	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  DSU	   DSU	  
Washington	   	  	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  	  	  DSU	   	  	  	  	  	  	  	  DSU	   DSU	  
York	   285  151  16,314  51.3  44.7	  -­‐	  57.8 
Public	  Health	  District	  
Aroostook	   127  71  7,905  59.2  49.8	  -­‐	  68.6 
Central	   289  147  15,912  49.8  43.2	  -­‐	  56.5 
Cumberland	   376  205  20,894  52.8  46.9	  -­‐	  58.8 
Downeast	   222  114  8,070  47.7  39.6	  -­‐	  55.7 
Midcoast	   441  205  12,533  42.1  36.4	  -­‐	  47.8 
Penquis	   263  128  12,382  45.9  38.9	  -­‐	  52.9 
Western	   331  170  17,070  52.2  45.8	  -­‐	  58.7 
York	   285  151  16,314  51.3  44.7	  -­‐	  57.8 
Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐
response.	  
Definition:	  Percentage	  of	  Maine	  males	  ages	  50	  years	  and	  older	  who	  reported	  that	  they	  had	  a	  PSA	  test	  within	  the	  past	  2	  years.	  
n:	  Number	  of	  male	  survey	  respondents	  ages	  50	  years	  and	  older	  who	  reported	  that	  they	  had	  a	  PSA	  test	  within	  the	  past	  2	  years.	  
N:	  Estimated	  number	  of	  Maine	  males	  ages	  50	  years	  and	  older	  who	  reported	  that	  they	  had	  a	  PSA	  test	  within	  the	  past	  2	  years.	  
Subgroup	  counts	  might	  not	  sum	  to	  Maine	  total	  due	  to	  missing	  data.	  
95%	  CI:	  95%	  confidence	  interval.	  
DSU:	  Data	  statistically	  unreliable;	  n<6	  or	  95%	  CI	  half-­‐width	  is	  >	  10.	  
Due	  to	  changes	  in	  survey	  methodology,	  data	  collected	  in	  2011	  and	  in	  subsequent	  years	  cannot	  be	  compared	  with	  data	  prior	  to	  
2011.	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Table	  6.1.	  Characteristics	  of	  Maine	  adults	  by	  cancer	  history,	  2011-­‐2012.	  
Maine	  Adults	  with	  Any	  Cancer	  History	  
(n	  =	  3,775;	  12.0%	  of	  Maine	  adults)	  
All	  Other	  Maine	  Adults	  
(n	  =	  19,271;	  88.0%	  of	  Maine	  adults)	  
Total	  
Respondents	   n	  
Average	  
Annual	  
N	   %	   95%	  CI	  
Total	  
Respondents	   n	  
Average	  
Annual	  
N	   %	   95%	  CI	  
Total	   23,046	   3,775	   125,944	   12.0	   11.5	  -­‐	  12.4	   23,046	   19,271	   927,135	   88.0	   87.6	  -­‐	  88.5	  
Sex	   3,775	   19,271	  
Female	   2,426	   37,098	   58.9	   56.9	  -­‐	  60.9	   11,334	   235,466	   50.8	   49.9	  -­‐	  51.7	  
Male	   1,349	   51,749	   41.1	   39.1	  -­‐	  43.1	   7,937	   228,102	   49.2	   48.3	  -­‐	  50.1	  
Age	   3,746	  
	   19,120	  
18-­‐24	   12	   686†	   1.1†	   0.4	  -­‐	  1.8†	   829	   58,619	   12.7	   11.9	  -­‐	  13.6	  
25-­‐34	   47	   1,723†	   2.7†	   1.8	  -­‐	  3.7†	   1,779	   71,353	   15.5	   14.8	  -­‐	  16.2	  
35-­‐44	   153	   4,105	   6.6	   5.3	  -­‐	  7.8	   2,661	   76,942	   16.7	   16.0	  -­‐	  17.4	  
45-­‐54	   413	   9,129	   14.6	   13.0	  -­‐	  16.1	   3,961	   95,128	   20.6	   19.9	  -­‐	  21.3	  
55-­‐64	   911	   14,328	   22.9	   21.3	  -­‐	  24.5	   4,663	   81,330	   17.6	   17.1	  -­‐	  18.2	  
65-­‐74	   1,080	   14,452	   23.1	   21.5	  -­‐	  24.6	   3,233	   46,099	   10.0	   9.6	  -­‐	  10.4	  
75	  and	  older	   1,130	   18,242	   29.1	   27.3	  -­‐	  30.9	   1,994	   31,350	   6.8	   6.4	  -­‐	  7.2	  
Education	   3,762	   19,240	  
Less	  than	  high	  school	  diploma	   230	   6,793	   10.8	   9.2	  -­‐	  12.4	   1,084	   47,724	   10.3	   9.6	  -­‐	  11.1	  
High	  school	  or	  GED	   1,181	   21,033	   33.5	   31.6	  -­‐	  35.4	   6,191	   161,534	   34.9	   34.0	  -­‐	  35.8	  
Some	  college	   931	   17,987	   28.6	   26.8	  -­‐	  30.5	   5,020	   140,262	   30.3	   29.4	  -­‐	  31.2	  
Bachelor's	  degree	  or	  higher	   1,420	   16,977	   27.0	   25.5	  -­‐	  28.6	   6,945	   113,399	   24.5	   23.8	  -­‐	  25.2	  
Income	   3,317	   17,241	  
Less	  than	  $15,000	   489	   7,637	   13.7	   12.2	  -­‐	  15.2	   2,255	   52,288	   12.7	   12.0	  -­‐	  13.4	  
$15,000-­‐24,999	   723	   12,057	   21.6	   19.8	  -­‐	  23.4	   3,179	   76,575	   18.6	   17.8	  -­‐	  19.4	  
$25,000-­‐34,999	   393	   6,607	   11.9	   10.5	  -­‐	  13.3	   2,101	   50,305	   12.2	   11.6	  -­‐	  12.9	  
$35,000-­‐49,999	   546	   9,365	   16.8	   15.2	  -­‐	  18.4	   2,744	   67,020	   16.3	   15.6	  -­‐	  17.0	  
$50,000	  or	  more	   1,166	   20,067	   36.0	   34.0	  -­‐	  38.0	   6,962	   165,777	   40.2	   39.3	  -­‐	  41.2	  
Sexual	  Orientation	   3,581	   17,765	  
Heterosexual	  or	  straight	   3,481	   56,266	   97.3	   96.7	  -­‐	  98.0	   17,217	   384,255	   96.5	   96.1	  -­‐	  96.9	  
Homosexual	  (gay	  or	  lesbian)	   60	   808	   1.4	   1.0	  -­‐	  1.8	   287	   6,845	   1.7	   1.5	  -­‐	  2.0	  
Bisexual	   28	   478†	   0.8†	   0.4	  -­‐	  1.3†	   181	   5,177	   1.3	   1.0	  -­‐	  1.6	  
Other	   12	   248†	   0.4†	   0.1	  -­‐	  0.7†	   80	   2,016	   0.5	   0.4	  -­‐	  0.6	  
Health	  Insurance	  Status	   3,768	   19,218	  
Has	  Health	  Insurance	   3,622	   59,848	   95.2	   94.3	  -­‐	  96.2	   17,175	   397,566	   86.2	   85.5	  -­‐	  86.9	  
	  	   No	  Health	  Insurance	   146	   2,987	   4.8	   3.8	  -­‐	  5.7	   2,043	   63,821	   13.8	   13.1	  -­‐	  14.5	  
Type	  of	  Health	  Insurance	  Coverage	   3,423	   15,921	  
Private	   1,157	   21,067	   36.5	   34.5	  -­‐	  38.5	   8,930	   232,685	   59.5	   58.5	  -­‐	  60.5	  
Medicare	   1,701	   25,348	   43.9	   41.9	  -­‐	  45.9	   4,105	   67,503	   17.3	   16.6	  -­‐	  17.9	  
Medicaid	  or	  MaineCare	   269	   6,127	   10.6	   9.1	  -­‐	  12.1	   1,693	   60,942	   15.6	   14.7	  -­‐	  16.5	  
Other	   293	   5,170	   9.0	   7.8	  -­‐	  10.1	   1,170	   29,475	   7.5	   7.0	  -­‐	  8.1	  
Uninsured	   3	   35†	   0.1†	   0.0	  -­‐	  0.1†	   23	   432†	   0.1†	   0.1	  -­‐	  0.2†	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Table	  6.1	  (continued).	  Characteristics	  of	  Maine	  adults	  by	  cancer	  history,	  2011-­‐2012.	  
Maine	  Adults	  with	  Any	  Cancer	  History	  
(n	  =	  3,775;	  12.0%	  of	  Maine	  adults)	  
All	  Other	  Maine	  Adults	  
(n	  =	  19,271;	  88.0%	  of	  Maine	  adults)	  
Total	  
Respondents	   n	  
Average	  
Annual	  
N	   %	   95%	  CI	  
Total	  
Respondents	   n	  
Average	  
Annual	  
N	   	  	  	  	  %	   95%	  CI	  
Mental	  Health	  Status	  
Current	  depression	   700	   3,065	  
Yes	   73	   7,314	   11.9	   8.9	  -­‐	  14.8	   282	   50,100	   11.6	   9.8	  -­‐	  13.4	  
	  	   No	   627	   54,337	   88.1	   85.2	  -­‐	  91.1	   2,783	   382,059	   88.4	   86.6	  -­‐	  90.2	  
Lifetime	  depression	  or	  anxiety	   701	   3,081	  
Yes	   238	   22,323	   36.1	   31.6	  -­‐	  40.7	   930	   141,205	   32.5	   30.0	  -­‐	  35.0	  
No	   463	   39,444	   63.9	   59.3	  -­‐	  68.4	   2,151	   292,866	   67.5	   65.0	  -­‐	  70.0	  
Chronic	  Disease	  Status	  
CHD	  or	  stroke	   3,726	   19,131	  
Yes	   701	   11,733	   18.8	   17.3	  -­‐	  20.4	   1,935	   37,476	   8.1	   7.7	  -­‐	  8.6	  
	  	   No	   3,025	   50,525	   81.2	   79.6	  -­‐	  82.7	   17,196	   423,231	   91.9	   91.4	  -­‐	  92.3	  
Current	  asthma	   3,737	   19,152	  
Yes	   473	   8,520	   13.6	   12.2	  -­‐	  15.1	   2,040	   51,951	   11.3	   10.7	  -­‐	  11.9	  
No	   3,264	   53,951	   86.4	   84.9	  -­‐	  87.8	   17,112	   408,205	   88.7	   88.1	  -­‐	  89.3	  
Diabetes	   3,771	   19,251	  
Yes	   608	   10,236	   16.3	   14.8	  -­‐	  17.7	   2,060	   40,277	   8.7	   8.2	  -­‐	  9.2	  
	  	   No	   3,163	   52,659	   83.7	   82.3	  -­‐	  85.2	   17,191	   422,982	   91.3	   90.8	  -­‐	  91.8	  
COPD	   3,751	   19,159	  
Yes	   550	   9,172	   14.7	   13.2	  -­‐	  16.1	   1,539	   31,480	   6.8	   6.4	  -­‐	  7.3	  
No	   3,201	   53,431	   85.3	   83.9	  -­‐	  86.8	   17,620	   429,257	   93.2	   92.7	  -­‐	  93.6	  
Number	  of	  other	  chronic	  diseases*	  	   3,775	   19,271	  
0	   2,173	   35,632	   56.6	   54.6	  -­‐	  58.6	   13,772	   342,871	   74.0	   73.2	  -­‐	  74.8	  
1	   1,009	   17,192	   27.3	   	  25.5 - 29.1	   3,814	   87,778	   18.9	   18.2 - 19.7
2	   419	   7,298	   11.6	   10.3 - 12.9	   1,185	   23,378	   5.0	   4.7 - 5.4
3	   130	   2,287	   3.6	   2.9 - 4.4	   398	   7,591	   1.6	   1.4 - 1.8	  
4	  or	  more	   44	   564†	   0.9†	   1.4	  -­‐	  2.8†	   102	   1,951	   0.4	   0.3 - 0.5	  
Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  
Abbreviations:	  	  CHD,	  Coronary	  Heart	  Disease;	  COPD,	  Chronic	  Obstructive	  Pulmonary	  Disease	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  Maine	  adults	  with	  any	  cancer	  history	  =	  Percentage	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  responded	  “yes”	  to	  questions	  about	  ever	  being	  told	  they	  had	  skin	  cancer	  or	  any	  other	  types	  of	  cancer.	  
N:	  Weighted	  numerator,	  estimated	  number	  of	  Maine	  adults.	  	  
Average	  Annual	  N:	  	  The	  total	  N	  divided	  by	  the	  total	  number	  of	  years	  in	  a	  multi-­‐year	  data	  analysis.	  
95%	  CI:	  95%	  confidence	  interval.	  
†Use	  with	  caution.	  Estimates	  based	  on	  n<50	  might	  be	  unstable.	  
Current	  depression	  =	  Self-­‐reported	  symptoms	  of	  current	  depression	  based	  on	  PHQ-­‐2	  depression	  scale.	  
Lifetime	  depression	  or	  anxiety	  =	  Current	  depression	  or	  any	  lifetime	  diagnosis	  of	  depression	  or	  anxiety.	  
*Number	  of	  other	  chronic	  diseases	  Includes	  CHD,	  stroke,	  current	  asthma,	  diabetes,	  or	  COPD.
Due	  to	  changes	  in	  survey	  methodology,	  data	  collected	  in	  2011	  and	  in	  subsequent	  years	  cannot	  be	  compared	  with	  data	  prior	  to	  2011.	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Table	  6.2.	  Race	  and	  ethnicity	  among	  Maine	  adults	  by	  cancer	  history,	  2011-­‐2012.	  
Maine	  Adults	  with	  Any	  Cancer	  History	  
(n	  =	  3,775;	  12.0%	  of	  Maine	  adults)	  
All	  Other	  Maine	  Adults	  
(n	  =	  19,271;	  88.0%	  of	  Maine	  adults)	  
Total	  
Respondents	   n	  
Average	  
Annual	  
N	   %	   95%	  CI	  
Total	  
Respondents	   n	  
Average	  
Annual	  
N	   %	   95%	  CI	  
Race	   3,727	   19,061	  
White	   3,625	   60,784	   97.7	   97.0	  -­‐	  98.3	   18,421	   441,922	   96.3	   95.9	  -­‐	  96.7	  
Black	  or	  African	  American	   11	   142†	   0.2†	   0.1	  -­‐	  0.4†	   94	   3,073	   0.7	   0.5	  -­‐	  0.8	  
American	  Indian	  or	  Alaska	  Native	   39	   669†	   1.1†	   0.6	  -­‐	  1.5†	  
Two	  or	  More	  Races	   47	   626†	   1.0†	   0.6	  -­‐	  1.4†	   214	   5,586	   1.2	   1.0	  -­‐	  1.5	  
Other	  Race	   5	   24†	   0.0†	   0.0	  -­‐	  0.1†	   99	   2,633	   0.6	   0.4	  -­‐	  0.7	  
Ethnicity	   3,742	   19,169	  
Non-­‐Hispanic	   3,720	   62,152	   99.5	   99.3	  -­‐	  99.8	   18,972	   456,197	   98.8	   98.6	  -­‐	  99.1	  
Hispanic	   22	   286†	   0.5†	   0.2	  -­‐	  0.7†	   197	   5,437	   1.2	   0.9	  -­‐	  1.4	  
Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  Maine	  adults	  with	  any	  cancer	  history	  =	  Percentage	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  responded	  “yes”	  to	  questions	  about	  being	  ever	  told	  they	  had	  skin	  cancer	  or	  any	  other	  types	  of	  
cancer.	  
n:	  Unweighted	  numerator	  
N:	  Weighted	  numerator,	  estimated	  number	  of	  Maine	  adults.	  
Average	  Annual	  N:	  	  The	  total	  N	  divided	  by	  the	  total	  number	  of	  years	  in	  a	  multi-­‐year	  data	  analysis.	  
95%	  CI:	  95%	  confidence	  interval.	  
†Use	  with	  caution.	  Estimates	  based	  on	  n<50	  might	  be	  unstable.	  
Due	  to	  changes	  in	  survey	  methodology,	  data	  collected	  in	  2011	  and	  in	  subsequent	  years	  cannot	  be	  compared	  with	  data	  prior	  to	  2011.	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233 5,742 1.3 1.0 - 1.5
Table	  6.3.	  County	  and	  public	  health	  district	  of	  residence	  among	  Maine	  adults	  by	  cancer	  history,	  2011-­‐2012.	  
Maine	  Adults	  with	  Any	  Cancer	  History	  
(n	  =	  3,775;	  12.0%	  of	  Maine	  adults)	  
All	  Other	  Maine	  Adults	  
(n	  =	  19,271;	  88.0%	  of	  Maine	  adults)	  
Total	  
Respondents	   n	  
Average	  
Annual	  
N	   %	   95%	  CI	  
Total	  
Respondents	   n	  
Average	  
Annual	  
N	   %	   95%	  CI	  
County	   3,702	   18,785	  
Androscoggin	   198	   3,693	   6.0	   5.0	  -­‐	  6.9	   1,302	   37,538	   8.4	   7.8	  -­‐	  8.9	  
Aroostook	   199	   4,115	   6.7	   5.6	  -­‐	  7.8	   1,053	   28,128	   6.3	   5.8	  -­‐	  6.7	  
Cumberland	   625	   11,712	   19.0	   17.4	  -­‐	  20.5	   3,236	   83,254	   18.6	   17.9	  -­‐	  19.2	  
Franklin	   124	   1,551	   2.5	   2.0	  -­‐	  3.1	   709	   12,211	   2.7	   2.4	  -­‐	  3.0	  
Hancock	   149	   2,406	   3.9	   3.2	  -­‐	  4.6	   844	   19,892	   4.4	   4.1	  -­‐	  4.8	  
Kennebec	   290	   5,225	   8.5	   7.3	  -­‐	  9.6	   1,607	   45,212	   10.1	   9.5	  -­‐	  10.6	  
Knox	   235	   2,317	   3.8	   3.2	  -­‐	  4.3	   866	   12,835	   2.9	   2.6	  -­‐	  3.1	  
Lincoln	   229	   2,432	   3.9	   3.3	  -­‐	  4.6	   852	   12,685	   2.8	   2.6	  -­‐	  3.1	  
Oxford	   152	   3,204	   5.2	   4.3	  -­‐	  6.1	   806	   21,624	   4.8	   4.4	  -­‐	  5.2	  
Penobscot	   307	   6,226	   10.1	   8.8	  -­‐	  11.4	   1,747	   48,818	   10.9	   10.3	  -­‐	  11.5	  
Piscataquis	   85	   1,187	   1.9	   1.5	  -­‐	  2.4	   452	   7,928	   1.8	   1.5	  -­‐	  2.0	  
Sagadahoc	   161	   2,162	   3.5	   2.8	  -­‐	  4.2	   679	   11,933	   2.7	   2.4	  -­‐	  2.9	  
Somerset	   121	   2,288	   3.7	   3.0	  -­‐	  4.5	   706	   20,056	   4.5	   4.1	  -­‐	  4.9	  
Waldo	   185	   2,068	   3.4	   2.7	  -­‐	  4.0	   842	   14,227	   3.2	   2.9	  -­‐	  3.5	  
Washington	   157	   1,855	   3.0	   2.4	  -­‐	  3.6	   889	   12,988	   2.9	   2.6	  -­‐	  3.1	  
York	   485	   9,232	   15.0	   13.5	  -­‐	  16.4	   2,195	   59,442	   13.2	   12.6	  -­‐	  13.8	  
Public	  Health	  District	   3,702	   18,785	  
Aroostook	   199	   4,115	   6.7	   5.6	  -­‐	  7.8	   1,053	   28,128	   6.3	   5.8	  -­‐	  6.7	  
Central	   411	   7,513	   12.2	   10.9	  -­‐	  13.5	   2,313	   65,268	   14.5	   13.9	  -­‐	  15.2	  
Cumberland	   625	   11,712	   19.0	   17.4	  -­‐	  20.5	   3,236	   83,254	   18.6	   17.9	  -­‐	  19.2	  
Downeast	   306	   4,262	   6.9	   6.0	  -­‐	  7.8	   1,733	   32,879	   7.3	   6.9	  -­‐	  7.8	  
Midcoast	   810	   8,978	   14.6	   13.4	  -­‐	  15.8	   3,239	   51,679	   11.5	   11.0	  -­‐	  12.0	  
Penquis	   392	   7,412	   12.0	   10.7	  -­‐	  13.3	   2,199	   56,746	   12.6	   12.0	  -­‐	  13.3	  
Western	   474	   8,447	   13.7	   12.3	  -­‐	  15.1	   2,817	   71,373	   15.9	   15.2	  -­‐	  16.6	  
York	   485	   9,232	   15.0	   13.5	  -­‐	  16.4	   2,195	   59,442	   13.2	   12.6	  -­‐	  13.8	  
Data	  source:	  Maine	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  
All	  percentages	  are	  weighted	  to	  be	  more	  representative	  of	  the	  general	  adult	  population	  of	  Maine	  and	  to	  adjust	  for	  non-­‐response.	  
Definition:	  Maine	  adults	  with	  any	  cancer	  history	  =	  Percentage	  of	  Maine	  adults	  ages	  18	  years	  and	  older	  who	  responded	  “yes”	  to	  questions	  about	  ever	  being	  told	  they	  had	  skin	  cancer	  or	  any	  other	  types	  of	  
cancer.	  
n:	  Unweighted	  numerator	  
N:	  Weighted	  numerator,	  estimated	  number	  of	  Maine	  adults.	  	  
Average	  Annual	  N:	  The	  total	  N	  divided	  by	  the	  total	  number	  of	  years	  in	  a	  multi-­‐year	  data	  analysis.	  
95%	  CI:	  95%	  confidence	  interval.	  
†Use	  with	  caution.	  Estimates	  based	  on	  n<50	  might	  be	  unstable.	  
Due	  to	  changes	  in	  survey	  methodology,	  data	  collected	  in	  2011	  and	  in	  subsequent	  years	  cannot	  be	  compared	  with	  data	  prior	  to	  2011.	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Incidence	  Case	  Definitions	  
Incidence	  data	  are	  based	  on	  SEER	  site	  recode	  ICD-­‐O-­‐3/WHO	  2008	  definitions,	  version	  2008.
Available	  at:	  http://www.seer.cancer.gov/siterecode/icdo3_dwhoheme/index.html.
Histologies	  consistent	  with	  Kaposi	  sarcoma	  and	  mesothelioma	  are	  excluded	  (were	  applicable).	  
Site	  Recode	  ICD-­‐O-­‐3/WHO	  2008	  Definition*,†	  
Site	  Group	   ICD-­‐O-­‐3	  Site	   ICD-­‐O-­‐3	  Histology	  (Type)	   Recode	  
	  Oral	  Cavity	  and	  Pharynx	  
	  	  Lip	   C000-­‐C009	   excluding	  9050-­‐9055,	  9140,	  9590-­‐9992	   20010	  
	  	  Tongue	  	   C019-­‐C029	   20020	  
	  	  Salivary	  Gland	   C079-­‐C089	   20030	  
	  	  Floor	  of	  Mouth	  	   C040-­‐C049	   20040	  
	  	  Gum	  and	  Other	  Mouth	  	   C030-­‐C039,	  C050-­‐C059,	  
C060-­‐C069	  	  
20050	  
	  	  Nasopharynx	  	   C110-­‐C119	   20060	  
	  	  Tonsil	   C090-­‐C099	   20070	  
	  	  Oropharynx	  	   C100-­‐C109	   20080	  
	  	  Hypopharynx	   C129,	  C130-­‐C139	   20090	  
	  	  Other	  Oral	  Cavity	  and	  
Pharynx	  	  
C140,	  C142-­‐C148	   20100	  
	  Digestive	  System	  	  
	  	  Esophagus	  	   C150-­‐C159	   excluding	  9050-­‐9055,	  9140,	  9590-­‐9992	   21010	  
	  	  Stomach	  	   C160-­‐C169	   21020	  
	  	  Small	  Intestine	  	   C170-­‐C179	   21030	  
	  	  Colon	  and	  Rectum	  
	  	  Colon	  excluding	  Rectum	  	  
	  	  Cecum	  	   C180	   excluding	  9050-­‐9055,	  9140,	  9590-­‐9992	   21041	  
	  	  Appendix	  	   C181	   21042	  
	  	  Ascending	  Colon	  	   C182	   21043	  
	  	  Hepatic	  Flexure	  	   C183	   21044	  
	  	  Transverse	  Colon	  	   C184	   21045	  
	  	  Splenic	  Flexure	  	   C185	   21046	  
	  	  Descending	  Colon	  	   C186	   21047	  
	  	  Sigmoid	  Colon	  	   C187	   21048	  
	  	  Large	  Intestine,	  NOS	  	   C188-­‐C189,	  C260	   21049	  
	  	  Rectum	  and	  Rectosigmoid	  
Junction	  	  
	  	  Rectosigmoid	  Junction	  	   C199	   excluding	  9050-­‐9055,	  9140,	  9590-­‐9992	   21051	  
	  	  Rectum	  	   C209	   21052	  
	  	  Anus,	  Anal	  Canal	  and	  
Anorectum	  	  
C210-­‐C212,	  C218	   21060	  
	  	  Liver	  and	  Intrahepatic	  Bile	  
Duct	  	  
	  	  Liver	  	   C220	   excluding	  9050-­‐9055,	  9140,	  9590-­‐9992	   21071	  
	  	  Intrahepatic	  Bile	  Duct	  	   C221	   21072	  
	  	  Gallbladder	  	   C239	   21080	  
	  	  Other	  Biliary	  	   C240-­‐C249	   21090	  
	  	  Pancreas	  	   C250-­‐C259	   21100	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  Retroperitoneum	   C480	   21110	  
	  	  Peritoneum,	  Omentum	  and	  
Mesentery	  	  
C481-­‐C482	   21120	  
	  	  Other	  Digestive	  Organs	   C268-­‐C269,	  C488	   21130	  
	  Respiratory	  System	  
	  	  Nose,	  Nasal	  Cavity	  and	  
Middle	  Ear	  	  
C300-­‐C301,	  C310-­‐C319	   excluding	  9050-­‐9055,	  9140,	  9590-­‐9992	   22010	  
	  	  Larynx	  	   C320-­‐C329	   22020	  
	  	  Lung	  and	  Bronchus	  	   C340-­‐C349	   22030	  
	  	  Pleura	  	   C384	   22050	  
	  	  Trachea,	  Mediastinum	  and	  
Other	  Respiratory	  Organs	  	  
C339,	  C381-­‐C383,	  C388,	  
C390,	  C398,	  C399	  	  
22060	  
	  Bones	  and	  Joints	  	   C400-­‐C419	   excluding	  9050-­‐9055,	  9140,	  9590-­‐9992	   23000	  
	  Soft	  Tissue	  including	  Heart	  	  
C380,	  C470-­‐C479,	  C490-­‐
C499	  	  
excluding	  9050-­‐9055,	  9140,	  9590-­‐9992	   24000	  
	  
Skin	  excluding	  Basal	  and	  
Squamous	  	  
	  	  Melanoma	  of	  the	  Skin	   C440-­‐C449	   8720-­‐8790	   25010	  
	  	  Other	  Non-­‐Epithelial	  Skin	  	   C440-­‐C449	   excluding	  8000-­‐8005,	  8010-­‐8046,	  8050-­‐8084,	  




Breast	  	   C500-­‐C509	   excluding	  9050-­‐9055,	  9140,	  9590-­‐9992	   26000	  
	  Female	  Genital	  System	  	  
	  	  Cervix	  Uteri	  	   C530-­‐C539	   excluding	  9050-­‐9055,	  9140,	  9590-­‐9992	   27010	  
	  	  Corpus	  and	  Uterus,	  NOS	  
	  	  Corpus	  Uteri	  	   C540-­‐C549	   excluding	  9050-­‐9055,	  9140,	  9590-­‐9992	   27020	  
	  	  Uterus,	  NOS	  	   C559	   27030	  
	  	  Ovary	   C569	   27040	  
	  	  Vagina	  	   C529	   27050	  
	  	  Vulva	  	   C510-­‐C519	   27060	  
	  	  Other	  Female	  Genital	  
Organs	  	  
C570-­‐C589	   27070	  
	  
Male	  Genital	  System	  	  
	  	  Prostate	   C619	   excluding	  9050-­‐9055,	  9140,	  9590-­‐9992	   28010	  
	  	  Testis	  	   C620-­‐C629	   28020	  
	  	  Penis	   C600-­‐C609	   28030	  
	  	  Other	  Male	  Genital	  Organs	  	   C630-­‐C639	   28040	  
	  Urinary	  System	  	  
	  	  Urinary	  Bladder	  	   C670-­‐C679	   excluding	  9050-­‐9055,	  9140,	  9590-­‐9992	   29010	  
	  	  Kidney	  and	  Renal	  Pelvis	  	   C649,	  C659	   29020	  
	  	  Ureter	   C669	   29030	  
	  	  Other	  Urinary	  Organs	  	   C680-­‐C689	   29040	  
	  Eye	  and	  Orbit	  	   C690-­‐C699	   excluding	  9050-­‐9055,	  9140,	  9590-­‐9992	   30000	  
	  
Brain	  and	  Other	  Nervous	  
System	  	  
	  	  Brain	  	   C710-­‐C719	   excluding	  9050-­‐9055,	  9140,	  9530-­‐9539,	  9590-­‐
9992	  
31010	  
	  	  Cranial	  Nerves	  Other	  
Nervous	  System	  	  
C710-­‐C719	   9530-­‐9539	   31040	  
C700-­‐C709,	  C720-­‐C729	   excluding	  9050-­‐9055,	  9140,	  9590-­‐9992	  
	  Endocrine	  System	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  Thyroid	  	  
	  
C739	  	   excluding	  9050-­‐9055,	  9140,	  9590-­‐9992	   32010	  	  






	  Lymphoma	  	  	   	  	  	   	  	  	   	  	  	  
	  	  	  	  	  Hodgkin	  Lymphoma	  	  
	  
	  	  	   	  	  	   	  	  	  
	  	  	  	  	  	  	  	  	  Hodgkin	  -­‐	  Nodal	  	  
	  
C024,	  C098-­‐C099,	  C111,	  
C142,	  C379,	  C422,	  C770-­‐
C779	  	  
9650-­‐9667	  	   33011	  	  
	  	  	  	  	  	  	  	  	  Hodgkin	  -­‐	  Extranodal	  	  
	  
All	  other	  sites	  	   33012	  	  
	  	  	  	  	  Non-­‐Hodgkin	  Lymphoma	  	  
	  
	  	  	   	  	  	   	  	  	  





9590-­‐9597,	  9670-­‐9671,	  9673,	  9675,	  9678-­‐
9680,	  9684,	  9687-­‐9691,	  9695,	  9698-­‐9702,	  
9705,	  9708-­‐9709,	  9712,	  9714-­‐9719,	  9724-­‐
9729,	  9735,	  9737-­‐9738,	  9811-­‐9818,	  9823,	  
9827,	  9837	  	  
33041	  	  
	  	  	  	  	  	  	  	  	  NHL	  -­‐	  Extranodal	  	  
	  
All	  sites	  except	  C024,	  
C098-­‐C099,	  C111,	  C142,	  
C379,	  C422,	  C770-­‐C779	  	  
9590-­‐9597,	  9670-­‐9671,	  9673,	  9675,	  9678-­‐
9680,	  9684,	  9687-­‐9691,	  9695,	  9698-­‐9702,	  
9705,	  9708-­‐9709,	  9712,	  9714-­‐9719,	  9724-­‐
9729,	  9735,	  9737-­‐9738	  	  
33042	  	  
All	  sites	  except	  C024,	  
C098-­‐C099,	  C111,	  C142,	  
C379,	  C420-­‐C422,	  C424,	  
C770-­‐C779	  	  
9811-­‐9818,	  9823,	  9827,	  9837	  	  
	  Myeloma	  	  	   	  	  	   9731-­‐9732,	  9734	  	   34000	  	  
	  Leukemia	  	  	   	  	  	   	  	  	   	  	  	  
	  	  	  	  	  Lymphocytic	  Leukemia	  	  
	  
	  	  	   	  	  	   	  	  	  
	  	  	  	  	  	  	  	  	  Acute	  Lymphocytic	  
Leukemia	  	  
	  
	  	  	   9826,	  9835-­‐9836	  	   35011	  	  
C420,	  C421,	  C424	  	   9811-­‐9818,	  9837	  	  
	  	  	  	  	  	  	  	  	  Chronic	  Lymphocytic	  
Leukemia	  	  
	  
C420,	  C421,	  C424	  	   9823	  	   35012	  	  
	  	  	  	  	  	  	  	  	  Other	  Lymphocytic	  
Leukemia	  	  
	  
	  	  	   9820,	  9832-­‐9834,	  9940	  	   35013	  	  
	  	  	  	  	  Myeloid	  and	  Monocytic	  
Leukemia	  	  
	  
	  	  	   	  	  	   	  	  	  
	  	  	  	  	  	  	  	  	  Acute	  Myeloid	  Leukemia	  	  
	  
	  	  	   9840,	  9861,	  9865-­‐9867,	  9869,	  9871-­‐9874,	  
9895-­‐9897,	  9898,	  9910-­‐9911,	  9920	  	  
35021	  	  
	  	  	  	  	  	  	  	  	  Acute	  Monocytic	  
Leukemia	  	  
	  
	  	  	   9891	  	   35031	  	  
	  	  	  	  	  	  	  	  	  Chronic	  Myeloid	  
Leukemia	  	  
	  
	  	  	   9863,	  9875-­‐9876,	  9945-­‐9946	  	   35022	  	  
	  	  	  	  	  	  	  	  	  Other	  Myeloid/Monocytic	  
Leukemia	  	  
	  
	  	  	   9860,	  9930	  	   35023	  	  
	  	  	  	  	  Other	  Leukemia	  	  
	  
	  	  	   	  	  	   	  	  	  
	  	  	  	  	  	  	  	  	  Other	  Acute	  Leukemia	  	  
	  
	  	  	   9801,	  9805-­‐9809,	  9931	  	   35041	  	  
	  	  	  	  	  	  	  	  	  Aleukemic,	  subleukemic	  
and	  NOS	  	  
	  
	  	  	   9733,	  9742,	  9800,	  9831,	  9870,	  9948,	  9963-­‐
9964	  	  
35043	  	  
C420,	  C421,	  C424	  	   9827	  	  
	  Mesothelioma	  	  	   	  	  	   9050-­‐9055	  	   36010	  	  
	  Kaposi	  Sarcoma	  	  	   	  	  	   9140	  	   36020	  	  
	  Miscellaneous	  	  	  
	  	  	   9740-­‐9741,	  9750-­‐9769,	  9950,	  9960-­‐9962,	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9987,	  9989,	  9991-­‐9992	  	  
C760-­‐C768,	  C809	  	   excluding	  9050-­‐9055,	  9140,	  9590-­‐9992	  
C420-­‐C424	  	  
C770-­‐C779	  	  
	  Invalid	  	  	  
Site	  or	  histology	  code	  not	  within	  valid	  range	  or	  site	  code	  not	  found	  in	  
this	  table.	  	  
99999	  	  
*	  This	  table	  was	  updated	  for	  Hematopoietic	  codes	  based	  on	  WHO	  Classification	  of	  Tumours	  of	  Haematopoietic	  
and	  Lymphoid	  Tissues	  (2008).	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Mortality	  Case	  Definitions	  
	  
















Site	  	   ICD-­‐10	  Code	   Recode	  
All	  Sites	   C00-­‐C97	   -­‐-­‐	  
Brain	  and	  Other	  Nervous	  System	   C70-­‐C72	   31010	  
Breast	   C50	   26000	  
Cervix	  Uteri	   C53	   27010	  
Colon	  and	  Rectum	   C18-­‐C20,	  C26.0	   21040,	  21050	  
Corpus	  Uterus	   C54,	  C55	   27020,	  27030	  
Esophagus	   C15	   21010	  
Hodgkin	  Lymphoma	   C81	   33010	  
Kidney	  and	  Renal	  Pelvis	   C64-­‐C65	   29020	  
Larynx	   C32	   22020	  
Leukemia	   C90.1,	  C91-­‐C95	   35011,	  35012,	  35013,	  35021,	  35022,	  35023,	  35031,	  35041,	  35043	  
Liver	  and	  Intrahepatic	  Bile	  Duct	   C22.0-­‐C22.4,	  C22.7,	  C22.9	   21071,	  21072,	  21080	  
Lung	  and	  Bronchus	   C34	   22030	  
Melanoma	  of	  the	  Skin	   C43	   25010	  
Myeloma	   C90.0,	  C90.2	   34000	  
Non-­‐Hodgkin	  Lymphoma	   C82-­‐C85,	  C96.3	   33040	  
Oral	  Cavity	  and	  Pharynx	  
C00-­‐C14	  
20010,	  20020,	  20030,	  20040,	  20050,	  20060,	  
20070,	  20080,	  20090,	  20100	  
Ovary	   C56	   27040	  
Pancreas	   C25	   21100	  
Prostate	   C61	   28010	  
Stomach	   C16	   21020	  
Testis	   C62	   28020	  
Thyroid	   C73	   32010	  
Urinary	  Bladder	   C67	   29010	  
Page 306
	  	  
Appendix	  III:	  Data	  Sources	  


















Appendix	  III:	  Data	  Sources	  





Maine	  CDC	  Cancer	  Registry	  	  
	  
Incidence	  data	  provide	  information	  about	  all	  newly	  diagnosed	  cases	  among	  Maine	  
residents,	  including	  stage	  at	  diagnosis	  and	  initial	  treatment	  course.	  	  Individual-­‐level	  
incidence	  data	  provide	  demographic	  characteristics	  (age,	  sex,	  and	  race)	  and	  geography	  
(county	  or	  public	  health	  district	  of	  residence).	  	  This	  data	  can	  be	  used	  to	  evaluate	  and	  
monitor	  trends	  in	  cancer	  incidence	  rates	  in	  Maine.	  These	  data	  are	  collected	  by	  the	  
Maine	  CDC	  Cancer	  Registry	  (MCR),	  a	  statewide	  population-­‐based	  cancer	  surveillance	  
system.	  	  All	  hospitals	  and	  health	  care	  facilities	  that	  diagnose	  or	  treat	  cancer	  are	  required	  
by	  law	  to	  report	  cancer	  cases	  to	  the	  MCR,	  as	  set	  forth	  by	  Maine	  Statute	  Title	  22:	  Health	  
Warfare,	  Chapter	  255:	  Cancer,	  §1402	  (Duty	  of	  physicians	  and	  hospitals).	  	  The	  MCR	  does	  
not	  collect	  data	  on	  basal	  and	  squamous	  cell	  carcinoma	  of	  the	  skin.	  	  	  
	  
Surveillance,	  Epidemiology	  and	  End	  Results	  Program	  
To	  compare	  Maine	  and	  U.S.	  incidence	  data,	  we	  used	  data	  from	  the	  National	  Cancer	  
Institute’s	  Surveillance,	  Epidemiology	  and	  End	  Results	  (SEER)	  Program.	  SEER	  is	  a	  network	  
of	  population-­‐based	  cancer	  registries	  that	  collects	  ongoing	  data	  on	  new	  cancer	  cases	  
with	  follow-­‐up	  and	  patient	  survival.	  	  Due	  to	  the	  predominately	  white	  population	  in	  
Maine,	  SEER	  incidence	  rates	  for	  both	  U.S.	  whites	  only	  and	  the	  overall	  U.S	  rate	  are	  
provided	  for	  comparison.	  In	  this	  report,	  U.S.	  cancer	  incidence	  rates	  presented	  were	  
obtained	  from	  SEER	  9	  (see	  “SEER”	  in	  Appendix	  IV	  for	  further	  details).	  
Mortality	  Data	  
	  
Mortality	  data	  provide	  cause	  of	  death	  information	  for	  all	  deaths	  in	  Maine,	  including	  
demographic	  characteristics	  (sex	  and	  age)	  and	  geography	  (county	  or	  public	  health	  
district	  of	  residence).	  This	  data	  can	  also	  be	  used	  to	  examine	  trends	  in	  cancer	  death	  rates	  
over	  time.	  	  For	  Maine,	  these	  data	  are	  collected	  by	  the	  Data,	  Research,	  and	  Vital	  
Statistics	  Program	  at	  the	  Maine	  Center	  for	  Disease	  Control	  and	  Prevention,	  in	  
accordance	  with	  the	  National	  Center	  for	  Health	  Statistics	  (NCHS)	  guidelines.	  	  Maine	  data	  
are	  then	  reported	  to	  the	  NCHS,	  which	  creates	  a	  national	  mortality	  database	  of	  deaths	  
from	  all	  states.	  	  In	  each	  state,	  mortality	  data	  are	  processed	  following	  a	  standard	  
protocol	  and	  uniformly	  reported	  to	  NCHS.	  Because	  of	  this	  process,	  Maine’s	  data	  can	  be	  
compared	  to	  mortality	  data	  from	  other	  states	  and	  national	  statistics.	  Because	  Maine’s	  
population	  is	  predominantly	  white,	  U.S.	  white	  comparison	  rates	  are	  provided	  along	  with	  





Appendix	  III:	  Data	  Sources	  
Maine	  Cancer	  Surveillance	  Report	  2014	  
Prevalence	  and	  Percentage	  Data	  
	  
Behavioral	  Risk	  Factor	  Surveillance	  System	  	  
We	  used	  the	  Behavioral	  Risk	  Factor	  Surveillance	  System	  (BRFSS)	  to	  obtain	  prevalence	  
and	  percentage	  estimates	  for	  adults	  ages	  18	  years	  and	  older.	  	  In	  1984,	  the	  U.S.	  Center	  
for	  Disease	  Control	  and	  Prevention	  (U.S.	  CDC)	  developed	  the	  BRFSS	  to	  examine	  trends	  
and	  patterns	  of	  state-­‐level	  prevalence	  of	  specific	  health	  behaviors	  and	  outcomes	  in	  an	  
ongoing,	  national	  surveillance	  system.	  	  BRFSS	  is	  an	  annual,	  cross-­‐sectional,	  multi-­‐mode	  
survey	  that	  collects	  self-­‐reported	  data	  on	  demographic	  characteristics	  (including	  
geography),	  health	  behaviors,	  preventive	  health	  practices,	  and	  health	  care	  access.	  	  
Currently,	  BRFSS	  is	  administered	  in	  all	  50	  states,	  the	  District	  of	  Columbia,	  Puerto	  Rico,	  
the	  U.S.	  Virgin	  Islands,	  and	  Guam,	  allowing	  for	  comparisons	  of	  state	  and	  national	  data.	  
BRFSS	  excludes	  individuals	  who	  are	  institutionalized,	  including	  those	  in	  prisons,	  nursing	  
homes,	  and	  college	  dormitories.	  	  In	  2011,	  cell	  phone	  surveys	  were	  incorporated	  and	  the	  
weighting	  methodology	  was	  changed	  to	  an	  improved	  method.	  Therefore,	  data	  collected	  
in	  2011	  and	  subsequent	  years	  cannot	  be	  compared	  to	  data	  prior	  to	  2011.	  	  In	  this	  report,	  
national	  BRFSS	  data	  used	  for	  comparison	  to	  Maine-­‐specific	  data	  are	  the	  median	  
estimates	  of	  all	  50	  states	  and	  the	  District	  of	  Columbia.	  
	  
In	  Maine,	  the	  BRFSS	  is	  conducted	  by	  the	  Maine	  Center	  for	  Disease	  Control	  and	  
Prevention	  (Maine	  CDC)	  in	  coordination	  with	  the	  U.S.	  CDC.	  	  Surveys	  are	  conducted	  each	  
month	  using	  trained	  interviewers	  who	  administer	  a	  standardized	  core	  questionnaire	  
along	  with	  optional	  modules	  and	  state-­‐added	  questions.	  From	  2000	  to	  2012,	  an	  average	  
of	  6,000	  Maine	  adults	  participated	  in	  this	  survey	  each	  year.	  Because	  of	  BRFSS	  exclusions,	  
not	  all	  segments	  of	  Maine’s	  population	  participate	  in	  the	  survey;	  however,	  respondent	  
data	  are	  weighted	  to	  be	  representative	  of	  the	  entire	  Maine	  adult	  population.	  
	  
Maine	  Integrated	  Youth	  Survey	  and	  the	  Youth	  Risk	  Behavior	  Survey	  	  
	  
For	  state-­‐specific	  prevalence	  estimates	  among	  youth,	  we	  used	  data	  from	  the	  Maine	  
Integrated	  Youth	  Health	  Survey	  (MIYHS).	  The	  development	  and	  implementation	  of	  
MIYHS	  is	  a	  collaborative	  effort	  between	  the	  Maine	  Department	  of	  Health	  and	  Human	  
Services	  (the	  Maine	  Center	  for	  Disease	  Control	  and	  Prevention	  and	  the	  Substance	  Abuse	  
and	  Mental	  Health	  Services	  Administration),	  and	  the	  Maine	  Department	  of	  Education.	  
Established	  in	  2009,	  MIYHS	  is	  a	  comprehensive	  survey	  of	  health	  topics	  and	  health-­‐
related	  behaviors	  administered	  biennially	  in	  odd-­‐numbered	  years.	  	  MIYHS	  is	  composed	  
of	  four	  surveys	  by	  grade	  category:	  1)	  Kindergarten	  and	  3rd	  grade,	  2)	  5th	  and	  6th	  grades,	  3)	  
7th	  and	  8th	  grade	  (middle	  school),	  and	  3)	  9th	  through	  12th	  grade	  (high	  school).	  	  Data	  from	  
Kindergarten	  through	  3rd	  grade	  students	  are	  collected	  from	  parental	  survey,	  whereas	  
data	  from	  5th	  through	  12th	  grade	  are	  self-­‐reported	  by	  the	  student.	  	  
	  
In	  this	  report,	  we	  only	  present	  MIYHS	  data	  from	  middle	  and	  high	  school	  students.	  	  All	  
eligible	  public	  middle	  and	  high	  schools	  in	  Maine	  are	  invited	  to	  participate	  in	  the	  survey.	  	  
About	  15,000	  middle	  school	  students	  and	  30,000	  high	  school	  students	  participate	  in	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MIYHS	  across	  Maine.	  Middle	  and	  high	  school	  surveys	  are	  comprised	  of	  four	  versions	  
(Version	  A,	  Version	  B,	  Version	  C,	  and	  Version	  D).	  Each	  school	  is	  randomly	  assigned	  either	  
version	  pair	  AB	  or	  version	  pair	  BC	  to	  ensure	  an	  equal	  distribution	  of	  survey	  versions	  
among	  middle	  and	  high	  schools	  within	  each	  county.	  Version	  C	  contains	  questions	  taken	  
the	  Maine	  Youth	  Risk	  Behavior	  Survey	  (YRBS).	  
	  
Similar	  to	  MIYHS,	  YRBS	  provides	  prevalence	  data	  on	  health-­‐related	  outcomes,	  behaviors	  
and	  attitudes	  among	  7th	  and	  8th	  grade	  and	  9th-­‐12th	  grade	  students.	  	  In	  2013,	  the	  YRBS	  
was	  implemented	  at	  the	  state-­‐level	  by	  42	  states,	  including	  Maine,	  and	  at	  the	  national	  
level.	  Although	  some	  MIYHS	  questions	  –	  including	  any	  current	  tobacco	  use,	  weight	  
status,	  and	  physical	  activity	  examined	  in	  this	  report	  -­‐	  are	  the	  same	  as	  YRBS	  questions,	  
due	  to	  differences	  in	  survey	  sampling	  methods,	  MIYHS	  and	  YRBS	  data	  may	  not	  be	  
directly	  comparable.	  	  However,	  when	  interpreted	  with	  caution,	  comparisons	  between	  
MIYHS	  and	  YRBS	  data	  can	  provide	  context	  for	  prevalence	  differences	  between	  Maine	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Technical	  Notes	  
A.	  	  Data Suppression for Confidentiality and Statistical Unreliability
Maine	  state	  legislature	  mandates	  that	  all	  cancer	  case	  data	  reported	  to	  the	  Maine	  CDC	  
Cancer	  Registry	  (MCR)	  remains	  confidential.	  The	  MCR	  manages	  and	  releases	  identifiable	  
data	  under	  the	  review	  and	  regulations	  of	  the	  Maine	  CDC	  (formerly	  known	  as	  the	  Bureau	  
of	  Health),	  as	  set	  forth	  by	  Maine	  Statute	  Title	  22:	  Health	  Warfare,	  Chapter	  255:	  Cancer,	  
§1406	  (Maine	  CDC	  Cancer	  Registry	  Data	  Review	  Committee).
In	  this	  report,	  we	  adhered	  to	  the	  Maine	  CDC	  Privacy	  Policy,	  which	  is	  used	  primarily	  in	  
sub-­‐state	  or	  small	  population	  analyses.	  	  This	  policy	  states	  if	  the	  numerator	  is	  5	  or	  fewer	  
or	  the	  denominator	  is	  less	  than	  5,000	  for	  a	  particular	  county	  or	  public	  health	  district,	  the	  
data	  must	  be	  suppressed.	  	  	  
For	  population	  data	  used	  to	  calculate	  incidence	  or	  mortality	  rates,	  we	  suppressed 
county-level	  and	  public	  health	  district-level	  data	  with	  non-zero counts	  of	  5	  or	  fewer	  	  
and	  denoted	  with	  ‘DSP’	  to	  protect	  privacy	  due	  to	  small	  numbers.	  Complementary	  
suppression	  is	  applied	  to	  prevent	  back-calculation	  of	  counts	  of	  5	  or	  fewer.	  
In	  other	  cases,	  suppression	  methods	  were	  used	  to	  flag	  data	  that	  were	  considered	  
statistically	  unreliable	  because	  of	  small	  numbers.	  We	  followed	  standard	  suppression	  
guidelines	  of	  the	  U.S.	  CDC,	  which	  included:	  
-­‐ Mortality	  rates	  with	  a	  numerator	  less	  than	  20	  are	  flagged	  with	  a	  dagger	  (†)	  and	  
the	  rate	  is	  considered	  statistically	  unreliable.	  
-­‐ Survey	  data	  from	  the	  Behavioral	  Risk	  Factor	  Surveillance	  System	  (BRFSS)	  with	  a	  
denominator	  less	  than	  50	  (total	  respondents)	  or	  with	  a	  95%	  confidence	  interval	  
(CI)	  half-width	  greater	  than	  10	  are	  presented	  as	  ‘DSU’	  because	  the	  data	  are	  
statistically	  unreliable.	  	  	  
-­‐ Survey	  data	  from	  BRFSS	  with	  a	  numerator	  (n)	  less	  than	  50	  are	  flagged	  with	  a	  
dagger	  (†)	  and	  those	  estimates	  are	  considered	  statistically	  unreliable,	  and	  these	  
data	  should	  be	  interpreted	  with	  caution.	  
B.	  	  Age	  Adjustment	  
Crude	  rates	  are	  a	  direct	  measure	  of	  a	  population’s	  disease	  burden.	  However,	  
comparisons	  of	  crude	  rates	  can	  be	  misleading	  if	  the	  age	  distribution	  of	  the	  population	  
varies	  over	  time	  or	  place.	  	  Age	  adjustment,	  also	  called	  age	  standardization,	  is	  a	  statistical	  
method	  used	  to	  allow	  comparisons	  between	  two	  or	  more	  populations	  in	  one	  point	  in	  
time	  or	  one	  population	  in	  two	  different	  periods	  of	  time.	  	  Age	  adjustment	  is	  particularly	  
important	  when	  comparing	  populations	  where	  the	  age	  structures	  of	  the	  populations	  are	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different.	  	  This	  type	  of	  adjustment	  accounts	  for	  differences	  in	  age	  distributions	  between	  
populations	  or	  within	  the	  same	  population	  over	  time,	  and	  allows	  rates	  to	  be	  more	  easily	  
compared	  across	  populations	  or	  time	  periods.	  	  
	  
In	  this	  report,	  age-­‐adjusted	  Maine-­‐specific	  incidence	  and	  mortality	  rates	  were	  calculated	  
with	  direct	  standardization	  using	  the	  U.S.	  population	  in	  the	  year	  2000	  as	  the	  standard	  
(2000	  U.S.	  standard	  population),	  which	  was	  adopted	  by	  the	  National	  Center	  for	  Health	  
Statistics	  (NCHS)	  as	  the	  standard	  for	  age-­‐adjusting	  incidence	  and	  mortality	  rates.	  	  For	  
additional	  information,	  please	  see	  the	  2001	  NCHS	  report	  Age	  Adjustment	  Using	  the	  
Projected	  2000	  U.S.	  Population	  at	  http://www.cdc.gov/nchs/data/statnt/statnt20.pdf.	  
	  
C.	  	  Combined-­‐Year	  Analysis	  
	  
Some	  types	  of	  cancer	  occur	  less	  commonly	  in	  a	  population	  and	  require	  that	  multiple	  
years	  of	  data	  are	  combined	  to	  obtain	  more	  stable	  rate	  estimates	  over	  time.	  In	  this	  
report,	  we	  combined	  three	  years	  of	  incidence	  data	  for	  bladder,	  oropharyngeal,	  and	  
cervical	  cancers,	  and	  melanoma,	  which	  are	  presented	  as	  rolling	  three-­‐year	  averages.	  	  
	  
As	  an	  example	  of	  how	  rolling	  three-­‐year	  averages	  were	  calculated,	  we	  summed	  the	  
numerators	  (incident	  cancers)	  and	  population	  denominators	  for	  2000,	  2001,	  and	  2002	  
for	  an	  average	  2000-­‐2002	  rate.	  Consecutive	  year-­‐groups,	  such	  as	  2000-­‐2002	  to	  2001-­‐
2003,	  will	  share	  two	  years	  of	  data,	  with	  only	  one	  year	  of	  new	  data,	  thus	  minimizing	  the	  
size	  of	  changes	  from	  year	  to	  year.	  This	  process	  increases	  the	  stability	  of	  rate	  estimates	  
by	  pooling	  years	  of	  data,	  but	  can	  dampen	  apparent	  time	  trends	  by	  smoothing	  changes	  
over	  time.	  	  Despite	  this	  limitation,	  the	  alternative	  of	  presenting	  single	  year	  estimates	  
would	  be	  more	  hindered	  by	  random	  variability,	  which	  makes	  it	  difficult	  to	  interpret	  
estimates	  over	  time.	  
	  
D.	  	  Surveillance,	  Epidemiology,	  and	  End	  Results	  Data	  
	  
The	  Surveillance,	  Epidemiology,	  and	  End	  Results	  (SEER)	  Program	  of	  the	  National	  Cancer	  
Institute	  (NCI)	  is	  a	  collection	  of	  central	  cancer	  registries	  in	  the	  United	  States	  that	  collect	  
and	  submit	  cancer	  incidence,	  prevalence,	  mortality,	  survival,	  and	  stage	  at	  diagnosis	  data	  
to	  the	  NCI.	  SEER	  incidence	  data	  are	  used	  to	  represent	  national	  cancer	  incidence	  data	  
because	  a	  true	  nationwide	  cancer	  registry	  does	  not	  exist.	  	  
	  
SEER	  currently	  has	  five	  combinations	  of	  population-­‐based	  national	  samples	  that	  are	  
used	  for	  a	  variety	  of	  statistical	  analysis:	  
	  
1. SEER	  9	  registries	  consist	  of	  Atlanta,	  Connecticut,	  Detroit,	  Hawaii,	  Iowa,	  New	  
Mexico,	  San	  Francisco-­‐Oakland,	  Seattle-­‐Puget	  Sound,	  and	  Utah.	  Data	  are	  
available	  for	  cases	  diagnosed	  from	  1973-­‐2010.	  
2. SEER	  11	  registries	  consist	  of	  SEER	  9	  plus	  Los	  Angeles	  and	  San	  Jose-­‐Monterey.	  
Data	  are	  available	  for	  cases	  diagnosed	  from	  1992	  onwards.	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3. SEER	  13	  consists	  of	  SEER	  11	  plus	  Rural	  Georgia	  and	  the	  Alaska	  Native	  Tumor	  	  
Registry.	  Data	  are	  available	  for	  cases	  diagnosed	  from	  1992	  onwards.	  
4. SEER	  17	  registries	  consist	  of	  the	  SEER	  13,	  plus	  Greater	  California,	  Kentucky,	  
Louisiana,	  and	  New	  Jersey.	  Data	  are	  available	  from	  all	  cases	  diagnosed	  from	  
2000	  onwards.	  Louisiana	  cases	  diagnosed	  from	  July	  -­‐	  December	  2005	  were	  
excluded	  from	  most	  analyses.	  
5. SEER	  18	  registries	  consist	  of	  the	  SEER	  17,	  as	  described	  above,	  plus	  Greater	  
Georgia.	  Data	  are	  available	  from	  all	  cases	  diagnosed	  from	  2000	  and	  later	  for	  
these	  registries,	  with	  the	  exception	  of	  adjustments	  for	  the	  areas	  impacted	  by	  
Hurricanes	  Katrina	  and	  Rita.	  
	  
SEER	  9,	  SEER	  11,	  SEER	  13,	  SEER	  17,	  and	  SEER	  18	  represent	  different	  proportions	  of	  the	  
U.S.	  population.	  In	  this	  report,	  national	  incidence	  and	  staging	  data	  are	  from	  SEER	  9,	  
respectively,	  which	  represent	  9.4%	  of	  the	  U.S.	  population.	  	  For	  more	  information,	  please	  
see	  NCI’s	  About	  SEER	  Registries	  website	  at	  http://seer.cancer.gov/registries/.	  
	  
SEER*Stat,	  a	  software	  that	  was	  developed	  by	  the	  NCI	  for	  the	  analysis	  of	  SEER	  cancer	  
data,	  was	  used	  to	  calculate	  incidence	  and	  mortality	  rates,	  and	  their	  confidence	  intervals.	  
The	  software	  is	  open	  source	  and	  can	  be	  downloaded	  (http://seer.cancer.gov/seerstat/).	  	  
In	  this	  report,	  we	  used	  the	  most	  current	  software	  version	  available	  (SEER*Stat	  Version	  
8.1.5)	  for	  data	  analysis.	  	  Rates	  obtained	  from	  SEER*Stat	  are	  based	  on	  denominators	  
from	  the	  U.S.	  Census	  Bureau.	  	  	  
	  
E.	  	  Stage	  at	  Diagnosis	  
	  
Stage	  at	  diagnosis	  is	  a	  measure	  of	  disease	  progression,	  detailing	  the	  degree	  to	  which	  a	  
cancer	  has	  advanced.	  Historically,	  three	  methods	  have	  been	  used	  to	  determine	  cancer	  
stage:	  TNM	  staging	  is	  primarily	  used	  for	  clinical	  evaluation	  and	  treatment;	  SEER	  Extent	  
of	  Degree	  staging	  is	  useful	  for	  clinical	  and	  epidemiologic	  research;	  and	  the	  SEER	  
Summary	  Stage	  is	  a	  broad	  staging	  system	  that	  is	  commonly	  used	  by	  epidemiologists	  to	  
measure	  the	  success	  of	  cancer	  control	  and	  prevention	  in	  populations.	  
	  
In	  this	  report,	  we	  used	  the	  SEER	  Collaborative	  Staging	  system,	  a	  comprehensive	  dataset	  
that	  unifies	  elements	  of	  each	  of	  the	  three	  staging	  methods	  to	  standardize	  rules	  for	  
assigning	  stage	  at	  diagnosis.	  More	  information	  about	  Collaborative	  Staging	  can	  be	  found	  
at	  the	  SEER’s	  Collaborative	  Stage	  website	  (http://seer.cancer.gov/tools/collabstaging/).	  
	  
SEER	  Collaborative	  Staging	  has	  five	  main	  categories:	  
	  
1. In	  situ	  cancer	  is	  early	  cancer	  that	  is	  present	  only	  in	  the	  layer	  of	  cells	  in	  which	  it	  
began.	  
2. Localized	  cancer	  is	  cancer	  that	  is	  limited	  to	  the	  organ	  in	  which	  it	  began,	  without	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3. Regional	  cancer	  is	  cancer	  that	  has	  spread	  beyond	  the	  original	  (primary)	  site	  to	  
nearby	  lymph	  nodes	  or	  organs	  and	  tissues.	  
4. Distant	  cancer	  is	  cancer	  that	  has	  spread	  from	  the	  primary	  site	  to	  distant	  organs	  
or	  distant	  lymph	  nodes.	  
5. Unknown	  cancer	  is	  cancer	  for	  which	  there	  is	  not	  enough	  information	  to	  indicate	  
a	  stage.	  
	  
For	  simplicity,	  we	  used	  three	  categories	  to	  examine	  stage	  at	  diagnosis	  in	  this	  report:	  	  1)	  
‘Early-­‐stage	  cancer’	  which	  includes	  in	  situ	  and	  localized	  cancer,	  2)	  ‘Late-­‐stage	  cancer’	  
which	  includes	  regional	  and	  distant	  cancer,	  and	  3)	  Unknown	  or	  unstaged	  cancers.	  
	  
F.	  	  Statistical	  Significance	  
	  
Statistical	  significance	  is	  a	  mathematical	  measure	  of	  difference	  between	  two	  or	  more	  
groups.	  In	  this	  report,	  rates	  or	  prevalence	  estimates	  are	  said	  to	  be	  statistically	  significant	  
if	  the	  95%	  confidence	  intervals	  for	  the	  estimates	  being	  compared	  do	  not	  overlap,	  thus	  
are	  not	  due	  to	  random	  chance.	  See	  hypothetical	  example	  below	  (all	  rates	  expressed	  per	  
100,000):	  
	  
• The	  lung	  cancer	  rate	  for	  males	  is	  120.0	  with	  a	  lower	  95%	  CI	  of	  115.0	  and	  an	  
upper	  95%	  CI	  of	  125.0.	  
• The	  lung	  cancer	  rate	  for	  females	  is	  105.0	  with	  a	  lower	  95%	  CI	  of	  100.0	  and	  an	  
upper	  95%	  CI	  of	  110.0.	  
• Because	  the	  two	  sets	  of	  confidence	  intervals—(115.0-­‐125.0)	  for	  males	  and	  
(100.0-­‐110.0)	  for	  females—do	  not	  overlap,	  we	  state	  that	  the	  lung	  cancer	  rate	  for	  
males	  is	  statistically	  significantly	  higher	  than	  the	  rate	  for	  females.	  
	  
G.	  	  U.S.	  Comparisons	  
	  
In	  this	  report,	  we	  present	  data	  on	  two	  U.S.	  comparison	  populations:	  the	  total	  U.S.	  
population	  and	  the	  U.S.	  white-­‐only	  population	  (U.S.	  whites).	  Depending	  on	  the	  cancer,	  
incidence	  and	  mortality	  may	  vary	  across	  racial	  and	  ethnic	  groups.	  Maine’s	  population	  is	  
predominantly	  non-­‐Hispanic	  white	  (about	  96%),	  and	  a	  U.S.	  white-­‐only	  population	  may	  
adjust	  for	  differences	  between	  Maine	  and	  the	  U.S.	  in	  terms	  of	  differences	  in	  race	  and	  
ethnicity.	  	  
	  
However,	  there	  are	  several	  reasons	  to	  present	  the	  total	  U.S.	  population	  as	  well.	  From	  a	  
methodological	  perspective,	  the	  white-­‐only	  analysis	  is	  not	  an	  appropriate	  comparison	  
since	  the	  U.S.	  population	  is	  completely	  restricted	  with	  respect	  to	  race	  and/or	  ethnicity.	  	  
Further,	  Maine’s	  population	  is	  becoming	  more	  diverse,	  and	  it	  will	  be	  increasingly	  
problematic	  to	  justify	  comparing	  Maine’s	  total	  population	  to	  the	  U.S.	  white	  population.	  
	  
In	  addition,	  such	  a	  comparison	  controls	  for	  an	  unnatural	  cause	  of	  disease,	  unlike	  
controlling	  for	  age.	  Although	  there	  are	  genetic	  differences	  among	  race	  and	  ethnic	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groups	  that	  may	  impact	  disease	  development,	  genetic	  differences	  among	  race	  and	  
ethnic	  groups	  are	  minimal	  in	  comparison	  to	  causes	  of	  varying	  socioeconomic	  status	  (i.e.,	  
employment	  status,	  household	  income),	  discriminatory	  practices,	  and	  disparities	  in	  
access	  to	  health	  education	  or	  health	  services	  –	  all	  of	  which	  can	  be	  addressed	  through	  
public	  health	  programming	  and	  policy.	  We	  do	  not	  similarly	  attempt	  to	  control	  for	  
differences	  between	  Maine	  and	  the	  U.S.	  by	  socioeconomic	  status.	  Ideally,	  with	  the	  
increasing	  diversity	  of	  Maine’s	  population,	  we	  will	  be	  able	  to	  present	  stratum-­‐specific	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Glossary	  of	  Terms	  
Age-­‐adjusted	  rate:	  A	  rate	  that	  has	  been	  statistically	  adjusted	  for	  differences	  in	  the	  age	  
distribution	  between	  populations	  or	  within	  the	  same	  population	  over	  time.	  Rates	  are	  
age-­‐adjusted	  to	  allow	  rate	  comparisons	  across	  populations	  or	  time	  periods.	  Age-­‐
adjusted	  rates	  can	  be	  interpreted	  as	  the	  disease	  experience	  each	  population	  would	  have	  
been	  expected	  to	  experience	  if	  they	  had	  the	  same	  age	  distribution.	  See	  Appendix	  IV	  for	  
more	  information	  on	  age	  adjustment.	  	  
Age-­‐specific	  rate:	  The	  rate	  for	  a	  specific	  age	  group;	  also	  called	  an	  age-­‐specific	  “crude	  
rate”	  (see	  “crude	  rate”	  below).	  
Average	  annual	  decline:	  A	  summary	  measure	  of	  the	  average	  percent	  change	  (or	  percent	  
decrease)	  in	  cancer	  rates	  from	  year	  to	  year	  when	  analyzing	  trends	  in	  data.	  	  This	  measure	  
is	  calculated	  by	  subtracting	  a	  year’s	  rate	  (Y1)	  from	  the	  rate	  of	  the	  previous	  year	  (Y2),	  
dividing	  by	  the	  year’s	  rate	  (Y1),	  taking	  an	  average	  of	  the	  percent	  change,	  and	  multiplying	  
by	  100.	  	  Calculating	  the	  average	  annual	  decline	  provides	  a	  more	  accurate	  assessment	  of	  
change	  in	  annual	  rates	  than	  the	  overall	  annual	  decline	  because	  it	  accounts	  for	  large	  and	  
small	  changes	  in	  rates	  that	  might	  occur	  from	  year	  to	  year	  instead	  of	  assuming	  that	  rates	  
change	  at	  a	  constant	  percentage	  each	  year.	  	  
Cancer:	  A	  group	  of	  diseases	  characterized	  by	  rapid,	  uncontrolled	  cell	  growth,	  with	  a	  
tendency	  to	  spread	  throughout	  the	  body.	  	  
Cancer	  incidence:	  The	  number	  of	  people	  who	  develop	  cancer	  during	  a	  specified	  period	  
of	  time	  in	  a	  specified	  population.	  In	  this	  report,	  cancer	  incidence	  is	  measured	  as	  cancer	  
that	  is	  diagnosed	  and	  reported	  to	  the	  Maine	  CDC	  Cancer	  Registry.	  Thus,	  our	  estimates	  of	  
cancer	  incidence	  are	  a	  function	  of	  true	  disease	  development,	  disease	  detection,	  and	  
disease	  reporting.	  Changes	  in	  cancer	  detection	  or	  reporting	  will	  result	  in	  changes	  in	  our	  
estimate	  of	  cancer	  incidence,	  even	  though	  cancer	  development	  might	  not	  be	  changing	  
in	  the	  population.	  	  
Cancer	  mortality:	  The	  number	  of	  people	  who	  die	  from	  cancer	  during	  a	  specified	  period	  
of	  time	  in	  a	  specified	  population.	  	  
Confidence	  interval:	  Confidence	  intervals	  quantify	  the	  degree	  of	  uncertainty	  in	  rate	  or	  
prevalence	  estimates	  that	  result	  from	  sampling	  or	  random	  variability.	  Like	  the	  margin	  of	  
error	  presented	  in	  political	  polls,	  the	  confidence	  interval	  presents	  a	  range	  of	  values	  
within	  which	  the	  true	  underlying	  rate	  or	  prevalence	  is	  likely	  to	  lie.	  The	  95%	  confidence	  
interval	  is	  most	  commonly	  used,	  and	  is	  presented	  in	  this	  report.	  In	  this	  report,	  we	  base	  
our	  determination	  of	  statistical	  significance	  on	  whether	  the	  confidence	  intervals	  of	  
compared	  estimates	  overlap.	  Non-­‐overlapping	  confidence	  intervals	  are	  considered	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Crude	  rate:	  A	  ratio	  of	  the	  number	  of	  people	  who	  have	  experienced	  the	  event	  of	  interest	  
in	  a	  specified	  time	  period	  over	  the	  size	  of	  the	  population	  who	  were	  eligible	  to	  
experience	  the	  event	  of	  interest	  during	  the	  same	  time	  period.	  Crude	  rates	  are	  
unadjusted	  for	  age	  and	  can	  be	  called	  an	  “unadjusted	  rate”.	  	  
Death	  rate:	  The	  number	  of	  deaths	  from	  cancer	  during	  a	  specific	  period	  of	  time	  divided	  
by	  the	  size	  of	  the	  population	  during	  that	  period	  of	  time.	  The	  result	  is	  often	  multiplied	  by	  
a	  constant,	  such	  as	  100,000,	  to	  represent	  the	  number	  of	  cancer	  deaths	  per	  100,000	  
people.	  	  
Early-­‐stage	  cancer:	  	  A	  stage	  of	  cancer	  diagnosis	  when	  a	  cancer	  or	  tumor	  is	  only	  present	  
in	  the	  layer	  of	  cells	  in	  which	  it	  originate,	  has	  not	  grown	  deeply	  into	  nearby	  tissues,	  and	  
has	  not	  spread	  to	  the	  lymph	  nodes	  or	  other	  parts	  of	  the	  body.	  	  This	  cancer	  is	  also	  
referred	  to	  as	  localized	  or	  in	  situ	  (see	  “in	  situ	  cancer”	  below).	  
Family	  history:	  The	  occurrence	  of	  cancer	  in	  a	  close	  blood	  relative,	  such	  as	  a	  parent	  or	  
sibling	  that	  may	  increase	  one’s	  risk	  of	  developing	  cancer.	  	  
ICD-­‐9-­‐CM:	  The	  International	  Classification	  of	  Diseases,	  Ninth	  Revision,	  Clinical	  
Modification,	  the	  official	  system	  of	  assigning	  codes	  to	  diagnoses	  and	  procedures	  
associated	  with	  medical	  care	  utilization	  in	  the	  United	  States.	  	  
ICD-­‐10:	  The	  tenth	  revisions	  of	  the	  International	  Classification	  of	  Diseases,	  the	  
classification	  system	  used	  to	  code	  and	  classify	  causes	  of	  death.	  ICD-­‐10	  has	  been	  in	  use	  in	  
the	  U.S.	  since	  1999.	  	  
ICD-­‐O-­‐3:	  The	  International	  Classification	  of	  Diseases	  for	  Oncology,	  Third	  Revision,	  the	  
standard	  reference	  for	  coding	  and	  classifying	  anatomic	  site	  and	  histologic	  type	  of	  cancer	  
cases.	  	  
Incidence	  rate:	  The	  rate	  of	  new	  cancer	  cases	  developing	  in	  the	  population	  during	  a	  
specific	  time.	  Incidence	  rates	  are	  calculated	  by	  dividing	  the	  number	  of	  new	  cases	  by	  the	  
size	  of	  the	  population	  at	  risk	  of	  becoming	  a	  case	  during	  that	  period	  of	  time.	  The	  result	  is	  
often	  multiplied	  by	  a	  constant,	  such	  as	  100,000,	  to	  represent	  the	  number	  of	  new	  cancer	  
cases	  per	  100,000	  people.	  	  
In	  situ	  cancer:	  An	  early	  stage	  of	  cancer	  that	  is	  present	  only	  in	  the	  layer	  of	  cells	  in	  which	  
it	  began.	  	  
Invasive	  cancer:	  Cancer	  that	  has	  spread	  beyond	  the	  layer	  of	  tissue	  in	  which	  it	  developed	  
and	  is	  growing	  into	  surrounding,	  healthy	  tissues.	  	  
Late-­‐stage	  cancer:	  	  A	  stage	  of	  cancer	  diagnosis	  when	  a	  cancer	  or	  tumor	  that	  are	  large	  in	  
size,	  have	  grown	  more	  deeply	  into	  nearby	  tissue,	  and	  have	  spread	  to	  lymph	  nodes,	  and	  
Page 319
	  	  
Appendix	  V:	  Glossary	  of	  Terms	  
Maine	  Cancer	  Surveillance	  Report	  2014	  
possibly	  have	  spread	  to	  other	  organs	  or	  parts	  of	  the	  body.	  	  It	  may	  also	  be	  called	  
advanced	  or	  metastatic	  cancer.	  
Metastasis:	  The	  spread	  of	  cancer	  (or	  cancer	  cells)	  from	  the	  organ	  where	  it	  started	  (the	  
primary	  site)	  to	  another	  organ	  or	  parts	  of	  the	  body.	  
Prevalence:	  The	  proportion	  or	  percentage	  of	  a	  defined	  population	  with	  a	  specific	  
condition,	  risk	  factor,	  or	  disease	  at	  a	  specified	  point	  in	  time.	  The	  numerator	  of	  the	  
proportion	  includes	  all	  those	  who	  have	  the	  condition,	  risk	  factor,	  or	  disease,	  regardless	  
of	  when	  it	  was	  diagnosed;	  the	  denominator	  includes	  all	  individuals	  at	  that	  point	  in	  time	  
in	  the	  population.	  	  
Prognosis:	  	  A	  forecast	  about	  the	  likely	  course	  of	  a	  disease	  or	  prospect	  of	  disease	  
recovery.	  
Screening:	  Screening	  is	  used	  to	  detect	  cancer	  (or	  conditions	  that	  cause	  cancer)	  in	  a	  
person	  before	  symptoms	  appear	  to	  increase	  the	  changes	  of	  cancer	  detection	  in	  situ	  or	  
at	  an	  early	  stage.	  
SEER	  (Surveillance,	  Epidemiology,	  and	  End	  Results):	  The	  Surveillance,	  Epidemiology,	  
and	  End	  Results	  (SEER)	  Program	  of	  the	  National	  Cancer	  Institute	  (NCI)	  is	  a	  collection	  of	  
central	  cancer	  registries	  in	  the	  United	  States	  that	  collect	  and	  submit	  cancer	  incidence,	  
prevalence,	  mortality,	  survival,	  stage	  at	  diagnosis	  data,	  and	  other	  statistics	  to	  the	  NCI.	  
SEER	  currently	  has	  four	  combinations	  of	  population-­‐based	  national	  samples	  that	  are	  
used	  for	  a	  variety	  of	  statistical	  analysis:	  SEER	  9,	  SEER	  11,	  SEER	  13,	  and	  SEER	  17.	  See	  
Appendix	  IV	  for	  more	  information.	  	  
Site:	  The	  anatomical	  site	  (organ	  or	  organ	  system)	  in	  which	  the	  cancer	  started,	  for	  
example,	  the	  lungs,	  colon,	  or	  bone	  marrow.	  	  
Stage	  at	  diagnosis:	  Stage	  of	  diagnosis	  describes	  the	  degree	  to	  which	  cancer	  has	  
progressed	  or	  advanced	  by	  the	  time	  it	  is	  diagnosed.	  See	  Appendix	  IV	  for	  further	  details.	  	  
Standard	  population:	  A	  population	  whose	  known	  age	  distribution	  is	  used	  to	  create	  
comparable	  statistics	  (e.g.,	  rates)	  for	  populations	  with	  different	  age	  distributions.	  In	  this	  
report,	  the	  standard	  population	  used	  to	  produce	  age-­‐adjusted	  rates	  was	  the	  total	  U.S.	  
population	  as	  measured	  by	  the	  year	  2000	  Census.	  	  
Statistically	  significant:	  Statistical	  significance	  is	  a	  mathematical	  determination	  of	  
differences	  between	  rates	  or	  prevalence	  estimates.	  In	  this	  report,	  rates	  or	  prevalence	  
estimates	  are	  said	  to	  be	  statistically	  significant	  if	  there	  is	  no	  overlap	  between	  the	  95%	  
confidence	  intervals	  for	  the	  groups	  being	  compared.	  In	  this	  report,	  the	  word	  
“significant”	  when	  describing	  differences	  implies	  statistical	  significance.	  There	  are	  
limitations	  to	  relying	  on	  statistical	  significance	  alone	  to	  determine	  differences.	  Statistical	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significance	  is	  sensitive	  to	  sample	  sizes;	  large	  samples	  are	  more	  likely	  to	  produce	  
statistically	  significant	  differences.	  Statistical	  significance	  is	  not	  necessarily	  a	  measure	  of	  
practical	  or	  clinical	  significance,	  and	  important	  differences	  in	  the	  population	  can	  exist	  
without	  statistical	  measures	  of	  significance.	  	  See	  Appendix	  IV	  for	  more	  information.	  	  
Surveillance:	  Public	  health	  surveillance	  is	  the	  ongoing,	  systematic	  collection,	  analysis,	  
interpretation,	  and	  dissemination	  of	  health	  data	  for	  public	  health	  program	  planning,	  
implementation,	  and	  evaluation.	  
Surveillance	  data:	  Data	  that	  are	  used	  to	  monitor	  health	  status	  in	  a	  population.	  
Surveillance	  data	  are	  systematically	  collected	  over	  time	  to	  detect	  changes.	  In	  this	  report,	  
surveillance	  data	  come	  from	  the	  Behavioral	  Risk	  Factor	  Surveillance	  System,	  the	  Maine	  
Integrated	  Youth	  Health	  Survey,	  Maine	  Cancer	  Registry,	  SEER	  Program,	  and	  National	  
Vital	  Statistics	  System	  (death	  certificates).	  These	  data	  sources	  enable	  the	  calculation	  of	  
statistics	  on	  the	  prevalence	  of	  risk	  behaviors,	  including	  risk	  factors	  for	  cancer	  and	  cancer	  
screening	  tests,	  cancer	  incidence	  and	  the	  stage	  at	  which	  cancers	  in	  Maine	  were	  
detected,	  and	  cancer	  mortality.	  	  
Trend:	  In	  this	  report,	  trend	  refers	  to	  a	  significant	  increase	  or	  decrease	  in	  cancer	  
incidence	  or	  mortality	  rates	  over	  time.	  	  
Tobacco-­‐related	  cancer:	  Cancers	  that	  have	  a	  direct	  causal	  link	  to	  tobacco	  use	  according	  
to	  the	  U.S.	  Surgeon	  General.	  Tobacco-­‐related	  cancer	  includes	  cancers	  of	  the	  lung,	  
larynx,	  oral	  cavity	  and	  pharynx,	  esophageal,	  stomach,	  pancreatic,	  kidney	  and	  renal	  
pelvis,	  urinary	  bladder,	  and	  cervical	  cancers,	  and	  acute	  myeloid	  leukemia.	  In	  this	  report,	  
tobacco-­‐related	  cancers	  excluding	  lung	  cancer	  are	  reported.	  	  See	  ‘Incidence	  Case	  
Definitions’	  for	  more	  information.	  
Unadjusted	  rate:	  See	  “crude	  rate”	  above.	  	  
Years	  of	  Potential	  Life	  Lost	  (YPLL):	  	  A	  measure	  of	  the	  premature	  mortality.	  	  This	  report	  
contains	  data	  on	  the	  YPLL	  before	  age	  75	  and	  is	  calculated	  by	  summing	  the	  total	  number	  
of	  years	  not	  lived	  by	  people	  who	  died	  before	  age	  75.	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